data_2m71_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m71 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 CA--C 1.51 -0.589 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.436 HG12 ' HB2' ' A' ' 38' ' ' HIS . 77.5 mt -119.44 132.16 70.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-O 120.845 0.355 . . . . 0.0 111.272 -175.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 74.2 mmtt -97.45 130.59 44.54 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.404 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 43.2 mt-10 -107.83 97.65 7.34 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.8 mt -88.74 125.09 41.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.639 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -96.98 145.87 25.52 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.197 -176.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.5 mp -135.69 176.89 8.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.279 173.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.441 ' HA ' HG23 ' A' ' 43' ' ' VAL . 16.2 p -139.1 156.22 47.32 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.85 -42.94 94.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.238 0.542 . . . . 0.0 109.995 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -95.33 76.46 3.4 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.495 HD13 ' OD2' ' A' ' 21' ' ' ASP . 19.3 tt -125.38 148.5 29.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.114 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.6 142.09 44.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.161 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -64.52 -33.73 76.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.955 0.407 . . . . 0.0 110.976 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.49 -40.71 92.35 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.526 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.495 ' OD2' HD13 ' A' ' 17' ' ' ILE . 23.2 t70 -66.6 -39.08 88.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.574 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.3 mt -62.92 -45.66 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.167 0.508 . . . . 0.0 110.271 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -61.1 -42.51 98.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.494 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -63.14 -44.32 95.89 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.954 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -64.93 -41.64 95.36 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 m -63.8 -28.83 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.508 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -60.06 -49.8 76.21 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 120.99 0.424 . . . . 0.0 110.49 176.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -68.3 -36.75 79.81 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.312 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.576 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -56.41 -45.62 80.56 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.025 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.635 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 88.9 mt -62.67 -42.83 99.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.073 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.01 -39.95 95.25 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.67 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -68.39 -34.43 76.02 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.931 0.396 . . . . 0.0 111.125 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 95.0 mt -63.6 -39.85 95.43 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.635 ' HG3' ' O ' ' A' ' 30' ' ' LEU . 63.3 mt-10 -61.02 -22.71 64.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.546 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -85.13 -6.35 59.3 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.59 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.05 19.61 55.29 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.706 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -105.81 172.41 6.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.173 0.511 . . . . 0.0 111.2 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.436 ' HB2' HG12 ' A' ' 8' ' ' ILE . 12.3 m80 -104.82 145.57 30.2 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.02 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.526 ' O ' HD12 ' A' ' 87' ' ' LEU . 41.5 t -118.33 125.71 74.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.404 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 71.2 ttt180 -102.74 115.19 30.1 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -90.2 116.64 28.35 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -122.45 132.99 54.61 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.575 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 4.9 p -128.26 131.29 69.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 121.061 0.458 . . . . 0.0 110.31 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.45 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 88.0 t80 -104.58 129.14 52.71 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.484 ' CD1' ' HA ' ' A' ' 50' ' ' MET . 30.0 mt -73.49 128.02 34.34 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -60.5 -46.2 90.99 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -171.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.63 -61.55 0.15 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.163 -1.018 . . . . 0.0 112.671 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.407 ' HD2' ' N ' ' A' ' 48' ' ' ARG . 6.6 mpt_? -67.05 -37.32 83.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.141 0.496 . . . . 0.0 111.512 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.426 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 1.1 pm0 -80.45 -3.95 51.83 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.952 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.484 ' HA ' ' CD1' ' A' ' 45' ' ' LEU . 56.3 ttm -63.21 -19.68 64.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.871 0.367 . . . . 0.0 111.351 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.51 -11.1 59.82 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.251 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.0 m -131.19 100.06 17.25 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 121.153 0.501 . . . . 0.0 111.449 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.34 -25.71 71.42 Favored 'Trans proline' 0 N--CA 1.477 0.504 0 C-N-CA 123.505 2.803 . . . . 0.0 112.511 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -63.07 -25.5 68.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.523 -177.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.3 -44.96 94.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.881 0.372 . . . . 0.0 110.32 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.1 -38.38 92.29 Favored Glycine 0 CA--C 1.506 -0.474 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.614 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.451 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 99.1 t -62.74 -47.3 93.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.516 -0.342 . . . . 0.0 110.831 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.09 -37.79 88.62 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.042 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.9 tp -62.57 -47.58 83.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.071 0.463 . . . . 0.0 110.239 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.421 HD12 HG13 ' A' ' 84' ' ' VAL . 62.1 mt -66.15 -39.6 89.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.666 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 57' ' ' VAL . 71.1 mt-10 -60.58 -36.66 79.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.684 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -63.84 -39.91 95.35 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.9 mt -61.7 -47.73 91.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.789 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.463 ' CZ2' ' HB2' ' A' ' 73' ' ' ARG . 40.3 t-105 -58.04 -40.64 81.4 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.414 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.425 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 19.0 m -61.28 -39.76 91.61 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.082 0.467 . . . . 0.0 110.728 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 97.3 mmm -66.78 -41.98 86.79 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.4 pt -105.06 -0.26 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -173.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 65' ' ' THR . 0.1 OUTLIER -56.31 -18.68 11.44 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.675 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -65.71 -36.55 83.93 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.492 ' HB2' HD22 ' A' ' 30' ' ' LEU . 47.8 mt-10 -122.75 6.09 9.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.801 0.334 . . . . 0.0 111.598 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -121.18 152.47 38.75 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.959 0.409 . . . . 0.0 111.752 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -112.23 148.37 34.25 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.477 ' NH2' ' HG2' ' A' ' 76' ' ' GLU . 74.9 ttt180 -90.94 111.12 22.42 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 120.763 0.316 . . . . 0.0 111.102 -176.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -72.71 -38.73 67.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.8 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -163.28 -177.8 5.56 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.902 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.477 ' HG2' ' NH2' ' A' ' 73' ' ' ARG . 42.4 mt-10 -91.92 150.62 40.97 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.971 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.425 ' HG2' HG11 ' A' ' 57' ' ' VAL . 34.7 Cg_endo -68.99 132.26 24.17 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.106 1.871 . . . . 0.0 110.541 174.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 62.7 t30 -147.63 151.49 36.3 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.82 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.511 ' CE1' ' HA ' ' A' ' 82' ' ' ARG . 91.1 t80 -86.87 115.48 24.31 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.744 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.97 109.74 3.65 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.181 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.54 31.57 21.38 Favored Glycine 0 C--O 1.223 -0.559 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.327 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.511 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . 96.4 mtt180 69.25 3.49 4.14 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.749 0.82 . . . . 0.0 112.15 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.45 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 89.7 m-85 -121.12 137.58 54.59 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.427 174.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.575 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 74.2 t -99.86 124.09 53.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -130.84 142.76 50.4 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -175.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.456 ' SD ' HG13 ' A' ' 88' ' ' VAL . 16.4 tmm? -135.1 143.21 46.49 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.167 176.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.526 HD12 ' O ' ' A' ' 39' ' ' VAL . 47.9 tp -122.57 140.5 52.72 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.104 0.478 . . . . 0.0 111.438 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.456 HG13 ' SD ' ' A' ' 86' ' ' MET . 17.8 m -122.85 133.63 68.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.701 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.434 HG22 ' CE1' ' A' ' 38' ' ' HIS . 18.1 m -98.74 136.88 20.56 Favored Pre-proline 0 C--N 1.312 -1.022 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.75 144.8 84.97 Favored 'Trans proline' 0 C--N 1.326 -0.64 0 C-N-CA 122.336 2.024 . . . . 0.0 111.088 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt . . . . . 0 C--N 1.319 -0.756 0 CA-C-O 121.483 0.659 . . . . 0.0 111.441 -176.443 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.513 ' HB2' ' HZ2' ' A' ' 37' ' ' LYS . 16.2 m-20 . . . . . 0 CA--C 1.5 -0.949 0 CA-C-O 121.195 0.521 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.443 HG12 ' HB2' ' A' ' 38' ' ' HIS . 79.8 mt -109.13 116.05 51.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 7' ' ' ASP . 3.5 mptp? -83.87 134.73 34.68 Favored 'General case' 0 CA--C 1.488 -1.427 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.675 -175.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -102.57 112.02 24.59 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.594 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.7 mt -104.11 115.09 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.099 177.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 86.5 tttt -96.58 141.28 30.03 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.991 -175.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 5.5 mp -135.52 171.21 14.78 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.868 175.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.8 m -132.5 154.18 50.19 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.614 ' HB ' ' OE1' ' A' ' 49' ' ' GLU . 86.0 t -63.53 -33.53 62.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.338 0.59 . . . . 0.0 109.777 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.497 ' HG3' ' OE2' ' A' ' 49' ' ' GLU . 65.2 mttp -97.38 76.65 2.59 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.0 tt -134.55 154.0 36.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.751 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.74 143.74 49.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.186 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -64.46 -30.2 71.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.215 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -63.28 -39.05 93.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.644 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.9 -43.08 99.58 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.089 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.1 mt -62.16 -44.83 99.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.774 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -62.12 -43.67 98.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.239 0.542 . . . . 0.0 111.625 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -64.58 -43.27 94.4 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.496 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -65.24 -42.18 93.63 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.411 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 12.9 m -63.22 -33.17 59.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.004 178.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -62.52 -41.47 98.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.454 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -67.42 -42.49 83.12 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.599 177.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.518 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -60.01 -38.84 83.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.124 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 26' ' ' VAL . 97.4 mt -62.02 -41.77 98.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.026 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.611 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 67.0 mm-40 -65.3 -43.04 92.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.549 0.214 . . . . 0.0 110.714 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -64.02 -38.04 89.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.521 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 96.7 mt -62.18 -43.57 98.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.452 0.644 . . . . 0.0 109.435 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -61.64 -22.81 65.59 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.257 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.611 ' HG2' ' O ' ' A' ' 31' ' ' GLU . 76.5 mm-40 -85.13 -8.5 58.6 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.934 0.397 . . . . 0.0 110.528 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.42 13.72 56.74 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.024 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.513 ' HZ2' ' HB2' ' A' ' 7' ' ' ASP . 75.7 mmtt -96.29 159.74 14.79 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.485 ' NE2' HG22 ' A' ' 89' ' ' THR . 23.6 m170 -107.85 147.29 31.13 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.464 ' O ' HD12 ' A' ' 87' ' ' LEU . 41.5 t -114.29 126.43 71.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -102.78 115.87 31.45 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -92.61 120.11 32.72 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 78.1 mtp180 -126.71 133.77 50.83 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.587 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.2 p -121.37 131.6 72.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 121.359 0.599 . . . . 0.0 111.217 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -101.26 124.37 46.84 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.849 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 49' ' ' GLU . 42.1 mt -76.24 133.61 40.06 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -112.31 116.81 30.98 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.082 0.467 . . . . 0.0 112.082 -174.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.48 -134.14 12.21 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.476 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 -74.84 -6.66 50.29 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.021 0.438 . . . . 0.0 110.817 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.614 ' OE1' ' HB ' ' A' ' 15' ' ' VAL . 99.5 mt-10 -60.35 -24.17 64.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.971 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 91.1 mtp -62.56 -29.27 70.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.528 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.49 -10.21 59.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.868 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.433 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 24.0 m -128.26 95.17 34.17 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-O 121.484 0.659 . . . . 0.0 111.456 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 52' ' ' THR . 37.9 Cg_endo -68.0 -18.09 46.18 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.296 2.664 . . . . 0.0 111.944 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -62.7 -31.67 72.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.936 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.74 -41.07 97.16 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.219 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.88 -38.4 95.48 Favored Glycine 0 CA--C 1.504 -0.625 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.813 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 99.4 t -63.66 -45.93 96.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 120.839 0.352 . . . . 0.0 110.413 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.17 -41.45 96.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.38 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.541 ' O ' HG13 ' A' ' 63' ' ' ILE . 44.5 tp -63.89 -47.24 81.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.785 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.8 mt -64.41 -41.18 96.77 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.938 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 57' ' ' VAL . 5.5 mm-40 -64.36 -35.74 81.88 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.52 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -63.81 -40.75 97.37 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 59' ' ' LEU . 65.9 mt -64.47 -44.98 97.02 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.865 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 57.2 t-105 -58.43 -38.15 76.87 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.599 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.9 m -57.44 -38.91 75.19 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.338 0.589 . . . . 0.0 110.225 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 98.1 mmm -67.32 -40.67 85.97 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.731 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.9 pt -102.02 -6.25 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -174.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -58.54 -21.13 51.52 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.074 0.464 . . . . 0.0 111.328 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -64.57 -33.25 75.48 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.306 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.479 ' HA ' ' HE3' ' A' ' 91' ' ' LYS . 73.3 mm-40 -131.94 6.5 4.29 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -122.0 157.56 31.07 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.957 0.408 . . . . 0.0 111.324 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -111.72 150.78 29.74 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -94.79 113.13 24.85 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 120.717 0.294 . . . . 0.0 111.172 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -77.96 -44.89 25.46 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.334 0.588 . . . . 0.0 110.422 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -145.68 149.99 35.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.332 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.438 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 9.9 pt-20 -80.38 163.15 58.39 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.402 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.577 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 29.9 Cg_endo -62.68 138.5 69.94 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 121.814 1.676 . . . . 0.0 111.981 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.566 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 23.3 p-10 -144.84 156.89 44.26 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.004 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -105.78 108.41 19.9 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.039 0.447 . . . . 0.0 110.487 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -123.33 120.08 31.99 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.511 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.72 -102.7 1.24 Allowed Glycine 0 N--CA 1.432 -1.619 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.683 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -127.17 7.13 6.5 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.738 0.304 . . . . 0.0 110.796 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -125.84 143.87 50.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.88 0.372 . . . . 0.0 111.844 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.587 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 92.3 t -99.54 124.9 53.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 172.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.577 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 10.8 m-80 -119.55 144.43 47.07 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -172.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 13.1 tmm? -145.03 132.31 20.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 39' ' ' VAL . 49.8 tp -114.91 142.74 46.18 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.062 0.458 . . . . 0.0 111.917 -175.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.0 m -124.92 158.71 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.27 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.485 HG22 ' NE2' ' A' ' 38' ' ' HIS . 25.3 m -131.86 143.51 49.37 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.434 ' HD2' ' CG2' ' A' ' 89' ' ' THR . 74.1 Cg_endo -68.17 153.86 73.7 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 122.15 1.9 . . . . 0.0 110.852 177.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 70' ' ' GLU . 97.2 mttt . . . . . 0 C--N 1.324 -0.516 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.551 ' OD2' ' HE2' ' A' ' 9' ' ' LYS . 7.7 t70 . . . . . 0 CA--C 1.533 0.327 0 CA-C-O 121.156 0.503 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 87.1 mt -127.07 136.79 59.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.503 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.551 ' HE2' ' OD2' ' A' ' 7' ' ' ASP . 4.1 mptp? -101.55 157.82 16.54 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-O 121.793 0.806 . . . . 0.0 112.65 -177.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.415 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 46.0 mt-10 -124.74 123.23 39.54 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.848 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.9 mt -109.13 114.6 47.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -98.72 135.52 40.08 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.139 -174.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.424 HD23 HD13 ' A' ' 63' ' ' ILE . 5.5 mp -132.07 -177.09 4.29 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.61 177.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.4 p -143.73 156.51 44.55 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.486 ' HB ' ' OE2' ' A' ' 49' ' ' GLU . 79.8 t -63.67 -44.02 98.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.698 ' HG2' ' OE2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -85.48 71.29 10.8 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 173.395 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.434 HD12 ' OD2' ' A' ' 21' ' ' ASP . 16.7 tt -122.62 160.67 24.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.864 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.73 147.12 24.04 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.12 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -63.52 -33.53 75.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.014 0.435 . . . . 0.0 110.283 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -62.28 -40.54 96.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.389 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 21.1 t70 -66.9 -34.79 78.56 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.839 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.8 mt -61.77 -41.55 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.261 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -58.13 -43.6 87.37 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.752 0.787 . . . . 0.0 109.795 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -61.88 -43.96 97.78 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.689 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 74.2 mmtt -61.96 -46.88 87.33 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.246 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.408 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 9.7 m -71.35 -32.96 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -60.76 -42.56 97.68 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.022 0.439 . . . . 0.0 109.94 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -73.38 -36.79 66.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.273 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.476 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -58.98 -38.49 79.24 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.193 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.416 ' HA ' HD11 ' A' ' 33' ' ' LEU . 96.7 mt -61.4 -39.54 91.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.527 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 61.8 mt-10 -65.54 -40.52 92.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.169 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -65.95 -37.65 86.58 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.117 0.484 . . . . 0.0 110.598 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 90' ' ' PRO . 97.2 mt -62.49 -42.2 99.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.068 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -57.62 -25.17 59.72 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.908 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 31' ' ' GLU . 64.1 mm-40 -84.05 -8.96 58.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.008 0.432 . . . . 0.0 110.67 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.79 9.97 63.6 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.267 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -101.84 174.0 6.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.01 0.433 . . . . 0.0 111.865 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -104.73 150.32 24.85 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.519 -176.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.2 t -116.06 125.05 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.018 173.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.415 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 40.0 ttm180 -100.68 111.97 24.3 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.505 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 63.5 m-85 -89.69 125.68 35.36 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -132.02 139.77 48.7 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.586 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.5 p -121.36 133.45 67.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 121.126 0.488 . . . . 0.0 110.891 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -101.72 125.9 48.47 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.633 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.0 mt -87.09 111.82 21.3 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.8 -44.99 84.02 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' ' 49' ' ' GLU . . . 168.01 141.04 3.07 Favored Glycine 0 N--CA 1.434 -1.437 0 C-N-CA 120.118 -1.039 . . . . 0.0 111.709 -177.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 72.44 -10.24 0.95 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.54 0.686 . . . . 0.0 110.23 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.698 ' OE2' ' HG2' ' A' ' 16' ' ' LYS . 61.0 mt-10 -90.3 -17.85 26.65 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.458 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 96.3 mtp -70.26 -16.11 62.99 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.767 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.36 -34.64 78.15 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.193 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.2 p -130.23 96.52 24.76 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.392 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -67.12 -14.37 43.1 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 123.509 2.806 . . . . 0.0 112.405 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.407 ' OE2' ' HB1' ' A' ' 58' ' ' ALA . 8.4 tm-20 -56.99 -35.01 68.71 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.649 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.43 -36.59 71.56 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.876 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.45 -42.22 97.67 Favored Glycine 0 CA--C 1.504 -0.602 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.96 -43.75 89.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.407 ' HB1' ' OE2' ' A' ' 54' ' ' GLU . . . -60.66 -40.05 90.62 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.136 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.6 tp -61.91 -45.91 91.66 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.76 -39.02 90.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.292 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -59.49 -43.82 93.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.118 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -63.1 -40.8 98.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.424 HD13 HD23 ' A' ' 13' ' ' LEU . 96.2 mt -63.5 -43.9 98.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.041 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.7 t-105 -58.55 -42.95 89.03 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.776 -178.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.55 ' HA ' ' OE2' ' A' ' 68' ' ' GLU . 22.4 p -64.4 -16.33 62.15 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 68.1 mtt -89.9 -48.52 7.17 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.156 0.503 . . . . 0.0 111.232 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.2 pt -86.0 -14.87 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -174.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.55 ' OE2' ' HA ' ' A' ' 65' ' ' THR . 14.0 pt-20 -57.48 -14.8 5.48 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -63.48 -41.57 98.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.476 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -117.89 -4.4 11.11 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.163 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -119.68 146.99 45.1 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.47 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -113.26 138.23 50.31 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -69.58 109.94 4.55 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-O 121.245 0.545 . . . . 0.0 111.359 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.402 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 10.2 t70 -77.94 -42.91 31.45 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.098 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -146.22 137.12 24.35 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.054 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -64.83 157.37 75.36 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.63 178.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 23.4 Cg_exo -61.82 142.35 93.28 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 122.06 1.84 . . . . 0.0 111.577 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -141.39 140.68 33.74 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.423 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -99.11 116.13 30.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.917 0.389 . . . . 0.0 110.418 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -134.49 128.89 34.29 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.74 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.85 -94.42 0.6 Allowed Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.803 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -140.97 6.89 2.01 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.66 0.743 . . . . 0.0 109.41 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -119.33 143.81 47.19 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.717 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.586 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 68.8 t -106.28 123.31 60.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 172.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 8.6 p30 -125.86 149.63 48.51 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -174.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 64.6 ttp -140.87 141.43 34.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.513 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.0 mt -109.75 131.65 54.87 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.024 0.44 . . . . 0.0 111.692 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.7 m -122.95 136.44 59.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.628 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.452 ' CG2' ' HD2' ' A' ' 90' ' ' PRO . 24.4 m -116.07 140.18 26.02 Favored Pre-proline 0 C--N 1.307 -1.276 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.357 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.498 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 72.1 Cg_endo -68.0 152.51 76.71 Favored 'Trans proline' 0 C--O 1.237 0.463 0 C-N-CA 122.815 2.343 . . . . 0.0 111.772 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 67.3 mttm . . . . . 0 C--N 1.323 -0.586 0 CA-C-O 121.199 0.523 . . . . 0.0 110.841 178.457 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 30.4 t70 . . . . . 0 C--O 1.241 0.611 0 CA-C-O 121.114 0.483 . . . . 0.0 109.915 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.448 HG12 ' HB2' ' A' ' 38' ' ' HIS . 71.1 mt -95.05 134.5 32.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.715 -178.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HG3' ' CD1' ' A' ' 32' ' ' PHE . 66.4 mmtt -85.71 127.05 34.41 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.83 -176.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -102.55 115.51 30.71 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 120.868 0.366 . . . . 0.0 110.363 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.0 mt -108.81 116.21 51.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.604 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -98.25 137.43 37.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.135 -175.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.5 mp -128.93 179.12 5.91 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.019 176.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 p -135.91 151.66 50.21 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.442 HG13 ' HG2' ' A' ' 49' ' ' GLU . 49.0 t -66.98 -25.6 34.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.383 0.611 . . . . 0.0 110.158 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.561 ' HE2' ' O ' ' A' ' 46' ' ' LYS . 64.6 mttm -103.29 72.37 1.15 Allowed 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 174.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.5 tt -126.84 153.42 35.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.124 -178.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.404 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -92.57 159.97 15.24 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -62.78 -33.09 74.45 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 120.948 0.404 . . . . 0.0 110.315 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -59.25 -45.05 92.22 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.242 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.4 -39.59 74.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.174 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.651 ' O ' HG23 ' A' ' 26' ' ' VAL . 75.7 mt -60.79 -51.43 73.23 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -60.39 -42.36 95.73 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.982 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.411 ' CZ ' ' HE1' ' A' ' 28' ' ' HIS . 92.0 t80 -64.3 -47.25 80.17 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.99 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -66.78 -42.91 85.29 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 22' ' ' ILE . 60.1 t -63.89 -29.63 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.473 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.05 -41.92 97.49 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 177.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.411 ' HE1' ' CZ ' ' A' ' 24' ' ' TYR . 31.4 m80 -68.41 -34.29 75.74 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.682 178.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.574 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -55.6 -45.25 77.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.238 -178.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.0 mt -62.76 -38.93 92.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.988 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -59.71 -46.23 89.74 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.172 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.407 ' CD1' ' HG3' ' A' ' 9' ' ' LYS . 84.2 m-85 -68.0 -34.78 77.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.82 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 95.0 mt -61.97 -43.01 99.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.287 0.565 . . . . 0.0 110.015 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -59.84 -34.45 73.12 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.596 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -69.4 -18.86 63.8 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.182 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.52 27.02 10.17 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.967 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -112.05 162.85 14.95 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.988 0.423 . . . . 0.0 110.519 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.448 ' HB2' HG12 ' A' ' 8' ' ' ILE . 5.4 m80 -97.53 146.7 25.0 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.7 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.3 t -115.27 129.56 71.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.635 176.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -108.4 112.25 24.58 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 97.4 m-85 -85.78 127.33 34.52 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.708 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 71.4 mtp85 -127.19 131.24 50.71 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.263 -176.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.584 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 5.9 p -130.0 137.05 57.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.106 0.479 . . . . 0.0 110.764 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.442 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 93.3 t80 -104.53 131.21 52.18 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.467 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.4 mt -80.21 85.32 5.75 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.129 0.49 . . . . 0.0 110.411 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.561 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 63.9 tttp -88.77 126.03 35.15 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.132 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.03 -154.94 16.35 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -77.81 -7.21 56.31 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.056 0.455 . . . . 0.0 110.68 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.442 ' HG2' HG13 ' A' ' 15' ' ' VAL . 2.3 mp0 -60.08 -13.61 12.67 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.594 178.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 10.3 mmt -59.33 -20.65 56.31 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.79 0.329 . . . . 0.0 111.361 177.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.45 -5.5 59.29 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.478 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.4 m -138.49 102.59 7.93 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-O 121.175 0.512 . . . . 0.0 111.455 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.28 -20.2 49.31 Favored 'Trans proline' 0 C--N 1.331 -0.369 0 C-N-CA 123.26 2.64 . . . . 0.0 111.76 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -64.04 -22.64 67.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.206 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.19 -45.17 91.77 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.96 0.409 . . . . 0.0 110.382 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.62 -38.86 93.61 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.941 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.1 t -64.12 -43.92 97.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 61' ' ' GLU . . . -63.66 -39.45 94.36 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.223 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.402 ' O ' HG13 ' A' ' 63' ' ' ILE . 38.8 tp -64.51 -47.23 79.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.091 0.472 . . . . 0.0 110.437 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.466 HD11 ' HB3' ' A' ' 77' ' ' PRO . 47.7 mt -66.6 -40.92 89.1 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.586 -177.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -64.09 -31.73 73.02 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.286 179.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -65.01 -40.89 95.56 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 59' ' ' LEU . 75.9 mt -65.53 -44.17 94.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.688 177.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 17.1 t-105 -55.76 -41.54 74.14 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.616 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.1 p -71.63 -12.74 61.5 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 98.0 mmm -87.21 -31.99 20.02 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.233 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.7 pt -108.15 -1.9 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -174.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -12.21 9.17 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -63.35 -46.89 84.47 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.407 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -119.43 0.89 11.17 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.87 0.367 . . . . 0.0 111.589 -174.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.453 ' HB3' HD12 ' A' ' 33' ' ' LEU . . . -125.26 149.81 47.67 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.178 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -114.17 131.73 56.34 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -72.53 106.67 4.69 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.24 -35.28 77.69 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.515 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -156.45 148.75 23.36 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.772 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -62.27 162.28 19.91 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.499 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.466 ' HB3' HD11 ' A' ' 60' ' ' LEU . 31.9 Cg_exo -59.05 144.79 99.22 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.348 2.032 . . . . 0.0 112.375 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -130.0 132.46 46.28 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.934 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -93.08 107.42 19.21 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -127.77 132.04 49.56 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.758 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.13 -109.83 3.13 Favored Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.385 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -124.85 9.86 8.24 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.179 0.514 . . . . 0.0 109.998 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.442 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 73.0 m-85 -125.0 144.5 50.35 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.306 -177.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.584 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 87.5 t -100.89 122.07 52.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 173.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.708 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 39.7 m-80 -114.61 144.64 43.08 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.764 -173.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.404 ' HB2' HD13 ' A' ' 60' ' ' LEU . 63.7 ttp -139.62 130.04 25.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.312 175.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 17.4 mt -108.99 129.73 55.45 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.25 0.547 . . . . 0.0 111.623 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.73 135.66 62.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.928 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.416 HG22 ' CE1' ' A' ' 38' ' ' HIS . 16.1 m -102.28 134.11 20.2 Favored Pre-proline 0 C--N 1.307 -1.251 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.467 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 56.0 Cg_endo -66.39 135.76 40.79 Favored 'Trans proline' 0 C--N 1.327 -0.555 0 C-N-CA 121.884 1.723 . . . . 0.0 110.201 177.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 CA--C 1.509 -0.599 0 CA-C-O 121.24 0.543 . . . . 0.0 112.286 -177.291 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 . . . . . 0 CA--C 1.496 -1.128 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.441 HG12 ' HB2' ' A' ' 38' ' ' HIS . 69.3 mt -91.49 119.31 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.771 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.439 ' HG3' ' CD1' ' A' ' 32' ' ' PHE . 73.1 mmtt -89.22 126.69 35.6 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.936 -174.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.431 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 59.3 mt-10 -102.14 110.72 22.76 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.569 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.0 mt -94.23 107.94 20.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 47.6 tttm -98.32 122.87 42.04 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.593 -175.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.9 mt -122.65 179.36 4.63 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.517 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.1 m -131.62 151.98 51.19 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.2 t -63.69 -40.98 91.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.331 0.586 . . . . 0.0 109.793 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -78.03 50.38 0.88 Allowed 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.323 176.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.2 tt -106.34 160.03 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.706 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.45 146.51 28.37 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 175.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -63.75 -36.43 83.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.949 0.404 . . . . 0.0 111.512 -178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -63.91 -35.97 82.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.977 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.575 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 29.0 t70 -65.51 -35.23 80.25 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.884 0.373 . . . . 0.0 110.752 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.3 mt -61.32 -41.57 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.109 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -58.4 -41.92 86.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.887 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -63.86 -43.22 96.76 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.167 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 75.8 mmtt -61.53 -46.51 89.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.664 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.468 ' CG1' HG21 ' A' ' 63' ' ' ILE . 4.2 m -66.71 -40.82 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 111.791 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.56 -42.7 98.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.083 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -80.04 -25.5 40.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.696 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.412 ' O ' HD12 ' A' ' 33' ' ' LEU . . . -63.68 -37.1 86.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.034 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.52 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 65.7 mt -62.14 -33.53 74.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.689 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -57.76 -41.45 82.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.352 . . . . 0.0 110.116 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.439 ' CD1' ' HG3' ' A' ' 9' ' ' LYS . 94.9 m-85 -66.04 -35.7 81.24 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.105 0.478 . . . . 0.0 110.634 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.562 ' CB ' ' HB3' ' A' ' 90' ' ' PRO . 10.8 mp -62.36 -41.73 98.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.434 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 30' ' ' LEU . 32.6 mt-10 -62.43 -30.09 70.98 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.518 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -79.41 -8.66 59.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.904 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.46 19.77 50.98 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.189 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -95.98 164.97 12.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.935 0.397 . . . . 0.0 110.366 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.441 ' HB2' HG12 ' A' ' 8' ' ' ILE . 17.4 m170 -110.56 148.94 31.13 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.8 t -118.18 130.2 73.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 121.282 0.563 . . . . 0.0 110.682 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.431 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 39.5 ttm180 -111.55 113.18 25.42 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 175.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.561 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 92.8 m-85 -86.51 121.55 29.21 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 78.1 mtp180 -124.27 132.6 53.59 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.541 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.1 p -126.42 135.06 64.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 121.186 0.517 . . . . 0.0 110.799 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -101.37 127.19 48.11 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.799 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.5 mt -82.23 116.43 21.76 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -102.45 113.6 27.08 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.319 0.581 . . . . 0.0 111.956 -173.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.57 -137.21 13.29 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.394 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.4 ptt-85 -69.57 -11.87 61.19 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 122.577 0.351 . . . . 0.0 111.407 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -60.72 -21.12 62.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.566 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 91.2 mtp -62.66 -29.82 70.92 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.618 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.85 -13.81 62.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.349 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.6 p -125.28 94.36 43.44 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-O 121.171 0.51 . . . . 0.0 111.274 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -64.63 -20.33 65.34 Favored 'Trans proline' 0 N--CA 1.477 0.524 0 C-N-CA 123.461 2.774 . . . . 0.0 111.756 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -61.87 -30.07 70.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.183 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.62 -44.01 93.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.811 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.79 -38.44 93.05 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.623 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.8 t -63.87 -44.87 98.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.487 -0.356 . . . . 0.0 110.638 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.45 88.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.032 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.7 tp -62.63 -47.47 83.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.156 0.503 . . . . 0.0 110.036 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.3 mt -67.33 -39.73 85.87 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.975 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -58.88 -39.47 81.51 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.704 0.288 . . . . 0.0 111.075 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -62.76 -46.14 89.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.231 0.538 . . . . 0.0 109.97 177.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.468 HG21 ' CG1' ' A' ' 26' ' ' VAL . 96.0 mt -63.1 -45.14 99.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.897 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -60.66 -40.27 91.45 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.421 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.6 m -61.09 -37.34 82.37 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.096 0.474 . . . . 0.0 111.203 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 82.4 mtp -71.92 -35.94 69.81 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.6 pt -103.28 -2.87 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -174.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.18 -25.97 59.85 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -177.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -65.79 -39.23 90.75 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -107.96 -8.44 15.91 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.958 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -123.27 155.77 36.55 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.54 ' OD1' ' HB ' ' A' ' 89' ' ' THR . 5.3 p30 -117.86 128.37 54.77 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -77.75 108.02 10.67 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 121.305 0.574 . . . . 0.0 111.361 -176.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -66.63 -42.33 86.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.685 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.579 ' HD3' ' N ' ' A' ' 76' ' ' GLU . 7.1 tmtm? -146.19 138.5 25.26 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.579 ' N ' ' HD3' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -63.04 158.72 52.62 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.369 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.13 121.8 9.99 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 121.817 1.678 . . . . 0.0 110.799 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -130.23 138.93 50.79 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.491 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -92.98 117.25 29.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.883 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -138.22 139.98 39.5 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.29 -92.42 0.32 Allowed Glycine 0 N--CA 1.432 -1.567 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -177.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -153.08 17.23 0.56 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.398 0.618 . . . . 0.0 110.473 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -129.23 143.43 50.85 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.909 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.541 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 95.9 t -99.83 126.22 53.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 173.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.561 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 9.3 p30 -133.07 153.07 51.85 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.499 -175.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 64.8 ttp -144.04 134.53 24.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.747 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.5 mt -103.89 129.27 51.39 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.053 0.454 . . . . 0.0 111.494 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.48 135.29 63.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.165 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.54 ' HB ' ' OD1' ' A' ' 72' ' ' ASN . 13.8 m -114.43 143.29 29.57 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.562 ' HB3' ' CB ' ' A' ' 33' ' ' LEU . 60.2 Cg_endo -67.0 155.14 72.17 Favored 'Trans proline' 0 C--O 1.242 0.711 0 C-N-CA 122.81 2.34 . . . . 0.0 112.584 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.7 mptt . . . . . 0 C--N 1.33 -0.272 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 176.555 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.629 ' HB3' ' HZ3' ' A' ' 37' ' ' LYS . 34.0 t70 . . . . . 0 N--CA 1.445 -0.717 0 CA-C-O 121.296 0.57 . . . . 0.0 110.6 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 88.7 mt -117.75 131.11 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.339 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.415 ' HG2' ' CD1' ' A' ' 32' ' ' PHE . 3.6 mptp? -86.26 135.78 33.42 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 121.565 0.698 . . . . 0.0 110.335 -178.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -115.21 120.28 39.17 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.046 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.6 mt -108.75 114.31 46.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.984 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -84.13 139.71 32.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.707 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.457 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 49.8 mt -127.27 166.83 17.04 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.748 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.0 m -137.09 146.25 44.9 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.7 t -62.73 -45.0 99.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.911 0.386 . . . . 0.0 110.25 177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -94.35 65.89 3.32 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.585 0.707 . . . . 0.0 109.975 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.431 HD13 ' OD1' ' A' ' 21' ' ' ASP . 19.7 tt -107.66 156.03 8.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.384 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.416 ' HB2' ' HB2' ' A' ' 21' ' ' ASP . . . -64.77 141.71 58.68 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.8 tp60 -62.11 -39.4 92.37 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.958 0.408 . . . . 0.0 110.883 -176.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -76.32 -18.33 58.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.883 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.431 ' OD1' HD13 ' A' ' 17' ' ' ILE . 12.5 t70 -67.88 -35.79 79.13 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.276 0.56 . . . . 0.0 110.669 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.3 mt -61.49 -42.14 92.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.124 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -58.73 -43.12 90.08 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.716 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.536 ' CZ ' ' HE1' ' A' ' 28' ' ' HIS . 83.7 t80 -63.75 -45.86 87.92 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.469 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -65.52 -41.13 93.47 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.466 ' CG1' HG23 ' A' ' 63' ' ' ILE . 1.4 m -60.77 -29.86 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.549 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -61.83 -46.76 88.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.014 0.435 . . . . 0.0 110.37 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.536 ' HE1' ' CZ ' ' A' ' 24' ' ' TYR . 38.4 m80 -64.57 -37.83 88.9 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.111 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.606 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -56.56 -44.93 81.42 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.407 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 94.6 mt -62.5 -41.38 98.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.932 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -61.75 -44.82 96.17 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.967 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.415 ' CD1' ' HG2' ' A' ' 9' ' ' LYS . 81.4 m-85 -68.8 -32.91 72.97 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 96.7 mt -62.05 -42.02 98.74 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.404 0.621 . . . . 0.0 110.219 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 30' ' ' LEU . 44.6 mm-40 -56.24 -31.7 63.8 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.768 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -76.37 -8.51 57.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.726 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.63 17.95 62.86 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.07 -176.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.629 ' HZ3' ' HB3' ' A' ' 7' ' ' ASP . 75.5 mmtt -99.04 158.87 15.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.78 0.324 . . . . 0.0 110.523 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -99.84 148.11 24.78 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.5 t -119.21 131.11 72.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.414 0.626 . . . . 0.0 111.829 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -112.38 126.0 54.8 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.053 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 96.8 m-85 -97.18 124.33 41.2 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.618 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 65.1 mtp180 -125.7 105.99 9.39 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.885 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.611 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 5.9 p -104.98 129.43 57.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.136 0.493 . . . . 0.0 111.31 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -99.01 134.79 41.34 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.915 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.2 mt -82.0 89.42 6.41 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 87.3 tttt -68.33 134.51 50.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.202 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.75 -132.38 11.16 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.349 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -110.6 18.37 19.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.683 0.278 . . . . 0.0 110.993 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 26.3 mm-40 -68.79 -2.47 9.51 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.196 -177.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 67.9 mtt -65.12 -13.33 57.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.037 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.49 -37.56 87.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.821 0.343 . . . . 0.0 110.697 178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.3 p -124.72 96.91 39.83 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 121.082 0.468 . . . . 0.0 111.583 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.4 ' HB3' ' CG ' ' A' ' 79' ' ' PHE . 31.4 Cg_exo -62.99 -19.58 69.46 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.601 2.867 . . . . 0.0 112.471 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -59.48 -20.38 54.85 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.346 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.59 -38.93 86.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.036 0.446 . . . . 0.0 110.347 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.22 -39.17 94.37 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.766 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.0 t -64.12 -45.19 97.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.699 -0.25 . . . . 0.0 110.694 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.76 -40.75 89.22 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.066 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.5 tp -62.93 -45.82 90.66 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.028 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 86' ' ' MET . 92.2 mt -65.22 -40.89 94.72 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.753 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -58.4 -43.05 88.41 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.95 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -64.34 -41.59 96.7 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.335 0.588 . . . . 0.0 109.89 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.466 HG23 ' CG1' ' A' ' 26' ' ' VAL . 91.6 mt -64.88 -43.84 96.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.384 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -58.26 -41.24 83.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.123 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.3 p -63.79 -16.82 62.19 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 68.7 mtt -85.97 -39.2 17.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.94 0.4 . . . . 0.0 111.824 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.6 pt -101.55 -7.15 9.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -57.1 -28.69 62.88 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -66.57 -22.23 66.15 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -130.15 8.41 5.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.665 0.269 . . . . 0.0 111.576 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.28 151.71 49.93 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.79 0.328 . . . . 0.0 111.116 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -113.44 152.45 30.07 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -94.71 128.35 41.33 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.064 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -90.48 -8.58 50.06 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.138 0.494 . . . . 0.0 110.28 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -176.06 164.58 2.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.458 -177.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -85.96 149.11 49.78 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.71 136.63 75.17 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.344 2.029 . . . . 0.0 111.63 177.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -145.35 138.6 26.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.338 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.4 ' CG ' ' HB3' ' A' ' 53' ' ' PRO . 87.7 t80 -83.3 118.14 23.46 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.659 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -130.59 115.54 16.89 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.092 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.71 -95.75 0.91 Allowed Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.149 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -132.61 4.87 3.96 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.942 0.401 . . . . 0.0 110.368 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 82.1 m-85 -127.65 143.93 51.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.091 -176.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.611 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 93.1 t -99.31 120.98 49.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 172.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.618 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 41.9 m-80 -111.79 145.94 38.52 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -171.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.466 ' HB2' HD11 ' A' ' 60' ' ' LEU . 64.9 ttp -146.49 135.95 22.94 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.289 174.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 22.9 mt -108.68 132.42 53.94 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.749 0.309 . . . . 0.0 111.822 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.16 132.66 70.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.294 0.569 . . . . 0.0 110.692 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.8 m -110.29 141.28 23.58 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.454 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 89.4 Cg_endo -69.29 150.82 71.55 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.762 1.641 . . . . 0.0 109.437 177.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.7 mttm . . . . . 0 C--N 1.325 -0.485 0 CA-C-O 121.565 0.698 . . . . 0.0 111.991 -175.605 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.517 ' HB2' ' HD3' ' A' ' 37' ' ' LYS . 7.0 m-20 . . . . . 0 CA--C 1.505 -0.767 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.424 HG12 ' HB2' ' A' ' 38' ' ' HIS . 97.7 mt -111.45 121.1 63.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 121.095 0.474 . . . . 0.0 110.176 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.423 ' HG3' ' CD1' ' A' ' 32' ' ' PHE . 75.1 mmtt -92.22 133.8 35.48 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.341 -173.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -102.75 102.89 13.08 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.589 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.1 mt -90.94 111.17 23.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.092 0.472 . . . . 0.0 109.85 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 88.3 tttt -85.26 137.67 32.83 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.988 -177.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.2 mt -126.8 175.98 7.61 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.648 -177.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.7 p -146.83 149.29 33.02 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.6 t -64.85 -42.95 96.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -80.8 63.04 5.05 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 174.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.7 tt -113.5 152.13 15.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.601 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.03 150.18 23.55 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -63.92 -36.47 84.04 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.764 0.316 . . . . 0.0 111.574 -177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -62.88 -39.13 93.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.724 0.297 . . . . 0.0 111.154 178.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -64.99 -38.11 89.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.31 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.658 ' O ' HG23 ' A' ' 26' ' ' VAL . 95.5 mt -62.77 -46.86 95.31 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -60.59 -44.39 96.31 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.349 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -65.12 -49.24 70.73 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.123 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -65.54 -41.08 93.44 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 22' ' ' ILE . 59.6 t -63.19 -40.41 88.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.178 0.514 . . . . 0.0 109.984 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -59.75 -45.69 91.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.368 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.443 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 17.8 t-160 -65.43 -31.63 72.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.475 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.85 -31.78 67.0 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 178.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.34 -39.97 94.85 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.026 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.443 ' OE1' ' HA ' ' A' ' 28' ' ' HIS . 1.3 mp0 -54.29 -47.05 72.83 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.423 ' CD1' ' HG3' ' A' ' 9' ' ' LYS . 95.0 m-85 -68.28 -37.1 80.34 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.638 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.35 -42.21 98.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.378 0.608 . . . . 0.0 110.087 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -61.76 -29.89 70.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.12 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -73.91 -9.45 58.66 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.504 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.04 16.38 57.87 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.709 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.517 ' HD3' ' HB2' ' A' ' 7' ' ' ASP . 65.8 mttm -99.82 173.36 6.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.015 0.436 . . . . 0.0 111.37 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.51 ' NE2' HG21 ' A' ' 89' ' ' THR . 17.5 m170 -111.15 149.7 30.51 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.899 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.3 t -118.86 130.68 73.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -109.5 111.37 22.86 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.576 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 83.8 m-85 -85.01 119.5 25.47 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 29.2 mtm180 -125.08 132.79 53.1 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -177.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.437 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.8 p -125.15 132.18 71.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 120.956 0.408 . . . . 0.0 111.142 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.427 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 90.1 t80 -102.72 127.51 49.83 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.672 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.4 mt -90.16 111.01 22.01 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -83.88 88.45 7.12 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.9 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.07 153.39 0.62 Allowed Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.365 -0.834 . . . . 0.0 114.41 175.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 64.17 -64.58 0.14 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.351 1.06 . . . . 0.0 113.111 176.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -65.64 -11.75 47.42 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.649 0.78 . . . . 0.0 111.413 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 80.6 mtp -61.32 -28.96 69.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.449 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.67 -19.37 64.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.543 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.4 m -122.31 97.8 44.8 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-O 121.282 0.563 . . . . 0.0 111.156 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -63.33 -22.15 71.82 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 123.515 2.81 . . . . 0.0 112.521 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -60.81 -28.14 68.55 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.444 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.01 -43.24 95.37 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.887 0.375 . . . . 0.0 110.728 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.26 -39.04 92.1 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.754 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.6 t -62.83 -43.71 99.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 122.629 0.372 . . . . 0.0 110.715 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.68 -40.3 91.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.413 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 48.1 tp -63.42 -45.8 89.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.193 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.8 mt -66.05 -42.18 89.86 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.33 -33.08 74.75 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.269 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -60.5 -47.88 84.23 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.4 mt -66.08 -42.49 91.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.602 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 37.3 t-105 -54.84 -40.38 69.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.026 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.5 m -63.34 -23.16 67.29 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-O 121.106 0.479 . . . . 0.0 111.021 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 96.1 mtp -90.03 -35.59 15.41 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.419 ' CG2' HG12 ' A' ' 26' ' ' VAL . 40.2 pt -92.35 -6.34 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -175.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.93 -4.4 6.9 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -63.34 -46.06 88.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.125 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -121.26 -3.66 9.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.696 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -118.87 145.55 45.61 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.167 0.508 . . . . 0.0 111.718 -176.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -115.36 133.87 55.63 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.782 175.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -68.84 113.24 6.1 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 120.972 0.415 . . . . 0.0 111.993 -177.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -87.45 -40.83 14.0 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.813 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 58.2 tptt -134.19 136.43 43.72 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.775 -177.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -74.47 155.3 87.63 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.584 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 24.2 Cg_exo -61.05 139.6 85.29 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.599 1.533 . . . . 0.0 111.312 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -145.85 141.56 27.98 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.802 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -92.44 112.6 24.6 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -153.57 124.53 7.34 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.586 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.81 31.47 55.87 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 66.49 14.71 9.84 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.672 0.789 . . . . 0.0 112.536 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 37.3 m-85 -125.44 143.53 50.95 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.351 176.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.437 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 78.9 t -103.54 124.09 57.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 172.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.584 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 5.9 p30 -131.67 156.95 44.97 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.959 -0.697 . . . . 0.0 112.423 -173.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 54.5 ttp -142.67 135.62 28.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.528 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.431 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 12.4 mt -108.18 131.06 55.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.969 0.414 . . . . 0.0 111.198 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.2 m -124.69 138.67 53.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.777 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.51 HG21 ' NE2' ' A' ' 38' ' ' HIS . 11.2 m -109.43 135.32 20.31 Favored Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.471 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.98 143.8 37.05 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 C-N-CA 122.374 2.049 . . . . 0.0 110.963 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt . . . . . 0 C--N 1.319 -0.725 0 CA-C-O 121.354 0.597 . . . . 0.0 110.486 179.71 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.538 ' OD2' ' HE2' ' A' ' 9' ' ' LYS . 34.0 t70 . . . . . 0 N--CA 1.442 -0.849 0 CA-C-O 121.02 0.438 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 88.4 mt -120.63 136.85 56.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.446 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.538 ' HE2' ' OD2' ' A' ' 7' ' ' ASP . 75.3 mmtt -98.24 136.47 38.39 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.904 -176.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.444 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 47.0 mt-10 -114.83 104.21 11.71 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.574 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.2 mt -90.21 103.6 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 121.753 0.787 . . . . 0.0 109.706 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -88.71 128.06 35.61 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.782 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 74.4 mt -125.42 -178.55 4.27 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.713 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.4 p -141.68 161.58 37.58 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.78 0.324 . . . . 0.0 110.436 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.1 t -64.4 -25.93 39.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.192 0.52 . . . . 0.0 112.3 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -90.09 11.54 20.51 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.526 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.3 tt -68.24 152.73 9.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 CA-C-O 121.009 0.433 . . . . 0.0 111.163 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.35 154.65 18.43 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.421 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -63.6 -34.21 77.31 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.765 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -64.16 -38.4 90.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.863 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -66.62 -36.87 83.63 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.895 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.6 mt -61.73 -43.74 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.555 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -60.42 -42.31 95.78 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.195 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -69.46 -39.54 77.69 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.452 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -63.39 -42.16 98.78 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.585 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 4.4 m -63.66 -34.13 65.96 Favored 'Isoleucine or valine' 0 C--N 1.342 0.275 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.177 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -63.48 -39.7 95.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.723 0.297 . . . . 0.0 110.686 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -64.7 -40.66 95.75 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.157 0.503 . . . . 0.0 110.278 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.647 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -61.66 -39.13 90.28 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.768 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 26' ' ' VAL . 93.1 mt -61.43 -40.35 94.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.699 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 46.0 mt-10 -58.44 -47.06 85.21 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.799 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.52 ' CE1' ' HE3' ' A' ' 9' ' ' LYS . 94.2 m-85 -71.35 -32.37 68.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.951 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 90.2 mt -62.23 -43.27 99.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.45 0.643 . . . . 0.0 109.817 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -62.6 -30.72 71.55 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.979 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 80.4 mt-30 -73.54 -10.12 59.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.726 178.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.38 7.44 65.28 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.15 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.431 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 88.5 mttt -91.23 178.24 6.03 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.162 0.506 . . . . 0.0 110.323 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.495 ' NE2' HG22 ' A' ' 89' ' ' THR . 23.7 m170 -117.24 150.76 38.24 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.914 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.0 t -117.53 128.58 74.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.079 0.466 . . . . 0.0 110.046 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.444 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 51.8 ttt180 -109.26 115.9 30.87 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.53 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 76.2 m-85 -90.15 113.92 25.78 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -117.09 134.62 54.53 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.493 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.7 p -118.77 130.59 73.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-O 121.211 0.529 . . . . 0.0 111.462 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -94.63 125.22 39.15 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.394 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.451 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 51.6 mt -91.59 129.03 37.63 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -62.39 -48.23 80.63 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.27 -44.96 0.17 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 119.941 -1.123 . . . . 0.0 113.329 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -90.96 -19.27 23.44 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 117.168 0.484 . . . . 0.0 111.471 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.451 ' HG2' ' HB3' ' A' ' 45' ' ' LEU . 1.6 pm0 -79.54 2.66 21.35 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.597 0.713 . . . . 0.0 109.583 175.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 61.2 mtt -82.43 -133.93 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.337 175.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 61.06 -61.06 0.08 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.312 0.645 . . . . 0.0 111.249 -173.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 t -121.85 133.82 24.44 Favored Pre-proline 0 N--CA 1.437 -1.103 0 C-N-CA 123.566 0.746 . . . . 0.0 109.431 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.87 -8.89 23.88 Favored 'Trans proline' 0 C--N 1.331 -0.385 0 C-N-CA 123.425 2.75 . . . . 0.0 113.487 -176.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.88 -30.14 68.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.26 96.03 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.86 0.362 . . . . 0.0 110.465 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.29 -39.88 87.67 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.18 -42.47 94.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.531 -0.334 . . . . 0.0 110.436 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.81 -40.87 76.77 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.293 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.9 tp -62.4 -45.84 91.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.245 0.545 . . . . 0.0 109.993 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.76 -41.09 96.16 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.891 -177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -60.37 -39.41 87.12 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.309 0.575 . . . . 0.0 110.992 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -63.8 -41.18 97.96 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.105 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.2 mt -70.04 -46.23 73.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.065 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.43 ' HB2' ' HE3' ' A' ' 86' ' ' MET . 41.7 t-105 -57.75 -41.4 81.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.322 -176.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.8 p -62.8 -24.69 67.87 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 98.4 mtp -75.78 -34.43 60.22 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.9 pt -107.76 -6.89 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -56.32 -23.08 34.76 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -64.41 -39.19 93.36 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -121.13 6.51 10.27 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.45 146.29 50.54 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.945 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -114.31 147.72 38.66 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.0 ptt-85 -81.16 127.63 32.88 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -74.12 -35.54 64.13 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.384 0.611 . . . . 0.0 109.782 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -161.43 172.22 16.86 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.063 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -77.4 152.59 81.41 Favored Pre-proline 0 C--N 1.311 -1.073 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -61.58 140.64 87.99 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.686 1.591 . . . . 0.0 110.57 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -140.88 165.6 27.08 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.495 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -101.96 113.57 26.92 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.991 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -114.39 113.07 24.02 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.56 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.52 -93.08 0.16 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.497 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -133.94 11.37 3.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.142 0.496 . . . . 0.0 110.492 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -118.27 140.72 49.39 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.863 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.493 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 55.9 t -100.81 127.28 54.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 172.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.53 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 7.2 p30 -134.3 153.84 51.65 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 119.353 -0.939 . . . . 0.0 113.078 -174.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.43 ' HE3' ' HB2' ' A' ' 64' ' ' TRP . 53.0 ttp -140.55 138.15 34.29 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.817 177.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -109.89 126.93 54.38 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.1 m -112.83 134.1 56.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.385 0.612 . . . . 0.0 110.896 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.495 HG22 ' NE2' ' A' ' 38' ' ' HIS . 13.3 m -113.56 139.29 23.16 Favored Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.218 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.549 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 69.2 Cg_endo -66.82 142.35 62.78 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.35 2.033 . . . . 0.0 110.541 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 C--N 1.326 -0.447 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.334 -179.269 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.48 ' HB2' ' HD3' ' A' ' 37' ' ' LYS . 22.2 m-20 . . . . . 0 CA--C 1.512 -0.497 0 CA-C-O 121.072 0.463 . . . . 0.0 111.015 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 90.7 mt -129.16 129.55 67.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -101.46 135.77 42.42 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.789 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.437 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 58.3 mt-10 -104.38 112.28 25.26 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.896 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.4 mt -97.73 111.74 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 87.8 tttt -98.14 136.01 38.98 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.545 -175.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 mp -131.77 179.93 5.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.119 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.7 p -138.98 156.54 47.15 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.97 -25.01 37.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.437 0.637 . . . . 0.0 111.247 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -104.61 22.29 15.29 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.988 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.1 tt -74.37 147.72 8.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.949 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.453 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -75.25 155.22 36.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.74 -177.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 -62.7 -38.75 91.65 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.166 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -61.06 -41.14 96.07 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.553 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 21.1 m-20 -64.75 -38.84 92.35 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.394 177.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 18' ' ' ALA . 68.6 mt -61.95 -45.67 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-O 121.075 0.464 . . . . 0.0 110.703 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -60.08 -41.73 93.1 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.818 0.818 . . . . 0.0 110.323 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -61.97 -44.2 97.25 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.377 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 75.1 mmtt -64.06 -44.76 91.44 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.7 m -67.9 -32.87 58.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.613 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -62.37 -45.47 93.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.096 0.474 . . . . 0.0 109.809 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -70.9 -32.53 69.51 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.191 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.59 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -55.85 -45.97 78.33 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.269 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.37 -40.41 96.36 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.79 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 52.2 mt-10 -57.14 -48.54 78.43 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 120.785 0.326 . . . . 0.0 111.159 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -68.76 -36.24 78.09 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 95.8 mt -63.04 -44.28 96.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.438 0.637 . . . . 0.0 110.428 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -57.88 -32.28 67.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.441 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 80.3 mt-30 -75.21 -7.36 53.66 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.281 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.68 15.75 56.1 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.021 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.48 ' HD3' ' HB2' ' A' ' 7' ' ' ASP . 31.1 mtmm -103.02 168.58 9.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.487 0.66 . . . . 0.0 112.306 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.417 ' NE2' HG21 ' A' ' 89' ' ' THR . 3.3 m80 -102.92 145.9 29.13 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.326 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.9 t -115.4 129.24 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.697 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.437 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 42.4 ttm180 -109.81 113.0 25.39 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.476 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 83.1 m-85 -89.89 124.29 34.57 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 73.0 mtp180 -128.22 135.53 49.82 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.498 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.7 p -118.88 131.95 70.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-O 121.18 0.514 . . . . 0.0 111.24 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -96.26 126.36 41.42 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.576 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.407 HD11 ' HA ' ' A' ' 50' ' ' MET . 31.9 mt -92.31 114.0 26.43 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -95.16 119.84 34.37 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.866 0.365 . . . . 0.0 111.518 -174.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.2 -140.73 15.08 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -91.88 13.67 17.78 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.273 0.558 . . . . 0.0 110.43 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -62.35 -21.99 65.74 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.65 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.407 ' HA ' HD11 ' A' ' 45' ' ' LEU . 65.5 mtt -67.4 -11.3 57.42 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.969 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.94 -28.3 69.73 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.151 0.501 . . . . 0.0 110.515 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.4 m -130.87 99.63 18.11 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-O 121.23 0.538 . . . . 0.0 110.843 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -60.46 -22.81 73.1 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 123.529 2.82 . . . . 0.0 112.897 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -61.65 -22.38 65.23 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.749 0.309 . . . . 0.0 110.827 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.81 -40.6 95.84 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.048 0.451 . . . . 0.0 109.856 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.83 -38.55 93.07 Favored Glycine 0 CA--C 1.506 -0.488 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.382 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.4 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 88.1 t -63.33 -44.44 99.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.439 -0.381 . . . . 0.0 110.508 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.31 -41.2 88.47 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.38 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.0 tp -63.93 -45.63 88.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.355 0.598 . . . . 0.0 110.356 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.434 ' HB3' ' CE ' ' A' ' 86' ' ' MET . 81.7 mt -64.53 -41.13 96.57 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.416 -177.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 57' ' ' VAL . 11.9 mm-40 -63.7 -34.26 77.46 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.539 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -62.04 -41.9 98.61 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.75 -44.32 98.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.281 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -59.72 -36.91 77.52 Favored 'General case' 0 C--O 1.213 -0.83 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.779 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.4 m -57.82 -33.78 68.96 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.306 0.574 . . . . 0.0 110.325 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 97.8 mmm -76.85 -32.73 57.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.603 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.534 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 41.1 pt -117.96 15.84 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -174.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -62.61 -22.48 66.43 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.774 0.797 . . . . 0.0 110.291 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.407 HD21 ' HG3' ' A' ' 70' ' ' GLU . 4.5 p-10 -97.58 141.34 30.74 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 173.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.407 ' HG3' HD21 ' A' ' 69' ' ' ASN . 35.4 mt-10 74.9 -13.89 0.79 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.597 0.759 . . . . 0.0 111.842 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 67' ' ' ILE . . . -129.71 150.79 50.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.661 0.267 . . . . 0.0 110.4 177.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -116.47 149.25 39.82 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -87.57 106.31 17.92 Favored 'General case' 0 N--CA 1.412 -2.368 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.658 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -80.74 -41.14 24.03 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.002 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -137.32 136.8 38.3 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.14 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.98 151.92 70.99 Favored Pre-proline 0 N--CA 1.442 -0.87 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 17.4 Cg_endo -56.29 131.1 43.75 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.463 2.109 . . . . 0.0 112.339 -177.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.421 ' ND2' ' HG3' ' A' ' 80' ' ' GLU . 3.1 p-10 -147.09 165.5 29.74 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.415 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.494 ' CZ ' ' HA ' ' A' ' 82' ' ' ARG . 84.6 t80 -93.83 123.32 37.1 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.844 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.421 ' HG3' ' ND2' ' A' ' 78' ' ' ASN . 38.4 mt-10 -146.77 120.07 8.96 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.48 178.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.446 ' O ' ' HD1' ' A' ' 83' ' ' TYR . . . 64.94 38.73 95.85 Favored Glycine 0 C--O 1.221 -0.696 0 CA-C-N 115.951 -0.568 . . . . 0.0 113.945 175.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.494 ' HA ' ' CZ ' ' A' ' 79' ' ' PHE . 75.2 mtt180 74.96 0.91 3.66 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.492 0.717 . . . . 0.0 111.228 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.446 ' HD1' ' O ' ' A' ' 81' ' ' GLY . 82.2 m-85 -117.38 149.17 40.97 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.891 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.498 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 70.3 t -105.2 128.09 59.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 173.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 9.2 p30 -133.11 161.44 34.4 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -173.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.434 ' CE ' ' HB3' ' A' ' 60' ' ' LEU . 13.8 ttm -143.71 146.01 32.85 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.217 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 16.2 mt -115.33 129.39 56.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.767 0.318 . . . . 0.0 111.238 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.7 132.46 70.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.85 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.417 HG21 ' NE2' ' A' ' 38' ' ' HIS . 15.2 m -104.95 141.2 22.04 Favored Pre-proline 0 C--N 1.309 -1.174 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.423 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 33.8 Cg_endo -61.38 147.21 96.1 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 121.949 1.766 . . . . 0.0 110.579 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? . . . . . 0 C--O 1.239 0.534 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.2 -175.429 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.423 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 25.2 t70 . . . . . 0 CA--C 1.516 -0.34 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.419 HG22 ' O ' ' A' ' 38' ' ' HIS . 92.7 mt -115.56 132.2 65.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.343 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -92.37 155.32 17.98 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.564 0.697 . . . . 0.0 111.126 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.571 ' CD ' HH21 ' A' ' 40' ' ' ARG . 43.4 mt-10 -125.74 114.35 18.52 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.972 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.5 mt -100.67 108.55 23.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -85.49 142.6 29.08 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.841 -176.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.0 mt -129.65 166.9 18.84 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.69 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.0 m -139.2 150.04 45.1 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 176.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.2 t -61.6 -43.89 97.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.309 0.576 . . . . 0.0 110.779 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -93.62 68.03 3.98 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.566 0.698 . . . . 0.0 110.797 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.3 tt -117.59 149.77 19.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.68 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.06 142.27 54.56 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.706 0.289 . . . . 0.0 110.874 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -62.96 -39.0 93.33 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.824 0.345 . . . . 0.0 111.32 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -61.8 -39.95 93.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.15 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.581 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 28.1 t70 -65.91 -38.23 88.15 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.024 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.87 -45.29 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.807 0.813 . . . . 0.0 109.47 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -65.39 -28.82 69.53 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.134 -1.393 . . . . 0.0 110.694 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -78.77 -40.77 32.32 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.161 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.581 ' HG3' ' O ' ' A' ' 21' ' ' ASP . 57.8 mttm -65.55 -38.94 91.06 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 m -59.59 -32.61 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.2 tttt -63.26 -42.24 99.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.852 0.358 . . . . 0.0 110.117 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -68.36 -38.53 81.52 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.52 176.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.414 ' O ' HD13 ' A' ' 33' ' ' LEU . . . -57.72 -44.17 85.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.28 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.426 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 88.2 mt -62.32 -34.66 77.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.82 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -56.22 -41.64 75.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.274 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -67.85 -37.14 81.49 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.935 0.398 . . . . 0.0 111.08 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.429 ' CB ' ' HB3' ' A' ' 90' ' ' PRO . 11.0 mp -63.09 -42.56 99.63 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.445 0.64 . . . . 0.0 110.423 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 30' ' ' LEU . 66.7 mm-40 -61.75 -22.8 65.71 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.993 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -87.74 -6.03 58.38 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.802 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.66 27.49 26.82 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.614 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.423 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 66.2 mttm -115.29 176.26 5.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.248 0.547 . . . . 0.0 111.311 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.435 ' NE2' HG23 ' A' ' 89' ' ' THR . 5.6 m80 -111.13 147.11 35.58 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.163 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.6 t -115.3 126.65 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.571 HH21 ' CD ' ' A' ' 10' ' ' GLU . 45.1 ttp180 -101.51 111.71 24.03 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -87.88 121.65 30.55 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.497 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 83.1 mtp180 -131.96 120.08 21.98 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.614 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 4.3 p -111.4 131.67 62.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.199 0.523 . . . . 0.0 111.53 -176.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.421 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 88.9 t80 -98.34 130.78 45.0 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.618 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 50' ' ' MET . 40.7 mt -89.93 122.52 33.04 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -107.32 114.12 27.95 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.178 0.513 . . . . 0.0 111.674 -174.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.52 -143.86 15.97 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.485 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -83.18 4.86 24.88 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.154 0.502 . . . . 0.0 111.015 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -65.72 -25.75 67.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.153 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.415 ' HA ' HD12 ' A' ' 45' ' ' LEU . 49.2 ttm -59.46 -24.34 63.48 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.462 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.9 -25.61 67.96 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.321 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.9 p -126.69 101.55 26.78 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 121.303 0.573 . . . . 0.0 110.741 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.3 -15.36 38.75 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.446 2.764 . . . . 0.0 112.631 -177.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -61.69 -26.14 67.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.811 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.67 90.59 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.036 0.446 . . . . 0.0 110.119 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.03 -38.67 92.81 Favored Glycine 0 CA--C 1.505 -0.563 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.584 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.412 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 93.5 t -63.13 -45.85 97.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.571 -0.315 . . . . 0.0 110.947 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.37 -40.76 92.0 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.198 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.2 tp -63.2 -45.69 90.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.183 0.516 . . . . 0.0 110.289 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.6 mt -65.17 -40.56 94.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.907 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 57' ' ' VAL . 46.6 mt-10 -62.55 -39.13 92.64 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.016 0.436 . . . . 0.0 110.471 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -62.64 -43.67 98.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.019 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.0 mt -67.35 -43.31 87.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.684 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.488 ' CZ2' ' HB2' ' A' ' 73' ' ' ARG . 41.9 t-105 -55.86 -41.16 73.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.281 -178.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 36.0 p -63.5 -29.13 70.45 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.256 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 66.0 mtt -67.66 -41.2 84.15 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.738 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.8 pt -106.52 -1.43 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -174.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -54.09 -32.0 53.54 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -176.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.545 ' ND2' ' HG2' ' A' ' 70' ' ' GLU . 4.9 p-10 -77.26 -14.74 59.7 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.545 ' HG2' ' ND2' ' A' ' 69' ' ' ASN . 58.6 mm-40 -117.71 -15.4 10.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.265 0.555 . . . . 0.0 111.203 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -124.16 155.57 38.25 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.788 -176.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -112.88 139.11 48.8 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 176.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.488 ' HB2' ' CZ2' ' A' ' 64' ' ' TRP . 71.0 ttp85 -87.28 112.3 21.91 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -177.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -70.97 -37.2 72.76 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.903 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -160.85 161.56 31.94 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.87 152.97 95.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.458 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.16 139.41 83.66 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.165 1.91 . . . . 0.0 111.398 177.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -140.29 148.39 41.35 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.412 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -91.76 107.7 19.39 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.219 0.533 . . . . 0.0 110.156 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -114.84 116.05 27.96 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.513 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.4 -104.71 1.56 Allowed Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 120.363 -0.922 . . . . 0.0 110.92 -177.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -127.56 10.54 6.68 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.05 0.453 . . . . 0.0 110.324 178.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.421 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 81.2 m-85 -121.52 145.31 48.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.299 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.614 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 86.5 t -97.46 119.05 45.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 172.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.497 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 78.5 m-20 -111.25 144.08 40.99 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.081 -171.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 15.5 tmm? -147.05 137.75 23.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.746 175.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.2 mt -114.65 134.29 55.18 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.1 m -117.09 131.29 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.219 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.435 HG23 ' NE2' ' A' ' 38' ' ' HIS . 15.8 m -104.83 137.7 19.29 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.429 ' HB3' ' CB ' ' A' ' 33' ' ' LEU . 57.9 Cg_endo -64.47 148.34 90.66 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.429 2.086 . . . . 0.0 111.632 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.437 ' HE2' ' O ' ' A' ' 69' ' ' ASN . 36.7 mttp . . . . . 0 C--N 1.323 -0.568 0 CA-C-O 120.925 0.393 . . . . 0.0 111.629 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.1 t70 . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 121.036 0.446 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.9 mt -89.32 133.57 31.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.015 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -94.01 143.79 26.05 Favored 'General case' 0 CA--C 1.492 -1.288 0 CA-C-O 121.428 0.632 . . . . 0.0 111.167 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.569 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 91.1 mt-10 -120.49 126.28 49.98 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.945 178.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.9 mt -110.46 117.77 55.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 12.3 mptt -97.51 139.76 32.96 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.186 0.517 . . . . 0.0 112.161 -177.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mp -130.22 177.17 7.52 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.192 176.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.6 m -135.05 154.08 51.82 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.9 t -63.3 -33.09 59.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.257 0.551 . . . . 0.0 110.059 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -106.9 74.59 1.0 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.967 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.4 tt -130.39 160.84 41.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.969 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.41 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -73.85 142.62 46.08 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -38.39 90.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.055 0.455 . . . . 0.0 109.987 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -61.88 -41.22 97.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.596 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.699 ' OD2' ' HE2' ' A' ' 25' ' ' LYS . 6.1 t70 -65.58 -36.49 83.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.679 -178.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.643 ' O ' HG21 ' A' ' 26' ' ' VAL . 68.4 mt -60.98 -46.62 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -59.14 -43.19 92.01 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.517 0.675 . . . . 0.0 110.571 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -61.66 -46.11 91.13 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.022 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.699 ' HE2' ' OD2' ' A' ' 21' ' ' ASP . 68.8 mttm -65.38 -40.89 94.04 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.756 0.312 . . . . 0.0 111.769 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.643 HG21 ' O ' ' A' ' 22' ' ' ILE . 55.8 t -61.57 -39.71 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.611 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -56.08 -39.65 72.42 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.534 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 20.9 m80 -64.35 -38.24 90.35 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.989 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.609 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -60.86 -38.58 86.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.726 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.68 -39.1 90.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.99 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 6.1 mm-40 -59.58 -50.64 73.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.057 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -64.75 -34.84 79.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.518 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 96.1 mt -62.75 -43.72 98.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.292 0.568 . . . . 0.0 110.474 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -67.14 -26.73 66.81 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.915 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.478 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 78.9 mt-30 -77.67 -7.65 56.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.902 178.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.63 22.52 50.1 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.908 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -103.71 158.83 16.11 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.994 0.426 . . . . 0.0 110.298 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -98.35 138.66 35.27 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.512 176.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.3 t -112.15 128.18 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.569 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 67.2 ttt180 -108.51 112.76 25.31 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 176.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -86.9 117.97 25.98 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 81.8 mtp180 -125.65 138.78 53.92 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.572 -177.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.592 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.1 p -126.61 135.66 63.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.014 0.435 . . . . 0.0 111.076 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -101.14 132.35 46.65 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.707 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.547 ' HB2' ' SD ' ' A' ' 50' ' ' MET . 29.1 mt -90.33 111.99 23.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.024 0.44 . . . . 0.0 109.852 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -104.27 123.21 46.95 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.58 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.45 -147.42 16.33 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.209 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -89.07 15.28 8.97 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.224 0.535 . . . . 0.0 110.02 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -73.86 -11.75 60.46 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.193 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.547 ' SD ' ' HB2' ' A' ' 45' ' ' LEU . 95.6 mmm -61.23 -35.92 78.54 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.276 -176.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.74 -21.22 65.65 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.486 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.0 p -119.71 94.94 48.97 Favored Pre-proline 0 N--CA 1.446 -0.64 0 CA-C-O 121.143 0.497 . . . . 0.0 111.839 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -64.4 -23.62 64.99 Favored 'Trans proline' 0 N--CA 1.477 0.552 0 C-N-CA 123.349 2.7 . . . . 0.0 111.26 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.94 -22.13 66.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.74 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.87 97.04 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.927 0.394 . . . . 0.0 110.519 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.406 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -68.37 -39.32 87.58 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.905 177.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.429 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 97.3 t -63.41 -44.98 99.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.648 0.261 . . . . 0.0 111.018 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.99 -40.94 95.43 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.16 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.3 tp -63.15 -45.15 93.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.192 0.52 . . . . 0.0 110.001 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 56' ' ' GLY . 63.1 mt -65.76 -37.75 87.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.767 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 57' ' ' VAL . 56.3 mt-10 -55.69 -42.23 74.89 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.621 0.248 . . . . 0.0 110.583 177.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -61.89 -43.53 98.65 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.06 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.468 ' O ' HG12 ' A' ' 67' ' ' ILE . 65.1 mt -62.39 -45.32 99.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.826 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.456 ' HA ' HG12 ' A' ' 67' ' ' ILE . 45.6 t-105 -57.6 -40.96 80.26 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.072 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.2 m -63.22 -25.69 68.45 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 121.126 0.489 . . . . 0.0 110.581 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 95.6 mtp -89.47 -43.3 10.94 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.888 0.375 . . . . 0.0 111.799 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 63' ' ' ILE . 40.5 pt -81.44 -18.35 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -174.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -58.8 -15.42 12.22 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.102 0.477 . . . . 0.0 111.863 -177.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -63.17 -40.71 98.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.668 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -116.48 -9.71 11.39 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.532 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.483 ' HB1' HD13 ' A' ' 33' ' ' LEU . . . -121.9 160.3 25.06 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.625 ' OD1' ' HG2' ' A' ' 91' ' ' LYS . 11.3 m-20 -116.08 156.89 25.57 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.732 176.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.453 ' HB2' ' CZ2' ' A' ' 64' ' ' TRP . 69.3 ttt180 -85.4 106.5 16.82 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.006 -176.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -82.25 -36.77 26.8 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.027 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -160.18 160.03 32.35 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.851 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.41 ' HB3' HH21 ' A' ' 73' ' ' ARG . 9.7 pt-20 -84.78 155.75 61.57 Favored Pre-proline 0 C--N 1.316 -0.868 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.43 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 16.1 Cg_endo -57.1 132.7 53.03 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.474 2.116 . . . . 0.0 111.788 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -127.75 134.04 49.52 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.347 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -82.28 113.66 20.24 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -127.34 114.86 18.13 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.234 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.39 -105.81 1.68 Allowed Glycine 0 N--CA 1.428 -1.888 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.687 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -121.31 7.73 10.2 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.209 0.528 . . . . 0.0 110.445 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -123.47 149.58 44.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.996 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.592 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 69.7 t -108.93 126.29 65.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 173.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.459 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 6.5 m-80 -124.06 139.04 54.33 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.492 -0.483 . . . . 0.0 112.124 -172.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 63.2 ttp -130.01 128.99 43.12 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -108.27 127.22 53.66 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.969 0.414 . . . . 0.0 110.031 -178.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.6 m -123.18 145.43 30.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.042 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.1 m -115.42 135.43 22.59 Favored Pre-proline 0 C--N 1.303 -1.414 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.125 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.404 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 55.5 Cg_endo -64.17 152.52 80.83 Favored 'Trans proline' 0 C--N 1.329 -0.481 0 C-N-CA 122.319 2.013 . . . . 0.0 110.054 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.625 ' HG2' ' OD1' ' A' ' 72' ' ' ASN . 68.6 mttm . . . . . 0 C--N 1.329 -0.292 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -174.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.6 t70 . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 121.016 0.436 . . . . 0.0 109.875 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 88.7 mt -104.22 133.49 48.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.387 0.613 . . . . 0.0 111.38 -176.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -96.13 149.59 21.46 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.833 -175.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -119.88 137.48 53.99 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.185 0.517 . . . . 0.0 111.272 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.8 mm -110.21 114.85 48.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -90.21 141.74 28.41 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.309 0.576 . . . . 0.0 111.321 -176.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.436 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 49.4 mt -133.46 165.99 23.58 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.597 -176.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.5 p -140.82 152.3 45.05 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.7 t -62.79 -33.74 61.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.325 0.583 . . . . 0.0 109.551 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -93.55 73.2 4.39 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.575 176.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.8 tt -126.34 145.58 33.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.515 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.77 142.55 53.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.292 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.409 HE22 ' HD3' ' A' ' 62' ' ' LYS . 62.2 tp60 -62.98 -38.33 90.71 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.305 0.574 . . . . 0.0 110.505 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -62.5 -38.25 89.18 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.952 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -64.96 -36.1 83.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.602 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 94.2 mt -61.73 -42.74 95.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.427 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 6.4 m-20 -60.15 -41.11 92.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.515 178.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -68.63 -40.5 80.3 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.8 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -60.81 -42.4 97.58 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.466 ' CG1' HG21 ' A' ' 63' ' ' ILE . 13.2 m -64.04 -35.97 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.316 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 23' ' ' ASN . 99.1 mttt -62.54 -42.67 99.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.411 0.624 . . . . 0.0 109.49 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -65.94 -41.6 91.12 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.218 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.427 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -64.03 -38.94 92.91 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.299 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.0 mt -61.36 -38.48 87.12 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.263 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 57.9 mt-10 -57.69 -42.85 84.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.683 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.447 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 80.1 m-85 -74.63 -37.19 62.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.873 0.368 . . . . 0.0 111.798 177.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 92.4 mt -62.84 -43.43 98.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.599 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -63.4 -22.88 67.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.919 0.39 . . . . 0.0 111.183 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 32' ' ' PHE . 78.1 mt-30 -71.17 -34.95 71.4 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.364 175.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.27 -0.3 12.85 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.268 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -88.13 164.81 15.51 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.56 151.25 20.86 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.652 -176.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.5 t -119.18 130.01 74.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.223 0.535 . . . . 0.0 110.315 175.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -103.33 114.53 28.88 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.514 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 85.9 m-85 -92.3 120.0 32.42 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.584 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.725 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 78.5 mtp85 -122.37 118.81 29.32 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.603 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.5 p -115.68 128.89 72.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.321 0.581 . . . . 0.0 110.931 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -95.58 121.38 37.22 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.817 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.4 mt -79.55 143.71 34.57 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -130.92 137.72 49.44 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.961 -0.295 . . . . 0.0 110.344 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.87 -147.07 33.11 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.102 -0.57 . . . . 0.0 113.576 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.448 ' O ' ' HD2' ' A' ' 48' ' ' ARG . 2.6 tmm_? -59.64 -35.85 75.21 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.909 0.884 . . . . 0.0 110.415 -177.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -54.18 -16.5 2.11 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 84.5 mtp -63.23 -34.08 76.89 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.073 0.463 . . . . 0.0 110.848 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.13 -33.53 73.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.232 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.414 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 68.4 p -117.11 105.25 49.41 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-O 121.097 0.475 . . . . 0.0 111.911 -177.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.63 -15.29 45.3 Favored 'Trans proline' 0 N--CA 1.485 0.998 0 C-N-CA 124.014 3.142 . . . . 0.0 113.14 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.414 ' HG2' ' HB ' ' A' ' 52' ' ' THR . 14.5 pt-20 -54.82 -31.26 58.96 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.585 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.08 -42.22 99.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.913 0.387 . . . . 0.0 111.102 -178.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.69 -41.32 89.49 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.749 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.4 t -63.66 -45.95 96.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.583 -0.309 . . . . 0.0 111.177 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.38 -38.5 87.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.769 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.2 tp -63.55 -45.88 88.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.288 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 86' ' ' MET . 94.2 mt -65.58 -40.74 93.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.14 -178.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -62.22 -33.99 75.62 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.776 0.322 . . . . 0.0 111.269 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.409 ' HD3' HE22 ' A' ' 19' ' ' GLN . 40.7 ttmt -62.11 -47.71 83.41 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-O 121.146 0.498 . . . . 0.0 109.688 176.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.466 HG21 ' CG1' ' A' ' 26' ' ' VAL . 70.8 mt -63.75 -43.06 97.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.047 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -56.66 -36.56 69.69 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.479 177.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.516 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 96.7 m -59.63 -44.38 93.5 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 120.988 0.423 . . . . 0.0 110.829 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -67.17 -39.55 86.46 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 63' ' ' ILE . 41.6 pt -98.37 -5.59 9.43 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.639 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -173.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 65' ' ' THR . 13.0 pt-20 -56.05 -34.86 66.3 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -176.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.402 ' ND2' ' HG3' ' A' ' 70' ' ' GLU . 3.3 p-10 -69.63 -18.77 63.62 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.402 ' HG3' ' ND2' ' A' ' 69' ' ' ASN . 43.3 mt-10 -123.44 -1.37 8.6 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.931 0.396 . . . . 0.0 111.76 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -131.87 153.75 49.89 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.965 -177.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -111.71 144.23 41.32 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -81.71 111.86 18.36 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -176.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -66.45 -41.76 88.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.194 0.521 . . . . 0.0 109.872 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -163.66 161.18 23.53 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.264 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -74.6 152.93 87.49 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.495 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.34 134.89 64.47 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.714 2.276 . . . . 0.0 111.884 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -135.5 137.77 42.45 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.689 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -90.69 106.78 18.74 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.166 0.507 . . . . 0.0 110.564 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -118.14 118.74 32.71 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.424 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.64 -108.93 2.67 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -123.33 8.77 9.1 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.974 0.416 . . . . 0.0 110.611 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -122.8 141.4 51.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.405 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.603 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 89.3 t -97.38 115.86 38.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 173.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.725 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 47.5 m-80 -108.52 144.16 36.56 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.195 -173.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.45 ' HB2' HD12 ' A' ' 60' ' ' LEU . 65.0 ttp -144.99 134.98 23.8 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.533 174.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 16.9 mt -109.72 135.34 50.81 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.032 0.444 . . . . 0.0 110.976 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.0 m -122.62 133.86 67.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.427 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.0 m -104.45 132.96 20.46 Favored Pre-proline 0 N--CA 1.432 -1.367 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -65.56 147.33 86.42 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.173 1.915 . . . . 0.0 111.656 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.1 mttp . . . . . 0 C--N 1.324 -0.503 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.004 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.1 t70 . . . . . 0 CA--C 1.51 -0.592 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 80.9 mt -90.65 122.85 42.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.121 0.486 . . . . 0.0 110.396 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.468 ' HG2' ' CE1' ' A' ' 32' ' ' PHE . 4.2 mptp? -85.01 148.98 25.9 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.624 -175.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -110.85 118.05 35.08 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.955 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.3 mm -96.18 97.9 7.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 175.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 62.8 tttp -81.15 134.97 35.72 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.89 -177.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 67.3 mt -129.33 171.44 12.49 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.384 -175.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.9 p -144.2 149.98 37.26 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.58 -40.54 89.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -88.06 67.25 8.86 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.0 tt -117.6 152.69 19.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.35 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.94 154.69 22.03 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.231 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -63.49 -37.41 87.2 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.844 0.354 . . . . 0.0 111.098 -178.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -60.33 -42.64 96.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.272 0.558 . . . . 0.0 110.052 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.49 -40.52 97.3 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.004 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.65 ' O ' HG23 ' A' ' 26' ' ' VAL . 72.0 mt -61.41 -48.69 87.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -61.05 -47.6 85.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.377 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -62.44 -48.84 77.89 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.689 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -65.66 -42.47 91.32 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -177.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 22' ' ' ILE . 60.5 t -64.69 -43.74 96.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.138 0.494 . . . . 0.0 110.079 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.2 -42.21 99.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.112 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -66.69 -36.41 82.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.696 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.38 -34.49 73.98 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.801 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.442 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 96.7 mt -61.41 -38.2 86.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.523 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.454 ' HA ' ' OE1' ' A' ' 34' ' ' GLU . 41.5 mt-10 -61.75 -37.05 82.85 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.068 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.468 ' CE1' ' HG2' ' A' ' 9' ' ' LYS . 93.1 m-85 -69.26 -35.95 76.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.058 0.456 . . . . 0.0 110.579 177.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 90' ' ' PRO . 87.9 mt -62.86 -41.16 99.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.416 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 31' ' ' GLU . 46.8 mt-10 -53.07 -32.89 49.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.404 177.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -78.16 -8.89 58.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.557 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.5 10.43 61.96 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.46 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -94.44 -176.47 3.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.958 0.409 . . . . 0.0 110.158 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -116.31 154.31 30.41 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.012 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.442 ' O ' HD11 ' A' ' 87' ' ' LEU . 25.6 t -118.51 125.33 74.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -103.24 112.32 25.14 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.261 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -84.07 128.29 34.46 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.341 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 9.1 mmm180 -131.33 107.69 9.13 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.225 -175.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.549 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 9.7 p -108.77 132.98 55.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 120.921 0.391 . . . . 0.0 110.568 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -106.99 134.0 50.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.243 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.408 ' CD1' ' HA ' ' A' ' 50' ' ' MET . 30.2 mt -94.58 115.02 27.07 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -106.86 -64.7 1.15 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -171.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.556 ' O ' ' HG3' ' A' ' 49' ' ' GLU . . . -82.74 88.2 1.47 Allowed Glycine 0 CA--C 1.49 -1.485 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -178.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 61.22 -111.4 0.45 Allowed 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -171.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.556 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 89.4 mt-10 63.21 -42.98 0.21 Allowed 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 173.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.408 ' HA ' ' CD1' ' A' ' 45' ' ' LEU . 42.9 ttm -63.28 -20.13 65.2 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.046 0.539 . . . . 0.0 111.866 -177.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.26 -30.43 71.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.168 0.509 . . . . 0.0 109.726 175.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 p -126.71 92.61 44.45 Favored Pre-proline 0 N--CA 1.452 -0.334 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.225 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -62.84 -20.51 71.46 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 123.6 2.867 . . . . 0.0 112.552 -176.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.05 -23.72 65.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.418 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.14 -41.05 91.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.017 0.437 . . . . 0.0 110.402 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.45 -39.61 91.34 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.7 t -64.73 -44.4 96.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.603 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.85 -39.77 86.29 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.252 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.4 tp -62.53 -46.49 88.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.165 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.3 mt -65.53 -40.46 92.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.298 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -58.12 -39.96 80.01 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.356 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -61.96 -43.62 98.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.418 0.627 . . . . 0.0 110.345 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.2 mt -65.36 -43.57 94.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.913 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.2 t-105 -58.34 -39.47 79.55 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.807 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.43 ' HA ' ' OE2' ' A' ' 68' ' ' GLU . 19.5 m -57.75 -38.23 75.02 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.3 0.571 . . . . 0.0 110.583 178.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 78.3 mtm -77.1 -34.2 56.83 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.9 pt -98.41 -12.01 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 113.493 0.924 . . . . 0.0 113.493 -174.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.43 ' OE2' ' HA ' ' A' ' 65' ' ' THR . 14.1 pt-20 -59.83 -23.85 63.7 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -175.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -65.29 -30.98 71.89 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -127.09 3.27 6.47 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -128.68 153.79 46.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.144 0.497 . . . . 0.0 111.56 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.471 ' OD1' ' HG2' ' A' ' 91' ' ' LYS . 75.8 m-20 -111.85 149.33 31.96 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -89.01 106.56 18.51 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-O 121.025 0.44 . . . . 0.0 110.821 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -75.9 -41.05 53.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.421 0.629 . . . . 0.0 110.715 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -137.27 150.03 47.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.061 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -85.31 154.8 60.08 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 29.1 Cg_endo -63.4 115.29 2.93 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.76 1.64 . . . . 0.0 110.961 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -136.1 144.56 45.19 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.336 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -81.91 109.83 16.63 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.494 ' HB3' HD22 ' A' ' 85' ' ' ASN . 73.4 tt0 -148.71 123.43 9.87 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.808 -176.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.52 28.53 61.31 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.315 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 72.28 3.18 4.6 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.357 0.663 . . . . 0.0 111.339 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -119.87 145.46 46.65 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.054 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.549 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 92.0 t -95.35 112.27 27.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 172.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.494 HD22 ' HB3' ' A' ' 80' ' ' GLU . 9.5 p30 -116.48 148.97 40.27 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -172.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 66.0 ttp -141.85 136.74 30.86 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.31 175.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.442 HD11 ' O ' ' A' ' 39' ' ' VAL . 44.7 tp -118.82 140.15 50.43 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.904 0.383 . . . . 0.0 110.59 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.8 m -130.26 161.72 39.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.229 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.2 m -137.28 138.94 26.45 Favored Pre-proline 0 C--N 1.309 -1.178 0 CA-C-N 115.46 -0.791 . . . . 0.0 108.985 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.498 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 92.8 Cg_endo -68.41 142.87 55.85 Favored 'Trans proline' 0 C--N 1.329 -0.48 0 C-N-CA 122.242 1.961 . . . . 0.0 110.15 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.471 ' HG2' ' OD1' ' A' ' 72' ' ' ASN . 69.0 mttm . . . . . 0 CA--C 1.535 0.39 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.605 -177.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.401 ' CG ' ' HZ1' ' A' ' 9' ' ' LYS . 13.6 t0 . . . . . 0 C--O 1.212 -0.919 0 CA-C-O 120.663 0.268 . . . . 0.0 110.693 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 74.4 mt -121.3 133.63 67.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.05 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.469 ' N ' ' HE2' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -80.26 147.76 31.07 Favored 'General case' 0 CA--C 1.485 -1.541 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.304 -177.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -133.78 112.21 11.16 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.661 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.9 mt -107.72 114.15 45.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.389 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 86.7 tttt -86.52 131.13 34.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 122.157 0.98 . . . . 0.0 112.297 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 83.2 mt -129.55 179.58 5.73 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.404 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.4 p -149.6 156.91 42.7 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.0 t -69.85 -17.71 21.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 121.529 0.68 . . . . 0.0 110.301 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -96.66 26.27 4.61 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.401 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.8 tt -88.72 138.89 18.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.255 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.76 145.57 48.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.927 177.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -56.43 -40.59 75.01 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -176.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -62.89 -36.0 81.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.754 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.57 -32.81 68.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.181 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.638 ' O ' HG22 ' A' ' 26' ' ' VAL . 62.5 mt -58.91 -46.9 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 109.614 -0.514 . . . . 0.0 109.614 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -57.48 -41.99 81.75 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 124.281 0.988 . . . . 0.0 110.573 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -62.99 -48.01 80.66 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.839 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -64.78 -43.36 93.46 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 120.568 0.223 . . . . 0.0 110.761 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 22' ' ' ILE . 50.0 t -63.55 -42.49 96.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.133 -178.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -57.22 -45.77 83.56 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.429 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -65.91 -37.13 85.28 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.601 177.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.71 -39.48 80.92 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.943 0.401 . . . . 0.0 109.971 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.494 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 98.2 mt -62.28 -41.35 98.41 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.211 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -63.32 -39.65 95.14 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.509 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -66.56 -35.18 79.6 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.183 0.516 . . . . 0.0 110.741 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.441 HD13 ' HB1' ' A' ' 71' ' ' ALA . 88.9 mt -62.56 -42.32 99.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.251 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 30' ' ' LEU . 86.9 mt-10 -56.7 -34.69 67.68 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.501 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -66.98 -19.82 65.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.598 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.77 35.54 6.11 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.306 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.441 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -124.52 164.92 18.75 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.304 0.573 . . . . 0.0 110.058 179.442 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.461 ' HE2' HG21 ' A' ' 89' ' ' THR . 16.2 m170 -97.81 137.5 36.58 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.961 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 68.5 t -104.48 118.97 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.697 175.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -95.37 110.48 22.5 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 94.0 m-85 -83.94 108.74 17.1 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.49 ' HA ' ' OD1' ' A' ' 85' ' ' ASN . 53.2 mtp85 -106.18 108.5 20.05 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.782 -177.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 84' ' ' VAL . 4.9 p -109.11 127.64 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-O 121.641 0.734 . . . . 0.0 111.161 -177.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -98.67 123.92 43.17 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.545 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.423 ' CD1' ' HA ' ' A' ' 50' ' ' MET . 89.4 mt -72.53 -56.28 5.62 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -176.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.8 tttp 69.08 124.81 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.118 0.485 . . . . 0.0 112.099 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.29 -155.57 25.25 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.798 176.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -72.41 -14.66 61.75 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.718 0.294 . . . . 0.0 111.384 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -61.88 -20.1 63.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.392 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.423 ' HA ' ' CD1' ' A' ' 45' ' ' LEU . 94.7 mtp -67.92 -15.3 63.55 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.737 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.56 -11.41 59.17 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 120.946 0.403 . . . . 0.0 110.684 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.432 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 41.5 p -128.33 106.58 19.44 Favored Pre-proline 0 N--CA 1.442 -0.856 0 CA-C-O 121.481 0.658 . . . . 0.0 111.204 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 52' ' ' THR . 35.3 Cg_endo -68.56 -16.65 42.95 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 122.902 2.401 . . . . 0.0 111.876 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -58.87 -33.82 70.91 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.974 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.49 -41.86 90.84 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.103 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.41 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -68.01 -41.58 87.13 Favored Glycine 0 C--O 1.219 -0.815 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 177.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.07 -44.49 99.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 O-C-N 123.727 0.31 . . . . 0.0 111.182 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.91 -41.82 96.88 Favored 'General case' 0 C--O 1.257 1.467 0 C-N-CA 122.448 0.299 . . . . 0.0 111.312 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.0 tp -62.85 -44.07 97.12 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.202 0.525 . . . . 0.0 109.805 177.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.469 HD11 ' HB2' ' A' ' 86' ' ' MET . 90.9 mt -65.76 -40.45 92.07 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.621 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -60.24 -37.67 81.11 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.333 0.396 . . . . 0.0 110.967 178.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -62.68 -44.32 96.55 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.603 0.716 . . . . 0.0 109.241 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 61.9 mt -67.26 -43.23 88.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.719 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.526 ' CZ2' ' HB2' ' A' ' 73' ' ' ARG . 37.6 t-105 -56.73 -39.23 73.56 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.827 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.7 m -63.23 -23.92 67.64 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 123.485 0.491 . . . . 0.0 111.212 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 96.5 mtp -91.1 -30.4 16.76 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.7 pt -98.73 -9.74 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -175.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -15.38 47.65 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -79.52 -21.9 44.64 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.668 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -119.9 -13.12 9.08 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.743 0.306 . . . . 0.0 111.246 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.441 ' HB1' HD13 ' A' ' 33' ' ' LEU . . . -126.67 154.68 43.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.102 0.477 . . . . 0.0 112.137 -175.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.442 ' OD1' ' HB ' ' A' ' 89' ' ' THR . 7.0 p30 -116.73 135.77 53.5 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.821 176.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.526 ' HB2' ' CZ2' ' A' ' 64' ' ' TRP . 36.1 ttp180 -74.87 112.14 10.78 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.247 -176.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -71.89 -37.84 70.07 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -159.32 158.94 33.32 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.115 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -72.79 150.52 90.78 Favored Pre-proline 0 C--N 1.306 -1.284 0 C-N-CA 122.536 0.334 . . . . 0.0 110.736 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.35 134.69 65.85 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 122.685 2.257 . . . . 0.0 112.511 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -133.62 149.12 51.6 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.99 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -91.82 116.25 28.74 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.38 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -128.3 137.76 52.1 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.64 -109.94 3.08 Favored Glycine 0 N--CA 1.426 -2.019 0 C-N-CA 119.966 -1.111 . . . . 0.0 111.769 -178.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -127.81 17.76 6.79 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.371 0.605 . . . . 0.0 110.273 177.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -129.24 150.94 50.41 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.908 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.527 ' O ' HG12 ' A' ' 43' ' ' VAL . 87.2 t -104.06 113.2 40.35 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.87 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 171.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.49 ' OD1' ' HA ' ' A' ' 42' ' ' ARG . 88.2 m-20 -113.88 137.5 51.58 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.343 -173.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.469 ' HB2' HD11 ' A' ' 60' ' ' LEU . 64.5 ttp -122.02 129.67 52.63 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.926 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -103.0 122.25 44.22 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 m -119.52 148.74 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.514 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.461 HG21 ' HE2' ' A' ' 38' ' ' HIS . 35.8 m -117.33 136.77 23.56 Favored Pre-proline 0 C--N 1.295 -1.785 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.429 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 91.4 Cg_endo -71.07 156.59 59.55 Favored 'Trans proline' 0 C--N 1.329 -0.494 0 C-N-CA 122.871 2.381 . . . . 0.0 111.508 177.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 N--CA 1.438 -1.072 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.299 179.157 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 35.4 t70 . . . . . 0 N--CA 1.447 -0.605 0 CA-C-O 121.382 0.61 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.402 HG12 ' HB2' ' A' ' 38' ' ' HIS . 77.0 mt -87.86 130.3 37.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.481 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -86.52 135.9 33.28 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.422 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 46.0 mt-10 -110.25 114.38 27.81 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.197 178.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.4 mt -107.14 109.27 27.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -101.51 126.7 48.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.222 -175.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.449 HD23 ' CD1' ' A' ' 17' ' ' ILE . 5.1 mp -116.69 -178.89 3.53 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.036 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.0 p -139.28 157.98 44.96 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.2 t -64.08 -36.66 77.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 175.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -83.21 65.64 8.35 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.695 174.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.449 ' CD1' HD23 ' A' ' 13' ' ' LEU . 18.1 tt -123.44 149.36 27.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.1 152.14 26.69 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.731 176.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -64.02 -34.82 78.86 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.182 0.515 . . . . 0.0 109.924 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -62.32 -40.34 96.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.155 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.593 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 20.8 t70 -65.42 -36.92 85.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.055 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.7 mt -61.51 -42.85 95.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -60.31 -42.72 96.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.596 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -63.81 -44.15 94.13 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.3 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.593 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 75.6 mmtt -63.97 -43.9 94.37 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -176.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.545 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 11.1 m -67.92 -28.91 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.606 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.89 -44.69 94.09 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.227 0.537 . . . . 0.0 109.626 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -75.2 -36.92 61.35 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.234 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.507 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -59.63 -37.56 78.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.021 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.628 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 94.0 mt -61.9 -41.29 97.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.192 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -59.74 -45.09 93.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.086 0.469 . . . . 0.0 111.303 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -66.37 -36.2 82.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.876 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 96.8 mt -63.11 -40.0 96.36 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.067 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.628 ' HG3' ' O ' ' A' ' 30' ' ' LEU . 60.4 mt-10 -59.48 -33.3 71.15 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.987 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -79.84 -5.35 55.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.011 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.45 18.4 62.32 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.713 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -92.85 153.66 18.71 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.338 0.589 . . . . 0.0 111.401 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.431 ' CE1' HG22 ' A' ' 89' ' ' THR . 7.7 m80 -98.21 140.18 32.9 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.69 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 49.6 t -115.15 128.42 72.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.422 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 64.5 ttt180 -102.43 111.01 23.13 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -90.94 120.44 31.95 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.432 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 82.1 mtp180 -131.2 138.45 49.4 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.662 -177.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.528 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.4 p -129.48 135.93 60.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 121.144 0.497 . . . . 0.0 110.751 177.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -98.55 130.59 45.12 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.001 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.7 mt -95.5 125.09 39.87 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -102.43 128.31 49.08 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -172.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.98 -120.18 8.5 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.214 -0.903 . . . . 0.0 113.65 177.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 61.2 mtt85 -76.48 -9.01 58.33 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 122.927 0.491 . . . . 0.0 111.696 -175.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -66.51 -23.23 66.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.999 0.428 . . . . 0.0 110.944 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 65.9 mtt -64.12 -19.51 65.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.92 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.41 -14.71 61.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.501 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -140.64 105.98 6.42 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 122.192 0.996 . . . . 0.0 111.331 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.27 -20.61 36.92 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.337 2.691 . . . . 0.0 113.773 -176.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -20.51 66.06 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -177.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.93 99.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.117 0.484 . . . . 0.0 109.783 176.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.44 -37.82 79.43 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.43 176.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.0 t -62.62 -44.72 99.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.265 -0.468 . . . . 0.0 111.055 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.27 -40.8 95.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.542 ' O ' HG13 ' A' ' 63' ' ' ILE . 39.1 tp -62.25 -46.72 87.59 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.287 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.6 mt -65.29 -41.13 94.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.054 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -64.78 -35.39 80.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.954 0.407 . . . . 0.0 110.5 179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -63.03 -41.56 99.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.538 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 59' ' ' LEU . 63.1 mt -64.32 -43.99 97.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.138 176.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 53.4 t-105 -56.48 -42.32 78.07 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.158 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.7 p -64.37 -21.8 66.75 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.58 -0.448 . . . . 0.0 112.133 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 66.9 mtt -83.05 -31.69 27.24 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.5 pt -108.16 -4.7 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -54.45 -30.5 53.01 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -175.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.6 ' ND2' ' HG2' ' A' ' 70' ' ' GLU . 3.7 p-10 -72.83 -23.11 60.72 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.6 ' HG2' ' ND2' ' A' ' 69' ' ' ASN . 61.1 mm-40 -112.25 -19.96 12.04 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.079 0.466 . . . . 0.0 110.845 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.475 ' HB1' HD12 ' A' ' 33' ' ' LEU . . . -117.76 150.64 38.77 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.551 -176.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -112.51 137.86 50.12 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 175.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -76.21 119.81 20.64 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.076 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -85.33 -38.81 18.38 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.014 0.435 . . . . 0.0 110.607 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -148.03 156.08 42.23 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.269 -177.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -77.4 155.0 81.86 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.935 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 23.2 Cg_endo -61.76 138.49 74.89 Favored 'Trans proline' 0 C--O 1.24 0.617 0 C-N-CA 122.095 1.863 . . . . 0.0 111.446 176.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 27.4 p-10 -145.21 167.24 23.27 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.244 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.575 ' CZ ' ' HA ' ' A' ' 82' ' ' ARG . 89.8 t80 -107.84 111.07 23.02 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.112 0.482 . . . . 0.0 110.486 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -138.58 126.06 21.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.399 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.67 34.42 88.87 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.841 177.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.575 ' HA ' ' CZ ' ' A' ' 79' ' ' PHE . 89.2 mtt180 70.74 11.3 7.18 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -120.58 145.54 47.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.401 175.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.528 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 92.7 t -99.27 114.16 36.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 173.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 80.8 m-20 -110.25 147.58 33.54 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.987 0.422 . . . . 0.0 112.093 -173.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.663 ' SD ' HG12 ' A' ' 88' ' ' VAL . 17.8 tmm? -145.48 130.55 18.38 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -112.32 130.95 55.78 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.128 0.489 . . . . 0.0 111.206 -175.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.663 HG12 ' SD ' ' A' ' 86' ' ' MET . 15.2 m -119.81 135.91 58.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.496 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.431 HG22 ' CE1' ' A' ' 38' ' ' HIS . 37.9 m -105.84 133.51 20.17 Favored Pre-proline 0 N--CA 1.431 -1.4 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 176.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.04 151.01 84.96 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.185 1.924 . . . . 0.0 110.189 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 N--CA 1.447 -0.6 0 CA-C-O 121.123 0.487 . . . . 0.0 110.764 -179.669 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.601 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 7.5 m-20 . . . . . 0 CA--C 1.504 -0.808 0 CA-C-O 120.796 0.332 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 88.3 mt -103.99 115.01 45.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.198 0.523 . . . . 0.0 109.599 176.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.426 ' HG2' ' CE1' ' A' ' 32' ' ' PHE . 4.0 mptp? -81.99 143.34 31.66 Favored 'General case' 0 CA--C 1.489 -1.367 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.202 -177.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -109.59 126.93 54.13 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.522 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.439 HG23 ' HD2' ' A' ' 25' ' ' LYS . 31.8 mm -100.54 107.22 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.197 178.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 2.1 mptt -80.47 139.94 36.17 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.651 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.448 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 60.7 mt -133.67 164.79 26.42 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.624 -177.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 63.5 m -141.46 151.46 43.4 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.6 t -61.03 -42.19 92.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -81.99 62.95 6.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.635 176.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.5 tt -115.68 151.07 17.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.856 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.11 150.82 21.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.339 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -62.76 -34.31 76.96 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.924 0.392 . . . . 0.0 110.899 -178.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -62.46 -41.26 98.64 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -66.63 -35.73 80.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.76 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 94.1 mt -61.49 -42.71 94.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.261 0.553 . . . . 0.0 109.563 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -60.46 -44.33 95.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.222 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -63.44 -44.31 94.89 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.069 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.439 ' HD2' HG23 ' A' ' 11' ' ' ILE . 49.7 mmtm -63.26 -45.39 91.72 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.525 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 17.3 m -67.09 -36.61 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.621 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -60.54 -47.09 87.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.203 0.525 . . . . 0.0 110.099 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -68.29 -39.25 82.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.579 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.96 -36.22 80.79 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.842 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.605 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 88.6 mt -60.71 -40.26 91.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.086 -178.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.58 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 62.7 mt-10 -61.21 -41.73 97.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.839 -177.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.426 ' CE1' ' HG2' ' A' ' 9' ' ' LYS . 93.4 m-85 -63.6 -37.76 88.55 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.192 0.52 . . . . 0.0 110.35 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 90' ' ' PRO . 97.2 mt -63.62 -42.22 98.22 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.567 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.605 ' HG3' ' O ' ' A' ' 30' ' ' LEU . 40.3 mt-10 -61.84 -21.37 64.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.309 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.58 ' HG2' ' O ' ' A' ' 31' ' ' GLU . 73.3 mm-40 -84.52 -6.6 59.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.799 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.3 15.16 59.21 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.627 -177.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.601 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 63.8 mttp -105.11 177.21 4.92 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 120.978 0.418 . . . . 0.0 110.512 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -112.84 158.78 19.74 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.843 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.6 t -113.42 130.24 67.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -98.8 102.41 14.13 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.696 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 69.3 m-85 -85.91 117.37 24.72 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 120.594 -0.442 . . . . 0.0 109.959 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 82.6 mtp180 -125.94 110.42 13.59 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.243 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.548 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.8 p -107.13 128.42 62.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-O 121.234 0.54 . . . . 0.0 110.955 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.406 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 83.8 t80 -95.55 132.4 40.71 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.033 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.0 mt -81.26 83.11 6.94 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.223 0.535 . . . . 0.0 110.355 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -76.54 131.18 38.81 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.143 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.66 -140.82 16.52 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.475 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -105.75 -2.49 23.17 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.393 0.616 . . . . 0.0 109.92 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -74.04 -2.46 24.37 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.298 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.499 ' SD ' ' HD2' ' A' ' 82' ' ' ARG . 56.6 ttm -61.6 -22.18 65.0 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 122.52 0.328 . . . . 0.0 111.801 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.34 -13.66 60.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.938 0.399 . . . . 0.0 111.124 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.432 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 26.3 p -123.14 103.56 36.04 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.256 0.551 . . . . 0.0 111.482 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 52' ' ' THR . 37.1 Cg_endo -67.75 -18.25 47.6 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.2 2.6 . . . . 0.0 112.548 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -63.52 -29.19 70.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.041 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.93 -43.62 86.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.03 0.443 . . . . 0.0 110.606 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.405 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -66.16 -41.52 94.87 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.862 177.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.09 -44.64 97.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.739 0.304 . . . . 0.0 110.639 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.0 -41.08 97.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.887 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.6 tp -62.8 -45.28 93.38 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.212 0.529 . . . . 0.0 110.19 177.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.449 HD13 ' HB2' ' A' ' 86' ' ' MET . 98.0 mt -64.03 -40.16 95.7 Favored 'General case' 0 C--O 1.212 -0.876 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.812 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -58.19 -41.89 84.95 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.719 0.295 . . . . 0.0 111.156 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -63.96 -46.34 85.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.462 0.648 . . . . 0.0 109.738 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.413 ' CD1' HD11 ' A' ' 13' ' ' LEU . 96.3 mt -65.06 -42.67 95.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.171 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.494 ' CZ2' ' HB2' ' A' ' 73' ' ' ARG . 28.1 t-105 -56.45 -40.19 74.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.78 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.2 m -61.13 -34.2 74.61 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.269 0.557 . . . . 0.0 110.736 178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 98.2 mmm -69.33 -39.25 78.31 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.261 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.9 pt -97.49 -10.06 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -174.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.06 -14.93 7.61 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -177.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -61.67 -41.95 98.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.902 0.382 . . . . 0.0 110.218 178.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -126.52 14.94 7.65 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.902 -175.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -134.73 144.68 47.87 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.329 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -113.41 142.12 46.27 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 175.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.494 ' HB2' ' CZ2' ' A' ' 64' ' ' TRP . 53.7 ttp180 -95.47 114.55 26.33 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.642 -177.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -65.51 -41.15 93.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.86 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -155.73 160.45 40.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.934 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -69.11 161.28 74.0 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 123.346 0.404 . . . . 0.0 110.054 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.61 146.05 97.76 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.544 2.163 . . . . 0.0 112.306 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -138.41 137.83 37.63 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.592 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -89.59 125.35 35.19 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.703 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -142.32 125.42 16.31 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.29 -109.25 2.8 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.499 ' HD2' ' SD ' ' A' ' 50' ' ' MET . 29.0 mmt180 -125.42 12.81 8.16 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.12 0.486 . . . . 0.0 110.627 176.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 95.5 m-85 -119.85 151.32 39.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.339 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.548 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 76.5 t -108.94 122.25 63.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 171.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 87.5 m-20 -112.49 143.04 44.3 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -171.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.449 ' HB2' HD13 ' A' ' 60' ' ' LEU . 62.5 ttp -138.5 126.89 23.09 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.192 175.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -104.04 126.35 51.09 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.1 m -117.77 140.34 41.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.227 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.3 m -107.0 138.84 19.93 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.411 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 55.6 Cg_endo -64.23 140.3 70.34 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 122.115 1.876 . . . . 0.0 111.978 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt . . . . . 0 N--CA 1.44 -0.943 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 176.936 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.492 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 34.6 t70 . . . . . 0 CA--C 1.508 -0.654 0 CA-C-O 120.991 0.424 . . . . 0.0 109.887 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 82.9 mt -88.84 129.68 39.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.148 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.484 ' HG3' ' CD1' ' A' ' 32' ' ' PHE . 73.6 mmtt -85.43 135.82 33.7 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.657 -177.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -107.6 107.83 18.84 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.086 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.9 mm -92.43 106.62 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -84.02 133.64 34.66 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.888 -178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.436 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 66.0 mt -125.17 169.49 12.16 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.733 -177.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.468 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 40.0 m -140.78 150.66 43.64 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -59.96 -43.73 93.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.273 0.558 . . . . 0.0 109.586 174.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -78.77 62.26 3.23 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 121.743 0.782 . . . . 0.0 110.311 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 14' ' ' SER . 18.8 tt -111.21 161.21 9.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.836 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.599 -178.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.35 150.22 22.82 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.239 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -66.69 -38.47 86.85 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.645 -177.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -67.7 -33.26 74.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.906 0.384 . . . . 0.0 110.231 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -64.2 -38.1 89.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.835 177.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.5 ' O ' HG23 ' A' ' 26' ' ' VAL . 92.5 mt -62.88 -43.64 99.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.568 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -61.38 -42.62 99.01 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.784 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -62.36 -47.4 84.36 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.987 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -65.72 -40.67 92.43 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -178.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 22' ' ' ILE . 2.3 m -64.09 -35.54 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.535 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -61.76 -41.54 97.81 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.405 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 7.0 m80 -67.98 -41.74 81.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.095 176.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.526 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -59.58 -37.53 78.74 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.703 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.522 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 94.1 mt -61.8 -39.35 91.4 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.519 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.538 ' HA ' ' OE1' ' A' ' 34' ' ' GLU . 46.0 mt-10 -65.16 -44.57 88.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.375 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.484 ' CD1' ' HG3' ' A' ' 9' ' ' LYS . 90.0 m-85 -65.68 -34.49 78.33 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.917 0.389 . . . . 0.0 111.15 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 93.7 mt -62.93 -39.65 95.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.736 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.538 ' OE1' ' HA ' ' A' ' 31' ' ' GLU . 45.3 mt-10 -51.36 -40.79 59.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.77 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -70.69 -4.82 25.54 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.94 20.65 49.37 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.562 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.538 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 63.5 mttm -101.07 177.04 5.06 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 120.997 0.427 . . . . 0.0 110.599 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.431 ' NE2' HG23 ' A' ' 89' ' ' THR . 15.0 m170 -112.69 155.59 24.22 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.921 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.9 t -116.07 127.96 73.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 173.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -102.63 109.8 21.53 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -88.49 112.37 22.89 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.337 -0.545 . . . . 0.0 109.708 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.684 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 76.4 mtp85 -115.78 120.39 39.14 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.634 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.537 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.6 p -121.07 129.69 75.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.232 0.539 . . . . 0.0 111.349 -178.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -95.49 130.68 42.23 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.0 mt -78.67 84.57 4.76 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.87 0.367 . . . . 0.0 111.043 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -83.65 120.6 26.17 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.86 -133.56 7.22 Favored Glycine 0 N--CA 1.433 -1.555 0 C-N-CA 120.216 -0.993 . . . . 0.0 112.106 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -124.59 10.43 8.46 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.484 0.659 . . . . 0.0 110.543 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -80.91 6.06 14.36 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.23 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 96.5 mtp -65.62 -30.38 71.09 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.055 0.455 . . . . 0.0 110.562 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.96 -26.92 66.39 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.723 178.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.5 m -143.39 116.91 6.03 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.148 0.499 . . . . 0.0 111.044 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.06 2.96 4.93 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 123.487 2.791 . . . . 0.0 113.269 -176.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -59.5 -36.05 75.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.8 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.96 -43.8 94.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.146 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.401 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -68.98 -43.32 73.68 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.315 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.4 t -63.39 -47.25 92.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-O 120.578 0.228 . . . . 0.0 111.069 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.06 -37.14 86.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.421 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.2 tp -61.2 -49.55 76.7 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.962 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.476 HD11 ' HB3' ' A' ' 77' ' ' PRO . 88.5 mt -65.22 -42.15 93.74 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.826 -177.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -67.83 -35.33 78.4 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -63.77 -42.71 97.74 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.501 0.667 . . . . 0.0 109.297 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.475 HG12 HG22 ' A' ' 22' ' ' ILE . 86.7 mt -64.4 -43.55 97.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.876 -1.057 . . . . 0.0 109.889 177.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 -57.29 -40.05 77.01 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.789 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 91.5 m -60.88 -29.43 69.55 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 121.102 0.477 . . . . 0.0 111.225 -178.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 67.6 mtt -72.5 -35.07 68.07 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.407 HD12 HG12 ' A' ' 88' ' ' VAL . 37.1 pt -102.37 -7.36 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -174.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 65' ' ' THR . 15.2 pt-20 -58.91 -16.02 15.62 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -177.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -70.67 -14.07 62.32 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.447 ' HA ' ' HD2' ' A' ' 91' ' ' LYS . 11.6 pt-20 -150.19 29.89 0.71 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.57 0.7 . . . . 0.0 110.259 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -147.23 153.27 39.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.723 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.467 ' OD1' ' HB ' ' A' ' 89' ' ' THR . 7.2 p30 -123.89 135.8 53.95 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -70.68 110.75 5.67 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.086 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -69.31 -43.24 74.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.211 0.529 . . . . 0.0 109.779 178.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -153.85 143.78 21.95 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.71 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -62.77 157.62 57.91 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.859 176.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 31.4 Cg_exo -59.45 142.42 98.95 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.156 1.904 . . . . 0.0 111.968 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -137.51 133.41 34.53 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.447 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -87.69 118.67 27.35 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.989 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -130.85 110.89 11.63 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.944 -178.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.14 -97.58 0.6 Allowed Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.629 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.34 8.11 5.97 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.859 0.361 . . . . 0.0 110.626 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 65.3 m-85 -119.8 141.87 49.11 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.448 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.537 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 97.2 t -103.8 118.22 50.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 172.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.684 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 35.0 m-80 -109.14 143.97 37.82 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -173.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -149.84 137.03 19.69 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.1 mt -112.92 134.32 54.48 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.407 HG12 HD12 ' A' ' 67' ' ' ILE . 14.6 m -117.22 133.72 63.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.58 176.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.482 ' CG2' ' HD2' ' A' ' 90' ' ' PRO . 14.6 m -109.27 143.89 28.64 Favored Pre-proline 0 C--N 1.302 -1.485 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 60.7 Cg_endo -65.46 152.99 80.23 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.989 1.793 . . . . 0.0 109.352 177.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.447 ' HD2' ' HA ' ' A' ' 70' ' ' GLU . 37.0 tttm . . . . . 0 C--N 1.323 -0.573 0 CA-C-O 121.235 0.54 . . . . 0.0 111.105 -174.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.424 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 21.9 t0 . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 121.047 0.451 . . . . 0.0 110.007 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 90.4 mt -118.71 133.4 65.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.718 -176.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 68.1 mmtt -84.12 121.81 27.96 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.607 0.718 . . . . 0.0 111.21 -175.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.454 ' OE1' ' HD3' ' A' ' 42' ' ' ARG . 47.9 mm-40 -93.47 105.53 17.58 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.12 -178.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.6 mt -108.29 110.82 33.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.385 0.612 . . . . 0.0 110.297 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 87.6 tttt -101.16 130.23 47.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.197 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.451 HD22 ' HG3' ' A' ' 25' ' ' LYS . 82.1 mt -129.23 -177.29 4.18 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.431 -178.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 p -137.53 158.22 44.86 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.726 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.41 ' HB ' ' OE1' ' A' ' 49' ' ' GLU . 72.4 t -64.19 -41.91 93.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.645 0.736 . . . . 0.0 109.169 177.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -90.28 71.94 7.15 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.384 177.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.4 tt -124.19 146.42 29.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.901 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.9 143.04 52.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.315 177.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -64.89 -32.42 74.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.519 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -62.08 -39.18 91.55 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.224 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.469 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 9.5 t70 -65.41 -37.81 88.05 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.569 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.418 ' O ' HG21 ' A' ' 26' ' ' VAL . 93.4 mt -62.05 -42.58 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.081 0.467 . . . . 0.0 109.95 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -59.52 -41.59 90.32 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.533 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -63.29 -43.33 98.19 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.574 177.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 75.5 mmtt -65.23 -44.74 87.26 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 22' ' ' ILE . 2.5 m -64.51 -34.44 69.63 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.653 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -60.32 -44.37 95.53 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 176.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.412 ' O ' ' HD2' ' A' ' 32' ' ' PHE . 11.2 m170 -64.5 -42.44 95.84 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.837 177.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.543 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -55.13 -48.62 73.39 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.661 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.62 -41.88 99.26 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.795 0.331 . . . . 0.0 111.099 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.5 -31.05 72.1 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.72 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.412 ' HD2' ' O ' ' A' ' 28' ' ' HIS . 82.4 m-85 -85.95 -31.7 21.96 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 121.059 -0.257 . . . . 0.0 111.483 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 86.9 mt -62.52 -44.97 95.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.96 0.41 . . . . 0.0 111.245 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -18.51 61.34 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.669 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -77.03 -13.63 59.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.887 0.375 . . . . 0.0 110.338 177.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.37 12.97 50.03 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.309 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.424 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 96.9 mttt -103.48 -179.56 3.99 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.107 0.48 . . . . 0.0 111.202 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -116.65 155.8 28.18 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.927 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.7 t -121.25 131.08 73.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 175.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -109.84 116.72 32.17 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 176.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -89.47 120.62 30.95 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 12.8 mtm180 -120.9 115.7 23.73 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -178.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.483 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 4.1 p -112.96 124.4 69.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.425 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.46 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 77.7 t80 -101.09 124.01 46.14 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.56 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.404 ' CD1' ' HA ' ' A' ' 50' ' ' MET . 34.2 mt -77.24 107.34 9.57 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -67.37 -78.84 0.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -171.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.529 ' C ' ' H ' ' A' ' 49' ' ' GLU . . . -126.13 119.74 3.53 Favored Glycine 0 CA--C 1.499 -0.908 0 C-N-CA 119.853 -1.165 . . . . 0.0 112.666 -175.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 72.18 -21.34 0.23 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.764 0.826 . . . . 0.0 111.308 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.529 ' H ' ' C ' ' A' ' 47' ' ' GLY . 14.9 mt-10 -61.94 -32.98 73.44 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.981 0.912 . . . . 0.0 110.623 178.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.459 ' SD ' ' HD2' ' A' ' 82' ' ' ARG . 44.3 ttm -63.61 -19.08 64.56 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.128 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.33 -13.62 61.14 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.913 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.405 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 32.3 m -140.78 101.27 6.52 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 121.334 0.588 . . . . 0.0 110.787 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 52' ' ' THR . 39.7 Cg_endo -68.7 -16.55 42.17 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.421 2.747 . . . . 0.0 112.321 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -58.48 -34.11 70.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.646 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.66 94.89 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.475 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.419 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -64.45 -40.98 98.19 Favored Glycine 0 CA--C 1.504 -0.654 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.859 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.8 t -66.26 -44.19 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 120.664 0.268 . . . . 0.0 110.734 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.2 -40.69 90.94 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.958 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.7 tp -61.89 -47.85 83.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.654 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.416 HD13 ' HB3' ' A' ' 77' ' ' PRO . 87.3 mt -65.26 -41.74 93.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.742 -178.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -64.49 -36.93 85.79 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.973 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -61.62 -43.53 98.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.464 0.65 . . . . 0.0 109.255 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.85 -44.12 96.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.462 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.411 ' CE3' HG13 ' A' ' 67' ' ' ILE . 50.8 t-105 -59.61 -35.84 75.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.377 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.6 m -60.3 -24.57 65.09 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.085 0.469 . . . . 0.0 110.85 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 92.6 mtp -91.55 -28.25 17.68 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.148 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.549 ' O ' ' HB1' ' A' ' 71' ' ' ALA . 32.8 pt -111.27 16.07 8.11 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -176.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -21.21 66.52 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.426 0.631 . . . . 0.0 111.08 178.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -73.93 134.97 43.24 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.093 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.435 ' N ' ' HZ1' ' A' ' 91' ' ' LYS . 10.0 pt-20 54.57 5.9 0.1 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.811 1.244 . . . . 0.0 113.295 -176.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.549 ' HB1' ' O ' ' A' ' 67' ' ' ILE . . . -124.02 161.55 25.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.813 0.339 . . . . 0.0 110.691 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -140.14 150.46 44.28 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -83.36 122.35 28.35 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 118.655 -1.218 . . . . 0.0 109.711 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.509 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 16.5 t70 -81.44 -15.85 53.82 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.406 0.622 . . . . 0.0 109.421 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -159.97 156.39 27.04 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.075 -175.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -93.68 151.57 40.1 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 14.8 Cg_exo -63.81 132.65 35.75 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.519 1.479 . . . . 0.0 110.689 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.428 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 58.3 t30 -148.43 149.41 31.66 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.133 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -91.83 111.73 23.37 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -152.22 129.49 11.26 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.68 -178.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.26 25.57 74.15 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.448 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.459 ' HD2' ' SD ' ' A' ' 50' ' ' MET . 42.4 mmt180 70.13 8.36 6.63 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 123.883 0.873 . . . . 0.0 112.041 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.46 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 55.1 m-85 -117.74 144.55 45.19 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.273 176.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.483 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 91.1 t -98.65 110.57 26.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 171.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 9.6 p30 -111.44 146.01 37.97 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -172.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 63.8 ttp -145.08 138.01 26.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.252 175.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 17.0 mt -110.61 135.35 51.37 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 120.785 0.326 . . . . 0.0 111.483 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.2 m -120.05 132.95 68.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 121.337 0.589 . . . . 0.0 110.979 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.509 ' OG1' ' HB2' ' A' ' 74' ' ' ASP . 28.2 m -121.25 143.16 36.7 Favored Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 91.8 Cg_endo -71.84 154.95 58.63 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.926 1.751 . . . . 0.0 109.929 177.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.435 ' HZ1' ' N ' ' A' ' 70' ' ' GLU . 63.9 mttp . . . . . 0 C--N 1.321 -0.65 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.559 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.562 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 27.1 t70 . . . . . 0 CA--C 1.512 -0.506 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 90.4 mt -88.95 129.1 40.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 120.992 0.425 . . . . 0.0 110.638 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -91.23 140.6 29.64 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-O 121.789 0.804 . . . . 0.0 111.43 -176.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.528 ' OE2' ' HD2' ' A' ' 42' ' ' ARG . 45.2 mt-10 -118.61 109.76 16.53 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.037 177.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 88.4 mt -93.14 118.98 40.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.63 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 62.3 tttm -88.82 136.68 32.88 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.643 0.735 . . . . 0.0 112.164 -177.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 46.4 mt -130.39 169.9 14.88 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.875 -178.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.513 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 19.9 m -128.7 149.84 50.52 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.0 t -64.41 -43.83 97.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.433 0.635 . . . . 0.0 109.755 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.487 ' HE2' ' O ' ' A' ' 46' ' ' LYS . 40.6 mttm -95.19 67.75 3.04 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' A' ' 14' ' ' SER . 18.8 tt -101.5 148.5 7.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.758 -174.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.83 144.85 54.16 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.175 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -63.89 -39.68 94.76 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.804 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -63.85 -38.96 93.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.741 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -62.7 -37.98 88.61 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.85 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.54 ' O ' HG23 ' A' ' 26' ' ' VAL . 79.9 mt -61.37 -48.84 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 120.954 0.406 . . . . 0.0 110.456 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -61.95 -44.63 96.35 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.603 -177.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -62.73 -50.05 72.64 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.982 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -67.86 -43.58 79.09 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 22' ' ' ILE . 60.0 t -64.54 -42.26 94.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.914 0.387 . . . . 0.0 110.074 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.48 -44.44 97.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.211 176.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -37.46 87.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.765 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.508 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -57.04 -32.82 66.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.078 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.59 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 95.2 mt -61.41 -41.51 97.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.75 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 60.6 mt-10 -65.98 -36.7 84.02 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.379 -178.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -66.79 -37.09 83.89 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.156 0.503 . . . . 0.0 110.19 177.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 94.8 mt -62.67 -40.73 97.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.798 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' A' ' 30' ' ' LEU . 51.8 mm-40 -59.3 -26.11 64.71 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.143 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 31' ' ' GLU . 74.0 mm-40 -77.39 -8.55 57.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.614 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.19 19.13 57.94 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.739 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.562 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 62.8 mttp -107.48 -178.3 3.59 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.337 0.589 . . . . 0.0 111.339 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.493 ' NE2' HG21 ' A' ' 89' ' ' THR . 7.2 m80 -113.35 146.22 39.8 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.386 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.8 t -114.78 127.59 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.386 175.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.468 ' HD2' ' OE2' ' A' ' 10' ' ' GLU . 42.4 ttm180 -111.61 113.03 25.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 177.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.625 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 93.3 m-85 -84.89 113.11 21.15 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.528 ' HD2' ' OE2' ' A' ' 10' ' ' GLU . 28.9 mtp180 -115.29 130.97 57.06 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.436 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.4 p -123.64 130.18 74.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-O 121.17 0.509 . . . . 0.0 110.626 -178.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.425 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 77.6 t80 -94.82 118.22 31.41 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.954 178.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.474 HD12 ' HA ' ' A' ' 50' ' ' MET . 35.1 mt -72.39 145.74 47.5 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.487 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 41.3 ttmt -142.4 118.0 10.37 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.924 -176.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.51 53.52 0.72 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.298 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 48' ' ' ARG . 41.0 ttm180 69.39 -0.82 2.41 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.781 0.433 . . . . 0.0 111.579 178.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.403 ' O ' HD11 ' A' ' 45' ' ' LEU . 38.0 mt-10 -70.63 1.45 5.24 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.474 ' HA ' HD12 ' A' ' 45' ' ' LEU . 1.5 mpt? -61.87 -34.51 76.13 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.135 0.493 . . . . 0.0 110.426 177.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.63 -8.19 55.6 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.111 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.1 m -124.23 92.08 48.69 Favored Pre-proline 0 N--CA 1.446 -0.645 0 CA-C-O 121.199 0.523 . . . . 0.0 111.063 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.401 ' O ' HG23 ' A' ' 57' ' ' VAL . 35.7 Cg_exo -64.5 -24.57 63.47 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.322 2.681 . . . . 0.0 111.529 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -56.76 -30.76 63.91 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.003 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.65 -38.79 82.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.027 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.16 -37.5 9.89 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.973 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 53' ' ' PRO . 63.5 t -63.85 -46.03 95.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.317 0.103 . . . . 0.0 111.141 -178.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.48 -37.47 87.43 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.031 0.443 . . . . 0.0 110.866 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.7 tp -62.01 -45.97 91.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.442 0.639 . . . . 0.0 109.759 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.429 HD13 ' HB2' ' A' ' 86' ' ' MET . 91.9 mt -67.2 -38.39 85.27 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.99 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -58.09 -39.9 79.74 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 121.074 -0.251 . . . . 0.0 110.606 177.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -60.63 -45.08 95.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.309 0.576 . . . . 0.0 109.76 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.25 -43.56 97.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.638 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -59.49 -37.49 78.41 Favored 'General case' 0 C--O 1.206 -1.201 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.991 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.2 m -61.34 -24.33 66.37 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.524 0.678 . . . . 0.0 110.69 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 97.0 mmm -84.11 -42.72 15.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.087 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.5 pt -105.23 8.08 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -173.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.91 -10.2 27.03 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -89.0 -53.35 4.63 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -96.02 -5.26 41.52 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -175.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -125.98 154.14 43.32 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.567 0.222 . . . . 0.0 110.483 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.565 ' OD1' ' HB ' ' A' ' 89' ' ' THR . 10.0 p30 -115.71 134.8 54.66 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.24 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -69.59 110.53 4.86 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.867 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.442 ' CB ' HD11 ' A' ' 87' ' ' LEU . 26.5 t70 -71.68 -46.46 58.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.197 0.522 . . . . 0.0 109.848 177.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -149.78 154.86 39.15 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.606 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.6 155.81 87.13 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.257 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -54.66 137.5 73.96 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.88 2.386 . . . . 0.0 112.56 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 49.7 t30 -128.44 150.07 50.29 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.409 -177.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -108.9 121.01 44.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.796 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -126.07 108.61 11.52 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.08 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.3 -78.91 0.31 Allowed Glycine 0 C--O 1.223 -0.544 0 C-N-CA 121.399 -0.429 . . . . 0.0 113.059 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.443 ' HD2' ' N ' ' A' ' 82' ' ' ARG . 0.6 OUTLIER -147.38 10.18 0.97 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.95 0.405 . . . . 0.0 110.605 178.1 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.425 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 89.2 m-85 -117.63 140.39 49.71 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.528 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.436 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 69.1 t -112.81 130.26 66.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 175.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.625 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 9.4 p30 -133.21 143.27 49.05 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -175.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.429 ' HB2' HD13 ' A' ' 60' ' ' LEU . 64.8 ttp -127.68 136.35 51.46 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.578 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.442 HD11 ' CB ' ' A' ' 74' ' ' ASP . 2.7 tm? -110.52 127.02 54.99 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.001 0.429 . . . . 0.0 109.853 -178.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.45 ' O ' ' HD2' ' A' ' 38' ' ' HIS . 19.1 m -120.1 134.27 64.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.138 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.565 ' HB ' ' OD1' ' A' ' 72' ' ' ASN . 21.1 m -102.0 136.21 19.53 Favored Pre-proline 0 C--N 1.31 -1.133 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.731 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.489 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 80.4 Cg_endo -68.83 144.16 58.11 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.714 2.276 . . . . 0.0 110.689 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 77.2 mttt . . . . . 0 N--CA 1.441 -0.894 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.95 179.459 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.6 t70 . . . . . 0 C--O 1.24 0.56 0 CA-C-O 120.821 0.344 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 88.7 mt -97.37 133.85 37.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.028 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -90.5 147.1 23.6 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.67 -175.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -125.83 132.16 52.29 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.693 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -120.54 112.12 34.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.403 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -85.4 141.91 29.65 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.608 -176.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.465 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 36.6 mt -128.51 175.15 8.76 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.646 -175.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.8 p -149.93 153.69 37.05 Favored 'General case' 0 C--O 1.214 -0.815 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 176.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -70.22 -20.6 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-O 121.621 0.724 . . . . 0.0 110.321 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -89.05 15.76 8.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.714 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.4 tt -73.13 148.42 8.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.112 0.482 . . . . 0.0 111.362 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.97 152.53 21.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.186 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -63.49 -40.22 96.51 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -177.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -65.14 -29.67 70.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.029 0.443 . . . . 0.0 110.182 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -71.77 -38.85 70.29 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.328 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.54 -44.46 99.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -61.46 -41.66 97.58 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.331 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -65.51 -44.4 87.1 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.139 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -64.65 -41.81 95.86 Favored 'General case' 0 N--CA 1.461 0.088 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.0 m -62.95 -33.2 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.174 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -59.84 -48.27 82.36 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.879 0.371 . . . . 0.0 110.582 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -69.3 -37.05 77.63 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.462 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.475 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -59.39 -42.16 91.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.515 HD21 ' HB2' ' A' ' 70' ' ' GLU . 93.3 mt -62.27 -41.39 98.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.497 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.495 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 46.9 mt-10 -65.53 -38.12 88.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.472 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -70.28 -38.05 74.96 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.041 175.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 90' ' ' PRO . 85.4 mt -62.29 -45.26 94.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.905 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -64.01 -18.45 64.33 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.895 0.379 . . . . 0.0 111.641 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 80.3 mt-30 -80.25 1.01 30.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.613 177.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.3 32.62 25.06 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -119.57 157.33 28.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.934 0.397 . . . . 0.0 111.066 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.487 ' NE2' HG23 ' A' ' 89' ' ' THR . 13.0 m170 -101.61 148.03 25.71 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.398 177.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.6 t -118.65 130.04 74.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.054 0.454 . . . . 0.0 109.994 176.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -108.29 115.46 30.15 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.653 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 73.9 m-85 -90.39 121.93 32.81 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.407 ' HG2' ' HB3' ' A' ' 85' ' ' ASN . 85.1 mtp180 -125.82 121.11 32.35 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.612 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 4.2 p -112.94 131.58 64.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.24 0.543 . . . . 0.0 111.556 -176.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.403 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 84.3 t80 -93.75 121.25 35.0 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.748 177.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.5 mt -84.79 85.53 7.44 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.302 0.572 . . . . 0.0 109.969 -178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -66.06 129.6 40.36 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.06 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.64 -148.32 16.64 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.108 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -95.0 8.2 43.67 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.985 0.422 . . . . 0.0 110.286 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -63.84 -18.5 64.2 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.682 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 67.1 mtt -65.02 -10.32 28.74 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.53 -27.32 68.37 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-O 121.118 0.485 . . . . 0.0 110.387 176.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.4 t -129.99 109.51 16.85 Favored Pre-proline 0 N--CA 1.44 -0.948 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.832 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -63.77 -19.77 67.62 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.225 2.616 . . . . 0.0 112.075 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -60.32 -29.75 69.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.588 -177.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.34 -44.82 92.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.11 0.481 . . . . 0.0 110.364 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.451 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -69.86 -39.16 75.87 Favored Glycine 0 CA--C 1.506 -0.519 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.835 178.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.486 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 59.5 t -63.39 -44.7 99.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.628 0.251 . . . . 0.0 110.722 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.63 -37.91 83.01 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.343 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.4 tp -62.04 -45.44 93.53 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.453 HD13 ' HB2' ' A' ' 86' ' ' MET . 93.4 mt -65.71 -39.19 90.96 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.161 179.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 57' ' ' VAL . 61.8 mm-40 -55.83 -44.84 78.33 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.571 177.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -65.8 -42.49 90.62 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.162 0.506 . . . . 0.0 110.944 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.6 mt -64.77 -42.39 94.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.289 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -55.04 -45.21 75.21 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.043 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.0 p -66.58 -19.93 65.89 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.736 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 96.8 mmm -75.41 -38.54 59.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.556 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.9 pt -104.47 -7.58 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -174.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -58.5 -16.75 16.65 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.063 0.458 . . . . 0.0 111.904 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -64.38 -41.16 96.83 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.678 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.515 ' HB2' HD21 ' A' ' 30' ' ' LEU . 40.9 mt-10 -124.3 14.44 8.97 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.245 0.545 . . . . 0.0 110.914 -178.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.65 142.27 37.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.646 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -114.98 145.4 42.29 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.995 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.0 ttt-85 -70.89 121.77 18.72 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.385 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.415 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 26.2 t70 -93.63 -42.45 9.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.361 0.601 . . . . 0.0 109.998 176.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -144.33 157.67 44.15 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.796 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -86.12 154.11 57.39 Favored Pre-proline 0 C--N 1.316 -0.848 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.401 ' CG ' HG11 ' A' ' 57' ' ' VAL . 12.2 Cg_endo -54.38 132.07 48.83 Favored 'Trans proline' 0 C--O 1.24 0.593 0 C-N-CA 122.674 2.249 . . . . 0.0 112.388 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -129.42 131.37 46.75 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.742 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.403 ' HB2' HG23 ' A' ' 84' ' ' VAL . 83.8 t80 -98.61 109.16 21.96 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.983 177.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -152.53 139.11 18.7 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.268 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.35 31.49 68.64 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.948 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 69.47 10.25 7.61 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 122.997 0.519 . . . . 0.0 112.14 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.403 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 56.3 m-85 -126.12 144.02 50.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.746 178.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.612 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 91.7 t -102.28 122.89 55.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 173.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.653 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 7.0 p30 -129.75 146.69 51.5 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -173.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.453 ' HB2' HD13 ' A' ' 60' ' ' LEU . 64.0 ttp -139.85 143.78 36.93 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.848 178.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 16.1 mt -107.6 129.76 54.96 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.475 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.6 m -122.06 135.33 62.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.562 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.487 HG23 ' NE2' ' A' ' 38' ' ' HIS . 17.9 m -108.89 143.15 27.0 Favored Pre-proline 0 C--N 1.306 -1.292 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.202 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.484 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 46.7 Cg_endo -63.73 143.57 86.96 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.256 1.971 . . . . 0.0 111.179 178.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt . . . . . 0 C--N 1.324 -0.543 0 CA-C-O 121.354 0.597 . . . . 0.0 111.945 -179.736 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--O 1.237 0.398 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.6 p -87.65 -18.84 8.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.556 0.693 . . . . 0.0 110.394 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 90.7 mt -85.18 108.6 17.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.704 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -91.11 127.99 36.75 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.22 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.436 HG12 ' HB2' ' A' ' 38' ' ' HIS . 77.5 mt -119.44 132.16 70.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-O 120.845 0.355 . . . . 0.0 111.272 -175.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 74.2 mmtt -97.45 130.59 44.54 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.404 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 43.2 mt-10 -107.83 97.65 7.34 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.8 mt -88.74 125.09 41.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.639 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -96.98 145.87 25.52 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.197 -176.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.5 mp -135.69 176.89 8.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.279 173.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.441 ' HA ' HG23 ' A' ' 43' ' ' VAL . 16.2 p -139.1 156.22 47.32 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.85 -42.94 94.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.238 0.542 . . . . 0.0 109.995 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -95.33 76.46 3.4 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.495 HD13 ' OD2' ' A' ' 21' ' ' ASP . 19.3 tt -125.38 148.5 29.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.114 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.6 142.09 44.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.161 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -64.52 -33.73 76.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.955 0.407 . . . . 0.0 110.976 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.49 -40.71 92.35 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.526 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.495 ' OD2' HD13 ' A' ' 17' ' ' ILE . 23.2 t70 -66.6 -39.08 88.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.574 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.3 mt -62.92 -45.66 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.167 0.508 . . . . 0.0 110.271 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -61.1 -42.51 98.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.494 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -63.14 -44.32 95.89 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.954 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -64.93 -41.64 95.36 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 m -63.8 -28.83 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.508 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -60.06 -49.8 76.21 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 120.99 0.424 . . . . 0.0 110.49 176.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -68.3 -36.75 79.81 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.312 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.576 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -56.41 -45.62 80.56 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.025 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.635 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 88.9 mt -62.67 -42.83 99.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.073 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.01 -39.95 95.25 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.67 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -68.39 -34.43 76.02 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.931 0.396 . . . . 0.0 111.125 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 95.0 mt -63.6 -39.85 95.43 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.635 ' HG3' ' O ' ' A' ' 30' ' ' LEU . 63.3 mt-10 -61.02 -22.71 64.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.546 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -85.13 -6.35 59.3 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.59 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.05 19.61 55.29 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.706 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -105.81 172.41 6.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.173 0.511 . . . . 0.0 111.2 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.436 ' HB2' HG12 ' A' ' 8' ' ' ILE . 12.3 m80 -104.82 145.57 30.2 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.02 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.526 ' O ' HD12 ' A' ' 87' ' ' LEU . 41.5 t -118.33 125.71 74.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.404 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 71.2 ttt180 -102.74 115.19 30.1 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -90.2 116.64 28.35 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -122.45 132.99 54.61 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.575 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 4.9 p -128.26 131.29 69.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 121.061 0.458 . . . . 0.0 110.31 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.45 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 88.0 t80 -104.58 129.14 52.71 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.484 ' CD1' ' HA ' ' A' ' 50' ' ' MET . 30.0 mt -73.49 128.02 34.34 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -60.5 -46.2 90.99 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -171.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.63 -61.55 0.15 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.163 -1.018 . . . . 0.0 112.671 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.407 ' HD2' ' N ' ' A' ' 48' ' ' ARG . 6.6 mpt_? -67.05 -37.32 83.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.141 0.496 . . . . 0.0 111.512 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.426 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 1.1 pm0 -80.45 -3.95 51.83 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.952 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.484 ' HA ' ' CD1' ' A' ' 45' ' ' LEU . 56.3 ttm -63.21 -19.68 64.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.871 0.367 . . . . 0.0 111.351 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.51 -11.1 59.82 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.251 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.0 m -131.19 100.06 17.25 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 121.153 0.501 . . . . 0.0 111.449 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.34 -25.71 71.42 Favored 'Trans proline' 0 N--CA 1.477 0.504 0 C-N-CA 123.505 2.803 . . . . 0.0 112.511 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -63.07 -25.5 68.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.523 -177.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.3 -44.96 94.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.881 0.372 . . . . 0.0 110.32 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.1 -38.38 92.29 Favored Glycine 0 CA--C 1.506 -0.474 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.614 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.451 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 99.1 t -62.74 -47.3 93.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.516 -0.342 . . . . 0.0 110.831 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.09 -37.79 88.62 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.042 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.9 tp -62.57 -47.58 83.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.071 0.463 . . . . 0.0 110.239 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.421 HD12 HG13 ' A' ' 84' ' ' VAL . 62.1 mt -66.15 -39.6 89.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.666 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 57' ' ' VAL . 71.1 mt-10 -60.58 -36.66 79.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.684 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -63.84 -39.91 95.35 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.9 mt -61.7 -47.73 91.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.789 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.463 ' CZ2' ' HB2' ' A' ' 73' ' ' ARG . 40.3 t-105 -58.04 -40.64 81.4 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.414 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.425 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 19.0 m -61.28 -39.76 91.61 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.082 0.467 . . . . 0.0 110.728 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 97.3 mmm -66.78 -41.98 86.79 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.4 pt -105.06 -0.26 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -173.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 65' ' ' THR . 0.1 OUTLIER -56.31 -18.68 11.44 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.675 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -65.71 -36.55 83.93 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.492 ' HB2' HD22 ' A' ' 30' ' ' LEU . 47.8 mt-10 -122.75 6.09 9.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.801 0.334 . . . . 0.0 111.598 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -121.18 152.47 38.75 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.959 0.409 . . . . 0.0 111.752 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -112.23 148.37 34.25 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.477 ' NH2' ' HG2' ' A' ' 76' ' ' GLU . 74.9 ttt180 -90.94 111.12 22.42 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 120.763 0.316 . . . . 0.0 111.102 -176.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -72.71 -38.73 67.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.8 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -163.28 -177.8 5.56 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.902 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.477 ' HG2' ' NH2' ' A' ' 73' ' ' ARG . 42.4 mt-10 -91.92 150.62 40.97 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.971 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.425 ' HG2' HG11 ' A' ' 57' ' ' VAL . 34.7 Cg_endo -68.99 132.26 24.17 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.106 1.871 . . . . 0.0 110.541 174.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 62.7 t30 -147.63 151.49 36.3 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.82 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.511 ' CE1' ' HA ' ' A' ' 82' ' ' ARG . 91.1 t80 -86.87 115.48 24.31 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.744 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.97 109.74 3.65 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.181 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.54 31.57 21.38 Favored Glycine 0 C--O 1.223 -0.559 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.327 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.511 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . 96.4 mtt180 69.25 3.49 4.14 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.749 0.82 . . . . 0.0 112.15 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.45 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 89.7 m-85 -121.12 137.58 54.59 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.427 174.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.575 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 74.2 t -99.86 124.09 53.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -130.84 142.76 50.4 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -175.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.456 ' SD ' HG13 ' A' ' 88' ' ' VAL . 16.4 tmm? -135.1 143.21 46.49 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.167 176.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.526 HD12 ' O ' ' A' ' 39' ' ' VAL . 47.9 tp -122.57 140.5 52.72 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.104 0.478 . . . . 0.0 111.438 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.456 HG13 ' SD ' ' A' ' 86' ' ' MET . 17.8 m -122.85 133.63 68.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.701 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.434 HG22 ' CE1' ' A' ' 38' ' ' HIS . 18.1 m -98.74 136.88 20.56 Favored Pre-proline 0 C--N 1.312 -1.022 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.75 144.8 84.97 Favored 'Trans proline' 0 C--N 1.326 -0.64 0 C-N-CA 122.336 2.024 . . . . 0.0 111.088 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -78.69 -3.3 43.41 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.483 0.659 . . . . 0.0 111.441 -176.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -91.2 13.92 15.76 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.83 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.38 168.92 19.19 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.686 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 66.27 24.12 10.71 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.03 -39.52 93.1 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 175.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 65.83 -48.33 0.4 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.726 1.21 . . . . 0.0 113.731 177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -112.64 -4.29 14.14 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.049 0.452 . . . . 0.0 110.582 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -84.68 69.82 10.7 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.311 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -163.04 144.09 9.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.559 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 83.5 t60 64.09 110.3 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.525 0.73 . . . . 0.0 111.838 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.105 179.217 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.0 pttm . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.48 -42.95 91.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-O 121.83 0.824 . . . . 0.0 109.563 175.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.4 mm -96.64 124.21 49.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.631 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.513 ' HB2' ' HZ2' ' A' ' 37' ' ' LYS . 16.2 m-20 -73.58 100.87 3.43 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-O 121.195 0.521 . . . . 0.0 110.833 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.443 HG12 ' HB2' ' A' ' 38' ' ' HIS . 79.8 mt -109.13 116.05 51.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 7' ' ' ASP . 3.5 mptp? -83.87 134.73 34.68 Favored 'General case' 0 CA--C 1.488 -1.427 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.675 -175.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -102.57 112.02 24.59 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.594 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.7 mt -104.11 115.09 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.099 177.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 86.5 tttt -96.58 141.28 30.03 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.991 -175.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 5.5 mp -135.52 171.21 14.78 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.868 175.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.8 m -132.5 154.18 50.19 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.614 ' HB ' ' OE1' ' A' ' 49' ' ' GLU . 86.0 t -63.53 -33.53 62.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.338 0.59 . . . . 0.0 109.777 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.497 ' HG3' ' OE2' ' A' ' 49' ' ' GLU . 65.2 mttp -97.38 76.65 2.59 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.0 tt -134.55 154.0 36.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.751 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.74 143.74 49.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.186 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -64.46 -30.2 71.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.215 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -63.28 -39.05 93.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.644 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.9 -43.08 99.58 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.089 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.1 mt -62.16 -44.83 99.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.774 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -62.12 -43.67 98.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.239 0.542 . . . . 0.0 111.625 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -64.58 -43.27 94.4 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.496 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -65.24 -42.18 93.63 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.411 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 12.9 m -63.22 -33.17 59.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.004 178.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -62.52 -41.47 98.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.454 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -67.42 -42.49 83.12 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.599 177.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.518 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -60.01 -38.84 83.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.124 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 26' ' ' VAL . 97.4 mt -62.02 -41.77 98.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.026 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.611 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 67.0 mm-40 -65.3 -43.04 92.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.549 0.214 . . . . 0.0 110.714 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -64.02 -38.04 89.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.521 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 96.7 mt -62.18 -43.57 98.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.452 0.644 . . . . 0.0 109.435 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -61.64 -22.81 65.59 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.257 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.611 ' HG2' ' O ' ' A' ' 31' ' ' GLU . 76.5 mm-40 -85.13 -8.5 58.6 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.934 0.397 . . . . 0.0 110.528 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.42 13.72 56.74 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.024 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.513 ' HZ2' ' HB2' ' A' ' 7' ' ' ASP . 75.7 mmtt -96.29 159.74 14.79 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.485 ' NE2' HG22 ' A' ' 89' ' ' THR . 23.6 m170 -107.85 147.29 31.13 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.464 ' O ' HD12 ' A' ' 87' ' ' LEU . 41.5 t -114.29 126.43 71.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -102.78 115.87 31.45 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -92.61 120.11 32.72 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 78.1 mtp180 -126.71 133.77 50.83 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.587 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.2 p -121.37 131.6 72.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 121.359 0.599 . . . . 0.0 111.217 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -101.26 124.37 46.84 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.849 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 49' ' ' GLU . 42.1 mt -76.24 133.61 40.06 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -112.31 116.81 30.98 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.082 0.467 . . . . 0.0 112.082 -174.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.48 -134.14 12.21 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.476 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 -74.84 -6.66 50.29 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.021 0.438 . . . . 0.0 110.817 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.614 ' OE1' ' HB ' ' A' ' 15' ' ' VAL . 99.5 mt-10 -60.35 -24.17 64.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.971 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 91.1 mtp -62.56 -29.27 70.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.528 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.49 -10.21 59.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.868 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.433 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 24.0 m -128.26 95.17 34.17 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-O 121.484 0.659 . . . . 0.0 111.456 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 52' ' ' THR . 37.9 Cg_endo -68.0 -18.09 46.18 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.296 2.664 . . . . 0.0 111.944 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -62.7 -31.67 72.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.936 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.74 -41.07 97.16 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.219 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.88 -38.4 95.48 Favored Glycine 0 CA--C 1.504 -0.625 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.813 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 99.4 t -63.66 -45.93 96.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 120.839 0.352 . . . . 0.0 110.413 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.17 -41.45 96.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.38 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.541 ' O ' HG13 ' A' ' 63' ' ' ILE . 44.5 tp -63.89 -47.24 81.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.785 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.8 mt -64.41 -41.18 96.77 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.938 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 57' ' ' VAL . 5.5 mm-40 -64.36 -35.74 81.88 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.52 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -63.81 -40.75 97.37 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 59' ' ' LEU . 65.9 mt -64.47 -44.98 97.02 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.865 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 57.2 t-105 -58.43 -38.15 76.87 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.599 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.9 m -57.44 -38.91 75.19 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.338 0.589 . . . . 0.0 110.225 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 98.1 mmm -67.32 -40.67 85.97 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.731 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.9 pt -102.02 -6.25 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -174.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -58.54 -21.13 51.52 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.074 0.464 . . . . 0.0 111.328 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -64.57 -33.25 75.48 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.306 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.479 ' HA ' ' HE3' ' A' ' 91' ' ' LYS . 73.3 mm-40 -131.94 6.5 4.29 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -122.0 157.56 31.07 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.957 0.408 . . . . 0.0 111.324 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -111.72 150.78 29.74 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -94.79 113.13 24.85 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 120.717 0.294 . . . . 0.0 111.172 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -77.96 -44.89 25.46 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.334 0.588 . . . . 0.0 110.422 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -145.68 149.99 35.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.332 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.438 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 9.9 pt-20 -80.38 163.15 58.39 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.402 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.577 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 29.9 Cg_endo -62.68 138.5 69.94 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 121.814 1.676 . . . . 0.0 111.981 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.566 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 23.3 p-10 -144.84 156.89 44.26 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.004 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -105.78 108.41 19.9 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.039 0.447 . . . . 0.0 110.487 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -123.33 120.08 31.99 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.511 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.72 -102.7 1.24 Allowed Glycine 0 N--CA 1.432 -1.619 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.683 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -127.17 7.13 6.5 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.738 0.304 . . . . 0.0 110.796 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -125.84 143.87 50.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.88 0.372 . . . . 0.0 111.844 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.587 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 92.3 t -99.54 124.9 53.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 172.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.577 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 10.8 m-80 -119.55 144.43 47.07 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -172.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 13.1 tmm? -145.03 132.31 20.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 39' ' ' VAL . 49.8 tp -114.91 142.74 46.18 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.062 0.458 . . . . 0.0 111.917 -175.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.0 m -124.92 158.71 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.27 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.485 HG22 ' NE2' ' A' ' 38' ' ' HIS . 25.3 m -131.86 143.51 49.37 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.434 ' HD2' ' CG2' ' A' ' 89' ' ' THR . 74.1 Cg_endo -68.17 153.86 73.7 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 122.15 1.9 . . . . 0.0 110.852 177.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 70' ' ' GLU . 97.2 mttt -65.04 85.91 0.05 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -100.66 -25.67 14.07 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.393 0.616 . . . . 0.0 109.485 175.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.92 79.61 1.47 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.037 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -94.4 -56.16 2.91 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -86.36 65.99 3.73 Favored Glycine 0 N--CA 1.438 -1.185 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -77.34 -55.42 5.41 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.18 0.514 . . . . 0.0 110.142 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 40.7 p-80 -121.95 124.59 44.4 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.11 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 26.5 p-80 -156.34 -43.53 0.07 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.441 -177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -120.08 115.2 23.23 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -148.13 162.27 39.75 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 71.9 m80 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.664 178.718 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.596 HG13 ' H ' ' A' ' 6' ' ' ILE . 1.6 t -129.67 -173.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -177.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.596 ' H ' HG13 ' A' ' 5' ' ' VAL . 84.4 mt -69.78 134.08 30.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.078 0.466 . . . . 0.0 110.907 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.551 ' OD2' ' HE2' ' A' ' 9' ' ' LYS . 7.7 t70 -70.45 119.83 15.2 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.184 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 87.1 mt -127.07 136.79 59.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.503 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.551 ' HE2' ' OD2' ' A' ' 7' ' ' ASP . 4.1 mptp? -101.55 157.82 16.54 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-O 121.793 0.806 . . . . 0.0 112.65 -177.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.415 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 46.0 mt-10 -124.74 123.23 39.54 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.848 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.9 mt -109.13 114.6 47.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -98.72 135.52 40.08 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.139 -174.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.424 HD23 HD13 ' A' ' 63' ' ' ILE . 5.5 mp -132.07 -177.09 4.29 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.61 177.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.4 p -143.73 156.51 44.55 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.486 ' HB ' ' OE2' ' A' ' 49' ' ' GLU . 79.8 t -63.67 -44.02 98.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.698 ' HG2' ' OE2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -85.48 71.29 10.8 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 173.395 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.434 HD12 ' OD2' ' A' ' 21' ' ' ASP . 16.7 tt -122.62 160.67 24.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.864 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.73 147.12 24.04 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.12 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -63.52 -33.53 75.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.014 0.435 . . . . 0.0 110.283 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -62.28 -40.54 96.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.389 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 21.1 t70 -66.9 -34.79 78.56 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.839 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.8 mt -61.77 -41.55 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.261 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -58.13 -43.6 87.37 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.752 0.787 . . . . 0.0 109.795 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -61.88 -43.96 97.78 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.689 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 74.2 mmtt -61.96 -46.88 87.33 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.246 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.408 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 9.7 m -71.35 -32.96 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -60.76 -42.56 97.68 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.022 0.439 . . . . 0.0 109.94 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -73.38 -36.79 66.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.273 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.476 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -58.98 -38.49 79.24 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.193 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.416 ' HA ' HD11 ' A' ' 33' ' ' LEU . 96.7 mt -61.4 -39.54 91.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.527 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 61.8 mt-10 -65.54 -40.52 92.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.169 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -65.95 -37.65 86.58 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.117 0.484 . . . . 0.0 110.598 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 90' ' ' PRO . 97.2 mt -62.49 -42.2 99.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.068 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -57.62 -25.17 59.72 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.908 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 31' ' ' GLU . 64.1 mm-40 -84.05 -8.96 58.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.008 0.432 . . . . 0.0 110.67 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.79 9.97 63.6 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.267 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -101.84 174.0 6.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.01 0.433 . . . . 0.0 111.865 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -104.73 150.32 24.85 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.519 -176.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.2 t -116.06 125.05 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.018 173.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.415 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 40.0 ttm180 -100.68 111.97 24.3 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.505 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 63.5 m-85 -89.69 125.68 35.36 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -132.02 139.77 48.7 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.586 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.5 p -121.36 133.45 67.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 121.126 0.488 . . . . 0.0 110.891 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -101.72 125.9 48.47 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.633 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.0 mt -87.09 111.82 21.3 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.8 -44.99 84.02 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' ' 49' ' ' GLU . . . 168.01 141.04 3.07 Favored Glycine 0 N--CA 1.434 -1.437 0 C-N-CA 120.118 -1.039 . . . . 0.0 111.709 -177.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 72.44 -10.24 0.95 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.54 0.686 . . . . 0.0 110.23 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.698 ' OE2' ' HG2' ' A' ' 16' ' ' LYS . 61.0 mt-10 -90.3 -17.85 26.65 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.458 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 96.3 mtp -70.26 -16.11 62.99 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.767 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.36 -34.64 78.15 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.193 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.2 p -130.23 96.52 24.76 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.392 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -67.12 -14.37 43.1 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 123.509 2.806 . . . . 0.0 112.405 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.407 ' OE2' ' HB1' ' A' ' 58' ' ' ALA . 8.4 tm-20 -56.99 -35.01 68.71 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.649 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.43 -36.59 71.56 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.876 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.45 -42.22 97.67 Favored Glycine 0 CA--C 1.504 -0.602 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.96 -43.75 89.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.407 ' HB1' ' OE2' ' A' ' 54' ' ' GLU . . . -60.66 -40.05 90.62 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.136 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.6 tp -61.91 -45.91 91.66 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.76 -39.02 90.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.292 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -59.49 -43.82 93.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.118 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -63.1 -40.8 98.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.424 HD13 HD23 ' A' ' 13' ' ' LEU . 96.2 mt -63.5 -43.9 98.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.041 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.7 t-105 -58.55 -42.95 89.03 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.776 -178.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.55 ' HA ' ' OE2' ' A' ' 68' ' ' GLU . 22.4 p -64.4 -16.33 62.15 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 68.1 mtt -89.9 -48.52 7.17 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.156 0.503 . . . . 0.0 111.232 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.2 pt -86.0 -14.87 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -174.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.55 ' OE2' ' HA ' ' A' ' 65' ' ' THR . 14.0 pt-20 -57.48 -14.8 5.48 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -63.48 -41.57 98.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.476 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -117.89 -4.4 11.11 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.163 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -119.68 146.99 45.1 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.47 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -113.26 138.23 50.31 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -69.58 109.94 4.55 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-O 121.245 0.545 . . . . 0.0 111.359 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.402 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 10.2 t70 -77.94 -42.91 31.45 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.098 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -146.22 137.12 24.35 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.054 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -64.83 157.37 75.36 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.63 178.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 23.4 Cg_exo -61.82 142.35 93.28 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 122.06 1.84 . . . . 0.0 111.577 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -141.39 140.68 33.74 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.423 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -99.11 116.13 30.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.917 0.389 . . . . 0.0 110.418 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -134.49 128.89 34.29 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.74 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.85 -94.42 0.6 Allowed Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.803 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -140.97 6.89 2.01 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.66 0.743 . . . . 0.0 109.41 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -119.33 143.81 47.19 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.717 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.586 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 68.8 t -106.28 123.31 60.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 172.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 8.6 p30 -125.86 149.63 48.51 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -174.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 64.6 ttp -140.87 141.43 34.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.513 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.0 mt -109.75 131.65 54.87 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.024 0.44 . . . . 0.0 111.692 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.7 m -122.95 136.44 59.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.628 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.452 ' CG2' ' HD2' ' A' ' 90' ' ' PRO . 24.4 m -116.07 140.18 26.02 Favored Pre-proline 0 C--N 1.307 -1.276 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.357 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.498 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 72.1 Cg_endo -68.0 152.51 76.71 Favored 'Trans proline' 0 C--O 1.237 0.463 0 C-N-CA 122.815 2.343 . . . . 0.0 111.772 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -77.62 65.09 3.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.199 0.523 . . . . 0.0 110.841 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -66.07 -40.7 91.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.114 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.07 103.89 8.29 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.098 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -137.35 101.85 4.63 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -92.01 125.73 8.2 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.869 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -95.45 81.07 3.53 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -127.0 109.78 12.27 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.185 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 -121.01 159.84 24.8 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -67.05 120.45 13.69 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -71.89 101.57 2.69 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.983 -177.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 7.4 p80 . . . . . 0 C--N 1.315 -0.913 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.063 178.664 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 121.125 0.488 . . . . 0.0 110.022 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.7 t -92.74 -22.47 5.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.677 0.751 . . . . 0.0 111.218 -177.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.2 mt -113.9 132.16 63.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.278 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -69.01 111.34 4.95 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.114 0.483 . . . . 0.0 109.915 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.448 HG12 ' HB2' ' A' ' 38' ' ' HIS . 71.1 mt -95.05 134.5 32.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.715 -178.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HG3' ' CD1' ' A' ' 32' ' ' PHE . 66.4 mmtt -85.71 127.05 34.41 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.83 -176.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -102.55 115.51 30.71 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 120.868 0.366 . . . . 0.0 110.363 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.0 mt -108.81 116.21 51.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.604 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -98.25 137.43 37.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.135 -175.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.5 mp -128.93 179.12 5.91 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.019 176.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 p -135.91 151.66 50.21 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.442 HG13 ' HG2' ' A' ' 49' ' ' GLU . 49.0 t -66.98 -25.6 34.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.383 0.611 . . . . 0.0 110.158 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.561 ' HE2' ' O ' ' A' ' 46' ' ' LYS . 64.6 mttm -103.29 72.37 1.15 Allowed 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 174.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.5 tt -126.84 153.42 35.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.124 -178.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.404 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -92.57 159.97 15.24 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -62.78 -33.09 74.45 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 120.948 0.404 . . . . 0.0 110.315 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -59.25 -45.05 92.22 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.242 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.4 -39.59 74.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.174 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.651 ' O ' HG23 ' A' ' 26' ' ' VAL . 75.7 mt -60.79 -51.43 73.23 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -60.39 -42.36 95.73 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.982 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.411 ' CZ ' ' HE1' ' A' ' 28' ' ' HIS . 92.0 t80 -64.3 -47.25 80.17 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.99 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -66.78 -42.91 85.29 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 22' ' ' ILE . 60.1 t -63.89 -29.63 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.473 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.05 -41.92 97.49 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 177.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.411 ' HE1' ' CZ ' ' A' ' 24' ' ' TYR . 31.4 m80 -68.41 -34.29 75.74 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.682 178.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.574 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -55.6 -45.25 77.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.238 -178.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.0 mt -62.76 -38.93 92.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.988 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -59.71 -46.23 89.74 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.172 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.407 ' CD1' ' HG3' ' A' ' 9' ' ' LYS . 84.2 m-85 -68.0 -34.78 77.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.82 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 95.0 mt -61.97 -43.01 99.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.287 0.565 . . . . 0.0 110.015 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -59.84 -34.45 73.12 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.596 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -69.4 -18.86 63.8 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.182 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.52 27.02 10.17 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.967 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -112.05 162.85 14.95 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.988 0.423 . . . . 0.0 110.519 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.448 ' HB2' HG12 ' A' ' 8' ' ' ILE . 5.4 m80 -97.53 146.7 25.0 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.7 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.3 t -115.27 129.56 71.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.635 176.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -108.4 112.25 24.58 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 97.4 m-85 -85.78 127.33 34.52 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.708 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 71.4 mtp85 -127.19 131.24 50.71 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.263 -176.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.584 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 5.9 p -130.0 137.05 57.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.106 0.479 . . . . 0.0 110.764 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.442 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 93.3 t80 -104.53 131.21 52.18 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.467 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.4 mt -80.21 85.32 5.75 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.129 0.49 . . . . 0.0 110.411 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.561 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 63.9 tttp -88.77 126.03 35.15 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.132 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.03 -154.94 16.35 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -77.81 -7.21 56.31 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.056 0.455 . . . . 0.0 110.68 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.442 ' HG2' HG13 ' A' ' 15' ' ' VAL . 2.3 mp0 -60.08 -13.61 12.67 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.594 178.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 10.3 mmt -59.33 -20.65 56.31 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.79 0.329 . . . . 0.0 111.361 177.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.45 -5.5 59.29 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.478 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.4 m -138.49 102.59 7.93 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-O 121.175 0.512 . . . . 0.0 111.455 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.28 -20.2 49.31 Favored 'Trans proline' 0 C--N 1.331 -0.369 0 C-N-CA 123.26 2.64 . . . . 0.0 111.76 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -64.04 -22.64 67.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.206 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.19 -45.17 91.77 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.96 0.409 . . . . 0.0 110.382 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.62 -38.86 93.61 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.941 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.1 t -64.12 -43.92 97.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 61' ' ' GLU . . . -63.66 -39.45 94.36 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.223 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.402 ' O ' HG13 ' A' ' 63' ' ' ILE . 38.8 tp -64.51 -47.23 79.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.091 0.472 . . . . 0.0 110.437 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.466 HD11 ' HB3' ' A' ' 77' ' ' PRO . 47.7 mt -66.6 -40.92 89.1 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.586 -177.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -64.09 -31.73 73.02 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.286 179.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -65.01 -40.89 95.56 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 59' ' ' LEU . 75.9 mt -65.53 -44.17 94.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.688 177.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 17.1 t-105 -55.76 -41.54 74.14 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.616 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.1 p -71.63 -12.74 61.5 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 98.0 mmm -87.21 -31.99 20.02 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.233 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.7 pt -108.15 -1.9 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -174.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -12.21 9.17 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -63.35 -46.89 84.47 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.407 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -119.43 0.89 11.17 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.87 0.367 . . . . 0.0 111.589 -174.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.453 ' HB3' HD12 ' A' ' 33' ' ' LEU . . . -125.26 149.81 47.67 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.178 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -114.17 131.73 56.34 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -72.53 106.67 4.69 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.24 -35.28 77.69 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.515 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -156.45 148.75 23.36 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.772 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -62.27 162.28 19.91 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.499 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.466 ' HB3' HD11 ' A' ' 60' ' ' LEU . 31.9 Cg_exo -59.05 144.79 99.22 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.348 2.032 . . . . 0.0 112.375 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -130.0 132.46 46.28 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.934 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -93.08 107.42 19.21 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -127.77 132.04 49.56 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.758 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.13 -109.83 3.13 Favored Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.385 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -124.85 9.86 8.24 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.179 0.514 . . . . 0.0 109.998 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.442 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 73.0 m-85 -125.0 144.5 50.35 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.306 -177.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.584 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 87.5 t -100.89 122.07 52.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 173.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.708 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 39.7 m-80 -114.61 144.64 43.08 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.764 -173.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.404 ' HB2' HD13 ' A' ' 60' ' ' LEU . 63.7 ttp -139.62 130.04 25.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.312 175.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 17.4 mt -108.99 129.73 55.45 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.25 0.547 . . . . 0.0 111.623 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.73 135.66 62.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.928 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.416 HG22 ' CE1' ' A' ' 38' ' ' HIS . 16.1 m -102.28 134.11 20.2 Favored Pre-proline 0 C--N 1.307 -1.251 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.467 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 56.0 Cg_endo -66.39 135.76 40.79 Favored 'Trans proline' 0 C--N 1.327 -0.555 0 C-N-CA 121.884 1.723 . . . . 0.0 110.201 177.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -65.28 -39.77 92.99 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.24 0.543 . . . . 0.0 112.286 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -95.43 -74.39 0.55 Allowed 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.467 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.405 ' HB2' ' HG2' ' A' ' 90' ' ' PRO . . . 62.62 -90.98 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.74 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -137.23 135.11 36.94 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -100.13 -38.56 3.53 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.692 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -91.32 -179.82 5.5 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 51.5 t60 74.87 -16.4 0.56 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.394 0.677 . . . . 0.0 111.625 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -66.0 -35.29 80.17 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.344 0.592 . . . . 0.0 110.264 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.401 ' O ' ' HB2' ' A' ' 100' ' ' HIS . 79.7 m-70 -90.41 30.01 1.19 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.603 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.401 ' HB2' ' O ' ' A' ' 99' ' ' HIS . 68.7 m80 74.11 -73.76 0.09 Allowed 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 123.963 0.905 . . . . 0.0 110.657 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.87 -179.964 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? . . . . . 0 N--CA 1.469 0.512 0 CA-C-O 121.217 0.532 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 t -107.71 -10.0 10.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.571 0.7 . . . . 0.0 110.856 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 92.6 mt -79.81 101.16 4.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.333 0.587 . . . . 0.0 110.103 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -78.35 115.18 17.88 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.441 HG12 ' HB2' ' A' ' 38' ' ' HIS . 69.3 mt -91.49 119.31 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.771 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.439 ' HG3' ' CD1' ' A' ' 32' ' ' PHE . 73.1 mmtt -89.22 126.69 35.6 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.936 -174.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.431 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 59.3 mt-10 -102.14 110.72 22.76 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.569 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.0 mt -94.23 107.94 20.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 47.6 tttm -98.32 122.87 42.04 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.593 -175.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.9 mt -122.65 179.36 4.63 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.517 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.1 m -131.62 151.98 51.19 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.2 t -63.69 -40.98 91.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.331 0.586 . . . . 0.0 109.793 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -78.03 50.38 0.88 Allowed 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.323 176.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.2 tt -106.34 160.03 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.706 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.45 146.51 28.37 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 175.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -63.75 -36.43 83.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.949 0.404 . . . . 0.0 111.512 -178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -63.91 -35.97 82.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.977 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.575 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 29.0 t70 -65.51 -35.23 80.25 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.884 0.373 . . . . 0.0 110.752 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.3 mt -61.32 -41.57 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.109 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -58.4 -41.92 86.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.887 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -63.86 -43.22 96.76 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.167 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 75.8 mmtt -61.53 -46.51 89.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.664 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.468 ' CG1' HG21 ' A' ' 63' ' ' ILE . 4.2 m -66.71 -40.82 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 111.791 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.56 -42.7 98.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.083 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -80.04 -25.5 40.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.696 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.412 ' O ' HD12 ' A' ' 33' ' ' LEU . . . -63.68 -37.1 86.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.034 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.52 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 65.7 mt -62.14 -33.53 74.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.689 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -57.76 -41.45 82.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.352 . . . . 0.0 110.116 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.439 ' CD1' ' HG3' ' A' ' 9' ' ' LYS . 94.9 m-85 -66.04 -35.7 81.24 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.105 0.478 . . . . 0.0 110.634 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.562 ' CB ' ' HB3' ' A' ' 90' ' ' PRO . 10.8 mp -62.36 -41.73 98.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.434 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 30' ' ' LEU . 32.6 mt-10 -62.43 -30.09 70.98 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.518 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -79.41 -8.66 59.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.904 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.46 19.77 50.98 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.189 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -95.98 164.97 12.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.935 0.397 . . . . 0.0 110.366 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.441 ' HB2' HG12 ' A' ' 8' ' ' ILE . 17.4 m170 -110.56 148.94 31.13 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.8 t -118.18 130.2 73.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 121.282 0.563 . . . . 0.0 110.682 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.431 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 39.5 ttm180 -111.55 113.18 25.42 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 175.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.561 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 92.8 m-85 -86.51 121.55 29.21 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 78.1 mtp180 -124.27 132.6 53.59 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.541 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.1 p -126.42 135.06 64.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 121.186 0.517 . . . . 0.0 110.799 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -101.37 127.19 48.11 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.799 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.5 mt -82.23 116.43 21.76 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -102.45 113.6 27.08 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.319 0.581 . . . . 0.0 111.956 -173.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.57 -137.21 13.29 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.394 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.4 ptt-85 -69.57 -11.87 61.19 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 122.577 0.351 . . . . 0.0 111.407 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -60.72 -21.12 62.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.566 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 91.2 mtp -62.66 -29.82 70.92 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.618 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.85 -13.81 62.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.349 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.6 p -125.28 94.36 43.44 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-O 121.171 0.51 . . . . 0.0 111.274 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -64.63 -20.33 65.34 Favored 'Trans proline' 0 N--CA 1.477 0.524 0 C-N-CA 123.461 2.774 . . . . 0.0 111.756 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -61.87 -30.07 70.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.183 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.62 -44.01 93.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.811 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.79 -38.44 93.05 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.623 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.8 t -63.87 -44.87 98.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.487 -0.356 . . . . 0.0 110.638 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.45 88.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.032 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.7 tp -62.63 -47.47 83.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.156 0.503 . . . . 0.0 110.036 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.3 mt -67.33 -39.73 85.87 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.975 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -58.88 -39.47 81.51 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.704 0.288 . . . . 0.0 111.075 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -62.76 -46.14 89.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.231 0.538 . . . . 0.0 109.97 177.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.468 HG21 ' CG1' ' A' ' 26' ' ' VAL . 96.0 mt -63.1 -45.14 99.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.897 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -60.66 -40.27 91.45 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.421 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.6 m -61.09 -37.34 82.37 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.096 0.474 . . . . 0.0 111.203 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 82.4 mtp -71.92 -35.94 69.81 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.6 pt -103.28 -2.87 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -174.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.18 -25.97 59.85 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -177.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -65.79 -39.23 90.75 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -107.96 -8.44 15.91 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.958 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -123.27 155.77 36.55 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.54 ' OD1' ' HB ' ' A' ' 89' ' ' THR . 5.3 p30 -117.86 128.37 54.77 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -77.75 108.02 10.67 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 121.305 0.574 . . . . 0.0 111.361 -176.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -66.63 -42.33 86.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.685 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.579 ' HD3' ' N ' ' A' ' 76' ' ' GLU . 7.1 tmtm? -146.19 138.5 25.26 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.579 ' N ' ' HD3' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -63.04 158.72 52.62 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.369 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.13 121.8 9.99 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 121.817 1.678 . . . . 0.0 110.799 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -130.23 138.93 50.79 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.491 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -92.98 117.25 29.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.883 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -138.22 139.98 39.5 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.29 -92.42 0.32 Allowed Glycine 0 N--CA 1.432 -1.567 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -177.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -153.08 17.23 0.56 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.398 0.618 . . . . 0.0 110.473 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -129.23 143.43 50.85 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.909 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.541 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 95.9 t -99.83 126.22 53.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 173.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.561 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 9.3 p30 -133.07 153.07 51.85 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.499 -175.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 64.8 ttp -144.04 134.53 24.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.747 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.5 mt -103.89 129.27 51.39 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.053 0.454 . . . . 0.0 111.494 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.48 135.29 63.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.165 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.54 ' HB ' ' OD1' ' A' ' 72' ' ' ASN . 13.8 m -114.43 143.29 29.57 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.562 ' HB3' ' CB ' ' A' ' 33' ' ' LEU . 60.2 Cg_endo -67.0 155.14 72.17 Favored 'Trans proline' 0 C--O 1.242 0.711 0 C-N-CA 122.81 2.34 . . . . 0.0 112.584 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -63.36 131.92 49.82 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -90.11 -71.23 0.63 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.951 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 57.88 -95.88 0.06 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.954 -176.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -140.14 7.46 2.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.7 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 65.82 -108.3 2.32 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.319 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -137.94 147.03 43.94 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.614 0.245 . . . . 0.0 110.636 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -98.88 -8.2 26.06 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.169 0.509 . . . . 0.0 110.228 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -113.88 146.31 40.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.176 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -66.15 -44.02 85.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.083 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -142.88 -32.02 0.49 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.425 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 72.4 t60 . . . . . 0 C--N 1.322 -0.623 0 CA-C-O 118.808 -0.615 . . . . 0.0 109.471 -178.331 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.3 tttt . . . . . 0 N--CA 1.438 -1.034 0 CA-C-O 121.029 0.442 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.3 t -84.15 133.2 29.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 94.8 mt -68.95 131.56 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-O 120.947 0.403 . . . . 0.0 110.004 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.629 ' HB3' ' HZ3' ' A' ' 37' ' ' LYS . 34.0 t70 -80.07 107.88 13.22 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.6 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 88.7 mt -117.75 131.11 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.339 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.415 ' HG2' ' CD1' ' A' ' 32' ' ' PHE . 3.6 mptp? -86.26 135.78 33.42 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 121.565 0.698 . . . . 0.0 110.335 -178.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -115.21 120.28 39.17 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.046 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.6 mt -108.75 114.31 46.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.984 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -84.13 139.71 32.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.707 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.457 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 49.8 mt -127.27 166.83 17.04 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.748 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.0 m -137.09 146.25 44.9 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.7 t -62.73 -45.0 99.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.911 0.386 . . . . 0.0 110.25 177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -94.35 65.89 3.32 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.585 0.707 . . . . 0.0 109.975 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.431 HD13 ' OD1' ' A' ' 21' ' ' ASP . 19.7 tt -107.66 156.03 8.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.384 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.416 ' HB2' ' HB2' ' A' ' 21' ' ' ASP . . . -64.77 141.71 58.68 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.8 tp60 -62.11 -39.4 92.37 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.958 0.408 . . . . 0.0 110.883 -176.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -76.32 -18.33 58.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.883 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.431 ' OD1' HD13 ' A' ' 17' ' ' ILE . 12.5 t70 -67.88 -35.79 79.13 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.276 0.56 . . . . 0.0 110.669 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.3 mt -61.49 -42.14 92.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.124 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -58.73 -43.12 90.08 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.716 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.536 ' CZ ' ' HE1' ' A' ' 28' ' ' HIS . 83.7 t80 -63.75 -45.86 87.92 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.469 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -65.52 -41.13 93.47 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.466 ' CG1' HG23 ' A' ' 63' ' ' ILE . 1.4 m -60.77 -29.86 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.549 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -61.83 -46.76 88.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.014 0.435 . . . . 0.0 110.37 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.536 ' HE1' ' CZ ' ' A' ' 24' ' ' TYR . 38.4 m80 -64.57 -37.83 88.9 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.111 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.606 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -56.56 -44.93 81.42 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.407 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 94.6 mt -62.5 -41.38 98.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.932 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -61.75 -44.82 96.17 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.967 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.415 ' CD1' ' HG2' ' A' ' 9' ' ' LYS . 81.4 m-85 -68.8 -32.91 72.97 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 96.7 mt -62.05 -42.02 98.74 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.404 0.621 . . . . 0.0 110.219 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 30' ' ' LEU . 44.6 mm-40 -56.24 -31.7 63.8 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.768 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -76.37 -8.51 57.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.726 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.63 17.95 62.86 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.07 -176.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.629 ' HZ3' ' HB3' ' A' ' 7' ' ' ASP . 75.5 mmtt -99.04 158.87 15.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.78 0.324 . . . . 0.0 110.523 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -99.84 148.11 24.78 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.5 t -119.21 131.11 72.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.414 0.626 . . . . 0.0 111.829 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -112.38 126.0 54.8 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.053 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 96.8 m-85 -97.18 124.33 41.2 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.618 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 65.1 mtp180 -125.7 105.99 9.39 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.885 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.611 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 5.9 p -104.98 129.43 57.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.136 0.493 . . . . 0.0 111.31 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -99.01 134.79 41.34 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.915 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.2 mt -82.0 89.42 6.41 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 87.3 tttt -68.33 134.51 50.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.202 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.75 -132.38 11.16 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.349 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -110.6 18.37 19.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.683 0.278 . . . . 0.0 110.993 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 26.3 mm-40 -68.79 -2.47 9.51 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.196 -177.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 67.9 mtt -65.12 -13.33 57.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.037 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.49 -37.56 87.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.821 0.343 . . . . 0.0 110.697 178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.3 p -124.72 96.91 39.83 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 121.082 0.468 . . . . 0.0 111.583 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.4 ' HB3' ' CG ' ' A' ' 79' ' ' PHE . 31.4 Cg_exo -62.99 -19.58 69.46 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.601 2.867 . . . . 0.0 112.471 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -59.48 -20.38 54.85 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.346 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.59 -38.93 86.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.036 0.446 . . . . 0.0 110.347 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.22 -39.17 94.37 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.766 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.0 t -64.12 -45.19 97.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.699 -0.25 . . . . 0.0 110.694 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.76 -40.75 89.22 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.066 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.5 tp -62.93 -45.82 90.66 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.028 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 86' ' ' MET . 92.2 mt -65.22 -40.89 94.72 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.753 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -58.4 -43.05 88.41 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.95 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -64.34 -41.59 96.7 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.335 0.588 . . . . 0.0 109.89 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.466 HG23 ' CG1' ' A' ' 26' ' ' VAL . 91.6 mt -64.88 -43.84 96.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.384 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -58.26 -41.24 83.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.123 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.3 p -63.79 -16.82 62.19 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 68.7 mtt -85.97 -39.2 17.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.94 0.4 . . . . 0.0 111.824 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.6 pt -101.55 -7.15 9.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -57.1 -28.69 62.88 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -66.57 -22.23 66.15 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -130.15 8.41 5.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.665 0.269 . . . . 0.0 111.576 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.28 151.71 49.93 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.79 0.328 . . . . 0.0 111.116 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -113.44 152.45 30.07 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -94.71 128.35 41.33 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.064 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -90.48 -8.58 50.06 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.138 0.494 . . . . 0.0 110.28 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -176.06 164.58 2.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.458 -177.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -85.96 149.11 49.78 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.71 136.63 75.17 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.344 2.029 . . . . 0.0 111.63 177.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -145.35 138.6 26.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.338 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.4 ' CG ' ' HB3' ' A' ' 53' ' ' PRO . 87.7 t80 -83.3 118.14 23.46 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.659 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -130.59 115.54 16.89 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.092 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.71 -95.75 0.91 Allowed Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.149 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -132.61 4.87 3.96 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.942 0.401 . . . . 0.0 110.368 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 82.1 m-85 -127.65 143.93 51.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.091 -176.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.611 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 93.1 t -99.31 120.98 49.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 172.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.618 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 41.9 m-80 -111.79 145.94 38.52 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -171.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.466 ' HB2' HD11 ' A' ' 60' ' ' LEU . 64.9 ttp -146.49 135.95 22.94 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.289 174.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 22.9 mt -108.68 132.42 53.94 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.749 0.309 . . . . 0.0 111.822 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.16 132.66 70.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.294 0.569 . . . . 0.0 110.692 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.8 m -110.29 141.28 23.58 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.454 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 89.4 Cg_endo -69.29 150.82 71.55 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.762 1.641 . . . . 0.0 109.437 177.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -66.99 107.72 2.35 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.565 0.698 . . . . 0.0 111.991 -175.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -76.02 102.49 5.67 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.9 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 64.71 175.26 0.2 Allowed 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.786 0.679 . . . . 0.0 111.103 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -107.69 121.08 43.98 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.621 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.8 132.34 4.5 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.68 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.532 ' ND1' ' HB3' ' A' ' 99' ' ' HIS . 61.2 t-80 -91.42 150.38 21.28 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -94.77 89.89 5.86 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.145 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 55.74 81.38 0.12 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.888 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.532 ' HB3' ' ND1' ' A' ' 96' ' ' HIS . 42.0 p-80 -100.38 -31.68 11.2 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.896 177.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 75.9 t60 57.93 -82.28 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 O-C-N 123.643 0.59 . . . . 0.0 110.771 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 . . . . . 0 C--O 1.245 0.832 0 C-N-CA 123.661 0.784 . . . . 0.0 111.295 179.403 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.0 t -122.49 132.54 70.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.2 mm -89.59 114.69 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.517 ' HB2' ' HD3' ' A' ' 37' ' ' LYS . 7.0 m-20 -73.23 109.58 6.87 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.851 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.424 HG12 ' HB2' ' A' ' 38' ' ' HIS . 97.7 mt -111.45 121.1 63.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 121.095 0.474 . . . . 0.0 110.176 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.423 ' HG3' ' CD1' ' A' ' 32' ' ' PHE . 75.1 mmtt -92.22 133.8 35.48 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.341 -173.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -102.75 102.89 13.08 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.589 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.1 mt -90.94 111.17 23.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.092 0.472 . . . . 0.0 109.85 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 88.3 tttt -85.26 137.67 32.83 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.988 -177.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.2 mt -126.8 175.98 7.61 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.648 -177.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.7 p -146.83 149.29 33.02 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.6 t -64.85 -42.95 96.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -80.8 63.04 5.05 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 174.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.7 tt -113.5 152.13 15.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.601 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.03 150.18 23.55 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -63.92 -36.47 84.04 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.764 0.316 . . . . 0.0 111.574 -177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -62.88 -39.13 93.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.724 0.297 . . . . 0.0 111.154 178.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -64.99 -38.11 89.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.31 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.658 ' O ' HG23 ' A' ' 26' ' ' VAL . 95.5 mt -62.77 -46.86 95.31 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -60.59 -44.39 96.31 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.349 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -65.12 -49.24 70.73 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.123 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -65.54 -41.08 93.44 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 22' ' ' ILE . 59.6 t -63.19 -40.41 88.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.178 0.514 . . . . 0.0 109.984 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -59.75 -45.69 91.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.368 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.443 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 17.8 t-160 -65.43 -31.63 72.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.475 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.85 -31.78 67.0 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 178.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.34 -39.97 94.85 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.026 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.443 ' OE1' ' HA ' ' A' ' 28' ' ' HIS . 1.3 mp0 -54.29 -47.05 72.83 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.423 ' CD1' ' HG3' ' A' ' 9' ' ' LYS . 95.0 m-85 -68.28 -37.1 80.34 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.638 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.35 -42.21 98.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.378 0.608 . . . . 0.0 110.087 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.427 ' OE1' ' HG3' ' A' ' 92' ' ' LYS . 6.0 mm-40 -61.76 -29.89 70.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.12 178.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -73.91 -9.45 58.66 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.504 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.04 16.38 57.87 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.709 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.517 ' HD3' ' HB2' ' A' ' 7' ' ' ASP . 65.8 mttm -99.82 173.36 6.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.015 0.436 . . . . 0.0 111.37 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.51 ' NE2' HG21 ' A' ' 89' ' ' THR . 17.5 m170 -111.15 149.7 30.51 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.899 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.3 t -118.86 130.68 73.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -109.5 111.37 22.86 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.576 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 83.8 m-85 -85.01 119.5 25.47 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 29.2 mtm180 -125.08 132.79 53.1 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -177.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.437 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.8 p -125.15 132.18 71.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 120.956 0.408 . . . . 0.0 111.142 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.427 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 90.1 t80 -102.72 127.51 49.83 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.672 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.4 mt -90.16 111.01 22.01 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -83.88 88.45 7.12 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.9 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.07 153.39 0.62 Allowed Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.365 -0.834 . . . . 0.0 114.41 175.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 64.17 -64.58 0.14 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.351 1.06 . . . . 0.0 113.111 176.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -65.64 -11.75 47.42 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.649 0.78 . . . . 0.0 111.413 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 80.6 mtp -61.32 -28.96 69.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.449 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.67 -19.37 64.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.543 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.4 m -122.31 97.8 44.8 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-O 121.282 0.563 . . . . 0.0 111.156 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -63.33 -22.15 71.82 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 123.515 2.81 . . . . 0.0 112.521 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -60.81 -28.14 68.55 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.444 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.01 -43.24 95.37 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.887 0.375 . . . . 0.0 110.728 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.26 -39.04 92.1 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.754 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.6 t -62.83 -43.71 99.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 122.629 0.372 . . . . 0.0 110.715 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.68 -40.3 91.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.413 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 48.1 tp -63.42 -45.8 89.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.193 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.8 mt -66.05 -42.18 89.86 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.33 -33.08 74.75 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.269 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -60.5 -47.88 84.23 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.4 mt -66.08 -42.49 91.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.602 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 37.3 t-105 -54.84 -40.38 69.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.026 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.5 m -63.34 -23.16 67.29 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-O 121.106 0.479 . . . . 0.0 111.021 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 96.1 mtp -90.03 -35.59 15.41 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.419 ' CG2' HG12 ' A' ' 26' ' ' VAL . 40.2 pt -92.35 -6.34 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -175.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.93 -4.4 6.9 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -63.34 -46.06 88.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.125 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -121.26 -3.66 9.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.696 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -118.87 145.55 45.61 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.167 0.508 . . . . 0.0 111.718 -176.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -115.36 133.87 55.63 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.782 175.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -68.84 113.24 6.1 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 120.972 0.415 . . . . 0.0 111.993 -177.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -87.45 -40.83 14.0 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.813 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 58.2 tptt -134.19 136.43 43.72 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.775 -177.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -74.47 155.3 87.63 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.584 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 24.2 Cg_exo -61.05 139.6 85.29 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.599 1.533 . . . . 0.0 111.312 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -145.85 141.56 27.98 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.802 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -92.44 112.6 24.6 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -153.57 124.53 7.34 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.586 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.81 31.47 55.87 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 66.49 14.71 9.84 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.672 0.789 . . . . 0.0 112.536 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 37.3 m-85 -125.44 143.53 50.95 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.351 176.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.437 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 78.9 t -103.54 124.09 57.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 172.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.584 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 5.9 p30 -131.67 156.95 44.97 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.959 -0.697 . . . . 0.0 112.423 -173.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 54.5 ttp -142.67 135.62 28.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.528 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.431 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 12.4 mt -108.18 131.06 55.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.969 0.414 . . . . 0.0 111.198 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.2 m -124.69 138.67 53.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.777 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.51 HG21 ' NE2' ' A' ' 38' ' ' HIS . 11.2 m -109.43 135.32 20.31 Favored Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.471 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.98 143.8 37.05 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 C-N-CA 122.374 2.049 . . . . 0.0 110.963 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -83.07 9.22 10.81 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.354 0.597 . . . . 0.0 110.486 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.427 ' HG3' ' OE1' ' A' ' 34' ' ' GLU . 35.2 mmtp -101.73 36.34 2.09 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.869 -178.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.77 11.29 1.41 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.703 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -66.55 -43.91 83.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.833 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -157.37 133.15 3.44 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.315 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -87.03 -32.89 19.76 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 28.3 p80 41.84 42.95 2.39 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 114.849 -1.069 . . . . 0.0 113.09 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -75.45 141.94 43.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.208 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -62.12 95.05 0.06 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.041 0.448 . . . . 0.0 110.296 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -76.92 -47.29 21.45 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.262 -177.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 20.3 m80 . . . . . 0 C--N 1.313 -1.004 0 CA-C-O 117.963 -1.017 . . . . 0.0 109.757 178.358 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt . . . . . 0 N--CA 1.473 0.712 0 CA-C-O 121.255 0.55 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.4 p -76.51 150.85 6.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.315 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 88.0 mt -73.49 109.07 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.538 ' OD2' ' HE2' ' A' ' 9' ' ' LYS . 34.0 t70 -80.14 122.96 27.45 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.787 -177.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 88.4 mt -120.63 136.85 56.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.446 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.538 ' HE2' ' OD2' ' A' ' 7' ' ' ASP . 75.3 mmtt -98.24 136.47 38.39 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.904 -176.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.444 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 47.0 mt-10 -114.83 104.21 11.71 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.574 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.2 mt -90.21 103.6 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 121.753 0.787 . . . . 0.0 109.706 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -88.71 128.06 35.61 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.782 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 74.4 mt -125.42 -178.55 4.27 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.713 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.4 p -141.68 161.58 37.58 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.78 0.324 . . . . 0.0 110.436 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.1 t -64.4 -25.93 39.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.192 0.52 . . . . 0.0 112.3 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -90.09 11.54 20.51 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.526 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.3 tt -68.24 152.73 9.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 CA-C-O 121.009 0.433 . . . . 0.0 111.163 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.35 154.65 18.43 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.421 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -63.6 -34.21 77.31 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.765 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -64.16 -38.4 90.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.863 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -66.62 -36.87 83.63 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.895 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.6 mt -61.73 -43.74 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.555 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -60.42 -42.31 95.78 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.195 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -69.46 -39.54 77.69 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.452 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -63.39 -42.16 98.78 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.585 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 4.4 m -63.66 -34.13 65.96 Favored 'Isoleucine or valine' 0 C--N 1.342 0.275 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.177 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -63.48 -39.7 95.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.723 0.297 . . . . 0.0 110.686 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -64.7 -40.66 95.75 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.157 0.503 . . . . 0.0 110.278 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.647 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -61.66 -39.13 90.28 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.768 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 26' ' ' VAL . 93.1 mt -61.43 -40.35 94.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.699 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 46.0 mt-10 -58.44 -47.06 85.21 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.799 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.52 ' CE1' ' HE3' ' A' ' 9' ' ' LYS . 94.2 m-85 -71.35 -32.37 68.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.951 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 90.2 mt -62.23 -43.27 99.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.45 0.643 . . . . 0.0 109.817 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -62.6 -30.72 71.55 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.979 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 80.4 mt-30 -73.54 -10.12 59.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.726 178.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.38 7.44 65.28 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.15 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.431 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 88.5 mttt -91.23 178.24 6.03 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.162 0.506 . . . . 0.0 110.323 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.495 ' NE2' HG22 ' A' ' 89' ' ' THR . 23.7 m170 -117.24 150.76 38.24 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.914 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.0 t -117.53 128.58 74.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.079 0.466 . . . . 0.0 110.046 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.444 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 51.8 ttt180 -109.26 115.9 30.87 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.53 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 76.2 m-85 -90.15 113.92 25.78 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -117.09 134.62 54.53 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.493 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.7 p -118.77 130.59 73.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-O 121.211 0.529 . . . . 0.0 111.462 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -94.63 125.22 39.15 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.394 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.451 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 51.6 mt -91.59 129.03 37.63 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -62.39 -48.23 80.63 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.27 -44.96 0.17 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 119.941 -1.123 . . . . 0.0 113.329 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -90.96 -19.27 23.44 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 117.168 0.484 . . . . 0.0 111.471 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.451 ' HG2' ' HB3' ' A' ' 45' ' ' LEU . 1.6 pm0 -79.54 2.66 21.35 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.597 0.713 . . . . 0.0 109.583 175.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 61.2 mtt -82.43 -133.93 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.337 175.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 61.06 -61.06 0.08 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.312 0.645 . . . . 0.0 111.249 -173.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 t -121.85 133.82 24.44 Favored Pre-proline 0 N--CA 1.437 -1.103 0 C-N-CA 123.566 0.746 . . . . 0.0 109.431 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.87 -8.89 23.88 Favored 'Trans proline' 0 C--N 1.331 -0.385 0 C-N-CA 123.425 2.75 . . . . 0.0 113.487 -176.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.88 -30.14 68.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.26 96.03 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.86 0.362 . . . . 0.0 110.465 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.29 -39.88 87.67 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.18 -42.47 94.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.531 -0.334 . . . . 0.0 110.436 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.81 -40.87 76.77 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.293 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.9 tp -62.4 -45.84 91.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.245 0.545 . . . . 0.0 109.993 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.76 -41.09 96.16 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.891 -177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -60.37 -39.41 87.12 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.309 0.575 . . . . 0.0 110.992 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -63.8 -41.18 97.96 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.105 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.2 mt -70.04 -46.23 73.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.065 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.43 ' HB2' ' HE3' ' A' ' 86' ' ' MET . 41.7 t-105 -57.75 -41.4 81.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.322 -176.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.8 p -62.8 -24.69 67.87 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 98.4 mtp -75.78 -34.43 60.22 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.9 pt -107.76 -6.89 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -56.32 -23.08 34.76 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -64.41 -39.19 93.36 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -121.13 6.51 10.27 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.45 146.29 50.54 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.945 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -114.31 147.72 38.66 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.0 ptt-85 -81.16 127.63 32.88 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -74.12 -35.54 64.13 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.384 0.611 . . . . 0.0 109.782 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -161.43 172.22 16.86 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.063 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -77.4 152.59 81.41 Favored Pre-proline 0 C--N 1.311 -1.073 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -61.58 140.64 87.99 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.686 1.591 . . . . 0.0 110.57 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -140.88 165.6 27.08 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.495 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -101.96 113.57 26.92 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.991 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -114.39 113.07 24.02 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.56 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.52 -93.08 0.16 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.497 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -133.94 11.37 3.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.142 0.496 . . . . 0.0 110.492 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -118.27 140.72 49.39 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.863 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.493 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 55.9 t -100.81 127.28 54.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 172.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.53 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 7.2 p30 -134.3 153.84 51.65 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 119.353 -0.939 . . . . 0.0 113.078 -174.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.43 ' HE3' ' HB2' ' A' ' 64' ' ' TRP . 53.0 ttp -140.55 138.15 34.29 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.817 177.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -109.89 126.93 54.38 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.1 m -112.83 134.1 56.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.385 0.612 . . . . 0.0 110.896 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.495 HG22 ' NE2' ' A' ' 38' ' ' HIS . 13.3 m -113.56 139.29 23.16 Favored Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.218 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.549 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 69.2 Cg_endo -66.82 142.35 62.78 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.35 2.033 . . . . 0.0 110.541 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -78.12 137.17 38.06 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.334 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -80.67 130.91 35.37 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.482 178.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.23 -46.53 83.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.937 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -167.05 -61.83 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.5 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 155.45 76.94 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.999 -0.619 . . . . 0.0 111.894 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -77.25 144.15 38.41 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -100.81 154.14 18.89 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.465 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -64.51 106.58 1.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.175 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -70.43 171.88 9.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.051 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -68.14 128.2 35.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.173 0.511 . . . . 0.0 111.493 -176.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 . . . . . 0 C--N 1.315 -0.93 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.777 178.553 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 65.6 pttt . . . . . 0 N--CA 1.446 -0.663 0 CA-C-O 120.831 0.348 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.3 t -103.21 133.86 45.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.5 mm -73.4 125.12 31.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.951 0.405 . . . . 0.0 110.288 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.48 ' HB2' ' HD3' ' A' ' 37' ' ' LYS . 22.2 m-20 -84.64 137.27 33.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.015 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 90.7 mt -129.16 129.55 67.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -101.46 135.77 42.42 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.789 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.437 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 58.3 mt-10 -104.38 112.28 25.26 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.896 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.4 mt -97.73 111.74 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 87.8 tttt -98.14 136.01 38.98 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.545 -175.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 mp -131.77 179.93 5.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.119 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.7 p -138.98 156.54 47.15 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.97 -25.01 37.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.437 0.637 . . . . 0.0 111.247 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -104.61 22.29 15.29 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.988 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.1 tt -74.37 147.72 8.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.949 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.453 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -75.25 155.22 36.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.74 -177.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 -62.7 -38.75 91.65 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.166 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -61.06 -41.14 96.07 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.553 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 21.1 m-20 -64.75 -38.84 92.35 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.394 177.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 18' ' ' ALA . 68.6 mt -61.95 -45.67 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-O 121.075 0.464 . . . . 0.0 110.703 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -60.08 -41.73 93.1 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.818 0.818 . . . . 0.0 110.323 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -61.97 -44.2 97.25 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.377 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 75.1 mmtt -64.06 -44.76 91.44 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.7 m -67.9 -32.87 58.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.613 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -62.37 -45.47 93.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.096 0.474 . . . . 0.0 109.809 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -70.9 -32.53 69.51 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.191 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.59 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -55.85 -45.97 78.33 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.269 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.37 -40.41 96.36 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.79 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 52.2 mt-10 -57.14 -48.54 78.43 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 120.785 0.326 . . . . 0.0 111.159 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -68.76 -36.24 78.09 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 95.8 mt -63.04 -44.28 96.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.438 0.637 . . . . 0.0 110.428 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -57.88 -32.28 67.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.441 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 80.3 mt-30 -75.21 -7.36 53.66 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.281 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.68 15.75 56.1 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.021 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.48 ' HD3' ' HB2' ' A' ' 7' ' ' ASP . 31.1 mtmm -103.02 168.58 9.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.487 0.66 . . . . 0.0 112.306 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.417 ' NE2' HG21 ' A' ' 89' ' ' THR . 3.3 m80 -102.92 145.9 29.13 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.326 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.9 t -115.4 129.24 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.697 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.437 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 42.4 ttm180 -109.81 113.0 25.39 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.476 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 83.1 m-85 -89.89 124.29 34.57 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 73.0 mtp180 -128.22 135.53 49.82 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.498 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.7 p -118.88 131.95 70.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-O 121.18 0.514 . . . . 0.0 111.24 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -96.26 126.36 41.42 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.576 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.407 HD11 ' HA ' ' A' ' 50' ' ' MET . 31.9 mt -92.31 114.0 26.43 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -95.16 119.84 34.37 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.866 0.365 . . . . 0.0 111.518 -174.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.2 -140.73 15.08 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -91.88 13.67 17.78 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.273 0.558 . . . . 0.0 110.43 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -62.35 -21.99 65.74 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.65 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.407 ' HA ' HD11 ' A' ' 45' ' ' LEU . 65.5 mtt -67.4 -11.3 57.42 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.969 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.94 -28.3 69.73 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.151 0.501 . . . . 0.0 110.515 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.4 m -130.87 99.63 18.11 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-O 121.23 0.538 . . . . 0.0 110.843 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -60.46 -22.81 73.1 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 123.529 2.82 . . . . 0.0 112.897 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -61.65 -22.38 65.23 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.749 0.309 . . . . 0.0 110.827 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.81 -40.6 95.84 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.048 0.451 . . . . 0.0 109.856 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.83 -38.55 93.07 Favored Glycine 0 CA--C 1.506 -0.488 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.382 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.4 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 88.1 t -63.33 -44.44 99.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.439 -0.381 . . . . 0.0 110.508 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.31 -41.2 88.47 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.38 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.0 tp -63.93 -45.63 88.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.355 0.598 . . . . 0.0 110.356 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.434 ' HB3' ' CE ' ' A' ' 86' ' ' MET . 81.7 mt -64.53 -41.13 96.57 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.416 -177.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 57' ' ' VAL . 11.9 mm-40 -63.7 -34.26 77.46 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.539 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -62.04 -41.9 98.61 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.75 -44.32 98.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.281 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -59.72 -36.91 77.52 Favored 'General case' 0 C--O 1.213 -0.83 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.779 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.4 m -57.82 -33.78 68.96 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.306 0.574 . . . . 0.0 110.325 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 97.8 mmm -76.85 -32.73 57.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.603 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.534 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 41.1 pt -117.96 15.84 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -174.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -62.61 -22.48 66.43 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.774 0.797 . . . . 0.0 110.291 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.407 HD21 ' HG3' ' A' ' 70' ' ' GLU . 4.5 p-10 -97.58 141.34 30.74 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 173.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.407 ' HG3' HD21 ' A' ' 69' ' ' ASN . 35.4 mt-10 74.9 -13.89 0.79 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.597 0.759 . . . . 0.0 111.842 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 67' ' ' ILE . . . -129.71 150.79 50.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.661 0.267 . . . . 0.0 110.4 177.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -116.47 149.25 39.82 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -87.57 106.31 17.92 Favored 'General case' 0 N--CA 1.412 -2.368 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.658 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -80.74 -41.14 24.03 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.002 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -137.32 136.8 38.3 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.14 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.98 151.92 70.99 Favored Pre-proline 0 N--CA 1.442 -0.87 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 17.4 Cg_endo -56.29 131.1 43.75 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.463 2.109 . . . . 0.0 112.339 -177.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.421 ' ND2' ' HG3' ' A' ' 80' ' ' GLU . 3.1 p-10 -147.09 165.5 29.74 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.415 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.494 ' CZ ' ' HA ' ' A' ' 82' ' ' ARG . 84.6 t80 -93.83 123.32 37.1 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.844 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.421 ' HG3' ' ND2' ' A' ' 78' ' ' ASN . 38.4 mt-10 -146.77 120.07 8.96 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.48 178.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.446 ' O ' ' HD1' ' A' ' 83' ' ' TYR . . . 64.94 38.73 95.85 Favored Glycine 0 C--O 1.221 -0.696 0 CA-C-N 115.951 -0.568 . . . . 0.0 113.945 175.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.494 ' HA ' ' CZ ' ' A' ' 79' ' ' PHE . 75.2 mtt180 74.96 0.91 3.66 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.492 0.717 . . . . 0.0 111.228 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.446 ' HD1' ' O ' ' A' ' 81' ' ' GLY . 82.2 m-85 -117.38 149.17 40.97 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.891 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.498 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 70.3 t -105.2 128.09 59.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 173.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 9.2 p30 -133.11 161.44 34.4 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -173.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.434 ' CE ' ' HB3' ' A' ' 60' ' ' LEU . 13.8 ttm -143.71 146.01 32.85 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.217 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 16.2 mt -115.33 129.39 56.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.767 0.318 . . . . 0.0 111.238 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.7 132.46 70.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.85 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.417 HG21 ' NE2' ' A' ' 38' ' ' HIS . 15.2 m -104.95 141.2 22.04 Favored Pre-proline 0 C--N 1.309 -1.174 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.423 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 33.8 Cg_endo -61.38 147.21 96.1 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 121.949 1.766 . . . . 0.0 110.579 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -57.1 135.49 56.35 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.2 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -79.36 177.15 9.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.917 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.43 150.83 45.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.06 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -67.58 151.19 47.75 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.294 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.26 -32.92 85.36 Favored Glycine 0 CA--C 1.519 0.31 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.525 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 72.78 -67.17 0.28 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.529 0.732 . . . . 0.0 110.833 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -130.27 142.28 50.56 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -79.47 90.5 5.07 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -113.73 -8.24 13.24 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.236 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -108.21 117.87 35.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.187 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 C--O 1.246 0.909 0 CA-C-O 118.529 -0.748 . . . . 0.0 110.57 -178.246 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 N--CA 1.448 -0.545 0 CA-C-O 120.989 0.423 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -116.99 136.19 54.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.435 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 78.2 mt -70.99 102.47 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.099 0.476 . . . . 0.0 110.347 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.423 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 25.2 t70 -79.59 132.71 36.35 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.867 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.419 HG22 ' O ' ' A' ' 38' ' ' HIS . 92.7 mt -115.56 132.2 65.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.343 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -92.37 155.32 17.98 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.564 0.697 . . . . 0.0 111.126 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.571 ' CD ' HH21 ' A' ' 40' ' ' ARG . 43.4 mt-10 -125.74 114.35 18.52 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.972 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.5 mt -100.67 108.55 23.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -85.49 142.6 29.08 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.841 -176.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.0 mt -129.65 166.9 18.84 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.69 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.0 m -139.2 150.04 45.1 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 176.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.2 t -61.6 -43.89 97.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.309 0.576 . . . . 0.0 110.779 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -93.62 68.03 3.98 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.566 0.698 . . . . 0.0 110.797 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.3 tt -117.59 149.77 19.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.68 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.06 142.27 54.56 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.706 0.289 . . . . 0.0 110.874 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -62.96 -39.0 93.33 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.824 0.345 . . . . 0.0 111.32 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -61.8 -39.95 93.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.15 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.581 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 28.1 t70 -65.91 -38.23 88.15 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.024 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.87 -45.29 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.807 0.813 . . . . 0.0 109.47 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -65.39 -28.82 69.53 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.134 -1.393 . . . . 0.0 110.694 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -78.77 -40.77 32.32 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.161 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.581 ' HG3' ' O ' ' A' ' 21' ' ' ASP . 57.8 mttm -65.55 -38.94 91.06 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 m -59.59 -32.61 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.2 tttt -63.26 -42.24 99.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.852 0.358 . . . . 0.0 110.117 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -68.36 -38.53 81.52 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.52 176.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.414 ' O ' HD13 ' A' ' 33' ' ' LEU . . . -57.72 -44.17 85.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.28 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.426 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 88.2 mt -62.32 -34.66 77.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.82 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -56.22 -41.64 75.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.274 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -67.85 -37.14 81.49 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.935 0.398 . . . . 0.0 111.08 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.429 ' CB ' ' HB3' ' A' ' 90' ' ' PRO . 11.0 mp -63.09 -42.56 99.63 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.445 0.64 . . . . 0.0 110.423 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 30' ' ' LEU . 66.7 mm-40 -61.75 -22.8 65.71 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.993 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -87.74 -6.03 58.38 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.802 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.66 27.49 26.82 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.614 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.423 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 66.2 mttm -115.29 176.26 5.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.248 0.547 . . . . 0.0 111.311 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.435 ' NE2' HG23 ' A' ' 89' ' ' THR . 5.6 m80 -111.13 147.11 35.58 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.163 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.6 t -115.3 126.65 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.571 HH21 ' CD ' ' A' ' 10' ' ' GLU . 45.1 ttp180 -101.51 111.71 24.03 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -87.88 121.65 30.55 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.497 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 83.1 mtp180 -131.96 120.08 21.98 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.614 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 4.3 p -111.4 131.67 62.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.199 0.523 . . . . 0.0 111.53 -176.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.421 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 88.9 t80 -98.34 130.78 45.0 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.618 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 50' ' ' MET . 40.7 mt -89.93 122.52 33.04 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -107.32 114.12 27.95 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.178 0.513 . . . . 0.0 111.674 -174.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.52 -143.86 15.97 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.485 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -83.18 4.86 24.88 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.154 0.502 . . . . 0.0 111.015 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -65.72 -25.75 67.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.153 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.415 ' HA ' HD12 ' A' ' 45' ' ' LEU . 49.2 ttm -59.46 -24.34 63.48 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.462 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.9 -25.61 67.96 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.321 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.9 p -126.69 101.55 26.78 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 121.303 0.573 . . . . 0.0 110.741 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.3 -15.36 38.75 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.446 2.764 . . . . 0.0 112.631 -177.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -61.69 -26.14 67.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.811 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.67 90.59 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.036 0.446 . . . . 0.0 110.119 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.03 -38.67 92.81 Favored Glycine 0 CA--C 1.505 -0.563 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.584 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.412 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 93.5 t -63.13 -45.85 97.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.571 -0.315 . . . . 0.0 110.947 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.37 -40.76 92.0 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.198 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.2 tp -63.2 -45.69 90.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.183 0.516 . . . . 0.0 110.289 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.6 mt -65.17 -40.56 94.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.907 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 57' ' ' VAL . 46.6 mt-10 -62.55 -39.13 92.64 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.016 0.436 . . . . 0.0 110.471 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -62.64 -43.67 98.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.019 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.0 mt -67.35 -43.31 87.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.684 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.488 ' CZ2' ' HB2' ' A' ' 73' ' ' ARG . 41.9 t-105 -55.86 -41.16 73.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.281 -178.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 36.0 p -63.5 -29.13 70.45 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.256 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 66.0 mtt -67.66 -41.2 84.15 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.738 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.8 pt -106.52 -1.43 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -174.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -54.09 -32.0 53.54 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -176.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.545 ' ND2' ' HG2' ' A' ' 70' ' ' GLU . 4.9 p-10 -77.26 -14.74 59.7 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.545 ' HG2' ' ND2' ' A' ' 69' ' ' ASN . 58.6 mm-40 -117.71 -15.4 10.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.265 0.555 . . . . 0.0 111.203 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -124.16 155.57 38.25 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.788 -176.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -112.88 139.11 48.8 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 176.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.488 ' HB2' ' CZ2' ' A' ' 64' ' ' TRP . 71.0 ttp85 -87.28 112.3 21.91 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -177.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -70.97 -37.2 72.76 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.903 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -160.85 161.56 31.94 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.87 152.97 95.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.458 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.16 139.41 83.66 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.165 1.91 . . . . 0.0 111.398 177.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -140.29 148.39 41.35 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.412 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -91.76 107.7 19.39 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.219 0.533 . . . . 0.0 110.156 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -114.84 116.05 27.96 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.513 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.4 -104.71 1.56 Allowed Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 120.363 -0.922 . . . . 0.0 110.92 -177.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -127.56 10.54 6.68 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.05 0.453 . . . . 0.0 110.324 178.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.421 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 81.2 m-85 -121.52 145.31 48.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.299 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.614 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 86.5 t -97.46 119.05 45.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 172.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.497 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 78.5 m-20 -111.25 144.08 40.99 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.081 -171.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 15.5 tmm? -147.05 137.75 23.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.746 175.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.2 mt -114.65 134.29 55.18 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.1 m -117.09 131.29 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.219 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.435 HG23 ' NE2' ' A' ' 38' ' ' HIS . 15.8 m -104.83 137.7 19.29 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.429 ' HB3' ' CB ' ' A' ' 33' ' ' LEU . 57.9 Cg_endo -64.47 148.34 90.66 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.429 2.086 . . . . 0.0 111.632 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.437 ' HE2' ' O ' ' A' ' 69' ' ' ASN . 36.7 mttp -70.26 98.87 1.44 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.925 0.393 . . . . 0.0 111.629 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -136.61 145.87 45.39 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.68 177.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -105.87 94.25 5.08 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 174.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -75.95 93.84 3.3 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.394 0.616 . . . . 0.0 112.298 -176.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -129.31 48.26 0.98 Allowed Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.8 m-70 -92.39 169.82 10.26 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -71.06 -100.99 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 51.71 23.01 1.81 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -60.76 -41.03 94.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.204 0.526 . . . . 0.0 110.19 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -94.89 91.18 6.3 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.313 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 . . . . . 0 C--N 1.307 -1.282 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.898 -178.191 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 66.2 tttm . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 p -71.19 141.22 17.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 87.2 mt -79.94 115.14 21.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -84.01 108.58 17.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.036 0.446 . . . . 0.0 110.57 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.9 mt -89.32 133.57 31.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.015 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -94.01 143.79 26.05 Favored 'General case' 0 CA--C 1.492 -1.288 0 CA-C-O 121.428 0.632 . . . . 0.0 111.167 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.569 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 91.1 mt-10 -120.49 126.28 49.98 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.945 178.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.9 mt -110.46 117.77 55.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 12.3 mptt -97.51 139.76 32.96 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.186 0.517 . . . . 0.0 112.161 -177.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mp -130.22 177.17 7.52 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.192 176.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.6 m -135.05 154.08 51.82 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.9 t -63.3 -33.09 59.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.257 0.551 . . . . 0.0 110.059 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -106.9 74.59 1.0 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.967 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.4 tt -130.39 160.84 41.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.969 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.41 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -73.85 142.62 46.08 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -38.39 90.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.055 0.455 . . . . 0.0 109.987 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -61.88 -41.22 97.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.596 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.699 ' OD2' ' HE2' ' A' ' 25' ' ' LYS . 6.1 t70 -65.58 -36.49 83.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.679 -178.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.643 ' O ' HG21 ' A' ' 26' ' ' VAL . 68.4 mt -60.98 -46.62 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -59.14 -43.19 92.01 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.517 0.675 . . . . 0.0 110.571 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -61.66 -46.11 91.13 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.022 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.699 ' HE2' ' OD2' ' A' ' 21' ' ' ASP . 68.8 mttm -65.38 -40.89 94.04 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.756 0.312 . . . . 0.0 111.769 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.643 HG21 ' O ' ' A' ' 22' ' ' ILE . 55.8 t -61.57 -39.71 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.611 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -56.08 -39.65 72.42 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.534 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 20.9 m80 -64.35 -38.24 90.35 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.989 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.609 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -60.86 -38.58 86.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.726 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.68 -39.1 90.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.99 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 6.1 mm-40 -59.58 -50.64 73.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.057 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -64.75 -34.84 79.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.518 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 96.1 mt -62.75 -43.72 98.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.292 0.568 . . . . 0.0 110.474 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -67.14 -26.73 66.81 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.915 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.478 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 78.9 mt-30 -77.67 -7.65 56.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.902 178.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.63 22.52 50.1 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.908 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -103.71 158.83 16.11 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.994 0.426 . . . . 0.0 110.298 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -98.35 138.66 35.27 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.512 176.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.3 t -112.15 128.18 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.569 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 67.2 ttt180 -108.51 112.76 25.31 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 176.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -86.9 117.97 25.98 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 81.8 mtp180 -125.65 138.78 53.92 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.572 -177.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.592 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.1 p -126.61 135.66 63.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.014 0.435 . . . . 0.0 111.076 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -101.14 132.35 46.65 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.707 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.547 ' HB2' ' SD ' ' A' ' 50' ' ' MET . 29.1 mt -90.33 111.99 23.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.024 0.44 . . . . 0.0 109.852 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -104.27 123.21 46.95 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.58 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.45 -147.42 16.33 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.209 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -89.07 15.28 8.97 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.224 0.535 . . . . 0.0 110.02 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -73.86 -11.75 60.46 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.193 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.547 ' SD ' ' HB2' ' A' ' 45' ' ' LEU . 95.6 mmm -61.23 -35.92 78.54 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.276 -176.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.74 -21.22 65.65 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.486 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.0 p -119.71 94.94 48.97 Favored Pre-proline 0 N--CA 1.446 -0.64 0 CA-C-O 121.143 0.497 . . . . 0.0 111.839 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -64.4 -23.62 64.99 Favored 'Trans proline' 0 N--CA 1.477 0.552 0 C-N-CA 123.349 2.7 . . . . 0.0 111.26 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.94 -22.13 66.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.74 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.87 97.04 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.927 0.394 . . . . 0.0 110.519 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.406 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -68.37 -39.32 87.58 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.905 177.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.429 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 97.3 t -63.41 -44.98 99.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.648 0.261 . . . . 0.0 111.018 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.99 -40.94 95.43 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.16 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.3 tp -63.15 -45.15 93.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.192 0.52 . . . . 0.0 110.001 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 56' ' ' GLY . 63.1 mt -65.76 -37.75 87.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.767 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 57' ' ' VAL . 56.3 mt-10 -55.69 -42.23 74.89 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.621 0.248 . . . . 0.0 110.583 177.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -61.89 -43.53 98.65 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.06 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.468 ' O ' HG12 ' A' ' 67' ' ' ILE . 65.1 mt -62.39 -45.32 99.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.826 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.456 ' HA ' HG12 ' A' ' 67' ' ' ILE . 45.6 t-105 -57.6 -40.96 80.26 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.072 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.2 m -63.22 -25.69 68.45 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 121.126 0.489 . . . . 0.0 110.581 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 95.6 mtp -89.47 -43.3 10.94 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.888 0.375 . . . . 0.0 111.799 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 63' ' ' ILE . 40.5 pt -81.44 -18.35 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -174.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -58.8 -15.42 12.22 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.102 0.477 . . . . 0.0 111.863 -177.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -63.17 -40.71 98.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.668 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -116.48 -9.71 11.39 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.532 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.483 ' HB1' HD13 ' A' ' 33' ' ' LEU . . . -121.9 160.3 25.06 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.625 ' OD1' ' HG2' ' A' ' 91' ' ' LYS . 11.3 m-20 -116.08 156.89 25.57 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.732 176.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.453 ' HB2' ' CZ2' ' A' ' 64' ' ' TRP . 69.3 ttt180 -85.4 106.5 16.82 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.006 -176.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -82.25 -36.77 26.8 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.027 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -160.18 160.03 32.35 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.851 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.41 ' HB3' HH21 ' A' ' 73' ' ' ARG . 9.7 pt-20 -84.78 155.75 61.57 Favored Pre-proline 0 C--N 1.316 -0.868 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.43 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 16.1 Cg_endo -57.1 132.7 53.03 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.474 2.116 . . . . 0.0 111.788 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -127.75 134.04 49.52 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.347 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -82.28 113.66 20.24 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -127.34 114.86 18.13 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.234 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.39 -105.81 1.68 Allowed Glycine 0 N--CA 1.428 -1.888 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.687 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -121.31 7.73 10.2 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.209 0.528 . . . . 0.0 110.445 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -123.47 149.58 44.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.996 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.592 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 69.7 t -108.93 126.29 65.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 173.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.459 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 6.5 m-80 -124.06 139.04 54.33 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.492 -0.483 . . . . 0.0 112.124 -172.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 63.2 ttp -130.01 128.99 43.12 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -108.27 127.22 53.66 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.969 0.414 . . . . 0.0 110.031 -178.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.6 m -123.18 145.43 30.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.042 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.1 m -115.42 135.43 22.59 Favored Pre-proline 0 C--N 1.303 -1.414 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.125 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.404 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 55.5 Cg_endo -64.17 152.52 80.83 Favored 'Trans proline' 0 C--N 1.329 -0.481 0 C-N-CA 122.319 2.013 . . . . 0.0 110.054 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.625 ' HG2' ' OD1' ' A' ' 72' ' ' ASN . 68.6 mttm -60.91 96.6 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -174.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -71.94 -34.61 69.16 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.987 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 73.87 149.66 0.1 Allowed 'General case' 0 N--CA 1.468 0.445 0 O-C-N 124.038 0.836 . . . . 0.0 111.544 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -78.31 -61.38 2.02 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.64 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 65.94 88.19 0.06 OUTLIER Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.034 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -72.84 143.48 47.82 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.855 0.36 . . . . 0.0 111.153 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -103.16 18.38 21.87 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.577 0.704 . . . . 0.0 109.154 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -87.53 167.78 13.65 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.263 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -70.48 155.62 40.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.441 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -61.4 123.67 18.45 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 . . . . . 0 C--N 1.316 -0.89 0 CA-C-O 118.53 -0.748 . . . . 0.0 110.267 -178.858 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.708 0.289 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.402 HG11 ' O ' ' A' ' 5' ' ' VAL . 33.2 t -78.43 -4.15 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.649 0.738 . . . . 0.0 110.931 -178.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.6 mm -67.96 144.8 14.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.182 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -64.62 118.71 9.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.875 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 88.7 mt -104.22 133.49 48.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.387 0.613 . . . . 0.0 111.38 -176.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -96.13 149.59 21.46 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.833 -175.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -119.88 137.48 53.99 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.185 0.517 . . . . 0.0 111.272 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.8 mm -110.21 114.85 48.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -90.21 141.74 28.41 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.309 0.576 . . . . 0.0 111.321 -176.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.436 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 49.4 mt -133.46 165.99 23.58 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.597 -176.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.5 p -140.82 152.3 45.05 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.7 t -62.79 -33.74 61.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.325 0.583 . . . . 0.0 109.551 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -93.55 73.2 4.39 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.575 176.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.8 tt -126.34 145.58 33.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.515 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.77 142.55 53.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.292 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.409 HE22 ' HD3' ' A' ' 62' ' ' LYS . 62.2 tp60 -62.98 -38.33 90.71 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.305 0.574 . . . . 0.0 110.505 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -62.5 -38.25 89.18 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.952 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -64.96 -36.1 83.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.602 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 94.2 mt -61.73 -42.74 95.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.427 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 6.4 m-20 -60.15 -41.11 92.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.515 178.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -68.63 -40.5 80.3 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.8 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -60.81 -42.4 97.58 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.466 ' CG1' HG21 ' A' ' 63' ' ' ILE . 13.2 m -64.04 -35.97 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.316 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 23' ' ' ASN . 99.1 mttt -62.54 -42.67 99.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.411 0.624 . . . . 0.0 109.49 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -65.94 -41.6 91.12 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.218 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.427 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -64.03 -38.94 92.91 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.299 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.0 mt -61.36 -38.48 87.12 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.263 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 57.9 mt-10 -57.69 -42.85 84.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.683 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.447 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 80.1 m-85 -74.63 -37.19 62.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.873 0.368 . . . . 0.0 111.798 177.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 92.4 mt -62.84 -43.43 98.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.599 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -63.4 -22.88 67.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.919 0.39 . . . . 0.0 111.183 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 32' ' ' PHE . 78.1 mt-30 -71.17 -34.95 71.4 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.364 175.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.27 -0.3 12.85 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.268 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -88.13 164.81 15.51 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.56 151.25 20.86 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.652 -176.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.5 t -119.18 130.01 74.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.223 0.535 . . . . 0.0 110.315 175.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -103.33 114.53 28.88 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.514 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 85.9 m-85 -92.3 120.0 32.42 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.584 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.725 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 78.5 mtp85 -122.37 118.81 29.32 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.603 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.5 p -115.68 128.89 72.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.321 0.581 . . . . 0.0 110.931 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -95.58 121.38 37.22 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.817 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.4 mt -79.55 143.71 34.57 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -130.92 137.72 49.44 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.961 -0.295 . . . . 0.0 110.344 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.87 -147.07 33.11 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.102 -0.57 . . . . 0.0 113.576 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.448 ' O ' ' HD2' ' A' ' 48' ' ' ARG . 2.6 tmm_? -59.64 -35.85 75.21 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.909 0.884 . . . . 0.0 110.415 -177.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -54.18 -16.5 2.11 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 84.5 mtp -63.23 -34.08 76.89 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.073 0.463 . . . . 0.0 110.848 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.13 -33.53 73.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.232 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.414 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 68.4 p -117.11 105.25 49.41 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-O 121.097 0.475 . . . . 0.0 111.911 -177.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.63 -15.29 45.3 Favored 'Trans proline' 0 N--CA 1.485 0.998 0 C-N-CA 124.014 3.142 . . . . 0.0 113.14 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.414 ' HG2' ' HB ' ' A' ' 52' ' ' THR . 14.5 pt-20 -54.82 -31.26 58.96 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.585 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.08 -42.22 99.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.913 0.387 . . . . 0.0 111.102 -178.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.69 -41.32 89.49 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.749 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.4 t -63.66 -45.95 96.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.583 -0.309 . . . . 0.0 111.177 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.38 -38.5 87.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.769 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.2 tp -63.55 -45.88 88.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.288 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 86' ' ' MET . 94.2 mt -65.58 -40.74 93.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.14 -178.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -62.22 -33.99 75.62 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.776 0.322 . . . . 0.0 111.269 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.409 ' HD3' HE22 ' A' ' 19' ' ' GLN . 40.7 ttmt -62.11 -47.71 83.41 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-O 121.146 0.498 . . . . 0.0 109.688 176.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.466 HG21 ' CG1' ' A' ' 26' ' ' VAL . 70.8 mt -63.75 -43.06 97.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.047 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -56.66 -36.56 69.69 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.479 177.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.516 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 96.7 m -59.63 -44.38 93.5 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 120.988 0.423 . . . . 0.0 110.829 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -67.17 -39.55 86.46 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 63' ' ' ILE . 41.6 pt -98.37 -5.59 9.43 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.639 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -173.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 65' ' ' THR . 13.0 pt-20 -56.05 -34.86 66.3 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -176.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.402 ' ND2' ' HG3' ' A' ' 70' ' ' GLU . 3.3 p-10 -69.63 -18.77 63.62 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.402 ' HG3' ' ND2' ' A' ' 69' ' ' ASN . 43.3 mt-10 -123.44 -1.37 8.6 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.931 0.396 . . . . 0.0 111.76 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -131.87 153.75 49.89 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.965 -177.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -111.71 144.23 41.32 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -81.71 111.86 18.36 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -176.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -66.45 -41.76 88.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.194 0.521 . . . . 0.0 109.872 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -163.66 161.18 23.53 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.264 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -74.6 152.93 87.49 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.495 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.34 134.89 64.47 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.714 2.276 . . . . 0.0 111.884 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -135.5 137.77 42.45 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.689 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -90.69 106.78 18.74 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.166 0.507 . . . . 0.0 110.564 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -118.14 118.74 32.71 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.424 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.64 -108.93 2.67 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -123.33 8.77 9.1 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.974 0.416 . . . . 0.0 110.611 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -122.8 141.4 51.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.405 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.603 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 89.3 t -97.38 115.86 38.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 173.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.725 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 47.5 m-80 -108.52 144.16 36.56 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.195 -173.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.45 ' HB2' HD12 ' A' ' 60' ' ' LEU . 65.0 ttp -144.99 134.98 23.8 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.533 174.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 16.9 mt -109.72 135.34 50.81 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.032 0.444 . . . . 0.0 110.976 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.0 m -122.62 133.86 67.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.427 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.0 m -104.45 132.96 20.46 Favored Pre-proline 0 N--CA 1.432 -1.367 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -65.56 147.33 86.42 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.173 1.915 . . . . 0.0 111.656 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -70.64 84.62 0.63 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -138.99 172.78 12.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.835 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 74.98 -171.07 0.1 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.523 0.729 . . . . 0.0 111.189 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -85.36 130.74 34.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.496 -177.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -156.47 17.61 0.43 Allowed Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.159 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -70.05 139.98 52.73 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.809 0.337 . . . . 0.0 110.986 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -138.42 -83.22 0.3 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.734 177.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -156.96 152.05 26.19 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.591 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -134.58 158.46 43.94 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.315 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -93.61 -10.98 32.8 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.628 -177.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 27.3 p-80 . . . . . 0 C--O 1.241 0.608 0 CA-C-O 118.481 -0.771 . . . . 0.0 110.758 179.181 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.8 pttt . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.1 t -91.04 125.57 43.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 67.8 mt -105.65 93.84 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -86.82 124.32 32.93 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.039 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 80.9 mt -90.65 122.85 42.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.121 0.486 . . . . 0.0 110.396 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.468 ' HG2' ' CE1' ' A' ' 32' ' ' PHE . 4.2 mptp? -85.01 148.98 25.9 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.624 -175.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -110.85 118.05 35.08 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.955 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.3 mm -96.18 97.9 7.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 175.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 62.8 tttp -81.15 134.97 35.72 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.89 -177.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 67.3 mt -129.33 171.44 12.49 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.384 -175.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.9 p -144.2 149.98 37.26 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.58 -40.54 89.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -88.06 67.25 8.86 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.0 tt -117.6 152.69 19.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.35 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.94 154.69 22.03 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.231 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -63.49 -37.41 87.2 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.844 0.354 . . . . 0.0 111.098 -178.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -60.33 -42.64 96.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.272 0.558 . . . . 0.0 110.052 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.49 -40.52 97.3 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.004 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.65 ' O ' HG23 ' A' ' 26' ' ' VAL . 72.0 mt -61.41 -48.69 87.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -61.05 -47.6 85.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.377 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -62.44 -48.84 77.89 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.689 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -65.66 -42.47 91.32 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -177.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 22' ' ' ILE . 60.5 t -64.69 -43.74 96.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.138 0.494 . . . . 0.0 110.079 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.2 -42.21 99.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.112 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -66.69 -36.41 82.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.696 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.38 -34.49 73.98 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.801 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.442 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 96.7 mt -61.41 -38.2 86.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.523 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.454 ' HA ' ' OE1' ' A' ' 34' ' ' GLU . 41.5 mt-10 -61.75 -37.05 82.85 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.068 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.468 ' CE1' ' HG2' ' A' ' 9' ' ' LYS . 93.1 m-85 -69.26 -35.95 76.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.058 0.456 . . . . 0.0 110.579 177.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 90' ' ' PRO . 87.9 mt -62.86 -41.16 99.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.416 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 31' ' ' GLU . 46.8 mt-10 -53.07 -32.89 49.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.404 177.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -78.16 -8.89 58.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.557 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.5 10.43 61.96 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.46 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -94.44 -176.47 3.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.958 0.409 . . . . 0.0 110.158 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -116.31 154.31 30.41 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.012 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.442 ' O ' HD11 ' A' ' 87' ' ' LEU . 25.6 t -118.51 125.33 74.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -103.24 112.32 25.14 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.261 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -84.07 128.29 34.46 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.341 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 9.1 mmm180 -131.33 107.69 9.13 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.225 -175.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.549 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 9.7 p -108.77 132.98 55.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 120.921 0.391 . . . . 0.0 110.568 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -106.99 134.0 50.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.243 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.408 ' CD1' ' HA ' ' A' ' 50' ' ' MET . 30.2 mt -94.58 115.02 27.07 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -106.86 -64.7 1.15 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -171.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.556 ' O ' ' HG3' ' A' ' 49' ' ' GLU . . . -82.74 88.2 1.47 Allowed Glycine 0 CA--C 1.49 -1.485 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -178.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 61.22 -111.4 0.45 Allowed 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -171.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.556 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 89.4 mt-10 63.21 -42.98 0.21 Allowed 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 173.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.408 ' HA ' ' CD1' ' A' ' 45' ' ' LEU . 42.9 ttm -63.28 -20.13 65.2 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.046 0.539 . . . . 0.0 111.866 -177.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.26 -30.43 71.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.168 0.509 . . . . 0.0 109.726 175.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 p -126.71 92.61 44.45 Favored Pre-proline 0 N--CA 1.452 -0.334 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.225 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -62.84 -20.51 71.46 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 123.6 2.867 . . . . 0.0 112.552 -176.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.05 -23.72 65.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.418 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.14 -41.05 91.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.017 0.437 . . . . 0.0 110.402 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.45 -39.61 91.34 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.7 t -64.73 -44.4 96.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.603 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.85 -39.77 86.29 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.252 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.4 tp -62.53 -46.49 88.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.165 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.3 mt -65.53 -40.46 92.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.298 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -58.12 -39.96 80.01 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.356 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -61.96 -43.62 98.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.418 0.627 . . . . 0.0 110.345 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.2 mt -65.36 -43.57 94.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.913 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.2 t-105 -58.34 -39.47 79.55 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.807 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.43 ' HA ' ' OE2' ' A' ' 68' ' ' GLU . 19.5 m -57.75 -38.23 75.02 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.3 0.571 . . . . 0.0 110.583 178.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 78.3 mtm -77.1 -34.2 56.83 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.9 pt -98.41 -12.01 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 113.493 0.924 . . . . 0.0 113.493 -174.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.43 ' OE2' ' HA ' ' A' ' 65' ' ' THR . 14.1 pt-20 -59.83 -23.85 63.7 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -175.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -65.29 -30.98 71.89 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -127.09 3.27 6.47 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -128.68 153.79 46.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.144 0.497 . . . . 0.0 111.56 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.471 ' OD1' ' HG2' ' A' ' 91' ' ' LYS . 75.8 m-20 -111.85 149.33 31.96 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -89.01 106.56 18.51 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-O 121.025 0.44 . . . . 0.0 110.821 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -75.9 -41.05 53.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.421 0.629 . . . . 0.0 110.715 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -137.27 150.03 47.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.061 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -85.31 154.8 60.08 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 29.1 Cg_endo -63.4 115.29 2.93 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.76 1.64 . . . . 0.0 110.961 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -136.1 144.56 45.19 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.336 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -81.91 109.83 16.63 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.494 ' HB3' HD22 ' A' ' 85' ' ' ASN . 73.4 tt0 -148.71 123.43 9.87 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.808 -176.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.52 28.53 61.31 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.315 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 72.28 3.18 4.6 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.357 0.663 . . . . 0.0 111.339 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -119.87 145.46 46.65 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.054 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.549 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 92.0 t -95.35 112.27 27.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 172.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.494 HD22 ' HB3' ' A' ' 80' ' ' GLU . 9.5 p30 -116.48 148.97 40.27 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -172.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 66.0 ttp -141.85 136.74 30.86 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.31 175.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.442 HD11 ' O ' ' A' ' 39' ' ' VAL . 44.7 tp -118.82 140.15 50.43 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.904 0.383 . . . . 0.0 110.59 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.8 m -130.26 161.72 39.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.229 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.2 m -137.28 138.94 26.45 Favored Pre-proline 0 C--N 1.309 -1.178 0 CA-C-N 115.46 -0.791 . . . . 0.0 108.985 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.498 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 92.8 Cg_endo -68.41 142.87 55.85 Favored 'Trans proline' 0 C--N 1.329 -0.48 0 C-N-CA 122.242 1.961 . . . . 0.0 110.15 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.471 ' HG2' ' OD1' ' A' ' 72' ' ' ASN . 69.0 mttm -64.86 124.01 20.89 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.605 -177.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt 61.11 80.54 0.21 Allowed 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.739 0.649 . . . . 0.0 111.452 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.92 -41.68 13.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.391 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -66.47 -44.82 81.64 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.006 0.431 . . . . 0.0 111.008 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.76 66.14 2.62 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.845 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -63.15 -36.05 82.33 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.19 0.519 . . . . 0.0 109.757 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -109.51 129.05 55.59 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -76.94 107.61 9.4 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.852 0.358 . . . . 0.0 110.346 -178.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -67.73 116.9 8.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.568 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -94.62 -16.05 23.51 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.285 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.3 t60 . . . . . 0 C--O 1.247 0.922 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.281 -177.821 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.7 mttt . . . . . 0 CA--C 1.511 -0.54 0 CA-C-O 121.899 0.857 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.3 t -86.45 97.53 6.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.901 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.4 mm -83.07 136.4 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.401 ' CG ' ' HZ1' ' A' ' 9' ' ' LYS . 13.6 t0 -77.18 114.57 16.13 Favored 'General case' 0 C--O 1.212 -0.919 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.693 -177.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 74.4 mt -121.3 133.63 67.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.05 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.469 ' N ' ' HE2' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -80.26 147.76 31.07 Favored 'General case' 0 CA--C 1.485 -1.541 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.304 -177.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -133.78 112.21 11.16 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.661 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.9 mt -107.72 114.15 45.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.389 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 86.7 tttt -86.52 131.13 34.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 122.157 0.98 . . . . 0.0 112.297 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 83.2 mt -129.55 179.58 5.73 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.404 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.4 p -149.6 156.91 42.7 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.0 t -69.85 -17.71 21.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 121.529 0.68 . . . . 0.0 110.301 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -96.66 26.27 4.61 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.401 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.8 tt -88.72 138.89 18.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.255 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.76 145.57 48.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.927 177.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -56.43 -40.59 75.01 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -176.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -62.89 -36.0 81.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.754 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.57 -32.81 68.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.181 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.638 ' O ' HG22 ' A' ' 26' ' ' VAL . 62.5 mt -58.91 -46.9 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 109.614 -0.514 . . . . 0.0 109.614 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -57.48 -41.99 81.75 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 124.281 0.988 . . . . 0.0 110.573 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -62.99 -48.01 80.66 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.839 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -64.78 -43.36 93.46 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 120.568 0.223 . . . . 0.0 110.761 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 22' ' ' ILE . 50.0 t -63.55 -42.49 96.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.133 -178.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -57.22 -45.77 83.56 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.429 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -65.91 -37.13 85.28 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.601 177.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.71 -39.48 80.92 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.943 0.401 . . . . 0.0 109.971 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.494 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 98.2 mt -62.28 -41.35 98.41 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.211 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -63.32 -39.65 95.14 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.509 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -66.56 -35.18 79.6 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.183 0.516 . . . . 0.0 110.741 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.441 HD13 ' HB1' ' A' ' 71' ' ' ALA . 88.9 mt -62.56 -42.32 99.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.251 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 30' ' ' LEU . 86.9 mt-10 -56.7 -34.69 67.68 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.501 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -66.98 -19.82 65.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.598 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.77 35.54 6.11 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.306 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.441 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -124.52 164.92 18.75 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.304 0.573 . . . . 0.0 110.058 179.442 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.461 ' HE2' HG21 ' A' ' 89' ' ' THR . 16.2 m170 -97.81 137.5 36.58 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.961 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 68.5 t -104.48 118.97 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.697 175.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -95.37 110.48 22.5 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 94.0 m-85 -83.94 108.74 17.1 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.49 ' HA ' ' OD1' ' A' ' 85' ' ' ASN . 53.2 mtp85 -106.18 108.5 20.05 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.782 -177.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 84' ' ' VAL . 4.9 p -109.11 127.64 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-O 121.641 0.734 . . . . 0.0 111.161 -177.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -98.67 123.92 43.17 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.545 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.423 ' CD1' ' HA ' ' A' ' 50' ' ' MET . 89.4 mt -72.53 -56.28 5.62 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -176.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.8 tttp 69.08 124.81 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.118 0.485 . . . . 0.0 112.099 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.29 -155.57 25.25 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.798 176.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -72.41 -14.66 61.75 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.718 0.294 . . . . 0.0 111.384 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -61.88 -20.1 63.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.392 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.423 ' HA ' ' CD1' ' A' ' 45' ' ' LEU . 94.7 mtp -67.92 -15.3 63.55 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.737 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.56 -11.41 59.17 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 120.946 0.403 . . . . 0.0 110.684 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.432 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 41.5 p -128.33 106.58 19.44 Favored Pre-proline 0 N--CA 1.442 -0.856 0 CA-C-O 121.481 0.658 . . . . 0.0 111.204 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 52' ' ' THR . 35.3 Cg_endo -68.56 -16.65 42.95 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 122.902 2.401 . . . . 0.0 111.876 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -58.87 -33.82 70.91 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.974 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.49 -41.86 90.84 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.103 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.41 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -68.01 -41.58 87.13 Favored Glycine 0 C--O 1.219 -0.815 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 177.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.07 -44.49 99.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 O-C-N 123.727 0.31 . . . . 0.0 111.182 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.91 -41.82 96.88 Favored 'General case' 0 C--O 1.257 1.467 0 C-N-CA 122.448 0.299 . . . . 0.0 111.312 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.0 tp -62.85 -44.07 97.12 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.202 0.525 . . . . 0.0 109.805 177.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.469 HD11 ' HB2' ' A' ' 86' ' ' MET . 90.9 mt -65.76 -40.45 92.07 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.621 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -60.24 -37.67 81.11 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.333 0.396 . . . . 0.0 110.967 178.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -62.68 -44.32 96.55 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.603 0.716 . . . . 0.0 109.241 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 61.9 mt -67.26 -43.23 88.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.719 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.526 ' CZ2' ' HB2' ' A' ' 73' ' ' ARG . 37.6 t-105 -56.73 -39.23 73.56 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.827 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.7 m -63.23 -23.92 67.64 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 123.485 0.491 . . . . 0.0 111.212 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 96.5 mtp -91.1 -30.4 16.76 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.7 pt -98.73 -9.74 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -175.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -15.38 47.65 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -79.52 -21.9 44.64 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.668 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -119.9 -13.12 9.08 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.743 0.306 . . . . 0.0 111.246 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.441 ' HB1' HD13 ' A' ' 33' ' ' LEU . . . -126.67 154.68 43.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.102 0.477 . . . . 0.0 112.137 -175.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.442 ' OD1' ' HB ' ' A' ' 89' ' ' THR . 7.0 p30 -116.73 135.77 53.5 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.821 176.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.526 ' HB2' ' CZ2' ' A' ' 64' ' ' TRP . 36.1 ttp180 -74.87 112.14 10.78 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.247 -176.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -71.89 -37.84 70.07 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -159.32 158.94 33.32 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.115 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -72.79 150.52 90.78 Favored Pre-proline 0 C--N 1.306 -1.284 0 C-N-CA 122.536 0.334 . . . . 0.0 110.736 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.35 134.69 65.85 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 122.685 2.257 . . . . 0.0 112.511 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -133.62 149.12 51.6 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.99 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -91.82 116.25 28.74 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.38 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -128.3 137.76 52.1 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.64 -109.94 3.08 Favored Glycine 0 N--CA 1.426 -2.019 0 C-N-CA 119.966 -1.111 . . . . 0.0 111.769 -178.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -127.81 17.76 6.79 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.371 0.605 . . . . 0.0 110.273 177.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -129.24 150.94 50.41 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.908 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.527 ' O ' HG12 ' A' ' 43' ' ' VAL . 87.2 t -104.06 113.2 40.35 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.87 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 171.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.49 ' OD1' ' HA ' ' A' ' 42' ' ' ARG . 88.2 m-20 -113.88 137.5 51.58 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.343 -173.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.469 ' HB2' HD11 ' A' ' 60' ' ' LEU . 64.5 ttp -122.02 129.67 52.63 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.926 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -103.0 122.25 44.22 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 m -119.52 148.74 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.514 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.461 HG21 ' HE2' ' A' ' 38' ' ' HIS . 35.8 m -117.33 136.77 23.56 Favored Pre-proline 0 C--N 1.295 -1.785 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.429 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 91.4 Cg_endo -71.07 156.59 59.55 Favored 'Trans proline' 0 C--N 1.329 -0.494 0 C-N-CA 122.871 2.381 . . . . 0.0 111.508 177.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -74.34 142.12 45.16 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.299 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 86.8 tttt 62.33 102.65 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 124.415 1.086 . . . . 0.0 112.055 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -167.26 -28.42 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.965 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 67.11 12.55 9.03 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.856 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.51 90.38 1.39 Allowed Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -132.64 171.44 13.84 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.749 0.309 . . . . 0.0 110.206 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -122.69 93.23 3.91 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.69 177.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -105.54 -53.58 2.63 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.652 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -74.14 -66.6 0.7 Allowed 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.511 0.507 . . . . 0.0 111.958 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 43.4 t60 67.8 -67.66 0.18 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.152 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 65.7 t60 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.824 -0.608 . . . . 0.0 110.577 -179.995 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 N--CA 1.45 -0.462 0 CA-C-O 121.015 0.436 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.2 p -143.25 134.83 23.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.853 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.8 pt -81.21 129.36 37.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.186 0.517 . . . . 0.0 110.92 178.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -84.91 101.56 12.43 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.318 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.402 HG12 ' HB2' ' A' ' 38' ' ' HIS . 77.0 mt -87.86 130.3 37.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.481 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -86.52 135.9 33.28 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.422 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 46.0 mt-10 -110.25 114.38 27.81 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.197 178.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.4 mt -107.14 109.27 27.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -101.51 126.7 48.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.222 -175.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.449 HD23 ' CD1' ' A' ' 17' ' ' ILE . 5.1 mp -116.69 -178.89 3.53 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.036 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.0 p -139.28 157.98 44.96 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.2 t -64.08 -36.66 77.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 175.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -83.21 65.64 8.35 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.695 174.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.449 ' CD1' HD23 ' A' ' 13' ' ' LEU . 18.1 tt -123.44 149.36 27.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.1 152.14 26.69 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.731 176.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -64.02 -34.82 78.86 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.182 0.515 . . . . 0.0 109.924 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -62.32 -40.34 96.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.155 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.593 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 20.8 t70 -65.42 -36.92 85.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.055 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.7 mt -61.51 -42.85 95.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -60.31 -42.72 96.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.596 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -63.81 -44.15 94.13 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.3 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.593 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 75.6 mmtt -63.97 -43.9 94.37 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -176.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.545 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 11.1 m -67.92 -28.91 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.606 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.89 -44.69 94.09 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.227 0.537 . . . . 0.0 109.626 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -75.2 -36.92 61.35 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.234 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.507 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -59.63 -37.56 78.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.021 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.628 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 94.0 mt -61.9 -41.29 97.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.192 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -59.74 -45.09 93.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.086 0.469 . . . . 0.0 111.303 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -66.37 -36.2 82.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.876 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 96.8 mt -63.11 -40.0 96.36 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.067 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.628 ' HG3' ' O ' ' A' ' 30' ' ' LEU . 60.4 mt-10 -59.48 -33.3 71.15 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.987 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -79.84 -5.35 55.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.011 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.45 18.4 62.32 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.713 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -92.85 153.66 18.71 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.338 0.589 . . . . 0.0 111.401 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.431 ' CE1' HG22 ' A' ' 89' ' ' THR . 7.7 m80 -98.21 140.18 32.9 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.69 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 49.6 t -115.15 128.42 72.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.422 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 64.5 ttt180 -102.43 111.01 23.13 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -90.94 120.44 31.95 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.432 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 82.1 mtp180 -131.2 138.45 49.4 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.662 -177.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.528 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.4 p -129.48 135.93 60.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 121.144 0.497 . . . . 0.0 110.751 177.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -98.55 130.59 45.12 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.001 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.7 mt -95.5 125.09 39.87 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -102.43 128.31 49.08 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -172.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.98 -120.18 8.5 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.214 -0.903 . . . . 0.0 113.65 177.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 61.2 mtt85 -76.48 -9.01 58.33 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 122.927 0.491 . . . . 0.0 111.696 -175.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -66.51 -23.23 66.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.999 0.428 . . . . 0.0 110.944 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 65.9 mtt -64.12 -19.51 65.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.92 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.41 -14.71 61.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.501 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -140.64 105.98 6.42 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 122.192 0.996 . . . . 0.0 111.331 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.27 -20.61 36.92 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.337 2.691 . . . . 0.0 113.773 -176.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -20.51 66.06 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -177.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.93 99.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.117 0.484 . . . . 0.0 109.783 176.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.44 -37.82 79.43 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.43 176.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.0 t -62.62 -44.72 99.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.265 -0.468 . . . . 0.0 111.055 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.27 -40.8 95.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.542 ' O ' HG13 ' A' ' 63' ' ' ILE . 39.1 tp -62.25 -46.72 87.59 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.287 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.6 mt -65.29 -41.13 94.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.054 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -64.78 -35.39 80.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.954 0.407 . . . . 0.0 110.5 179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -63.03 -41.56 99.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.538 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 59' ' ' LEU . 63.1 mt -64.32 -43.99 97.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.138 176.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 53.4 t-105 -56.48 -42.32 78.07 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.158 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.7 p -64.37 -21.8 66.75 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.58 -0.448 . . . . 0.0 112.133 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 66.9 mtt -83.05 -31.69 27.24 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.5 pt -108.16 -4.7 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -54.45 -30.5 53.01 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -175.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.6 ' ND2' ' HG2' ' A' ' 70' ' ' GLU . 3.7 p-10 -72.83 -23.11 60.72 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.6 ' HG2' ' ND2' ' A' ' 69' ' ' ASN . 61.1 mm-40 -112.25 -19.96 12.04 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.079 0.466 . . . . 0.0 110.845 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.475 ' HB1' HD12 ' A' ' 33' ' ' LEU . . . -117.76 150.64 38.77 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.551 -176.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -112.51 137.86 50.12 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 175.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -76.21 119.81 20.64 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.076 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -85.33 -38.81 18.38 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.014 0.435 . . . . 0.0 110.607 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -148.03 156.08 42.23 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.269 -177.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -77.4 155.0 81.86 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.935 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 23.2 Cg_endo -61.76 138.49 74.89 Favored 'Trans proline' 0 C--O 1.24 0.617 0 C-N-CA 122.095 1.863 . . . . 0.0 111.446 176.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 27.4 p-10 -145.21 167.24 23.27 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.244 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.575 ' CZ ' ' HA ' ' A' ' 82' ' ' ARG . 89.8 t80 -107.84 111.07 23.02 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.112 0.482 . . . . 0.0 110.486 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -138.58 126.06 21.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.399 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.67 34.42 88.87 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.841 177.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.575 ' HA ' ' CZ ' ' A' ' 79' ' ' PHE . 89.2 mtt180 70.74 11.3 7.18 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -120.58 145.54 47.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.401 175.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.528 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 92.7 t -99.27 114.16 36.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 173.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 80.8 m-20 -110.25 147.58 33.54 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.987 0.422 . . . . 0.0 112.093 -173.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.663 ' SD ' HG12 ' A' ' 88' ' ' VAL . 17.8 tmm? -145.48 130.55 18.38 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -112.32 130.95 55.78 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.128 0.489 . . . . 0.0 111.206 -175.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.663 HG12 ' SD ' ' A' ' 86' ' ' MET . 15.2 m -119.81 135.91 58.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.496 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.431 HG22 ' CE1' ' A' ' 38' ' ' HIS . 37.9 m -105.84 133.51 20.17 Favored Pre-proline 0 N--CA 1.431 -1.4 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 176.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.04 151.01 84.96 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.185 1.924 . . . . 0.0 110.189 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.27 92.01 0.4 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.123 0.487 . . . . 0.0 110.764 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -145.22 136.33 24.85 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.378 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.64 113.29 24.73 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.69 0.281 . . . . 0.0 110.487 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -164.94 153.71 12.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.05 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 119.79 136.51 5.26 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.668 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -91.22 65.58 5.47 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.562 0.696 . . . . 0.0 110.423 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -142.46 137.85 30.61 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.82 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -132.47 153.61 50.71 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 177.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -113.91 4.8 15.96 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.768 0.318 . . . . 0.0 111.588 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -154.86 -53.11 0.09 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.276 -178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.429 -0.796 . . . . 0.0 111.091 -178.572 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 120.657 0.265 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.5 t -67.05 -43.26 89.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.512 0.672 . . . . 0.0 111.46 -178.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 80.5 mt -102.91 126.58 57.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.806 -177.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.601 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 7.5 m-20 -78.16 113.29 15.98 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.755 178.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 88.3 mt -103.99 115.01 45.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.198 0.523 . . . . 0.0 109.599 176.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.426 ' HG2' ' CE1' ' A' ' 32' ' ' PHE . 4.0 mptp? -81.99 143.34 31.66 Favored 'General case' 0 CA--C 1.489 -1.367 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.202 -177.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -109.59 126.93 54.13 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.522 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.439 HG23 ' HD2' ' A' ' 25' ' ' LYS . 31.8 mm -100.54 107.22 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.197 178.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 2.1 mptt -80.47 139.94 36.17 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.651 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.448 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 60.7 mt -133.67 164.79 26.42 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.624 -177.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 63.5 m -141.46 151.46 43.4 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.6 t -61.03 -42.19 92.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -81.99 62.95 6.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.635 176.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.5 tt -115.68 151.07 17.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.856 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.11 150.82 21.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.339 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -62.76 -34.31 76.96 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.924 0.392 . . . . 0.0 110.899 -178.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -62.46 -41.26 98.64 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -66.63 -35.73 80.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.76 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 94.1 mt -61.49 -42.71 94.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.261 0.553 . . . . 0.0 109.563 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -60.46 -44.33 95.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.222 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -63.44 -44.31 94.89 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.069 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.439 ' HD2' HG23 ' A' ' 11' ' ' ILE . 49.7 mmtm -63.26 -45.39 91.72 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.525 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 17.3 m -67.09 -36.61 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.621 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -60.54 -47.09 87.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.203 0.525 . . . . 0.0 110.099 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -68.29 -39.25 82.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.579 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.96 -36.22 80.79 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.842 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.605 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 88.6 mt -60.71 -40.26 91.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.086 -178.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.58 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 62.7 mt-10 -61.21 -41.73 97.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.839 -177.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.426 ' CE1' ' HG2' ' A' ' 9' ' ' LYS . 93.4 m-85 -63.6 -37.76 88.55 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.192 0.52 . . . . 0.0 110.35 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 90' ' ' PRO . 97.2 mt -63.62 -42.22 98.22 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.567 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.605 ' HG3' ' O ' ' A' ' 30' ' ' LEU . 40.3 mt-10 -61.84 -21.37 64.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.309 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.58 ' HG2' ' O ' ' A' ' 31' ' ' GLU . 73.3 mm-40 -84.52 -6.6 59.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.799 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.3 15.16 59.21 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.627 -177.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.601 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 63.8 mttp -105.11 177.21 4.92 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 120.978 0.418 . . . . 0.0 110.512 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -112.84 158.78 19.74 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.843 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.6 t -113.42 130.24 67.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -98.8 102.41 14.13 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.696 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 69.3 m-85 -85.91 117.37 24.72 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 120.594 -0.442 . . . . 0.0 109.959 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 82.6 mtp180 -125.94 110.42 13.59 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.243 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.548 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.8 p -107.13 128.42 62.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-O 121.234 0.54 . . . . 0.0 110.955 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.406 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 83.8 t80 -95.55 132.4 40.71 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.033 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.0 mt -81.26 83.11 6.94 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.223 0.535 . . . . 0.0 110.355 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -76.54 131.18 38.81 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.143 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.66 -140.82 16.52 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.475 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -105.75 -2.49 23.17 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.393 0.616 . . . . 0.0 109.92 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -74.04 -2.46 24.37 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.298 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.499 ' SD ' ' HD2' ' A' ' 82' ' ' ARG . 56.6 ttm -61.6 -22.18 65.0 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 122.52 0.328 . . . . 0.0 111.801 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.34 -13.66 60.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.938 0.399 . . . . 0.0 111.124 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.432 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 26.3 p -123.14 103.56 36.04 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.256 0.551 . . . . 0.0 111.482 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 52' ' ' THR . 37.1 Cg_endo -67.75 -18.25 47.6 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.2 2.6 . . . . 0.0 112.548 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -63.52 -29.19 70.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.041 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.93 -43.62 86.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.03 0.443 . . . . 0.0 110.606 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.405 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -66.16 -41.52 94.87 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.862 177.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.09 -44.64 97.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.739 0.304 . . . . 0.0 110.639 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.0 -41.08 97.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.887 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.6 tp -62.8 -45.28 93.38 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.212 0.529 . . . . 0.0 110.19 177.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.449 HD13 ' HB2' ' A' ' 86' ' ' MET . 98.0 mt -64.03 -40.16 95.7 Favored 'General case' 0 C--O 1.212 -0.876 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.812 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -58.19 -41.89 84.95 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.719 0.295 . . . . 0.0 111.156 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -63.96 -46.34 85.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.462 0.648 . . . . 0.0 109.738 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.413 ' CD1' HD11 ' A' ' 13' ' ' LEU . 96.3 mt -65.06 -42.67 95.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.171 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.494 ' CZ2' ' HB2' ' A' ' 73' ' ' ARG . 28.1 t-105 -56.45 -40.19 74.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.78 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.2 m -61.13 -34.2 74.61 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.269 0.557 . . . . 0.0 110.736 178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 98.2 mmm -69.33 -39.25 78.31 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.261 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.9 pt -97.49 -10.06 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -174.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.06 -14.93 7.61 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -177.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -61.67 -41.95 98.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.902 0.382 . . . . 0.0 110.218 178.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -126.52 14.94 7.65 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.902 -175.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -134.73 144.68 47.87 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.329 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -113.41 142.12 46.27 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 175.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.494 ' HB2' ' CZ2' ' A' ' 64' ' ' TRP . 53.7 ttp180 -95.47 114.55 26.33 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.642 -177.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -65.51 -41.15 93.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.86 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -155.73 160.45 40.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.934 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -69.11 161.28 74.0 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 123.346 0.404 . . . . 0.0 110.054 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.61 146.05 97.76 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.544 2.163 . . . . 0.0 112.306 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -138.41 137.83 37.63 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.592 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -89.59 125.35 35.19 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.703 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -142.32 125.42 16.31 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.29 -109.25 2.8 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.499 ' HD2' ' SD ' ' A' ' 50' ' ' MET . 29.0 mmt180 -125.42 12.81 8.16 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.12 0.486 . . . . 0.0 110.627 176.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 95.5 m-85 -119.85 151.32 39.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.339 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.548 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 76.5 t -108.94 122.25 63.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 171.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 87.5 m-20 -112.49 143.04 44.3 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -171.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.449 ' HB2' HD13 ' A' ' 60' ' ' LEU . 62.5 ttp -138.5 126.89 23.09 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.192 175.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -104.04 126.35 51.09 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.1 m -117.77 140.34 41.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.227 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.3 m -107.0 138.84 19.93 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.411 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 55.6 Cg_endo -64.23 140.3 70.34 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 122.115 1.876 . . . . 0.0 111.978 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -85.83 96.43 9.76 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 176.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -68.66 122.65 18.96 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.272 0.558 . . . . 0.0 111.524 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.29 -4.14 58.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.448 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -63.37 -41.39 98.82 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.602 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 146.76 154.69 6.27 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.323 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -101.47 14.96 30.39 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.388 0.613 . . . . 0.0 109.602 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -148.72 161.81 41.03 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.64 -177.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -152.85 143.64 22.86 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -165.1 155.13 13.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.251 -0.432 . . . . 0.0 109.89 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -125.81 -63.52 1.12 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.5 m80 . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.415 177.939 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 CA--C 1.52 -0.188 0 CA-C-O 121.536 0.684 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.1 p -102.24 12.93 6.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 122.319 1.057 . . . . 0.0 109.172 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.401 HG22 ' HG2' ' A' ' 37' ' ' LYS . 83.1 mt -90.93 114.73 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 CA-C-N 114.728 -1.123 . . . . 0.0 109.739 -177.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.492 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 34.6 t70 -76.69 115.23 16.27 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.887 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 82.9 mt -88.84 129.68 39.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.148 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.484 ' HG3' ' CD1' ' A' ' 32' ' ' PHE . 73.6 mmtt -85.43 135.82 33.7 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.657 -177.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -107.6 107.83 18.84 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.086 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.9 mm -92.43 106.62 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -84.02 133.64 34.66 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.888 -178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.436 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 66.0 mt -125.17 169.49 12.16 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.733 -177.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.468 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 40.0 m -140.78 150.66 43.64 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -59.96 -43.73 93.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.273 0.558 . . . . 0.0 109.586 174.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -78.77 62.26 3.23 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 121.743 0.782 . . . . 0.0 110.311 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 14' ' ' SER . 18.8 tt -111.21 161.21 9.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.836 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.599 -178.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.35 150.22 22.82 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.239 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -66.69 -38.47 86.85 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.645 -177.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -67.7 -33.26 74.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.906 0.384 . . . . 0.0 110.231 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -64.2 -38.1 89.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.835 177.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.5 ' O ' HG23 ' A' ' 26' ' ' VAL . 92.5 mt -62.88 -43.64 99.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.568 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -61.38 -42.62 99.01 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.784 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -62.36 -47.4 84.36 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.987 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -65.72 -40.67 92.43 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -178.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 22' ' ' ILE . 2.3 m -64.09 -35.54 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.535 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -61.76 -41.54 97.81 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.405 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 7.0 m80 -67.98 -41.74 81.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.095 176.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.526 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -59.58 -37.53 78.74 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.703 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.522 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 94.1 mt -61.8 -39.35 91.4 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.519 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.538 ' HA ' ' OE1' ' A' ' 34' ' ' GLU . 46.0 mt-10 -65.16 -44.57 88.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.375 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.484 ' CD1' ' HG3' ' A' ' 9' ' ' LYS . 90.0 m-85 -65.68 -34.49 78.33 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.917 0.389 . . . . 0.0 111.15 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 93.7 mt -62.93 -39.65 95.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.736 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.538 ' OE1' ' HA ' ' A' ' 31' ' ' GLU . 45.3 mt-10 -51.36 -40.79 59.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.77 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -70.69 -4.82 25.54 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.94 20.65 49.37 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.562 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.538 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 63.5 mttm -101.07 177.04 5.06 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 120.997 0.427 . . . . 0.0 110.599 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.431 ' NE2' HG23 ' A' ' 89' ' ' THR . 15.0 m170 -112.69 155.59 24.22 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.921 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.9 t -116.07 127.96 73.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 173.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -102.63 109.8 21.53 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -88.49 112.37 22.89 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.337 -0.545 . . . . 0.0 109.708 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.684 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 76.4 mtp85 -115.78 120.39 39.14 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.634 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.537 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.6 p -121.07 129.69 75.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.232 0.539 . . . . 0.0 111.349 -178.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -95.49 130.68 42.23 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.0 mt -78.67 84.57 4.76 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.87 0.367 . . . . 0.0 111.043 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -83.65 120.6 26.17 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.86 -133.56 7.22 Favored Glycine 0 N--CA 1.433 -1.555 0 C-N-CA 120.216 -0.993 . . . . 0.0 112.106 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -124.59 10.43 8.46 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.484 0.659 . . . . 0.0 110.543 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -80.91 6.06 14.36 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.23 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 96.5 mtp -65.62 -30.38 71.09 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.055 0.455 . . . . 0.0 110.562 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.96 -26.92 66.39 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.723 178.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.5 m -143.39 116.91 6.03 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.148 0.499 . . . . 0.0 111.044 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.06 2.96 4.93 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 123.487 2.791 . . . . 0.0 113.269 -176.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -59.5 -36.05 75.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.8 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.96 -43.8 94.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.146 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.401 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -68.98 -43.32 73.68 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.315 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.4 t -63.39 -47.25 92.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-O 120.578 0.228 . . . . 0.0 111.069 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.06 -37.14 86.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.421 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.2 tp -61.2 -49.55 76.7 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.962 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.476 HD11 ' HB3' ' A' ' 77' ' ' PRO . 88.5 mt -65.22 -42.15 93.74 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.826 -177.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -67.83 -35.33 78.4 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -63.77 -42.71 97.74 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.501 0.667 . . . . 0.0 109.297 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.475 HG12 HG22 ' A' ' 22' ' ' ILE . 86.7 mt -64.4 -43.55 97.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.876 -1.057 . . . . 0.0 109.889 177.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 -57.29 -40.05 77.01 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.789 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 91.5 m -60.88 -29.43 69.55 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 121.102 0.477 . . . . 0.0 111.225 -178.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 67.6 mtt -72.5 -35.07 68.07 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.407 HD12 HG12 ' A' ' 88' ' ' VAL . 37.1 pt -102.37 -7.36 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -174.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 65' ' ' THR . 15.2 pt-20 -58.91 -16.02 15.62 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -177.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -70.67 -14.07 62.32 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.447 ' HA ' ' HD2' ' A' ' 91' ' ' LYS . 11.6 pt-20 -150.19 29.89 0.71 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.57 0.7 . . . . 0.0 110.259 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -147.23 153.27 39.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.723 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.467 ' OD1' ' HB ' ' A' ' 89' ' ' THR . 7.2 p30 -123.89 135.8 53.95 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -70.68 110.75 5.67 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.086 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -69.31 -43.24 74.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.211 0.529 . . . . 0.0 109.779 178.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -153.85 143.78 21.95 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.71 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -62.77 157.62 57.91 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.859 176.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 31.4 Cg_exo -59.45 142.42 98.95 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.156 1.904 . . . . 0.0 111.968 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -137.51 133.41 34.53 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.447 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -87.69 118.67 27.35 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.989 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -130.85 110.89 11.63 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.944 -178.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.14 -97.58 0.6 Allowed Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.629 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.34 8.11 5.97 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.859 0.361 . . . . 0.0 110.626 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 65.3 m-85 -119.8 141.87 49.11 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.448 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.537 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 97.2 t -103.8 118.22 50.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 172.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.684 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 35.0 m-80 -109.14 143.97 37.82 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -173.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -149.84 137.03 19.69 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.1 mt -112.92 134.32 54.48 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.407 HG12 HD12 ' A' ' 67' ' ' ILE . 14.6 m -117.22 133.72 63.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.58 176.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.482 ' CG2' ' HD2' ' A' ' 90' ' ' PRO . 14.6 m -109.27 143.89 28.64 Favored Pre-proline 0 C--N 1.302 -1.485 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 60.7 Cg_endo -65.46 152.99 80.23 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.989 1.793 . . . . 0.0 109.352 177.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.447 ' HD2' ' HA ' ' A' ' 70' ' ' GLU . 37.0 tttm -53.94 119.83 5.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.235 0.54 . . . . 0.0 111.105 -174.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -65.9 138.3 57.76 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.94 -175.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.23 110.31 10.63 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.488 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 73.79 130.99 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 O-C-N 124.057 0.848 . . . . 0.0 110.824 -177.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 133.3 -110.38 0.9 Allowed Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -77.72 90.34 4.01 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 177.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -65.62 -52.25 53.38 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.912 -178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -144.34 178.32 8.01 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.699 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 54.0 p-80 -130.9 132.38 45.09 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.652 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -66.17 -46.39 77.54 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.1 t60 . . . . . 0 C--O 1.243 0.762 0 CA-C-O 118.707 -0.664 . . . . 0.0 109.929 -179.705 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt . . . . . 0 CA--C 1.52 -0.174 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.6 t 72.74 94.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.992 -177.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.1 mm -106.05 124.1 61.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.416 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.424 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 21.9 t0 -80.05 117.43 20.87 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.007 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 90.4 mt -118.71 133.4 65.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.718 -176.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 68.1 mmtt -84.12 121.81 27.96 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.607 0.718 . . . . 0.0 111.21 -175.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.454 ' OE1' ' HD3' ' A' ' 42' ' ' ARG . 47.9 mm-40 -93.47 105.53 17.58 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.12 -178.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.6 mt -108.29 110.82 33.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.385 0.612 . . . . 0.0 110.297 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 87.6 tttt -101.16 130.23 47.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.197 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.451 HD22 ' HG3' ' A' ' 25' ' ' LYS . 82.1 mt -129.23 -177.29 4.18 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.431 -178.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 p -137.53 158.22 44.86 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.726 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.41 ' HB ' ' OE1' ' A' ' 49' ' ' GLU . 72.4 t -64.19 -41.91 93.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.645 0.736 . . . . 0.0 109.169 177.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -90.28 71.94 7.15 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.384 177.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.4 tt -124.19 146.42 29.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.901 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.9 143.04 52.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.315 177.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -64.89 -32.42 74.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.519 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -62.08 -39.18 91.55 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.224 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.469 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 9.5 t70 -65.41 -37.81 88.05 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.569 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.418 ' O ' HG21 ' A' ' 26' ' ' VAL . 93.4 mt -62.05 -42.58 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.081 0.467 . . . . 0.0 109.95 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -59.52 -41.59 90.32 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.533 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -63.29 -43.33 98.19 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.574 177.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 75.5 mmtt -65.23 -44.74 87.26 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 22' ' ' ILE . 2.5 m -64.51 -34.44 69.63 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.653 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -60.32 -44.37 95.53 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 176.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.412 ' O ' ' HD2' ' A' ' 32' ' ' PHE . 11.2 m170 -64.5 -42.44 95.84 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.837 177.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.543 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -55.13 -48.62 73.39 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.661 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.62 -41.88 99.26 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.795 0.331 . . . . 0.0 111.099 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.5 -31.05 72.1 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.72 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.412 ' HD2' ' O ' ' A' ' 28' ' ' HIS . 82.4 m-85 -85.95 -31.7 21.96 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 121.059 -0.257 . . . . 0.0 111.483 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 86.9 mt -62.52 -44.97 95.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.96 0.41 . . . . 0.0 111.245 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -18.51 61.34 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.669 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -77.03 -13.63 59.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.887 0.375 . . . . 0.0 110.338 177.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.37 12.97 50.03 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.309 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.424 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 96.9 mttt -103.48 -179.56 3.99 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.107 0.48 . . . . 0.0 111.202 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -116.65 155.8 28.18 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.927 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.7 t -121.25 131.08 73.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 175.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -109.84 116.72 32.17 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 176.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -89.47 120.62 30.95 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 12.8 mtm180 -120.9 115.7 23.73 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -178.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.483 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 4.1 p -112.96 124.4 69.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.425 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.46 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 77.7 t80 -101.09 124.01 46.14 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.56 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.404 ' CD1' ' HA ' ' A' ' 50' ' ' MET . 34.2 mt -77.24 107.34 9.57 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -67.37 -78.84 0.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -171.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.529 ' C ' ' H ' ' A' ' 49' ' ' GLU . . . -126.13 119.74 3.53 Favored Glycine 0 CA--C 1.499 -0.908 0 C-N-CA 119.853 -1.165 . . . . 0.0 112.666 -175.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 72.18 -21.34 0.23 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.764 0.826 . . . . 0.0 111.308 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.529 ' H ' ' C ' ' A' ' 47' ' ' GLY . 14.9 mt-10 -61.94 -32.98 73.44 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.981 0.912 . . . . 0.0 110.623 178.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.459 ' SD ' ' HD2' ' A' ' 82' ' ' ARG . 44.3 ttm -63.61 -19.08 64.56 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.128 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.33 -13.62 61.14 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.913 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.405 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 32.3 m -140.78 101.27 6.52 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 121.334 0.588 . . . . 0.0 110.787 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 52' ' ' THR . 39.7 Cg_endo -68.7 -16.55 42.17 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.421 2.747 . . . . 0.0 112.321 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -58.48 -34.11 70.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.646 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.66 94.89 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.475 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.419 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -64.45 -40.98 98.19 Favored Glycine 0 CA--C 1.504 -0.654 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.859 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.8 t -66.26 -44.19 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 120.664 0.268 . . . . 0.0 110.734 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.2 -40.69 90.94 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.958 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.7 tp -61.89 -47.85 83.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.654 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.416 HD13 ' HB3' ' A' ' 77' ' ' PRO . 87.3 mt -65.26 -41.74 93.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.742 -178.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -64.49 -36.93 85.79 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.973 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -61.62 -43.53 98.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.464 0.65 . . . . 0.0 109.255 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.85 -44.12 96.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.462 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.411 ' CE3' HG13 ' A' ' 67' ' ' ILE . 50.8 t-105 -59.61 -35.84 75.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.377 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.6 m -60.3 -24.57 65.09 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.085 0.469 . . . . 0.0 110.85 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 92.6 mtp -91.55 -28.25 17.68 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.148 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.549 ' O ' ' HB1' ' A' ' 71' ' ' ALA . 32.8 pt -111.27 16.07 8.11 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -176.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -21.21 66.52 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.426 0.631 . . . . 0.0 111.08 178.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -73.93 134.97 43.24 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.093 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.435 ' N ' ' HZ1' ' A' ' 91' ' ' LYS . 10.0 pt-20 54.57 5.9 0.1 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.811 1.244 . . . . 0.0 113.295 -176.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.549 ' HB1' ' O ' ' A' ' 67' ' ' ILE . . . -124.02 161.55 25.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.813 0.339 . . . . 0.0 110.691 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -140.14 150.46 44.28 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -83.36 122.35 28.35 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 118.655 -1.218 . . . . 0.0 109.711 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.509 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 16.5 t70 -81.44 -15.85 53.82 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.406 0.622 . . . . 0.0 109.421 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -159.97 156.39 27.04 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.075 -175.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -93.68 151.57 40.1 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 14.8 Cg_exo -63.81 132.65 35.75 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.519 1.479 . . . . 0.0 110.689 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.428 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 58.3 t30 -148.43 149.41 31.66 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.133 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -91.83 111.73 23.37 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -152.22 129.49 11.26 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.68 -178.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.26 25.57 74.15 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.448 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.459 ' HD2' ' SD ' ' A' ' 50' ' ' MET . 42.4 mmt180 70.13 8.36 6.63 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 123.883 0.873 . . . . 0.0 112.041 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.46 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 55.1 m-85 -117.74 144.55 45.19 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.273 176.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.483 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 91.1 t -98.65 110.57 26.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 171.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 9.6 p30 -111.44 146.01 37.97 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -172.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 63.8 ttp -145.08 138.01 26.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.252 175.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 17.0 mt -110.61 135.35 51.37 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 120.785 0.326 . . . . 0.0 111.483 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.2 m -120.05 132.95 68.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 121.337 0.589 . . . . 0.0 110.979 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.509 ' OG1' ' HB2' ' A' ' 74' ' ' ASP . 28.2 m -121.25 143.16 36.7 Favored Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 91.8 Cg_endo -71.84 154.95 58.63 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.926 1.751 . . . . 0.0 109.929 177.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.435 ' HZ1' ' N ' ' A' ' 70' ' ' GLU . 63.9 mttp -63.98 134.96 56.02 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.559 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -70.03 98.78 1.35 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.404 -175.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.96 -37.83 87.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.368 0.604 . . . . 0.0 109.531 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -116.15 132.81 56.55 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.617 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 85.43 81.33 1.1 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.436 -178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -102.96 166.99 10.13 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.146 0.498 . . . . 0.0 110.993 -177.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -69.77 163.2 26.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.829 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -60.75 -77.26 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.608 0.242 . . . . 0.0 111.186 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -168.36 9.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.342 0.592 . . . . 0.0 109.845 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -90.53 -4.9 56.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.388 -176.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 . . . . . 0 C--O 1.243 0.757 0 O-C-N 123.803 0.689 . . . . 0.0 109.964 -176.716 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 N--CA 1.446 -0.67 0 CA-C-O 121.266 0.555 . . . . 0.0 111.368 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.26 76.34 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-O 122.082 0.944 . . . . 0.0 109.906 177.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 77.7 mt -113.91 107.68 23.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.998 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.562 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 27.1 t70 -103.17 107.38 18.17 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.788 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 90.4 mt -88.95 129.1 40.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 120.992 0.425 . . . . 0.0 110.638 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -91.23 140.6 29.64 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-O 121.789 0.804 . . . . 0.0 111.43 -176.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.528 ' OE2' ' HD2' ' A' ' 42' ' ' ARG . 45.2 mt-10 -118.61 109.76 16.53 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.037 177.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 88.4 mt -93.14 118.98 40.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.63 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 62.3 tttm -88.82 136.68 32.88 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.643 0.735 . . . . 0.0 112.164 -177.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 46.4 mt -130.39 169.9 14.88 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.875 -178.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.513 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 19.9 m -128.7 149.84 50.52 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.0 t -64.41 -43.83 97.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.433 0.635 . . . . 0.0 109.755 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.487 ' HE2' ' O ' ' A' ' 46' ' ' LYS . 40.6 mttm -95.19 67.75 3.04 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' A' ' 14' ' ' SER . 18.8 tt -101.5 148.5 7.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.758 -174.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.83 144.85 54.16 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.175 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -63.89 -39.68 94.76 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.804 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -63.85 -38.96 93.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.741 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -62.7 -37.98 88.61 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.85 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.54 ' O ' HG23 ' A' ' 26' ' ' VAL . 79.9 mt -61.37 -48.84 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 120.954 0.406 . . . . 0.0 110.456 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -61.95 -44.63 96.35 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.603 -177.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -62.73 -50.05 72.64 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.982 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -67.86 -43.58 79.09 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 22' ' ' ILE . 60.0 t -64.54 -42.26 94.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.914 0.387 . . . . 0.0 110.074 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.48 -44.44 97.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.211 176.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -37.46 87.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.765 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.508 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -57.04 -32.82 66.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.078 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.59 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 95.2 mt -61.41 -41.51 97.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.75 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 60.6 mt-10 -65.98 -36.7 84.02 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.379 -178.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -66.79 -37.09 83.89 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.156 0.503 . . . . 0.0 110.19 177.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 94.8 mt -62.67 -40.73 97.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.798 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' A' ' 30' ' ' LEU . 51.8 mm-40 -59.3 -26.11 64.71 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.143 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 31' ' ' GLU . 74.0 mm-40 -77.39 -8.55 57.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.614 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.19 19.13 57.94 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.739 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.562 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 62.8 mttp -107.48 -178.3 3.59 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.337 0.589 . . . . 0.0 111.339 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.493 ' NE2' HG21 ' A' ' 89' ' ' THR . 7.2 m80 -113.35 146.22 39.8 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.386 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.8 t -114.78 127.59 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.386 175.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.468 ' HD2' ' OE2' ' A' ' 10' ' ' GLU . 42.4 ttm180 -111.61 113.03 25.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 177.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.625 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 93.3 m-85 -84.89 113.11 21.15 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.528 ' HD2' ' OE2' ' A' ' 10' ' ' GLU . 28.9 mtp180 -115.29 130.97 57.06 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.436 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.4 p -123.64 130.18 74.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-O 121.17 0.509 . . . . 0.0 110.626 -178.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.425 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 77.6 t80 -94.82 118.22 31.41 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.954 178.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.474 HD12 ' HA ' ' A' ' 50' ' ' MET . 35.1 mt -72.39 145.74 47.5 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.487 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 41.3 ttmt -142.4 118.0 10.37 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.924 -176.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.51 53.52 0.72 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.298 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 48' ' ' ARG . 41.0 ttm180 69.39 -0.82 2.41 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.781 0.433 . . . . 0.0 111.579 178.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.403 ' O ' HD11 ' A' ' 45' ' ' LEU . 38.0 mt-10 -70.63 1.45 5.24 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.474 ' HA ' HD12 ' A' ' 45' ' ' LEU . 1.5 mpt? -61.87 -34.51 76.13 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.135 0.493 . . . . 0.0 110.426 177.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.63 -8.19 55.6 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.111 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.1 m -124.23 92.08 48.69 Favored Pre-proline 0 N--CA 1.446 -0.645 0 CA-C-O 121.199 0.523 . . . . 0.0 111.063 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.401 ' O ' HG23 ' A' ' 57' ' ' VAL . 35.7 Cg_exo -64.5 -24.57 63.47 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.322 2.681 . . . . 0.0 111.529 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -56.76 -30.76 63.91 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.003 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.65 -38.79 82.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.027 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.16 -37.5 9.89 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.973 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 53' ' ' PRO . 63.5 t -63.85 -46.03 95.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.317 0.103 . . . . 0.0 111.141 -178.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.48 -37.47 87.43 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.031 0.443 . . . . 0.0 110.866 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.7 tp -62.01 -45.97 91.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.442 0.639 . . . . 0.0 109.759 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.429 HD13 ' HB2' ' A' ' 86' ' ' MET . 91.9 mt -67.2 -38.39 85.27 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.99 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -58.09 -39.9 79.74 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 121.074 -0.251 . . . . 0.0 110.606 177.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -60.63 -45.08 95.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.309 0.576 . . . . 0.0 109.76 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.25 -43.56 97.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.638 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -59.49 -37.49 78.41 Favored 'General case' 0 C--O 1.206 -1.201 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.991 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.2 m -61.34 -24.33 66.37 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.524 0.678 . . . . 0.0 110.69 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 97.0 mmm -84.11 -42.72 15.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.087 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.5 pt -105.23 8.08 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -173.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.91 -10.2 27.03 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -89.0 -53.35 4.63 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -96.02 -5.26 41.52 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -175.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -125.98 154.14 43.32 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.567 0.222 . . . . 0.0 110.483 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.565 ' OD1' ' HB ' ' A' ' 89' ' ' THR . 10.0 p30 -115.71 134.8 54.66 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.24 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -69.59 110.53 4.86 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.867 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.442 ' CB ' HD11 ' A' ' 87' ' ' LEU . 26.5 t70 -71.68 -46.46 58.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.197 0.522 . . . . 0.0 109.848 177.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -149.78 154.86 39.15 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.606 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.6 155.81 87.13 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.257 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -54.66 137.5 73.96 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.88 2.386 . . . . 0.0 112.56 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 49.7 t30 -128.44 150.07 50.29 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.409 -177.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -108.9 121.01 44.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.796 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -126.07 108.61 11.52 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.08 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.3 -78.91 0.31 Allowed Glycine 0 C--O 1.223 -0.544 0 C-N-CA 121.399 -0.429 . . . . 0.0 113.059 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.443 ' HD2' ' N ' ' A' ' 82' ' ' ARG . 0.6 OUTLIER -147.38 10.18 0.97 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.95 0.405 . . . . 0.0 110.605 178.1 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.425 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 89.2 m-85 -117.63 140.39 49.71 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.528 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.436 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 69.1 t -112.81 130.26 66.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 175.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.625 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 9.4 p30 -133.21 143.27 49.05 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -175.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.429 ' HB2' HD13 ' A' ' 60' ' ' LEU . 64.8 ttp -127.68 136.35 51.46 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.578 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.442 HD11 ' CB ' ' A' ' 74' ' ' ASP . 2.7 tm? -110.52 127.02 54.99 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.001 0.429 . . . . 0.0 109.853 -178.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.45 ' O ' ' HD2' ' A' ' 38' ' ' HIS . 19.1 m -120.1 134.27 64.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.138 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.565 ' HB ' ' OD1' ' A' ' 72' ' ' ASN . 21.1 m -102.0 136.21 19.53 Favored Pre-proline 0 C--N 1.31 -1.133 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.731 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.489 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 80.4 Cg_endo -68.83 144.16 58.11 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.714 2.276 . . . . 0.0 110.689 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -85.78 88.9 7.62 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.95 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -82.21 -46.56 13.58 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.867 177.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -167.08 79.53 0.2 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.59 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -94.28 144.15 25.77 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.045 0.45 . . . . 0.0 111.215 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.67 1.65 69.04 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -72.21 133.4 45.08 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.451 -0.374 . . . . 0.0 110.194 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -80.33 134.49 36.06 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.998 178.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -65.58 -67.5 0.44 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.914 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -163.61 73.18 0.3 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -104.67 163.45 12.47 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.197 -176.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 65.3 m80 . . . . . 0 C--N 1.312 -1.05 0 CA-C-O 118.635 -0.698 . . . . 0.0 110.23 -179.5 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.0 mtpt . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.8 t 66.53 151.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 O-C-N 123.514 0.509 . . . . 0.0 111.03 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.1 mm -80.95 97.22 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -73.37 122.2 21.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.717 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 88.7 mt -97.37 133.85 37.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.028 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -90.5 147.1 23.6 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.67 -175.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -125.83 132.16 52.29 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.693 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -120.54 112.12 34.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.403 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -85.4 141.91 29.65 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.608 -176.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.465 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 36.6 mt -128.51 175.15 8.76 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.646 -175.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.8 p -149.93 153.69 37.05 Favored 'General case' 0 C--O 1.214 -0.815 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 176.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -70.22 -20.6 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-O 121.621 0.724 . . . . 0.0 110.321 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -89.05 15.76 8.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.714 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.4 tt -73.13 148.42 8.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.112 0.482 . . . . 0.0 111.362 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.97 152.53 21.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.186 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -63.49 -40.22 96.51 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -177.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -65.14 -29.67 70.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.029 0.443 . . . . 0.0 110.182 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -71.77 -38.85 70.29 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.328 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.54 -44.46 99.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -61.46 -41.66 97.58 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.331 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -65.51 -44.4 87.1 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.139 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -64.65 -41.81 95.86 Favored 'General case' 0 N--CA 1.461 0.088 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.0 m -62.95 -33.2 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.174 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -59.84 -48.27 82.36 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.879 0.371 . . . . 0.0 110.582 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -69.3 -37.05 77.63 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.462 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.475 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -59.39 -42.16 91.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.515 HD21 ' HB2' ' A' ' 70' ' ' GLU . 93.3 mt -62.27 -41.39 98.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.497 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.495 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 46.9 mt-10 -65.53 -38.12 88.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.472 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -70.28 -38.05 74.96 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.041 175.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 90' ' ' PRO . 85.4 mt -62.29 -45.26 94.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.905 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -64.01 -18.45 64.33 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.895 0.379 . . . . 0.0 111.641 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 80.3 mt-30 -80.25 1.01 30.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.613 177.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.3 32.62 25.06 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -119.57 157.33 28.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.934 0.397 . . . . 0.0 111.066 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.487 ' NE2' HG23 ' A' ' 89' ' ' THR . 13.0 m170 -101.61 148.03 25.71 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.398 177.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.6 t -118.65 130.04 74.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.054 0.454 . . . . 0.0 109.994 176.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -108.29 115.46 30.15 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.653 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 73.9 m-85 -90.39 121.93 32.81 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.407 ' HG2' ' HB3' ' A' ' 85' ' ' ASN . 85.1 mtp180 -125.82 121.11 32.35 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.612 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 4.2 p -112.94 131.58 64.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.24 0.543 . . . . 0.0 111.556 -176.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.403 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 84.3 t80 -93.75 121.25 35.0 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.748 177.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.5 mt -84.79 85.53 7.44 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.302 0.572 . . . . 0.0 109.969 -178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -66.06 129.6 40.36 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.06 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.64 -148.32 16.64 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.108 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -95.0 8.2 43.67 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.985 0.422 . . . . 0.0 110.286 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -63.84 -18.5 64.2 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.682 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 67.1 mtt -65.02 -10.32 28.74 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.53 -27.32 68.37 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-O 121.118 0.485 . . . . 0.0 110.387 176.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.4 t -129.99 109.51 16.85 Favored Pre-proline 0 N--CA 1.44 -0.948 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.832 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -63.77 -19.77 67.62 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.225 2.616 . . . . 0.0 112.075 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -60.32 -29.75 69.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.588 -177.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.34 -44.82 92.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.11 0.481 . . . . 0.0 110.364 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.451 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -69.86 -39.16 75.87 Favored Glycine 0 CA--C 1.506 -0.519 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.835 178.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.486 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 59.5 t -63.39 -44.7 99.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.628 0.251 . . . . 0.0 110.722 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.63 -37.91 83.01 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.343 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.4 tp -62.04 -45.44 93.53 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.453 HD13 ' HB2' ' A' ' 86' ' ' MET . 93.4 mt -65.71 -39.19 90.96 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.161 179.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 57' ' ' VAL . 61.8 mm-40 -55.83 -44.84 78.33 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.571 177.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -65.8 -42.49 90.62 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.162 0.506 . . . . 0.0 110.944 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.6 mt -64.77 -42.39 94.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.289 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -55.04 -45.21 75.21 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.043 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.0 p -66.58 -19.93 65.89 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.736 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 96.8 mmm -75.41 -38.54 59.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.556 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.9 pt -104.47 -7.58 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -174.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -58.5 -16.75 16.65 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.063 0.458 . . . . 0.0 111.904 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -64.38 -41.16 96.83 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.678 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.515 ' HB2' HD21 ' A' ' 30' ' ' LEU . 40.9 mt-10 -124.3 14.44 8.97 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.245 0.545 . . . . 0.0 110.914 -178.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.65 142.27 37.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.646 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -114.98 145.4 42.29 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.995 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.0 ttt-85 -70.89 121.77 18.72 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.385 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.415 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 26.2 t70 -93.63 -42.45 9.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.361 0.601 . . . . 0.0 109.998 176.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -144.33 157.67 44.15 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.796 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -86.12 154.11 57.39 Favored Pre-proline 0 C--N 1.316 -0.848 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.401 ' CG ' HG11 ' A' ' 57' ' ' VAL . 12.2 Cg_endo -54.38 132.07 48.83 Favored 'Trans proline' 0 C--O 1.24 0.593 0 C-N-CA 122.674 2.249 . . . . 0.0 112.388 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -129.42 131.37 46.75 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.742 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.403 ' HB2' HG23 ' A' ' 84' ' ' VAL . 83.8 t80 -98.61 109.16 21.96 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.983 177.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -152.53 139.11 18.7 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.268 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.35 31.49 68.64 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.948 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 69.47 10.25 7.61 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 122.997 0.519 . . . . 0.0 112.14 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.403 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 56.3 m-85 -126.12 144.02 50.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.746 178.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.612 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 91.7 t -102.28 122.89 55.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 173.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.653 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 7.0 p30 -129.75 146.69 51.5 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -173.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.453 ' HB2' HD13 ' A' ' 60' ' ' LEU . 64.0 ttp -139.85 143.78 36.93 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.848 178.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 16.1 mt -107.6 129.76 54.96 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.475 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.6 m -122.06 135.33 62.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.562 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.487 HG23 ' NE2' ' A' ' 38' ' ' HIS . 17.9 m -108.89 143.15 27.0 Favored Pre-proline 0 C--N 1.306 -1.292 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.202 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.484 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 46.7 Cg_endo -63.73 143.57 86.96 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.256 1.971 . . . . 0.0 111.179 178.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -80.34 66.91 6.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.354 0.597 . . . . 0.0 111.945 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 55.31 -89.78 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.509 -1.223 . . . . 0.0 112.982 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -152.41 38.05 0.55 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.747 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -74.59 152.24 39.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.164 0.507 . . . . 0.0 112.057 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.84 103.35 2.87 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.945 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -76.01 -54.18 7.25 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 49.8 p-80 -136.06 121.05 18.76 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.121 177.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -86.29 90.65 8.23 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.264 0.554 . . . . 0.0 110.316 -176.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.428 ' CE1' ' HA ' ' A' ' 101' ' ' HIS . 36.1 t-80 -165.69 122.26 1.39 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.481 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -92.65 -6.24 49.75 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.497 -177.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.428 ' HA ' ' CE1' ' A' ' 99' ' ' HIS . 37.6 t60 . . . . . 0 C--O 1.245 0.853 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.274 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 CA--C 1.51 -0.589 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.455 HG12 ' HB2' ' A' ' 38' ' ' HIS . 77.5 mt -119.44 132.16 70.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-O 120.845 0.355 . . . . 0.0 111.272 -175.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 74.2 mmtt -97.45 130.59 44.54 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.441 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 43.2 mt-10 -107.83 97.65 7.34 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.8 mt -88.74 125.09 41.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.639 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -96.98 145.87 25.52 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.197 -176.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.538 HD22 HD11 ' A' ' 63' ' ' ILE . 5.5 mp -135.69 176.89 8.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.279 173.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.468 ' HA ' HG23 ' A' ' 43' ' ' VAL . 16.2 p -139.1 156.22 47.32 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.85 -42.94 94.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.238 0.542 . . . . 0.0 109.995 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -95.33 76.46 3.4 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.516 HD11 ' OD2' ' A' ' 21' ' ' ASP . 19.3 tt -125.38 148.5 29.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.114 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.6 142.09 44.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.161 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -64.52 -33.73 76.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.955 0.407 . . . . 0.0 110.976 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.49 -40.71 92.35 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.526 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.516 ' OD2' HD11 ' A' ' 17' ' ' ILE . 23.2 t70 -66.6 -39.08 88.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.574 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.3 mt -62.92 -45.66 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.167 0.508 . . . . 0.0 110.271 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -61.1 -42.51 98.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.494 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -63.14 -44.32 95.89 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.954 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -64.93 -41.64 95.36 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 m -63.8 -28.83 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.508 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -60.06 -49.8 76.21 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 120.99 0.424 . . . . 0.0 110.49 176.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -68.3 -36.75 79.81 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.312 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.585 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -56.41 -45.62 80.56 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.025 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.639 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 88.9 mt -62.67 -42.83 99.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.073 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.01 -39.95 95.25 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.67 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -68.39 -34.43 76.02 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.931 0.396 . . . . 0.0 111.125 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 95.0 mt -63.6 -39.85 95.43 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.639 ' HG3' ' O ' ' A' ' 30' ' ' LEU . 63.3 mt-10 -61.02 -22.71 64.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.546 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -85.13 -6.35 59.3 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.59 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.05 19.61 55.29 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.706 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -105.81 172.41 6.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.173 0.511 . . . . 0.0 111.2 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.455 ' HB2' HG12 ' A' ' 8' ' ' ILE . 12.3 m80 -104.82 145.57 30.2 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.02 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.528 ' O ' HD12 ' A' ' 87' ' ' LEU . 41.5 t -118.33 125.71 74.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.441 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 71.2 ttt180 -102.74 115.19 30.1 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -90.2 116.64 28.35 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -122.45 132.99 54.61 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.592 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 4.9 p -128.26 131.29 69.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 121.061 0.458 . . . . 0.0 110.31 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.451 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 88.0 t80 -104.58 129.14 52.71 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.494 ' CD1' ' HA ' ' A' ' 50' ' ' MET . 30.0 mt -73.49 128.02 34.34 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -60.5 -46.2 90.99 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -171.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.63 -61.55 0.15 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.163 -1.018 . . . . 0.0 112.671 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.417 ' HD2' ' N ' ' A' ' 48' ' ' ARG . 6.6 mpt_? -67.05 -37.32 83.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.141 0.496 . . . . 0.0 111.512 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.501 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 1.1 pm0 -80.45 -3.95 51.83 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.952 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.494 ' HA ' ' CD1' ' A' ' 45' ' ' LEU . 56.3 ttm -63.21 -19.68 64.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.871 0.367 . . . . 0.0 111.351 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.51 -11.1 59.82 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.251 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.0 m -131.19 100.06 17.25 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 121.153 0.501 . . . . 0.0 111.449 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.34 -25.71 71.42 Favored 'Trans proline' 0 N--CA 1.477 0.504 0 C-N-CA 123.505 2.803 . . . . 0.0 112.511 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -63.07 -25.5 68.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.523 -177.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.3 -44.96 94.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.881 0.372 . . . . 0.0 110.32 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.1 -38.38 92.29 Favored Glycine 0 CA--C 1.506 -0.474 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.614 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.504 HG13 ' HG2' ' A' ' 77' ' ' PRO . 99.1 t -62.74 -47.3 93.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.516 -0.342 . . . . 0.0 110.831 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.09 -37.79 88.62 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.042 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.4 ' O ' HG13 ' A' ' 63' ' ' ILE . 39.9 tp -62.57 -47.58 83.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.071 0.463 . . . . 0.0 110.239 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.562 HD12 HG12 ' A' ' 84' ' ' VAL . 62.1 mt -66.15 -39.6 89.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.666 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 57' ' ' VAL . 71.1 mt-10 -60.58 -36.66 79.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.684 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 66' ' ' MET . 86.0 tttt -63.84 -39.91 95.35 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.538 HD11 HD22 ' A' ' 13' ' ' LEU . 65.9 mt -61.7 -47.73 91.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.789 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.489 ' CZ2' ' HB2' ' A' ' 73' ' ' ARG . 40.3 t-105 -58.04 -40.64 81.4 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.414 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.45 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 19.0 m -61.28 -39.76 91.61 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.082 0.467 . . . . 0.0 110.728 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' A' ' 62' ' ' LYS . 97.3 mmm -66.78 -41.98 86.79 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.4 pt -105.06 -0.26 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -173.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 65' ' ' THR . 0.1 OUTLIER -56.31 -18.68 11.44 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.675 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -65.71 -36.55 83.93 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.523 ' HB2' HD22 ' A' ' 30' ' ' LEU . 47.8 mt-10 -122.75 6.09 9.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.801 0.334 . . . . 0.0 111.598 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -121.18 152.47 38.75 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.959 0.409 . . . . 0.0 111.752 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -112.23 148.37 34.25 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.489 ' HB2' ' CZ2' ' A' ' 64' ' ' TRP . 74.9 ttt180 -90.94 111.12 22.42 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 120.763 0.316 . . . . 0.0 111.102 -176.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -72.71 -38.73 67.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.8 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -163.28 -177.8 5.56 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.902 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.473 ' HG2' ' NH2' ' A' ' 73' ' ' ARG . 42.4 mt-10 -91.92 150.62 40.97 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.971 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.504 ' HG2' HG13 ' A' ' 57' ' ' VAL . 34.7 Cg_endo -68.99 132.26 24.17 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.106 1.871 . . . . 0.0 110.541 174.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.443 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 62.7 t30 -147.63 151.49 36.3 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.82 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.51 ' CE1' ' HA ' ' A' ' 82' ' ' ARG . 91.1 t80 -86.87 115.48 24.31 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.744 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.97 109.74 3.65 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.181 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.54 31.57 21.38 Favored Glycine 0 C--O 1.223 -0.559 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.327 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.51 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . 96.4 mtt180 69.25 3.49 4.14 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.749 0.82 . . . . 0.0 112.15 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 89.7 m-85 -121.12 137.58 54.59 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.427 174.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.592 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 74.2 t -99.86 124.09 53.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -130.84 142.76 50.4 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -175.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.467 ' SD ' HG13 ' A' ' 88' ' ' VAL . 16.4 tmm? -135.1 143.21 46.49 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.167 176.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.528 HD12 ' O ' ' A' ' 39' ' ' VAL . 47.9 tp -122.57 140.5 52.72 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.104 0.478 . . . . 0.0 111.438 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.467 HG13 ' SD ' ' A' ' 86' ' ' MET . 17.8 m -122.85 133.63 68.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.701 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.438 HG23 ' CE1' ' A' ' 38' ' ' HIS . 18.1 m -98.74 136.88 20.56 Favored Pre-proline 0 C--N 1.312 -1.022 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.75 144.8 84.97 Favored 'Trans proline' 0 C--N 1.326 -0.64 0 C-N-CA 122.336 2.024 . . . . 0.0 111.088 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt . . . . . 0 C--N 1.319 -0.756 0 CA-C-O 121.483 0.659 . . . . 0.0 111.441 -176.443 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.471 ' HB2' ' HD2' ' A' ' 37' ' ' LYS . 16.2 m-20 . . . . . 0 CA--C 1.5 -0.949 0 CA-C-O 121.195 0.521 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.458 HG12 ' HB2' ' A' ' 38' ' ' HIS . 79.8 mt -109.13 116.05 51.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.43 ' HE2' ' HB3' ' A' ' 7' ' ' ASP . 3.5 mptp? -83.87 134.73 34.68 Favored 'General case' 0 CA--C 1.488 -1.427 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.675 -175.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.415 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 59.9 mt-10 -102.57 112.02 24.59 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.594 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.7 mt -104.11 115.09 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.099 177.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 86.5 tttt -96.58 141.28 30.03 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.991 -175.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 5.5 mp -135.52 171.21 14.78 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.868 175.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.8 m -132.5 154.18 50.19 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.616 ' HB ' ' OE1' ' A' ' 49' ' ' GLU . 86.0 t -63.53 -33.53 62.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.338 0.59 . . . . 0.0 109.777 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.516 ' HG3' ' OE2' ' A' ' 49' ' ' GLU . 65.2 mttp -97.38 76.65 2.59 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.0 tt -134.55 154.0 36.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.751 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.74 143.74 49.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.186 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -64.46 -30.2 71.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.215 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -63.28 -39.05 93.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.644 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.9 -43.08 99.58 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.089 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.1 mt -62.16 -44.83 99.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.774 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -62.12 -43.67 98.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.239 0.542 . . . . 0.0 111.625 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -64.58 -43.27 94.4 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.496 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -65.24 -42.18 93.63 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.421 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 12.9 m -63.22 -33.17 59.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.004 178.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -62.52 -41.47 98.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.454 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -67.42 -42.49 83.12 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.599 177.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.531 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -60.01 -38.84 83.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.124 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 26' ' ' VAL . 97.4 mt -62.02 -41.77 98.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.026 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.617 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 67.0 mm-40 -65.3 -43.04 92.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.549 0.214 . . . . 0.0 110.714 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -64.02 -38.04 89.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.521 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 96.7 mt -62.18 -43.57 98.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.452 0.644 . . . . 0.0 109.435 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -61.64 -22.81 65.59 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.257 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.617 ' HG2' ' O ' ' A' ' 31' ' ' GLU . 76.5 mm-40 -85.13 -8.5 58.6 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.934 0.397 . . . . 0.0 110.528 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.42 13.72 56.74 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.024 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.471 ' HD2' ' HB2' ' A' ' 7' ' ' ASP . 75.7 mmtt -96.29 159.74 14.79 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.484 ' NE2' HG23 ' A' ' 89' ' ' THR . 23.6 m170 -107.85 147.29 31.13 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.476 ' O ' HD12 ' A' ' 87' ' ' LEU . 41.5 t -114.29 126.43 71.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.415 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 41.6 ttm180 -102.78 115.87 31.45 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -92.61 120.11 32.72 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 78.1 mtp180 -126.71 133.77 50.83 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.604 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.2 p -121.37 131.6 72.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 121.359 0.599 . . . . 0.0 111.217 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -101.26 124.37 46.84 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.849 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 49' ' ' GLU . 42.1 mt -76.24 133.61 40.06 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -112.31 116.81 30.98 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.082 0.467 . . . . 0.0 112.082 -174.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.48 -134.14 12.21 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.476 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 -74.84 -6.66 50.29 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.021 0.438 . . . . 0.0 110.817 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.616 ' OE1' ' HB ' ' A' ' 15' ' ' VAL . 99.5 mt-10 -60.35 -24.17 64.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.971 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 91.1 mtp -62.56 -29.27 70.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.528 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.49 -10.21 59.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.868 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.454 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 24.0 m -128.26 95.17 34.17 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-O 121.484 0.659 . . . . 0.0 111.456 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' A' ' 52' ' ' THR . 37.9 Cg_endo -68.0 -18.09 46.18 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.296 2.664 . . . . 0.0 111.944 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -62.7 -31.67 72.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.936 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.74 -41.07 97.16 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.219 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.47 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -64.88 -38.4 95.48 Favored Glycine 0 CA--C 1.504 -0.625 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.813 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.466 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 99.4 t -63.66 -45.93 96.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 120.839 0.352 . . . . 0.0 110.413 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.17 -41.45 96.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.38 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.544 ' O ' HG13 ' A' ' 63' ' ' ILE . 44.5 tp -63.89 -47.24 81.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.785 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.551 HD12 HG12 ' A' ' 84' ' ' VAL . 82.8 mt -64.41 -41.18 96.77 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.938 -177.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 57' ' ' VAL . 5.5 mm-40 -64.36 -35.74 81.88 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.52 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -63.81 -40.75 97.37 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 59' ' ' LEU . 65.9 mt -64.47 -44.98 97.02 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.865 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 57.2 t-105 -58.43 -38.15 76.87 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.599 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.9 m -57.44 -38.91 75.19 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.338 0.589 . . . . 0.0 110.225 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 98.1 mmm -67.32 -40.67 85.97 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.731 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.9 pt -102.02 -6.25 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -174.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -58.54 -21.13 51.52 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.074 0.464 . . . . 0.0 111.328 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -64.57 -33.25 75.48 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.306 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.518 ' HA ' ' HE3' ' A' ' 91' ' ' LYS . 73.3 mm-40 -131.94 6.5 4.29 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -122.0 157.56 31.07 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.957 0.408 . . . . 0.0 111.324 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -111.72 150.78 29.74 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -94.79 113.13 24.85 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 120.717 0.294 . . . . 0.0 111.172 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -77.96 -44.89 25.46 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.334 0.588 . . . . 0.0 110.422 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -145.68 149.99 35.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.332 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.46 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 9.9 pt-20 -80.38 163.15 58.39 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.402 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.629 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 29.9 Cg_endo -62.68 138.5 69.94 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 121.814 1.676 . . . . 0.0 111.981 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.585 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 23.3 p-10 -144.84 156.89 44.26 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.004 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -105.78 108.41 19.9 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.039 0.447 . . . . 0.0 110.487 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -123.33 120.08 31.99 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.511 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.72 -102.7 1.24 Allowed Glycine 0 N--CA 1.432 -1.619 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.683 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -127.17 7.13 6.5 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.738 0.304 . . . . 0.0 110.796 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -125.84 143.87 50.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.88 0.372 . . . . 0.0 111.844 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.604 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 92.3 t -99.54 124.9 53.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 172.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.629 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 10.8 m-80 -119.55 144.43 47.07 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -172.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 13.1 tmm? -145.03 132.31 20.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.476 HD12 ' O ' ' A' ' 39' ' ' VAL . 49.8 tp -114.91 142.74 46.18 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.062 0.458 . . . . 0.0 111.917 -175.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.0 m -124.92 158.71 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.27 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.484 HG23 ' NE2' ' A' ' 38' ' ' HIS . 25.3 m -131.86 143.51 49.37 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.429 ' HD2' ' CG2' ' A' ' 89' ' ' THR . 74.1 Cg_endo -68.17 153.86 73.7 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 122.15 1.9 . . . . 0.0 110.852 177.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' A' ' 70' ' ' GLU . 97.2 mttt . . . . . 0 C--N 1.324 -0.516 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.526 ' OD2' ' HE2' ' A' ' 9' ' ' LYS . 7.7 t70 . . . . . 0 CA--C 1.533 0.327 0 CA-C-O 121.156 0.503 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 87.1 mt -127.07 136.79 59.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.503 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.526 ' HE2' ' OD2' ' A' ' 7' ' ' ASP . 4.1 mptp? -101.55 157.82 16.54 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-O 121.793 0.806 . . . . 0.0 112.65 -177.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.444 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 46.0 mt-10 -124.74 123.23 39.54 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.848 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.9 mt -109.13 114.6 47.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 87.7 tttt -98.72 135.52 40.08 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.139 -174.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.639 HD22 HD11 ' A' ' 63' ' ' ILE . 5.5 mp -132.07 -177.09 4.29 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.61 177.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.403 ' HA ' HG23 ' A' ' 43' ' ' VAL . 22.4 p -143.73 156.51 44.55 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.512 ' HB ' ' OE2' ' A' ' 49' ' ' GLU . 79.8 t -63.67 -44.02 98.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.706 ' HG2' ' OE2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -85.48 71.29 10.8 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 173.395 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.444 HD11 ' OD2' ' A' ' 21' ' ' ASP . 16.7 tt -122.62 160.67 24.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.864 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.73 147.12 24.04 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.12 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -63.52 -33.53 75.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.014 0.435 . . . . 0.0 110.283 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -62.28 -40.54 96.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.389 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 21.1 t70 -66.9 -34.79 78.56 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.839 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.8 mt -61.77 -41.55 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.261 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -58.13 -43.6 87.37 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.752 0.787 . . . . 0.0 109.795 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.403 ' HB3' ' O ' ' A' ' 21' ' ' ASP . 57.9 t80 -61.88 -43.96 97.78 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.689 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 74.2 mmtt -61.96 -46.88 87.33 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.246 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.416 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 9.7 m -71.35 -32.96 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -60.76 -42.56 97.68 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.022 0.439 . . . . 0.0 109.94 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -73.38 -36.79 66.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.273 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.486 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -58.98 -38.49 79.24 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.193 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.427 ' HA ' HD12 ' A' ' 33' ' ' LEU . 96.7 mt -61.4 -39.54 91.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.527 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 61.8 mt-10 -65.54 -40.52 92.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.169 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -65.95 -37.65 86.58 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.117 0.484 . . . . 0.0 110.598 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 90' ' ' PRO . 97.2 mt -62.49 -42.2 99.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.068 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -57.62 -25.17 59.72 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.908 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 31' ' ' GLU . 64.1 mm-40 -84.05 -8.96 58.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.008 0.432 . . . . 0.0 110.67 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.79 9.97 63.6 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.267 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -101.84 174.0 6.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.01 0.433 . . . . 0.0 111.865 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -104.73 150.32 24.85 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.519 -176.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.2 t -116.06 125.05 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.018 173.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.444 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 40.0 ttm180 -100.68 111.97 24.3 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.506 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 63.5 m-85 -89.69 125.68 35.36 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 81.6 mtp180 -132.02 139.77 48.7 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.602 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.5 p -121.36 133.45 67.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 121.126 0.488 . . . . 0.0 110.891 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -101.72 125.9 48.47 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.633 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 50' ' ' MET . 33.0 mt -87.09 111.82 21.3 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.8 -44.99 84.02 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 49' ' ' GLU . . . 168.01 141.04 3.07 Favored Glycine 0 N--CA 1.434 -1.437 0 C-N-CA 120.118 -1.039 . . . . 0.0 111.709 -177.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 72.44 -10.24 0.95 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.54 0.686 . . . . 0.0 110.23 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.706 ' OE2' ' HG2' ' A' ' 16' ' ' LYS . 61.0 mt-10 -90.3 -17.85 26.65 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.458 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.416 ' HA ' HD13 ' A' ' 45' ' ' LEU . 96.3 mtp -70.26 -16.11 62.99 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.767 -177.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.36 -34.64 78.15 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.193 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.2 p -130.23 96.52 24.76 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.392 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -67.12 -14.37 43.1 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 123.509 2.806 . . . . 0.0 112.405 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.41 ' OE2' ' HB2' ' A' ' 58' ' ' ALA . 8.4 tm-20 -56.99 -35.01 68.71 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.649 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.43 -36.59 71.56 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.876 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.45 -42.22 97.67 Favored Glycine 0 CA--C 1.504 -0.602 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.96 -43.75 89.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.41 ' HB2' ' OE2' ' A' ' 54' ' ' GLU . . . -60.66 -40.05 90.62 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.136 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.6 tp -61.91 -45.91 91.66 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.448 HD12 HG12 ' A' ' 84' ' ' VAL . 88.1 mt -65.76 -39.02 90.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.292 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -59.49 -43.82 93.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.118 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -63.1 -40.8 98.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.639 HD11 HD22 ' A' ' 13' ' ' LEU . 96.2 mt -63.5 -43.9 98.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.041 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.7 t-105 -58.55 -42.95 89.03 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.776 -178.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.555 ' HA ' ' OE2' ' A' ' 68' ' ' GLU . 22.4 p -64.4 -16.33 62.15 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 68.1 mtt -89.9 -48.52 7.17 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.156 0.503 . . . . 0.0 111.232 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.2 pt -86.0 -14.87 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -174.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.555 ' OE2' ' HA ' ' A' ' 65' ' ' THR . 14.0 pt-20 -57.48 -14.8 5.48 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -63.48 -41.57 98.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.476 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -117.89 -4.4 11.11 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.163 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.454 ' HB2' HD13 ' A' ' 33' ' ' LEU . . . -119.68 146.99 45.1 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.47 -177.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -113.26 138.23 50.31 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -69.58 109.94 4.55 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-O 121.245 0.545 . . . . 0.0 111.359 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.4 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 10.2 t70 -77.94 -42.91 31.45 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.098 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -146.22 137.12 24.35 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.054 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -64.83 157.37 75.36 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.63 178.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 23.4 Cg_exo -61.82 142.35 93.28 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 122.06 1.84 . . . . 0.0 111.577 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -141.39 140.68 33.74 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.423 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -99.11 116.13 30.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.917 0.389 . . . . 0.0 110.418 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -134.49 128.89 34.29 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.74 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.85 -94.42 0.6 Allowed Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.803 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -140.97 6.89 2.01 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.66 0.743 . . . . 0.0 109.41 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -119.33 143.81 47.19 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.717 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.602 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 68.8 t -106.28 123.31 60.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 172.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.538 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 8.6 p30 -125.86 149.63 48.51 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -174.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 64.6 ttp -140.87 141.43 34.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.513 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.0 mt -109.75 131.65 54.87 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.024 0.44 . . . . 0.0 111.692 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.7 m -122.95 136.44 59.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.628 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.454 ' CG2' ' HD2' ' A' ' 90' ' ' PRO . 24.4 m -116.07 140.18 26.02 Favored Pre-proline 0 C--N 1.307 -1.276 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.357 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.521 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 72.1 Cg_endo -68.0 152.51 76.71 Favored 'Trans proline' 0 C--O 1.237 0.463 0 C-N-CA 122.815 2.343 . . . . 0.0 111.772 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 67.3 mttm . . . . . 0 C--N 1.323 -0.586 0 CA-C-O 121.199 0.523 . . . . 0.0 110.841 178.457 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 30.4 t70 . . . . . 0 C--O 1.241 0.611 0 CA-C-O 121.114 0.483 . . . . 0.0 109.915 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.477 HG12 ' HB2' ' A' ' 38' ' ' HIS . 71.1 mt -95.05 134.5 32.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.715 -178.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.41 ' HG3' ' CD1' ' A' ' 32' ' ' PHE . 66.4 mmtt -85.71 127.05 34.41 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.83 -176.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -102.55 115.51 30.71 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 120.868 0.366 . . . . 0.0 110.363 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.0 mt -108.81 116.21 51.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.604 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -98.25 137.43 37.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.135 -175.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.492 HD22 HD11 ' A' ' 63' ' ' ILE . 5.5 mp -128.93 179.12 5.91 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.019 176.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 p -135.91 151.66 50.21 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.579 HG11 ' HG2' ' A' ' 49' ' ' GLU . 49.0 t -66.98 -25.6 34.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.383 0.611 . . . . 0.0 110.158 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.565 ' HE2' ' O ' ' A' ' 46' ' ' LYS . 64.6 mttm -103.29 72.37 1.15 Allowed 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 174.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.5 tt -126.84 153.42 35.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.124 -178.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.407 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -92.57 159.97 15.24 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -62.78 -33.09 74.45 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 120.948 0.404 . . . . 0.0 110.315 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -59.25 -45.05 92.22 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.242 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.4 -39.59 74.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.174 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.62 ' O ' HG23 ' A' ' 26' ' ' VAL . 75.7 mt -60.79 -51.43 73.23 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -60.39 -42.36 95.73 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.982 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -64.3 -47.25 80.17 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.99 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -66.78 -42.91 85.29 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 22' ' ' ILE . 60.1 t -63.89 -29.63 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.473 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.05 -41.92 97.49 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 177.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -68.41 -34.29 75.74 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.682 178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.583 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -55.6 -45.25 77.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.238 -178.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.0 mt -62.76 -38.93 92.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.988 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -59.71 -46.23 89.74 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.172 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.41 ' CD1' ' HG3' ' A' ' 9' ' ' LYS . 84.2 m-85 -68.0 -34.78 77.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.82 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 95.0 mt -61.97 -43.01 99.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.287 0.565 . . . . 0.0 110.015 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -59.84 -34.45 73.12 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.596 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -69.4 -18.86 63.8 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.182 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.52 27.02 10.17 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.967 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -112.05 162.85 14.95 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.988 0.423 . . . . 0.0 110.519 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.477 ' HB2' HG12 ' A' ' 8' ' ' ILE . 5.4 m80 -97.53 146.7 25.0 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.7 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.3 t -115.27 129.56 71.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.635 176.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -108.4 112.25 24.58 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 97.4 m-85 -85.78 127.33 34.52 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.724 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 71.4 mtp85 -127.19 131.24 50.71 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.263 -176.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.6 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 5.9 p -130.0 137.05 57.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.106 0.479 . . . . 0.0 110.764 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.446 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 93.3 t80 -104.53 131.21 52.18 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.467 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.4 mt -80.21 85.32 5.75 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.129 0.49 . . . . 0.0 110.411 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.565 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 63.9 tttp -88.77 126.03 35.15 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.132 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.03 -154.94 16.35 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -77.81 -7.21 56.31 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.056 0.455 . . . . 0.0 110.68 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.579 ' HG2' HG11 ' A' ' 15' ' ' VAL . 2.3 mp0 -60.08 -13.61 12.67 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.594 178.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 10.3 mmt -59.33 -20.65 56.31 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.79 0.329 . . . . 0.0 111.361 177.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.45 -5.5 59.29 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.478 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.4 m -138.49 102.59 7.93 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-O 121.175 0.512 . . . . 0.0 111.455 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.28 -20.2 49.31 Favored 'Trans proline' 0 C--N 1.331 -0.369 0 C-N-CA 123.26 2.64 . . . . 0.0 111.76 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -64.04 -22.64 67.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.206 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.19 -45.17 91.77 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.96 0.409 . . . . 0.0 110.382 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.62 -38.86 93.61 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.941 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.1 t -64.12 -43.92 97.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 61' ' ' GLU . . . -63.66 -39.45 94.36 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.223 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.407 ' O ' HG13 ' A' ' 63' ' ' ILE . 38.8 tp -64.51 -47.23 79.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.091 0.472 . . . . 0.0 110.437 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.612 HD12 HG12 ' A' ' 84' ' ' VAL . 47.7 mt -66.6 -40.92 89.1 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.586 -177.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -64.09 -31.73 73.02 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.286 179.175 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -65.01 -40.89 95.56 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.579 HG23 HG22 ' A' ' 26' ' ' VAL . 75.9 mt -65.53 -44.17 94.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.688 177.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 17.1 t-105 -55.76 -41.54 74.14 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.616 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.1 p -71.63 -12.74 61.5 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 98.0 mmm -87.21 -31.99 20.02 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.233 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.409 HG23 HG13 ' A' ' 26' ' ' VAL . 32.7 pt -108.15 -1.9 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -174.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -12.21 9.17 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -63.35 -46.89 84.47 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.407 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -119.43 0.89 11.17 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.87 0.367 . . . . 0.0 111.589 -174.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.57 ' HB2' HD13 ' A' ' 33' ' ' LEU . . . -125.26 149.81 47.67 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.178 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -114.17 131.73 56.34 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -72.53 106.67 4.69 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.24 -35.28 77.69 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.515 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -156.45 148.75 23.36 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.772 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.457 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 1.6 mp0 -62.27 162.28 19.91 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.499 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.401 ' HB3' HD12 ' A' ' 60' ' ' LEU . 31.9 Cg_exo -59.05 144.79 99.22 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.348 2.032 . . . . 0.0 112.375 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -130.0 132.46 46.28 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.934 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -93.08 107.42 19.21 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -127.77 132.04 49.56 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.758 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.13 -109.83 3.13 Favored Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.385 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -124.85 9.86 8.24 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.179 0.514 . . . . 0.0 109.998 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.446 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 73.0 m-85 -125.0 144.5 50.35 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.306 -177.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.612 HG12 HD12 ' A' ' 60' ' ' LEU . 87.5 t -100.89 122.07 52.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 173.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.724 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 39.7 m-80 -114.61 144.64 43.08 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.764 -173.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.557 ' HB2' HD13 ' A' ' 60' ' ' LEU . 63.7 ttp -139.62 130.04 25.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.312 175.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 17.4 mt -108.99 129.73 55.45 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.25 0.547 . . . . 0.0 111.623 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.73 135.66 62.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.928 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.418 HG23 ' CE1' ' A' ' 38' ' ' HIS . 16.1 m -102.28 134.11 20.2 Favored Pre-proline 0 C--N 1.307 -1.251 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.487 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 56.0 Cg_endo -66.39 135.76 40.79 Favored 'Trans proline' 0 C--N 1.327 -0.555 0 C-N-CA 121.884 1.723 . . . . 0.0 110.201 177.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 CA--C 1.509 -0.599 0 CA-C-O 121.24 0.543 . . . . 0.0 112.286 -177.291 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 . . . . . 0 CA--C 1.496 -1.128 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.467 HG12 ' HB2' ' A' ' 38' ' ' HIS . 69.3 mt -91.49 119.31 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.771 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.45 ' HG3' ' CD1' ' A' ' 32' ' ' PHE . 73.1 mmtt -89.22 126.69 35.6 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.936 -174.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.456 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 59.3 mt-10 -102.14 110.72 22.76 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.569 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.0 mt -94.23 107.94 20.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 47.6 tttm -98.32 122.87 42.04 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.593 -175.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.419 HD21 ' HG3' ' A' ' 25' ' ' LYS . 79.9 mt -122.65 179.36 4.63 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.517 -178.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.1 m -131.62 151.98 51.19 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.2 t -63.69 -40.98 91.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.331 0.586 . . . . 0.0 109.793 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -78.03 50.38 0.88 Allowed 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.323 176.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.2 tt -106.34 160.03 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.706 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.45 146.51 28.37 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 175.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.421 HE22 ' HD3' ' A' ' 62' ' ' LYS . 58.7 tp60 -63.75 -36.43 83.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.949 0.404 . . . . 0.0 111.512 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -63.91 -35.97 82.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.977 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.595 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 29.0 t70 -65.51 -35.23 80.25 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.884 0.373 . . . . 0.0 110.752 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.3 mt -61.32 -41.57 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.109 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -58.4 -41.92 86.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.887 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -63.86 -43.22 96.76 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.167 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.595 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 75.8 mmtt -61.53 -46.51 89.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.664 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.487 ' CG1' HG23 ' A' ' 63' ' ' ILE . 4.2 m -66.71 -40.82 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 111.791 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.56 -42.7 98.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.083 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -80.04 -25.5 40.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.696 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.419 ' O ' HD13 ' A' ' 33' ' ' LEU . . . -63.68 -37.1 86.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.034 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.536 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 65.7 mt -62.14 -33.53 74.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.689 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -57.76 -41.45 82.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.352 . . . . 0.0 110.116 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.45 ' CD1' ' HG3' ' A' ' 9' ' ' LYS . 94.9 m-85 -66.04 -35.7 81.24 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.105 0.478 . . . . 0.0 110.634 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.572 ' CB ' ' HB3' ' A' ' 90' ' ' PRO . 10.8 mp -62.36 -41.73 98.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.434 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 30' ' ' LEU . 32.6 mt-10 -62.43 -30.09 70.98 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.518 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -79.41 -8.66 59.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.904 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.46 19.77 50.98 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.189 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -95.98 164.97 12.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.935 0.397 . . . . 0.0 110.366 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.467 ' HB2' HG12 ' A' ' 8' ' ' ILE . 17.4 m170 -110.56 148.94 31.13 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.8 t -118.18 130.2 73.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 121.282 0.563 . . . . 0.0 110.682 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.456 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 39.5 ttm180 -111.55 113.18 25.42 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 175.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 92.8 m-85 -86.51 121.55 29.21 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.551 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 78.1 mtp180 -124.27 132.6 53.59 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.555 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.1 p -126.42 135.06 64.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 121.186 0.517 . . . . 0.0 110.799 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -101.37 127.19 48.11 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.799 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.5 mt -82.23 116.43 21.76 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -102.45 113.6 27.08 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.319 0.581 . . . . 0.0 111.956 -173.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.57 -137.21 13.29 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.394 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.4 ptt-85 -69.57 -11.87 61.19 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 122.577 0.351 . . . . 0.0 111.407 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -60.72 -21.12 62.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.566 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 91.2 mtp -62.66 -29.82 70.92 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.618 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.85 -13.81 62.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.349 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.6 p -125.28 94.36 43.44 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-O 121.171 0.51 . . . . 0.0 111.274 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -64.63 -20.33 65.34 Favored 'Trans proline' 0 N--CA 1.477 0.524 0 C-N-CA 123.461 2.774 . . . . 0.0 111.756 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -61.87 -30.07 70.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.183 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.62 -44.01 93.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.811 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.435 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -66.79 -38.44 93.05 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.623 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.8 t -63.87 -44.87 98.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.487 -0.356 . . . . 0.0 110.638 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.45 88.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.032 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.7 tp -62.63 -47.47 83.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.156 0.503 . . . . 0.0 110.036 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.427 HD12 HG12 ' A' ' 84' ' ' VAL . 56.3 mt -67.33 -39.73 85.87 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.975 -178.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -58.88 -39.47 81.51 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.704 0.288 . . . . 0.0 111.075 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.421 ' HD3' HE22 ' A' ' 19' ' ' GLN . 40.5 ttmt -62.76 -46.14 89.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.231 0.538 . . . . 0.0 109.97 177.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.487 HG23 ' CG1' ' A' ' 26' ' ' VAL . 96.0 mt -63.1 -45.14 99.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.897 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -60.66 -40.27 91.45 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.421 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.41 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 19.6 m -61.09 -37.34 82.37 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.096 0.474 . . . . 0.0 111.203 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 82.4 mtp -71.92 -35.94 69.81 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 63' ' ' ILE . 41.6 pt -103.28 -2.87 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -174.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -57.18 -25.97 59.85 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -177.252 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.417 ' ND2' ' H ' ' A' ' 69' ' ' ASN . 1.7 p30 -65.79 -39.23 90.75 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -107.96 -8.44 15.91 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.958 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -123.27 155.77 36.55 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.552 ' OD1' ' HB ' ' A' ' 89' ' ' THR . 5.3 p30 -117.86 128.37 54.77 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -77.75 108.02 10.67 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 121.305 0.574 . . . . 0.0 111.361 -176.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -66.63 -42.33 86.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.685 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.592 ' HD3' ' N ' ' A' ' 76' ' ' GLU . 7.1 tmtm? -146.19 138.5 25.26 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.592 ' N ' ' HD3' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -63.04 158.72 52.62 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.369 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.13 121.8 9.99 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 121.817 1.678 . . . . 0.0 110.799 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -130.23 138.93 50.79 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.491 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -92.98 117.25 29.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.883 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -138.22 139.98 39.5 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.29 -92.42 0.32 Allowed Glycine 0 N--CA 1.432 -1.567 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -177.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -153.08 17.23 0.56 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.398 0.618 . . . . 0.0 110.473 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -129.23 143.43 50.85 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.909 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.555 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 95.9 t -99.83 126.22 53.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 173.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.569 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 9.3 p30 -133.07 153.07 51.85 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.499 -175.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 64.8 ttp -144.04 134.53 24.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.747 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.5 mt -103.89 129.27 51.39 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.053 0.454 . . . . 0.0 111.494 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.48 135.29 63.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.165 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.552 ' HB ' ' OD1' ' A' ' 72' ' ' ASN . 13.8 m -114.43 143.29 29.57 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.572 ' HB3' ' CB ' ' A' ' 33' ' ' LEU . 60.2 Cg_endo -67.0 155.14 72.17 Favored 'Trans proline' 0 C--O 1.242 0.711 0 C-N-CA 122.81 2.34 . . . . 0.0 112.584 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.7 mptt . . . . . 0 C--N 1.33 -0.272 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 176.555 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.0 t70 . . . . . 0 N--CA 1.445 -0.717 0 CA-C-O 121.296 0.57 . . . . 0.0 110.6 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.432 HG23 ' HB3' ' A' ' 38' ' ' HIS . 88.7 mt -117.75 131.11 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.339 -178.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.418 ' HG2' ' CD1' ' A' ' 32' ' ' PHE . 3.6 mptp? -86.26 135.78 33.42 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 121.565 0.698 . . . . 0.0 110.335 -178.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -115.21 120.28 39.17 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.046 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.6 mt -108.75 114.31 46.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.984 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -84.13 139.71 32.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.707 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.487 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 49.8 mt -127.27 166.83 17.04 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.748 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.0 m -137.09 146.25 44.9 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.7 t -62.73 -45.0 99.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.911 0.386 . . . . 0.0 110.25 177.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -94.35 65.89 3.32 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.585 0.707 . . . . 0.0 109.975 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.433 HD11 ' OD1' ' A' ' 21' ' ' ASP . 19.7 tt -107.66 156.03 8.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.384 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 21' ' ' ASP . . . -64.77 141.71 58.68 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -62.11 -39.4 92.37 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.958 0.408 . . . . 0.0 110.883 -176.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -76.32 -18.33 58.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.883 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.461 ' HB2' ' HB3' ' A' ' 18' ' ' ALA . 12.5 t70 -67.88 -35.79 79.13 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.276 0.56 . . . . 0.0 110.669 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.3 mt -61.49 -42.14 92.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.124 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -58.73 -43.12 90.08 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.716 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -63.75 -45.86 87.92 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.469 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -65.52 -41.13 93.47 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.481 ' CG1' HG23 ' A' ' 63' ' ' ILE . 1.4 m -60.77 -29.86 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.549 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -61.83 -46.76 88.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.014 0.435 . . . . 0.0 110.37 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -64.57 -37.83 88.9 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.111 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.612 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -56.56 -44.93 81.42 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.429 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 94.6 mt -62.5 -41.38 98.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.932 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -61.75 -44.82 96.17 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.967 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.418 ' CD1' ' HG2' ' A' ' 9' ' ' LYS . 81.4 m-85 -68.8 -32.91 72.97 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 96.7 mt -62.05 -42.02 98.74 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.404 0.621 . . . . 0.0 110.219 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 30' ' ' LEU . 44.6 mm-40 -56.24 -31.7 63.8 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.768 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -76.37 -8.51 57.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.726 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.63 17.95 62.86 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.07 -176.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -99.04 158.87 15.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.78 0.324 . . . . 0.0 110.523 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.432 ' HB3' HG23 ' A' ' 8' ' ' ILE . 1.9 t-80 -99.84 148.11 24.78 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.5 t -119.21 131.11 72.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.414 0.626 . . . . 0.0 111.829 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -112.38 126.0 54.8 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.053 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 96.8 m-85 -97.18 124.33 41.2 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.636 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 65.1 mtp180 -125.7 105.99 9.39 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.885 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.632 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 5.9 p -104.98 129.43 57.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.136 0.493 . . . . 0.0 111.31 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -99.01 134.79 41.34 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.915 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.2 mt -82.0 89.42 6.41 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 87.3 tttt -68.33 134.51 50.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.202 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.75 -132.38 11.16 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.349 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -110.6 18.37 19.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.683 0.278 . . . . 0.0 110.993 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 26.3 mm-40 -68.79 -2.47 9.51 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.196 -177.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 67.9 mtt -65.12 -13.33 57.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.037 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.49 -37.56 87.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.821 0.343 . . . . 0.0 110.697 178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.3 p -124.72 96.91 39.83 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 121.082 0.468 . . . . 0.0 111.583 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.416 ' HB3' ' CG ' ' A' ' 79' ' ' PHE . 31.4 Cg_exo -62.99 -19.58 69.46 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.601 2.867 . . . . 0.0 112.471 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -59.48 -20.38 54.85 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.346 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.59 -38.93 86.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.036 0.446 . . . . 0.0 110.347 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.469 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -66.22 -39.17 94.37 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.766 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.0 t -64.12 -45.19 97.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.699 -0.25 . . . . 0.0 110.694 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.76 -40.75 89.22 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.066 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.5 tp -62.93 -45.82 90.66 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.028 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.528 HD13 ' HB2' ' A' ' 86' ' ' MET . 92.2 mt -65.22 -40.89 94.72 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.753 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -58.4 -43.05 88.41 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.95 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -64.34 -41.59 96.7 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.335 0.588 . . . . 0.0 109.89 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.481 HG23 ' CG1' ' A' ' 26' ' ' VAL . 91.6 mt -64.88 -43.84 96.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.384 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -58.26 -41.24 83.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.123 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.3 p -63.79 -16.82 62.19 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 68.7 mtt -85.97 -39.2 17.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.94 0.4 . . . . 0.0 111.824 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.6 pt -101.55 -7.15 9.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -57.1 -28.69 62.88 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -66.57 -22.23 66.15 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -130.15 8.41 5.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.665 0.269 . . . . 0.0 111.576 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.28 151.71 49.93 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.79 0.328 . . . . 0.0 111.116 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -113.44 152.45 30.07 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -94.71 128.35 41.33 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.064 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -90.48 -8.58 50.06 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.138 0.494 . . . . 0.0 110.28 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -176.06 164.58 2.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.458 -177.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -85.96 149.11 49.78 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 19.2 Cg_endo -58.71 136.63 75.17 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.344 2.029 . . . . 0.0 111.63 177.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -145.35 138.6 26.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.338 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.416 ' CG ' ' HB3' ' A' ' 53' ' ' PRO . 87.7 t80 -83.3 118.14 23.46 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.659 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -130.59 115.54 16.89 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.092 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.71 -95.75 0.91 Allowed Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.149 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -132.61 4.87 3.96 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.942 0.401 . . . . 0.0 110.368 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 82.1 m-85 -127.65 143.93 51.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.091 -176.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.632 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 93.1 t -99.31 120.98 49.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 172.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.636 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 41.9 m-80 -111.79 145.94 38.52 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -171.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.528 ' HB2' HD13 ' A' ' 60' ' ' LEU . 64.9 ttp -146.49 135.95 22.94 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.289 174.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 22.9 mt -108.68 132.42 53.94 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.749 0.309 . . . . 0.0 111.822 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.16 132.66 70.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.294 0.569 . . . . 0.0 110.692 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.8 m -110.29 141.28 23.58 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.491 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 89.4 Cg_endo -69.29 150.82 71.55 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.762 1.641 . . . . 0.0 109.437 177.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.7 mttm . . . . . 0 C--N 1.325 -0.485 0 CA-C-O 121.565 0.698 . . . . 0.0 111.991 -175.605 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.545 ' HB2' ' HD3' ' A' ' 37' ' ' LYS . 7.0 m-20 . . . . . 0 CA--C 1.505 -0.767 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.423 HG12 ' HB2' ' A' ' 38' ' ' HIS . 97.7 mt -111.45 121.1 63.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 121.095 0.474 . . . . 0.0 110.176 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.439 ' HG3' ' CD1' ' A' ' 32' ' ' PHE . 75.1 mmtt -92.22 133.8 35.48 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.341 -173.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -102.75 102.89 13.08 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.589 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.1 mt -90.94 111.17 23.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.092 0.472 . . . . 0.0 109.85 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 88.3 tttt -85.26 137.67 32.83 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.988 -177.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.2 mt -126.8 175.98 7.61 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.648 -177.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.7 p -146.83 149.29 33.02 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.6 t -64.85 -42.95 96.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -80.8 63.04 5.05 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 174.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.7 tt -113.5 152.13 15.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.601 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.03 150.18 23.55 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -63.92 -36.47 84.04 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.764 0.316 . . . . 0.0 111.574 -177.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -62.88 -39.13 93.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.724 0.297 . . . . 0.0 111.154 178.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -64.99 -38.11 89.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.31 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.635 ' O ' HG23 ' A' ' 26' ' ' VAL . 95.5 mt -62.77 -46.86 95.31 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -60.59 -44.39 96.31 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.349 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -65.12 -49.24 70.73 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.123 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -65.54 -41.08 93.44 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 22' ' ' ILE . 59.6 t -63.19 -40.41 88.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.178 0.514 . . . . 0.0 109.984 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -59.75 -45.69 91.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.368 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.456 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 17.8 t-160 -65.43 -31.63 72.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.475 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.85 -31.78 67.0 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 178.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.34 -39.97 94.85 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.026 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.456 ' OE1' ' HA ' ' A' ' 28' ' ' HIS . 1.3 mp0 -54.29 -47.05 72.83 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.439 ' CD1' ' HG3' ' A' ' 9' ' ' LYS . 95.0 m-85 -68.28 -37.1 80.34 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.638 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.35 -42.21 98.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.378 0.608 . . . . 0.0 110.087 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -61.76 -29.89 70.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.12 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -73.91 -9.45 58.66 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.504 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.04 16.38 57.87 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.709 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.545 ' HD3' ' HB2' ' A' ' 7' ' ' ASP . 65.8 mttm -99.82 173.36 6.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.015 0.436 . . . . 0.0 111.37 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.514 ' NE2' HG23 ' A' ' 89' ' ' THR . 17.5 m170 -111.15 149.7 30.51 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.899 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.3 t -118.86 130.68 73.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -109.5 111.37 22.86 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.58 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 83.8 m-85 -85.01 119.5 25.47 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 29.2 mtm180 -125.08 132.79 53.1 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -177.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.454 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.8 p -125.15 132.18 71.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 120.956 0.408 . . . . 0.0 111.142 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.438 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 90.1 t80 -102.72 127.51 49.83 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.672 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.4 mt -90.16 111.01 22.01 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -83.88 88.45 7.12 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.9 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.07 153.39 0.62 Allowed Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.365 -0.834 . . . . 0.0 114.41 175.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 64.17 -64.58 0.14 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.351 1.06 . . . . 0.0 113.111 176.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -65.64 -11.75 47.42 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.649 0.78 . . . . 0.0 111.413 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 80.6 mtp -61.32 -28.96 69.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.449 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.67 -19.37 64.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.543 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.4 m -122.31 97.8 44.8 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-O 121.282 0.563 . . . . 0.0 111.156 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -63.33 -22.15 71.82 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 123.515 2.81 . . . . 0.0 112.521 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -60.81 -28.14 68.55 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.444 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.01 -43.24 95.37 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.887 0.375 . . . . 0.0 110.728 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.26 -39.04 92.1 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.754 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.6 t -62.83 -43.71 99.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 122.629 0.372 . . . . 0.0 110.715 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.68 -40.3 91.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.413 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 48.1 tp -63.42 -45.8 89.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.193 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.428 HD12 HG12 ' A' ' 84' ' ' VAL . 86.8 mt -66.05 -42.18 89.86 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.33 -33.08 74.75 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.269 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -60.5 -47.88 84.23 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.4 mt -66.08 -42.49 91.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.602 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 37.3 t-105 -54.84 -40.38 69.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.026 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.5 m -63.34 -23.16 67.29 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-O 121.106 0.479 . . . . 0.0 111.021 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 96.1 mtp -90.03 -35.59 15.41 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.451 ' CG2' HG13 ' A' ' 26' ' ' VAL . 40.2 pt -92.35 -6.34 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -175.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.93 -4.4 6.9 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -63.34 -46.06 88.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.125 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -121.26 -3.66 9.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.696 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -118.87 145.55 45.61 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.167 0.508 . . . . 0.0 111.718 -176.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -115.36 133.87 55.63 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.782 175.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -68.84 113.24 6.1 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 120.972 0.415 . . . . 0.0 111.993 -177.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -87.45 -40.83 14.0 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.813 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 58.2 tptt -134.19 136.43 43.72 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.775 -177.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -74.47 155.3 87.63 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.613 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 24.2 Cg_exo -61.05 139.6 85.29 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.599 1.533 . . . . 0.0 111.312 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -145.85 141.56 27.98 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.802 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -92.44 112.6 24.6 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -153.57 124.53 7.34 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.586 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.81 31.47 55.87 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 66.49 14.71 9.84 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.672 0.789 . . . . 0.0 112.536 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 37.3 m-85 -125.44 143.53 50.95 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.351 176.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.454 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 78.9 t -103.54 124.09 57.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 172.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.613 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 5.9 p30 -131.67 156.95 44.97 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.959 -0.697 . . . . 0.0 112.423 -173.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 54.5 ttp -142.67 135.62 28.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.528 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 12.4 mt -108.18 131.06 55.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.969 0.414 . . . . 0.0 111.198 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.2 m -124.69 138.67 53.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.777 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.514 HG23 ' NE2' ' A' ' 38' ' ' HIS . 11.2 m -109.43 135.32 20.31 Favored Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.471 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.98 143.8 37.05 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 C-N-CA 122.374 2.049 . . . . 0.0 110.963 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt . . . . . 0 C--N 1.319 -0.725 0 CA-C-O 121.354 0.597 . . . . 0.0 110.486 179.71 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.517 ' OD2' ' HE2' ' A' ' 9' ' ' LYS . 34.0 t70 . . . . . 0 N--CA 1.442 -0.849 0 CA-C-O 121.02 0.438 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 88.4 mt -120.63 136.85 56.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.446 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.541 ' HE3' ' CE1' ' A' ' 32' ' ' PHE . 75.3 mmtt -98.24 136.47 38.39 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.904 -176.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.475 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 47.0 mt-10 -114.83 104.21 11.71 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.574 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.2 mt -90.21 103.6 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 121.753 0.787 . . . . 0.0 109.706 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.427 ' HE2' ' HB2' ' A' ' 44' ' ' PHE . 50.7 tttm -88.71 128.06 35.61 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.782 -177.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.502 HD21 ' HG3' ' A' ' 25' ' ' LYS . 74.4 mt -125.42 -178.55 4.27 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.713 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.424 ' HA ' HG23 ' A' ' 43' ' ' VAL . 58.4 p -141.68 161.58 37.58 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.78 0.324 . . . . 0.0 110.436 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.1 t -64.4 -25.93 39.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.192 0.52 . . . . 0.0 112.3 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -90.09 11.54 20.51 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.526 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.48 HD12 HD22 ' A' ' 13' ' ' LEU . 14.3 tt -68.24 152.73 9.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 CA-C-O 121.009 0.433 . . . . 0.0 111.163 -178.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.35 154.65 18.43 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.421 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -63.6 -34.21 77.31 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.765 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -64.16 -38.4 90.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.863 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -66.62 -36.87 83.63 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.895 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.6 mt -61.73 -43.74 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.555 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -60.42 -42.31 95.78 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.195 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -69.46 -39.54 77.69 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.452 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.502 ' HG3' HD21 ' A' ' 13' ' ' LEU . 48.6 mmtm -63.39 -42.16 98.78 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.595 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 4.4 m -63.66 -34.13 65.96 Favored 'Isoleucine or valine' 0 C--N 1.342 0.275 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.177 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -63.48 -39.7 95.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.723 0.297 . . . . 0.0 110.686 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -64.7 -40.66 95.75 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.157 0.503 . . . . 0.0 110.278 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.659 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -61.66 -39.13 90.28 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.768 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 26' ' ' VAL . 93.1 mt -61.43 -40.35 94.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.699 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 46.0 mt-10 -58.44 -47.06 85.21 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.799 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.541 ' CE1' ' HE3' ' A' ' 9' ' ' LYS . 94.2 m-85 -71.35 -32.37 68.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.951 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.659 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 90.2 mt -62.23 -43.27 99.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.45 0.643 . . . . 0.0 109.817 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -62.6 -30.72 71.55 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.979 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 80.4 mt-30 -73.54 -10.12 59.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.726 178.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.38 7.44 65.28 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.15 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.4 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 88.5 mttt -91.23 178.24 6.03 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.162 0.506 . . . . 0.0 110.323 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.496 ' NE2' HG23 ' A' ' 89' ' ' THR . 23.7 m170 -117.24 150.76 38.24 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.914 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.0 t -117.53 128.58 74.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.079 0.466 . . . . 0.0 110.046 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.475 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 51.8 ttt180 -109.26 115.9 30.87 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.528 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 76.2 m-85 -90.15 113.92 25.78 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -117.09 134.62 54.53 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.512 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.7 p -118.77 130.59 73.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-O 121.211 0.529 . . . . 0.0 111.462 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.427 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 91.2 t80 -94.63 125.22 39.15 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.394 177.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.474 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 51.6 mt -91.59 129.03 37.63 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -62.39 -48.23 80.63 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.27 -44.96 0.17 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 119.941 -1.123 . . . . 0.0 113.329 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -90.96 -19.27 23.44 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 117.168 0.484 . . . . 0.0 111.471 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.474 ' HG2' ' HB3' ' A' ' 45' ' ' LEU . 1.6 pm0 -79.54 2.66 21.35 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.597 0.713 . . . . 0.0 109.583 175.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 61.2 mtt -82.43 -133.93 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.337 175.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 61.06 -61.06 0.08 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.312 0.645 . . . . 0.0 111.249 -173.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 t -121.85 133.82 24.44 Favored Pre-proline 0 N--CA 1.437 -1.103 0 C-N-CA 123.566 0.746 . . . . 0.0 109.431 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.87 -8.89 23.88 Favored 'Trans proline' 0 C--N 1.331 -0.385 0 C-N-CA 123.425 2.75 . . . . 0.0 113.487 -176.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.88 -30.14 68.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.26 96.03 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.86 0.362 . . . . 0.0 110.465 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.29 -39.88 87.67 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.18 -42.47 94.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.531 -0.334 . . . . 0.0 110.436 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.81 -40.87 76.77 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.293 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.9 tp -62.4 -45.84 91.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.245 0.545 . . . . 0.0 109.993 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.414 ' CD1' HG12 ' A' ' 84' ' ' VAL . 89.3 mt -64.76 -41.09 96.16 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.891 -177.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -60.37 -39.41 87.12 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.309 0.575 . . . . 0.0 110.992 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -63.8 -41.18 97.96 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.105 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.2 mt -70.04 -46.23 73.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.065 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 41.7 t-105 -57.75 -41.4 81.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.322 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.8 p -62.8 -24.69 67.87 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 98.4 mtp -75.78 -34.43 60.22 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.9 pt -107.76 -6.89 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -56.32 -23.08 34.76 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -64.41 -39.19 93.36 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -121.13 6.51 10.27 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.45 146.29 50.54 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.945 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -114.31 147.72 38.66 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.0 ptt-85 -81.16 127.63 32.88 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.418 ' CB ' HD12 ' A' ' 87' ' ' LEU . 23.5 t70 -74.12 -35.54 64.13 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.384 0.611 . . . . 0.0 109.782 176.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -161.43 172.22 16.86 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.063 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -77.4 152.59 81.41 Favored Pre-proline 0 C--N 1.311 -1.073 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -61.58 140.64 87.99 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.686 1.591 . . . . 0.0 110.57 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -140.88 165.6 27.08 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.495 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -101.96 113.57 26.92 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.991 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -114.39 113.07 24.02 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.56 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.52 -93.08 0.16 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.497 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -133.94 11.37 3.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.142 0.496 . . . . 0.0 110.492 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -118.27 140.72 49.39 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.863 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.512 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 55.9 t -100.81 127.28 54.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 172.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.528 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 7.2 p30 -134.3 153.84 51.65 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 119.353 -0.939 . . . . 0.0 113.078 -174.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.402 ' HB2' HD13 ' A' ' 60' ' ' LEU . 53.0 ttp -140.55 138.15 34.29 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.817 177.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.418 HD12 ' CB ' ' A' ' 74' ' ' ASP . 2.9 tm? -109.89 126.93 54.38 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.1 m -112.83 134.1 56.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.385 0.612 . . . . 0.0 110.896 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.496 HG23 ' NE2' ' A' ' 38' ' ' HIS . 13.3 m -113.56 139.29 23.16 Favored Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.218 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.582 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 69.2 Cg_endo -66.82 142.35 62.78 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.35 2.033 . . . . 0.0 110.541 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 C--N 1.326 -0.447 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.334 -179.269 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.539 ' HB2' ' HD3' ' A' ' 37' ' ' LYS . 22.2 m-20 . . . . . 0 CA--C 1.512 -0.497 0 CA-C-O 121.072 0.463 . . . . 0.0 111.015 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 90.7 mt -129.16 129.55 67.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -101.46 135.77 42.42 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.789 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.466 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 58.3 mt-10 -104.38 112.28 25.26 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.896 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.4 mt -97.73 111.74 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 87.8 tttt -98.14 136.01 38.98 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.545 -175.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.554 HD22 HD11 ' A' ' 63' ' ' ILE . 5.2 mp -131.77 179.93 5.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.119 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.7 p -138.98 156.54 47.15 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.97 -25.01 37.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.437 0.637 . . . . 0.0 111.247 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -104.61 22.29 15.29 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.988 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.1 tt -74.37 147.72 8.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.949 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.46 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -75.25 155.22 36.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.74 -177.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 -62.7 -38.75 91.65 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.166 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -61.06 -41.14 96.07 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.563 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 21.1 m-20 -64.75 -38.84 92.35 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.394 177.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 18' ' ' ALA . 68.6 mt -61.95 -45.67 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-O 121.075 0.464 . . . . 0.0 110.703 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -60.08 -41.73 93.1 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.818 0.818 . . . . 0.0 110.323 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -61.97 -44.2 97.25 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.377 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 75.1 mmtt -64.06 -44.76 91.44 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.469 HG11 ' HB2' ' A' ' 66' ' ' MET . 4.7 m -67.9 -32.87 58.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.613 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -62.37 -45.47 93.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.096 0.474 . . . . 0.0 109.809 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -70.9 -32.53 69.51 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.191 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.595 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -55.85 -45.97 78.33 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.269 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.37 -40.41 96.36 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.79 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 52.2 mt-10 -57.14 -48.54 78.43 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 120.785 0.326 . . . . 0.0 111.159 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -68.76 -36.24 78.09 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 95.8 mt -63.04 -44.28 96.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.438 0.637 . . . . 0.0 110.428 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -57.88 -32.28 67.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.441 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 80.3 mt-30 -75.21 -7.36 53.66 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.281 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.68 15.75 56.1 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.021 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.539 ' HD3' ' HB2' ' A' ' 7' ' ' ASP . 31.1 mtmm -103.02 168.58 9.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.487 0.66 . . . . 0.0 112.306 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.407 ' NE2' HG23 ' A' ' 89' ' ' THR . 3.3 m80 -102.92 145.9 29.13 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.326 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.9 t -115.4 129.24 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.697 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.466 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 42.4 ttm180 -109.81 113.0 25.39 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 83.1 m-85 -89.89 124.29 34.57 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 73.0 mtp180 -128.22 135.53 49.82 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.513 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.7 p -118.88 131.95 70.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-O 121.18 0.514 . . . . 0.0 111.24 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -96.26 126.36 41.42 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.576 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 50' ' ' MET . 31.9 mt -92.31 114.0 26.43 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -95.16 119.84 34.37 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.866 0.365 . . . . 0.0 111.518 -174.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.2 -140.73 15.08 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -91.88 13.67 17.78 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.273 0.558 . . . . 0.0 110.43 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.422 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 71.8 mt-10 -62.35 -21.99 65.74 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.65 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.453 ' HA ' HD12 ' A' ' 45' ' ' LEU . 65.5 mtt -67.4 -11.3 57.42 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.969 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.94 -28.3 69.73 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.151 0.501 . . . . 0.0 110.515 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.4 m -130.87 99.63 18.11 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-O 121.23 0.538 . . . . 0.0 110.843 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -60.46 -22.81 73.1 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 123.529 2.82 . . . . 0.0 112.897 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -61.65 -22.38 65.23 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.749 0.309 . . . . 0.0 110.827 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.81 -40.6 95.84 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.048 0.451 . . . . 0.0 109.856 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.83 -38.55 93.07 Favored Glycine 0 CA--C 1.506 -0.488 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.382 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.411 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 88.1 t -63.33 -44.44 99.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.439 -0.381 . . . . 0.0 110.508 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.31 -41.2 88.47 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.38 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.0 tp -63.93 -45.63 88.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.355 0.598 . . . . 0.0 110.356 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.494 HD23 HD12 ' A' ' 63' ' ' ILE . 81.7 mt -64.53 -41.13 96.57 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.416 -177.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 57' ' ' VAL . 11.9 mm-40 -63.7 -34.26 77.46 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.539 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -62.04 -41.9 98.61 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.554 HD11 HD22 ' A' ' 13' ' ' LEU . 96.4 mt -63.75 -44.32 98.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.281 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -59.72 -36.91 77.52 Favored 'General case' 0 C--O 1.213 -0.83 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.779 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.4 m -57.82 -33.78 68.96 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.306 0.574 . . . . 0.0 110.325 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.469 ' HB2' HG11 ' A' ' 26' ' ' VAL . 97.8 mmm -76.85 -32.73 57.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.603 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.621 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 41.1 pt -117.96 15.84 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -174.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -62.61 -22.48 66.43 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.774 0.797 . . . . 0.0 110.291 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -97.58 141.34 30.74 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 173.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 74.9 -13.89 0.79 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.597 0.759 . . . . 0.0 111.842 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 67' ' ' ILE . . . -129.71 150.79 50.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.661 0.267 . . . . 0.0 110.4 177.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -116.47 149.25 39.82 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -87.57 106.31 17.92 Favored 'General case' 0 N--CA 1.412 -2.368 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.658 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -80.74 -41.14 24.03 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.002 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -137.32 136.8 38.3 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.14 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.42 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 0.3 OUTLIER -80.98 151.92 70.99 Favored Pre-proline 0 N--CA 1.442 -0.87 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.788 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 17.4 Cg_endo -56.29 131.1 43.75 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.463 2.109 . . . . 0.0 112.339 -177.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.427 ' ND2' ' HG3' ' A' ' 80' ' ' GLU . 3.1 p-10 -147.09 165.5 29.74 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.415 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.504 ' CZ ' ' HA ' ' A' ' 82' ' ' ARG . 84.6 t80 -93.83 123.32 37.1 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.844 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.427 ' HG3' ' ND2' ' A' ' 78' ' ' ASN . 38.4 mt-10 -146.77 120.07 8.96 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.48 178.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.447 ' O ' ' HD1' ' A' ' 83' ' ' TYR . . . 64.94 38.73 95.85 Favored Glycine 0 C--O 1.221 -0.696 0 CA-C-N 115.951 -0.568 . . . . 0.0 113.945 175.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.504 ' HA ' ' CZ ' ' A' ' 79' ' ' PHE . 75.2 mtt180 74.96 0.91 3.66 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.492 0.717 . . . . 0.0 111.228 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.447 ' HD1' ' O ' ' A' ' 81' ' ' GLY . 82.2 m-85 -117.38 149.17 40.97 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.891 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.513 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 70.3 t -105.2 128.09 59.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 173.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.529 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 9.2 p30 -133.11 161.44 34.4 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -173.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.445 ' CE ' ' HB3' ' A' ' 60' ' ' LEU . 13.8 ttm -143.71 146.01 32.85 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.217 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 16.2 mt -115.33 129.39 56.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.767 0.318 . . . . 0.0 111.238 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.7 132.46 70.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.85 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.41 ' CG2' ' HD2' ' A' ' 90' ' ' PRO . 15.2 m -104.95 141.2 22.04 Favored Pre-proline 0 C--N 1.309 -1.174 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.431 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 33.8 Cg_endo -61.38 147.21 96.1 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 121.949 1.766 . . . . 0.0 110.579 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? . . . . . 0 C--O 1.239 0.534 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.2 -175.429 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.416 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 25.2 t70 . . . . . 0 CA--C 1.516 -0.34 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.427 HG23 ' O ' ' A' ' 38' ' ' HIS . 92.7 mt -115.56 132.2 65.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.343 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -92.37 155.32 17.98 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.564 0.697 . . . . 0.0 111.126 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.585 ' CD ' HH21 ' A' ' 40' ' ' ARG . 43.4 mt-10 -125.74 114.35 18.52 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.972 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.5 mt -100.67 108.55 23.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -85.49 142.6 29.08 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.841 -176.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.0 mt -129.65 166.9 18.84 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.69 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.0 m -139.2 150.04 45.1 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 176.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.2 t -61.6 -43.89 97.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.309 0.576 . . . . 0.0 110.779 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -93.62 68.03 3.98 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.566 0.698 . . . . 0.0 110.797 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.431 HD11 ' HE2' ' A' ' 25' ' ' LYS . 18.3 tt -117.59 149.77 19.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.68 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.06 142.27 54.56 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.706 0.289 . . . . 0.0 110.874 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -62.96 -39.0 93.33 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.824 0.345 . . . . 0.0 111.32 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -61.8 -39.95 93.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.15 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.584 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 28.1 t70 -65.91 -38.23 88.15 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.024 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.87 -45.29 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.807 0.813 . . . . 0.0 109.47 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -65.39 -28.82 69.53 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.134 -1.393 . . . . 0.0 110.694 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -78.77 -40.77 32.32 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.161 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 21' ' ' ASP . 57.8 mttm -65.55 -38.94 91.06 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 m -59.59 -32.61 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.2 tttt -63.26 -42.24 99.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.852 0.358 . . . . 0.0 110.117 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -68.36 -38.53 81.52 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.52 176.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.415 ' O ' HD13 ' A' ' 33' ' ' LEU . . . -57.72 -44.17 85.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.28 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.446 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 88.2 mt -62.32 -34.66 77.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.82 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -56.22 -41.64 75.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.274 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -67.85 -37.14 81.49 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.935 0.398 . . . . 0.0 111.08 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.43 ' CB ' ' HB3' ' A' ' 90' ' ' PRO . 11.0 mp -63.09 -42.56 99.63 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.445 0.64 . . . . 0.0 110.423 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 30' ' ' LEU . 66.7 mm-40 -61.75 -22.8 65.71 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.993 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -87.74 -6.03 58.38 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.802 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.66 27.49 26.82 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.614 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.416 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 66.2 mttm -115.29 176.26 5.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.248 0.547 . . . . 0.0 111.311 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.427 ' O ' HG23 ' A' ' 8' ' ' ILE . 5.6 m80 -111.13 147.11 35.58 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.163 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.6 t -115.3 126.65 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.585 HH21 ' CD ' ' A' ' 10' ' ' GLU . 45.1 ttp180 -101.51 111.71 24.03 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -87.88 121.65 30.55 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.495 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 83.1 mtp180 -131.96 120.08 21.98 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.63 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 4.3 p -111.4 131.67 62.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.199 0.523 . . . . 0.0 111.53 -176.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.423 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 88.9 t80 -98.34 130.78 45.0 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.618 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' A' ' 50' ' ' MET . 40.7 mt -89.93 122.52 33.04 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -107.32 114.12 27.95 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.178 0.513 . . . . 0.0 111.674 -174.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.52 -143.86 15.97 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.485 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -83.18 4.86 24.88 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.154 0.502 . . . . 0.0 111.015 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -65.72 -25.75 67.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.153 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.523 ' HA ' HD12 ' A' ' 45' ' ' LEU . 49.2 ttm -59.46 -24.34 63.48 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.462 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.9 -25.61 67.96 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.321 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.9 p -126.69 101.55 26.78 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 121.303 0.573 . . . . 0.0 110.741 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.3 -15.36 38.75 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.446 2.764 . . . . 0.0 112.631 -177.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -61.69 -26.14 67.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.811 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.67 90.59 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.036 0.446 . . . . 0.0 110.119 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.437 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -67.03 -38.67 92.81 Favored Glycine 0 CA--C 1.505 -0.563 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.584 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.412 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 93.5 t -63.13 -45.85 97.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.571 -0.315 . . . . 0.0 110.947 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.37 -40.76 92.0 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.198 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.2 tp -63.2 -45.69 90.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.183 0.516 . . . . 0.0 110.289 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.442 HD13 ' HB2' ' A' ' 86' ' ' MET . 97.6 mt -65.17 -40.56 94.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.907 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 57' ' ' VAL . 46.6 mt-10 -62.55 -39.13 92.64 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.016 0.436 . . . . 0.0 110.471 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -62.64 -43.67 98.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.019 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.0 mt -67.35 -43.31 87.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.684 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.523 ' CZ2' ' HB2' ' A' ' 73' ' ' ARG . 41.9 t-105 -55.86 -41.16 73.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.281 -178.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 36.0 p -63.5 -29.13 70.45 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.256 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 66.0 mtt -67.66 -41.2 84.15 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.738 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.8 pt -106.52 -1.43 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -174.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -54.09 -32.0 53.54 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -176.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.418 ' O ' ' HE2' ' A' ' 91' ' ' LYS . 5.0 p30 -77.26 -14.74 59.7 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.404 ' HG2' ' OD1' ' A' ' 69' ' ' ASN . 58.6 mm-40 -117.71 -15.4 10.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.265 0.555 . . . . 0.0 111.203 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -124.16 155.57 38.25 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.788 -176.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -112.88 139.11 48.8 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 176.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.523 ' HB2' ' CZ2' ' A' ' 64' ' ' TRP . 71.0 ttp85 -87.28 112.3 21.91 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -177.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -70.97 -37.2 72.76 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.903 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -160.85 161.56 31.94 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.87 152.97 95.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.458 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 22.4 Cg_endo -61.16 139.41 83.66 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.165 1.91 . . . . 0.0 111.398 177.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -140.29 148.39 41.35 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.412 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -91.76 107.7 19.39 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.219 0.533 . . . . 0.0 110.156 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -114.84 116.05 27.96 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.513 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.4 -104.71 1.56 Allowed Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 120.363 -0.922 . . . . 0.0 110.92 -177.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -127.56 10.54 6.68 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.05 0.453 . . . . 0.0 110.324 178.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 81.2 m-85 -121.52 145.31 48.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.299 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.63 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 86.5 t -97.46 119.05 45.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 172.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.495 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 78.5 m-20 -111.25 144.08 40.99 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.081 -171.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.442 ' HB2' HD13 ' A' ' 60' ' ' LEU . 15.5 tmm? -147.05 137.75 23.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.746 175.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.2 mt -114.65 134.29 55.18 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.1 m -117.09 131.29 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.219 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.41 HG23 ' NE2' ' A' ' 38' ' ' HIS . 15.8 m -104.83 137.7 19.29 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.43 ' HB3' ' CB ' ' A' ' 33' ' ' LEU . 57.9 Cg_endo -64.47 148.34 90.66 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.429 2.086 . . . . 0.0 111.632 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 69' ' ' ASN . 36.7 mttp . . . . . 0 C--N 1.323 -0.568 0 CA-C-O 120.925 0.393 . . . . 0.0 111.629 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.1 t70 . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 121.036 0.446 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.9 mt -89.32 133.57 31.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.015 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -94.01 143.79 26.05 Favored 'General case' 0 CA--C 1.492 -1.288 0 CA-C-O 121.428 0.632 . . . . 0.0 111.167 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.615 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 91.1 mt-10 -120.49 126.28 49.98 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.945 178.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.9 mt -110.46 117.77 55.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 12.3 mptt -97.51 139.76 32.96 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.186 0.517 . . . . 0.0 112.161 -177.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mp -130.22 177.17 7.52 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.192 176.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.6 m -135.05 154.08 51.82 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.9 t -63.3 -33.09 59.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.257 0.551 . . . . 0.0 110.059 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -106.9 74.59 1.0 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.967 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.4 tt -130.39 160.84 41.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.969 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.418 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -73.85 142.62 46.08 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -38.39 90.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.055 0.455 . . . . 0.0 109.987 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -61.88 -41.22 97.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.596 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.71 ' OD2' ' HE2' ' A' ' 25' ' ' LYS . 6.1 t70 -65.58 -36.49 83.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.679 -178.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.647 ' O ' HG23 ' A' ' 26' ' ' VAL . 68.4 mt -60.98 -46.62 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -59.14 -43.19 92.01 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.517 0.675 . . . . 0.0 110.571 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -61.66 -46.11 91.13 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.022 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.71 ' HE2' ' OD2' ' A' ' 21' ' ' ASP . 68.8 mttm -65.38 -40.89 94.04 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.756 0.312 . . . . 0.0 111.769 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 22' ' ' ILE . 55.8 t -61.57 -39.71 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.611 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -56.08 -39.65 72.42 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.534 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 20.9 m80 -64.35 -38.24 90.35 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.989 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.614 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -60.86 -38.58 86.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.726 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.68 -39.1 90.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.99 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 6.1 mm-40 -59.58 -50.64 73.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.057 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -64.75 -34.84 79.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.518 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.649 HD13 ' HB2' ' A' ' 71' ' ' ALA . 96.1 mt -62.75 -43.72 98.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.292 0.568 . . . . 0.0 110.474 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -67.14 -26.73 66.81 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.915 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 78.9 mt-30 -77.67 -7.65 56.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.902 178.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.63 22.52 50.1 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.908 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -103.71 158.83 16.11 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.994 0.426 . . . . 0.0 110.298 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -98.35 138.66 35.27 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.512 176.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.3 t -112.15 128.18 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.615 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 67.2 ttt180 -108.51 112.76 25.31 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 176.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -86.9 117.97 25.98 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 81.8 mtp180 -125.65 138.78 53.92 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.572 -177.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.606 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.1 p -126.61 135.66 63.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.014 0.435 . . . . 0.0 111.076 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -101.14 132.35 46.65 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.707 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.56 ' HB2' ' SD ' ' A' ' 50' ' ' MET . 29.1 mt -90.33 111.99 23.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.024 0.44 . . . . 0.0 109.852 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -104.27 123.21 46.95 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.58 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.45 -147.42 16.33 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.209 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -89.07 15.28 8.97 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.224 0.535 . . . . 0.0 110.02 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -73.86 -11.75 60.46 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.193 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.56 ' SD ' ' HB2' ' A' ' 45' ' ' LEU . 95.6 mmm -61.23 -35.92 78.54 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.276 -176.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.74 -21.22 65.65 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.486 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.0 p -119.71 94.94 48.97 Favored Pre-proline 0 N--CA 1.446 -0.64 0 CA-C-O 121.143 0.497 . . . . 0.0 111.839 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -64.4 -23.62 64.99 Favored 'Trans proline' 0 N--CA 1.477 0.552 0 C-N-CA 123.349 2.7 . . . . 0.0 111.26 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.94 -22.13 66.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.74 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.87 97.04 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.927 0.394 . . . . 0.0 110.519 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.42 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -68.37 -39.32 87.58 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.905 177.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.427 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 97.3 t -63.41 -44.98 99.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.648 0.261 . . . . 0.0 111.018 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.99 -40.94 95.43 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.16 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.3 tp -63.15 -45.15 93.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.192 0.52 . . . . 0.0 110.001 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.488 HD12 HG12 ' A' ' 84' ' ' VAL . 63.1 mt -65.76 -37.75 87.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.767 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 57' ' ' VAL . 56.3 mt-10 -55.69 -42.23 74.89 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.621 0.248 . . . . 0.0 110.583 177.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -61.89 -43.53 98.65 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.06 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.473 ' O ' HG12 ' A' ' 67' ' ' ILE . 65.1 mt -62.39 -45.32 99.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.826 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.477 ' CZ2' ' HB2' ' A' ' 73' ' ' ARG . 45.6 t-105 -57.6 -40.96 80.26 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.072 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.405 ' HA ' ' OE2' ' A' ' 68' ' ' GLU . 25.2 m -63.22 -25.69 68.45 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 121.126 0.489 . . . . 0.0 110.581 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 95.6 mtp -89.47 -43.3 10.94 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.888 0.375 . . . . 0.0 111.799 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.474 HG12 ' HA ' ' A' ' 64' ' ' TRP . 40.5 pt -81.44 -18.35 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -174.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.405 ' OE2' ' HA ' ' A' ' 65' ' ' THR . 14.6 pt-20 -58.8 -15.42 12.22 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.102 0.477 . . . . 0.0 111.863 -177.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -63.17 -40.71 98.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.668 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -116.48 -9.71 11.39 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.532 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.649 ' HB2' HD13 ' A' ' 33' ' ' LEU . . . -121.9 160.3 25.06 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.642 ' OD1' ' HG2' ' A' ' 91' ' ' LYS . 11.3 m-20 -116.08 156.89 25.57 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.732 176.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.477 ' HB2' ' CZ2' ' A' ' 64' ' ' TRP . 69.3 ttt180 -85.4 106.5 16.82 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.006 -176.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -82.25 -36.77 26.8 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.027 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -160.18 160.03 32.35 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.851 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.449 ' HB3' HH21 ' A' ' 73' ' ' ARG . 9.7 pt-20 -84.78 155.75 61.57 Favored Pre-proline 0 C--N 1.316 -0.868 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 16.1 Cg_endo -57.1 132.7 53.03 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.474 2.116 . . . . 0.0 111.788 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -127.75 134.04 49.52 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.347 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -82.28 113.66 20.24 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -127.34 114.86 18.13 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.234 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.39 -105.81 1.68 Allowed Glycine 0 N--CA 1.428 -1.888 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.687 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -121.31 7.73 10.2 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.209 0.528 . . . . 0.0 110.445 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -123.47 149.58 44.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.996 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.606 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 69.7 t -108.93 126.29 65.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 173.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 6.5 m-80 -124.06 139.04 54.33 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.492 -0.483 . . . . 0.0 112.124 -172.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.423 ' HB2' HD13 ' A' ' 60' ' ' LEU . 63.2 ttp -130.01 128.99 43.12 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -108.27 127.22 53.66 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.969 0.414 . . . . 0.0 110.031 -178.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.431 HG11 ' CD1' ' A' ' 67' ' ' ILE . 20.6 m -123.18 145.43 30.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.042 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.1 m -115.42 135.43 22.59 Favored Pre-proline 0 C--N 1.303 -1.414 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.125 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.422 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 55.5 Cg_endo -64.17 152.52 80.83 Favored 'Trans proline' 0 C--N 1.329 -0.481 0 C-N-CA 122.319 2.013 . . . . 0.0 110.054 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.642 ' HG2' ' OD1' ' A' ' 72' ' ' ASN . 68.6 mttm . . . . . 0 C--N 1.329 -0.292 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -174.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.6 t70 . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 121.016 0.436 . . . . 0.0 109.875 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 88.7 mt -104.22 133.49 48.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.387 0.613 . . . . 0.0 111.38 -176.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -96.13 149.59 21.46 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.833 -175.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -119.88 137.48 53.99 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.185 0.517 . . . . 0.0 111.272 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.8 mm -110.21 114.85 48.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -90.21 141.74 28.41 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.309 0.576 . . . . 0.0 111.321 -176.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.47 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 49.4 mt -133.46 165.99 23.58 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.597 -176.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.5 p -140.82 152.3 45.05 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.7 t -62.79 -33.74 61.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.325 0.583 . . . . 0.0 109.551 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -93.55 73.2 4.39 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.575 176.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.8 tt -126.34 145.58 33.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.515 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.77 142.55 53.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.292 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.446 HE22 ' HD3' ' A' ' 62' ' ' LYS . 62.2 tp60 -62.98 -38.33 90.71 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.305 0.574 . . . . 0.0 110.505 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -62.5 -38.25 89.18 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.952 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -64.96 -36.1 83.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.602 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 94.2 mt -61.73 -42.74 95.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.424 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 6.4 m-20 -60.15 -41.11 92.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.515 178.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -68.63 -40.5 80.3 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.8 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -60.81 -42.4 97.58 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.57 HG12 HG23 ' A' ' 63' ' ' ILE . 13.2 m -64.04 -35.97 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.316 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 23' ' ' ASN . 99.1 mttt -62.54 -42.67 99.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.411 0.624 . . . . 0.0 109.49 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -65.94 -41.6 91.12 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.218 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.432 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -64.03 -38.94 92.91 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.299 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.0 mt -61.36 -38.48 87.12 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.263 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 57.9 mt-10 -57.69 -42.85 84.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.683 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.442 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 80.1 m-85 -74.63 -37.19 62.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.873 0.368 . . . . 0.0 111.798 177.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 92.4 mt -62.84 -43.43 98.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.599 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -63.4 -22.88 67.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.919 0.39 . . . . 0.0 111.183 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 32' ' ' PHE . 78.1 mt-30 -71.17 -34.95 71.4 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.364 175.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.27 -0.3 12.85 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.268 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -88.13 164.81 15.51 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.56 151.25 20.86 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.652 -176.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.5 t -119.18 130.01 74.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.223 0.535 . . . . 0.0 110.315 175.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -103.33 114.53 28.88 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 85.9 m-85 -92.3 120.0 32.42 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.584 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.739 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 78.5 mtp85 -122.37 118.81 29.32 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.623 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.5 p -115.68 128.89 72.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.321 0.581 . . . . 0.0 110.931 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -95.58 121.38 37.22 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.817 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.4 mt -79.55 143.71 34.57 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -130.92 137.72 49.44 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.961 -0.295 . . . . 0.0 110.344 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.87 -147.07 33.11 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.102 -0.57 . . . . 0.0 113.576 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.444 ' HD2' ' O ' ' A' ' 48' ' ' ARG . 2.6 tmm_? -59.64 -35.85 75.21 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.909 0.884 . . . . 0.0 110.415 -177.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -54.18 -16.5 2.11 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 84.5 mtp -63.23 -34.08 76.89 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.073 0.463 . . . . 0.0 110.848 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.13 -33.53 73.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.232 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.428 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 68.4 p -117.11 105.25 49.41 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-O 121.097 0.475 . . . . 0.0 111.911 -177.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.63 -15.29 45.3 Favored 'Trans proline' 0 N--CA 1.485 0.998 0 C-N-CA 124.014 3.142 . . . . 0.0 113.14 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.428 ' HG2' ' HB ' ' A' ' 52' ' ' THR . 14.5 pt-20 -54.82 -31.26 58.96 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.585 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.08 -42.22 99.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.913 0.387 . . . . 0.0 111.102 -178.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.485 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -67.69 -41.32 89.49 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.749 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.4 t -63.66 -45.95 96.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.583 -0.309 . . . . 0.0 111.177 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.38 -38.5 87.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.769 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.405 HD21 ' HB3' ' A' ' 13' ' ' LEU . 39.2 tp -63.55 -45.88 88.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.288 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.51 ' CD1' HG12 ' A' ' 84' ' ' VAL . 94.2 mt -65.58 -40.74 93.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.14 -178.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -62.22 -33.99 75.62 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.776 0.322 . . . . 0.0 111.269 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HD3' HE22 ' A' ' 19' ' ' GLN . 40.7 ttmt -62.11 -47.71 83.41 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-O 121.146 0.498 . . . . 0.0 109.688 176.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.57 HG23 HG12 ' A' ' 26' ' ' VAL . 70.8 mt -63.75 -43.06 97.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.047 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -56.66 -36.56 69.69 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.479 177.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.52 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 96.7 m -59.63 -44.38 93.5 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 120.988 0.423 . . . . 0.0 110.829 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -67.17 -39.55 86.46 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 63' ' ' ILE . 41.6 pt -98.37 -5.59 9.43 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.639 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -173.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 65' ' ' THR . 13.0 pt-20 -56.05 -34.86 66.3 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -176.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -69.63 -18.77 63.62 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -123.44 -1.37 8.6 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.931 0.396 . . . . 0.0 111.76 178.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -131.87 153.75 49.89 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.965 -177.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -111.71 144.23 41.32 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -81.71 111.86 18.36 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -176.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -66.45 -41.76 88.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.194 0.521 . . . . 0.0 109.872 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -163.66 161.18 23.53 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.264 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -74.6 152.93 87.49 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.495 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.34 134.89 64.47 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.714 2.276 . . . . 0.0 111.884 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -135.5 137.77 42.45 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.689 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -90.69 106.78 18.74 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.166 0.507 . . . . 0.0 110.564 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -118.14 118.74 32.71 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.424 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.64 -108.93 2.67 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -123.33 8.77 9.1 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.974 0.416 . . . . 0.0 110.611 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -122.8 141.4 51.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.405 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.623 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 89.3 t -97.38 115.86 38.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 173.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.739 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 47.5 m-80 -108.52 144.16 36.56 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.195 -173.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.496 ' HB2' HD13 ' A' ' 60' ' ' LEU . 65.0 ttp -144.99 134.98 23.8 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.533 174.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 16.9 mt -109.72 135.34 50.81 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.032 0.444 . . . . 0.0 110.976 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.0 m -122.62 133.86 67.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.427 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.0 m -104.45 132.96 20.46 Favored Pre-proline 0 N--CA 1.432 -1.367 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -65.56 147.33 86.42 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.173 1.915 . . . . 0.0 111.656 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.1 mttp . . . . . 0 C--N 1.324 -0.503 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.004 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.1 t70 . . . . . 0 CA--C 1.51 -0.592 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 80.9 mt -90.65 122.85 42.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.121 0.486 . . . . 0.0 110.396 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.472 ' HG2' ' CE1' ' A' ' 32' ' ' PHE . 4.2 mptp? -85.01 148.98 25.9 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.624 -175.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -110.85 118.05 35.08 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.955 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.3 mm -96.18 97.9 7.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 175.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 62.8 tttp -81.15 134.97 35.72 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.89 -177.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 67.3 mt -129.33 171.44 12.49 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.384 -175.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.9 p -144.2 149.98 37.26 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.58 -40.54 89.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -88.06 67.25 8.86 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.0 tt -117.6 152.69 19.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.35 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.403 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -84.94 154.69 22.03 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.231 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -63.49 -37.41 87.2 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.844 0.354 . . . . 0.0 111.098 -178.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -60.33 -42.64 96.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.272 0.558 . . . . 0.0 110.052 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.49 -40.52 97.3 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.004 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.619 ' O ' HG23 ' A' ' 26' ' ' VAL . 72.0 mt -61.41 -48.69 87.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -61.05 -47.6 85.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.377 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -62.44 -48.84 77.89 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.689 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -65.66 -42.47 91.32 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -177.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 22' ' ' ILE . 60.5 t -64.69 -43.74 96.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.138 0.494 . . . . 0.0 110.079 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.2 -42.21 99.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.112 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -66.69 -36.41 82.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.696 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.38 -34.49 73.98 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.801 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.452 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 96.7 mt -61.41 -38.2 86.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.523 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.463 ' HA ' ' OE1' ' A' ' 34' ' ' GLU . 41.5 mt-10 -61.75 -37.05 82.85 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.068 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.472 ' CE1' ' HG2' ' A' ' 9' ' ' LYS . 93.1 m-85 -69.26 -35.95 76.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.058 0.456 . . . . 0.0 110.579 177.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 90' ' ' PRO . 87.9 mt -62.86 -41.16 99.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.416 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.463 ' OE1' ' HA ' ' A' ' 31' ' ' GLU . 46.8 mt-10 -53.07 -32.89 49.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.404 177.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -78.16 -8.89 58.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.557 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.5 10.43 61.96 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.46 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -94.44 -176.47 3.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.958 0.409 . . . . 0.0 110.158 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -116.31 154.31 30.41 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.012 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.474 ' O ' HD12 ' A' ' 87' ' ' LEU . 25.6 t -118.51 125.33 74.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -103.24 112.32 25.14 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.261 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -84.07 128.29 34.46 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.341 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 9.1 mmm180 -131.33 107.69 9.13 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.225 -175.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.565 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 9.7 p -108.77 132.98 55.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 120.921 0.391 . . . . 0.0 110.568 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -106.99 134.0 50.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.243 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.404 ' CD1' ' HA ' ' A' ' 50' ' ' MET . 30.2 mt -94.58 115.02 27.07 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -106.86 -64.7 1.15 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -171.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.559 ' O ' ' HG3' ' A' ' 49' ' ' GLU . . . -82.74 88.2 1.47 Allowed Glycine 0 CA--C 1.49 -1.485 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -178.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 61.22 -111.4 0.45 Allowed 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -171.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.559 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 89.4 mt-10 63.21 -42.98 0.21 Allowed 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 173.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.404 ' HA ' ' CD1' ' A' ' 45' ' ' LEU . 42.9 ttm -63.28 -20.13 65.2 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.046 0.539 . . . . 0.0 111.866 -177.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.26 -30.43 71.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.168 0.509 . . . . 0.0 109.726 175.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 p -126.71 92.61 44.45 Favored Pre-proline 0 N--CA 1.452 -0.334 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.225 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -62.84 -20.51 71.46 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 123.6 2.867 . . . . 0.0 112.552 -176.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.05 -23.72 65.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.418 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.14 -41.05 91.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.017 0.437 . . . . 0.0 110.402 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.45 -39.61 91.34 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.7 t -64.73 -44.4 96.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.603 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.85 -39.77 86.29 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.252 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.4 tp -62.53 -46.49 88.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.165 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.434 HD13 ' HB2' ' A' ' 86' ' ' MET . 94.3 mt -65.53 -40.46 92.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.298 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -58.12 -39.96 80.01 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.356 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -61.96 -43.62 98.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.418 0.627 . . . . 0.0 110.345 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.2 mt -65.36 -43.57 94.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.913 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.2 t-105 -58.34 -39.47 79.55 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.807 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.439 ' HA ' ' OE2' ' A' ' 68' ' ' GLU . 19.5 m -57.75 -38.23 75.02 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.3 0.571 . . . . 0.0 110.583 178.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 78.3 mtm -77.1 -34.2 56.83 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.9 pt -98.41 -12.01 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 113.493 0.924 . . . . 0.0 113.493 -174.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.439 ' OE2' ' HA ' ' A' ' 65' ' ' THR . 14.1 pt-20 -59.83 -23.85 63.7 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -175.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -65.29 -30.98 71.89 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -127.09 3.27 6.47 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -128.68 153.79 46.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.144 0.497 . . . . 0.0 111.56 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.488 ' OD1' ' HG2' ' A' ' 91' ' ' LYS . 75.8 m-20 -111.85 149.33 31.96 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -89.01 106.56 18.51 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-O 121.025 0.44 . . . . 0.0 110.821 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -75.9 -41.05 53.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.421 0.629 . . . . 0.0 110.715 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -137.27 150.03 47.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.061 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -85.31 154.8 60.08 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 29.1 Cg_endo -63.4 115.29 2.93 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.76 1.64 . . . . 0.0 110.961 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -136.1 144.56 45.19 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.336 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -81.91 109.83 16.63 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.562 ' HB3' HD21 ' A' ' 85' ' ' ASN . 73.4 tt0 -148.71 123.43 9.87 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.808 -176.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 82' ' ' ARG . . . 75.52 28.53 61.31 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.315 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 81' ' ' GLY . 88.0 mtm180 72.28 3.18 4.6 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.357 0.663 . . . . 0.0 111.339 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -119.87 145.46 46.65 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.054 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.565 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 92.0 t -95.35 112.27 27.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 172.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.562 HD21 ' HB3' ' A' ' 80' ' ' GLU . 9.5 p30 -116.48 148.97 40.27 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -172.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.434 ' HB2' HD13 ' A' ' 60' ' ' LEU . 66.0 ttp -141.85 136.74 30.86 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.31 175.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.474 HD12 ' O ' ' A' ' 39' ' ' VAL . 44.7 tp -118.82 140.15 50.43 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.904 0.383 . . . . 0.0 110.59 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.8 m -130.26 161.72 39.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.229 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.2 m -137.28 138.94 26.45 Favored Pre-proline 0 C--N 1.309 -1.178 0 CA-C-N 115.46 -0.791 . . . . 0.0 108.985 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.519 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 92.8 Cg_endo -68.41 142.87 55.85 Favored 'Trans proline' 0 C--N 1.329 -0.48 0 C-N-CA 122.242 1.961 . . . . 0.0 110.15 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.488 ' HG2' ' OD1' ' A' ' 72' ' ' ASN . 69.0 mttm . . . . . 0 CA--C 1.535 0.39 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.605 -177.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.418 ' CG ' ' HZ1' ' A' ' 9' ' ' LYS . 13.6 t0 . . . . . 0 C--O 1.212 -0.919 0 CA-C-O 120.663 0.268 . . . . 0.0 110.693 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 74.4 mt -121.3 133.63 67.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.05 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.48 ' HE2' ' N ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -80.26 147.76 31.07 Favored 'General case' 0 CA--C 1.485 -1.541 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.304 -177.931 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -133.78 112.21 11.16 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.661 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.9 mt -107.72 114.15 45.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.389 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 86.7 tttt -86.52 131.13 34.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 122.157 0.98 . . . . 0.0 112.297 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.2 mt -129.55 179.58 5.73 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.404 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.425 ' HA ' HG23 ' A' ' 43' ' ' VAL . 42.4 p -149.6 156.91 42.7 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.0 t -69.85 -17.71 21.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 121.529 0.68 . . . . 0.0 110.301 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -96.66 26.27 4.61 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.401 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.8 tt -88.72 138.89 18.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.255 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.76 145.57 48.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.927 177.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -56.43 -40.59 75.01 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -176.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -62.89 -36.0 81.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.754 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.57 -32.81 68.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.181 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.626 ' O ' HG23 ' A' ' 26' ' ' VAL . 62.5 mt -58.91 -46.9 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 109.614 -0.514 . . . . 0.0 109.614 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -57.48 -41.99 81.75 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 124.281 0.988 . . . . 0.0 110.573 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -62.99 -48.01 80.66 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.839 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -64.78 -43.36 93.46 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 120.568 0.223 . . . . 0.0 110.761 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 22' ' ' ILE . 50.0 t -63.55 -42.49 96.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.133 -178.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -57.22 -45.77 83.56 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.429 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -65.91 -37.13 85.28 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.601 177.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.71 -39.48 80.92 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.943 0.401 . . . . 0.0 109.971 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.493 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 98.2 mt -62.28 -41.35 98.41 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.211 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -63.32 -39.65 95.14 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.509 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -66.56 -35.18 79.6 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.183 0.516 . . . . 0.0 110.741 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.616 HD13 ' HB2' ' A' ' 71' ' ' ALA . 88.9 mt -62.56 -42.32 99.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.251 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 30' ' ' LEU . 86.9 mt-10 -56.7 -34.69 67.68 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.501 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -66.98 -19.82 65.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.598 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.77 35.54 6.11 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.306 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.482 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -124.52 164.92 18.75 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.304 0.573 . . . . 0.0 110.058 179.442 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.421 ' CD2' ' HA ' ' A' ' 89' ' ' THR . 16.2 m170 -97.81 137.5 36.58 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.961 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 68.5 t -104.48 118.97 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.697 175.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -95.37 110.48 22.5 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.44 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 94.0 m-85 -83.94 108.74 17.1 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.502 ' HA ' ' OD1' ' A' ' 85' ' ' ASN . 53.2 mtp85 -106.18 108.5 20.05 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.782 -177.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 84' ' ' VAL . 4.9 p -109.11 127.64 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-O 121.641 0.734 . . . . 0.0 111.161 -177.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -98.67 123.92 43.17 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.545 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 50' ' ' MET . 89.4 mt -72.53 -56.28 5.62 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -176.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.8 tttp 69.08 124.81 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.118 0.485 . . . . 0.0 112.099 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.29 -155.57 25.25 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.798 176.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -72.41 -14.66 61.75 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.718 0.294 . . . . 0.0 111.384 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -61.88 -20.1 63.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.392 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.483 ' HA ' HD12 ' A' ' 45' ' ' LEU . 94.7 mtp -67.92 -15.3 63.55 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.737 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.56 -11.41 59.17 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 120.946 0.403 . . . . 0.0 110.684 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.436 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 41.5 p -128.33 106.58 19.44 Favored Pre-proline 0 N--CA 1.442 -0.856 0 CA-C-O 121.481 0.658 . . . . 0.0 111.204 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 52' ' ' THR . 35.3 Cg_endo -68.56 -16.65 42.95 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 122.902 2.401 . . . . 0.0 111.876 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -58.87 -33.82 70.91 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.974 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.49 -41.86 90.84 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.103 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.444 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -68.01 -41.58 87.13 Favored Glycine 0 C--O 1.219 -0.815 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 177.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.07 -44.49 99.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 O-C-N 123.727 0.31 . . . . 0.0 111.182 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.91 -41.82 96.88 Favored 'General case' 0 C--O 1.257 1.467 0 C-N-CA 122.448 0.299 . . . . 0.0 111.312 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.0 tp -62.85 -44.07 97.12 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.202 0.525 . . . . 0.0 109.805 177.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.56 HD13 ' HB2' ' A' ' 86' ' ' MET . 90.9 mt -65.76 -40.45 92.07 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.621 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -60.24 -37.67 81.11 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.333 0.396 . . . . 0.0 110.967 178.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -62.68 -44.32 96.55 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.603 0.716 . . . . 0.0 109.241 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.56 HG23 HG22 ' A' ' 26' ' ' VAL . 61.9 mt -67.26 -43.23 88.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.719 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.555 ' CZ2' ' HB2' ' A' ' 73' ' ' ARG . 37.6 t-105 -56.73 -39.23 73.56 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.827 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.7 m -63.23 -23.92 67.64 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 123.485 0.491 . . . . 0.0 111.212 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 96.5 mtp -91.1 -30.4 16.76 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.7 pt -98.73 -9.74 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -175.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -15.38 47.65 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -79.52 -21.9 44.64 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.668 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -119.9 -13.12 9.08 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.743 0.306 . . . . 0.0 111.246 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.616 ' HB2' HD13 ' A' ' 33' ' ' LEU . . . -126.67 154.68 43.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.102 0.477 . . . . 0.0 112.137 -175.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.464 ' OD1' ' HB ' ' A' ' 89' ' ' THR . 7.0 p30 -116.73 135.77 53.5 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.821 176.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.555 ' HB2' ' CZ2' ' A' ' 64' ' ' TRP . 36.1 ttp180 -74.87 112.14 10.78 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.247 -176.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -71.89 -37.84 70.07 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -159.32 158.94 33.32 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.115 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -72.79 150.52 90.78 Favored Pre-proline 0 C--N 1.306 -1.284 0 C-N-CA 122.536 0.334 . . . . 0.0 110.736 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.35 134.69 65.85 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 122.685 2.257 . . . . 0.0 112.511 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -133.62 149.12 51.6 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.99 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -91.82 116.25 28.74 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.38 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -128.3 137.76 52.1 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.64 -109.94 3.08 Favored Glycine 0 N--CA 1.426 -2.019 0 C-N-CA 119.966 -1.111 . . . . 0.0 111.769 -178.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -127.81 17.76 6.79 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.371 0.605 . . . . 0.0 110.273 177.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -129.24 150.94 50.41 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.908 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 43' ' ' VAL . 87.2 t -104.06 113.2 40.35 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.87 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 171.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' ' 42' ' ' ARG . 88.2 m-20 -113.88 137.5 51.58 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.343 -173.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.56 ' HB2' HD13 ' A' ' 60' ' ' LEU . 64.5 ttp -122.02 129.67 52.63 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.926 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -103.0 122.25 44.22 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 m -119.52 148.74 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.514 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.464 ' HB ' ' OD1' ' A' ' 72' ' ' ASN . 35.8 m -117.33 136.77 23.56 Favored Pre-proline 0 C--N 1.295 -1.785 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.474 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 91.4 Cg_endo -71.07 156.59 59.55 Favored 'Trans proline' 0 C--N 1.329 -0.494 0 C-N-CA 122.871 2.381 . . . . 0.0 111.508 177.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 N--CA 1.438 -1.072 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.299 179.157 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.423 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 35.4 t70 . . . . . 0 N--CA 1.447 -0.605 0 CA-C-O 121.382 0.61 . . . . 0.0 110.318 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.442 HG12 ' HB2' ' A' ' 38' ' ' HIS . 77.0 mt -87.86 130.3 37.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.481 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -86.52 135.9 33.28 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.452 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 46.0 mt-10 -110.25 114.38 27.81 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.197 178.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.4 mt -107.14 109.27 27.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -101.51 126.7 48.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.222 -175.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.46 HD23 ' CD1' ' A' ' 17' ' ' ILE . 5.1 mp -116.69 -178.89 3.53 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.036 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.0 p -139.28 157.98 44.96 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.2 t -64.08 -36.66 77.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 175.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -83.21 65.64 8.35 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.695 174.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.46 ' CD1' HD23 ' A' ' 13' ' ' LEU . 18.1 tt -123.44 149.36 27.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.1 152.14 26.69 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.731 176.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -64.02 -34.82 78.86 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.182 0.515 . . . . 0.0 109.924 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -62.32 -40.34 96.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.155 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.612 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 20.8 t70 -65.42 -36.92 85.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.055 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.7 mt -61.51 -42.85 95.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -60.31 -42.72 96.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.596 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -63.81 -44.15 94.13 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.3 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 75.6 mmtt -63.97 -43.9 94.37 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -176.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.555 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 11.1 m -67.92 -28.91 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.606 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.89 -44.69 94.09 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.227 0.537 . . . . 0.0 109.626 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -75.2 -36.92 61.35 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.234 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.511 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -59.63 -37.56 78.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.021 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.636 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 94.0 mt -61.9 -41.29 97.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.192 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -59.74 -45.09 93.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.086 0.469 . . . . 0.0 111.303 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -66.37 -36.2 82.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.876 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.653 HD13 ' HB2' ' A' ' 71' ' ' ALA . 96.8 mt -63.11 -40.0 96.36 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.067 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.636 ' HG3' ' O ' ' A' ' 30' ' ' LEU . 60.4 mt-10 -59.48 -33.3 71.15 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.987 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -79.84 -5.35 55.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.011 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.45 18.4 62.32 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.713 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.423 ' HD2' ' O ' ' A' ' 7' ' ' ASP . 41.4 mmtm -92.85 153.66 18.71 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.338 0.589 . . . . 0.0 111.401 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.442 ' HB2' HG12 ' A' ' 8' ' ' ILE . 7.7 m80 -98.21 140.18 32.9 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.69 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 49.6 t -115.15 128.42 72.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.452 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 64.5 ttt180 -102.43 111.01 23.13 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -90.94 120.44 31.95 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.422 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 82.1 mtp180 -131.2 138.45 49.4 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.662 -177.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.542 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.4 p -129.48 135.93 60.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 121.144 0.497 . . . . 0.0 110.751 177.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -98.55 130.59 45.12 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.001 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.7 mt -95.5 125.09 39.87 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -102.43 128.31 49.08 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -172.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.98 -120.18 8.5 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.214 -0.903 . . . . 0.0 113.65 177.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 48' ' ' ARG . 61.2 mtt85 -76.48 -9.01 58.33 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 122.927 0.491 . . . . 0.0 111.696 -175.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -66.51 -23.23 66.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.999 0.428 . . . . 0.0 110.944 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 65.9 mtt -64.12 -19.51 65.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.92 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.41 -14.71 61.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.501 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -140.64 105.98 6.42 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 122.192 0.996 . . . . 0.0 111.331 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.27 -20.61 36.92 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.337 2.691 . . . . 0.0 113.773 -176.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.432 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -66.49 -20.51 66.06 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -177.044 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.93 99.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.117 0.484 . . . . 0.0 109.783 176.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.444 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -69.44 -37.82 79.43 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.43 176.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.0 t -62.62 -44.72 99.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.265 -0.468 . . . . 0.0 111.055 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.27 -40.8 95.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.541 ' O ' HG13 ' A' ' 63' ' ' ILE . 39.1 tp -62.25 -46.72 87.59 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.287 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.492 HD12 HG12 ' A' ' 84' ' ' VAL . 88.6 mt -65.29 -41.13 94.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.054 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -64.78 -35.39 80.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.954 0.407 . . . . 0.0 110.5 179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -63.03 -41.56 99.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.538 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 59' ' ' LEU . 63.1 mt -64.32 -43.99 97.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.138 176.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 53.4 t-105 -56.48 -42.32 78.07 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.158 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.7 p -64.37 -21.8 66.75 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.58 -0.448 . . . . 0.0 112.133 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 66.9 mtt -83.05 -31.69 27.24 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.5 pt -108.16 -4.7 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -54.45 -30.5 53.01 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -175.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.455 ' OD1' ' HG2' ' A' ' 70' ' ' GLU . 5.3 p30 -72.83 -23.11 60.72 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.455 ' HG2' ' OD1' ' A' ' 69' ' ' ASN . 61.1 mm-40 -112.25 -19.96 12.04 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.079 0.466 . . . . 0.0 110.845 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.653 ' HB2' HD13 ' A' ' 33' ' ' LEU . . . -117.76 150.64 38.77 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.551 -176.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -112.51 137.86 50.12 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 175.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -76.21 119.81 20.64 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.076 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -85.33 -38.81 18.38 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.014 0.435 . . . . 0.0 110.607 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -148.03 156.08 42.23 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.269 -177.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -77.4 155.0 81.86 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.935 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 23.2 Cg_endo -61.76 138.49 74.89 Favored 'Trans proline' 0 C--O 1.24 0.617 0 C-N-CA 122.095 1.863 . . . . 0.0 111.446 176.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 27.4 p-10 -145.21 167.24 23.27 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.244 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.583 ' CZ ' ' HA ' ' A' ' 82' ' ' ARG . 89.8 t80 -107.84 111.07 23.02 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.112 0.482 . . . . 0.0 110.486 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -138.58 126.06 21.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.399 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.67 34.42 88.87 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.841 177.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.583 ' HA ' ' CZ ' ' A' ' 79' ' ' PHE . 89.2 mtt180 70.74 11.3 7.18 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -120.58 145.54 47.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.401 175.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.542 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 92.7 t -99.27 114.16 36.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 173.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.547 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 80.8 m-20 -110.25 147.58 33.54 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.987 0.422 . . . . 0.0 112.093 -173.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.676 ' SD ' HG13 ' A' ' 88' ' ' VAL . 17.8 tmm? -145.48 130.55 18.38 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -112.32 130.95 55.78 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.128 0.489 . . . . 0.0 111.206 -175.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.676 HG13 ' SD ' ' A' ' 86' ' ' MET . 15.2 m -119.81 135.91 58.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.496 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.409 HG23 ' CE1' ' A' ' 38' ' ' HIS . 37.9 m -105.84 133.51 20.17 Favored Pre-proline 0 N--CA 1.431 -1.4 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 176.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.04 151.01 84.96 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.185 1.924 . . . . 0.0 110.189 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 N--CA 1.447 -0.6 0 CA-C-O 121.123 0.487 . . . . 0.0 110.764 -179.669 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.591 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 7.5 m-20 . . . . . 0 CA--C 1.504 -0.808 0 CA-C-O 120.796 0.332 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 88.3 mt -103.99 115.01 45.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.198 0.523 . . . . 0.0 109.599 176.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.422 ' HG2' ' CE1' ' A' ' 32' ' ' PHE . 4.0 mptp? -81.99 143.34 31.66 Favored 'General case' 0 CA--C 1.489 -1.367 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.202 -177.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -109.59 126.93 54.13 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.522 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.481 HG23 ' HD2' ' A' ' 25' ' ' LYS . 31.8 mm -100.54 107.22 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.197 178.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 2.1 mptt -80.47 139.94 36.17 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.651 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 60.7 mt -133.67 164.79 26.42 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.624 -177.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 63.5 m -141.46 151.46 43.4 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.6 t -61.03 -42.19 92.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -81.99 62.95 6.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.635 176.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.5 tt -115.68 151.07 17.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.856 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.11 150.82 21.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.339 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -62.76 -34.31 76.96 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.924 0.392 . . . . 0.0 110.899 -178.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -62.46 -41.26 98.64 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -66.63 -35.73 80.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.76 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.417 HG23 HG12 ' A' ' 63' ' ' ILE . 94.1 mt -61.49 -42.71 94.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.261 0.553 . . . . 0.0 109.563 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -60.46 -44.33 95.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.222 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -63.44 -44.31 94.89 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.069 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.481 ' HD2' HG23 ' A' ' 11' ' ' ILE . 49.7 mmtm -63.26 -45.39 91.72 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.531 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 17.3 m -67.09 -36.61 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.621 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -60.54 -47.09 87.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.203 0.525 . . . . 0.0 110.099 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -68.29 -39.25 82.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.579 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.96 -36.22 80.79 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.842 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.616 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 88.6 mt -60.71 -40.26 91.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.086 -178.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.584 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 62.7 mt-10 -61.21 -41.73 97.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.839 -177.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.422 ' CE1' ' HG2' ' A' ' 9' ' ' LYS . 93.4 m-85 -63.6 -37.76 88.55 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.192 0.52 . . . . 0.0 110.35 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 90' ' ' PRO . 97.2 mt -63.62 -42.22 98.22 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.567 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.616 ' HG3' ' O ' ' A' ' 30' ' ' LEU . 40.3 mt-10 -61.84 -21.37 64.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.309 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 31' ' ' GLU . 73.3 mm-40 -84.52 -6.6 59.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.799 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.3 15.16 59.21 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.627 -177.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.591 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 63.8 mttp -105.11 177.21 4.92 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 120.978 0.418 . . . . 0.0 110.512 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -112.84 158.78 19.74 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.843 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.6 t -113.42 130.24 67.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -98.8 102.41 14.13 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.696 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 69.3 m-85 -85.91 117.37 24.72 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 120.594 -0.442 . . . . 0.0 109.959 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 82.6 mtp180 -125.94 110.42 13.59 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.243 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.569 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.8 p -107.13 128.42 62.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-O 121.234 0.54 . . . . 0.0 110.955 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.411 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 83.8 t80 -95.55 132.4 40.71 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.033 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.0 mt -81.26 83.11 6.94 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.223 0.535 . . . . 0.0 110.355 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -76.54 131.18 38.81 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.143 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.66 -140.82 16.52 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.475 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -105.75 -2.49 23.17 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.393 0.616 . . . . 0.0 109.92 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -74.04 -2.46 24.37 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.298 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.498 ' SD ' ' HD2' ' A' ' 82' ' ' ARG . 56.6 ttm -61.6 -22.18 65.0 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 122.52 0.328 . . . . 0.0 111.801 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.34 -13.66 60.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.938 0.399 . . . . 0.0 111.124 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.3 p -123.14 103.56 36.04 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.256 0.551 . . . . 0.0 111.482 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.75 -18.25 47.6 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.2 2.6 . . . . 0.0 112.548 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -63.52 -29.19 70.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.041 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.93 -43.62 86.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.03 0.443 . . . . 0.0 110.606 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.406 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -66.16 -41.52 94.87 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.862 177.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.09 -44.64 97.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.739 0.304 . . . . 0.0 110.639 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.0 -41.08 97.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.887 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.44 HD23 HG21 ' A' ' 43' ' ' VAL . 42.6 tp -62.8 -45.28 93.38 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.212 0.529 . . . . 0.0 110.19 177.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.495 HD13 ' HB2' ' A' ' 86' ' ' MET . 98.0 mt -64.03 -40.16 95.7 Favored 'General case' 0 C--O 1.212 -0.876 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.812 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -58.19 -41.89 84.95 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.719 0.295 . . . . 0.0 111.156 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -63.96 -46.34 85.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.462 0.648 . . . . 0.0 109.738 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.466 ' CD1' HD13 ' A' ' 13' ' ' LEU . 96.3 mt -65.06 -42.67 95.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.171 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.526 ' CZ2' ' HB2' ' A' ' 73' ' ' ARG . 28.1 t-105 -56.45 -40.19 74.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.78 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 23.2 m -61.13 -34.2 74.61 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.269 0.557 . . . . 0.0 110.736 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 98.2 mmm -69.33 -39.25 78.31 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.261 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.9 pt -97.49 -10.06 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -174.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -58.06 -14.93 7.61 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -177.499 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -61.67 -41.95 98.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.902 0.382 . . . . 0.0 110.218 178.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -126.52 14.94 7.65 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.902 -175.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -134.73 144.68 47.87 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.329 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -113.41 142.12 46.27 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 175.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.526 ' HB2' ' CZ2' ' A' ' 64' ' ' TRP . 53.7 ttp180 -95.47 114.55 26.33 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.642 -177.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -65.51 -41.15 93.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.86 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -155.73 160.45 40.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.934 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.434 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 22.9 mp0 -69.11 161.28 74.0 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 123.346 0.404 . . . . 0.0 110.054 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.413 ' HB3' HD12 ' A' ' 60' ' ' LEU . 38.0 Cg_exo -60.61 146.05 97.76 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.544 2.163 . . . . 0.0 112.306 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -138.41 137.83 37.63 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.592 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -89.59 125.35 35.19 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.703 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -142.32 125.42 16.31 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.29 -109.25 2.8 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.498 ' HD2' ' SD ' ' A' ' 50' ' ' MET . 29.0 mmt180 -125.42 12.81 8.16 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.12 0.486 . . . . 0.0 110.627 176.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.411 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 95.5 m-85 -119.85 151.32 39.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.339 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.569 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 76.5 t -108.94 122.25 63.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 171.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 87.5 m-20 -112.49 143.04 44.3 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -171.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.495 ' HB2' HD13 ' A' ' 60' ' ' LEU . 62.5 ttp -138.5 126.89 23.09 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.192 175.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -104.04 126.35 51.09 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.1 m -117.77 140.34 41.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.227 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.3 m -107.0 138.84 19.93 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.422 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 55.6 Cg_endo -64.23 140.3 70.34 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 122.115 1.876 . . . . 0.0 111.978 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt . . . . . 0 N--CA 1.44 -0.943 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 176.936 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.5 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 34.6 t70 . . . . . 0 CA--C 1.508 -0.654 0 CA-C-O 120.991 0.424 . . . . 0.0 109.887 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 82.9 mt -88.84 129.68 39.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.148 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.499 ' HG3' ' CD1' ' A' ' 32' ' ' PHE . 73.6 mmtt -85.43 135.82 33.7 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.657 -177.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -107.6 107.83 18.84 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.086 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.9 mm -92.43 106.62 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 65.2 tttp -84.02 133.64 34.66 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.888 -178.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.465 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 66.0 mt -125.17 169.49 12.16 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.733 -177.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.457 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 40.0 m -140.78 150.66 43.64 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -59.96 -43.73 93.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.273 0.558 . . . . 0.0 109.586 174.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -78.77 62.26 3.23 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 121.743 0.782 . . . . 0.0 110.311 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.539 HG21 HD11 ' A' ' 59' ' ' LEU . 18.8 tt -111.21 161.21 9.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.836 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.599 -178.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.35 150.22 22.82 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.239 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -66.69 -38.47 86.85 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.645 -177.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -67.7 -33.26 74.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.906 0.384 . . . . 0.0 110.231 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -64.2 -38.1 89.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.835 177.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.688 HG23 HG12 ' A' ' 63' ' ' ILE . 92.5 mt -62.88 -43.64 99.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.568 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -61.38 -42.62 99.01 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.784 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -62.36 -47.4 84.36 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.987 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -65.72 -40.67 92.43 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -178.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 22' ' ' ILE . 2.3 m -64.09 -35.54 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.535 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -61.76 -41.54 97.81 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.416 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 7.0 m80 -67.98 -41.74 81.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.095 176.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.54 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -59.58 -37.53 78.74 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.703 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.534 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 94.1 mt -61.8 -39.35 91.4 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.519 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.544 ' HA ' ' OE1' ' A' ' 34' ' ' GLU . 46.0 mt-10 -65.16 -44.57 88.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.375 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.499 ' CD1' ' HG3' ' A' ' 9' ' ' LYS . 90.0 m-85 -65.68 -34.49 78.33 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.917 0.389 . . . . 0.0 111.15 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 93.7 mt -62.93 -39.65 95.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.736 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.544 ' OE1' ' HA ' ' A' ' 31' ' ' GLU . 45.3 mt-10 -51.36 -40.79 59.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.77 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -70.69 -4.82 25.54 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.94 20.65 49.37 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.562 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.55 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 63.5 mttm -101.07 177.04 5.06 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 120.997 0.427 . . . . 0.0 110.599 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.423 ' NE2' HG23 ' A' ' 89' ' ' THR . 15.0 m170 -112.69 155.59 24.22 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.921 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.9 t -116.07 127.96 73.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 173.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -102.63 109.8 21.53 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -88.49 112.37 22.89 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.337 -0.545 . . . . 0.0 109.708 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.705 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 76.4 mtp85 -115.78 120.39 39.14 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.634 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.551 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.6 p -121.07 129.69 75.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.232 0.539 . . . . 0.0 111.349 -178.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -95.49 130.68 42.23 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.0 mt -78.67 84.57 4.76 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.87 0.367 . . . . 0.0 111.043 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.415 ' HD3' ' N ' ' A' ' 47' ' ' GLY . 4.8 tmtt? -83.65 120.6 26.17 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.415 ' N ' ' HD3' ' A' ' 46' ' ' LYS . . . 131.86 -133.56 7.22 Favored Glycine 0 N--CA 1.433 -1.555 0 C-N-CA 120.216 -0.993 . . . . 0.0 112.106 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -124.59 10.43 8.46 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.484 0.659 . . . . 0.0 110.543 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -80.91 6.06 14.36 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.23 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 96.5 mtp -65.62 -30.38 71.09 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.055 0.455 . . . . 0.0 110.562 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.96 -26.92 66.39 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.723 178.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.5 m -143.39 116.91 6.03 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.148 0.499 . . . . 0.0 111.044 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.06 2.96 4.93 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 123.487 2.791 . . . . 0.0 113.269 -176.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -59.5 -36.05 75.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.8 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.96 -43.8 94.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.146 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.415 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -68.98 -43.32 73.68 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.315 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.4 t -63.39 -47.25 92.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-O 120.578 0.228 . . . . 0.0 111.069 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.06 -37.14 86.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.421 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.539 HD11 HG21 ' A' ' 17' ' ' ILE . 42.2 tp -61.2 -49.55 76.7 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.962 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.531 HD12 HG12 ' A' ' 84' ' ' VAL . 88.5 mt -65.22 -42.15 93.74 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.826 -177.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.413 ' HA ' ' HB3' ' A' ' 64' ' ' TRP . 42.5 mt-10 -67.83 -35.33 78.4 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -63.77 -42.71 97.74 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.501 0.667 . . . . 0.0 109.297 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.688 HG12 HG23 ' A' ' 22' ' ' ILE . 86.7 mt -64.4 -43.55 97.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.876 -1.057 . . . . 0.0 109.889 177.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.413 ' HB3' ' HA ' ' A' ' 61' ' ' GLU . 13.0 t-105 -57.29 -40.05 77.01 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.789 176.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.49 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 91.5 m -60.88 -29.43 69.55 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 121.102 0.477 . . . . 0.0 111.225 -178.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 67.6 mtt -72.5 -35.07 68.07 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.558 HD11 HG11 ' A' ' 88' ' ' VAL . 37.1 pt -102.37 -7.36 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -174.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 65' ' ' THR . 15.2 pt-20 -58.91 -16.02 15.62 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -177.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -70.67 -14.07 62.32 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.479 ' HA ' ' HD2' ' A' ' 91' ' ' LYS . 11.6 pt-20 -150.19 29.89 0.71 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.57 0.7 . . . . 0.0 110.259 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -147.23 153.27 39.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.723 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.47 ' OD1' ' HB ' ' A' ' 89' ' ' THR . 7.2 p30 -123.89 135.8 53.95 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -70.68 110.75 5.67 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.086 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -69.31 -43.24 74.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.211 0.529 . . . . 0.0 109.779 178.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -153.85 143.78 21.95 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.71 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -62.77 157.62 57.91 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.859 176.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 31.4 Cg_exo -59.45 142.42 98.95 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.156 1.904 . . . . 0.0 111.968 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -137.51 133.41 34.53 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.447 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -87.69 118.67 27.35 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.989 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -130.85 110.89 11.63 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.944 -178.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.14 -97.58 0.6 Allowed Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.629 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.34 8.11 5.97 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.859 0.361 . . . . 0.0 110.626 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.432 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 65.3 m-85 -119.8 141.87 49.11 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.448 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.551 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 97.2 t -103.8 118.22 50.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 172.359 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.705 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 35.0 m-80 -109.14 143.97 37.82 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -173.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -149.84 137.03 19.69 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.1 mt -112.92 134.32 54.48 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.558 HG11 HD11 ' A' ' 67' ' ' ILE . 14.6 m -117.22 133.72 63.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.58 176.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.485 ' CG2' ' HD2' ' A' ' 90' ' ' PRO . 14.6 m -109.27 143.89 28.64 Favored Pre-proline 0 C--N 1.302 -1.485 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 60.7 Cg_endo -65.46 152.99 80.23 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.989 1.793 . . . . 0.0 109.352 177.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.479 ' HD2' ' HA ' ' A' ' 70' ' ' GLU . 37.0 tttm . . . . . 0 C--N 1.323 -0.573 0 CA-C-O 121.235 0.54 . . . . 0.0 111.105 -174.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.407 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 21.9 t0 . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 121.047 0.451 . . . . 0.0 110.007 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 90.4 mt -118.71 133.4 65.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.718 -176.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.461 ' HB2' HG22 ' A' ' 39' ' ' VAL . 68.1 mmtt -84.12 121.81 27.96 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.607 0.718 . . . . 0.0 111.21 -175.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.47 ' OE1' ' HD3' ' A' ' 42' ' ' ARG . 47.9 mm-40 -93.47 105.53 17.58 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.12 -178.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.6 mt -108.29 110.82 33.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.385 0.612 . . . . 0.0 110.297 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 87.6 tttt -101.16 130.23 47.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.197 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.587 HD21 ' HG3' ' A' ' 25' ' ' LYS . 82.1 mt -129.23 -177.29 4.18 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.431 -178.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 p -137.53 158.22 44.86 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.726 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.401 ' HB ' ' OE1' ' A' ' 49' ' ' GLU . 72.4 t -64.19 -41.91 93.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.645 0.736 . . . . 0.0 109.169 177.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -90.28 71.94 7.15 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.384 177.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.4 tt -124.19 146.42 29.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.901 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.9 143.04 52.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.315 177.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -64.89 -32.42 74.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.519 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -62.08 -39.18 91.55 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.224 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.492 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 9.5 t70 -65.41 -37.81 88.05 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.569 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.429 ' O ' HG22 ' A' ' 26' ' ' VAL . 93.4 mt -62.05 -42.58 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.081 0.467 . . . . 0.0 109.95 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -59.52 -41.59 90.32 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.533 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -63.29 -43.33 98.19 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.574 177.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.587 ' HG3' HD21 ' A' ' 13' ' ' LEU . 75.5 mmtt -65.23 -44.74 87.26 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 22' ' ' ILE . 2.5 m -64.51 -34.44 69.63 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.653 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -60.32 -44.37 95.53 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 176.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.417 ' O ' ' HD2' ' A' ' 32' ' ' PHE . 11.2 m170 -64.5 -42.44 95.84 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.837 177.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.557 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -55.13 -48.62 73.39 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.661 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.62 -41.88 99.26 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.795 0.331 . . . . 0.0 111.099 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.5 -31.05 72.1 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.72 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.417 ' HD2' ' O ' ' A' ' 28' ' ' HIS . 82.4 m-85 -85.95 -31.7 21.96 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 121.059 -0.257 . . . . 0.0 111.483 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 86.9 mt -62.52 -44.97 95.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.96 0.41 . . . . 0.0 111.245 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -18.51 61.34 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.669 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -77.03 -13.63 59.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.887 0.375 . . . . 0.0 110.338 177.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.37 12.97 50.03 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.309 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.407 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 96.9 mttt -103.48 -179.56 3.99 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.107 0.48 . . . . 0.0 111.202 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -116.65 155.8 28.18 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.927 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.461 HG22 ' HB2' ' A' ' 9' ' ' LYS . 41.7 t -121.25 131.08 73.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 175.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.413 ' HG2' ' HG2' ' A' ' 42' ' ' ARG . 40.4 ttp180 -109.84 116.72 32.17 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 176.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -89.47 120.62 30.95 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.47 ' HD3' ' OE1' ' A' ' 10' ' ' GLU . 12.8 mtm180 -120.9 115.7 23.73 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -178.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.503 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 4.1 p -112.96 124.4 69.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.425 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.464 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 77.7 t80 -101.09 124.01 46.14 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.56 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' A' ' 50' ' ' MET . 34.2 mt -77.24 107.34 9.57 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -67.37 -78.84 0.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -171.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 49' ' ' GLU . . . -126.13 119.74 3.53 Favored Glycine 0 CA--C 1.499 -0.908 0 C-N-CA 119.853 -1.165 . . . . 0.0 112.666 -175.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 72.18 -21.34 0.23 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.764 0.826 . . . . 0.0 111.308 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.508 ' H ' ' C ' ' A' ' 47' ' ' GLY . 14.9 mt-10 -61.94 -32.98 73.44 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.981 0.912 . . . . 0.0 110.623 178.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.522 ' HA ' HD12 ' A' ' 45' ' ' LEU . 44.3 ttm -63.61 -19.08 64.56 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.128 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.33 -13.62 61.14 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.913 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.424 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 32.3 m -140.78 101.27 6.52 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 121.334 0.588 . . . . 0.0 110.787 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 52' ' ' THR . 39.7 Cg_endo -68.7 -16.55 42.17 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.421 2.747 . . . . 0.0 112.321 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -58.48 -34.11 70.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.646 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.66 94.89 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.475 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.459 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -64.45 -40.98 98.19 Favored Glycine 0 CA--C 1.504 -0.654 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.859 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.8 t -66.26 -44.19 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 120.664 0.268 . . . . 0.0 110.734 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.2 -40.69 90.94 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.958 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.7 tp -61.89 -47.85 83.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.654 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.534 HD12 HG12 ' A' ' 84' ' ' VAL . 87.3 mt -65.26 -41.74 93.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.742 -178.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -64.49 -36.93 85.79 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.973 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -61.62 -43.53 98.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.464 0.65 . . . . 0.0 109.255 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.85 -44.12 96.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.462 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.419 ' CE3' HG13 ' A' ' 67' ' ' ILE . 50.8 t-105 -59.61 -35.84 75.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.377 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.6 m -60.3 -24.57 65.09 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.085 0.469 . . . . 0.0 110.85 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 92.6 mtp -91.55 -28.25 17.68 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.148 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.59 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 32.8 pt -111.27 16.07 8.11 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -176.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -21.21 66.52 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.426 0.631 . . . . 0.0 111.08 178.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.421 ' O ' ' HG2' ' A' ' 70' ' ' GLU . 3.2 p30 -73.93 134.97 43.24 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.093 178.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 69' ' ' ASN . 10.0 pt-20 54.57 5.9 0.1 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.811 1.244 . . . . 0.0 113.295 -176.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 67' ' ' ILE . . . -124.02 161.55 25.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.813 0.339 . . . . 0.0 110.691 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -140.14 150.46 44.28 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -83.36 122.35 28.35 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 118.655 -1.218 . . . . 0.0 109.711 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.512 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 16.5 t70 -81.44 -15.85 53.82 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.406 0.622 . . . . 0.0 109.421 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -159.97 156.39 27.04 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.075 -175.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -93.68 151.57 40.1 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 14.8 Cg_exo -63.81 132.65 35.75 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.519 1.479 . . . . 0.0 110.689 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 58.3 t30 -148.43 149.41 31.66 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.133 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -91.83 111.73 23.37 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -152.22 129.49 11.26 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.68 -178.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.26 25.57 74.15 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.448 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.462 ' HD2' ' SD ' ' A' ' 50' ' ' MET . 42.4 mmt180 70.13 8.36 6.63 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 123.883 0.873 . . . . 0.0 112.041 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.464 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 55.1 m-85 -117.74 144.55 45.19 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.273 176.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.534 HG12 HD12 ' A' ' 60' ' ' LEU . 91.1 t -98.65 110.57 26.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 171.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.55 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 9.6 p30 -111.44 146.01 37.97 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -172.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 63.8 ttp -145.08 138.01 26.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.252 175.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 17.0 mt -110.61 135.35 51.37 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 120.785 0.326 . . . . 0.0 111.483 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.407 ' CG2' ' HB ' ' A' ' 39' ' ' VAL . 14.2 m -120.05 132.95 68.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 121.337 0.589 . . . . 0.0 110.979 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.512 ' OG1' ' HB2' ' A' ' 74' ' ' ASP . 28.2 m -121.25 143.16 36.7 Favored Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.527 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 91.8 Cg_endo -71.84 154.95 58.63 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.926 1.751 . . . . 0.0 109.929 177.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.9 mttp . . . . . 0 C--N 1.321 -0.65 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.559 -179.928 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.566 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 27.1 t70 . . . . . 0 CA--C 1.512 -0.506 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 90.4 mt -88.95 129.1 40.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 120.992 0.425 . . . . 0.0 110.638 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -91.23 140.6 29.64 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-O 121.789 0.804 . . . . 0.0 111.43 -176.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.548 ' OE2' ' HD2' ' A' ' 42' ' ' ARG . 45.2 mt-10 -118.61 109.76 16.53 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.037 177.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 88.4 mt -93.14 118.98 40.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.63 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 62.3 tttm -88.82 136.68 32.88 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.643 0.735 . . . . 0.0 112.164 -177.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 46.4 mt -130.39 169.9 14.88 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.875 -178.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.499 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 19.9 m -128.7 149.84 50.52 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.0 t -64.41 -43.83 97.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.433 0.635 . . . . 0.0 109.755 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.495 ' HE2' ' O ' ' A' ' 46' ' ' LYS . 40.6 mttm -95.19 67.75 3.04 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.499 ' HB ' ' O ' ' A' ' 14' ' ' SER . 18.8 tt -101.5 148.5 7.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.758 -174.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.83 144.85 54.16 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.175 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -63.89 -39.68 94.76 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.804 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -63.85 -38.96 93.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.741 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -62.7 -37.98 88.61 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.85 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.52 ' O ' HG23 ' A' ' 26' ' ' VAL . 79.9 mt -61.37 -48.84 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 120.954 0.406 . . . . 0.0 110.456 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -61.95 -44.63 96.35 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.603 -177.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -62.73 -50.05 72.64 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.982 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -67.86 -43.58 79.09 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 22' ' ' ILE . 60.0 t -64.54 -42.26 94.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.914 0.387 . . . . 0.0 110.074 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.48 -44.44 97.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.211 176.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -37.46 87.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.765 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.513 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -57.04 -32.82 66.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.078 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.612 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 95.2 mt -61.41 -41.51 97.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.75 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 60.6 mt-10 -65.98 -36.7 84.02 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.379 -178.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -66.79 -37.09 83.89 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.156 0.503 . . . . 0.0 110.19 177.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 94.8 mt -62.67 -40.73 97.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.798 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.612 ' HG2' ' O ' ' A' ' 30' ' ' LEU . 51.8 mm-40 -59.3 -26.11 64.71 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.143 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 31' ' ' GLU . 74.0 mm-40 -77.39 -8.55 57.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.614 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.19 19.13 57.94 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.739 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.566 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 62.8 mttp -107.48 -178.3 3.59 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.337 0.589 . . . . 0.0 111.339 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.477 ' NE2' HG23 ' A' ' 89' ' ' THR . 7.2 m80 -113.35 146.22 39.8 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.386 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.8 t -114.78 127.59 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.386 175.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.486 ' HD2' ' OE2' ' A' ' 10' ' ' GLU . 42.4 ttm180 -111.61 113.03 25.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 177.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.621 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 93.3 m-85 -84.89 113.11 21.15 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.548 ' HD2' ' OE2' ' A' ' 10' ' ' GLU . 28.9 mtp180 -115.29 130.97 57.06 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.45 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.4 p -123.64 130.18 74.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-O 121.17 0.509 . . . . 0.0 110.626 -178.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.426 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 77.6 t80 -94.82 118.22 31.41 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.954 178.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.514 HD12 ' HA ' ' A' ' 50' ' ' MET . 35.1 mt -72.39 145.74 47.5 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.495 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 41.3 ttmt -142.4 118.0 10.37 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.924 -176.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.51 53.52 0.72 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.298 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 48' ' ' ARG . 41.0 ttm180 69.39 -0.82 2.41 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.781 0.433 . . . . 0.0 111.579 178.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.403 ' O ' HD13 ' A' ' 45' ' ' LEU . 38.0 mt-10 -70.63 1.45 5.24 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.514 ' HA ' HD12 ' A' ' 45' ' ' LEU . 1.5 mpt? -61.87 -34.51 76.13 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.135 0.493 . . . . 0.0 110.426 177.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.63 -8.19 55.6 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.111 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.1 m -124.23 92.08 48.69 Favored Pre-proline 0 N--CA 1.446 -0.645 0 CA-C-O 121.199 0.523 . . . . 0.0 111.063 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.406 ' O ' HG23 ' A' ' 57' ' ' VAL . 35.7 Cg_exo -64.5 -24.57 63.47 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.322 2.681 . . . . 0.0 111.529 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -56.76 -30.76 63.91 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.003 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.65 -38.79 82.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.027 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.16 -37.5 9.89 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.973 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 53' ' ' PRO . 63.5 t -63.85 -46.03 95.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.317 0.103 . . . . 0.0 111.141 -178.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.48 -37.47 87.43 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.031 0.443 . . . . 0.0 110.866 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.7 tp -62.01 -45.97 91.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.442 0.639 . . . . 0.0 109.759 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.517 HD13 ' HB2' ' A' ' 86' ' ' MET . 91.9 mt -67.2 -38.39 85.27 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.99 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -58.09 -39.9 79.74 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 121.074 -0.251 . . . . 0.0 110.606 177.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -60.63 -45.08 95.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.309 0.576 . . . . 0.0 109.76 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.25 -43.56 97.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.638 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -59.49 -37.49 78.41 Favored 'General case' 0 C--O 1.206 -1.201 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.991 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.2 m -61.34 -24.33 66.37 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.524 0.678 . . . . 0.0 110.69 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 97.0 mmm -84.11 -42.72 15.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.087 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.5 pt -105.23 8.08 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -173.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.91 -10.2 27.03 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -89.0 -53.35 4.63 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -96.02 -5.26 41.52 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -175.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -125.98 154.14 43.32 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.567 0.222 . . . . 0.0 110.483 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.58 ' OD1' ' HB ' ' A' ' 89' ' ' THR . 10.0 p30 -115.71 134.8 54.66 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.24 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -69.59 110.53 4.86 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.867 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.464 ' CB ' HD12 ' A' ' 87' ' ' LEU . 26.5 t70 -71.68 -46.46 58.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.197 0.522 . . . . 0.0 109.848 177.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -149.78 154.86 39.15 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.606 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.6 155.81 87.13 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.257 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -54.66 137.5 73.96 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.88 2.386 . . . . 0.0 112.56 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 49.7 t30 -128.44 150.07 50.29 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.409 -177.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -108.9 121.01 44.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.796 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -126.07 108.61 11.52 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.08 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.3 -78.91 0.31 Allowed Glycine 0 C--O 1.223 -0.544 0 C-N-CA 121.399 -0.429 . . . . 0.0 113.059 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.427 ' N ' ' HD2' ' A' ' 82' ' ' ARG . 0.6 OUTLIER -147.38 10.18 0.97 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.95 0.405 . . . . 0.0 110.605 178.1 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.426 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 89.2 m-85 -117.63 140.39 49.71 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.528 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.45 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 69.1 t -112.81 130.26 66.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 175.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.621 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 9.4 p30 -133.21 143.27 49.05 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -175.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.517 ' HB2' HD13 ' A' ' 60' ' ' LEU . 64.8 ttp -127.68 136.35 51.46 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.578 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.464 HD12 ' CB ' ' A' ' 74' ' ' ASP . 2.7 tm? -110.52 127.02 54.99 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.001 0.429 . . . . 0.0 109.853 -178.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.445 ' O ' ' HD2' ' A' ' 38' ' ' HIS . 19.1 m -120.1 134.27 64.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.138 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.58 ' HB ' ' OD1' ' A' ' 72' ' ' ASN . 21.1 m -102.0 136.21 19.53 Favored Pre-proline 0 C--N 1.31 -1.133 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.731 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.502 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 80.4 Cg_endo -68.83 144.16 58.11 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.714 2.276 . . . . 0.0 110.689 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 77.2 mttt . . . . . 0 N--CA 1.441 -0.894 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.95 179.459 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.6 t70 . . . . . 0 C--O 1.24 0.56 0 CA-C-O 120.821 0.344 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 88.7 mt -97.37 133.85 37.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.028 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -90.5 147.1 23.6 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.67 -175.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -125.83 132.16 52.29 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.693 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -120.54 112.12 34.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.403 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 40.3 ttmt -85.4 141.91 29.65 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.608 -176.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.5 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 36.6 mt -128.51 175.15 8.76 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.646 -175.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.8 p -149.93 153.69 37.05 Favored 'General case' 0 C--O 1.214 -0.815 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 176.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -70.22 -20.6 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-O 121.621 0.724 . . . . 0.0 110.321 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -89.05 15.76 8.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.714 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.4 tt -73.13 148.42 8.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.112 0.482 . . . . 0.0 111.362 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.97 152.53 21.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.186 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -63.49 -40.22 96.51 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -177.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -65.14 -29.67 70.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.029 0.443 . . . . 0.0 110.182 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -71.77 -38.85 70.29 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.328 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.54 -44.46 99.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -61.46 -41.66 97.58 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.331 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -65.51 -44.4 87.1 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.139 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -64.65 -41.81 95.86 Favored 'General case' 0 N--CA 1.461 0.088 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.0 m -62.95 -33.2 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.174 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -59.84 -48.27 82.36 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.879 0.371 . . . . 0.0 110.582 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -69.3 -37.05 77.63 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.462 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.487 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -59.39 -42.16 91.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.578 HD22 ' HB2' ' A' ' 70' ' ' GLU . 93.3 mt -62.27 -41.39 98.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.497 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 46.9 mt-10 -65.53 -38.12 88.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.472 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -70.28 -38.05 74.96 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.041 175.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.49 ' HB3' ' HB3' ' A' ' 90' ' ' PRO . 85.4 mt -62.29 -45.26 94.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.905 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -64.01 -18.45 64.33 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.895 0.379 . . . . 0.0 111.641 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 80.3 mt-30 -80.25 1.01 30.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.613 177.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.3 32.62 25.06 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -119.57 157.33 28.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.934 0.397 . . . . 0.0 111.066 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.481 ' NE2' HG23 ' A' ' 89' ' ' THR . 13.0 m170 -101.61 148.03 25.71 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.398 177.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.6 t -118.65 130.04 74.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.054 0.454 . . . . 0.0 109.994 176.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -108.29 115.46 30.15 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.665 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 73.9 m-85 -90.39 121.93 32.81 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.448 ' HG2' ' HB3' ' A' ' 85' ' ' ASN . 85.1 mtp180 -125.82 121.11 32.35 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.628 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 4.2 p -112.94 131.58 64.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.24 0.543 . . . . 0.0 111.556 -176.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.409 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 84.3 t80 -93.75 121.25 35.0 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.748 177.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.5 mt -84.79 85.53 7.44 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.302 0.572 . . . . 0.0 109.969 -178.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -66.06 129.6 40.36 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.06 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.64 -148.32 16.64 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.108 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -95.0 8.2 43.67 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.985 0.422 . . . . 0.0 110.286 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -63.84 -18.5 64.2 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.682 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 67.1 mtt -65.02 -10.32 28.74 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.53 -27.32 68.37 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-O 121.118 0.485 . . . . 0.0 110.387 176.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.4 t -129.99 109.51 16.85 Favored Pre-proline 0 N--CA 1.44 -0.948 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.832 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -63.77 -19.77 67.62 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.225 2.616 . . . . 0.0 112.075 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -60.32 -29.75 69.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.588 -177.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.34 -44.82 92.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.11 0.481 . . . . 0.0 110.364 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.537 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -69.86 -39.16 75.87 Favored Glycine 0 CA--C 1.506 -0.519 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.835 178.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.499 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 59.5 t -63.39 -44.7 99.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.628 0.251 . . . . 0.0 110.722 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.63 -37.91 83.01 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.343 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.4 tp -62.04 -45.44 93.53 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.495 HD13 ' HB2' ' A' ' 86' ' ' MET . 93.4 mt -65.71 -39.19 90.96 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.161 179.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 57' ' ' VAL . 61.8 mm-40 -55.83 -44.84 78.33 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.571 177.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -65.8 -42.49 90.62 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.162 0.506 . . . . 0.0 110.944 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.6 mt -64.77 -42.39 94.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.289 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -55.04 -45.21 75.21 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.043 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.0 p -66.58 -19.93 65.89 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.736 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 96.8 mmm -75.41 -38.54 59.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.556 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.9 pt -104.47 -7.58 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -174.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -58.5 -16.75 16.65 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.063 0.458 . . . . 0.0 111.904 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -64.38 -41.16 96.83 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.678 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.578 ' HB2' HD22 ' A' ' 30' ' ' LEU . 40.9 mt-10 -124.3 14.44 8.97 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.245 0.545 . . . . 0.0 110.914 -178.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.65 142.27 37.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.646 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -114.98 145.4 42.29 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.995 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.0 ttt-85 -70.89 121.77 18.72 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.385 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.425 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 26.2 t70 -93.63 -42.45 9.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.361 0.601 . . . . 0.0 109.998 176.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -144.33 157.67 44.15 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.796 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -86.12 154.11 57.39 Favored Pre-proline 0 C--N 1.316 -0.848 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.38 132.07 48.83 Favored 'Trans proline' 0 C--O 1.24 0.593 0 C-N-CA 122.674 2.249 . . . . 0.0 112.388 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -129.42 131.37 46.75 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.742 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.432 ' HB2' HG22 ' A' ' 84' ' ' VAL . 83.8 t80 -98.61 109.16 21.96 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.983 177.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -152.53 139.11 18.7 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.268 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.35 31.49 68.64 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.948 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 69.47 10.25 7.61 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 122.997 0.519 . . . . 0.0 112.14 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 56.3 m-85 -126.12 144.02 50.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.746 178.074 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.628 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 91.7 t -102.28 122.89 55.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 173.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.665 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 7.0 p30 -129.75 146.69 51.5 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -173.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.495 ' HB2' HD13 ' A' ' 60' ' ' LEU . 64.0 ttp -139.85 143.78 36.93 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.848 178.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 16.1 mt -107.6 129.76 54.96 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.475 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.6 m -122.06 135.33 62.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.562 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.481 HG23 ' NE2' ' A' ' 38' ' ' HIS . 17.9 m -108.89 143.15 27.0 Favored Pre-proline 0 C--N 1.306 -1.292 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.202 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.49 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 46.7 Cg_endo -63.73 143.57 86.96 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.256 1.971 . . . . 0.0 111.179 178.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt . . . . . 0 C--N 1.324 -0.543 0 CA-C-O 121.354 0.597 . . . . 0.0 111.945 -179.736 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--O 1.237 0.398 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.6 p -87.65 -18.84 8.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.556 0.693 . . . . 0.0 110.394 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 90.7 mt -85.18 108.6 17.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.704 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -91.11 127.99 36.75 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.22 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.455 HG12 ' HB2' ' A' ' 38' ' ' HIS . 77.5 mt -119.44 132.16 70.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-O 120.845 0.355 . . . . 0.0 111.272 -175.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 74.2 mmtt -97.45 130.59 44.54 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.441 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 43.2 mt-10 -107.83 97.65 7.34 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.8 mt -88.74 125.09 41.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.639 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -96.98 145.87 25.52 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.197 -176.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.538 HD22 HD11 ' A' ' 63' ' ' ILE . 5.5 mp -135.69 176.89 8.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.279 173.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.468 ' HA ' HG23 ' A' ' 43' ' ' VAL . 16.2 p -139.1 156.22 47.32 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.85 -42.94 94.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.238 0.542 . . . . 0.0 109.995 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -95.33 76.46 3.4 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.516 HD11 ' OD2' ' A' ' 21' ' ' ASP . 19.3 tt -125.38 148.5 29.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.114 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.6 142.09 44.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.161 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -64.52 -33.73 76.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.955 0.407 . . . . 0.0 110.976 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.49 -40.71 92.35 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.526 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.516 ' OD2' HD11 ' A' ' 17' ' ' ILE . 23.2 t70 -66.6 -39.08 88.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.574 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.3 mt -62.92 -45.66 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.167 0.508 . . . . 0.0 110.271 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -61.1 -42.51 98.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.494 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -63.14 -44.32 95.89 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.954 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -64.93 -41.64 95.36 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 m -63.8 -28.83 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.508 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -60.06 -49.8 76.21 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 120.99 0.424 . . . . 0.0 110.49 176.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -68.3 -36.75 79.81 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.312 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.585 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -56.41 -45.62 80.56 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.025 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.639 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 88.9 mt -62.67 -42.83 99.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.073 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.01 -39.95 95.25 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.67 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -68.39 -34.43 76.02 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.931 0.396 . . . . 0.0 111.125 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 95.0 mt -63.6 -39.85 95.43 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.639 ' HG3' ' O ' ' A' ' 30' ' ' LEU . 63.3 mt-10 -61.02 -22.71 64.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.546 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -85.13 -6.35 59.3 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.59 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.05 19.61 55.29 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.706 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -105.81 172.41 6.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.173 0.511 . . . . 0.0 111.2 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.455 ' HB2' HG12 ' A' ' 8' ' ' ILE . 12.3 m80 -104.82 145.57 30.2 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.02 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.528 ' O ' HD12 ' A' ' 87' ' ' LEU . 41.5 t -118.33 125.71 74.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.441 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 71.2 ttt180 -102.74 115.19 30.1 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -90.2 116.64 28.35 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -122.45 132.99 54.61 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.592 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 4.9 p -128.26 131.29 69.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 121.061 0.458 . . . . 0.0 110.31 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.451 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 88.0 t80 -104.58 129.14 52.71 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.494 ' CD1' ' HA ' ' A' ' 50' ' ' MET . 30.0 mt -73.49 128.02 34.34 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -60.5 -46.2 90.99 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -171.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.63 -61.55 0.15 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.163 -1.018 . . . . 0.0 112.671 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.417 ' HD2' ' N ' ' A' ' 48' ' ' ARG . 6.6 mpt_? -67.05 -37.32 83.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.141 0.496 . . . . 0.0 111.512 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.501 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 1.1 pm0 -80.45 -3.95 51.83 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.952 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.494 ' HA ' ' CD1' ' A' ' 45' ' ' LEU . 56.3 ttm -63.21 -19.68 64.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.871 0.367 . . . . 0.0 111.351 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.51 -11.1 59.82 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.251 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.0 m -131.19 100.06 17.25 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 121.153 0.501 . . . . 0.0 111.449 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.34 -25.71 71.42 Favored 'Trans proline' 0 N--CA 1.477 0.504 0 C-N-CA 123.505 2.803 . . . . 0.0 112.511 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -63.07 -25.5 68.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.523 -177.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.3 -44.96 94.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.881 0.372 . . . . 0.0 110.32 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.1 -38.38 92.29 Favored Glycine 0 CA--C 1.506 -0.474 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.614 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.504 HG13 ' HG2' ' A' ' 77' ' ' PRO . 99.1 t -62.74 -47.3 93.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.516 -0.342 . . . . 0.0 110.831 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.09 -37.79 88.62 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.042 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.4 ' O ' HG13 ' A' ' 63' ' ' ILE . 39.9 tp -62.57 -47.58 83.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.071 0.463 . . . . 0.0 110.239 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.562 HD12 HG12 ' A' ' 84' ' ' VAL . 62.1 mt -66.15 -39.6 89.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.666 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 57' ' ' VAL . 71.1 mt-10 -60.58 -36.66 79.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.684 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 66' ' ' MET . 86.0 tttt -63.84 -39.91 95.35 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.538 HD11 HD22 ' A' ' 13' ' ' LEU . 65.9 mt -61.7 -47.73 91.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.789 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.489 ' CZ2' ' HB2' ' A' ' 73' ' ' ARG . 40.3 t-105 -58.04 -40.64 81.4 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.414 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.45 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 19.0 m -61.28 -39.76 91.61 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.082 0.467 . . . . 0.0 110.728 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' A' ' 62' ' ' LYS . 97.3 mmm -66.78 -41.98 86.79 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.4 pt -105.06 -0.26 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -173.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 65' ' ' THR . 0.1 OUTLIER -56.31 -18.68 11.44 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.675 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -65.71 -36.55 83.93 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.523 ' HB2' HD22 ' A' ' 30' ' ' LEU . 47.8 mt-10 -122.75 6.09 9.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.801 0.334 . . . . 0.0 111.598 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -121.18 152.47 38.75 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.959 0.409 . . . . 0.0 111.752 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -112.23 148.37 34.25 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.489 ' HB2' ' CZ2' ' A' ' 64' ' ' TRP . 74.9 ttt180 -90.94 111.12 22.42 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 120.763 0.316 . . . . 0.0 111.102 -176.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -72.71 -38.73 67.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.8 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -163.28 -177.8 5.56 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.902 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.473 ' HG2' ' NH2' ' A' ' 73' ' ' ARG . 42.4 mt-10 -91.92 150.62 40.97 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.971 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.504 ' HG2' HG13 ' A' ' 57' ' ' VAL . 34.7 Cg_endo -68.99 132.26 24.17 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.106 1.871 . . . . 0.0 110.541 174.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.443 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 62.7 t30 -147.63 151.49 36.3 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.82 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.51 ' CE1' ' HA ' ' A' ' 82' ' ' ARG . 91.1 t80 -86.87 115.48 24.31 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.744 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.97 109.74 3.65 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.181 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.54 31.57 21.38 Favored Glycine 0 C--O 1.223 -0.559 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.327 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.51 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . 96.4 mtt180 69.25 3.49 4.14 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.749 0.82 . . . . 0.0 112.15 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 89.7 m-85 -121.12 137.58 54.59 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.427 174.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.592 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 74.2 t -99.86 124.09 53.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -130.84 142.76 50.4 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -175.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.467 ' SD ' HG13 ' A' ' 88' ' ' VAL . 16.4 tmm? -135.1 143.21 46.49 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.167 176.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.528 HD12 ' O ' ' A' ' 39' ' ' VAL . 47.9 tp -122.57 140.5 52.72 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.104 0.478 . . . . 0.0 111.438 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.467 HG13 ' SD ' ' A' ' 86' ' ' MET . 17.8 m -122.85 133.63 68.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.701 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.438 HG23 ' CE1' ' A' ' 38' ' ' HIS . 18.1 m -98.74 136.88 20.56 Favored Pre-proline 0 C--N 1.312 -1.022 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.75 144.8 84.97 Favored 'Trans proline' 0 C--N 1.326 -0.64 0 C-N-CA 122.336 2.024 . . . . 0.0 111.088 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -78.69 -3.3 43.41 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.483 0.659 . . . . 0.0 111.441 -176.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -91.2 13.92 15.76 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.83 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.38 168.92 19.19 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.686 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 66.27 24.12 10.71 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.03 -39.52 93.1 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 175.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 65.83 -48.33 0.4 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.726 1.21 . . . . 0.0 113.731 177.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -112.64 -4.29 14.14 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.049 0.452 . . . . 0.0 110.582 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -84.68 69.82 10.7 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.311 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 31.6 p80 -163.04 144.09 9.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.559 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 83.5 t60 64.09 110.3 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.525 0.73 . . . . 0.0 111.838 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.105 179.217 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.0 pttm . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.48 -42.95 91.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-O 121.83 0.824 . . . . 0.0 109.563 175.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.4 mm -96.64 124.21 49.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.631 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.471 ' HB2' ' HD2' ' A' ' 37' ' ' LYS . 16.2 m-20 -73.58 100.87 3.43 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-O 121.195 0.521 . . . . 0.0 110.833 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.458 HG12 ' HB2' ' A' ' 38' ' ' HIS . 79.8 mt -109.13 116.05 51.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.43 ' HE2' ' HB3' ' A' ' 7' ' ' ASP . 3.5 mptp? -83.87 134.73 34.68 Favored 'General case' 0 CA--C 1.488 -1.427 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.675 -175.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.415 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 59.9 mt-10 -102.57 112.02 24.59 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.594 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.7 mt -104.11 115.09 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.099 177.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 86.5 tttt -96.58 141.28 30.03 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.991 -175.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 5.5 mp -135.52 171.21 14.78 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.868 175.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.8 m -132.5 154.18 50.19 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.616 ' HB ' ' OE1' ' A' ' 49' ' ' GLU . 86.0 t -63.53 -33.53 62.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.338 0.59 . . . . 0.0 109.777 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.516 ' HG3' ' OE2' ' A' ' 49' ' ' GLU . 65.2 mttp -97.38 76.65 2.59 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.0 tt -134.55 154.0 36.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.751 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.74 143.74 49.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.186 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -64.46 -30.2 71.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.215 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -63.28 -39.05 93.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.644 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.9 -43.08 99.58 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.089 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.1 mt -62.16 -44.83 99.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.774 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -62.12 -43.67 98.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.239 0.542 . . . . 0.0 111.625 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -64.58 -43.27 94.4 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.496 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -65.24 -42.18 93.63 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.421 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 12.9 m -63.22 -33.17 59.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.004 178.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -62.52 -41.47 98.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.454 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -67.42 -42.49 83.12 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.599 177.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.531 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -60.01 -38.84 83.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.124 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 26' ' ' VAL . 97.4 mt -62.02 -41.77 98.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.026 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.617 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 67.0 mm-40 -65.3 -43.04 92.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.549 0.214 . . . . 0.0 110.714 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -64.02 -38.04 89.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.521 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 96.7 mt -62.18 -43.57 98.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.452 0.644 . . . . 0.0 109.435 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -61.64 -22.81 65.59 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.257 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.617 ' HG2' ' O ' ' A' ' 31' ' ' GLU . 76.5 mm-40 -85.13 -8.5 58.6 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.934 0.397 . . . . 0.0 110.528 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.42 13.72 56.74 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.024 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.471 ' HD2' ' HB2' ' A' ' 7' ' ' ASP . 75.7 mmtt -96.29 159.74 14.79 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.484 ' NE2' HG23 ' A' ' 89' ' ' THR . 23.6 m170 -107.85 147.29 31.13 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.476 ' O ' HD12 ' A' ' 87' ' ' LEU . 41.5 t -114.29 126.43 71.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.415 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 41.6 ttm180 -102.78 115.87 31.45 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -92.61 120.11 32.72 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 78.1 mtp180 -126.71 133.77 50.83 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.604 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.2 p -121.37 131.6 72.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 121.359 0.599 . . . . 0.0 111.217 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -101.26 124.37 46.84 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.849 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 49' ' ' GLU . 42.1 mt -76.24 133.61 40.06 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -112.31 116.81 30.98 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.082 0.467 . . . . 0.0 112.082 -174.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.48 -134.14 12.21 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.476 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 -74.84 -6.66 50.29 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.021 0.438 . . . . 0.0 110.817 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.616 ' OE1' ' HB ' ' A' ' 15' ' ' VAL . 99.5 mt-10 -60.35 -24.17 64.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.971 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 91.1 mtp -62.56 -29.27 70.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.528 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.49 -10.21 59.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.868 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.454 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 24.0 m -128.26 95.17 34.17 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-O 121.484 0.659 . . . . 0.0 111.456 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' A' ' 52' ' ' THR . 37.9 Cg_endo -68.0 -18.09 46.18 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.296 2.664 . . . . 0.0 111.944 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -62.7 -31.67 72.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.936 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.74 -41.07 97.16 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.219 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.47 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -64.88 -38.4 95.48 Favored Glycine 0 CA--C 1.504 -0.625 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.813 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.466 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 99.4 t -63.66 -45.93 96.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 120.839 0.352 . . . . 0.0 110.413 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.17 -41.45 96.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.38 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.544 ' O ' HG13 ' A' ' 63' ' ' ILE . 44.5 tp -63.89 -47.24 81.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.785 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.551 HD12 HG12 ' A' ' 84' ' ' VAL . 82.8 mt -64.41 -41.18 96.77 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.938 -177.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 57' ' ' VAL . 5.5 mm-40 -64.36 -35.74 81.88 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.52 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -63.81 -40.75 97.37 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 59' ' ' LEU . 65.9 mt -64.47 -44.98 97.02 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.865 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 57.2 t-105 -58.43 -38.15 76.87 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.599 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.9 m -57.44 -38.91 75.19 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.338 0.589 . . . . 0.0 110.225 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 98.1 mmm -67.32 -40.67 85.97 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.731 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.9 pt -102.02 -6.25 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -174.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -58.54 -21.13 51.52 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.074 0.464 . . . . 0.0 111.328 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -64.57 -33.25 75.48 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.306 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.518 ' HA ' ' HE3' ' A' ' 91' ' ' LYS . 73.3 mm-40 -131.94 6.5 4.29 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -122.0 157.56 31.07 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.957 0.408 . . . . 0.0 111.324 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -111.72 150.78 29.74 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -94.79 113.13 24.85 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 120.717 0.294 . . . . 0.0 111.172 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -77.96 -44.89 25.46 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.334 0.588 . . . . 0.0 110.422 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -145.68 149.99 35.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.332 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.46 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 9.9 pt-20 -80.38 163.15 58.39 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.402 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.629 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 29.9 Cg_endo -62.68 138.5 69.94 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 121.814 1.676 . . . . 0.0 111.981 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.585 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 23.3 p-10 -144.84 156.89 44.26 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.004 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -105.78 108.41 19.9 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.039 0.447 . . . . 0.0 110.487 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -123.33 120.08 31.99 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.511 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.72 -102.7 1.24 Allowed Glycine 0 N--CA 1.432 -1.619 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.683 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -127.17 7.13 6.5 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.738 0.304 . . . . 0.0 110.796 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -125.84 143.87 50.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.88 0.372 . . . . 0.0 111.844 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.604 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 92.3 t -99.54 124.9 53.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 172.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.629 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 10.8 m-80 -119.55 144.43 47.07 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -172.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 13.1 tmm? -145.03 132.31 20.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.476 HD12 ' O ' ' A' ' 39' ' ' VAL . 49.8 tp -114.91 142.74 46.18 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.062 0.458 . . . . 0.0 111.917 -175.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.0 m -124.92 158.71 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.27 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.484 HG23 ' NE2' ' A' ' 38' ' ' HIS . 25.3 m -131.86 143.51 49.37 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.429 ' HD2' ' CG2' ' A' ' 89' ' ' THR . 74.1 Cg_endo -68.17 153.86 73.7 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 122.15 1.9 . . . . 0.0 110.852 177.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' A' ' 70' ' ' GLU . 97.2 mttt -65.04 85.91 0.05 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -100.66 -25.67 14.07 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.393 0.616 . . . . 0.0 109.485 175.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.92 79.61 1.47 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.037 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -94.4 -56.16 2.91 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -86.36 65.99 3.73 Favored Glycine 0 N--CA 1.438 -1.185 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -77.34 -55.42 5.41 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.18 0.514 . . . . 0.0 110.142 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 40.7 p-80 -121.95 124.59 44.4 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.11 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 26.5 p-80 -156.34 -43.53 0.07 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.441 -177.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -120.08 115.2 23.23 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -148.13 162.27 39.75 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 71.9 m80 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.664 178.718 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.645 HG12 ' H ' ' A' ' 6' ' ' ILE . 1.6 t -129.67 -173.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -177.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.645 ' H ' HG12 ' A' ' 5' ' ' VAL . 84.4 mt -69.78 134.08 30.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.078 0.466 . . . . 0.0 110.907 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.526 ' OD2' ' HE2' ' A' ' 9' ' ' LYS . 7.7 t70 -70.45 119.83 15.2 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.184 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 87.1 mt -127.07 136.79 59.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.503 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.526 ' HE2' ' OD2' ' A' ' 7' ' ' ASP . 4.1 mptp? -101.55 157.82 16.54 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-O 121.793 0.806 . . . . 0.0 112.65 -177.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.444 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 46.0 mt-10 -124.74 123.23 39.54 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.848 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.9 mt -109.13 114.6 47.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 87.7 tttt -98.72 135.52 40.08 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.139 -174.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.639 HD22 HD11 ' A' ' 63' ' ' ILE . 5.5 mp -132.07 -177.09 4.29 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.61 177.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.403 ' HA ' HG23 ' A' ' 43' ' ' VAL . 22.4 p -143.73 156.51 44.55 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.512 ' HB ' ' OE2' ' A' ' 49' ' ' GLU . 79.8 t -63.67 -44.02 98.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.706 ' HG2' ' OE2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -85.48 71.29 10.8 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 173.395 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.444 HD11 ' OD2' ' A' ' 21' ' ' ASP . 16.7 tt -122.62 160.67 24.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.864 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.73 147.12 24.04 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.12 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -63.52 -33.53 75.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.014 0.435 . . . . 0.0 110.283 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -62.28 -40.54 96.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.389 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 21.1 t70 -66.9 -34.79 78.56 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.839 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.8 mt -61.77 -41.55 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.261 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -58.13 -43.6 87.37 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.752 0.787 . . . . 0.0 109.795 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.403 ' HB3' ' O ' ' A' ' 21' ' ' ASP . 57.9 t80 -61.88 -43.96 97.78 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.689 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 74.2 mmtt -61.96 -46.88 87.33 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.246 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.416 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 9.7 m -71.35 -32.96 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -60.76 -42.56 97.68 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.022 0.439 . . . . 0.0 109.94 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -73.38 -36.79 66.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.273 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.486 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -58.98 -38.49 79.24 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.193 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.427 ' HA ' HD12 ' A' ' 33' ' ' LEU . 96.7 mt -61.4 -39.54 91.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.527 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 61.8 mt-10 -65.54 -40.52 92.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.169 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -65.95 -37.65 86.58 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.117 0.484 . . . . 0.0 110.598 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 90' ' ' PRO . 97.2 mt -62.49 -42.2 99.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.068 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -57.62 -25.17 59.72 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.908 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 31' ' ' GLU . 64.1 mm-40 -84.05 -8.96 58.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.008 0.432 . . . . 0.0 110.67 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.79 9.97 63.6 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.267 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -101.84 174.0 6.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.01 0.433 . . . . 0.0 111.865 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -104.73 150.32 24.85 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.519 -176.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.2 t -116.06 125.05 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.018 173.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.444 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 40.0 ttm180 -100.68 111.97 24.3 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.506 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 63.5 m-85 -89.69 125.68 35.36 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 81.6 mtp180 -132.02 139.77 48.7 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.602 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.5 p -121.36 133.45 67.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 121.126 0.488 . . . . 0.0 110.891 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -101.72 125.9 48.47 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.633 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 50' ' ' MET . 33.0 mt -87.09 111.82 21.3 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.8 -44.99 84.02 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 49' ' ' GLU . . . 168.01 141.04 3.07 Favored Glycine 0 N--CA 1.434 -1.437 0 C-N-CA 120.118 -1.039 . . . . 0.0 111.709 -177.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 72.44 -10.24 0.95 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.54 0.686 . . . . 0.0 110.23 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.706 ' OE2' ' HG2' ' A' ' 16' ' ' LYS . 61.0 mt-10 -90.3 -17.85 26.65 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.458 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.416 ' HA ' HD13 ' A' ' 45' ' ' LEU . 96.3 mtp -70.26 -16.11 62.99 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.767 -177.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.36 -34.64 78.15 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.193 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.2 p -130.23 96.52 24.76 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.392 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -67.12 -14.37 43.1 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 123.509 2.806 . . . . 0.0 112.405 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.41 ' OE2' ' HB2' ' A' ' 58' ' ' ALA . 8.4 tm-20 -56.99 -35.01 68.71 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.649 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.43 -36.59 71.56 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.876 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.45 -42.22 97.67 Favored Glycine 0 CA--C 1.504 -0.602 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.96 -43.75 89.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.41 ' HB2' ' OE2' ' A' ' 54' ' ' GLU . . . -60.66 -40.05 90.62 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.136 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.6 tp -61.91 -45.91 91.66 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.448 HD12 HG12 ' A' ' 84' ' ' VAL . 88.1 mt -65.76 -39.02 90.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.292 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -59.49 -43.82 93.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.118 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -63.1 -40.8 98.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.639 HD11 HD22 ' A' ' 13' ' ' LEU . 96.2 mt -63.5 -43.9 98.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.041 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.7 t-105 -58.55 -42.95 89.03 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.776 -178.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.555 ' HA ' ' OE2' ' A' ' 68' ' ' GLU . 22.4 p -64.4 -16.33 62.15 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 68.1 mtt -89.9 -48.52 7.17 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.156 0.503 . . . . 0.0 111.232 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.2 pt -86.0 -14.87 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -174.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.555 ' OE2' ' HA ' ' A' ' 65' ' ' THR . 14.0 pt-20 -57.48 -14.8 5.48 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -63.48 -41.57 98.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.476 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -117.89 -4.4 11.11 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.163 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.454 ' HB2' HD13 ' A' ' 33' ' ' LEU . . . -119.68 146.99 45.1 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.47 -177.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -113.26 138.23 50.31 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -69.58 109.94 4.55 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-O 121.245 0.545 . . . . 0.0 111.359 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.4 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 10.2 t70 -77.94 -42.91 31.45 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.098 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -146.22 137.12 24.35 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.054 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -64.83 157.37 75.36 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.63 178.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 23.4 Cg_exo -61.82 142.35 93.28 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 122.06 1.84 . . . . 0.0 111.577 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -141.39 140.68 33.74 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.423 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -99.11 116.13 30.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.917 0.389 . . . . 0.0 110.418 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -134.49 128.89 34.29 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.74 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.85 -94.42 0.6 Allowed Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.803 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -140.97 6.89 2.01 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.66 0.743 . . . . 0.0 109.41 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -119.33 143.81 47.19 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.717 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.602 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 68.8 t -106.28 123.31 60.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 172.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.538 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 8.6 p30 -125.86 149.63 48.51 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -174.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 64.6 ttp -140.87 141.43 34.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.513 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.0 mt -109.75 131.65 54.87 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.024 0.44 . . . . 0.0 111.692 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.7 m -122.95 136.44 59.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.628 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.454 ' CG2' ' HD2' ' A' ' 90' ' ' PRO . 24.4 m -116.07 140.18 26.02 Favored Pre-proline 0 C--N 1.307 -1.276 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.357 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.521 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 72.1 Cg_endo -68.0 152.51 76.71 Favored 'Trans proline' 0 C--O 1.237 0.463 0 C-N-CA 122.815 2.343 . . . . 0.0 111.772 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -77.62 65.09 3.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.199 0.523 . . . . 0.0 110.841 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -66.07 -40.7 91.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.114 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.07 103.89 8.29 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.098 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -137.35 101.85 4.63 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -92.01 125.73 8.2 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.869 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -95.45 81.07 3.53 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -127.0 109.78 12.27 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.185 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 -121.01 159.84 24.8 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -67.05 120.45 13.69 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -71.89 101.57 2.69 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.983 -177.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 26.5 p-80 . . . . . 0 C--N 1.315 -0.913 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.063 178.664 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 121.125 0.488 . . . . 0.0 110.022 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.7 t -92.74 -22.47 5.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.677 0.751 . . . . 0.0 111.218 -177.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.2 mt -113.9 132.16 63.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.278 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -69.01 111.34 4.95 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.114 0.483 . . . . 0.0 109.915 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.477 HG12 ' HB2' ' A' ' 38' ' ' HIS . 71.1 mt -95.05 134.5 32.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.715 -178.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.41 ' HG3' ' CD1' ' A' ' 32' ' ' PHE . 66.4 mmtt -85.71 127.05 34.41 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.83 -176.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -102.55 115.51 30.71 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 120.868 0.366 . . . . 0.0 110.363 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.0 mt -108.81 116.21 51.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.604 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -98.25 137.43 37.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.135 -175.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.492 HD22 HD11 ' A' ' 63' ' ' ILE . 5.5 mp -128.93 179.12 5.91 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.019 176.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 p -135.91 151.66 50.21 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.579 HG11 ' HG2' ' A' ' 49' ' ' GLU . 49.0 t -66.98 -25.6 34.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.383 0.611 . . . . 0.0 110.158 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.565 ' HE2' ' O ' ' A' ' 46' ' ' LYS . 64.6 mttm -103.29 72.37 1.15 Allowed 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 174.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.5 tt -126.84 153.42 35.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.124 -178.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.407 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -92.57 159.97 15.24 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -62.78 -33.09 74.45 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 120.948 0.404 . . . . 0.0 110.315 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -59.25 -45.05 92.22 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.242 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.4 -39.59 74.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.174 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.62 ' O ' HG23 ' A' ' 26' ' ' VAL . 75.7 mt -60.79 -51.43 73.23 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -60.39 -42.36 95.73 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.982 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -64.3 -47.25 80.17 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.99 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -66.78 -42.91 85.29 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 22' ' ' ILE . 60.1 t -63.89 -29.63 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.473 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.05 -41.92 97.49 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 177.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -68.41 -34.29 75.74 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.682 178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.583 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -55.6 -45.25 77.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.238 -178.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.0 mt -62.76 -38.93 92.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.988 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -59.71 -46.23 89.74 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.172 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.41 ' CD1' ' HG3' ' A' ' 9' ' ' LYS . 84.2 m-85 -68.0 -34.78 77.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.82 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 95.0 mt -61.97 -43.01 99.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.287 0.565 . . . . 0.0 110.015 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -59.84 -34.45 73.12 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.596 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -69.4 -18.86 63.8 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.182 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.52 27.02 10.17 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.967 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -112.05 162.85 14.95 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.988 0.423 . . . . 0.0 110.519 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.477 ' HB2' HG12 ' A' ' 8' ' ' ILE . 5.4 m80 -97.53 146.7 25.0 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.7 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.3 t -115.27 129.56 71.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.635 176.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -108.4 112.25 24.58 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 97.4 m-85 -85.78 127.33 34.52 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.724 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 71.4 mtp85 -127.19 131.24 50.71 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.263 -176.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.6 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 5.9 p -130.0 137.05 57.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.106 0.479 . . . . 0.0 110.764 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.446 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 93.3 t80 -104.53 131.21 52.18 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.467 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.4 mt -80.21 85.32 5.75 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.129 0.49 . . . . 0.0 110.411 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.565 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 63.9 tttp -88.77 126.03 35.15 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.132 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.03 -154.94 16.35 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -77.81 -7.21 56.31 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.056 0.455 . . . . 0.0 110.68 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.579 ' HG2' HG11 ' A' ' 15' ' ' VAL . 2.3 mp0 -60.08 -13.61 12.67 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.594 178.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 10.3 mmt -59.33 -20.65 56.31 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.79 0.329 . . . . 0.0 111.361 177.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.45 -5.5 59.29 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.478 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.4 m -138.49 102.59 7.93 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-O 121.175 0.512 . . . . 0.0 111.455 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.28 -20.2 49.31 Favored 'Trans proline' 0 C--N 1.331 -0.369 0 C-N-CA 123.26 2.64 . . . . 0.0 111.76 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -64.04 -22.64 67.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.206 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.19 -45.17 91.77 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.96 0.409 . . . . 0.0 110.382 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.62 -38.86 93.61 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.941 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.1 t -64.12 -43.92 97.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 61' ' ' GLU . . . -63.66 -39.45 94.36 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.223 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.407 ' O ' HG13 ' A' ' 63' ' ' ILE . 38.8 tp -64.51 -47.23 79.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.091 0.472 . . . . 0.0 110.437 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.612 HD12 HG12 ' A' ' 84' ' ' VAL . 47.7 mt -66.6 -40.92 89.1 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.586 -177.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -64.09 -31.73 73.02 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.286 179.175 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -65.01 -40.89 95.56 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.579 HG23 HG22 ' A' ' 26' ' ' VAL . 75.9 mt -65.53 -44.17 94.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.688 177.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 17.1 t-105 -55.76 -41.54 74.14 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.616 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.1 p -71.63 -12.74 61.5 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 98.0 mmm -87.21 -31.99 20.02 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.233 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.409 HG23 HG13 ' A' ' 26' ' ' VAL . 32.7 pt -108.15 -1.9 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -174.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -12.21 9.17 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -63.35 -46.89 84.47 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.407 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -119.43 0.89 11.17 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.87 0.367 . . . . 0.0 111.589 -174.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.57 ' HB2' HD13 ' A' ' 33' ' ' LEU . . . -125.26 149.81 47.67 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.178 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -114.17 131.73 56.34 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -72.53 106.67 4.69 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.24 -35.28 77.69 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.515 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -156.45 148.75 23.36 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.772 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.457 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 1.6 mp0 -62.27 162.28 19.91 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.499 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.401 ' HB3' HD12 ' A' ' 60' ' ' LEU . 31.9 Cg_exo -59.05 144.79 99.22 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.348 2.032 . . . . 0.0 112.375 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -130.0 132.46 46.28 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.934 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -93.08 107.42 19.21 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -127.77 132.04 49.56 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.758 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.13 -109.83 3.13 Favored Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.385 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -124.85 9.86 8.24 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.179 0.514 . . . . 0.0 109.998 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.446 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 73.0 m-85 -125.0 144.5 50.35 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.306 -177.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.612 HG12 HD12 ' A' ' 60' ' ' LEU . 87.5 t -100.89 122.07 52.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 173.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.724 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 39.7 m-80 -114.61 144.64 43.08 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.764 -173.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.557 ' HB2' HD13 ' A' ' 60' ' ' LEU . 63.7 ttp -139.62 130.04 25.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.312 175.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 17.4 mt -108.99 129.73 55.45 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.25 0.547 . . . . 0.0 111.623 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.73 135.66 62.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.928 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.418 HG23 ' CE1' ' A' ' 38' ' ' HIS . 16.1 m -102.28 134.11 20.2 Favored Pre-proline 0 C--N 1.307 -1.251 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.487 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 56.0 Cg_endo -66.39 135.76 40.79 Favored 'Trans proline' 0 C--N 1.327 -0.555 0 C-N-CA 121.884 1.723 . . . . 0.0 110.201 177.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -65.28 -39.77 92.99 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.24 0.543 . . . . 0.0 112.286 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -95.43 -74.39 0.55 Allowed 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.467 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.435 ' HB2' ' HG2' ' A' ' 90' ' ' PRO . . . 62.62 -90.98 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.74 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -137.23 135.11 36.94 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -100.13 -38.56 3.53 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.692 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -91.32 -179.82 5.5 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 51.5 t60 74.87 -16.4 0.56 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.394 0.677 . . . . 0.0 111.625 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -66.0 -35.29 80.17 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.344 0.592 . . . . 0.0 110.264 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -90.41 30.01 1.19 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.603 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.7 m80 74.11 -73.76 0.09 Allowed 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 123.963 0.905 . . . . 0.0 110.657 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.87 -179.964 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? . . . . . 0 N--CA 1.469 0.512 0 CA-C-O 121.217 0.532 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 t -107.71 -10.0 10.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.571 0.7 . . . . 0.0 110.856 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 92.6 mt -79.81 101.16 4.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.333 0.587 . . . . 0.0 110.103 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -78.35 115.18 17.88 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.467 HG12 ' HB2' ' A' ' 38' ' ' HIS . 69.3 mt -91.49 119.31 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.771 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.45 ' HG3' ' CD1' ' A' ' 32' ' ' PHE . 73.1 mmtt -89.22 126.69 35.6 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.936 -174.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.456 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 59.3 mt-10 -102.14 110.72 22.76 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.569 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.0 mt -94.23 107.94 20.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 47.6 tttm -98.32 122.87 42.04 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.593 -175.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.419 HD21 ' HG3' ' A' ' 25' ' ' LYS . 79.9 mt -122.65 179.36 4.63 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.517 -178.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.1 m -131.62 151.98 51.19 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.2 t -63.69 -40.98 91.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.331 0.586 . . . . 0.0 109.793 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -78.03 50.38 0.88 Allowed 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.323 176.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.2 tt -106.34 160.03 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.706 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.45 146.51 28.37 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 175.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.421 HE22 ' HD3' ' A' ' 62' ' ' LYS . 58.7 tp60 -63.75 -36.43 83.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.949 0.404 . . . . 0.0 111.512 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -63.91 -35.97 82.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.977 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.595 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 29.0 t70 -65.51 -35.23 80.25 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.884 0.373 . . . . 0.0 110.752 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.3 mt -61.32 -41.57 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.109 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -58.4 -41.92 86.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.887 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -63.86 -43.22 96.76 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.167 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.595 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 75.8 mmtt -61.53 -46.51 89.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.664 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.487 ' CG1' HG23 ' A' ' 63' ' ' ILE . 4.2 m -66.71 -40.82 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 111.791 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.56 -42.7 98.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.083 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -80.04 -25.5 40.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.696 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.419 ' O ' HD13 ' A' ' 33' ' ' LEU . . . -63.68 -37.1 86.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.034 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.536 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 65.7 mt -62.14 -33.53 74.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.689 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -57.76 -41.45 82.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.352 . . . . 0.0 110.116 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.45 ' CD1' ' HG3' ' A' ' 9' ' ' LYS . 94.9 m-85 -66.04 -35.7 81.24 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.105 0.478 . . . . 0.0 110.634 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.572 ' CB ' ' HB3' ' A' ' 90' ' ' PRO . 10.8 mp -62.36 -41.73 98.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.434 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 30' ' ' LEU . 32.6 mt-10 -62.43 -30.09 70.98 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.518 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -79.41 -8.66 59.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.904 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.46 19.77 50.98 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.189 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -95.98 164.97 12.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.935 0.397 . . . . 0.0 110.366 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.467 ' HB2' HG12 ' A' ' 8' ' ' ILE . 17.4 m170 -110.56 148.94 31.13 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.8 t -118.18 130.2 73.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 121.282 0.563 . . . . 0.0 110.682 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.456 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 39.5 ttm180 -111.55 113.18 25.42 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 175.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 92.8 m-85 -86.51 121.55 29.21 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.551 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 78.1 mtp180 -124.27 132.6 53.59 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.555 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.1 p -126.42 135.06 64.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 121.186 0.517 . . . . 0.0 110.799 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -101.37 127.19 48.11 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.799 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.5 mt -82.23 116.43 21.76 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -102.45 113.6 27.08 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.319 0.581 . . . . 0.0 111.956 -173.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.57 -137.21 13.29 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.394 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.4 ptt-85 -69.57 -11.87 61.19 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 122.577 0.351 . . . . 0.0 111.407 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -60.72 -21.12 62.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.566 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 91.2 mtp -62.66 -29.82 70.92 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.618 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.85 -13.81 62.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.349 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.6 p -125.28 94.36 43.44 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-O 121.171 0.51 . . . . 0.0 111.274 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -64.63 -20.33 65.34 Favored 'Trans proline' 0 N--CA 1.477 0.524 0 C-N-CA 123.461 2.774 . . . . 0.0 111.756 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -61.87 -30.07 70.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.183 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.62 -44.01 93.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.811 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.435 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -66.79 -38.44 93.05 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.623 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.8 t -63.87 -44.87 98.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.487 -0.356 . . . . 0.0 110.638 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.45 88.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.032 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.7 tp -62.63 -47.47 83.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.156 0.503 . . . . 0.0 110.036 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.427 HD12 HG12 ' A' ' 84' ' ' VAL . 56.3 mt -67.33 -39.73 85.87 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.975 -178.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -58.88 -39.47 81.51 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.704 0.288 . . . . 0.0 111.075 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.421 ' HD3' HE22 ' A' ' 19' ' ' GLN . 40.5 ttmt -62.76 -46.14 89.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.231 0.538 . . . . 0.0 109.97 177.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.487 HG23 ' CG1' ' A' ' 26' ' ' VAL . 96.0 mt -63.1 -45.14 99.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.897 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -60.66 -40.27 91.45 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.421 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.41 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 19.6 m -61.09 -37.34 82.37 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.096 0.474 . . . . 0.0 111.203 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 82.4 mtp -71.92 -35.94 69.81 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 63' ' ' ILE . 41.6 pt -103.28 -2.87 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -174.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -57.18 -25.97 59.85 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -177.252 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.417 ' ND2' ' H ' ' A' ' 69' ' ' ASN . 1.7 p30 -65.79 -39.23 90.75 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -107.96 -8.44 15.91 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.958 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -123.27 155.77 36.55 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.552 ' OD1' ' HB ' ' A' ' 89' ' ' THR . 5.3 p30 -117.86 128.37 54.77 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -77.75 108.02 10.67 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 121.305 0.574 . . . . 0.0 111.361 -176.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -66.63 -42.33 86.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.685 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.592 ' HD3' ' N ' ' A' ' 76' ' ' GLU . 7.1 tmtm? -146.19 138.5 25.26 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.592 ' N ' ' HD3' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -63.04 158.72 52.62 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.369 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.13 121.8 9.99 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 121.817 1.678 . . . . 0.0 110.799 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -130.23 138.93 50.79 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.491 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -92.98 117.25 29.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.883 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -138.22 139.98 39.5 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.29 -92.42 0.32 Allowed Glycine 0 N--CA 1.432 -1.567 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -177.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -153.08 17.23 0.56 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.398 0.618 . . . . 0.0 110.473 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -129.23 143.43 50.85 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.909 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.555 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 95.9 t -99.83 126.22 53.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 173.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.569 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 9.3 p30 -133.07 153.07 51.85 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.499 -175.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 64.8 ttp -144.04 134.53 24.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.747 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.5 mt -103.89 129.27 51.39 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.053 0.454 . . . . 0.0 111.494 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.48 135.29 63.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.165 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.552 ' HB ' ' OD1' ' A' ' 72' ' ' ASN . 13.8 m -114.43 143.29 29.57 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.572 ' HB3' ' CB ' ' A' ' 33' ' ' LEU . 60.2 Cg_endo -67.0 155.14 72.17 Favored 'Trans proline' 0 C--O 1.242 0.711 0 C-N-CA 122.81 2.34 . . . . 0.0 112.584 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -63.36 131.92 49.82 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -90.11 -71.23 0.63 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.951 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 57.88 -95.88 0.06 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.954 -176.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -140.14 7.46 2.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.7 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 65.82 -108.3 2.32 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.319 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -137.94 147.03 43.94 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.614 0.245 . . . . 0.0 110.636 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -98.88 -8.2 26.06 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.169 0.509 . . . . 0.0 110.228 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -113.88 146.31 40.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.176 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -66.15 -44.02 85.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.083 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -142.88 -32.02 0.49 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.425 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 72.4 t60 . . . . . 0 C--N 1.322 -0.623 0 CA-C-O 118.808 -0.615 . . . . 0.0 109.471 -178.331 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.3 tttt . . . . . 0 N--CA 1.438 -1.034 0 CA-C-O 121.029 0.442 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.3 t -84.15 133.2 29.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 94.8 mt -68.95 131.56 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-O 120.947 0.403 . . . . 0.0 110.004 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -80.07 107.88 13.22 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.6 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.432 HG23 ' HB3' ' A' ' 38' ' ' HIS . 88.7 mt -117.75 131.11 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.339 -178.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.418 ' HG2' ' CD1' ' A' ' 32' ' ' PHE . 3.6 mptp? -86.26 135.78 33.42 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 121.565 0.698 . . . . 0.0 110.335 -178.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -115.21 120.28 39.17 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.046 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.6 mt -108.75 114.31 46.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.984 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -84.13 139.71 32.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.707 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.487 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 49.8 mt -127.27 166.83 17.04 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.748 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.0 m -137.09 146.25 44.9 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.7 t -62.73 -45.0 99.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.911 0.386 . . . . 0.0 110.25 177.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -94.35 65.89 3.32 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.585 0.707 . . . . 0.0 109.975 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.433 HD11 ' OD1' ' A' ' 21' ' ' ASP . 19.7 tt -107.66 156.03 8.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.384 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 21' ' ' ASP . . . -64.77 141.71 58.68 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -62.11 -39.4 92.37 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.958 0.408 . . . . 0.0 110.883 -176.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -76.32 -18.33 58.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.883 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.461 ' HB2' ' HB3' ' A' ' 18' ' ' ALA . 12.5 t70 -67.88 -35.79 79.13 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.276 0.56 . . . . 0.0 110.669 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.3 mt -61.49 -42.14 92.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.124 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -58.73 -43.12 90.08 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.716 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -63.75 -45.86 87.92 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.469 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -65.52 -41.13 93.47 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.481 ' CG1' HG23 ' A' ' 63' ' ' ILE . 1.4 m -60.77 -29.86 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.549 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -61.83 -46.76 88.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.014 0.435 . . . . 0.0 110.37 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -64.57 -37.83 88.9 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.111 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.612 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -56.56 -44.93 81.42 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.429 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 94.6 mt -62.5 -41.38 98.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.932 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -61.75 -44.82 96.17 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.967 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.418 ' CD1' ' HG2' ' A' ' 9' ' ' LYS . 81.4 m-85 -68.8 -32.91 72.97 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 96.7 mt -62.05 -42.02 98.74 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.404 0.621 . . . . 0.0 110.219 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 30' ' ' LEU . 44.6 mm-40 -56.24 -31.7 63.8 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.768 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -76.37 -8.51 57.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.726 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.63 17.95 62.86 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.07 -176.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -99.04 158.87 15.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.78 0.324 . . . . 0.0 110.523 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.432 ' HB3' HG23 ' A' ' 8' ' ' ILE . 1.9 t-80 -99.84 148.11 24.78 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.5 t -119.21 131.11 72.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.414 0.626 . . . . 0.0 111.829 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -112.38 126.0 54.8 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.053 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 96.8 m-85 -97.18 124.33 41.2 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.636 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 65.1 mtp180 -125.7 105.99 9.39 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.885 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.632 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 5.9 p -104.98 129.43 57.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.136 0.493 . . . . 0.0 111.31 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -99.01 134.79 41.34 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.915 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.2 mt -82.0 89.42 6.41 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 87.3 tttt -68.33 134.51 50.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.202 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.75 -132.38 11.16 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.349 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -110.6 18.37 19.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.683 0.278 . . . . 0.0 110.993 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 26.3 mm-40 -68.79 -2.47 9.51 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.196 -177.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 67.9 mtt -65.12 -13.33 57.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.037 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.49 -37.56 87.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.821 0.343 . . . . 0.0 110.697 178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.3 p -124.72 96.91 39.83 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 121.082 0.468 . . . . 0.0 111.583 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.416 ' HB3' ' CG ' ' A' ' 79' ' ' PHE . 31.4 Cg_exo -62.99 -19.58 69.46 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.601 2.867 . . . . 0.0 112.471 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -59.48 -20.38 54.85 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.346 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.59 -38.93 86.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.036 0.446 . . . . 0.0 110.347 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.469 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -66.22 -39.17 94.37 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.766 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.0 t -64.12 -45.19 97.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.699 -0.25 . . . . 0.0 110.694 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.76 -40.75 89.22 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.066 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.5 tp -62.93 -45.82 90.66 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.028 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.528 HD13 ' HB2' ' A' ' 86' ' ' MET . 92.2 mt -65.22 -40.89 94.72 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.753 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -58.4 -43.05 88.41 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.95 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -64.34 -41.59 96.7 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.335 0.588 . . . . 0.0 109.89 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.481 HG23 ' CG1' ' A' ' 26' ' ' VAL . 91.6 mt -64.88 -43.84 96.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.384 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -58.26 -41.24 83.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.123 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.3 p -63.79 -16.82 62.19 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 68.7 mtt -85.97 -39.2 17.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.94 0.4 . . . . 0.0 111.824 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.6 pt -101.55 -7.15 9.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -57.1 -28.69 62.88 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -66.57 -22.23 66.15 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -130.15 8.41 5.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.665 0.269 . . . . 0.0 111.576 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.28 151.71 49.93 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.79 0.328 . . . . 0.0 111.116 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -113.44 152.45 30.07 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -94.71 128.35 41.33 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.064 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -90.48 -8.58 50.06 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.138 0.494 . . . . 0.0 110.28 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -176.06 164.58 2.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.458 -177.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -85.96 149.11 49.78 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 19.2 Cg_endo -58.71 136.63 75.17 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.344 2.029 . . . . 0.0 111.63 177.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -145.35 138.6 26.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.338 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.416 ' CG ' ' HB3' ' A' ' 53' ' ' PRO . 87.7 t80 -83.3 118.14 23.46 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.659 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -130.59 115.54 16.89 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.092 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.71 -95.75 0.91 Allowed Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.149 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -132.61 4.87 3.96 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.942 0.401 . . . . 0.0 110.368 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 82.1 m-85 -127.65 143.93 51.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.091 -176.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.632 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 93.1 t -99.31 120.98 49.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 172.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.636 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 41.9 m-80 -111.79 145.94 38.52 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -171.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.528 ' HB2' HD13 ' A' ' 60' ' ' LEU . 64.9 ttp -146.49 135.95 22.94 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.289 174.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 22.9 mt -108.68 132.42 53.94 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.749 0.309 . . . . 0.0 111.822 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.16 132.66 70.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.294 0.569 . . . . 0.0 110.692 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.8 m -110.29 141.28 23.58 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.491 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 89.4 Cg_endo -69.29 150.82 71.55 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.762 1.641 . . . . 0.0 109.437 177.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -66.99 107.72 2.35 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.565 0.698 . . . . 0.0 111.991 -175.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -76.02 102.49 5.67 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.9 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 64.71 175.26 0.2 Allowed 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.786 0.679 . . . . 0.0 111.103 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -107.69 121.08 43.98 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.621 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.8 132.34 4.5 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.68 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.533 ' ND1' ' HB3' ' A' ' 99' ' ' HIS . 61.2 t-80 -91.42 150.38 21.28 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -94.77 89.89 5.86 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.145 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 55.74 81.38 0.12 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.888 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.533 ' HB3' ' ND1' ' A' ' 96' ' ' HIS . 42.0 p-80 -100.38 -31.68 11.2 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.896 177.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 75.9 t60 57.93 -82.28 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 O-C-N 123.643 0.59 . . . . 0.0 110.771 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 . . . . . 0 C--O 1.245 0.832 0 C-N-CA 123.661 0.784 . . . . 0.0 111.295 179.403 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.0 t -122.49 132.54 70.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.2 mm -89.59 114.69 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.545 ' HB2' ' HD3' ' A' ' 37' ' ' LYS . 7.0 m-20 -73.23 109.58 6.87 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.851 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.423 HG12 ' HB2' ' A' ' 38' ' ' HIS . 97.7 mt -111.45 121.1 63.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 121.095 0.474 . . . . 0.0 110.176 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.439 ' HG3' ' CD1' ' A' ' 32' ' ' PHE . 75.1 mmtt -92.22 133.8 35.48 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.341 -173.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -102.75 102.89 13.08 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.589 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.1 mt -90.94 111.17 23.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.092 0.472 . . . . 0.0 109.85 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 88.3 tttt -85.26 137.67 32.83 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.988 -177.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.2 mt -126.8 175.98 7.61 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.648 -177.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.7 p -146.83 149.29 33.02 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.6 t -64.85 -42.95 96.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -80.8 63.04 5.05 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 174.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.7 tt -113.5 152.13 15.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.601 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.03 150.18 23.55 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -63.92 -36.47 84.04 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.764 0.316 . . . . 0.0 111.574 -177.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -62.88 -39.13 93.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.724 0.297 . . . . 0.0 111.154 178.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -64.99 -38.11 89.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.31 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.635 ' O ' HG23 ' A' ' 26' ' ' VAL . 95.5 mt -62.77 -46.86 95.31 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -60.59 -44.39 96.31 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.349 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -65.12 -49.24 70.73 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.123 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -65.54 -41.08 93.44 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 22' ' ' ILE . 59.6 t -63.19 -40.41 88.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.178 0.514 . . . . 0.0 109.984 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -59.75 -45.69 91.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.368 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.456 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 17.8 t-160 -65.43 -31.63 72.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.475 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.85 -31.78 67.0 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 178.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.34 -39.97 94.85 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.026 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.456 ' OE1' ' HA ' ' A' ' 28' ' ' HIS . 1.3 mp0 -54.29 -47.05 72.83 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.439 ' CD1' ' HG3' ' A' ' 9' ' ' LYS . 95.0 m-85 -68.28 -37.1 80.34 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.638 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.35 -42.21 98.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.378 0.608 . . . . 0.0 110.087 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' OE1' ' HG3' ' A' ' 92' ' ' LYS . 6.0 mm-40 -61.76 -29.89 70.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.12 178.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -73.91 -9.45 58.66 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.504 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.04 16.38 57.87 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.709 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.545 ' HD3' ' HB2' ' A' ' 7' ' ' ASP . 65.8 mttm -99.82 173.36 6.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.015 0.436 . . . . 0.0 111.37 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.514 ' NE2' HG23 ' A' ' 89' ' ' THR . 17.5 m170 -111.15 149.7 30.51 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.899 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.3 t -118.86 130.68 73.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -109.5 111.37 22.86 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.58 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 83.8 m-85 -85.01 119.5 25.47 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 29.2 mtm180 -125.08 132.79 53.1 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -177.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.454 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.8 p -125.15 132.18 71.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 120.956 0.408 . . . . 0.0 111.142 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.438 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 90.1 t80 -102.72 127.51 49.83 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.672 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.4 mt -90.16 111.01 22.01 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -83.88 88.45 7.12 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.9 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.07 153.39 0.62 Allowed Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.365 -0.834 . . . . 0.0 114.41 175.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 64.17 -64.58 0.14 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.351 1.06 . . . . 0.0 113.111 176.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -65.64 -11.75 47.42 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.649 0.78 . . . . 0.0 111.413 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 80.6 mtp -61.32 -28.96 69.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.449 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.67 -19.37 64.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.543 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.4 m -122.31 97.8 44.8 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-O 121.282 0.563 . . . . 0.0 111.156 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -63.33 -22.15 71.82 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 123.515 2.81 . . . . 0.0 112.521 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -60.81 -28.14 68.55 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.444 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.01 -43.24 95.37 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.887 0.375 . . . . 0.0 110.728 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.26 -39.04 92.1 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.754 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.6 t -62.83 -43.71 99.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 122.629 0.372 . . . . 0.0 110.715 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.68 -40.3 91.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.413 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 48.1 tp -63.42 -45.8 89.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.193 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.428 HD12 HG12 ' A' ' 84' ' ' VAL . 86.8 mt -66.05 -42.18 89.86 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.33 -33.08 74.75 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.269 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -60.5 -47.88 84.23 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.4 mt -66.08 -42.49 91.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.602 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 37.3 t-105 -54.84 -40.38 69.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.026 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.5 m -63.34 -23.16 67.29 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-O 121.106 0.479 . . . . 0.0 111.021 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 96.1 mtp -90.03 -35.59 15.41 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.451 ' CG2' HG13 ' A' ' 26' ' ' VAL . 40.2 pt -92.35 -6.34 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -175.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.93 -4.4 6.9 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -63.34 -46.06 88.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.125 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -121.26 -3.66 9.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.696 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -118.87 145.55 45.61 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.167 0.508 . . . . 0.0 111.718 -176.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -115.36 133.87 55.63 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.782 175.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -68.84 113.24 6.1 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 120.972 0.415 . . . . 0.0 111.993 -177.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -87.45 -40.83 14.0 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.813 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 58.2 tptt -134.19 136.43 43.72 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.775 -177.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -74.47 155.3 87.63 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.613 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 24.2 Cg_exo -61.05 139.6 85.29 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.599 1.533 . . . . 0.0 111.312 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -145.85 141.56 27.98 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.802 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -92.44 112.6 24.6 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -153.57 124.53 7.34 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.586 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.81 31.47 55.87 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 66.49 14.71 9.84 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.672 0.789 . . . . 0.0 112.536 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 37.3 m-85 -125.44 143.53 50.95 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.351 176.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.454 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 78.9 t -103.54 124.09 57.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 172.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.613 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 5.9 p30 -131.67 156.95 44.97 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.959 -0.697 . . . . 0.0 112.423 -173.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 54.5 ttp -142.67 135.62 28.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.528 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 12.4 mt -108.18 131.06 55.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.969 0.414 . . . . 0.0 111.198 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.2 m -124.69 138.67 53.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.777 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.514 HG23 ' NE2' ' A' ' 38' ' ' HIS . 11.2 m -109.43 135.32 20.31 Favored Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.471 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.98 143.8 37.05 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 C-N-CA 122.374 2.049 . . . . 0.0 110.963 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -83.07 9.22 10.81 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.354 0.597 . . . . 0.0 110.486 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.437 ' HG3' ' OE1' ' A' ' 34' ' ' GLU . 35.2 mmtp -101.73 36.34 2.09 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.869 -178.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.77 11.29 1.41 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.703 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -66.55 -43.91 83.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.833 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -157.37 133.15 3.44 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.315 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -87.03 -32.89 19.76 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 28.3 p80 41.84 42.95 2.39 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 114.849 -1.069 . . . . 0.0 113.09 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -75.45 141.94 43.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.208 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -62.12 95.05 0.06 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.041 0.448 . . . . 0.0 110.296 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -76.92 -47.29 21.45 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.262 -177.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 20.3 m80 . . . . . 0 C--N 1.313 -1.004 0 CA-C-O 117.963 -1.017 . . . . 0.0 109.757 178.358 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt . . . . . 0 N--CA 1.473 0.712 0 CA-C-O 121.255 0.55 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.4 p -76.51 150.85 6.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.315 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 88.0 mt -73.49 109.07 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.517 ' OD2' ' HE2' ' A' ' 9' ' ' LYS . 34.0 t70 -80.14 122.96 27.45 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.787 -177.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 88.4 mt -120.63 136.85 56.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.446 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.541 ' HE3' ' CE1' ' A' ' 32' ' ' PHE . 75.3 mmtt -98.24 136.47 38.39 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.904 -176.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.475 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 47.0 mt-10 -114.83 104.21 11.71 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.574 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.2 mt -90.21 103.6 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 121.753 0.787 . . . . 0.0 109.706 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.427 ' HE2' ' HB2' ' A' ' 44' ' ' PHE . 50.7 tttm -88.71 128.06 35.61 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.782 -177.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.502 HD21 ' HG3' ' A' ' 25' ' ' LYS . 74.4 mt -125.42 -178.55 4.27 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.713 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.424 ' HA ' HG23 ' A' ' 43' ' ' VAL . 58.4 p -141.68 161.58 37.58 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.78 0.324 . . . . 0.0 110.436 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.1 t -64.4 -25.93 39.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.192 0.52 . . . . 0.0 112.3 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -90.09 11.54 20.51 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.526 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.48 HD12 HD22 ' A' ' 13' ' ' LEU . 14.3 tt -68.24 152.73 9.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 CA-C-O 121.009 0.433 . . . . 0.0 111.163 -178.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.35 154.65 18.43 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.421 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -63.6 -34.21 77.31 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.765 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -64.16 -38.4 90.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.863 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -66.62 -36.87 83.63 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.895 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.6 mt -61.73 -43.74 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.555 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -60.42 -42.31 95.78 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.195 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -69.46 -39.54 77.69 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.452 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.502 ' HG3' HD21 ' A' ' 13' ' ' LEU . 48.6 mmtm -63.39 -42.16 98.78 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.595 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 4.4 m -63.66 -34.13 65.96 Favored 'Isoleucine or valine' 0 C--N 1.342 0.275 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.177 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -63.48 -39.7 95.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.723 0.297 . . . . 0.0 110.686 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -64.7 -40.66 95.75 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.157 0.503 . . . . 0.0 110.278 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.659 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -61.66 -39.13 90.28 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.768 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 26' ' ' VAL . 93.1 mt -61.43 -40.35 94.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.699 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 46.0 mt-10 -58.44 -47.06 85.21 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.799 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.541 ' CE1' ' HE3' ' A' ' 9' ' ' LYS . 94.2 m-85 -71.35 -32.37 68.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.951 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.659 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 90.2 mt -62.23 -43.27 99.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.45 0.643 . . . . 0.0 109.817 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -62.6 -30.72 71.55 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.979 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 80.4 mt-30 -73.54 -10.12 59.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.726 178.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.38 7.44 65.28 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.15 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.4 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 88.5 mttt -91.23 178.24 6.03 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.162 0.506 . . . . 0.0 110.323 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.496 ' NE2' HG23 ' A' ' 89' ' ' THR . 23.7 m170 -117.24 150.76 38.24 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.914 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.0 t -117.53 128.58 74.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.079 0.466 . . . . 0.0 110.046 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.475 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 51.8 ttt180 -109.26 115.9 30.87 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.528 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 76.2 m-85 -90.15 113.92 25.78 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -117.09 134.62 54.53 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.512 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.7 p -118.77 130.59 73.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-O 121.211 0.529 . . . . 0.0 111.462 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.427 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 91.2 t80 -94.63 125.22 39.15 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.394 177.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.474 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 51.6 mt -91.59 129.03 37.63 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -62.39 -48.23 80.63 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.27 -44.96 0.17 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 119.941 -1.123 . . . . 0.0 113.329 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -90.96 -19.27 23.44 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 117.168 0.484 . . . . 0.0 111.471 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.474 ' HG2' ' HB3' ' A' ' 45' ' ' LEU . 1.6 pm0 -79.54 2.66 21.35 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.597 0.713 . . . . 0.0 109.583 175.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 61.2 mtt -82.43 -133.93 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.337 175.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 61.06 -61.06 0.08 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.312 0.645 . . . . 0.0 111.249 -173.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 t -121.85 133.82 24.44 Favored Pre-proline 0 N--CA 1.437 -1.103 0 C-N-CA 123.566 0.746 . . . . 0.0 109.431 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.87 -8.89 23.88 Favored 'Trans proline' 0 C--N 1.331 -0.385 0 C-N-CA 123.425 2.75 . . . . 0.0 113.487 -176.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.88 -30.14 68.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.26 96.03 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.86 0.362 . . . . 0.0 110.465 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.29 -39.88 87.67 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.18 -42.47 94.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.531 -0.334 . . . . 0.0 110.436 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.81 -40.87 76.77 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.293 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.9 tp -62.4 -45.84 91.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.245 0.545 . . . . 0.0 109.993 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.414 ' CD1' HG12 ' A' ' 84' ' ' VAL . 89.3 mt -64.76 -41.09 96.16 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.891 -177.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -60.37 -39.41 87.12 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.309 0.575 . . . . 0.0 110.992 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -63.8 -41.18 97.96 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.105 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.2 mt -70.04 -46.23 73.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.065 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 41.7 t-105 -57.75 -41.4 81.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.322 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.8 p -62.8 -24.69 67.87 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 98.4 mtp -75.78 -34.43 60.22 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.9 pt -107.76 -6.89 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -56.32 -23.08 34.76 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -64.41 -39.19 93.36 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -121.13 6.51 10.27 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.45 146.29 50.54 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.945 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -114.31 147.72 38.66 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.0 ptt-85 -81.16 127.63 32.88 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.418 ' CB ' HD12 ' A' ' 87' ' ' LEU . 23.5 t70 -74.12 -35.54 64.13 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.384 0.611 . . . . 0.0 109.782 176.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -161.43 172.22 16.86 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.063 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -77.4 152.59 81.41 Favored Pre-proline 0 C--N 1.311 -1.073 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -61.58 140.64 87.99 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.686 1.591 . . . . 0.0 110.57 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -140.88 165.6 27.08 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.495 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -101.96 113.57 26.92 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.991 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -114.39 113.07 24.02 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.56 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.52 -93.08 0.16 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.497 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -133.94 11.37 3.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.142 0.496 . . . . 0.0 110.492 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -118.27 140.72 49.39 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.863 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.512 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 55.9 t -100.81 127.28 54.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 172.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.528 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 7.2 p30 -134.3 153.84 51.65 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 119.353 -0.939 . . . . 0.0 113.078 -174.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.402 ' HB2' HD13 ' A' ' 60' ' ' LEU . 53.0 ttp -140.55 138.15 34.29 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.817 177.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.418 HD12 ' CB ' ' A' ' 74' ' ' ASP . 2.9 tm? -109.89 126.93 54.38 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.1 m -112.83 134.1 56.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.385 0.612 . . . . 0.0 110.896 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.496 HG23 ' NE2' ' A' ' 38' ' ' HIS . 13.3 m -113.56 139.29 23.16 Favored Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.218 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.582 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 69.2 Cg_endo -66.82 142.35 62.78 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.35 2.033 . . . . 0.0 110.541 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -78.12 137.17 38.06 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.334 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -80.67 130.91 35.37 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.482 178.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.23 -46.53 83.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.937 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -167.05 -61.83 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.5 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 155.45 76.94 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.999 -0.619 . . . . 0.0 111.894 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -77.25 144.15 38.41 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -100.81 154.14 18.89 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.465 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -64.51 106.58 1.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.175 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -70.43 171.88 9.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.051 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -68.14 128.2 35.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.173 0.511 . . . . 0.0 111.493 -176.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 . . . . . 0 C--N 1.315 -0.93 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.777 178.553 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 65.6 pttt . . . . . 0 N--CA 1.446 -0.663 0 CA-C-O 120.831 0.348 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.3 t -103.21 133.86 45.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.5 mm -73.4 125.12 31.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.951 0.405 . . . . 0.0 110.288 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.539 ' HB2' ' HD3' ' A' ' 37' ' ' LYS . 22.2 m-20 -84.64 137.27 33.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.015 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 90.7 mt -129.16 129.55 67.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -101.46 135.77 42.42 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.789 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.466 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 58.3 mt-10 -104.38 112.28 25.26 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.896 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.4 mt -97.73 111.74 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 87.8 tttt -98.14 136.01 38.98 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.545 -175.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.554 HD22 HD11 ' A' ' 63' ' ' ILE . 5.2 mp -131.77 179.93 5.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.119 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.7 p -138.98 156.54 47.15 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.97 -25.01 37.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.437 0.637 . . . . 0.0 111.247 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -104.61 22.29 15.29 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.988 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.1 tt -74.37 147.72 8.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.949 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.46 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -75.25 155.22 36.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.74 -177.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 -62.7 -38.75 91.65 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.166 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -61.06 -41.14 96.07 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.563 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 21.1 m-20 -64.75 -38.84 92.35 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.394 177.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 18' ' ' ALA . 68.6 mt -61.95 -45.67 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-O 121.075 0.464 . . . . 0.0 110.703 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -60.08 -41.73 93.1 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.818 0.818 . . . . 0.0 110.323 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -61.97 -44.2 97.25 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.377 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 75.1 mmtt -64.06 -44.76 91.44 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.469 HG11 ' HB2' ' A' ' 66' ' ' MET . 4.7 m -67.9 -32.87 58.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.613 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -62.37 -45.47 93.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.096 0.474 . . . . 0.0 109.809 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -70.9 -32.53 69.51 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.191 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.595 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -55.85 -45.97 78.33 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.269 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.37 -40.41 96.36 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.79 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 52.2 mt-10 -57.14 -48.54 78.43 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 120.785 0.326 . . . . 0.0 111.159 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -68.76 -36.24 78.09 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 95.8 mt -63.04 -44.28 96.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.438 0.637 . . . . 0.0 110.428 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -57.88 -32.28 67.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.441 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 80.3 mt-30 -75.21 -7.36 53.66 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.281 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.68 15.75 56.1 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.021 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.539 ' HD3' ' HB2' ' A' ' 7' ' ' ASP . 31.1 mtmm -103.02 168.58 9.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.487 0.66 . . . . 0.0 112.306 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.407 ' NE2' HG23 ' A' ' 89' ' ' THR . 3.3 m80 -102.92 145.9 29.13 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.326 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.9 t -115.4 129.24 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.697 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.466 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 42.4 ttm180 -109.81 113.0 25.39 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 83.1 m-85 -89.89 124.29 34.57 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 73.0 mtp180 -128.22 135.53 49.82 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.513 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.7 p -118.88 131.95 70.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-O 121.18 0.514 . . . . 0.0 111.24 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -96.26 126.36 41.42 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.576 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 50' ' ' MET . 31.9 mt -92.31 114.0 26.43 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -95.16 119.84 34.37 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.866 0.365 . . . . 0.0 111.518 -174.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.2 -140.73 15.08 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -91.88 13.67 17.78 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.273 0.558 . . . . 0.0 110.43 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.422 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 71.8 mt-10 -62.35 -21.99 65.74 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.65 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.453 ' HA ' HD12 ' A' ' 45' ' ' LEU . 65.5 mtt -67.4 -11.3 57.42 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.969 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.94 -28.3 69.73 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.151 0.501 . . . . 0.0 110.515 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.4 m -130.87 99.63 18.11 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-O 121.23 0.538 . . . . 0.0 110.843 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -60.46 -22.81 73.1 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 123.529 2.82 . . . . 0.0 112.897 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -61.65 -22.38 65.23 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.749 0.309 . . . . 0.0 110.827 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.81 -40.6 95.84 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.048 0.451 . . . . 0.0 109.856 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.83 -38.55 93.07 Favored Glycine 0 CA--C 1.506 -0.488 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.382 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.411 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 88.1 t -63.33 -44.44 99.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.439 -0.381 . . . . 0.0 110.508 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.31 -41.2 88.47 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.38 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.0 tp -63.93 -45.63 88.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.355 0.598 . . . . 0.0 110.356 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.494 HD23 HD12 ' A' ' 63' ' ' ILE . 81.7 mt -64.53 -41.13 96.57 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.416 -177.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 57' ' ' VAL . 11.9 mm-40 -63.7 -34.26 77.46 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.539 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -62.04 -41.9 98.61 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.554 HD11 HD22 ' A' ' 13' ' ' LEU . 96.4 mt -63.75 -44.32 98.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.281 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -59.72 -36.91 77.52 Favored 'General case' 0 C--O 1.213 -0.83 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.779 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.4 m -57.82 -33.78 68.96 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.306 0.574 . . . . 0.0 110.325 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.469 ' HB2' HG11 ' A' ' 26' ' ' VAL . 97.8 mmm -76.85 -32.73 57.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.603 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.621 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 41.1 pt -117.96 15.84 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -174.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -62.61 -22.48 66.43 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.774 0.797 . . . . 0.0 110.291 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -97.58 141.34 30.74 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 173.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 74.9 -13.89 0.79 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.597 0.759 . . . . 0.0 111.842 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 67' ' ' ILE . . . -129.71 150.79 50.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.661 0.267 . . . . 0.0 110.4 177.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -116.47 149.25 39.82 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -87.57 106.31 17.92 Favored 'General case' 0 N--CA 1.412 -2.368 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.658 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -80.74 -41.14 24.03 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.002 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -137.32 136.8 38.3 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.14 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.42 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 0.3 OUTLIER -80.98 151.92 70.99 Favored Pre-proline 0 N--CA 1.442 -0.87 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.788 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 17.4 Cg_endo -56.29 131.1 43.75 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.463 2.109 . . . . 0.0 112.339 -177.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.427 ' ND2' ' HG3' ' A' ' 80' ' ' GLU . 3.1 p-10 -147.09 165.5 29.74 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.415 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.504 ' CZ ' ' HA ' ' A' ' 82' ' ' ARG . 84.6 t80 -93.83 123.32 37.1 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.844 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.427 ' HG3' ' ND2' ' A' ' 78' ' ' ASN . 38.4 mt-10 -146.77 120.07 8.96 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.48 178.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.447 ' O ' ' HD1' ' A' ' 83' ' ' TYR . . . 64.94 38.73 95.85 Favored Glycine 0 C--O 1.221 -0.696 0 CA-C-N 115.951 -0.568 . . . . 0.0 113.945 175.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.504 ' HA ' ' CZ ' ' A' ' 79' ' ' PHE . 75.2 mtt180 74.96 0.91 3.66 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.492 0.717 . . . . 0.0 111.228 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.447 ' HD1' ' O ' ' A' ' 81' ' ' GLY . 82.2 m-85 -117.38 149.17 40.97 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.891 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.513 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 70.3 t -105.2 128.09 59.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 173.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.529 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 9.2 p30 -133.11 161.44 34.4 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -173.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.445 ' CE ' ' HB3' ' A' ' 60' ' ' LEU . 13.8 ttm -143.71 146.01 32.85 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.217 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 16.2 mt -115.33 129.39 56.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.767 0.318 . . . . 0.0 111.238 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.7 132.46 70.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.85 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.41 ' CG2' ' HD2' ' A' ' 90' ' ' PRO . 15.2 m -104.95 141.2 22.04 Favored Pre-proline 0 C--N 1.309 -1.174 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.431 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 33.8 Cg_endo -61.38 147.21 96.1 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 121.949 1.766 . . . . 0.0 110.579 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -57.1 135.49 56.35 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.2 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -79.36 177.15 9.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.917 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.43 150.83 45.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.06 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -67.58 151.19 47.75 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.294 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.26 -32.92 85.36 Favored Glycine 0 CA--C 1.519 0.31 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.525 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 72.78 -67.17 0.28 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.529 0.732 . . . . 0.0 110.833 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -130.27 142.28 50.56 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -79.47 90.5 5.07 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -113.73 -8.24 13.24 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.236 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -108.21 117.87 35.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.187 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 C--O 1.246 0.909 0 CA-C-O 118.529 -0.748 . . . . 0.0 110.57 -178.246 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 N--CA 1.448 -0.545 0 CA-C-O 120.989 0.423 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -116.99 136.19 54.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.435 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 78.2 mt -70.99 102.47 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.099 0.476 . . . . 0.0 110.347 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.416 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 25.2 t70 -79.59 132.71 36.35 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.867 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.427 HG23 ' O ' ' A' ' 38' ' ' HIS . 92.7 mt -115.56 132.2 65.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.343 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -92.37 155.32 17.98 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.564 0.697 . . . . 0.0 111.126 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.585 ' CD ' HH21 ' A' ' 40' ' ' ARG . 43.4 mt-10 -125.74 114.35 18.52 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.972 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.5 mt -100.67 108.55 23.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -85.49 142.6 29.08 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.841 -176.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.0 mt -129.65 166.9 18.84 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.69 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.0 m -139.2 150.04 45.1 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 176.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.2 t -61.6 -43.89 97.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.309 0.576 . . . . 0.0 110.779 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -93.62 68.03 3.98 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.566 0.698 . . . . 0.0 110.797 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.431 HD11 ' HE2' ' A' ' 25' ' ' LYS . 18.3 tt -117.59 149.77 19.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.68 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.06 142.27 54.56 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.706 0.289 . . . . 0.0 110.874 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -62.96 -39.0 93.33 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.824 0.345 . . . . 0.0 111.32 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -61.8 -39.95 93.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.15 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.584 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 28.1 t70 -65.91 -38.23 88.15 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.024 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.87 -45.29 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.807 0.813 . . . . 0.0 109.47 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -65.39 -28.82 69.53 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.134 -1.393 . . . . 0.0 110.694 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -78.77 -40.77 32.32 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.161 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 21' ' ' ASP . 57.8 mttm -65.55 -38.94 91.06 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 m -59.59 -32.61 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.2 tttt -63.26 -42.24 99.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.852 0.358 . . . . 0.0 110.117 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -68.36 -38.53 81.52 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.52 176.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.415 ' O ' HD13 ' A' ' 33' ' ' LEU . . . -57.72 -44.17 85.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.28 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.446 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 88.2 mt -62.32 -34.66 77.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.82 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -56.22 -41.64 75.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.274 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -67.85 -37.14 81.49 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.935 0.398 . . . . 0.0 111.08 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.43 ' CB ' ' HB3' ' A' ' 90' ' ' PRO . 11.0 mp -63.09 -42.56 99.63 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.445 0.64 . . . . 0.0 110.423 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 30' ' ' LEU . 66.7 mm-40 -61.75 -22.8 65.71 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.993 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -87.74 -6.03 58.38 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.802 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.66 27.49 26.82 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.614 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.416 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 66.2 mttm -115.29 176.26 5.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.248 0.547 . . . . 0.0 111.311 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.427 ' O ' HG23 ' A' ' 8' ' ' ILE . 5.6 m80 -111.13 147.11 35.58 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.163 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.6 t -115.3 126.65 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.585 HH21 ' CD ' ' A' ' 10' ' ' GLU . 45.1 ttp180 -101.51 111.71 24.03 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -87.88 121.65 30.55 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.495 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 83.1 mtp180 -131.96 120.08 21.98 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.63 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 4.3 p -111.4 131.67 62.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.199 0.523 . . . . 0.0 111.53 -176.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.423 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 88.9 t80 -98.34 130.78 45.0 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.618 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' A' ' 50' ' ' MET . 40.7 mt -89.93 122.52 33.04 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -107.32 114.12 27.95 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.178 0.513 . . . . 0.0 111.674 -174.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.52 -143.86 15.97 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.485 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -83.18 4.86 24.88 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.154 0.502 . . . . 0.0 111.015 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -65.72 -25.75 67.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.153 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.523 ' HA ' HD12 ' A' ' 45' ' ' LEU . 49.2 ttm -59.46 -24.34 63.48 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.462 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.9 -25.61 67.96 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.321 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.9 p -126.69 101.55 26.78 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 121.303 0.573 . . . . 0.0 110.741 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.3 -15.36 38.75 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.446 2.764 . . . . 0.0 112.631 -177.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -61.69 -26.14 67.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.811 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.67 90.59 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.036 0.446 . . . . 0.0 110.119 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.437 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -67.03 -38.67 92.81 Favored Glycine 0 CA--C 1.505 -0.563 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.584 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.412 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 93.5 t -63.13 -45.85 97.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.571 -0.315 . . . . 0.0 110.947 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.37 -40.76 92.0 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.198 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.2 tp -63.2 -45.69 90.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.183 0.516 . . . . 0.0 110.289 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.442 HD13 ' HB2' ' A' ' 86' ' ' MET . 97.6 mt -65.17 -40.56 94.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.907 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 57' ' ' VAL . 46.6 mt-10 -62.55 -39.13 92.64 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.016 0.436 . . . . 0.0 110.471 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -62.64 -43.67 98.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.019 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.0 mt -67.35 -43.31 87.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.684 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.523 ' CZ2' ' HB2' ' A' ' 73' ' ' ARG . 41.9 t-105 -55.86 -41.16 73.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.281 -178.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 36.0 p -63.5 -29.13 70.45 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.256 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 66.0 mtt -67.66 -41.2 84.15 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.738 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.8 pt -106.52 -1.43 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -174.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -54.09 -32.0 53.54 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -176.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.418 ' O ' ' HE2' ' A' ' 91' ' ' LYS . 5.0 p30 -77.26 -14.74 59.7 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.404 ' HG2' ' OD1' ' A' ' 69' ' ' ASN . 58.6 mm-40 -117.71 -15.4 10.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.265 0.555 . . . . 0.0 111.203 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -124.16 155.57 38.25 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.788 -176.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -112.88 139.11 48.8 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 176.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.523 ' HB2' ' CZ2' ' A' ' 64' ' ' TRP . 71.0 ttp85 -87.28 112.3 21.91 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -177.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -70.97 -37.2 72.76 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.903 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -160.85 161.56 31.94 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.87 152.97 95.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.458 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 22.4 Cg_endo -61.16 139.41 83.66 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.165 1.91 . . . . 0.0 111.398 177.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -140.29 148.39 41.35 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.412 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -91.76 107.7 19.39 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.219 0.533 . . . . 0.0 110.156 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -114.84 116.05 27.96 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.513 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.4 -104.71 1.56 Allowed Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 120.363 -0.922 . . . . 0.0 110.92 -177.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -127.56 10.54 6.68 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.05 0.453 . . . . 0.0 110.324 178.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 81.2 m-85 -121.52 145.31 48.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.299 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.63 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 86.5 t -97.46 119.05 45.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 172.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.495 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 78.5 m-20 -111.25 144.08 40.99 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.081 -171.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.442 ' HB2' HD13 ' A' ' 60' ' ' LEU . 15.5 tmm? -147.05 137.75 23.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.746 175.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.2 mt -114.65 134.29 55.18 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.1 m -117.09 131.29 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.219 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.41 HG23 ' NE2' ' A' ' 38' ' ' HIS . 15.8 m -104.83 137.7 19.29 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.43 ' HB3' ' CB ' ' A' ' 33' ' ' LEU . 57.9 Cg_endo -64.47 148.34 90.66 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.429 2.086 . . . . 0.0 111.632 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 69' ' ' ASN . 36.7 mttp -70.26 98.87 1.44 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.925 0.393 . . . . 0.0 111.629 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -136.61 145.87 45.39 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.68 177.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -105.87 94.25 5.08 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 174.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -75.95 93.84 3.3 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.394 0.616 . . . . 0.0 112.298 -176.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -129.31 48.26 0.98 Allowed Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.8 m-70 -92.39 169.82 10.26 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -71.06 -100.99 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 51.71 23.01 1.81 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -60.76 -41.03 94.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.204 0.526 . . . . 0.0 110.19 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -94.89 91.18 6.3 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.313 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 . . . . . 0 C--N 1.307 -1.282 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.898 -178.191 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 66.2 tttm . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 p -71.19 141.22 17.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 87.2 mt -79.94 115.14 21.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -84.01 108.58 17.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.036 0.446 . . . . 0.0 110.57 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.9 mt -89.32 133.57 31.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.015 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -94.01 143.79 26.05 Favored 'General case' 0 CA--C 1.492 -1.288 0 CA-C-O 121.428 0.632 . . . . 0.0 111.167 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.615 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 91.1 mt-10 -120.49 126.28 49.98 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.945 178.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.9 mt -110.46 117.77 55.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 12.3 mptt -97.51 139.76 32.96 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.186 0.517 . . . . 0.0 112.161 -177.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mp -130.22 177.17 7.52 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.192 176.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.6 m -135.05 154.08 51.82 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.9 t -63.3 -33.09 59.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.257 0.551 . . . . 0.0 110.059 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -106.9 74.59 1.0 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.967 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.4 tt -130.39 160.84 41.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.969 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.418 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -73.85 142.62 46.08 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -38.39 90.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.055 0.455 . . . . 0.0 109.987 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -61.88 -41.22 97.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.596 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.71 ' OD2' ' HE2' ' A' ' 25' ' ' LYS . 6.1 t70 -65.58 -36.49 83.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.679 -178.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.647 ' O ' HG23 ' A' ' 26' ' ' VAL . 68.4 mt -60.98 -46.62 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -59.14 -43.19 92.01 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.517 0.675 . . . . 0.0 110.571 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -61.66 -46.11 91.13 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.022 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.71 ' HE2' ' OD2' ' A' ' 21' ' ' ASP . 68.8 mttm -65.38 -40.89 94.04 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.756 0.312 . . . . 0.0 111.769 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 22' ' ' ILE . 55.8 t -61.57 -39.71 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.611 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -56.08 -39.65 72.42 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.534 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 20.9 m80 -64.35 -38.24 90.35 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.989 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.614 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -60.86 -38.58 86.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.726 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.68 -39.1 90.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.99 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 6.1 mm-40 -59.58 -50.64 73.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.057 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -64.75 -34.84 79.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.518 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.649 HD13 ' HB2' ' A' ' 71' ' ' ALA . 96.1 mt -62.75 -43.72 98.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.292 0.568 . . . . 0.0 110.474 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -67.14 -26.73 66.81 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.915 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 78.9 mt-30 -77.67 -7.65 56.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.902 178.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.63 22.52 50.1 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.908 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -103.71 158.83 16.11 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.994 0.426 . . . . 0.0 110.298 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -98.35 138.66 35.27 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.512 176.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.3 t -112.15 128.18 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.615 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 67.2 ttt180 -108.51 112.76 25.31 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 176.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -86.9 117.97 25.98 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 81.8 mtp180 -125.65 138.78 53.92 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.572 -177.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.606 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.1 p -126.61 135.66 63.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.014 0.435 . . . . 0.0 111.076 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -101.14 132.35 46.65 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.707 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.56 ' HB2' ' SD ' ' A' ' 50' ' ' MET . 29.1 mt -90.33 111.99 23.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.024 0.44 . . . . 0.0 109.852 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -104.27 123.21 46.95 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.58 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.45 -147.42 16.33 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.209 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -89.07 15.28 8.97 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.224 0.535 . . . . 0.0 110.02 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -73.86 -11.75 60.46 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.193 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.56 ' SD ' ' HB2' ' A' ' 45' ' ' LEU . 95.6 mmm -61.23 -35.92 78.54 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.276 -176.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.74 -21.22 65.65 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.486 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.0 p -119.71 94.94 48.97 Favored Pre-proline 0 N--CA 1.446 -0.64 0 CA-C-O 121.143 0.497 . . . . 0.0 111.839 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -64.4 -23.62 64.99 Favored 'Trans proline' 0 N--CA 1.477 0.552 0 C-N-CA 123.349 2.7 . . . . 0.0 111.26 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.94 -22.13 66.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.74 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.87 97.04 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.927 0.394 . . . . 0.0 110.519 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.42 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -68.37 -39.32 87.58 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.905 177.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.427 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 97.3 t -63.41 -44.98 99.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.648 0.261 . . . . 0.0 111.018 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.99 -40.94 95.43 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.16 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.3 tp -63.15 -45.15 93.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.192 0.52 . . . . 0.0 110.001 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.488 HD12 HG12 ' A' ' 84' ' ' VAL . 63.1 mt -65.76 -37.75 87.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.767 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 57' ' ' VAL . 56.3 mt-10 -55.69 -42.23 74.89 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.621 0.248 . . . . 0.0 110.583 177.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -61.89 -43.53 98.65 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.06 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.473 ' O ' HG12 ' A' ' 67' ' ' ILE . 65.1 mt -62.39 -45.32 99.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.826 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.477 ' CZ2' ' HB2' ' A' ' 73' ' ' ARG . 45.6 t-105 -57.6 -40.96 80.26 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.072 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.405 ' HA ' ' OE2' ' A' ' 68' ' ' GLU . 25.2 m -63.22 -25.69 68.45 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 121.126 0.489 . . . . 0.0 110.581 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 95.6 mtp -89.47 -43.3 10.94 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.888 0.375 . . . . 0.0 111.799 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.474 HG12 ' HA ' ' A' ' 64' ' ' TRP . 40.5 pt -81.44 -18.35 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -174.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.405 ' OE2' ' HA ' ' A' ' 65' ' ' THR . 14.6 pt-20 -58.8 -15.42 12.22 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.102 0.477 . . . . 0.0 111.863 -177.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -63.17 -40.71 98.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.668 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -116.48 -9.71 11.39 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.532 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.649 ' HB2' HD13 ' A' ' 33' ' ' LEU . . . -121.9 160.3 25.06 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.642 ' OD1' ' HG2' ' A' ' 91' ' ' LYS . 11.3 m-20 -116.08 156.89 25.57 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.732 176.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.477 ' HB2' ' CZ2' ' A' ' 64' ' ' TRP . 69.3 ttt180 -85.4 106.5 16.82 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.006 -176.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -82.25 -36.77 26.8 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.027 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -160.18 160.03 32.35 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.851 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.449 ' HB3' HH21 ' A' ' 73' ' ' ARG . 9.7 pt-20 -84.78 155.75 61.57 Favored Pre-proline 0 C--N 1.316 -0.868 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 16.1 Cg_endo -57.1 132.7 53.03 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.474 2.116 . . . . 0.0 111.788 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -127.75 134.04 49.52 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.347 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -82.28 113.66 20.24 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -127.34 114.86 18.13 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.234 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.39 -105.81 1.68 Allowed Glycine 0 N--CA 1.428 -1.888 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.687 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -121.31 7.73 10.2 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.209 0.528 . . . . 0.0 110.445 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -123.47 149.58 44.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.996 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.606 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 69.7 t -108.93 126.29 65.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 173.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 6.5 m-80 -124.06 139.04 54.33 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.492 -0.483 . . . . 0.0 112.124 -172.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.423 ' HB2' HD13 ' A' ' 60' ' ' LEU . 63.2 ttp -130.01 128.99 43.12 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -108.27 127.22 53.66 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.969 0.414 . . . . 0.0 110.031 -178.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.431 HG11 ' CD1' ' A' ' 67' ' ' ILE . 20.6 m -123.18 145.43 30.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.042 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.1 m -115.42 135.43 22.59 Favored Pre-proline 0 C--N 1.303 -1.414 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.125 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.422 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 55.5 Cg_endo -64.17 152.52 80.83 Favored 'Trans proline' 0 C--N 1.329 -0.481 0 C-N-CA 122.319 2.013 . . . . 0.0 110.054 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.642 ' HG2' ' OD1' ' A' ' 72' ' ' ASN . 68.6 mttm -60.91 96.6 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -174.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -71.94 -34.61 69.16 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.987 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 73.87 149.66 0.1 Allowed 'General case' 0 N--CA 1.468 0.445 0 O-C-N 124.038 0.836 . . . . 0.0 111.544 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -78.31 -61.38 2.02 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.64 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 65.94 88.19 0.06 OUTLIER Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.034 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -72.84 143.48 47.82 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.855 0.36 . . . . 0.0 111.153 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -103.16 18.38 21.87 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.577 0.704 . . . . 0.0 109.154 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -87.53 167.78 13.65 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.263 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -70.48 155.62 40.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.441 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -61.4 123.67 18.45 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 . . . . . 0 C--N 1.316 -0.89 0 CA-C-O 118.53 -0.748 . . . . 0.0 110.267 -178.858 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.708 0.289 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.2 t -78.43 -4.15 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.649 0.738 . . . . 0.0 110.931 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.6 mm -67.96 144.8 14.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.182 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -64.62 118.71 9.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.875 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 88.7 mt -104.22 133.49 48.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.387 0.613 . . . . 0.0 111.38 -176.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -96.13 149.59 21.46 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.833 -175.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -119.88 137.48 53.99 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.185 0.517 . . . . 0.0 111.272 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.8 mm -110.21 114.85 48.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -90.21 141.74 28.41 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.309 0.576 . . . . 0.0 111.321 -176.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.47 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 49.4 mt -133.46 165.99 23.58 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.597 -176.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.5 p -140.82 152.3 45.05 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.7 t -62.79 -33.74 61.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.325 0.583 . . . . 0.0 109.551 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -93.55 73.2 4.39 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.575 176.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.8 tt -126.34 145.58 33.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.515 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.77 142.55 53.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.292 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.446 HE22 ' HD3' ' A' ' 62' ' ' LYS . 62.2 tp60 -62.98 -38.33 90.71 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.305 0.574 . . . . 0.0 110.505 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -62.5 -38.25 89.18 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.952 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -64.96 -36.1 83.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.602 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 94.2 mt -61.73 -42.74 95.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.424 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 6.4 m-20 -60.15 -41.11 92.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.515 178.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -68.63 -40.5 80.3 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.8 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -60.81 -42.4 97.58 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.57 HG12 HG23 ' A' ' 63' ' ' ILE . 13.2 m -64.04 -35.97 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.316 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 23' ' ' ASN . 99.1 mttt -62.54 -42.67 99.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.411 0.624 . . . . 0.0 109.49 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -65.94 -41.6 91.12 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.218 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.432 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -64.03 -38.94 92.91 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.299 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.0 mt -61.36 -38.48 87.12 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.263 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 57.9 mt-10 -57.69 -42.85 84.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.683 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.442 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 80.1 m-85 -74.63 -37.19 62.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.873 0.368 . . . . 0.0 111.798 177.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 92.4 mt -62.84 -43.43 98.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.599 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -63.4 -22.88 67.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.919 0.39 . . . . 0.0 111.183 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 32' ' ' PHE . 78.1 mt-30 -71.17 -34.95 71.4 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.364 175.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.27 -0.3 12.85 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.268 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -88.13 164.81 15.51 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.56 151.25 20.86 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.652 -176.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.5 t -119.18 130.01 74.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.223 0.535 . . . . 0.0 110.315 175.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -103.33 114.53 28.88 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 85.9 m-85 -92.3 120.0 32.42 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.584 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.739 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 78.5 mtp85 -122.37 118.81 29.32 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.623 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.5 p -115.68 128.89 72.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.321 0.581 . . . . 0.0 110.931 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -95.58 121.38 37.22 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.817 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.4 mt -79.55 143.71 34.57 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -130.92 137.72 49.44 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.961 -0.295 . . . . 0.0 110.344 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.87 -147.07 33.11 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.102 -0.57 . . . . 0.0 113.576 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.444 ' HD2' ' O ' ' A' ' 48' ' ' ARG . 2.6 tmm_? -59.64 -35.85 75.21 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.909 0.884 . . . . 0.0 110.415 -177.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -54.18 -16.5 2.11 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 84.5 mtp -63.23 -34.08 76.89 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.073 0.463 . . . . 0.0 110.848 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.13 -33.53 73.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.232 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.428 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 68.4 p -117.11 105.25 49.41 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-O 121.097 0.475 . . . . 0.0 111.911 -177.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.63 -15.29 45.3 Favored 'Trans proline' 0 N--CA 1.485 0.998 0 C-N-CA 124.014 3.142 . . . . 0.0 113.14 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.428 ' HG2' ' HB ' ' A' ' 52' ' ' THR . 14.5 pt-20 -54.82 -31.26 58.96 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.585 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.08 -42.22 99.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.913 0.387 . . . . 0.0 111.102 -178.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.485 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -67.69 -41.32 89.49 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.749 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.4 t -63.66 -45.95 96.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.583 -0.309 . . . . 0.0 111.177 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.38 -38.5 87.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.769 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.405 HD21 ' HB3' ' A' ' 13' ' ' LEU . 39.2 tp -63.55 -45.88 88.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.288 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.51 ' CD1' HG12 ' A' ' 84' ' ' VAL . 94.2 mt -65.58 -40.74 93.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.14 -178.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -62.22 -33.99 75.62 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.776 0.322 . . . . 0.0 111.269 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HD3' HE22 ' A' ' 19' ' ' GLN . 40.7 ttmt -62.11 -47.71 83.41 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-O 121.146 0.498 . . . . 0.0 109.688 176.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.57 HG23 HG12 ' A' ' 26' ' ' VAL . 70.8 mt -63.75 -43.06 97.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.047 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -56.66 -36.56 69.69 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.479 177.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.52 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 96.7 m -59.63 -44.38 93.5 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 120.988 0.423 . . . . 0.0 110.829 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -67.17 -39.55 86.46 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 63' ' ' ILE . 41.6 pt -98.37 -5.59 9.43 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.639 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -173.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 65' ' ' THR . 13.0 pt-20 -56.05 -34.86 66.3 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -176.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -69.63 -18.77 63.62 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -123.44 -1.37 8.6 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.931 0.396 . . . . 0.0 111.76 178.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -131.87 153.75 49.89 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.965 -177.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -111.71 144.23 41.32 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -81.71 111.86 18.36 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -176.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -66.45 -41.76 88.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.194 0.521 . . . . 0.0 109.872 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -163.66 161.18 23.53 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.264 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -74.6 152.93 87.49 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.495 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.34 134.89 64.47 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.714 2.276 . . . . 0.0 111.884 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -135.5 137.77 42.45 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.689 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -90.69 106.78 18.74 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.166 0.507 . . . . 0.0 110.564 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -118.14 118.74 32.71 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.424 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.64 -108.93 2.67 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -123.33 8.77 9.1 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.974 0.416 . . . . 0.0 110.611 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -122.8 141.4 51.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.405 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.623 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 89.3 t -97.38 115.86 38.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 173.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.739 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 47.5 m-80 -108.52 144.16 36.56 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.195 -173.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.496 ' HB2' HD13 ' A' ' 60' ' ' LEU . 65.0 ttp -144.99 134.98 23.8 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.533 174.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 16.9 mt -109.72 135.34 50.81 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.032 0.444 . . . . 0.0 110.976 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.0 m -122.62 133.86 67.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.427 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.0 m -104.45 132.96 20.46 Favored Pre-proline 0 N--CA 1.432 -1.367 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -65.56 147.33 86.42 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.173 1.915 . . . . 0.0 111.656 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -70.64 84.62 0.63 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -138.99 172.78 12.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.835 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 74.98 -171.07 0.1 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.523 0.729 . . . . 0.0 111.189 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -85.36 130.74 34.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.496 -177.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -156.47 17.61 0.43 Allowed Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.159 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -70.05 139.98 52.73 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.809 0.337 . . . . 0.0 110.986 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -138.42 -83.22 0.3 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.734 177.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -156.96 152.05 26.19 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.591 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -134.58 158.46 43.94 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.315 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -93.61 -10.98 32.8 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.628 -177.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 27.3 p-80 . . . . . 0 C--O 1.241 0.608 0 CA-C-O 118.481 -0.771 . . . . 0.0 110.758 179.181 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.8 pttt . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.1 t -91.04 125.57 43.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 67.8 mt -105.65 93.84 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -86.82 124.32 32.93 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.039 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 80.9 mt -90.65 122.85 42.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.121 0.486 . . . . 0.0 110.396 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.472 ' HG2' ' CE1' ' A' ' 32' ' ' PHE . 4.2 mptp? -85.01 148.98 25.9 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.624 -175.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -110.85 118.05 35.08 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.955 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.3 mm -96.18 97.9 7.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 175.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 62.8 tttp -81.15 134.97 35.72 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.89 -177.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 67.3 mt -129.33 171.44 12.49 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.384 -175.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.9 p -144.2 149.98 37.26 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.58 -40.54 89.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -88.06 67.25 8.86 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.0 tt -117.6 152.69 19.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.35 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.403 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -84.94 154.69 22.03 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.231 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -63.49 -37.41 87.2 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.844 0.354 . . . . 0.0 111.098 -178.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -60.33 -42.64 96.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.272 0.558 . . . . 0.0 110.052 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.49 -40.52 97.3 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.004 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.619 ' O ' HG23 ' A' ' 26' ' ' VAL . 72.0 mt -61.41 -48.69 87.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -61.05 -47.6 85.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.377 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -62.44 -48.84 77.89 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.689 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -65.66 -42.47 91.32 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -177.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 22' ' ' ILE . 60.5 t -64.69 -43.74 96.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.138 0.494 . . . . 0.0 110.079 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.2 -42.21 99.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.112 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -66.69 -36.41 82.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.696 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.38 -34.49 73.98 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.801 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.452 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 96.7 mt -61.41 -38.2 86.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.523 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.463 ' HA ' ' OE1' ' A' ' 34' ' ' GLU . 41.5 mt-10 -61.75 -37.05 82.85 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.068 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.472 ' CE1' ' HG2' ' A' ' 9' ' ' LYS . 93.1 m-85 -69.26 -35.95 76.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.058 0.456 . . . . 0.0 110.579 177.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 90' ' ' PRO . 87.9 mt -62.86 -41.16 99.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.416 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.463 ' OE1' ' HA ' ' A' ' 31' ' ' GLU . 46.8 mt-10 -53.07 -32.89 49.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.404 177.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -78.16 -8.89 58.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.557 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.5 10.43 61.96 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.46 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -94.44 -176.47 3.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.958 0.409 . . . . 0.0 110.158 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -116.31 154.31 30.41 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.012 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.474 ' O ' HD12 ' A' ' 87' ' ' LEU . 25.6 t -118.51 125.33 74.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -103.24 112.32 25.14 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.261 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -84.07 128.29 34.46 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.341 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 9.1 mmm180 -131.33 107.69 9.13 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.225 -175.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.565 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 9.7 p -108.77 132.98 55.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 120.921 0.391 . . . . 0.0 110.568 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -106.99 134.0 50.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.243 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.404 ' CD1' ' HA ' ' A' ' 50' ' ' MET . 30.2 mt -94.58 115.02 27.07 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -106.86 -64.7 1.15 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -171.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.559 ' O ' ' HG3' ' A' ' 49' ' ' GLU . . . -82.74 88.2 1.47 Allowed Glycine 0 CA--C 1.49 -1.485 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -178.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 61.22 -111.4 0.45 Allowed 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -171.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.559 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 89.4 mt-10 63.21 -42.98 0.21 Allowed 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 173.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.404 ' HA ' ' CD1' ' A' ' 45' ' ' LEU . 42.9 ttm -63.28 -20.13 65.2 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.046 0.539 . . . . 0.0 111.866 -177.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.26 -30.43 71.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.168 0.509 . . . . 0.0 109.726 175.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 p -126.71 92.61 44.45 Favored Pre-proline 0 N--CA 1.452 -0.334 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.225 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -62.84 -20.51 71.46 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 123.6 2.867 . . . . 0.0 112.552 -176.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.05 -23.72 65.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.418 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.14 -41.05 91.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.017 0.437 . . . . 0.0 110.402 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.45 -39.61 91.34 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.7 t -64.73 -44.4 96.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.603 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.85 -39.77 86.29 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.252 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.4 tp -62.53 -46.49 88.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.165 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.434 HD13 ' HB2' ' A' ' 86' ' ' MET . 94.3 mt -65.53 -40.46 92.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.298 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -58.12 -39.96 80.01 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.356 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -61.96 -43.62 98.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.418 0.627 . . . . 0.0 110.345 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.2 mt -65.36 -43.57 94.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.913 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.2 t-105 -58.34 -39.47 79.55 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.807 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.439 ' HA ' ' OE2' ' A' ' 68' ' ' GLU . 19.5 m -57.75 -38.23 75.02 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.3 0.571 . . . . 0.0 110.583 178.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 78.3 mtm -77.1 -34.2 56.83 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.9 pt -98.41 -12.01 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 113.493 0.924 . . . . 0.0 113.493 -174.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.439 ' OE2' ' HA ' ' A' ' 65' ' ' THR . 14.1 pt-20 -59.83 -23.85 63.7 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -175.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -65.29 -30.98 71.89 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -127.09 3.27 6.47 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -128.68 153.79 46.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.144 0.497 . . . . 0.0 111.56 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.488 ' OD1' ' HG2' ' A' ' 91' ' ' LYS . 75.8 m-20 -111.85 149.33 31.96 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -89.01 106.56 18.51 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-O 121.025 0.44 . . . . 0.0 110.821 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -75.9 -41.05 53.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.421 0.629 . . . . 0.0 110.715 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -137.27 150.03 47.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.061 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -85.31 154.8 60.08 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 29.1 Cg_endo -63.4 115.29 2.93 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.76 1.64 . . . . 0.0 110.961 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -136.1 144.56 45.19 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.336 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -81.91 109.83 16.63 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.562 ' HB3' HD21 ' A' ' 85' ' ' ASN . 73.4 tt0 -148.71 123.43 9.87 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.808 -176.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 82' ' ' ARG . . . 75.52 28.53 61.31 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.315 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 81' ' ' GLY . 88.0 mtm180 72.28 3.18 4.6 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.357 0.663 . . . . 0.0 111.339 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -119.87 145.46 46.65 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.054 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.565 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 92.0 t -95.35 112.27 27.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 172.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.562 HD21 ' HB3' ' A' ' 80' ' ' GLU . 9.5 p30 -116.48 148.97 40.27 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -172.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.434 ' HB2' HD13 ' A' ' 60' ' ' LEU . 66.0 ttp -141.85 136.74 30.86 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.31 175.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.474 HD12 ' O ' ' A' ' 39' ' ' VAL . 44.7 tp -118.82 140.15 50.43 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.904 0.383 . . . . 0.0 110.59 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.8 m -130.26 161.72 39.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.229 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.2 m -137.28 138.94 26.45 Favored Pre-proline 0 C--N 1.309 -1.178 0 CA-C-N 115.46 -0.791 . . . . 0.0 108.985 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.519 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 92.8 Cg_endo -68.41 142.87 55.85 Favored 'Trans proline' 0 C--N 1.329 -0.48 0 C-N-CA 122.242 1.961 . . . . 0.0 110.15 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.488 ' HG2' ' OD1' ' A' ' 72' ' ' ASN . 69.0 mttm -64.86 124.01 20.89 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.605 -177.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt 61.11 80.54 0.21 Allowed 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.739 0.649 . . . . 0.0 111.452 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.92 -41.68 13.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.391 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -66.47 -44.82 81.64 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.006 0.431 . . . . 0.0 111.008 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.76 66.14 2.62 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.845 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -63.15 -36.05 82.33 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.19 0.519 . . . . 0.0 109.757 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -109.51 129.05 55.59 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -76.94 107.61 9.4 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.852 0.358 . . . . 0.0 110.346 -178.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -67.73 116.9 8.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.568 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -94.62 -16.05 23.51 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.285 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.3 t60 . . . . . 0 C--O 1.247 0.922 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.281 -177.821 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.7 mttt . . . . . 0 CA--C 1.511 -0.54 0 CA-C-O 121.899 0.857 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.3 t -86.45 97.53 6.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.901 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.4 mm -83.07 136.4 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.418 ' CG ' ' HZ1' ' A' ' 9' ' ' LYS . 13.6 t0 -77.18 114.57 16.13 Favored 'General case' 0 C--O 1.212 -0.919 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.693 -177.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 74.4 mt -121.3 133.63 67.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.05 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.48 ' HE2' ' N ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -80.26 147.76 31.07 Favored 'General case' 0 CA--C 1.485 -1.541 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.304 -177.931 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -133.78 112.21 11.16 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.661 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.9 mt -107.72 114.15 45.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.389 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 86.7 tttt -86.52 131.13 34.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 122.157 0.98 . . . . 0.0 112.297 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.2 mt -129.55 179.58 5.73 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.404 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.425 ' HA ' HG23 ' A' ' 43' ' ' VAL . 42.4 p -149.6 156.91 42.7 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.0 t -69.85 -17.71 21.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 121.529 0.68 . . . . 0.0 110.301 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -96.66 26.27 4.61 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.401 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.8 tt -88.72 138.89 18.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.255 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.76 145.57 48.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.927 177.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -56.43 -40.59 75.01 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -176.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -62.89 -36.0 81.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.754 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.57 -32.81 68.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.181 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.626 ' O ' HG23 ' A' ' 26' ' ' VAL . 62.5 mt -58.91 -46.9 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 109.614 -0.514 . . . . 0.0 109.614 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -57.48 -41.99 81.75 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 124.281 0.988 . . . . 0.0 110.573 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -62.99 -48.01 80.66 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.839 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -64.78 -43.36 93.46 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 120.568 0.223 . . . . 0.0 110.761 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 22' ' ' ILE . 50.0 t -63.55 -42.49 96.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.133 -178.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -57.22 -45.77 83.56 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.429 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -65.91 -37.13 85.28 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.601 177.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.71 -39.48 80.92 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.943 0.401 . . . . 0.0 109.971 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.493 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 98.2 mt -62.28 -41.35 98.41 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.211 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -63.32 -39.65 95.14 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.509 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -66.56 -35.18 79.6 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.183 0.516 . . . . 0.0 110.741 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.616 HD13 ' HB2' ' A' ' 71' ' ' ALA . 88.9 mt -62.56 -42.32 99.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.251 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 30' ' ' LEU . 86.9 mt-10 -56.7 -34.69 67.68 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.501 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -66.98 -19.82 65.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.598 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.77 35.54 6.11 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.306 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.482 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -124.52 164.92 18.75 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.304 0.573 . . . . 0.0 110.058 179.442 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.421 ' CD2' ' HA ' ' A' ' 89' ' ' THR . 16.2 m170 -97.81 137.5 36.58 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.961 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 68.5 t -104.48 118.97 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.697 175.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -95.37 110.48 22.5 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.44 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 94.0 m-85 -83.94 108.74 17.1 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.502 ' HA ' ' OD1' ' A' ' 85' ' ' ASN . 53.2 mtp85 -106.18 108.5 20.05 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.782 -177.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 84' ' ' VAL . 4.9 p -109.11 127.64 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-O 121.641 0.734 . . . . 0.0 111.161 -177.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -98.67 123.92 43.17 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.545 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 50' ' ' MET . 89.4 mt -72.53 -56.28 5.62 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -176.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.8 tttp 69.08 124.81 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.118 0.485 . . . . 0.0 112.099 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.29 -155.57 25.25 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.798 176.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -72.41 -14.66 61.75 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.718 0.294 . . . . 0.0 111.384 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -61.88 -20.1 63.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.392 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.483 ' HA ' HD12 ' A' ' 45' ' ' LEU . 94.7 mtp -67.92 -15.3 63.55 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.737 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.56 -11.41 59.17 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 120.946 0.403 . . . . 0.0 110.684 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.436 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 41.5 p -128.33 106.58 19.44 Favored Pre-proline 0 N--CA 1.442 -0.856 0 CA-C-O 121.481 0.658 . . . . 0.0 111.204 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 52' ' ' THR . 35.3 Cg_endo -68.56 -16.65 42.95 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 122.902 2.401 . . . . 0.0 111.876 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -58.87 -33.82 70.91 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.974 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.49 -41.86 90.84 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.103 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.444 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -68.01 -41.58 87.13 Favored Glycine 0 C--O 1.219 -0.815 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 177.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.07 -44.49 99.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 O-C-N 123.727 0.31 . . . . 0.0 111.182 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.91 -41.82 96.88 Favored 'General case' 0 C--O 1.257 1.467 0 C-N-CA 122.448 0.299 . . . . 0.0 111.312 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.0 tp -62.85 -44.07 97.12 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.202 0.525 . . . . 0.0 109.805 177.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.56 HD13 ' HB2' ' A' ' 86' ' ' MET . 90.9 mt -65.76 -40.45 92.07 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.621 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -60.24 -37.67 81.11 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.333 0.396 . . . . 0.0 110.967 178.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -62.68 -44.32 96.55 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.603 0.716 . . . . 0.0 109.241 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.56 HG23 HG22 ' A' ' 26' ' ' VAL . 61.9 mt -67.26 -43.23 88.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.719 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.555 ' CZ2' ' HB2' ' A' ' 73' ' ' ARG . 37.6 t-105 -56.73 -39.23 73.56 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.827 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.7 m -63.23 -23.92 67.64 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 123.485 0.491 . . . . 0.0 111.212 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 96.5 mtp -91.1 -30.4 16.76 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.7 pt -98.73 -9.74 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -175.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -15.38 47.65 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -79.52 -21.9 44.64 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.668 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -119.9 -13.12 9.08 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.743 0.306 . . . . 0.0 111.246 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.616 ' HB2' HD13 ' A' ' 33' ' ' LEU . . . -126.67 154.68 43.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.102 0.477 . . . . 0.0 112.137 -175.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.464 ' OD1' ' HB ' ' A' ' 89' ' ' THR . 7.0 p30 -116.73 135.77 53.5 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.821 176.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.555 ' HB2' ' CZ2' ' A' ' 64' ' ' TRP . 36.1 ttp180 -74.87 112.14 10.78 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.247 -176.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -71.89 -37.84 70.07 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -159.32 158.94 33.32 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.115 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -72.79 150.52 90.78 Favored Pre-proline 0 C--N 1.306 -1.284 0 C-N-CA 122.536 0.334 . . . . 0.0 110.736 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.35 134.69 65.85 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 122.685 2.257 . . . . 0.0 112.511 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -133.62 149.12 51.6 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.99 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -91.82 116.25 28.74 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.38 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -128.3 137.76 52.1 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.64 -109.94 3.08 Favored Glycine 0 N--CA 1.426 -2.019 0 C-N-CA 119.966 -1.111 . . . . 0.0 111.769 -178.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -127.81 17.76 6.79 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.371 0.605 . . . . 0.0 110.273 177.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -129.24 150.94 50.41 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.908 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 43' ' ' VAL . 87.2 t -104.06 113.2 40.35 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.87 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 171.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' ' 42' ' ' ARG . 88.2 m-20 -113.88 137.5 51.58 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.343 -173.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.56 ' HB2' HD13 ' A' ' 60' ' ' LEU . 64.5 ttp -122.02 129.67 52.63 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.926 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -103.0 122.25 44.22 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 m -119.52 148.74 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.514 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.464 ' HB ' ' OD1' ' A' ' 72' ' ' ASN . 35.8 m -117.33 136.77 23.56 Favored Pre-proline 0 C--N 1.295 -1.785 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.474 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 91.4 Cg_endo -71.07 156.59 59.55 Favored 'Trans proline' 0 C--N 1.329 -0.494 0 C-N-CA 122.871 2.381 . . . . 0.0 111.508 177.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -74.34 142.12 45.16 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.299 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 86.8 tttt 62.33 102.65 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 124.415 1.086 . . . . 0.0 112.055 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -167.26 -28.42 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.965 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 67.11 12.55 9.03 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.856 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.51 90.38 1.39 Allowed Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -132.64 171.44 13.84 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.749 0.309 . . . . 0.0 110.206 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -122.69 93.23 3.91 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.69 177.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -105.54 -53.58 2.63 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.652 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -74.14 -66.6 0.7 Allowed 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.511 0.507 . . . . 0.0 111.958 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 43.4 t60 67.8 -67.66 0.18 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.152 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 65.7 t60 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.824 -0.608 . . . . 0.0 110.577 -179.995 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 N--CA 1.45 -0.462 0 CA-C-O 121.015 0.436 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.2 p -143.25 134.83 23.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.853 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.8 pt -81.21 129.36 37.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.186 0.517 . . . . 0.0 110.92 178.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.423 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 35.4 t70 -84.91 101.56 12.43 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.318 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.442 HG12 ' HB2' ' A' ' 38' ' ' HIS . 77.0 mt -87.86 130.3 37.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.481 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -86.52 135.9 33.28 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.452 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 46.0 mt-10 -110.25 114.38 27.81 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.197 178.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.4 mt -107.14 109.27 27.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -101.51 126.7 48.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.222 -175.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.46 HD23 ' CD1' ' A' ' 17' ' ' ILE . 5.1 mp -116.69 -178.89 3.53 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.036 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.0 p -139.28 157.98 44.96 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.2 t -64.08 -36.66 77.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 175.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -83.21 65.64 8.35 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.695 174.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.46 ' CD1' HD23 ' A' ' 13' ' ' LEU . 18.1 tt -123.44 149.36 27.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.1 152.14 26.69 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.731 176.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -64.02 -34.82 78.86 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.182 0.515 . . . . 0.0 109.924 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -62.32 -40.34 96.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.155 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.612 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 20.8 t70 -65.42 -36.92 85.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.055 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.7 mt -61.51 -42.85 95.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -60.31 -42.72 96.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.596 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -63.81 -44.15 94.13 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.3 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 75.6 mmtt -63.97 -43.9 94.37 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -176.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.555 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 11.1 m -67.92 -28.91 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.606 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.89 -44.69 94.09 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.227 0.537 . . . . 0.0 109.626 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -75.2 -36.92 61.35 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.234 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.511 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -59.63 -37.56 78.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.021 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.636 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 94.0 mt -61.9 -41.29 97.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.192 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -59.74 -45.09 93.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.086 0.469 . . . . 0.0 111.303 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -66.37 -36.2 82.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.876 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.653 HD13 ' HB2' ' A' ' 71' ' ' ALA . 96.8 mt -63.11 -40.0 96.36 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.067 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.636 ' HG3' ' O ' ' A' ' 30' ' ' LEU . 60.4 mt-10 -59.48 -33.3 71.15 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.987 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -79.84 -5.35 55.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.011 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.45 18.4 62.32 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.713 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.423 ' HD2' ' O ' ' A' ' 7' ' ' ASP . 41.4 mmtm -92.85 153.66 18.71 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.338 0.589 . . . . 0.0 111.401 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.442 ' HB2' HG12 ' A' ' 8' ' ' ILE . 7.7 m80 -98.21 140.18 32.9 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.69 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 49.6 t -115.15 128.42 72.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.452 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 64.5 ttt180 -102.43 111.01 23.13 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -90.94 120.44 31.95 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.422 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 82.1 mtp180 -131.2 138.45 49.4 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.662 -177.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.542 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.4 p -129.48 135.93 60.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 121.144 0.497 . . . . 0.0 110.751 177.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -98.55 130.59 45.12 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.001 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.7 mt -95.5 125.09 39.87 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -102.43 128.31 49.08 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -172.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.98 -120.18 8.5 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.214 -0.903 . . . . 0.0 113.65 177.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 48' ' ' ARG . 61.2 mtt85 -76.48 -9.01 58.33 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 122.927 0.491 . . . . 0.0 111.696 -175.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -66.51 -23.23 66.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.999 0.428 . . . . 0.0 110.944 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 65.9 mtt -64.12 -19.51 65.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.92 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.41 -14.71 61.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.501 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -140.64 105.98 6.42 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 122.192 0.996 . . . . 0.0 111.331 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.27 -20.61 36.92 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.337 2.691 . . . . 0.0 113.773 -176.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.432 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -66.49 -20.51 66.06 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -177.044 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.93 99.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.117 0.484 . . . . 0.0 109.783 176.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.444 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -69.44 -37.82 79.43 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.43 176.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.0 t -62.62 -44.72 99.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.265 -0.468 . . . . 0.0 111.055 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.27 -40.8 95.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.541 ' O ' HG13 ' A' ' 63' ' ' ILE . 39.1 tp -62.25 -46.72 87.59 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.287 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.492 HD12 HG12 ' A' ' 84' ' ' VAL . 88.6 mt -65.29 -41.13 94.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.054 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -64.78 -35.39 80.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.954 0.407 . . . . 0.0 110.5 179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -63.03 -41.56 99.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.538 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 59' ' ' LEU . 63.1 mt -64.32 -43.99 97.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.138 176.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 53.4 t-105 -56.48 -42.32 78.07 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.158 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.7 p -64.37 -21.8 66.75 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.58 -0.448 . . . . 0.0 112.133 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 66.9 mtt -83.05 -31.69 27.24 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.5 pt -108.16 -4.7 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -54.45 -30.5 53.01 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -175.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.455 ' OD1' ' HG2' ' A' ' 70' ' ' GLU . 5.3 p30 -72.83 -23.11 60.72 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.455 ' HG2' ' OD1' ' A' ' 69' ' ' ASN . 61.1 mm-40 -112.25 -19.96 12.04 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.079 0.466 . . . . 0.0 110.845 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.653 ' HB2' HD13 ' A' ' 33' ' ' LEU . . . -117.76 150.64 38.77 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.551 -176.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -112.51 137.86 50.12 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 175.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -76.21 119.81 20.64 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.076 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -85.33 -38.81 18.38 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.014 0.435 . . . . 0.0 110.607 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -148.03 156.08 42.23 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.269 -177.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -77.4 155.0 81.86 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.935 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 23.2 Cg_endo -61.76 138.49 74.89 Favored 'Trans proline' 0 C--O 1.24 0.617 0 C-N-CA 122.095 1.863 . . . . 0.0 111.446 176.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 27.4 p-10 -145.21 167.24 23.27 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.244 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.583 ' CZ ' ' HA ' ' A' ' 82' ' ' ARG . 89.8 t80 -107.84 111.07 23.02 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.112 0.482 . . . . 0.0 110.486 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -138.58 126.06 21.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.399 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.67 34.42 88.87 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.841 177.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.583 ' HA ' ' CZ ' ' A' ' 79' ' ' PHE . 89.2 mtt180 70.74 11.3 7.18 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -120.58 145.54 47.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.401 175.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.542 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 92.7 t -99.27 114.16 36.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 173.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.547 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 80.8 m-20 -110.25 147.58 33.54 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.987 0.422 . . . . 0.0 112.093 -173.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.676 ' SD ' HG13 ' A' ' 88' ' ' VAL . 17.8 tmm? -145.48 130.55 18.38 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -112.32 130.95 55.78 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.128 0.489 . . . . 0.0 111.206 -175.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.676 HG13 ' SD ' ' A' ' 86' ' ' MET . 15.2 m -119.81 135.91 58.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.496 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.409 HG23 ' CE1' ' A' ' 38' ' ' HIS . 37.9 m -105.84 133.51 20.17 Favored Pre-proline 0 N--CA 1.431 -1.4 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 176.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.04 151.01 84.96 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.185 1.924 . . . . 0.0 110.189 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.27 92.01 0.4 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.123 0.487 . . . . 0.0 110.764 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -145.22 136.33 24.85 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.378 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.64 113.29 24.73 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.69 0.281 . . . . 0.0 110.487 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -164.94 153.71 12.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.05 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 119.79 136.51 5.26 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.668 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -91.22 65.58 5.47 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.562 0.696 . . . . 0.0 110.423 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -142.46 137.85 30.61 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.82 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -132.47 153.61 50.71 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 177.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -113.91 4.8 15.96 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.768 0.318 . . . . 0.0 111.588 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -154.86 -53.11 0.09 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.276 -178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.429 -0.796 . . . . 0.0 111.091 -178.572 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 120.657 0.265 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.5 t -67.05 -43.26 89.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.512 0.672 . . . . 0.0 111.46 -178.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 80.5 mt -102.91 126.58 57.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.806 -177.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.591 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 7.5 m-20 -78.16 113.29 15.98 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.755 178.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 88.3 mt -103.99 115.01 45.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.198 0.523 . . . . 0.0 109.599 176.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.422 ' HG2' ' CE1' ' A' ' 32' ' ' PHE . 4.0 mptp? -81.99 143.34 31.66 Favored 'General case' 0 CA--C 1.489 -1.367 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.202 -177.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -109.59 126.93 54.13 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.522 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.481 HG23 ' HD2' ' A' ' 25' ' ' LYS . 31.8 mm -100.54 107.22 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.197 178.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 2.1 mptt -80.47 139.94 36.17 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.651 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 60.7 mt -133.67 164.79 26.42 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.624 -177.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 63.5 m -141.46 151.46 43.4 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.6 t -61.03 -42.19 92.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -81.99 62.95 6.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.635 176.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.5 tt -115.68 151.07 17.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.856 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.11 150.82 21.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.339 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -62.76 -34.31 76.96 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.924 0.392 . . . . 0.0 110.899 -178.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -62.46 -41.26 98.64 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -66.63 -35.73 80.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.76 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.417 HG23 HG12 ' A' ' 63' ' ' ILE . 94.1 mt -61.49 -42.71 94.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.261 0.553 . . . . 0.0 109.563 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -60.46 -44.33 95.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.222 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -63.44 -44.31 94.89 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.069 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.481 ' HD2' HG23 ' A' ' 11' ' ' ILE . 49.7 mmtm -63.26 -45.39 91.72 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.531 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 17.3 m -67.09 -36.61 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.621 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -60.54 -47.09 87.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.203 0.525 . . . . 0.0 110.099 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -68.29 -39.25 82.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.579 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.96 -36.22 80.79 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.842 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.616 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 88.6 mt -60.71 -40.26 91.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.086 -178.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.584 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 62.7 mt-10 -61.21 -41.73 97.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.839 -177.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.422 ' CE1' ' HG2' ' A' ' 9' ' ' LYS . 93.4 m-85 -63.6 -37.76 88.55 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.192 0.52 . . . . 0.0 110.35 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 90' ' ' PRO . 97.2 mt -63.62 -42.22 98.22 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.567 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.616 ' HG3' ' O ' ' A' ' 30' ' ' LEU . 40.3 mt-10 -61.84 -21.37 64.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.309 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 31' ' ' GLU . 73.3 mm-40 -84.52 -6.6 59.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.799 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.3 15.16 59.21 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.627 -177.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.591 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 63.8 mttp -105.11 177.21 4.92 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 120.978 0.418 . . . . 0.0 110.512 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -112.84 158.78 19.74 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.843 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.6 t -113.42 130.24 67.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -98.8 102.41 14.13 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.696 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 69.3 m-85 -85.91 117.37 24.72 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 120.594 -0.442 . . . . 0.0 109.959 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 82.6 mtp180 -125.94 110.42 13.59 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.243 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.569 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.8 p -107.13 128.42 62.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-O 121.234 0.54 . . . . 0.0 110.955 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.411 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 83.8 t80 -95.55 132.4 40.71 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.033 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.0 mt -81.26 83.11 6.94 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.223 0.535 . . . . 0.0 110.355 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -76.54 131.18 38.81 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.143 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.66 -140.82 16.52 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.475 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -105.75 -2.49 23.17 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.393 0.616 . . . . 0.0 109.92 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -74.04 -2.46 24.37 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.298 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.498 ' SD ' ' HD2' ' A' ' 82' ' ' ARG . 56.6 ttm -61.6 -22.18 65.0 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 122.52 0.328 . . . . 0.0 111.801 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.34 -13.66 60.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.938 0.399 . . . . 0.0 111.124 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.3 p -123.14 103.56 36.04 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.256 0.551 . . . . 0.0 111.482 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.75 -18.25 47.6 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.2 2.6 . . . . 0.0 112.548 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -63.52 -29.19 70.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.041 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.93 -43.62 86.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.03 0.443 . . . . 0.0 110.606 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.406 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -66.16 -41.52 94.87 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.862 177.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.09 -44.64 97.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.739 0.304 . . . . 0.0 110.639 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.0 -41.08 97.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.887 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.44 HD23 HG21 ' A' ' 43' ' ' VAL . 42.6 tp -62.8 -45.28 93.38 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.212 0.529 . . . . 0.0 110.19 177.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.495 HD13 ' HB2' ' A' ' 86' ' ' MET . 98.0 mt -64.03 -40.16 95.7 Favored 'General case' 0 C--O 1.212 -0.876 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.812 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -58.19 -41.89 84.95 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.719 0.295 . . . . 0.0 111.156 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -63.96 -46.34 85.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.462 0.648 . . . . 0.0 109.738 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.466 ' CD1' HD13 ' A' ' 13' ' ' LEU . 96.3 mt -65.06 -42.67 95.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.171 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.526 ' CZ2' ' HB2' ' A' ' 73' ' ' ARG . 28.1 t-105 -56.45 -40.19 74.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.78 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 23.2 m -61.13 -34.2 74.61 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.269 0.557 . . . . 0.0 110.736 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 98.2 mmm -69.33 -39.25 78.31 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.261 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.9 pt -97.49 -10.06 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -174.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -58.06 -14.93 7.61 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -177.499 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -61.67 -41.95 98.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.902 0.382 . . . . 0.0 110.218 178.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -126.52 14.94 7.65 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.902 -175.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -134.73 144.68 47.87 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.329 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -113.41 142.12 46.27 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 175.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.526 ' HB2' ' CZ2' ' A' ' 64' ' ' TRP . 53.7 ttp180 -95.47 114.55 26.33 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.642 -177.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -65.51 -41.15 93.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.86 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -155.73 160.45 40.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.934 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.434 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 22.9 mp0 -69.11 161.28 74.0 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 123.346 0.404 . . . . 0.0 110.054 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.413 ' HB3' HD12 ' A' ' 60' ' ' LEU . 38.0 Cg_exo -60.61 146.05 97.76 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.544 2.163 . . . . 0.0 112.306 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -138.41 137.83 37.63 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.592 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -89.59 125.35 35.19 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.703 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -142.32 125.42 16.31 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.29 -109.25 2.8 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.498 ' HD2' ' SD ' ' A' ' 50' ' ' MET . 29.0 mmt180 -125.42 12.81 8.16 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.12 0.486 . . . . 0.0 110.627 176.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.411 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 95.5 m-85 -119.85 151.32 39.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.339 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.569 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 76.5 t -108.94 122.25 63.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 171.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 87.5 m-20 -112.49 143.04 44.3 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -171.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.495 ' HB2' HD13 ' A' ' 60' ' ' LEU . 62.5 ttp -138.5 126.89 23.09 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.192 175.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -104.04 126.35 51.09 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.1 m -117.77 140.34 41.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.227 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.3 m -107.0 138.84 19.93 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.422 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 55.6 Cg_endo -64.23 140.3 70.34 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 122.115 1.876 . . . . 0.0 111.978 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -85.83 96.43 9.76 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 176.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -68.66 122.65 18.96 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.272 0.558 . . . . 0.0 111.524 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.29 -4.14 58.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.448 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -63.37 -41.39 98.82 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.602 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 146.76 154.69 6.27 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.323 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -101.47 14.96 30.39 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.388 0.613 . . . . 0.0 109.602 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -148.72 161.81 41.03 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.64 -177.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -152.85 143.64 22.86 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -165.1 155.13 13.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.251 -0.432 . . . . 0.0 109.89 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -125.81 -63.52 1.12 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.5 m80 . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.415 177.939 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 CA--C 1.52 -0.188 0 CA-C-O 121.536 0.684 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.1 p -102.24 12.93 6.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 122.319 1.057 . . . . 0.0 109.172 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.417 HG23 ' HG2' ' A' ' 37' ' ' LYS . 83.1 mt -90.93 114.73 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 CA-C-N 114.728 -1.123 . . . . 0.0 109.739 -177.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.5 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 34.6 t70 -76.69 115.23 16.27 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.887 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 82.9 mt -88.84 129.68 39.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.148 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.499 ' HG3' ' CD1' ' A' ' 32' ' ' PHE . 73.6 mmtt -85.43 135.82 33.7 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.657 -177.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -107.6 107.83 18.84 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.086 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.9 mm -92.43 106.62 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 65.2 tttp -84.02 133.64 34.66 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.888 -178.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.465 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 66.0 mt -125.17 169.49 12.16 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.733 -177.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.457 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 40.0 m -140.78 150.66 43.64 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -59.96 -43.73 93.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.273 0.558 . . . . 0.0 109.586 174.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -78.77 62.26 3.23 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 121.743 0.782 . . . . 0.0 110.311 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.539 HG21 HD11 ' A' ' 59' ' ' LEU . 18.8 tt -111.21 161.21 9.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.836 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.599 -178.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.35 150.22 22.82 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.239 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -66.69 -38.47 86.85 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.645 -177.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -67.7 -33.26 74.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.906 0.384 . . . . 0.0 110.231 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -64.2 -38.1 89.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.835 177.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.688 HG23 HG12 ' A' ' 63' ' ' ILE . 92.5 mt -62.88 -43.64 99.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.568 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -61.38 -42.62 99.01 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.784 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -62.36 -47.4 84.36 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.987 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -65.72 -40.67 92.43 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -178.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 22' ' ' ILE . 2.3 m -64.09 -35.54 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.535 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -61.76 -41.54 97.81 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.416 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 7.0 m80 -67.98 -41.74 81.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.095 176.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.54 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -59.58 -37.53 78.74 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.703 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.534 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 94.1 mt -61.8 -39.35 91.4 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.519 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.544 ' HA ' ' OE1' ' A' ' 34' ' ' GLU . 46.0 mt-10 -65.16 -44.57 88.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.375 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.499 ' CD1' ' HG3' ' A' ' 9' ' ' LYS . 90.0 m-85 -65.68 -34.49 78.33 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.917 0.389 . . . . 0.0 111.15 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 93.7 mt -62.93 -39.65 95.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.736 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.544 ' OE1' ' HA ' ' A' ' 31' ' ' GLU . 45.3 mt-10 -51.36 -40.79 59.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.77 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -70.69 -4.82 25.54 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.94 20.65 49.37 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.562 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.55 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 63.5 mttm -101.07 177.04 5.06 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 120.997 0.427 . . . . 0.0 110.599 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.423 ' NE2' HG23 ' A' ' 89' ' ' THR . 15.0 m170 -112.69 155.59 24.22 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.921 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.9 t -116.07 127.96 73.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 173.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -102.63 109.8 21.53 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -88.49 112.37 22.89 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.337 -0.545 . . . . 0.0 109.708 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.705 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 76.4 mtp85 -115.78 120.39 39.14 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.634 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.551 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.6 p -121.07 129.69 75.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.232 0.539 . . . . 0.0 111.349 -178.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -95.49 130.68 42.23 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.0 mt -78.67 84.57 4.76 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.87 0.367 . . . . 0.0 111.043 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.415 ' HD3' ' N ' ' A' ' 47' ' ' GLY . 4.8 tmtt? -83.65 120.6 26.17 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.415 ' N ' ' HD3' ' A' ' 46' ' ' LYS . . . 131.86 -133.56 7.22 Favored Glycine 0 N--CA 1.433 -1.555 0 C-N-CA 120.216 -0.993 . . . . 0.0 112.106 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -124.59 10.43 8.46 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.484 0.659 . . . . 0.0 110.543 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -80.91 6.06 14.36 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.23 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 96.5 mtp -65.62 -30.38 71.09 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.055 0.455 . . . . 0.0 110.562 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.96 -26.92 66.39 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.723 178.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.5 m -143.39 116.91 6.03 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.148 0.499 . . . . 0.0 111.044 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.06 2.96 4.93 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 123.487 2.791 . . . . 0.0 113.269 -176.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -59.5 -36.05 75.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.8 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.96 -43.8 94.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.146 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.415 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -68.98 -43.32 73.68 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.315 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.4 t -63.39 -47.25 92.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-O 120.578 0.228 . . . . 0.0 111.069 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.06 -37.14 86.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.421 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.539 HD11 HG21 ' A' ' 17' ' ' ILE . 42.2 tp -61.2 -49.55 76.7 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.962 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.531 HD12 HG12 ' A' ' 84' ' ' VAL . 88.5 mt -65.22 -42.15 93.74 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.826 -177.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.413 ' HA ' ' HB3' ' A' ' 64' ' ' TRP . 42.5 mt-10 -67.83 -35.33 78.4 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -63.77 -42.71 97.74 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.501 0.667 . . . . 0.0 109.297 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.688 HG12 HG23 ' A' ' 22' ' ' ILE . 86.7 mt -64.4 -43.55 97.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.876 -1.057 . . . . 0.0 109.889 177.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.413 ' HB3' ' HA ' ' A' ' 61' ' ' GLU . 13.0 t-105 -57.29 -40.05 77.01 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.789 176.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.49 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 91.5 m -60.88 -29.43 69.55 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 121.102 0.477 . . . . 0.0 111.225 -178.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 67.6 mtt -72.5 -35.07 68.07 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.558 HD11 HG11 ' A' ' 88' ' ' VAL . 37.1 pt -102.37 -7.36 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -174.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 65' ' ' THR . 15.2 pt-20 -58.91 -16.02 15.62 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -177.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -70.67 -14.07 62.32 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.479 ' HA ' ' HD2' ' A' ' 91' ' ' LYS . 11.6 pt-20 -150.19 29.89 0.71 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.57 0.7 . . . . 0.0 110.259 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -147.23 153.27 39.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.723 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.47 ' OD1' ' HB ' ' A' ' 89' ' ' THR . 7.2 p30 -123.89 135.8 53.95 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -70.68 110.75 5.67 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.086 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -69.31 -43.24 74.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.211 0.529 . . . . 0.0 109.779 178.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -153.85 143.78 21.95 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.71 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -62.77 157.62 57.91 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.859 176.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 31.4 Cg_exo -59.45 142.42 98.95 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.156 1.904 . . . . 0.0 111.968 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -137.51 133.41 34.53 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.447 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -87.69 118.67 27.35 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.989 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -130.85 110.89 11.63 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.944 -178.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.14 -97.58 0.6 Allowed Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.629 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.34 8.11 5.97 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.859 0.361 . . . . 0.0 110.626 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.432 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 65.3 m-85 -119.8 141.87 49.11 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.448 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.551 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 97.2 t -103.8 118.22 50.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 172.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.705 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 35.0 m-80 -109.14 143.97 37.82 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -173.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -149.84 137.03 19.69 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.1 mt -112.92 134.32 54.48 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.558 HG11 HD11 ' A' ' 67' ' ' ILE . 14.6 m -117.22 133.72 63.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.58 176.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.485 ' CG2' ' HD2' ' A' ' 90' ' ' PRO . 14.6 m -109.27 143.89 28.64 Favored Pre-proline 0 C--N 1.302 -1.485 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 60.7 Cg_endo -65.46 152.99 80.23 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.989 1.793 . . . . 0.0 109.352 177.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.479 ' HD2' ' HA ' ' A' ' 70' ' ' GLU . 37.0 tttm -53.94 119.83 5.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.235 0.54 . . . . 0.0 111.105 -174.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -65.9 138.3 57.76 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.94 -175.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.23 110.31 10.63 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.488 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 73.79 130.99 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 O-C-N 124.057 0.848 . . . . 0.0 110.824 -177.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 133.3 -110.38 0.9 Allowed Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -77.72 90.34 4.01 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 177.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -65.62 -52.25 53.38 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.912 -178.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -144.34 178.32 8.01 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.699 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 54.0 p-80 -130.9 132.38 45.09 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.652 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -66.17 -46.39 77.54 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.1 t60 . . . . . 0 C--O 1.243 0.762 0 CA-C-O 118.707 -0.664 . . . . 0.0 109.929 -179.705 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt . . . . . 0 CA--C 1.52 -0.174 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.6 t 72.74 94.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.992 -177.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.1 mm -106.05 124.1 61.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.416 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.407 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 21.9 t0 -80.05 117.43 20.87 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.007 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 90.4 mt -118.71 133.4 65.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.718 -176.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.461 ' HB2' HG22 ' A' ' 39' ' ' VAL . 68.1 mmtt -84.12 121.81 27.96 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.607 0.718 . . . . 0.0 111.21 -175.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.47 ' OE1' ' HD3' ' A' ' 42' ' ' ARG . 47.9 mm-40 -93.47 105.53 17.58 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.12 -178.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.6 mt -108.29 110.82 33.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.385 0.612 . . . . 0.0 110.297 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 87.6 tttt -101.16 130.23 47.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.197 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.587 HD21 ' HG3' ' A' ' 25' ' ' LYS . 82.1 mt -129.23 -177.29 4.18 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.431 -178.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 p -137.53 158.22 44.86 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.726 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.401 ' HB ' ' OE1' ' A' ' 49' ' ' GLU . 72.4 t -64.19 -41.91 93.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.645 0.736 . . . . 0.0 109.169 177.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -90.28 71.94 7.15 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.384 177.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.4 tt -124.19 146.42 29.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.901 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.9 143.04 52.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.315 177.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -64.89 -32.42 74.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.519 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -62.08 -39.18 91.55 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.224 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.492 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 9.5 t70 -65.41 -37.81 88.05 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.569 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.429 ' O ' HG22 ' A' ' 26' ' ' VAL . 93.4 mt -62.05 -42.58 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.081 0.467 . . . . 0.0 109.95 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -59.52 -41.59 90.32 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.533 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -63.29 -43.33 98.19 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.574 177.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.587 ' HG3' HD21 ' A' ' 13' ' ' LEU . 75.5 mmtt -65.23 -44.74 87.26 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 22' ' ' ILE . 2.5 m -64.51 -34.44 69.63 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.653 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -60.32 -44.37 95.53 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 176.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.417 ' O ' ' HD2' ' A' ' 32' ' ' PHE . 11.2 m170 -64.5 -42.44 95.84 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.837 177.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.557 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -55.13 -48.62 73.39 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.661 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.62 -41.88 99.26 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.795 0.331 . . . . 0.0 111.099 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.5 -31.05 72.1 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.72 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.417 ' HD2' ' O ' ' A' ' 28' ' ' HIS . 82.4 m-85 -85.95 -31.7 21.96 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 121.059 -0.257 . . . . 0.0 111.483 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 86.9 mt -62.52 -44.97 95.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.96 0.41 . . . . 0.0 111.245 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -18.51 61.34 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.669 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -77.03 -13.63 59.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.887 0.375 . . . . 0.0 110.338 177.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.37 12.97 50.03 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.309 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.407 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 96.9 mttt -103.48 -179.56 3.99 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.107 0.48 . . . . 0.0 111.202 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -116.65 155.8 28.18 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.927 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.461 HG22 ' HB2' ' A' ' 9' ' ' LYS . 41.7 t -121.25 131.08 73.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 175.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.413 ' HG2' ' HG2' ' A' ' 42' ' ' ARG . 40.4 ttp180 -109.84 116.72 32.17 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 176.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -89.47 120.62 30.95 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.47 ' HD3' ' OE1' ' A' ' 10' ' ' GLU . 12.8 mtm180 -120.9 115.7 23.73 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -178.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.503 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 4.1 p -112.96 124.4 69.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.425 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.464 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 77.7 t80 -101.09 124.01 46.14 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.56 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' A' ' 50' ' ' MET . 34.2 mt -77.24 107.34 9.57 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -67.37 -78.84 0.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -171.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 49' ' ' GLU . . . -126.13 119.74 3.53 Favored Glycine 0 CA--C 1.499 -0.908 0 C-N-CA 119.853 -1.165 . . . . 0.0 112.666 -175.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 72.18 -21.34 0.23 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.764 0.826 . . . . 0.0 111.308 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.508 ' H ' ' C ' ' A' ' 47' ' ' GLY . 14.9 mt-10 -61.94 -32.98 73.44 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.981 0.912 . . . . 0.0 110.623 178.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.522 ' HA ' HD12 ' A' ' 45' ' ' LEU . 44.3 ttm -63.61 -19.08 64.56 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.128 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.33 -13.62 61.14 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.913 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.424 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 32.3 m -140.78 101.27 6.52 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 121.334 0.588 . . . . 0.0 110.787 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 52' ' ' THR . 39.7 Cg_endo -68.7 -16.55 42.17 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.421 2.747 . . . . 0.0 112.321 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -58.48 -34.11 70.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.646 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.66 94.89 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.475 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.459 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -64.45 -40.98 98.19 Favored Glycine 0 CA--C 1.504 -0.654 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.859 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.8 t -66.26 -44.19 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 120.664 0.268 . . . . 0.0 110.734 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.2 -40.69 90.94 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.958 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.7 tp -61.89 -47.85 83.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.654 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.534 HD12 HG12 ' A' ' 84' ' ' VAL . 87.3 mt -65.26 -41.74 93.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.742 -178.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -64.49 -36.93 85.79 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.973 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -61.62 -43.53 98.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.464 0.65 . . . . 0.0 109.255 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.85 -44.12 96.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.462 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.419 ' CE3' HG13 ' A' ' 67' ' ' ILE . 50.8 t-105 -59.61 -35.84 75.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.377 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.6 m -60.3 -24.57 65.09 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.085 0.469 . . . . 0.0 110.85 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 92.6 mtp -91.55 -28.25 17.68 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.148 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.59 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 32.8 pt -111.27 16.07 8.11 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -176.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -21.21 66.52 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.426 0.631 . . . . 0.0 111.08 178.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.421 ' O ' ' HG2' ' A' ' 70' ' ' GLU . 3.2 p30 -73.93 134.97 43.24 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.093 178.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 69' ' ' ASN . 10.0 pt-20 54.57 5.9 0.1 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.811 1.244 . . . . 0.0 113.295 -176.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 67' ' ' ILE . . . -124.02 161.55 25.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.813 0.339 . . . . 0.0 110.691 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -140.14 150.46 44.28 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -83.36 122.35 28.35 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 118.655 -1.218 . . . . 0.0 109.711 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.512 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 16.5 t70 -81.44 -15.85 53.82 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.406 0.622 . . . . 0.0 109.421 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -159.97 156.39 27.04 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.075 -175.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -93.68 151.57 40.1 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 14.8 Cg_exo -63.81 132.65 35.75 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.519 1.479 . . . . 0.0 110.689 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 58.3 t30 -148.43 149.41 31.66 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.133 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -91.83 111.73 23.37 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -152.22 129.49 11.26 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.68 -178.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.26 25.57 74.15 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.448 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.462 ' HD2' ' SD ' ' A' ' 50' ' ' MET . 42.4 mmt180 70.13 8.36 6.63 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 123.883 0.873 . . . . 0.0 112.041 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.464 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 55.1 m-85 -117.74 144.55 45.19 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.273 176.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.534 HG12 HD12 ' A' ' 60' ' ' LEU . 91.1 t -98.65 110.57 26.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 171.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.55 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 9.6 p30 -111.44 146.01 37.97 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -172.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 63.8 ttp -145.08 138.01 26.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.252 175.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 17.0 mt -110.61 135.35 51.37 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 120.785 0.326 . . . . 0.0 111.483 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.407 ' CG2' ' HB ' ' A' ' 39' ' ' VAL . 14.2 m -120.05 132.95 68.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 121.337 0.589 . . . . 0.0 110.979 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.512 ' OG1' ' HB2' ' A' ' 74' ' ' ASP . 28.2 m -121.25 143.16 36.7 Favored Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.527 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 91.8 Cg_endo -71.84 154.95 58.63 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.926 1.751 . . . . 0.0 109.929 177.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -63.98 134.96 56.02 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.559 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -70.03 98.78 1.35 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.404 -175.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.96 -37.83 87.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.368 0.604 . . . . 0.0 109.531 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -116.15 132.81 56.55 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.617 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 85.43 81.33 1.1 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.436 -178.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -102.96 166.99 10.13 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.146 0.498 . . . . 0.0 110.993 -177.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -69.77 163.2 26.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.829 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -60.75 -77.26 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.608 0.242 . . . . 0.0 111.186 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -168.36 9.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.342 0.592 . . . . 0.0 109.845 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -90.53 -4.9 56.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.388 -176.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 . . . . . 0 C--O 1.243 0.757 0 O-C-N 123.803 0.689 . . . . 0.0 109.964 -176.716 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 N--CA 1.446 -0.67 0 CA-C-O 121.266 0.555 . . . . 0.0 111.368 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.26 76.34 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-O 122.082 0.944 . . . . 0.0 109.906 177.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 77.7 mt -113.91 107.68 23.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.998 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.566 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 27.1 t70 -103.17 107.38 18.17 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.788 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 90.4 mt -88.95 129.1 40.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 120.992 0.425 . . . . 0.0 110.638 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -91.23 140.6 29.64 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-O 121.789 0.804 . . . . 0.0 111.43 -176.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.548 ' OE2' ' HD2' ' A' ' 42' ' ' ARG . 45.2 mt-10 -118.61 109.76 16.53 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.037 177.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 88.4 mt -93.14 118.98 40.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.63 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 62.3 tttm -88.82 136.68 32.88 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.643 0.735 . . . . 0.0 112.164 -177.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 46.4 mt -130.39 169.9 14.88 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.875 -178.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.499 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 19.9 m -128.7 149.84 50.52 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.0 t -64.41 -43.83 97.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.433 0.635 . . . . 0.0 109.755 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.495 ' HE2' ' O ' ' A' ' 46' ' ' LYS . 40.6 mttm -95.19 67.75 3.04 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.499 ' HB ' ' O ' ' A' ' 14' ' ' SER . 18.8 tt -101.5 148.5 7.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.758 -174.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.83 144.85 54.16 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.175 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -63.89 -39.68 94.76 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.804 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -63.85 -38.96 93.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.741 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -62.7 -37.98 88.61 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.85 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.52 ' O ' HG23 ' A' ' 26' ' ' VAL . 79.9 mt -61.37 -48.84 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 120.954 0.406 . . . . 0.0 110.456 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -61.95 -44.63 96.35 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.603 -177.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -62.73 -50.05 72.64 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.982 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -67.86 -43.58 79.09 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 22' ' ' ILE . 60.0 t -64.54 -42.26 94.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.914 0.387 . . . . 0.0 110.074 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.48 -44.44 97.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.211 176.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -37.46 87.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.765 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.513 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -57.04 -32.82 66.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.078 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.612 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 95.2 mt -61.41 -41.51 97.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.75 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 60.6 mt-10 -65.98 -36.7 84.02 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.379 -178.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -66.79 -37.09 83.89 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.156 0.503 . . . . 0.0 110.19 177.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 94.8 mt -62.67 -40.73 97.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.798 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.612 ' HG2' ' O ' ' A' ' 30' ' ' LEU . 51.8 mm-40 -59.3 -26.11 64.71 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.143 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 31' ' ' GLU . 74.0 mm-40 -77.39 -8.55 57.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.614 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.19 19.13 57.94 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.739 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.566 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 62.8 mttp -107.48 -178.3 3.59 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.337 0.589 . . . . 0.0 111.339 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.477 ' NE2' HG23 ' A' ' 89' ' ' THR . 7.2 m80 -113.35 146.22 39.8 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.386 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.8 t -114.78 127.59 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.386 175.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.486 ' HD2' ' OE2' ' A' ' 10' ' ' GLU . 42.4 ttm180 -111.61 113.03 25.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 177.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.621 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 93.3 m-85 -84.89 113.11 21.15 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.548 ' HD2' ' OE2' ' A' ' 10' ' ' GLU . 28.9 mtp180 -115.29 130.97 57.06 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.45 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.4 p -123.64 130.18 74.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-O 121.17 0.509 . . . . 0.0 110.626 -178.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.426 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 77.6 t80 -94.82 118.22 31.41 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.954 178.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.514 HD12 ' HA ' ' A' ' 50' ' ' MET . 35.1 mt -72.39 145.74 47.5 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.495 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 41.3 ttmt -142.4 118.0 10.37 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.924 -176.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.51 53.52 0.72 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.298 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 48' ' ' ARG . 41.0 ttm180 69.39 -0.82 2.41 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.781 0.433 . . . . 0.0 111.579 178.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.403 ' O ' HD13 ' A' ' 45' ' ' LEU . 38.0 mt-10 -70.63 1.45 5.24 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.514 ' HA ' HD12 ' A' ' 45' ' ' LEU . 1.5 mpt? -61.87 -34.51 76.13 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.135 0.493 . . . . 0.0 110.426 177.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.63 -8.19 55.6 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.111 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.1 m -124.23 92.08 48.69 Favored Pre-proline 0 N--CA 1.446 -0.645 0 CA-C-O 121.199 0.523 . . . . 0.0 111.063 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.406 ' O ' HG23 ' A' ' 57' ' ' VAL . 35.7 Cg_exo -64.5 -24.57 63.47 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.322 2.681 . . . . 0.0 111.529 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -56.76 -30.76 63.91 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.003 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.65 -38.79 82.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.027 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.16 -37.5 9.89 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.973 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 53' ' ' PRO . 63.5 t -63.85 -46.03 95.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.317 0.103 . . . . 0.0 111.141 -178.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.48 -37.47 87.43 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.031 0.443 . . . . 0.0 110.866 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.7 tp -62.01 -45.97 91.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.442 0.639 . . . . 0.0 109.759 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.517 HD13 ' HB2' ' A' ' 86' ' ' MET . 91.9 mt -67.2 -38.39 85.27 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.99 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -58.09 -39.9 79.74 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 121.074 -0.251 . . . . 0.0 110.606 177.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -60.63 -45.08 95.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.309 0.576 . . . . 0.0 109.76 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.25 -43.56 97.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.638 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -59.49 -37.49 78.41 Favored 'General case' 0 C--O 1.206 -1.201 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.991 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.2 m -61.34 -24.33 66.37 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.524 0.678 . . . . 0.0 110.69 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 97.0 mmm -84.11 -42.72 15.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.087 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.5 pt -105.23 8.08 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -173.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.91 -10.2 27.03 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -89.0 -53.35 4.63 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -96.02 -5.26 41.52 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -175.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -125.98 154.14 43.32 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.567 0.222 . . . . 0.0 110.483 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.58 ' OD1' ' HB ' ' A' ' 89' ' ' THR . 10.0 p30 -115.71 134.8 54.66 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.24 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -69.59 110.53 4.86 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.867 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.464 ' CB ' HD12 ' A' ' 87' ' ' LEU . 26.5 t70 -71.68 -46.46 58.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.197 0.522 . . . . 0.0 109.848 177.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -149.78 154.86 39.15 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.606 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.6 155.81 87.13 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.257 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -54.66 137.5 73.96 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.88 2.386 . . . . 0.0 112.56 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 49.7 t30 -128.44 150.07 50.29 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.409 -177.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -108.9 121.01 44.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.796 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -126.07 108.61 11.52 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.08 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.3 -78.91 0.31 Allowed Glycine 0 C--O 1.223 -0.544 0 C-N-CA 121.399 -0.429 . . . . 0.0 113.059 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.427 ' N ' ' HD2' ' A' ' 82' ' ' ARG . 0.6 OUTLIER -147.38 10.18 0.97 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.95 0.405 . . . . 0.0 110.605 178.1 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.426 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 89.2 m-85 -117.63 140.39 49.71 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.528 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.45 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 69.1 t -112.81 130.26 66.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 175.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.621 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 9.4 p30 -133.21 143.27 49.05 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -175.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.517 ' HB2' HD13 ' A' ' 60' ' ' LEU . 64.8 ttp -127.68 136.35 51.46 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.578 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.464 HD12 ' CB ' ' A' ' 74' ' ' ASP . 2.7 tm? -110.52 127.02 54.99 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.001 0.429 . . . . 0.0 109.853 -178.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.445 ' O ' ' HD2' ' A' ' 38' ' ' HIS . 19.1 m -120.1 134.27 64.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.138 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.58 ' HB ' ' OD1' ' A' ' 72' ' ' ASN . 21.1 m -102.0 136.21 19.53 Favored Pre-proline 0 C--N 1.31 -1.133 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.731 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.502 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 80.4 Cg_endo -68.83 144.16 58.11 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.714 2.276 . . . . 0.0 110.689 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -85.78 88.9 7.62 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.95 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -82.21 -46.56 13.58 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.867 177.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -167.08 79.53 0.2 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.59 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -94.28 144.15 25.77 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.045 0.45 . . . . 0.0 111.215 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.67 1.65 69.04 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -72.21 133.4 45.08 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.451 -0.374 . . . . 0.0 110.194 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -80.33 134.49 36.06 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.998 178.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -65.58 -67.5 0.44 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.914 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -163.61 73.18 0.3 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -104.67 163.45 12.47 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.197 -176.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 65.3 m80 . . . . . 0 C--N 1.312 -1.05 0 CA-C-O 118.635 -0.698 . . . . 0.0 110.23 -179.5 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.0 mtpt . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.8 t 66.53 151.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 O-C-N 123.514 0.509 . . . . 0.0 111.03 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.1 mm -80.95 97.22 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -73.37 122.2 21.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.717 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 88.7 mt -97.37 133.85 37.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.028 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -90.5 147.1 23.6 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.67 -175.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -125.83 132.16 52.29 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.693 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -120.54 112.12 34.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.403 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 40.3 ttmt -85.4 141.91 29.65 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.608 -176.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.5 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 36.6 mt -128.51 175.15 8.76 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.646 -175.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.8 p -149.93 153.69 37.05 Favored 'General case' 0 C--O 1.214 -0.815 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 176.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -70.22 -20.6 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-O 121.621 0.724 . . . . 0.0 110.321 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -89.05 15.76 8.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.714 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.4 tt -73.13 148.42 8.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.112 0.482 . . . . 0.0 111.362 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.97 152.53 21.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.186 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -63.49 -40.22 96.51 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -177.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -65.14 -29.67 70.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.029 0.443 . . . . 0.0 110.182 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -71.77 -38.85 70.29 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.328 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.54 -44.46 99.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -61.46 -41.66 97.58 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.331 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -65.51 -44.4 87.1 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.139 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -64.65 -41.81 95.86 Favored 'General case' 0 N--CA 1.461 0.088 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.0 m -62.95 -33.2 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.174 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -59.84 -48.27 82.36 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.879 0.371 . . . . 0.0 110.582 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -69.3 -37.05 77.63 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.462 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.487 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -59.39 -42.16 91.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.578 HD22 ' HB2' ' A' ' 70' ' ' GLU . 93.3 mt -62.27 -41.39 98.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.497 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 46.9 mt-10 -65.53 -38.12 88.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.472 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -70.28 -38.05 74.96 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.041 175.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.49 ' HB3' ' HB3' ' A' ' 90' ' ' PRO . 85.4 mt -62.29 -45.26 94.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.905 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -64.01 -18.45 64.33 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.895 0.379 . . . . 0.0 111.641 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 80.3 mt-30 -80.25 1.01 30.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.613 177.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.3 32.62 25.06 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -119.57 157.33 28.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.934 0.397 . . . . 0.0 111.066 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.481 ' NE2' HG23 ' A' ' 89' ' ' THR . 13.0 m170 -101.61 148.03 25.71 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.398 177.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.6 t -118.65 130.04 74.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.054 0.454 . . . . 0.0 109.994 176.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -108.29 115.46 30.15 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.665 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 73.9 m-85 -90.39 121.93 32.81 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.448 ' HG2' ' HB3' ' A' ' 85' ' ' ASN . 85.1 mtp180 -125.82 121.11 32.35 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.628 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 4.2 p -112.94 131.58 64.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.24 0.543 . . . . 0.0 111.556 -176.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.409 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 84.3 t80 -93.75 121.25 35.0 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.748 177.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.5 mt -84.79 85.53 7.44 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.302 0.572 . . . . 0.0 109.969 -178.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -66.06 129.6 40.36 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.06 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.64 -148.32 16.64 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.108 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -95.0 8.2 43.67 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.985 0.422 . . . . 0.0 110.286 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -63.84 -18.5 64.2 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.682 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 67.1 mtt -65.02 -10.32 28.74 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.53 -27.32 68.37 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-O 121.118 0.485 . . . . 0.0 110.387 176.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.4 t -129.99 109.51 16.85 Favored Pre-proline 0 N--CA 1.44 -0.948 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.832 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -63.77 -19.77 67.62 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.225 2.616 . . . . 0.0 112.075 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -60.32 -29.75 69.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.588 -177.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.34 -44.82 92.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.11 0.481 . . . . 0.0 110.364 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.537 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -69.86 -39.16 75.87 Favored Glycine 0 CA--C 1.506 -0.519 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.835 178.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.499 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 59.5 t -63.39 -44.7 99.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.628 0.251 . . . . 0.0 110.722 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.63 -37.91 83.01 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.343 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.4 tp -62.04 -45.44 93.53 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.495 HD13 ' HB2' ' A' ' 86' ' ' MET . 93.4 mt -65.71 -39.19 90.96 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.161 179.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 57' ' ' VAL . 61.8 mm-40 -55.83 -44.84 78.33 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.571 177.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -65.8 -42.49 90.62 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.162 0.506 . . . . 0.0 110.944 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.6 mt -64.77 -42.39 94.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.289 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -55.04 -45.21 75.21 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.043 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.0 p -66.58 -19.93 65.89 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.736 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 96.8 mmm -75.41 -38.54 59.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.556 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.9 pt -104.47 -7.58 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -174.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -58.5 -16.75 16.65 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.063 0.458 . . . . 0.0 111.904 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -64.38 -41.16 96.83 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.678 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.578 ' HB2' HD22 ' A' ' 30' ' ' LEU . 40.9 mt-10 -124.3 14.44 8.97 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.245 0.545 . . . . 0.0 110.914 -178.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.65 142.27 37.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.646 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -114.98 145.4 42.29 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.995 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.0 ttt-85 -70.89 121.77 18.72 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.385 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.425 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 26.2 t70 -93.63 -42.45 9.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.361 0.601 . . . . 0.0 109.998 176.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -144.33 157.67 44.15 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.796 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -86.12 154.11 57.39 Favored Pre-proline 0 C--N 1.316 -0.848 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.38 132.07 48.83 Favored 'Trans proline' 0 C--O 1.24 0.593 0 C-N-CA 122.674 2.249 . . . . 0.0 112.388 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -129.42 131.37 46.75 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.742 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.432 ' HB2' HG22 ' A' ' 84' ' ' VAL . 83.8 t80 -98.61 109.16 21.96 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.983 177.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -152.53 139.11 18.7 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.268 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.35 31.49 68.64 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.948 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 69.47 10.25 7.61 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 122.997 0.519 . . . . 0.0 112.14 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 56.3 m-85 -126.12 144.02 50.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.746 178.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.628 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 91.7 t -102.28 122.89 55.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 173.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.665 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 7.0 p30 -129.75 146.69 51.5 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -173.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.495 ' HB2' HD13 ' A' ' 60' ' ' LEU . 64.0 ttp -139.85 143.78 36.93 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.848 178.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 16.1 mt -107.6 129.76 54.96 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.475 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.6 m -122.06 135.33 62.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.562 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.481 HG23 ' NE2' ' A' ' 38' ' ' HIS . 17.9 m -108.89 143.15 27.0 Favored Pre-proline 0 C--N 1.306 -1.292 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.202 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.49 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 46.7 Cg_endo -63.73 143.57 86.96 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.256 1.971 . . . . 0.0 111.179 178.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -80.34 66.91 6.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.354 0.597 . . . . 0.0 111.945 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 55.31 -89.78 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.509 -1.223 . . . . 0.0 112.982 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -152.41 38.05 0.55 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.747 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -74.59 152.24 39.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.164 0.507 . . . . 0.0 112.057 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.84 103.35 2.87 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.945 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -76.01 -54.18 7.25 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 49.8 p-80 -136.06 121.05 18.76 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.121 177.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -86.29 90.65 8.23 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.264 0.554 . . . . 0.0 110.316 -176.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -165.69 122.26 1.39 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.481 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -92.65 -6.24 49.75 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.497 -177.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 37.6 t60 . . . . . 0 C--O 1.245 0.853 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.274 -179.413 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 CA--C 1.51 -0.589 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.455 HG12 ' HB2' ' A' ' 38' ' ' HIS . 77.5 mt -119.44 132.16 70.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-O 120.845 0.355 . . . . 0.0 111.272 -175.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 74.2 mmtt -97.45 130.59 44.54 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.441 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 43.2 mt-10 -107.83 97.65 7.34 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.8 mt -88.74 125.09 41.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.639 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -96.98 145.87 25.52 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.197 -176.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.538 HD22 HD11 ' A' ' 63' ' ' ILE . 5.5 mp -135.69 176.89 8.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.279 173.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.468 ' HA ' HG23 ' A' ' 43' ' ' VAL . 16.2 p -139.1 156.22 47.32 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.85 -42.94 94.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.238 0.542 . . . . 0.0 109.995 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -95.33 76.46 3.4 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.516 HD11 ' OD2' ' A' ' 21' ' ' ASP . 19.3 tt -125.38 148.5 29.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.114 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.6 142.09 44.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.161 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -64.52 -33.73 76.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.955 0.407 . . . . 0.0 110.976 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.49 -40.71 92.35 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.526 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.516 ' OD2' HD11 ' A' ' 17' ' ' ILE . 23.2 t70 -66.6 -39.08 88.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.574 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.3 mt -62.92 -45.66 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.167 0.508 . . . . 0.0 110.271 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -61.1 -42.51 98.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.494 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -63.14 -44.32 95.89 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.954 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -64.93 -41.64 95.36 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 m -63.8 -28.83 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.508 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -60.06 -49.8 76.21 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 120.99 0.424 . . . . 0.0 110.49 176.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -68.3 -36.75 79.81 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.312 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.585 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -56.41 -45.62 80.56 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.025 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.639 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 88.9 mt -62.67 -42.83 99.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.073 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.01 -39.95 95.25 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.67 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -68.39 -34.43 76.02 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.931 0.396 . . . . 0.0 111.125 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 95.0 mt -63.6 -39.85 95.43 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.639 ' HG3' ' O ' ' A' ' 30' ' ' LEU . 63.3 mt-10 -61.02 -22.71 64.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.546 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -85.13 -6.35 59.3 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.59 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.05 19.61 55.29 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.706 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -105.81 172.41 6.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.173 0.511 . . . . 0.0 111.2 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.455 ' HB2' HG12 ' A' ' 8' ' ' ILE . 12.3 m80 -104.82 145.57 30.2 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.02 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.528 ' O ' HD12 ' A' ' 87' ' ' LEU . 41.5 t -118.33 125.71 74.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.441 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 71.2 ttt180 -102.74 115.19 30.1 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -90.2 116.64 28.35 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -122.45 132.99 54.61 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.592 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 4.9 p -128.26 131.29 69.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 121.061 0.458 . . . . 0.0 110.31 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.451 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 88.0 t80 -104.58 129.14 52.71 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.494 ' CD1' ' HA ' ' A' ' 50' ' ' MET . 30.0 mt -73.49 128.02 34.34 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -60.5 -46.2 90.99 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -171.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.63 -61.55 0.15 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.163 -1.018 . . . . 0.0 112.671 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.417 ' HD2' ' N ' ' A' ' 48' ' ' ARG . 6.6 mpt_? -67.05 -37.32 83.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.141 0.496 . . . . 0.0 111.512 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.501 ' CD ' ' H ' ' A' ' 49' ' ' GLU . 1.1 pm0 -80.45 -3.95 51.83 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.952 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.494 ' HA ' ' CD1' ' A' ' 45' ' ' LEU . 56.3 ttm -63.21 -19.68 64.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.871 0.367 . . . . 0.0 111.351 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.51 -11.1 59.82 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.251 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.0 m -131.19 100.06 17.25 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 121.153 0.501 . . . . 0.0 111.449 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.34 -25.71 71.42 Favored 'Trans proline' 0 N--CA 1.477 0.504 0 C-N-CA 123.505 2.803 . . . . 0.0 112.511 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -63.07 -25.5 68.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.523 -177.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.3 -44.96 94.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.881 0.372 . . . . 0.0 110.32 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.1 -38.38 92.29 Favored Glycine 0 CA--C 1.506 -0.474 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.614 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.504 HG13 ' HG2' ' A' ' 77' ' ' PRO . 99.1 t -62.74 -47.3 93.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.516 -0.342 . . . . 0.0 110.831 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.09 -37.79 88.62 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.042 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.4 ' O ' HG13 ' A' ' 63' ' ' ILE . 39.9 tp -62.57 -47.58 83.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.071 0.463 . . . . 0.0 110.239 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.562 HD12 HG12 ' A' ' 84' ' ' VAL . 62.1 mt -66.15 -39.6 89.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.666 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 57' ' ' VAL . 71.1 mt-10 -60.58 -36.66 79.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.684 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 66' ' ' MET . 86.0 tttt -63.84 -39.91 95.35 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.538 HD11 HD22 ' A' ' 13' ' ' LEU . 65.9 mt -61.7 -47.73 91.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.789 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.489 ' CZ2' ' HB2' ' A' ' 73' ' ' ARG . 40.3 t-105 -58.04 -40.64 81.4 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.414 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.45 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 19.0 m -61.28 -39.76 91.61 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.082 0.467 . . . . 0.0 110.728 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' A' ' 62' ' ' LYS . 97.3 mmm -66.78 -41.98 86.79 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.4 pt -105.06 -0.26 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -173.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 65' ' ' THR . 0.1 OUTLIER -56.31 -18.68 11.44 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -65.71 -36.55 83.93 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.523 ' HB2' HD22 ' A' ' 30' ' ' LEU . 47.8 mt-10 -122.75 6.09 9.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.801 0.334 . . . . 0.0 111.598 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -121.18 152.47 38.75 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.959 0.409 . . . . 0.0 111.752 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -112.23 148.37 34.25 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.489 ' HB2' ' CZ2' ' A' ' 64' ' ' TRP . 74.9 ttt180 -90.94 111.12 22.42 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 120.763 0.316 . . . . 0.0 111.102 -176.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -72.71 -38.73 67.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.8 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -163.28 -177.8 5.56 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.902 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.473 ' HG2' ' NH2' ' A' ' 73' ' ' ARG . 42.4 mt-10 -91.92 150.62 40.97 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.971 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.504 ' HG2' HG13 ' A' ' 57' ' ' VAL . 34.7 Cg_endo -68.99 132.26 24.17 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.106 1.871 . . . . 0.0 110.541 174.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.443 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 62.7 t30 -147.63 151.49 36.3 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.82 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.51 ' CE1' ' HA ' ' A' ' 82' ' ' ARG . 91.1 t80 -86.87 115.48 24.31 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.744 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.97 109.74 3.65 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.181 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.54 31.57 21.38 Favored Glycine 0 C--O 1.223 -0.559 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.327 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.51 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . 96.4 mtt180 69.25 3.49 4.14 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.749 0.82 . . . . 0.0 112.15 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 89.7 m-85 -121.12 137.58 54.59 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.427 174.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.592 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 74.2 t -99.86 124.09 53.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -130.84 142.76 50.4 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -175.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.467 ' SD ' HG13 ' A' ' 88' ' ' VAL . 16.4 tmm? -135.1 143.21 46.49 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.167 176.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.528 HD12 ' O ' ' A' ' 39' ' ' VAL . 47.9 tp -122.57 140.5 52.72 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.104 0.478 . . . . 0.0 111.438 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.467 HG13 ' SD ' ' A' ' 86' ' ' MET . 17.8 m -122.85 133.63 68.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.701 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.438 HG23 ' CE1' ' A' ' 38' ' ' HIS . 18.1 m -98.74 136.88 20.56 Favored Pre-proline 0 C--N 1.312 -1.022 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.75 144.8 84.97 Favored 'Trans proline' 0 C--N 1.326 -0.64 0 C-N-CA 122.336 2.024 . . . . 0.0 111.088 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt . . . . . 0 C--N 1.319 -0.756 0 CA-C-O 121.483 0.659 . . . . 0.0 111.441 -176.443 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.471 ' HB2' ' HD2' ' A' ' 37' ' ' LYS . 16.2 m-20 . . . . . 0 CA--C 1.5 -0.949 0 CA-C-O 121.195 0.521 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.458 HG12 ' HB2' ' A' ' 38' ' ' HIS . 79.8 mt -109.13 116.05 51.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.43 ' HE2' ' HB3' ' A' ' 7' ' ' ASP . 3.5 mptp? -83.87 134.73 34.68 Favored 'General case' 0 CA--C 1.488 -1.427 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.675 -175.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.415 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 59.9 mt-10 -102.57 112.02 24.59 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.594 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.7 mt -104.11 115.09 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.099 177.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 86.5 tttt -96.58 141.28 30.03 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.991 -175.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 5.5 mp -135.52 171.21 14.78 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.868 175.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.8 m -132.5 154.18 50.19 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.616 ' HB ' ' OE1' ' A' ' 49' ' ' GLU . 86.0 t -63.53 -33.53 62.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.338 0.59 . . . . 0.0 109.777 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.516 ' HG3' ' OE2' ' A' ' 49' ' ' GLU . 65.2 mttp -97.38 76.65 2.59 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.0 tt -134.55 154.0 36.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.751 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.74 143.74 49.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.186 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -64.46 -30.2 71.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.215 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -63.28 -39.05 93.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.644 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.9 -43.08 99.58 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.089 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.1 mt -62.16 -44.83 99.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.774 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -62.12 -43.67 98.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.239 0.542 . . . . 0.0 111.625 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -64.58 -43.27 94.4 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.496 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -65.24 -42.18 93.63 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.421 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 12.9 m -63.22 -33.17 59.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.004 178.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -62.52 -41.47 98.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.454 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -67.42 -42.49 83.12 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.599 177.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.531 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -60.01 -38.84 83.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.124 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 26' ' ' VAL . 97.4 mt -62.02 -41.77 98.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.026 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.617 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 67.0 mm-40 -65.3 -43.04 92.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.549 0.214 . . . . 0.0 110.714 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -64.02 -38.04 89.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.521 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 96.7 mt -62.18 -43.57 98.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.452 0.644 . . . . 0.0 109.435 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -61.64 -22.81 65.59 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.257 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.617 ' HG2' ' O ' ' A' ' 31' ' ' GLU . 76.5 mm-40 -85.13 -8.5 58.6 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.934 0.397 . . . . 0.0 110.528 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.42 13.72 56.74 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.024 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.471 ' HD2' ' HB2' ' A' ' 7' ' ' ASP . 75.7 mmtt -96.29 159.74 14.79 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.484 ' NE2' HG23 ' A' ' 89' ' ' THR . 23.6 m170 -107.85 147.29 31.13 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.476 ' O ' HD12 ' A' ' 87' ' ' LEU . 41.5 t -114.29 126.43 71.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.415 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 41.6 ttm180 -102.78 115.87 31.45 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -92.61 120.11 32.72 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 78.1 mtp180 -126.71 133.77 50.83 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.604 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.2 p -121.37 131.6 72.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 121.359 0.599 . . . . 0.0 111.217 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -101.26 124.37 46.84 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.849 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 49' ' ' GLU . 42.1 mt -76.24 133.61 40.06 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -112.31 116.81 30.98 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.082 0.467 . . . . 0.0 112.082 -174.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.48 -134.14 12.21 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.476 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 -74.84 -6.66 50.29 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.021 0.438 . . . . 0.0 110.817 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.616 ' OE1' ' HB ' ' A' ' 15' ' ' VAL . 99.5 mt-10 -60.35 -24.17 64.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.971 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 91.1 mtp -62.56 -29.27 70.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.528 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.49 -10.21 59.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.868 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.454 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 24.0 m -128.26 95.17 34.17 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-O 121.484 0.659 . . . . 0.0 111.456 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' A' ' 52' ' ' THR . 37.9 Cg_endo -68.0 -18.09 46.18 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.296 2.664 . . . . 0.0 111.944 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -62.7 -31.67 72.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.936 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.74 -41.07 97.16 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.219 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.47 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -64.88 -38.4 95.48 Favored Glycine 0 CA--C 1.504 -0.625 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.813 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.466 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 99.4 t -63.66 -45.93 96.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 120.839 0.352 . . . . 0.0 110.413 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.17 -41.45 96.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.38 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.544 ' O ' HG13 ' A' ' 63' ' ' ILE . 44.5 tp -63.89 -47.24 81.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.785 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.551 HD12 HG12 ' A' ' 84' ' ' VAL . 82.8 mt -64.41 -41.18 96.77 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.938 -177.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 57' ' ' VAL . 5.5 mm-40 -64.36 -35.74 81.88 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.52 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -63.81 -40.75 97.37 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 59' ' ' LEU . 65.9 mt -64.47 -44.98 97.02 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.865 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 57.2 t-105 -58.43 -38.15 76.87 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.599 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.9 m -57.44 -38.91 75.19 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.338 0.589 . . . . 0.0 110.225 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 98.1 mmm -67.32 -40.67 85.97 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.731 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.9 pt -102.02 -6.25 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -174.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -58.54 -21.13 51.52 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.074 0.464 . . . . 0.0 111.328 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -64.57 -33.25 75.48 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.306 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.518 ' HA ' ' HE3' ' A' ' 91' ' ' LYS . 73.3 mm-40 -131.94 6.5 4.29 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -122.0 157.56 31.07 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.957 0.408 . . . . 0.0 111.324 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -111.72 150.78 29.74 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -94.79 113.13 24.85 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 120.717 0.294 . . . . 0.0 111.172 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -77.96 -44.89 25.46 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.334 0.588 . . . . 0.0 110.422 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -145.68 149.99 35.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.332 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.46 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 9.9 pt-20 -80.38 163.15 58.39 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.402 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.629 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 29.9 Cg_endo -62.68 138.5 69.94 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 121.814 1.676 . . . . 0.0 111.981 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.585 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 23.3 p-10 -144.84 156.89 44.26 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.004 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -105.78 108.41 19.9 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.039 0.447 . . . . 0.0 110.487 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -123.33 120.08 31.99 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.511 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.72 -102.7 1.24 Allowed Glycine 0 N--CA 1.432 -1.619 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.683 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -127.17 7.13 6.5 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.738 0.304 . . . . 0.0 110.796 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -125.84 143.87 50.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.88 0.372 . . . . 0.0 111.844 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.604 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 92.3 t -99.54 124.9 53.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 172.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.629 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 10.8 m-80 -119.55 144.43 47.07 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -172.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 13.1 tmm? -145.03 132.31 20.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.476 HD12 ' O ' ' A' ' 39' ' ' VAL . 49.8 tp -114.91 142.74 46.18 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.062 0.458 . . . . 0.0 111.917 -175.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.0 m -124.92 158.71 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.27 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.484 HG23 ' NE2' ' A' ' 38' ' ' HIS . 25.3 m -131.86 143.51 49.37 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.429 ' HD2' ' CG2' ' A' ' 89' ' ' THR . 74.1 Cg_endo -68.17 153.86 73.7 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 122.15 1.9 . . . . 0.0 110.852 177.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' A' ' 70' ' ' GLU . 97.2 mttt . . . . . 0 C--N 1.324 -0.516 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.526 ' OD2' ' HE2' ' A' ' 9' ' ' LYS . 7.7 t70 . . . . . 0 CA--C 1.533 0.327 0 CA-C-O 121.156 0.503 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 87.1 mt -127.07 136.79 59.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.503 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.526 ' HE2' ' OD2' ' A' ' 7' ' ' ASP . 4.1 mptp? -101.55 157.82 16.54 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-O 121.793 0.806 . . . . 0.0 112.65 -177.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.444 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 46.0 mt-10 -124.74 123.23 39.54 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.848 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.9 mt -109.13 114.6 47.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 87.7 tttt -98.72 135.52 40.08 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.139 -174.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.639 HD22 HD11 ' A' ' 63' ' ' ILE . 5.5 mp -132.07 -177.09 4.29 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.61 177.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.403 ' HA ' HG23 ' A' ' 43' ' ' VAL . 22.4 p -143.73 156.51 44.55 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.512 ' HB ' ' OE2' ' A' ' 49' ' ' GLU . 79.8 t -63.67 -44.02 98.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.706 ' HG2' ' OE2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -85.48 71.29 10.8 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 173.395 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.444 HD11 ' OD2' ' A' ' 21' ' ' ASP . 16.7 tt -122.62 160.67 24.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.864 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.73 147.12 24.04 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.12 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -63.52 -33.53 75.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.014 0.435 . . . . 0.0 110.283 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -62.28 -40.54 96.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.389 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 21.1 t70 -66.9 -34.79 78.56 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.839 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.8 mt -61.77 -41.55 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.261 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -58.13 -43.6 87.37 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.752 0.787 . . . . 0.0 109.795 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.403 ' HB3' ' O ' ' A' ' 21' ' ' ASP . 57.9 t80 -61.88 -43.96 97.78 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.689 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 74.2 mmtt -61.96 -46.88 87.33 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.246 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.416 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 9.7 m -71.35 -32.96 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -60.76 -42.56 97.68 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.022 0.439 . . . . 0.0 109.94 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -73.38 -36.79 66.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.273 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.486 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -58.98 -38.49 79.24 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.193 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.427 ' HA ' HD12 ' A' ' 33' ' ' LEU . 96.7 mt -61.4 -39.54 91.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.527 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 61.8 mt-10 -65.54 -40.52 92.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.169 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -65.95 -37.65 86.58 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.117 0.484 . . . . 0.0 110.598 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 90' ' ' PRO . 97.2 mt -62.49 -42.2 99.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.068 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -57.62 -25.17 59.72 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.908 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 31' ' ' GLU . 64.1 mm-40 -84.05 -8.96 58.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.008 0.432 . . . . 0.0 110.67 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.79 9.97 63.6 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.267 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -101.84 174.0 6.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.01 0.433 . . . . 0.0 111.865 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -104.73 150.32 24.85 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.519 -176.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.2 t -116.06 125.05 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.018 173.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.444 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 40.0 ttm180 -100.68 111.97 24.3 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.506 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 63.5 m-85 -89.69 125.68 35.36 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 81.6 mtp180 -132.02 139.77 48.7 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.602 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.5 p -121.36 133.45 67.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 121.126 0.488 . . . . 0.0 110.891 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -101.72 125.9 48.47 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.633 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 50' ' ' MET . 33.0 mt -87.09 111.82 21.3 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.8 -44.99 84.02 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 49' ' ' GLU . . . 168.01 141.04 3.07 Favored Glycine 0 N--CA 1.434 -1.437 0 C-N-CA 120.118 -1.039 . . . . 0.0 111.709 -177.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 72.44 -10.24 0.95 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.54 0.686 . . . . 0.0 110.23 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.706 ' OE2' ' HG2' ' A' ' 16' ' ' LYS . 61.0 mt-10 -90.3 -17.85 26.65 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.458 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.416 ' HA ' HD13 ' A' ' 45' ' ' LEU . 96.3 mtp -70.26 -16.11 62.99 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.767 -177.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.36 -34.64 78.15 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.193 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.2 p -130.23 96.52 24.76 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.392 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -67.12 -14.37 43.1 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 123.509 2.806 . . . . 0.0 112.405 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.41 ' OE2' ' HB2' ' A' ' 58' ' ' ALA . 8.4 tm-20 -56.99 -35.01 68.71 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.649 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.43 -36.59 71.56 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.876 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.45 -42.22 97.67 Favored Glycine 0 CA--C 1.504 -0.602 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.96 -43.75 89.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.41 ' HB2' ' OE2' ' A' ' 54' ' ' GLU . . . -60.66 -40.05 90.62 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.136 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.6 tp -61.91 -45.91 91.66 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.448 HD12 HG12 ' A' ' 84' ' ' VAL . 88.1 mt -65.76 -39.02 90.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.292 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -59.49 -43.82 93.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.118 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -63.1 -40.8 98.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.639 HD11 HD22 ' A' ' 13' ' ' LEU . 96.2 mt -63.5 -43.9 98.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.041 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.7 t-105 -58.55 -42.95 89.03 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.776 -178.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.555 ' HA ' ' OE2' ' A' ' 68' ' ' GLU . 22.4 p -64.4 -16.33 62.15 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 68.1 mtt -89.9 -48.52 7.17 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.156 0.503 . . . . 0.0 111.232 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.2 pt -86.0 -14.87 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -174.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.555 ' OE2' ' HA ' ' A' ' 65' ' ' THR . 14.0 pt-20 -57.48 -14.8 5.48 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -63.48 -41.57 98.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.476 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -117.89 -4.4 11.11 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.163 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.454 ' HB2' HD13 ' A' ' 33' ' ' LEU . . . -119.68 146.99 45.1 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.47 -177.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -113.26 138.23 50.31 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -69.58 109.94 4.55 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-O 121.245 0.545 . . . . 0.0 111.359 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.4 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 10.2 t70 -77.94 -42.91 31.45 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.098 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -146.22 137.12 24.35 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.054 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -64.83 157.37 75.36 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.63 178.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 23.4 Cg_exo -61.82 142.35 93.28 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 122.06 1.84 . . . . 0.0 111.577 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -141.39 140.68 33.74 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.423 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -99.11 116.13 30.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.917 0.389 . . . . 0.0 110.418 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -134.49 128.89 34.29 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.74 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.85 -94.42 0.6 Allowed Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.803 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -140.97 6.89 2.01 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.66 0.743 . . . . 0.0 109.41 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -119.33 143.81 47.19 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.717 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.602 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 68.8 t -106.28 123.31 60.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 172.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.538 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 8.6 p30 -125.86 149.63 48.51 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -174.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 64.6 ttp -140.87 141.43 34.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.513 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.0 mt -109.75 131.65 54.87 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.024 0.44 . . . . 0.0 111.692 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.7 m -122.95 136.44 59.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.628 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.454 ' CG2' ' HD2' ' A' ' 90' ' ' PRO . 24.4 m -116.07 140.18 26.02 Favored Pre-proline 0 C--N 1.307 -1.276 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.357 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.521 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 72.1 Cg_endo -68.0 152.51 76.71 Favored 'Trans proline' 0 C--O 1.237 0.463 0 C-N-CA 122.815 2.343 . . . . 0.0 111.772 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 67.3 mttm . . . . . 0 C--N 1.323 -0.586 0 CA-C-O 121.199 0.523 . . . . 0.0 110.841 178.457 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 30.4 t70 . . . . . 0 C--O 1.241 0.611 0 CA-C-O 121.114 0.483 . . . . 0.0 109.915 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.477 HG12 ' HB2' ' A' ' 38' ' ' HIS . 71.1 mt -95.05 134.5 32.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.715 -178.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.41 ' HG3' ' CD1' ' A' ' 32' ' ' PHE . 66.4 mmtt -85.71 127.05 34.41 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.83 -176.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -102.55 115.51 30.71 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 120.868 0.366 . . . . 0.0 110.363 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.0 mt -108.81 116.21 51.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.604 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -98.25 137.43 37.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.135 -175.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.492 HD22 HD11 ' A' ' 63' ' ' ILE . 5.5 mp -128.93 179.12 5.91 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.019 176.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 p -135.91 151.66 50.21 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.579 HG11 ' HG2' ' A' ' 49' ' ' GLU . 49.0 t -66.98 -25.6 34.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.383 0.611 . . . . 0.0 110.158 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.565 ' HE2' ' O ' ' A' ' 46' ' ' LYS . 64.6 mttm -103.29 72.37 1.15 Allowed 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 174.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.5 tt -126.84 153.42 35.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.124 -178.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.407 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -92.57 159.97 15.24 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -62.78 -33.09 74.45 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 120.948 0.404 . . . . 0.0 110.315 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -59.25 -45.05 92.22 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.242 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.4 -39.59 74.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.174 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.62 ' O ' HG23 ' A' ' 26' ' ' VAL . 75.7 mt -60.79 -51.43 73.23 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -60.39 -42.36 95.73 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.982 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.412 ' CZ ' ' HE1' ' A' ' 28' ' ' HIS . 92.0 t80 -64.3 -47.25 80.17 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.99 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -66.78 -42.91 85.29 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 22' ' ' ILE . 60.1 t -63.89 -29.63 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.473 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.05 -41.92 97.49 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 177.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.412 ' HE1' ' CZ ' ' A' ' 24' ' ' TYR . 31.4 m80 -68.41 -34.29 75.74 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.682 178.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.583 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -55.6 -45.25 77.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.238 -178.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.0 mt -62.76 -38.93 92.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.988 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -59.71 -46.23 89.74 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.172 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.41 ' CD1' ' HG3' ' A' ' 9' ' ' LYS . 84.2 m-85 -68.0 -34.78 77.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.82 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 95.0 mt -61.97 -43.01 99.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.287 0.565 . . . . 0.0 110.015 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -59.84 -34.45 73.12 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.596 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -69.4 -18.86 63.8 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.182 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.52 27.02 10.17 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.967 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -112.05 162.85 14.95 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.988 0.423 . . . . 0.0 110.519 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.477 ' HB2' HG12 ' A' ' 8' ' ' ILE . 5.4 m80 -97.53 146.7 25.0 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.7 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.3 t -115.27 129.56 71.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.635 176.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -108.4 112.25 24.58 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 97.4 m-85 -85.78 127.33 34.52 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.724 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 71.4 mtp85 -127.19 131.24 50.71 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.263 -176.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.6 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 5.9 p -130.0 137.05 57.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.106 0.479 . . . . 0.0 110.764 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.446 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 93.3 t80 -104.53 131.21 52.18 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.467 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.4 mt -80.21 85.32 5.75 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.129 0.49 . . . . 0.0 110.411 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.565 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 63.9 tttp -88.77 126.03 35.15 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.132 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.03 -154.94 16.35 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -77.81 -7.21 56.31 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.056 0.455 . . . . 0.0 110.68 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.579 ' HG2' HG11 ' A' ' 15' ' ' VAL . 2.3 mp0 -60.08 -13.61 12.67 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.594 178.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 10.3 mmt -59.33 -20.65 56.31 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.79 0.329 . . . . 0.0 111.361 177.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.45 -5.5 59.29 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.478 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.4 m -138.49 102.59 7.93 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-O 121.175 0.512 . . . . 0.0 111.455 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.28 -20.2 49.31 Favored 'Trans proline' 0 C--N 1.331 -0.369 0 C-N-CA 123.26 2.64 . . . . 0.0 111.76 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -64.04 -22.64 67.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.206 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.19 -45.17 91.77 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.96 0.409 . . . . 0.0 110.382 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.62 -38.86 93.61 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.941 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.1 t -64.12 -43.92 97.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 61' ' ' GLU . . . -63.66 -39.45 94.36 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.223 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.407 ' O ' HG13 ' A' ' 63' ' ' ILE . 38.8 tp -64.51 -47.23 79.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.091 0.472 . . . . 0.0 110.437 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.612 HD12 HG12 ' A' ' 84' ' ' VAL . 47.7 mt -66.6 -40.92 89.1 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.586 -177.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -64.09 -31.73 73.02 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.286 179.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -65.01 -40.89 95.56 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.579 HG23 HG22 ' A' ' 26' ' ' VAL . 75.9 mt -65.53 -44.17 94.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.688 177.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 17.1 t-105 -55.76 -41.54 74.14 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.616 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.1 p -71.63 -12.74 61.5 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 98.0 mmm -87.21 -31.99 20.02 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.233 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.409 HG23 HG13 ' A' ' 26' ' ' VAL . 32.7 pt -108.15 -1.9 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -174.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -12.21 9.17 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -63.35 -46.89 84.47 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.407 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -119.43 0.89 11.17 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.87 0.367 . . . . 0.0 111.589 -174.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.57 ' HB2' HD13 ' A' ' 33' ' ' LEU . . . -125.26 149.81 47.67 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.178 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -114.17 131.73 56.34 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -72.53 106.67 4.69 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.24 -35.28 77.69 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.515 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -156.45 148.75 23.36 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.772 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' A' ' 76' ' ' GLU . 1.6 mp0 -62.27 162.28 19.91 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.499 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.401 ' HB3' HD12 ' A' ' 60' ' ' LEU . 31.9 Cg_exo -59.05 144.79 99.22 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.348 2.032 . . . . 0.0 112.375 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -130.0 132.46 46.28 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.934 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -93.08 107.42 19.21 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -127.77 132.04 49.56 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.758 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.13 -109.83 3.13 Favored Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.385 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -124.85 9.86 8.24 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.179 0.514 . . . . 0.0 109.998 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.446 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 73.0 m-85 -125.0 144.5 50.35 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.306 -177.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.612 HG12 HD12 ' A' ' 60' ' ' LEU . 87.5 t -100.89 122.07 52.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 173.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.724 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 39.7 m-80 -114.61 144.64 43.08 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.764 -173.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.557 ' HB2' HD13 ' A' ' 60' ' ' LEU . 63.7 ttp -139.62 130.04 25.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.312 175.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 17.4 mt -108.99 129.73 55.45 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.25 0.547 . . . . 0.0 111.623 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.73 135.66 62.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.928 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.418 HG23 ' CE1' ' A' ' 38' ' ' HIS . 16.1 m -102.28 134.11 20.2 Favored Pre-proline 0 C--N 1.307 -1.251 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.487 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 56.0 Cg_endo -66.39 135.76 40.79 Favored 'Trans proline' 0 C--N 1.327 -0.555 0 C-N-CA 121.884 1.723 . . . . 0.0 110.201 177.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 CA--C 1.509 -0.599 0 CA-C-O 121.24 0.543 . . . . 0.0 112.286 -177.291 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 . . . . . 0 CA--C 1.496 -1.128 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.467 HG12 ' HB2' ' A' ' 38' ' ' HIS . 69.3 mt -91.49 119.31 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.771 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.45 ' HG3' ' CD1' ' A' ' 32' ' ' PHE . 73.1 mmtt -89.22 126.69 35.6 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.936 -174.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.456 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 59.3 mt-10 -102.14 110.72 22.76 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.569 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.0 mt -94.23 107.94 20.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 47.6 tttm -98.32 122.87 42.04 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.593 -175.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.419 HD21 ' HG3' ' A' ' 25' ' ' LYS . 79.9 mt -122.65 179.36 4.63 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.517 -178.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.1 m -131.62 151.98 51.19 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.2 t -63.69 -40.98 91.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.331 0.586 . . . . 0.0 109.793 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -78.03 50.38 0.88 Allowed 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.323 176.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.2 tt -106.34 160.03 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.706 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.45 146.51 28.37 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 175.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.421 HE22 ' HD3' ' A' ' 62' ' ' LYS . 58.7 tp60 -63.75 -36.43 83.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.949 0.404 . . . . 0.0 111.512 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -63.91 -35.97 82.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.977 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.595 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 29.0 t70 -65.51 -35.23 80.25 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.884 0.373 . . . . 0.0 110.752 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.3 mt -61.32 -41.57 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.109 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -58.4 -41.92 86.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.887 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -63.86 -43.22 96.76 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.167 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.595 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 75.8 mmtt -61.53 -46.51 89.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.664 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.487 ' CG1' HG23 ' A' ' 63' ' ' ILE . 4.2 m -66.71 -40.82 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 111.791 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.56 -42.7 98.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.083 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -80.04 -25.5 40.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.696 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.419 ' O ' HD13 ' A' ' 33' ' ' LEU . . . -63.68 -37.1 86.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.034 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.536 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 65.7 mt -62.14 -33.53 74.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.689 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -57.76 -41.45 82.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.352 . . . . 0.0 110.116 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.45 ' CD1' ' HG3' ' A' ' 9' ' ' LYS . 94.9 m-85 -66.04 -35.7 81.24 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.105 0.478 . . . . 0.0 110.634 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.572 ' CB ' ' HB3' ' A' ' 90' ' ' PRO . 10.8 mp -62.36 -41.73 98.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.434 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 30' ' ' LEU . 32.6 mt-10 -62.43 -30.09 70.98 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.518 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -79.41 -8.66 59.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.904 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.46 19.77 50.98 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.189 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -95.98 164.97 12.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.935 0.397 . . . . 0.0 110.366 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.467 ' HB2' HG12 ' A' ' 8' ' ' ILE . 17.4 m170 -110.56 148.94 31.13 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.8 t -118.18 130.2 73.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 121.282 0.563 . . . . 0.0 110.682 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.456 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 39.5 ttm180 -111.55 113.18 25.42 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 175.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 92.8 m-85 -86.51 121.55 29.21 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.551 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 78.1 mtp180 -124.27 132.6 53.59 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.555 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.1 p -126.42 135.06 64.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 121.186 0.517 . . . . 0.0 110.799 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -101.37 127.19 48.11 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.799 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.5 mt -82.23 116.43 21.76 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -102.45 113.6 27.08 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.319 0.581 . . . . 0.0 111.956 -173.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.57 -137.21 13.29 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.394 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.4 ptt-85 -69.57 -11.87 61.19 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 122.577 0.351 . . . . 0.0 111.407 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -60.72 -21.12 62.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.566 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 91.2 mtp -62.66 -29.82 70.92 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.618 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.85 -13.81 62.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.349 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.6 p -125.28 94.36 43.44 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-O 121.171 0.51 . . . . 0.0 111.274 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -64.63 -20.33 65.34 Favored 'Trans proline' 0 N--CA 1.477 0.524 0 C-N-CA 123.461 2.774 . . . . 0.0 111.756 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -61.87 -30.07 70.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.183 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.62 -44.01 93.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.811 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.435 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -66.79 -38.44 93.05 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.623 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.8 t -63.87 -44.87 98.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.487 -0.356 . . . . 0.0 110.638 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.45 88.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.032 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.7 tp -62.63 -47.47 83.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.156 0.503 . . . . 0.0 110.036 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.427 HD12 HG12 ' A' ' 84' ' ' VAL . 56.3 mt -67.33 -39.73 85.87 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.975 -178.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -58.88 -39.47 81.51 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.704 0.288 . . . . 0.0 111.075 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.421 ' HD3' HE22 ' A' ' 19' ' ' GLN . 40.5 ttmt -62.76 -46.14 89.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.231 0.538 . . . . 0.0 109.97 177.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.487 HG23 ' CG1' ' A' ' 26' ' ' VAL . 96.0 mt -63.1 -45.14 99.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.897 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -60.66 -40.27 91.45 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.421 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.41 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 19.6 m -61.09 -37.34 82.37 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.096 0.474 . . . . 0.0 111.203 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 82.4 mtp -71.92 -35.94 69.81 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 63' ' ' ILE . 41.6 pt -103.28 -2.87 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -174.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -57.18 -25.97 59.85 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -177.252 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.417 ' H ' ' ND2' ' A' ' 69' ' ' ASN . 1.7 p30 -65.79 -39.23 90.75 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -107.96 -8.44 15.91 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.958 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -123.27 155.77 36.55 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.552 ' OD1' ' HB ' ' A' ' 89' ' ' THR . 5.3 p30 -117.86 128.37 54.77 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -77.75 108.02 10.67 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 121.305 0.574 . . . . 0.0 111.361 -176.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -66.63 -42.33 86.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.685 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.592 ' HD3' ' N ' ' A' ' 76' ' ' GLU . 7.1 tmtm? -146.19 138.5 25.26 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.592 ' N ' ' HD3' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -63.04 158.72 52.62 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.369 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.13 121.8 9.99 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 121.817 1.678 . . . . 0.0 110.799 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -130.23 138.93 50.79 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.491 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -92.98 117.25 29.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.883 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -138.22 139.98 39.5 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.29 -92.42 0.32 Allowed Glycine 0 N--CA 1.432 -1.567 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -177.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -153.08 17.23 0.56 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.398 0.618 . . . . 0.0 110.473 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -129.23 143.43 50.85 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.909 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.555 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 95.9 t -99.83 126.22 53.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 173.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.569 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 9.3 p30 -133.07 153.07 51.85 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.499 -175.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 64.8 ttp -144.04 134.53 24.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.747 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.5 mt -103.89 129.27 51.39 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.053 0.454 . . . . 0.0 111.494 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.48 135.29 63.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.165 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.552 ' HB ' ' OD1' ' A' ' 72' ' ' ASN . 13.8 m -114.43 143.29 29.57 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.572 ' HB3' ' CB ' ' A' ' 33' ' ' LEU . 60.2 Cg_endo -67.0 155.14 72.17 Favored 'Trans proline' 0 C--O 1.242 0.711 0 C-N-CA 122.81 2.34 . . . . 0.0 112.584 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.7 mptt . . . . . 0 C--N 1.33 -0.272 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 176.555 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.0 t70 . . . . . 0 N--CA 1.445 -0.717 0 CA-C-O 121.296 0.57 . . . . 0.0 110.6 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.432 HG23 ' HB3' ' A' ' 38' ' ' HIS . 88.7 mt -117.75 131.11 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.339 -178.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.418 ' HG2' ' CD1' ' A' ' 32' ' ' PHE . 3.6 mptp? -86.26 135.78 33.42 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 121.565 0.698 . . . . 0.0 110.335 -178.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -115.21 120.28 39.17 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.046 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.6 mt -108.75 114.31 46.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.984 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -84.13 139.71 32.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.707 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.487 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 49.8 mt -127.27 166.83 17.04 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.748 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.0 m -137.09 146.25 44.9 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.7 t -62.73 -45.0 99.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.911 0.386 . . . . 0.0 110.25 177.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -94.35 65.89 3.32 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.585 0.707 . . . . 0.0 109.975 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.433 HD11 ' OD1' ' A' ' 21' ' ' ASP . 19.7 tt -107.66 156.03 8.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.384 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 21' ' ' ASP . . . -64.77 141.71 58.68 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.8 tp60 -62.11 -39.4 92.37 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.958 0.408 . . . . 0.0 110.883 -176.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -76.32 -18.33 58.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.883 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.461 ' HB2' ' HB3' ' A' ' 18' ' ' ALA . 12.5 t70 -67.88 -35.79 79.13 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.276 0.56 . . . . 0.0 110.669 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.3 mt -61.49 -42.14 92.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.124 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -58.73 -43.12 90.08 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.716 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.534 ' CZ ' ' HE1' ' A' ' 28' ' ' HIS . 83.7 t80 -63.75 -45.86 87.92 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.469 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -65.52 -41.13 93.47 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.481 ' CG1' HG23 ' A' ' 63' ' ' ILE . 1.4 m -60.77 -29.86 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.549 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -61.83 -46.76 88.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.014 0.435 . . . . 0.0 110.37 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.534 ' HE1' ' CZ ' ' A' ' 24' ' ' TYR . 38.4 m80 -64.57 -37.83 88.9 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.111 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.612 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -56.56 -44.93 81.42 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.429 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 94.6 mt -62.5 -41.38 98.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.932 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -61.75 -44.82 96.17 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.967 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.418 ' CD1' ' HG2' ' A' ' 9' ' ' LYS . 81.4 m-85 -68.8 -32.91 72.97 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 96.7 mt -62.05 -42.02 98.74 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.404 0.621 . . . . 0.0 110.219 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 30' ' ' LEU . 44.6 mm-40 -56.24 -31.7 63.8 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.768 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -76.37 -8.51 57.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.726 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.63 17.95 62.86 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.07 -176.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -99.04 158.87 15.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.78 0.324 . . . . 0.0 110.523 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.432 ' HB3' HG23 ' A' ' 8' ' ' ILE . 1.9 t-80 -99.84 148.11 24.78 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.5 t -119.21 131.11 72.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.414 0.626 . . . . 0.0 111.829 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -112.38 126.0 54.8 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.053 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 96.8 m-85 -97.18 124.33 41.2 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.636 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 65.1 mtp180 -125.7 105.99 9.39 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.885 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.632 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 5.9 p -104.98 129.43 57.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.136 0.493 . . . . 0.0 111.31 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -99.01 134.79 41.34 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.915 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.2 mt -82.0 89.42 6.41 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 87.3 tttt -68.33 134.51 50.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.202 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.75 -132.38 11.16 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.349 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -110.6 18.37 19.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.683 0.278 . . . . 0.0 110.993 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 26.3 mm-40 -68.79 -2.47 9.51 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.196 -177.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 67.9 mtt -65.12 -13.33 57.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.037 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.49 -37.56 87.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.821 0.343 . . . . 0.0 110.697 178.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.3 p -124.72 96.91 39.83 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 121.082 0.468 . . . . 0.0 111.583 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.416 ' HB3' ' CG ' ' A' ' 79' ' ' PHE . 31.4 Cg_exo -62.99 -19.58 69.46 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.601 2.867 . . . . 0.0 112.471 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -59.48 -20.38 54.85 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.346 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.59 -38.93 86.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.036 0.446 . . . . 0.0 110.347 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.469 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -66.22 -39.17 94.37 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.766 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.0 t -64.12 -45.19 97.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.699 -0.25 . . . . 0.0 110.694 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.76 -40.75 89.22 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.066 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.5 tp -62.93 -45.82 90.66 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.028 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.528 HD13 ' HB2' ' A' ' 86' ' ' MET . 92.2 mt -65.22 -40.89 94.72 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.753 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -58.4 -43.05 88.41 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.95 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -64.34 -41.59 96.7 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.335 0.588 . . . . 0.0 109.89 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.481 HG23 ' CG1' ' A' ' 26' ' ' VAL . 91.6 mt -64.88 -43.84 96.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.384 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -58.26 -41.24 83.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.123 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.3 p -63.79 -16.82 62.19 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 68.7 mtt -85.97 -39.2 17.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.94 0.4 . . . . 0.0 111.824 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.6 pt -101.55 -7.15 9.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -57.1 -28.69 62.88 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -66.57 -22.23 66.15 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -130.15 8.41 5.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.665 0.269 . . . . 0.0 111.576 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.28 151.71 49.93 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.79 0.328 . . . . 0.0 111.116 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -113.44 152.45 30.07 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -94.71 128.35 41.33 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.064 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -90.48 -8.58 50.06 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.138 0.494 . . . . 0.0 110.28 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -176.06 164.58 2.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.458 -177.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -85.96 149.11 49.78 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 19.2 Cg_endo -58.71 136.63 75.17 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.344 2.029 . . . . 0.0 111.63 177.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -145.35 138.6 26.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.338 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.416 ' CG ' ' HB3' ' A' ' 53' ' ' PRO . 87.7 t80 -83.3 118.14 23.46 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.659 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -130.59 115.54 16.89 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.092 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.71 -95.75 0.91 Allowed Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.149 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -132.61 4.87 3.96 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.942 0.401 . . . . 0.0 110.368 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 82.1 m-85 -127.65 143.93 51.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.091 -176.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.632 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 93.1 t -99.31 120.98 49.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 172.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.636 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 41.9 m-80 -111.79 145.94 38.52 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -171.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.528 ' HB2' HD13 ' A' ' 60' ' ' LEU . 64.9 ttp -146.49 135.95 22.94 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.289 174.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 22.9 mt -108.68 132.42 53.94 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.749 0.309 . . . . 0.0 111.822 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.16 132.66 70.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.294 0.569 . . . . 0.0 110.692 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.8 m -110.29 141.28 23.58 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.491 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 89.4 Cg_endo -69.29 150.82 71.55 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.762 1.641 . . . . 0.0 109.437 177.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.7 mttm . . . . . 0 C--N 1.325 -0.485 0 CA-C-O 121.565 0.698 . . . . 0.0 111.991 -175.605 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.545 ' HB2' ' HD3' ' A' ' 37' ' ' LYS . 7.0 m-20 . . . . . 0 CA--C 1.505 -0.767 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.423 HG12 ' HB2' ' A' ' 38' ' ' HIS . 97.7 mt -111.45 121.1 63.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 121.095 0.474 . . . . 0.0 110.176 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.439 ' HG3' ' CD1' ' A' ' 32' ' ' PHE . 75.1 mmtt -92.22 133.8 35.48 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.341 -173.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -102.75 102.89 13.08 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.589 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.1 mt -90.94 111.17 23.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.092 0.472 . . . . 0.0 109.85 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 88.3 tttt -85.26 137.67 32.83 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.988 -177.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.2 mt -126.8 175.98 7.61 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.648 -177.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.7 p -146.83 149.29 33.02 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.6 t -64.85 -42.95 96.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -80.8 63.04 5.05 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 174.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.7 tt -113.5 152.13 15.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.601 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.03 150.18 23.55 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -63.92 -36.47 84.04 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.764 0.316 . . . . 0.0 111.574 -177.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -62.88 -39.13 93.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.724 0.297 . . . . 0.0 111.154 178.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -64.99 -38.11 89.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.31 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.635 ' O ' HG23 ' A' ' 26' ' ' VAL . 95.5 mt -62.77 -46.86 95.31 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -60.59 -44.39 96.31 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.349 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -65.12 -49.24 70.73 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.123 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -65.54 -41.08 93.44 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 22' ' ' ILE . 59.6 t -63.19 -40.41 88.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.178 0.514 . . . . 0.0 109.984 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -59.75 -45.69 91.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.368 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.456 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 17.8 t-160 -65.43 -31.63 72.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.475 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.85 -31.78 67.0 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 178.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.34 -39.97 94.85 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.026 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.456 ' OE1' ' HA ' ' A' ' 28' ' ' HIS . 1.3 mp0 -54.29 -47.05 72.83 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.439 ' CD1' ' HG3' ' A' ' 9' ' ' LYS . 95.0 m-85 -68.28 -37.1 80.34 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.638 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.35 -42.21 98.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.378 0.608 . . . . 0.0 110.087 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -61.76 -29.89 70.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.12 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -73.91 -9.45 58.66 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.504 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.04 16.38 57.87 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.709 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.545 ' HD3' ' HB2' ' A' ' 7' ' ' ASP . 65.8 mttm -99.82 173.36 6.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.015 0.436 . . . . 0.0 111.37 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.514 ' NE2' HG23 ' A' ' 89' ' ' THR . 17.5 m170 -111.15 149.7 30.51 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.899 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.3 t -118.86 130.68 73.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -109.5 111.37 22.86 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.58 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 83.8 m-85 -85.01 119.5 25.47 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 29.2 mtm180 -125.08 132.79 53.1 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -177.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.454 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.8 p -125.15 132.18 71.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 120.956 0.408 . . . . 0.0 111.142 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.438 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 90.1 t80 -102.72 127.51 49.83 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.672 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.4 mt -90.16 111.01 22.01 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -83.88 88.45 7.12 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.9 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.07 153.39 0.62 Allowed Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.365 -0.834 . . . . 0.0 114.41 175.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 64.17 -64.58 0.14 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.351 1.06 . . . . 0.0 113.111 176.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -65.64 -11.75 47.42 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.649 0.78 . . . . 0.0 111.413 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 80.6 mtp -61.32 -28.96 69.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.449 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.67 -19.37 64.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.543 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.4 m -122.31 97.8 44.8 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-O 121.282 0.563 . . . . 0.0 111.156 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -63.33 -22.15 71.82 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 123.515 2.81 . . . . 0.0 112.521 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -60.81 -28.14 68.55 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.444 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.01 -43.24 95.37 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.887 0.375 . . . . 0.0 110.728 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.26 -39.04 92.1 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.754 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.6 t -62.83 -43.71 99.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 122.629 0.372 . . . . 0.0 110.715 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.68 -40.3 91.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.413 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 48.1 tp -63.42 -45.8 89.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.193 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.428 HD12 HG12 ' A' ' 84' ' ' VAL . 86.8 mt -66.05 -42.18 89.86 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.33 -33.08 74.75 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.269 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -60.5 -47.88 84.23 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.4 mt -66.08 -42.49 91.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.602 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 37.3 t-105 -54.84 -40.38 69.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.026 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.5 m -63.34 -23.16 67.29 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-O 121.106 0.479 . . . . 0.0 111.021 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 96.1 mtp -90.03 -35.59 15.41 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.451 ' CG2' HG13 ' A' ' 26' ' ' VAL . 40.2 pt -92.35 -6.34 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -175.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.93 -4.4 6.9 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -63.34 -46.06 88.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.125 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -121.26 -3.66 9.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.696 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -118.87 145.55 45.61 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.167 0.508 . . . . 0.0 111.718 -176.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -115.36 133.87 55.63 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.782 175.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -68.84 113.24 6.1 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 120.972 0.415 . . . . 0.0 111.993 -177.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -87.45 -40.83 14.0 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.813 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 58.2 tptt -134.19 136.43 43.72 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.775 -177.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -74.47 155.3 87.63 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.613 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 24.2 Cg_exo -61.05 139.6 85.29 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.599 1.533 . . . . 0.0 111.312 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -145.85 141.56 27.98 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.802 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -92.44 112.6 24.6 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -153.57 124.53 7.34 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.586 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.81 31.47 55.87 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 66.49 14.71 9.84 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.672 0.789 . . . . 0.0 112.536 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 37.3 m-85 -125.44 143.53 50.95 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.351 176.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.454 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 78.9 t -103.54 124.09 57.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 172.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.613 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 5.9 p30 -131.67 156.95 44.97 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.959 -0.697 . . . . 0.0 112.423 -173.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 54.5 ttp -142.67 135.62 28.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.528 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 12.4 mt -108.18 131.06 55.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.969 0.414 . . . . 0.0 111.198 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.2 m -124.69 138.67 53.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.777 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.514 HG23 ' NE2' ' A' ' 38' ' ' HIS . 11.2 m -109.43 135.32 20.31 Favored Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.471 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.98 143.8 37.05 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 C-N-CA 122.374 2.049 . . . . 0.0 110.963 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt . . . . . 0 C--N 1.319 -0.725 0 CA-C-O 121.354 0.597 . . . . 0.0 110.486 179.71 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.517 ' OD2' ' HE2' ' A' ' 9' ' ' LYS . 34.0 t70 . . . . . 0 N--CA 1.442 -0.849 0 CA-C-O 121.02 0.438 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 88.4 mt -120.63 136.85 56.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.446 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.541 ' HE3' ' CE1' ' A' ' 32' ' ' PHE . 75.3 mmtt -98.24 136.47 38.39 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.904 -176.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.475 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 47.0 mt-10 -114.83 104.21 11.71 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.574 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.2 mt -90.21 103.6 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 121.753 0.787 . . . . 0.0 109.706 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.427 ' HE2' ' HB2' ' A' ' 44' ' ' PHE . 50.7 tttm -88.71 128.06 35.61 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.782 -177.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.502 HD21 ' HG3' ' A' ' 25' ' ' LYS . 74.4 mt -125.42 -178.55 4.27 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.713 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.424 ' HA ' HG23 ' A' ' 43' ' ' VAL . 58.4 p -141.68 161.58 37.58 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.78 0.324 . . . . 0.0 110.436 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.1 t -64.4 -25.93 39.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.192 0.52 . . . . 0.0 112.3 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -90.09 11.54 20.51 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.526 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.48 HD12 HD22 ' A' ' 13' ' ' LEU . 14.3 tt -68.24 152.73 9.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 CA-C-O 121.009 0.433 . . . . 0.0 111.163 -178.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.35 154.65 18.43 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.421 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -63.6 -34.21 77.31 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.765 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -64.16 -38.4 90.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.863 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -66.62 -36.87 83.63 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.895 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.6 mt -61.73 -43.74 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.555 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -60.42 -42.31 95.78 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.195 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -69.46 -39.54 77.69 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.452 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.502 ' HG3' HD21 ' A' ' 13' ' ' LEU . 48.6 mmtm -63.39 -42.16 98.78 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.595 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 4.4 m -63.66 -34.13 65.96 Favored 'Isoleucine or valine' 0 C--N 1.342 0.275 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.177 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -63.48 -39.7 95.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.723 0.297 . . . . 0.0 110.686 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -64.7 -40.66 95.75 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.157 0.503 . . . . 0.0 110.278 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.659 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -61.66 -39.13 90.28 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.768 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 26' ' ' VAL . 93.1 mt -61.43 -40.35 94.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.699 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 46.0 mt-10 -58.44 -47.06 85.21 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.799 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.541 ' CE1' ' HE3' ' A' ' 9' ' ' LYS . 94.2 m-85 -71.35 -32.37 68.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.951 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.659 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 90.2 mt -62.23 -43.27 99.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.45 0.643 . . . . 0.0 109.817 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -62.6 -30.72 71.55 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.979 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 80.4 mt-30 -73.54 -10.12 59.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.726 178.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.38 7.44 65.28 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.15 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.4 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 88.5 mttt -91.23 178.24 6.03 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.162 0.506 . . . . 0.0 110.323 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.496 ' NE2' HG23 ' A' ' 89' ' ' THR . 23.7 m170 -117.24 150.76 38.24 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.914 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.0 t -117.53 128.58 74.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.079 0.466 . . . . 0.0 110.046 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.475 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 51.8 ttt180 -109.26 115.9 30.87 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.528 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 76.2 m-85 -90.15 113.92 25.78 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -117.09 134.62 54.53 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.512 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.7 p -118.77 130.59 73.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-O 121.211 0.529 . . . . 0.0 111.462 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.427 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 91.2 t80 -94.63 125.22 39.15 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.394 177.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.474 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 51.6 mt -91.59 129.03 37.63 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -62.39 -48.23 80.63 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.27 -44.96 0.17 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 119.941 -1.123 . . . . 0.0 113.329 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -90.96 -19.27 23.44 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 117.168 0.484 . . . . 0.0 111.471 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.474 ' HG2' ' HB3' ' A' ' 45' ' ' LEU . 1.6 pm0 -79.54 2.66 21.35 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.597 0.713 . . . . 0.0 109.583 175.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 61.2 mtt -82.43 -133.93 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.337 175.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 61.06 -61.06 0.08 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.312 0.645 . . . . 0.0 111.249 -173.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 t -121.85 133.82 24.44 Favored Pre-proline 0 N--CA 1.437 -1.103 0 C-N-CA 123.566 0.746 . . . . 0.0 109.431 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.87 -8.89 23.88 Favored 'Trans proline' 0 C--N 1.331 -0.385 0 C-N-CA 123.425 2.75 . . . . 0.0 113.487 -176.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.88 -30.14 68.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.26 96.03 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.86 0.362 . . . . 0.0 110.465 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.29 -39.88 87.67 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.18 -42.47 94.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.531 -0.334 . . . . 0.0 110.436 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.81 -40.87 76.77 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.293 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.9 tp -62.4 -45.84 91.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.245 0.545 . . . . 0.0 109.993 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.414 ' CD1' HG12 ' A' ' 84' ' ' VAL . 89.3 mt -64.76 -41.09 96.16 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.891 -177.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -60.37 -39.41 87.12 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.309 0.575 . . . . 0.0 110.992 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -63.8 -41.18 97.96 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.105 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.2 mt -70.04 -46.23 73.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.065 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 41.7 t-105 -57.75 -41.4 81.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.322 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.8 p -62.8 -24.69 67.87 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 98.4 mtp -75.78 -34.43 60.22 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.9 pt -107.76 -6.89 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -56.32 -23.08 34.76 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -64.41 -39.19 93.36 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -121.13 6.51 10.27 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.45 146.29 50.54 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.945 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -114.31 147.72 38.66 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.0 ptt-85 -81.16 127.63 32.88 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.418 ' CB ' HD12 ' A' ' 87' ' ' LEU . 23.5 t70 -74.12 -35.54 64.13 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.384 0.611 . . . . 0.0 109.782 176.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -161.43 172.22 16.86 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.063 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -77.4 152.59 81.41 Favored Pre-proline 0 C--N 1.311 -1.073 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -61.58 140.64 87.99 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.686 1.591 . . . . 0.0 110.57 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -140.88 165.6 27.08 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.495 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -101.96 113.57 26.92 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.991 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -114.39 113.07 24.02 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.56 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.52 -93.08 0.16 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.497 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -133.94 11.37 3.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.142 0.496 . . . . 0.0 110.492 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -118.27 140.72 49.39 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.863 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.512 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 55.9 t -100.81 127.28 54.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 172.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.528 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 7.2 p30 -134.3 153.84 51.65 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 119.353 -0.939 . . . . 0.0 113.078 -174.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.402 ' HB2' HD13 ' A' ' 60' ' ' LEU . 53.0 ttp -140.55 138.15 34.29 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.817 177.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.418 HD12 ' CB ' ' A' ' 74' ' ' ASP . 2.9 tm? -109.89 126.93 54.38 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.1 m -112.83 134.1 56.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.385 0.612 . . . . 0.0 110.896 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.496 HG23 ' NE2' ' A' ' 38' ' ' HIS . 13.3 m -113.56 139.29 23.16 Favored Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.218 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.582 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 69.2 Cg_endo -66.82 142.35 62.78 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.35 2.033 . . . . 0.0 110.541 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 C--N 1.326 -0.447 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.334 -179.269 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.539 ' HB2' ' HD3' ' A' ' 37' ' ' LYS . 22.2 m-20 . . . . . 0 CA--C 1.512 -0.497 0 CA-C-O 121.072 0.463 . . . . 0.0 111.015 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 90.7 mt -129.16 129.55 67.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -101.46 135.77 42.42 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.789 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.466 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 58.3 mt-10 -104.38 112.28 25.26 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.896 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.4 mt -97.73 111.74 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 87.8 tttt -98.14 136.01 38.98 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.545 -175.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.554 HD22 HD11 ' A' ' 63' ' ' ILE . 5.2 mp -131.77 179.93 5.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.119 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.7 p -138.98 156.54 47.15 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.97 -25.01 37.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.437 0.637 . . . . 0.0 111.247 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -104.61 22.29 15.29 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.988 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.1 tt -74.37 147.72 8.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.949 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.46 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -75.25 155.22 36.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.74 -177.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 -62.7 -38.75 91.65 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.166 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -61.06 -41.14 96.07 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.563 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 21.1 m-20 -64.75 -38.84 92.35 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.394 177.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 18' ' ' ALA . 68.6 mt -61.95 -45.67 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-O 121.075 0.464 . . . . 0.0 110.703 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -60.08 -41.73 93.1 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.818 0.818 . . . . 0.0 110.323 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -61.97 -44.2 97.25 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.377 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 75.1 mmtt -64.06 -44.76 91.44 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.469 HG11 ' HB2' ' A' ' 66' ' ' MET . 4.7 m -67.9 -32.87 58.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.613 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -62.37 -45.47 93.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.096 0.474 . . . . 0.0 109.809 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -70.9 -32.53 69.51 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.191 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.595 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -55.85 -45.97 78.33 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.269 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.37 -40.41 96.36 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.79 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 52.2 mt-10 -57.14 -48.54 78.43 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 120.785 0.326 . . . . 0.0 111.159 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -68.76 -36.24 78.09 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 95.8 mt -63.04 -44.28 96.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.438 0.637 . . . . 0.0 110.428 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -57.88 -32.28 67.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.441 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 80.3 mt-30 -75.21 -7.36 53.66 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.281 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.68 15.75 56.1 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.021 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.539 ' HD3' ' HB2' ' A' ' 7' ' ' ASP . 31.1 mtmm -103.02 168.58 9.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.487 0.66 . . . . 0.0 112.306 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.407 ' NE2' HG23 ' A' ' 89' ' ' THR . 3.3 m80 -102.92 145.9 29.13 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.326 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.9 t -115.4 129.24 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.697 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.466 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 42.4 ttm180 -109.81 113.0 25.39 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 83.1 m-85 -89.89 124.29 34.57 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 73.0 mtp180 -128.22 135.53 49.82 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.513 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.7 p -118.88 131.95 70.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-O 121.18 0.514 . . . . 0.0 111.24 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -96.26 126.36 41.42 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.576 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 50' ' ' MET . 31.9 mt -92.31 114.0 26.43 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -95.16 119.84 34.37 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.866 0.365 . . . . 0.0 111.518 -174.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.2 -140.73 15.08 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -91.88 13.67 17.78 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.273 0.558 . . . . 0.0 110.43 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.422 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 71.8 mt-10 -62.35 -21.99 65.74 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.65 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.453 ' HA ' HD12 ' A' ' 45' ' ' LEU . 65.5 mtt -67.4 -11.3 57.42 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.969 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.94 -28.3 69.73 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.151 0.501 . . . . 0.0 110.515 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.4 m -130.87 99.63 18.11 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-O 121.23 0.538 . . . . 0.0 110.843 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -60.46 -22.81 73.1 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 123.529 2.82 . . . . 0.0 112.897 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -61.65 -22.38 65.23 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.749 0.309 . . . . 0.0 110.827 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.81 -40.6 95.84 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.048 0.451 . . . . 0.0 109.856 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.83 -38.55 93.07 Favored Glycine 0 CA--C 1.506 -0.488 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.382 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.411 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 88.1 t -63.33 -44.44 99.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.439 -0.381 . . . . 0.0 110.508 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.31 -41.2 88.47 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.38 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.0 tp -63.93 -45.63 88.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.355 0.598 . . . . 0.0 110.356 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.494 HD23 HD12 ' A' ' 63' ' ' ILE . 81.7 mt -64.53 -41.13 96.57 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.416 -177.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 57' ' ' VAL . 11.9 mm-40 -63.7 -34.26 77.46 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.539 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -62.04 -41.9 98.61 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.554 HD11 HD22 ' A' ' 13' ' ' LEU . 96.4 mt -63.75 -44.32 98.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.281 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -59.72 -36.91 77.52 Favored 'General case' 0 C--O 1.213 -0.83 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.779 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.4 m -57.82 -33.78 68.96 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.306 0.574 . . . . 0.0 110.325 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.469 ' HB2' HG11 ' A' ' 26' ' ' VAL . 97.8 mmm -76.85 -32.73 57.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.603 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.621 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 41.1 pt -117.96 15.84 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -174.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -62.61 -22.48 66.43 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.774 0.797 . . . . 0.0 110.291 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.443 HD22 ' HG3' ' A' ' 70' ' ' GLU . 4.5 p-10 -97.58 141.34 30.74 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 173.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.443 ' HG3' HD22 ' A' ' 69' ' ' ASN . 35.4 mt-10 74.9 -13.89 0.79 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.597 0.759 . . . . 0.0 111.842 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 67' ' ' ILE . . . -129.71 150.79 50.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.661 0.267 . . . . 0.0 110.4 177.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -116.47 149.25 39.82 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -87.57 106.31 17.92 Favored 'General case' 0 N--CA 1.412 -2.368 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.658 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -80.74 -41.14 24.03 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.002 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -137.32 136.8 38.3 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.14 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.42 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 0.3 OUTLIER -80.98 151.92 70.99 Favored Pre-proline 0 N--CA 1.442 -0.87 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 17.4 Cg_endo -56.29 131.1 43.75 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.463 2.109 . . . . 0.0 112.339 -177.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.427 ' ND2' ' HG3' ' A' ' 80' ' ' GLU . 3.1 p-10 -147.09 165.5 29.74 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.415 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.504 ' CZ ' ' HA ' ' A' ' 82' ' ' ARG . 84.6 t80 -93.83 123.32 37.1 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.844 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.427 ' HG3' ' ND2' ' A' ' 78' ' ' ASN . 38.4 mt-10 -146.77 120.07 8.96 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.48 178.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.447 ' O ' ' HD1' ' A' ' 83' ' ' TYR . . . 64.94 38.73 95.85 Favored Glycine 0 C--O 1.221 -0.696 0 CA-C-N 115.951 -0.568 . . . . 0.0 113.945 175.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.504 ' HA ' ' CZ ' ' A' ' 79' ' ' PHE . 75.2 mtt180 74.96 0.91 3.66 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.492 0.717 . . . . 0.0 111.228 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.447 ' HD1' ' O ' ' A' ' 81' ' ' GLY . 82.2 m-85 -117.38 149.17 40.97 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.891 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.513 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 70.3 t -105.2 128.09 59.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 173.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.529 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 9.2 p30 -133.11 161.44 34.4 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -173.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.445 ' CE ' ' HB3' ' A' ' 60' ' ' LEU . 13.8 ttm -143.71 146.01 32.85 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.217 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 16.2 mt -115.33 129.39 56.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.767 0.318 . . . . 0.0 111.238 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.7 132.46 70.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.85 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.41 ' CG2' ' HD2' ' A' ' 90' ' ' PRO . 15.2 m -104.95 141.2 22.04 Favored Pre-proline 0 C--N 1.309 -1.174 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.431 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 33.8 Cg_endo -61.38 147.21 96.1 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 121.949 1.766 . . . . 0.0 110.579 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? . . . . . 0 C--O 1.239 0.534 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.2 -175.429 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.416 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 25.2 t70 . . . . . 0 CA--C 1.516 -0.34 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.427 HG23 ' O ' ' A' ' 38' ' ' HIS . 92.7 mt -115.56 132.2 65.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.343 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -92.37 155.32 17.98 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.564 0.697 . . . . 0.0 111.126 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.585 ' CD ' HH21 ' A' ' 40' ' ' ARG . 43.4 mt-10 -125.74 114.35 18.52 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.972 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.5 mt -100.67 108.55 23.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -85.49 142.6 29.08 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.841 -176.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.0 mt -129.65 166.9 18.84 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.69 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.0 m -139.2 150.04 45.1 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 176.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.2 t -61.6 -43.89 97.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.309 0.576 . . . . 0.0 110.779 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -93.62 68.03 3.98 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.566 0.698 . . . . 0.0 110.797 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.431 HD11 ' HE2' ' A' ' 25' ' ' LYS . 18.3 tt -117.59 149.77 19.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.68 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.06 142.27 54.56 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.706 0.289 . . . . 0.0 110.874 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -62.96 -39.0 93.33 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.824 0.345 . . . . 0.0 111.32 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -61.8 -39.95 93.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.15 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.584 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 28.1 t70 -65.91 -38.23 88.15 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.024 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.87 -45.29 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.807 0.813 . . . . 0.0 109.47 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -65.39 -28.82 69.53 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.134 -1.393 . . . . 0.0 110.694 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -78.77 -40.77 32.32 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.161 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 21' ' ' ASP . 57.8 mttm -65.55 -38.94 91.06 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 m -59.59 -32.61 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.2 tttt -63.26 -42.24 99.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.852 0.358 . . . . 0.0 110.117 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -68.36 -38.53 81.52 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.52 176.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.415 ' O ' HD13 ' A' ' 33' ' ' LEU . . . -57.72 -44.17 85.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.28 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.446 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 88.2 mt -62.32 -34.66 77.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.82 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -56.22 -41.64 75.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.274 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -67.85 -37.14 81.49 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.935 0.398 . . . . 0.0 111.08 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.43 ' CB ' ' HB3' ' A' ' 90' ' ' PRO . 11.0 mp -63.09 -42.56 99.63 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.445 0.64 . . . . 0.0 110.423 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 30' ' ' LEU . 66.7 mm-40 -61.75 -22.8 65.71 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.993 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -87.74 -6.03 58.38 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.802 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.66 27.49 26.82 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.614 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.416 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 66.2 mttm -115.29 176.26 5.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.248 0.547 . . . . 0.0 111.311 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.427 ' O ' HG23 ' A' ' 8' ' ' ILE . 5.6 m80 -111.13 147.11 35.58 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.163 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.6 t -115.3 126.65 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.585 HH21 ' CD ' ' A' ' 10' ' ' GLU . 45.1 ttp180 -101.51 111.71 24.03 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -87.88 121.65 30.55 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.495 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 83.1 mtp180 -131.96 120.08 21.98 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.63 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 4.3 p -111.4 131.67 62.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.199 0.523 . . . . 0.0 111.53 -176.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.423 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 88.9 t80 -98.34 130.78 45.0 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.618 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' A' ' 50' ' ' MET . 40.7 mt -89.93 122.52 33.04 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -107.32 114.12 27.95 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.178 0.513 . . . . 0.0 111.674 -174.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.52 -143.86 15.97 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.485 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -83.18 4.86 24.88 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.154 0.502 . . . . 0.0 111.015 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -65.72 -25.75 67.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.153 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.523 ' HA ' HD12 ' A' ' 45' ' ' LEU . 49.2 ttm -59.46 -24.34 63.48 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.462 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.9 -25.61 67.96 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.321 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.9 p -126.69 101.55 26.78 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 121.303 0.573 . . . . 0.0 110.741 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.3 -15.36 38.75 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.446 2.764 . . . . 0.0 112.631 -177.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -61.69 -26.14 67.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.811 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.67 90.59 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.036 0.446 . . . . 0.0 110.119 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.437 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -67.03 -38.67 92.81 Favored Glycine 0 CA--C 1.505 -0.563 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.584 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.412 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 93.5 t -63.13 -45.85 97.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.571 -0.315 . . . . 0.0 110.947 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.37 -40.76 92.0 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.198 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.2 tp -63.2 -45.69 90.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.183 0.516 . . . . 0.0 110.289 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.442 HD13 ' HB2' ' A' ' 86' ' ' MET . 97.6 mt -65.17 -40.56 94.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.907 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 57' ' ' VAL . 46.6 mt-10 -62.55 -39.13 92.64 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.016 0.436 . . . . 0.0 110.471 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -62.64 -43.67 98.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.019 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.0 mt -67.35 -43.31 87.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.684 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.523 ' CZ2' ' HB2' ' A' ' 73' ' ' ARG . 41.9 t-105 -55.86 -41.16 73.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.281 -178.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 36.0 p -63.5 -29.13 70.45 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.256 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 66.0 mtt -67.66 -41.2 84.15 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.738 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.8 pt -106.52 -1.43 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -174.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -54.09 -32.0 53.54 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -176.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.554 ' ND2' ' HG2' ' A' ' 70' ' ' GLU . 4.9 p-10 -77.26 -14.74 59.7 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.554 ' HG2' ' ND2' ' A' ' 69' ' ' ASN . 58.6 mm-40 -117.71 -15.4 10.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.265 0.555 . . . . 0.0 111.203 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -124.16 155.57 38.25 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.788 -176.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -112.88 139.11 48.8 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 176.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.523 ' HB2' ' CZ2' ' A' ' 64' ' ' TRP . 71.0 ttp85 -87.28 112.3 21.91 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -177.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -70.97 -37.2 72.76 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.903 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -160.85 161.56 31.94 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.87 152.97 95.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.458 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 22.4 Cg_endo -61.16 139.41 83.66 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.165 1.91 . . . . 0.0 111.398 177.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -140.29 148.39 41.35 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.412 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -91.76 107.7 19.39 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.219 0.533 . . . . 0.0 110.156 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -114.84 116.05 27.96 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.513 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.4 -104.71 1.56 Allowed Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 120.363 -0.922 . . . . 0.0 110.92 -177.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -127.56 10.54 6.68 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.05 0.453 . . . . 0.0 110.324 178.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 81.2 m-85 -121.52 145.31 48.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.299 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.63 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 86.5 t -97.46 119.05 45.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 172.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.495 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 78.5 m-20 -111.25 144.08 40.99 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.081 -171.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.442 ' HB2' HD13 ' A' ' 60' ' ' LEU . 15.5 tmm? -147.05 137.75 23.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.746 175.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.2 mt -114.65 134.29 55.18 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.1 m -117.09 131.29 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.219 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.41 HG23 ' NE2' ' A' ' 38' ' ' HIS . 15.8 m -104.83 137.7 19.29 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.43 ' HB3' ' CB ' ' A' ' 33' ' ' LEU . 57.9 Cg_endo -64.47 148.34 90.66 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.429 2.086 . . . . 0.0 111.632 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 69' ' ' ASN . 36.7 mttp . . . . . 0 C--N 1.323 -0.568 0 CA-C-O 120.925 0.393 . . . . 0.0 111.629 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.1 t70 . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 121.036 0.446 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.9 mt -89.32 133.57 31.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.015 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -94.01 143.79 26.05 Favored 'General case' 0 CA--C 1.492 -1.288 0 CA-C-O 121.428 0.632 . . . . 0.0 111.167 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.615 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 91.1 mt-10 -120.49 126.28 49.98 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.945 178.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.9 mt -110.46 117.77 55.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 12.3 mptt -97.51 139.76 32.96 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.186 0.517 . . . . 0.0 112.161 -177.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mp -130.22 177.17 7.52 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.192 176.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.6 m -135.05 154.08 51.82 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.9 t -63.3 -33.09 59.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.257 0.551 . . . . 0.0 110.059 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -106.9 74.59 1.0 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.967 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.4 tt -130.39 160.84 41.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.969 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.418 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -73.85 142.62 46.08 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -38.39 90.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.055 0.455 . . . . 0.0 109.987 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -61.88 -41.22 97.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.596 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.71 ' OD2' ' HE2' ' A' ' 25' ' ' LYS . 6.1 t70 -65.58 -36.49 83.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.679 -178.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.647 ' O ' HG23 ' A' ' 26' ' ' VAL . 68.4 mt -60.98 -46.62 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -59.14 -43.19 92.01 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.517 0.675 . . . . 0.0 110.571 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -61.66 -46.11 91.13 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.022 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.71 ' HE2' ' OD2' ' A' ' 21' ' ' ASP . 68.8 mttm -65.38 -40.89 94.04 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.756 0.312 . . . . 0.0 111.769 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 22' ' ' ILE . 55.8 t -61.57 -39.71 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.611 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -56.08 -39.65 72.42 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.534 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 20.9 m80 -64.35 -38.24 90.35 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.989 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.614 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -60.86 -38.58 86.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.726 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.68 -39.1 90.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.99 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 6.1 mm-40 -59.58 -50.64 73.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.057 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -64.75 -34.84 79.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.518 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.649 HD13 ' HB2' ' A' ' 71' ' ' ALA . 96.1 mt -62.75 -43.72 98.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.292 0.568 . . . . 0.0 110.474 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -67.14 -26.73 66.81 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.915 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 78.9 mt-30 -77.67 -7.65 56.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.902 178.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.63 22.52 50.1 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.908 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -103.71 158.83 16.11 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.994 0.426 . . . . 0.0 110.298 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -98.35 138.66 35.27 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.512 176.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.3 t -112.15 128.18 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.615 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 67.2 ttt180 -108.51 112.76 25.31 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 176.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -86.9 117.97 25.98 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 81.8 mtp180 -125.65 138.78 53.92 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.572 -177.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.606 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.1 p -126.61 135.66 63.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.014 0.435 . . . . 0.0 111.076 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -101.14 132.35 46.65 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.707 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.56 ' HB2' ' SD ' ' A' ' 50' ' ' MET . 29.1 mt -90.33 111.99 23.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.024 0.44 . . . . 0.0 109.852 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -104.27 123.21 46.95 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.58 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.45 -147.42 16.33 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.209 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -89.07 15.28 8.97 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.224 0.535 . . . . 0.0 110.02 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -73.86 -11.75 60.46 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.193 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.56 ' SD ' ' HB2' ' A' ' 45' ' ' LEU . 95.6 mmm -61.23 -35.92 78.54 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.276 -176.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.74 -21.22 65.65 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.486 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.0 p -119.71 94.94 48.97 Favored Pre-proline 0 N--CA 1.446 -0.64 0 CA-C-O 121.143 0.497 . . . . 0.0 111.839 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -64.4 -23.62 64.99 Favored 'Trans proline' 0 N--CA 1.477 0.552 0 C-N-CA 123.349 2.7 . . . . 0.0 111.26 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.94 -22.13 66.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.74 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.87 97.04 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.927 0.394 . . . . 0.0 110.519 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.42 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -68.37 -39.32 87.58 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.905 177.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.427 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 97.3 t -63.41 -44.98 99.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.648 0.261 . . . . 0.0 111.018 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.99 -40.94 95.43 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.16 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.3 tp -63.15 -45.15 93.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.192 0.52 . . . . 0.0 110.001 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.488 HD12 HG12 ' A' ' 84' ' ' VAL . 63.1 mt -65.76 -37.75 87.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.767 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 57' ' ' VAL . 56.3 mt-10 -55.69 -42.23 74.89 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.621 0.248 . . . . 0.0 110.583 177.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -61.89 -43.53 98.65 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.06 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.473 ' O ' HG12 ' A' ' 67' ' ' ILE . 65.1 mt -62.39 -45.32 99.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.826 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.477 ' CZ2' ' HB2' ' A' ' 73' ' ' ARG . 45.6 t-105 -57.6 -40.96 80.26 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.072 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.405 ' HA ' ' OE2' ' A' ' 68' ' ' GLU . 25.2 m -63.22 -25.69 68.45 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 121.126 0.489 . . . . 0.0 110.581 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 95.6 mtp -89.47 -43.3 10.94 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.888 0.375 . . . . 0.0 111.799 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.474 HG12 ' HA ' ' A' ' 64' ' ' TRP . 40.5 pt -81.44 -18.35 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -174.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.405 ' OE2' ' HA ' ' A' ' 65' ' ' THR . 14.6 pt-20 -58.8 -15.42 12.22 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.102 0.477 . . . . 0.0 111.863 -177.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -63.17 -40.71 98.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.668 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -116.48 -9.71 11.39 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.532 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.649 ' HB2' HD13 ' A' ' 33' ' ' LEU . . . -121.9 160.3 25.06 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.642 ' OD1' ' HG2' ' A' ' 91' ' ' LYS . 11.3 m-20 -116.08 156.89 25.57 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.732 176.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.477 ' HB2' ' CZ2' ' A' ' 64' ' ' TRP . 69.3 ttt180 -85.4 106.5 16.82 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.006 -176.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -82.25 -36.77 26.8 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.027 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -160.18 160.03 32.35 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.851 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.449 ' HB3' HH21 ' A' ' 73' ' ' ARG . 9.7 pt-20 -84.78 155.75 61.57 Favored Pre-proline 0 C--N 1.316 -0.868 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 16.1 Cg_endo -57.1 132.7 53.03 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.474 2.116 . . . . 0.0 111.788 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -127.75 134.04 49.52 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.347 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -82.28 113.66 20.24 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -127.34 114.86 18.13 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.234 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.39 -105.81 1.68 Allowed Glycine 0 N--CA 1.428 -1.888 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.687 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -121.31 7.73 10.2 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.209 0.528 . . . . 0.0 110.445 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -123.47 149.58 44.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.996 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.606 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 69.7 t -108.93 126.29 65.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 173.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 6.5 m-80 -124.06 139.04 54.33 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.492 -0.483 . . . . 0.0 112.124 -172.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.423 ' HB2' HD13 ' A' ' 60' ' ' LEU . 63.2 ttp -130.01 128.99 43.12 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -108.27 127.22 53.66 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.969 0.414 . . . . 0.0 110.031 -178.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.431 HG11 ' CD1' ' A' ' 67' ' ' ILE . 20.6 m -123.18 145.43 30.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.042 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.1 m -115.42 135.43 22.59 Favored Pre-proline 0 C--N 1.303 -1.414 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.125 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.422 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 55.5 Cg_endo -64.17 152.52 80.83 Favored 'Trans proline' 0 C--N 1.329 -0.481 0 C-N-CA 122.319 2.013 . . . . 0.0 110.054 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.642 ' HG2' ' OD1' ' A' ' 72' ' ' ASN . 68.6 mttm . . . . . 0 C--N 1.329 -0.292 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -174.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.6 t70 . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 121.016 0.436 . . . . 0.0 109.875 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 88.7 mt -104.22 133.49 48.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.387 0.613 . . . . 0.0 111.38 -176.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -96.13 149.59 21.46 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.833 -175.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -119.88 137.48 53.99 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.185 0.517 . . . . 0.0 111.272 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.8 mm -110.21 114.85 48.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -90.21 141.74 28.41 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.309 0.576 . . . . 0.0 111.321 -176.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.47 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 49.4 mt -133.46 165.99 23.58 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.597 -176.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.5 p -140.82 152.3 45.05 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.7 t -62.79 -33.74 61.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.325 0.583 . . . . 0.0 109.551 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -93.55 73.2 4.39 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.575 176.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.8 tt -126.34 145.58 33.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.515 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.77 142.55 53.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.292 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.446 HE22 ' HD3' ' A' ' 62' ' ' LYS . 62.2 tp60 -62.98 -38.33 90.71 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.305 0.574 . . . . 0.0 110.505 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -62.5 -38.25 89.18 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.952 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -64.96 -36.1 83.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.602 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 94.2 mt -61.73 -42.74 95.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.424 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 6.4 m-20 -60.15 -41.11 92.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.515 178.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -68.63 -40.5 80.3 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.8 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -60.81 -42.4 97.58 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.57 HG12 HG23 ' A' ' 63' ' ' ILE . 13.2 m -64.04 -35.97 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.316 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 23' ' ' ASN . 99.1 mttt -62.54 -42.67 99.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.411 0.624 . . . . 0.0 109.49 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -65.94 -41.6 91.12 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.218 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.432 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -64.03 -38.94 92.91 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.299 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.0 mt -61.36 -38.48 87.12 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.263 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 57.9 mt-10 -57.69 -42.85 84.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.683 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.442 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 80.1 m-85 -74.63 -37.19 62.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.873 0.368 . . . . 0.0 111.798 177.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 92.4 mt -62.84 -43.43 98.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.599 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -63.4 -22.88 67.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.919 0.39 . . . . 0.0 111.183 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 32' ' ' PHE . 78.1 mt-30 -71.17 -34.95 71.4 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.364 175.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.27 -0.3 12.85 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.268 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -88.13 164.81 15.51 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.56 151.25 20.86 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.652 -176.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.5 t -119.18 130.01 74.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.223 0.535 . . . . 0.0 110.315 175.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -103.33 114.53 28.88 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 85.9 m-85 -92.3 120.0 32.42 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.584 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.739 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 78.5 mtp85 -122.37 118.81 29.32 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.623 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.5 p -115.68 128.89 72.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.321 0.581 . . . . 0.0 110.931 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -95.58 121.38 37.22 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.817 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.4 mt -79.55 143.71 34.57 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -130.92 137.72 49.44 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.961 -0.295 . . . . 0.0 110.344 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.87 -147.07 33.11 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.102 -0.57 . . . . 0.0 113.576 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.444 ' O ' ' HD2' ' A' ' 48' ' ' ARG . 2.6 tmm_? -59.64 -35.85 75.21 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.909 0.884 . . . . 0.0 110.415 -177.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -54.18 -16.5 2.11 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 84.5 mtp -63.23 -34.08 76.89 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.073 0.463 . . . . 0.0 110.848 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.13 -33.53 73.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.232 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.428 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 68.4 p -117.11 105.25 49.41 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-O 121.097 0.475 . . . . 0.0 111.911 -177.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.63 -15.29 45.3 Favored 'Trans proline' 0 N--CA 1.485 0.998 0 C-N-CA 124.014 3.142 . . . . 0.0 113.14 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.428 ' HG2' ' HB ' ' A' ' 52' ' ' THR . 14.5 pt-20 -54.82 -31.26 58.96 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.585 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.08 -42.22 99.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.913 0.387 . . . . 0.0 111.102 -178.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.485 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -67.69 -41.32 89.49 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.749 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.4 t -63.66 -45.95 96.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.583 -0.309 . . . . 0.0 111.177 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.38 -38.5 87.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.769 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.405 HD21 ' HB3' ' A' ' 13' ' ' LEU . 39.2 tp -63.55 -45.88 88.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.288 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.51 ' CD1' HG12 ' A' ' 84' ' ' VAL . 94.2 mt -65.58 -40.74 93.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.14 -178.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -62.22 -33.99 75.62 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.776 0.322 . . . . 0.0 111.269 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HD3' HE22 ' A' ' 19' ' ' GLN . 40.7 ttmt -62.11 -47.71 83.41 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-O 121.146 0.498 . . . . 0.0 109.688 176.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.57 HG23 HG12 ' A' ' 26' ' ' VAL . 70.8 mt -63.75 -43.06 97.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.047 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -56.66 -36.56 69.69 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.479 177.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.52 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 96.7 m -59.63 -44.38 93.5 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 120.988 0.423 . . . . 0.0 110.829 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -67.17 -39.55 86.46 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 63' ' ' ILE . 41.6 pt -98.37 -5.59 9.43 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.639 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -173.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 65' ' ' THR . 13.0 pt-20 -56.05 -34.86 66.3 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -176.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.413 ' ND2' ' HG3' ' A' ' 70' ' ' GLU . 3.3 p-10 -69.63 -18.77 63.62 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.413 ' HG3' ' ND2' ' A' ' 69' ' ' ASN . 43.3 mt-10 -123.44 -1.37 8.6 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.931 0.396 . . . . 0.0 111.76 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -131.87 153.75 49.89 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.965 -177.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -111.71 144.23 41.32 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -81.71 111.86 18.36 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -176.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -66.45 -41.76 88.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.194 0.521 . . . . 0.0 109.872 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -163.66 161.18 23.53 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.264 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -74.6 152.93 87.49 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.495 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.34 134.89 64.47 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.714 2.276 . . . . 0.0 111.884 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -135.5 137.77 42.45 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.689 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -90.69 106.78 18.74 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.166 0.507 . . . . 0.0 110.564 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -118.14 118.74 32.71 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.424 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.64 -108.93 2.67 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -123.33 8.77 9.1 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.974 0.416 . . . . 0.0 110.611 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -122.8 141.4 51.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.405 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.623 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 89.3 t -97.38 115.86 38.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 173.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.739 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 47.5 m-80 -108.52 144.16 36.56 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.195 -173.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.496 ' HB2' HD13 ' A' ' 60' ' ' LEU . 65.0 ttp -144.99 134.98 23.8 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.533 174.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 16.9 mt -109.72 135.34 50.81 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.032 0.444 . . . . 0.0 110.976 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.0 m -122.62 133.86 67.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.427 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.0 m -104.45 132.96 20.46 Favored Pre-proline 0 N--CA 1.432 -1.367 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -65.56 147.33 86.42 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.173 1.915 . . . . 0.0 111.656 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.1 mttp . . . . . 0 C--N 1.324 -0.503 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.004 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.1 t70 . . . . . 0 CA--C 1.51 -0.592 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 80.9 mt -90.65 122.85 42.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.121 0.486 . . . . 0.0 110.396 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.472 ' HG2' ' CE1' ' A' ' 32' ' ' PHE . 4.2 mptp? -85.01 148.98 25.9 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.624 -175.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -110.85 118.05 35.08 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.955 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.3 mm -96.18 97.9 7.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 175.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 62.8 tttp -81.15 134.97 35.72 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.89 -177.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 67.3 mt -129.33 171.44 12.49 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.384 -175.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.9 p -144.2 149.98 37.26 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.58 -40.54 89.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -88.06 67.25 8.86 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.0 tt -117.6 152.69 19.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.35 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.403 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -84.94 154.69 22.03 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.231 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -63.49 -37.41 87.2 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.844 0.354 . . . . 0.0 111.098 -178.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -60.33 -42.64 96.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.272 0.558 . . . . 0.0 110.052 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.49 -40.52 97.3 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.004 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.619 ' O ' HG23 ' A' ' 26' ' ' VAL . 72.0 mt -61.41 -48.69 87.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -61.05 -47.6 85.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.377 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -62.44 -48.84 77.89 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.689 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -65.66 -42.47 91.32 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -177.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 22' ' ' ILE . 60.5 t -64.69 -43.74 96.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.138 0.494 . . . . 0.0 110.079 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.2 -42.21 99.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.112 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -66.69 -36.41 82.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.696 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.38 -34.49 73.98 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.801 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.452 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 96.7 mt -61.41 -38.2 86.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.523 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.463 ' HA ' ' OE1' ' A' ' 34' ' ' GLU . 41.5 mt-10 -61.75 -37.05 82.85 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.068 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.472 ' CE1' ' HG2' ' A' ' 9' ' ' LYS . 93.1 m-85 -69.26 -35.95 76.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.058 0.456 . . . . 0.0 110.579 177.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 90' ' ' PRO . 87.9 mt -62.86 -41.16 99.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.416 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.463 ' OE1' ' HA ' ' A' ' 31' ' ' GLU . 46.8 mt-10 -53.07 -32.89 49.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.404 177.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -78.16 -8.89 58.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.557 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.5 10.43 61.96 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.46 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -94.44 -176.47 3.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.958 0.409 . . . . 0.0 110.158 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -116.31 154.31 30.41 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.012 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.474 ' O ' HD12 ' A' ' 87' ' ' LEU . 25.6 t -118.51 125.33 74.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -103.24 112.32 25.14 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.261 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -84.07 128.29 34.46 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.341 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 9.1 mmm180 -131.33 107.69 9.13 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.225 -175.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.565 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 9.7 p -108.77 132.98 55.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 120.921 0.391 . . . . 0.0 110.568 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -106.99 134.0 50.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.243 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.404 ' CD1' ' HA ' ' A' ' 50' ' ' MET . 30.2 mt -94.58 115.02 27.07 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -106.86 -64.7 1.15 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -171.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.559 ' O ' ' HG3' ' A' ' 49' ' ' GLU . . . -82.74 88.2 1.47 Allowed Glycine 0 CA--C 1.49 -1.485 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -178.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 61.22 -111.4 0.45 Allowed 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -171.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.559 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 89.4 mt-10 63.21 -42.98 0.21 Allowed 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 173.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.404 ' HA ' ' CD1' ' A' ' 45' ' ' LEU . 42.9 ttm -63.28 -20.13 65.2 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.046 0.539 . . . . 0.0 111.866 -177.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.26 -30.43 71.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.168 0.509 . . . . 0.0 109.726 175.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 p -126.71 92.61 44.45 Favored Pre-proline 0 N--CA 1.452 -0.334 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.225 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -62.84 -20.51 71.46 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 123.6 2.867 . . . . 0.0 112.552 -176.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.05 -23.72 65.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.418 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.14 -41.05 91.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.017 0.437 . . . . 0.0 110.402 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.45 -39.61 91.34 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.7 t -64.73 -44.4 96.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.603 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.85 -39.77 86.29 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.252 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.4 tp -62.53 -46.49 88.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.165 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.434 HD13 ' HB2' ' A' ' 86' ' ' MET . 94.3 mt -65.53 -40.46 92.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.298 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -58.12 -39.96 80.01 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.356 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -61.96 -43.62 98.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.418 0.627 . . . . 0.0 110.345 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.2 mt -65.36 -43.57 94.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.913 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.2 t-105 -58.34 -39.47 79.55 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.807 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.439 ' HA ' ' OE2' ' A' ' 68' ' ' GLU . 19.5 m -57.75 -38.23 75.02 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.3 0.571 . . . . 0.0 110.583 178.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 78.3 mtm -77.1 -34.2 56.83 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.9 pt -98.41 -12.01 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 113.493 0.924 . . . . 0.0 113.493 -174.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.439 ' OE2' ' HA ' ' A' ' 65' ' ' THR . 14.1 pt-20 -59.83 -23.85 63.7 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -175.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -65.29 -30.98 71.89 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -127.09 3.27 6.47 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -128.68 153.79 46.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.144 0.497 . . . . 0.0 111.56 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.488 ' OD1' ' HG2' ' A' ' 91' ' ' LYS . 75.8 m-20 -111.85 149.33 31.96 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -89.01 106.56 18.51 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-O 121.025 0.44 . . . . 0.0 110.821 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -75.9 -41.05 53.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.421 0.629 . . . . 0.0 110.715 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -137.27 150.03 47.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.061 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -85.31 154.8 60.08 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 29.1 Cg_endo -63.4 115.29 2.93 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.76 1.64 . . . . 0.0 110.961 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -136.1 144.56 45.19 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.336 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -81.91 109.83 16.63 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.562 ' HB3' HD21 ' A' ' 85' ' ' ASN . 73.4 tt0 -148.71 123.43 9.87 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.808 -176.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 82' ' ' ARG . . . 75.52 28.53 61.31 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.315 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 81' ' ' GLY . 88.0 mtm180 72.28 3.18 4.6 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.357 0.663 . . . . 0.0 111.339 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -119.87 145.46 46.65 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.054 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.565 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 92.0 t -95.35 112.27 27.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 172.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.562 HD21 ' HB3' ' A' ' 80' ' ' GLU . 9.5 p30 -116.48 148.97 40.27 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -172.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.434 ' HB2' HD13 ' A' ' 60' ' ' LEU . 66.0 ttp -141.85 136.74 30.86 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.31 175.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.474 HD12 ' O ' ' A' ' 39' ' ' VAL . 44.7 tp -118.82 140.15 50.43 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.904 0.383 . . . . 0.0 110.59 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.8 m -130.26 161.72 39.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.229 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.2 m -137.28 138.94 26.45 Favored Pre-proline 0 C--N 1.309 -1.178 0 CA-C-N 115.46 -0.791 . . . . 0.0 108.985 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.519 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 92.8 Cg_endo -68.41 142.87 55.85 Favored 'Trans proline' 0 C--N 1.329 -0.48 0 C-N-CA 122.242 1.961 . . . . 0.0 110.15 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.488 ' HG2' ' OD1' ' A' ' 72' ' ' ASN . 69.0 mttm . . . . . 0 CA--C 1.535 0.39 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.605 -177.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.418 ' CG ' ' HZ1' ' A' ' 9' ' ' LYS . 13.6 t0 . . . . . 0 C--O 1.212 -0.919 0 CA-C-O 120.663 0.268 . . . . 0.0 110.693 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 74.4 mt -121.3 133.63 67.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.05 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.48 ' N ' ' HE2' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -80.26 147.76 31.07 Favored 'General case' 0 CA--C 1.485 -1.541 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.304 -177.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -133.78 112.21 11.16 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.661 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.9 mt -107.72 114.15 45.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.389 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 86.7 tttt -86.52 131.13 34.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 122.157 0.98 . . . . 0.0 112.297 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.2 mt -129.55 179.58 5.73 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.404 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.425 ' HA ' HG23 ' A' ' 43' ' ' VAL . 42.4 p -149.6 156.91 42.7 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.0 t -69.85 -17.71 21.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 121.529 0.68 . . . . 0.0 110.301 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -96.66 26.27 4.61 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.401 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.8 tt -88.72 138.89 18.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.255 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.76 145.57 48.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.927 177.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -56.43 -40.59 75.01 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -176.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -62.89 -36.0 81.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.754 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.57 -32.81 68.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.181 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.626 ' O ' HG23 ' A' ' 26' ' ' VAL . 62.5 mt -58.91 -46.9 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 109.614 -0.514 . . . . 0.0 109.614 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -57.48 -41.99 81.75 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 124.281 0.988 . . . . 0.0 110.573 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -62.99 -48.01 80.66 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.839 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -64.78 -43.36 93.46 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 120.568 0.223 . . . . 0.0 110.761 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 22' ' ' ILE . 50.0 t -63.55 -42.49 96.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.133 -178.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -57.22 -45.77 83.56 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.429 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -65.91 -37.13 85.28 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.601 177.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.71 -39.48 80.92 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.943 0.401 . . . . 0.0 109.971 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.493 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 98.2 mt -62.28 -41.35 98.41 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.211 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -63.32 -39.65 95.14 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.509 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -66.56 -35.18 79.6 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.183 0.516 . . . . 0.0 110.741 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.616 HD13 ' HB2' ' A' ' 71' ' ' ALA . 88.9 mt -62.56 -42.32 99.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.251 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 30' ' ' LEU . 86.9 mt-10 -56.7 -34.69 67.68 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.501 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -66.98 -19.82 65.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.598 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.77 35.54 6.11 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.306 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.482 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -124.52 164.92 18.75 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.304 0.573 . . . . 0.0 110.058 179.442 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.421 ' CD2' ' HA ' ' A' ' 89' ' ' THR . 16.2 m170 -97.81 137.5 36.58 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.961 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 68.5 t -104.48 118.97 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.697 175.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -95.37 110.48 22.5 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.44 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 94.0 m-85 -83.94 108.74 17.1 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.502 ' HA ' ' OD1' ' A' ' 85' ' ' ASN . 53.2 mtp85 -106.18 108.5 20.05 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.782 -177.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 84' ' ' VAL . 4.9 p -109.11 127.64 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-O 121.641 0.734 . . . . 0.0 111.161 -177.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -98.67 123.92 43.17 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.545 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 50' ' ' MET . 89.4 mt -72.53 -56.28 5.62 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -176.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.8 tttp 69.08 124.81 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.118 0.485 . . . . 0.0 112.099 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.29 -155.57 25.25 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.798 176.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -72.41 -14.66 61.75 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.718 0.294 . . . . 0.0 111.384 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -61.88 -20.1 63.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.392 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.483 ' HA ' HD12 ' A' ' 45' ' ' LEU . 94.7 mtp -67.92 -15.3 63.55 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.737 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.56 -11.41 59.17 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 120.946 0.403 . . . . 0.0 110.684 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.436 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 41.5 p -128.33 106.58 19.44 Favored Pre-proline 0 N--CA 1.442 -0.856 0 CA-C-O 121.481 0.658 . . . . 0.0 111.204 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 52' ' ' THR . 35.3 Cg_endo -68.56 -16.65 42.95 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 122.902 2.401 . . . . 0.0 111.876 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -58.87 -33.82 70.91 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.974 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.49 -41.86 90.84 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.103 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.444 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -68.01 -41.58 87.13 Favored Glycine 0 C--O 1.219 -0.815 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 177.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.07 -44.49 99.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 O-C-N 123.727 0.31 . . . . 0.0 111.182 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.91 -41.82 96.88 Favored 'General case' 0 C--O 1.257 1.467 0 C-N-CA 122.448 0.299 . . . . 0.0 111.312 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.0 tp -62.85 -44.07 97.12 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.202 0.525 . . . . 0.0 109.805 177.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.56 HD13 ' HB2' ' A' ' 86' ' ' MET . 90.9 mt -65.76 -40.45 92.07 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.621 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -60.24 -37.67 81.11 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.333 0.396 . . . . 0.0 110.967 178.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -62.68 -44.32 96.55 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.603 0.716 . . . . 0.0 109.241 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.56 HG23 HG22 ' A' ' 26' ' ' VAL . 61.9 mt -67.26 -43.23 88.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.719 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.555 ' CZ2' ' HB2' ' A' ' 73' ' ' ARG . 37.6 t-105 -56.73 -39.23 73.56 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.827 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.7 m -63.23 -23.92 67.64 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 123.485 0.491 . . . . 0.0 111.212 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 96.5 mtp -91.1 -30.4 16.76 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.7 pt -98.73 -9.74 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -175.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -15.38 47.65 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -79.52 -21.9 44.64 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.668 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -119.9 -13.12 9.08 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.743 0.306 . . . . 0.0 111.246 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.616 ' HB2' HD13 ' A' ' 33' ' ' LEU . . . -126.67 154.68 43.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.102 0.477 . . . . 0.0 112.137 -175.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.464 ' OD1' ' HB ' ' A' ' 89' ' ' THR . 7.0 p30 -116.73 135.77 53.5 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.821 176.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.555 ' HB2' ' CZ2' ' A' ' 64' ' ' TRP . 36.1 ttp180 -74.87 112.14 10.78 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.247 -176.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -71.89 -37.84 70.07 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -159.32 158.94 33.32 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.115 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -72.79 150.52 90.78 Favored Pre-proline 0 C--N 1.306 -1.284 0 C-N-CA 122.536 0.334 . . . . 0.0 110.736 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.35 134.69 65.85 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 122.685 2.257 . . . . 0.0 112.511 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -133.62 149.12 51.6 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.99 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -91.82 116.25 28.74 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.38 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -128.3 137.76 52.1 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.64 -109.94 3.08 Favored Glycine 0 N--CA 1.426 -2.019 0 C-N-CA 119.966 -1.111 . . . . 0.0 111.769 -178.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -127.81 17.76 6.79 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.371 0.605 . . . . 0.0 110.273 177.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -129.24 150.94 50.41 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.908 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 43' ' ' VAL . 87.2 t -104.06 113.2 40.35 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.87 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 171.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' ' 42' ' ' ARG . 88.2 m-20 -113.88 137.5 51.58 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.343 -173.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.56 ' HB2' HD13 ' A' ' 60' ' ' LEU . 64.5 ttp -122.02 129.67 52.63 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.926 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -103.0 122.25 44.22 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 m -119.52 148.74 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.514 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.464 ' HB ' ' OD1' ' A' ' 72' ' ' ASN . 35.8 m -117.33 136.77 23.56 Favored Pre-proline 0 C--N 1.295 -1.785 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.474 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 91.4 Cg_endo -71.07 156.59 59.55 Favored 'Trans proline' 0 C--N 1.329 -0.494 0 C-N-CA 122.871 2.381 . . . . 0.0 111.508 177.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 N--CA 1.438 -1.072 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.299 179.157 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.423 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 35.4 t70 . . . . . 0 N--CA 1.447 -0.605 0 CA-C-O 121.382 0.61 . . . . 0.0 110.318 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.442 HG12 ' HB2' ' A' ' 38' ' ' HIS . 77.0 mt -87.86 130.3 37.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.481 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -86.52 135.9 33.28 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.452 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 46.0 mt-10 -110.25 114.38 27.81 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.197 178.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.4 mt -107.14 109.27 27.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -101.51 126.7 48.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.222 -175.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.46 HD23 ' CD1' ' A' ' 17' ' ' ILE . 5.1 mp -116.69 -178.89 3.53 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.036 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.0 p -139.28 157.98 44.96 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.2 t -64.08 -36.66 77.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 175.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -83.21 65.64 8.35 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.695 174.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.46 ' CD1' HD23 ' A' ' 13' ' ' LEU . 18.1 tt -123.44 149.36 27.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.1 152.14 26.69 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.731 176.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -64.02 -34.82 78.86 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.182 0.515 . . . . 0.0 109.924 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -62.32 -40.34 96.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.155 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.612 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 20.8 t70 -65.42 -36.92 85.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.055 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.7 mt -61.51 -42.85 95.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -60.31 -42.72 96.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.596 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -63.81 -44.15 94.13 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.3 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 75.6 mmtt -63.97 -43.9 94.37 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -176.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.555 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 11.1 m -67.92 -28.91 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.606 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.89 -44.69 94.09 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.227 0.537 . . . . 0.0 109.626 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -75.2 -36.92 61.35 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.234 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.511 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -59.63 -37.56 78.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.021 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.636 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 94.0 mt -61.9 -41.29 97.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.192 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -59.74 -45.09 93.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.086 0.469 . . . . 0.0 111.303 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -66.37 -36.2 82.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.876 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.653 HD13 ' HB2' ' A' ' 71' ' ' ALA . 96.8 mt -63.11 -40.0 96.36 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.067 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.636 ' HG3' ' O ' ' A' ' 30' ' ' LEU . 60.4 mt-10 -59.48 -33.3 71.15 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.987 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -79.84 -5.35 55.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.011 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.45 18.4 62.32 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.713 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.423 ' HD2' ' O ' ' A' ' 7' ' ' ASP . 41.4 mmtm -92.85 153.66 18.71 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.338 0.589 . . . . 0.0 111.401 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.442 ' HB2' HG12 ' A' ' 8' ' ' ILE . 7.7 m80 -98.21 140.18 32.9 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.69 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 49.6 t -115.15 128.42 72.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.452 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 64.5 ttt180 -102.43 111.01 23.13 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -90.94 120.44 31.95 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.422 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 82.1 mtp180 -131.2 138.45 49.4 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.662 -177.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.542 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.4 p -129.48 135.93 60.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 121.144 0.497 . . . . 0.0 110.751 177.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -98.55 130.59 45.12 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.001 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.7 mt -95.5 125.09 39.87 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -102.43 128.31 49.08 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -172.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.98 -120.18 8.5 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.214 -0.903 . . . . 0.0 113.65 177.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 48' ' ' ARG . 61.2 mtt85 -76.48 -9.01 58.33 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 122.927 0.491 . . . . 0.0 111.696 -175.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -66.51 -23.23 66.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.999 0.428 . . . . 0.0 110.944 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 65.9 mtt -64.12 -19.51 65.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.92 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.41 -14.71 61.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.501 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -140.64 105.98 6.42 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 122.192 0.996 . . . . 0.0 111.331 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.27 -20.61 36.92 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.337 2.691 . . . . 0.0 113.773 -176.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.432 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -66.49 -20.51 66.06 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -177.044 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.93 99.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.117 0.484 . . . . 0.0 109.783 176.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.444 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -69.44 -37.82 79.43 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.43 176.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.0 t -62.62 -44.72 99.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.265 -0.468 . . . . 0.0 111.055 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.27 -40.8 95.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.541 ' O ' HG13 ' A' ' 63' ' ' ILE . 39.1 tp -62.25 -46.72 87.59 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.287 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.492 HD12 HG12 ' A' ' 84' ' ' VAL . 88.6 mt -65.29 -41.13 94.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.054 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -64.78 -35.39 80.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.954 0.407 . . . . 0.0 110.5 179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -63.03 -41.56 99.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.538 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 59' ' ' LEU . 63.1 mt -64.32 -43.99 97.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.138 176.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 53.4 t-105 -56.48 -42.32 78.07 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.158 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.7 p -64.37 -21.8 66.75 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.58 -0.448 . . . . 0.0 112.133 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 66.9 mtt -83.05 -31.69 27.24 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.5 pt -108.16 -4.7 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -54.45 -30.5 53.01 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -175.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.607 ' ND2' ' HG2' ' A' ' 70' ' ' GLU . 3.7 p-10 -72.83 -23.11 60.72 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.607 ' HG2' ' ND2' ' A' ' 69' ' ' ASN . 61.1 mm-40 -112.25 -19.96 12.04 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.079 0.466 . . . . 0.0 110.845 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.653 ' HB2' HD13 ' A' ' 33' ' ' LEU . . . -117.76 150.64 38.77 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.551 -176.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -112.51 137.86 50.12 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 175.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -76.21 119.81 20.64 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.076 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -85.33 -38.81 18.38 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.014 0.435 . . . . 0.0 110.607 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -148.03 156.08 42.23 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.269 -177.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -77.4 155.0 81.86 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.935 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 23.2 Cg_endo -61.76 138.49 74.89 Favored 'Trans proline' 0 C--O 1.24 0.617 0 C-N-CA 122.095 1.863 . . . . 0.0 111.446 176.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 27.4 p-10 -145.21 167.24 23.27 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.244 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.583 ' CZ ' ' HA ' ' A' ' 82' ' ' ARG . 89.8 t80 -107.84 111.07 23.02 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.112 0.482 . . . . 0.0 110.486 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -138.58 126.06 21.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.399 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.67 34.42 88.87 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.841 177.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.583 ' HA ' ' CZ ' ' A' ' 79' ' ' PHE . 89.2 mtt180 70.74 11.3 7.18 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -120.58 145.54 47.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.401 175.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.542 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 92.7 t -99.27 114.16 36.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 173.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.547 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 80.8 m-20 -110.25 147.58 33.54 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.987 0.422 . . . . 0.0 112.093 -173.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.676 ' SD ' HG13 ' A' ' 88' ' ' VAL . 17.8 tmm? -145.48 130.55 18.38 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -112.32 130.95 55.78 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.128 0.489 . . . . 0.0 111.206 -175.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.676 HG13 ' SD ' ' A' ' 86' ' ' MET . 15.2 m -119.81 135.91 58.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.496 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.409 HG23 ' CE1' ' A' ' 38' ' ' HIS . 37.9 m -105.84 133.51 20.17 Favored Pre-proline 0 N--CA 1.431 -1.4 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 176.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.04 151.01 84.96 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.185 1.924 . . . . 0.0 110.189 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 N--CA 1.447 -0.6 0 CA-C-O 121.123 0.487 . . . . 0.0 110.764 -179.669 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.591 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 7.5 m-20 . . . . . 0 CA--C 1.504 -0.808 0 CA-C-O 120.796 0.332 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 88.3 mt -103.99 115.01 45.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.198 0.523 . . . . 0.0 109.599 176.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.422 ' HG2' ' CE1' ' A' ' 32' ' ' PHE . 4.0 mptp? -81.99 143.34 31.66 Favored 'General case' 0 CA--C 1.489 -1.367 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.202 -177.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -109.59 126.93 54.13 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.522 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.481 HG23 ' HD2' ' A' ' 25' ' ' LYS . 31.8 mm -100.54 107.22 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.197 178.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 2.1 mptt -80.47 139.94 36.17 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.651 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 60.7 mt -133.67 164.79 26.42 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.624 -177.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 63.5 m -141.46 151.46 43.4 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.6 t -61.03 -42.19 92.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -81.99 62.95 6.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.635 176.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.5 tt -115.68 151.07 17.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.856 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.11 150.82 21.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.339 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -62.76 -34.31 76.96 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.924 0.392 . . . . 0.0 110.899 -178.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -62.46 -41.26 98.64 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -66.63 -35.73 80.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.76 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.417 HG23 HG12 ' A' ' 63' ' ' ILE . 94.1 mt -61.49 -42.71 94.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.261 0.553 . . . . 0.0 109.563 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -60.46 -44.33 95.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.222 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -63.44 -44.31 94.89 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.069 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.481 ' HD2' HG23 ' A' ' 11' ' ' ILE . 49.7 mmtm -63.26 -45.39 91.72 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.531 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 17.3 m -67.09 -36.61 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.621 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -60.54 -47.09 87.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.203 0.525 . . . . 0.0 110.099 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -68.29 -39.25 82.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.579 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.96 -36.22 80.79 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.842 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.616 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 88.6 mt -60.71 -40.26 91.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.086 -178.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.584 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 62.7 mt-10 -61.21 -41.73 97.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.839 -177.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.422 ' CE1' ' HG2' ' A' ' 9' ' ' LYS . 93.4 m-85 -63.6 -37.76 88.55 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.192 0.52 . . . . 0.0 110.35 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 90' ' ' PRO . 97.2 mt -63.62 -42.22 98.22 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.567 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.616 ' HG3' ' O ' ' A' ' 30' ' ' LEU . 40.3 mt-10 -61.84 -21.37 64.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.309 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 31' ' ' GLU . 73.3 mm-40 -84.52 -6.6 59.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.799 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.3 15.16 59.21 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.627 -177.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.591 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 63.8 mttp -105.11 177.21 4.92 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 120.978 0.418 . . . . 0.0 110.512 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -112.84 158.78 19.74 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.843 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.6 t -113.42 130.24 67.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -98.8 102.41 14.13 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.696 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 69.3 m-85 -85.91 117.37 24.72 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 120.594 -0.442 . . . . 0.0 109.959 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 82.6 mtp180 -125.94 110.42 13.59 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.243 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.569 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.8 p -107.13 128.42 62.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-O 121.234 0.54 . . . . 0.0 110.955 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.411 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 83.8 t80 -95.55 132.4 40.71 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.033 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.0 mt -81.26 83.11 6.94 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.223 0.535 . . . . 0.0 110.355 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -76.54 131.18 38.81 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.143 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.66 -140.82 16.52 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.475 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -105.75 -2.49 23.17 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.393 0.616 . . . . 0.0 109.92 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -74.04 -2.46 24.37 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.298 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.498 ' SD ' ' HD2' ' A' ' 82' ' ' ARG . 56.6 ttm -61.6 -22.18 65.0 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 122.52 0.328 . . . . 0.0 111.801 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.34 -13.66 60.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.938 0.399 . . . . 0.0 111.124 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.3 p -123.14 103.56 36.04 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.256 0.551 . . . . 0.0 111.482 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.75 -18.25 47.6 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.2 2.6 . . . . 0.0 112.548 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -63.52 -29.19 70.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.041 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.93 -43.62 86.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.03 0.443 . . . . 0.0 110.606 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.406 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -66.16 -41.52 94.87 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.862 177.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.09 -44.64 97.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.739 0.304 . . . . 0.0 110.639 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.0 -41.08 97.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.887 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.44 HD23 HG21 ' A' ' 43' ' ' VAL . 42.6 tp -62.8 -45.28 93.38 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.212 0.529 . . . . 0.0 110.19 177.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.495 HD13 ' HB2' ' A' ' 86' ' ' MET . 98.0 mt -64.03 -40.16 95.7 Favored 'General case' 0 C--O 1.212 -0.876 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.812 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -58.19 -41.89 84.95 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.719 0.295 . . . . 0.0 111.156 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -63.96 -46.34 85.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.462 0.648 . . . . 0.0 109.738 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.466 ' CD1' HD13 ' A' ' 13' ' ' LEU . 96.3 mt -65.06 -42.67 95.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.171 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.526 ' CZ2' ' HB2' ' A' ' 73' ' ' ARG . 28.1 t-105 -56.45 -40.19 74.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.78 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 23.2 m -61.13 -34.2 74.61 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.269 0.557 . . . . 0.0 110.736 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 98.2 mmm -69.33 -39.25 78.31 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.261 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.9 pt -97.49 -10.06 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -174.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -58.06 -14.93 7.61 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -177.499 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -61.67 -41.95 98.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.902 0.382 . . . . 0.0 110.218 178.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -126.52 14.94 7.65 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.902 -175.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -134.73 144.68 47.87 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.329 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -113.41 142.12 46.27 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 175.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.526 ' HB2' ' CZ2' ' A' ' 64' ' ' TRP . 53.7 ttp180 -95.47 114.55 26.33 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.642 -177.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -65.51 -41.15 93.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.86 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -155.73 160.45 40.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.934 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.434 ' CD ' ' H ' ' A' ' 76' ' ' GLU . 22.9 mp0 -69.11 161.28 74.0 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 123.346 0.404 . . . . 0.0 110.054 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.413 ' HB3' HD12 ' A' ' 60' ' ' LEU . 38.0 Cg_exo -60.61 146.05 97.76 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.544 2.163 . . . . 0.0 112.306 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -138.41 137.83 37.63 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.592 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -89.59 125.35 35.19 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.703 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -142.32 125.42 16.31 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.29 -109.25 2.8 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.498 ' HD2' ' SD ' ' A' ' 50' ' ' MET . 29.0 mmt180 -125.42 12.81 8.16 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.12 0.486 . . . . 0.0 110.627 176.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.411 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 95.5 m-85 -119.85 151.32 39.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.339 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.569 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 76.5 t -108.94 122.25 63.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 171.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 87.5 m-20 -112.49 143.04 44.3 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -171.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.495 ' HB2' HD13 ' A' ' 60' ' ' LEU . 62.5 ttp -138.5 126.89 23.09 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.192 175.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -104.04 126.35 51.09 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.1 m -117.77 140.34 41.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.227 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.3 m -107.0 138.84 19.93 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.422 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 55.6 Cg_endo -64.23 140.3 70.34 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 122.115 1.876 . . . . 0.0 111.978 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt . . . . . 0 N--CA 1.44 -0.943 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 176.936 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.5 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 34.6 t70 . . . . . 0 CA--C 1.508 -0.654 0 CA-C-O 120.991 0.424 . . . . 0.0 109.887 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 82.9 mt -88.84 129.68 39.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.148 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.499 ' HG3' ' CD1' ' A' ' 32' ' ' PHE . 73.6 mmtt -85.43 135.82 33.7 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.657 -177.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -107.6 107.83 18.84 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.086 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.9 mm -92.43 106.62 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 65.2 tttp -84.02 133.64 34.66 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.888 -178.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.465 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 66.0 mt -125.17 169.49 12.16 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.733 -177.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.457 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 40.0 m -140.78 150.66 43.64 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -59.96 -43.73 93.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.273 0.558 . . . . 0.0 109.586 174.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -78.77 62.26 3.23 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 121.743 0.782 . . . . 0.0 110.311 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.539 HG21 HD11 ' A' ' 59' ' ' LEU . 18.8 tt -111.21 161.21 9.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.836 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.599 -178.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.35 150.22 22.82 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.239 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -66.69 -38.47 86.85 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.645 -177.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -67.7 -33.26 74.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.906 0.384 . . . . 0.0 110.231 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -64.2 -38.1 89.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.835 177.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.688 HG23 HG12 ' A' ' 63' ' ' ILE . 92.5 mt -62.88 -43.64 99.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.568 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -61.38 -42.62 99.01 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.784 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -62.36 -47.4 84.36 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.987 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -65.72 -40.67 92.43 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -178.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 22' ' ' ILE . 2.3 m -64.09 -35.54 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.535 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -61.76 -41.54 97.81 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.416 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 7.0 m80 -67.98 -41.74 81.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.095 176.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.54 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -59.58 -37.53 78.74 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.703 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.534 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 94.1 mt -61.8 -39.35 91.4 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.519 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.544 ' HA ' ' OE1' ' A' ' 34' ' ' GLU . 46.0 mt-10 -65.16 -44.57 88.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.375 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.499 ' CD1' ' HG3' ' A' ' 9' ' ' LYS . 90.0 m-85 -65.68 -34.49 78.33 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.917 0.389 . . . . 0.0 111.15 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 93.7 mt -62.93 -39.65 95.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.736 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.544 ' OE1' ' HA ' ' A' ' 31' ' ' GLU . 45.3 mt-10 -51.36 -40.79 59.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.77 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -70.69 -4.82 25.54 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.94 20.65 49.37 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.562 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.55 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 63.5 mttm -101.07 177.04 5.06 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 120.997 0.427 . . . . 0.0 110.599 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.423 ' NE2' HG23 ' A' ' 89' ' ' THR . 15.0 m170 -112.69 155.59 24.22 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.921 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.9 t -116.07 127.96 73.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 173.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -102.63 109.8 21.53 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -88.49 112.37 22.89 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.337 -0.545 . . . . 0.0 109.708 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.705 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 76.4 mtp85 -115.78 120.39 39.14 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.634 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.551 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.6 p -121.07 129.69 75.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.232 0.539 . . . . 0.0 111.349 -178.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -95.49 130.68 42.23 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.0 mt -78.67 84.57 4.76 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.87 0.367 . . . . 0.0 111.043 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.415 ' HD3' ' N ' ' A' ' 47' ' ' GLY . 4.8 tmtt? -83.65 120.6 26.17 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.415 ' N ' ' HD3' ' A' ' 46' ' ' LYS . . . 131.86 -133.56 7.22 Favored Glycine 0 N--CA 1.433 -1.555 0 C-N-CA 120.216 -0.993 . . . . 0.0 112.106 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -124.59 10.43 8.46 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.484 0.659 . . . . 0.0 110.543 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -80.91 6.06 14.36 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.23 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 96.5 mtp -65.62 -30.38 71.09 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.055 0.455 . . . . 0.0 110.562 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.96 -26.92 66.39 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.723 178.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.5 m -143.39 116.91 6.03 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.148 0.499 . . . . 0.0 111.044 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.06 2.96 4.93 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 123.487 2.791 . . . . 0.0 113.269 -176.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -59.5 -36.05 75.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.8 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.96 -43.8 94.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.146 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.415 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -68.98 -43.32 73.68 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.315 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.4 t -63.39 -47.25 92.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-O 120.578 0.228 . . . . 0.0 111.069 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.06 -37.14 86.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.421 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.539 HD11 HG21 ' A' ' 17' ' ' ILE . 42.2 tp -61.2 -49.55 76.7 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.962 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.531 HD12 HG12 ' A' ' 84' ' ' VAL . 88.5 mt -65.22 -42.15 93.74 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.826 -177.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.413 ' HA ' ' HB3' ' A' ' 64' ' ' TRP . 42.5 mt-10 -67.83 -35.33 78.4 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -63.77 -42.71 97.74 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.501 0.667 . . . . 0.0 109.297 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.688 HG12 HG23 ' A' ' 22' ' ' ILE . 86.7 mt -64.4 -43.55 97.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.876 -1.057 . . . . 0.0 109.889 177.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.413 ' HB3' ' HA ' ' A' ' 61' ' ' GLU . 13.0 t-105 -57.29 -40.05 77.01 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.789 176.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.49 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 91.5 m -60.88 -29.43 69.55 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 121.102 0.477 . . . . 0.0 111.225 -178.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 67.6 mtt -72.5 -35.07 68.07 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.558 HD11 HG11 ' A' ' 88' ' ' VAL . 37.1 pt -102.37 -7.36 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -174.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 65' ' ' THR . 15.2 pt-20 -58.91 -16.02 15.62 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -177.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -70.67 -14.07 62.32 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.479 ' HA ' ' HD2' ' A' ' 91' ' ' LYS . 11.6 pt-20 -150.19 29.89 0.71 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.57 0.7 . . . . 0.0 110.259 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -147.23 153.27 39.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.723 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.47 ' OD1' ' HB ' ' A' ' 89' ' ' THR . 7.2 p30 -123.89 135.8 53.95 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -70.68 110.75 5.67 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.086 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -69.31 -43.24 74.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.211 0.529 . . . . 0.0 109.779 178.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -153.85 143.78 21.95 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.71 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -62.77 157.62 57.91 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.859 176.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 31.4 Cg_exo -59.45 142.42 98.95 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.156 1.904 . . . . 0.0 111.968 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -137.51 133.41 34.53 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.447 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -87.69 118.67 27.35 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.989 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -130.85 110.89 11.63 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.944 -178.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.14 -97.58 0.6 Allowed Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.629 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.34 8.11 5.97 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.859 0.361 . . . . 0.0 110.626 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.432 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 65.3 m-85 -119.8 141.87 49.11 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.448 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.551 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 97.2 t -103.8 118.22 50.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 172.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.705 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 35.0 m-80 -109.14 143.97 37.82 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -173.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -149.84 137.03 19.69 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.1 mt -112.92 134.32 54.48 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.558 HG11 HD11 ' A' ' 67' ' ' ILE . 14.6 m -117.22 133.72 63.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.58 176.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.485 ' CG2' ' HD2' ' A' ' 90' ' ' PRO . 14.6 m -109.27 143.89 28.64 Favored Pre-proline 0 C--N 1.302 -1.485 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 60.7 Cg_endo -65.46 152.99 80.23 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.989 1.793 . . . . 0.0 109.352 177.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.479 ' HD2' ' HA ' ' A' ' 70' ' ' GLU . 37.0 tttm . . . . . 0 C--N 1.323 -0.573 0 CA-C-O 121.235 0.54 . . . . 0.0 111.105 -174.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.407 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 21.9 t0 . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 121.047 0.451 . . . . 0.0 110.007 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 90.4 mt -118.71 133.4 65.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.718 -176.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.461 ' HB2' HG22 ' A' ' 39' ' ' VAL . 68.1 mmtt -84.12 121.81 27.96 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.607 0.718 . . . . 0.0 111.21 -175.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.47 ' OE1' ' HD3' ' A' ' 42' ' ' ARG . 47.9 mm-40 -93.47 105.53 17.58 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.12 -178.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.6 mt -108.29 110.82 33.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.385 0.612 . . . . 0.0 110.297 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 87.6 tttt -101.16 130.23 47.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.197 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.587 HD21 ' HG3' ' A' ' 25' ' ' LYS . 82.1 mt -129.23 -177.29 4.18 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.431 -178.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 p -137.53 158.22 44.86 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.726 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.401 ' HB ' ' OE1' ' A' ' 49' ' ' GLU . 72.4 t -64.19 -41.91 93.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.645 0.736 . . . . 0.0 109.169 177.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -90.28 71.94 7.15 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.384 177.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.4 tt -124.19 146.42 29.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.901 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.9 143.04 52.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.315 177.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -64.89 -32.42 74.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.519 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -62.08 -39.18 91.55 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.224 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.492 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 9.5 t70 -65.41 -37.81 88.05 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.569 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.429 ' O ' HG22 ' A' ' 26' ' ' VAL . 93.4 mt -62.05 -42.58 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.081 0.467 . . . . 0.0 109.95 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -59.52 -41.59 90.32 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.533 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -63.29 -43.33 98.19 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.574 177.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.587 ' HG3' HD21 ' A' ' 13' ' ' LEU . 75.5 mmtt -65.23 -44.74 87.26 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 22' ' ' ILE . 2.5 m -64.51 -34.44 69.63 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.653 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -60.32 -44.37 95.53 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 176.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.417 ' O ' ' HD2' ' A' ' 32' ' ' PHE . 11.2 m170 -64.5 -42.44 95.84 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.837 177.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.557 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -55.13 -48.62 73.39 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.661 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.62 -41.88 99.26 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.795 0.331 . . . . 0.0 111.099 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.5 -31.05 72.1 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.72 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.417 ' HD2' ' O ' ' A' ' 28' ' ' HIS . 82.4 m-85 -85.95 -31.7 21.96 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 121.059 -0.257 . . . . 0.0 111.483 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 86.9 mt -62.52 -44.97 95.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.96 0.41 . . . . 0.0 111.245 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -18.51 61.34 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.669 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -77.03 -13.63 59.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.887 0.375 . . . . 0.0 110.338 177.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.37 12.97 50.03 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.309 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.407 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 96.9 mttt -103.48 -179.56 3.99 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.107 0.48 . . . . 0.0 111.202 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -116.65 155.8 28.18 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.927 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.461 HG22 ' HB2' ' A' ' 9' ' ' LYS . 41.7 t -121.25 131.08 73.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 175.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.413 ' HG2' ' HG2' ' A' ' 42' ' ' ARG . 40.4 ttp180 -109.84 116.72 32.17 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 176.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -89.47 120.62 30.95 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.47 ' HD3' ' OE1' ' A' ' 10' ' ' GLU . 12.8 mtm180 -120.9 115.7 23.73 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -178.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.503 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 4.1 p -112.96 124.4 69.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.425 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.464 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 77.7 t80 -101.09 124.01 46.14 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.56 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' A' ' 50' ' ' MET . 34.2 mt -77.24 107.34 9.57 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -67.37 -78.84 0.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -171.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 49' ' ' GLU . . . -126.13 119.74 3.53 Favored Glycine 0 CA--C 1.499 -0.908 0 C-N-CA 119.853 -1.165 . . . . 0.0 112.666 -175.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 72.18 -21.34 0.23 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.764 0.826 . . . . 0.0 111.308 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.508 ' H ' ' C ' ' A' ' 47' ' ' GLY . 14.9 mt-10 -61.94 -32.98 73.44 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.981 0.912 . . . . 0.0 110.623 178.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.522 ' HA ' HD12 ' A' ' 45' ' ' LEU . 44.3 ttm -63.61 -19.08 64.56 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.128 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.33 -13.62 61.14 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.913 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.424 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 32.3 m -140.78 101.27 6.52 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 121.334 0.588 . . . . 0.0 110.787 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 52' ' ' THR . 39.7 Cg_endo -68.7 -16.55 42.17 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.421 2.747 . . . . 0.0 112.321 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -58.48 -34.11 70.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.646 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.66 94.89 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.475 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.459 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -64.45 -40.98 98.19 Favored Glycine 0 CA--C 1.504 -0.654 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.859 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.8 t -66.26 -44.19 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 120.664 0.268 . . . . 0.0 110.734 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.2 -40.69 90.94 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.958 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.7 tp -61.89 -47.85 83.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.654 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.534 HD12 HG12 ' A' ' 84' ' ' VAL . 87.3 mt -65.26 -41.74 93.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.742 -178.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -64.49 -36.93 85.79 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.973 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -61.62 -43.53 98.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.464 0.65 . . . . 0.0 109.255 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.85 -44.12 96.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.462 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.419 ' CE3' HG13 ' A' ' 67' ' ' ILE . 50.8 t-105 -59.61 -35.84 75.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.377 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.6 m -60.3 -24.57 65.09 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.085 0.469 . . . . 0.0 110.85 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 92.6 mtp -91.55 -28.25 17.68 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.148 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.59 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 32.8 pt -111.27 16.07 8.11 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -176.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -21.21 66.52 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.426 0.631 . . . . 0.0 111.08 178.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.421 ' O ' ' HG2' ' A' ' 70' ' ' GLU . 3.2 p30 -73.93 134.97 43.24 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.093 178.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 69' ' ' ASN . 10.0 pt-20 54.57 5.9 0.1 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.811 1.244 . . . . 0.0 113.295 -176.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 67' ' ' ILE . . . -124.02 161.55 25.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.813 0.339 . . . . 0.0 110.691 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -140.14 150.46 44.28 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -83.36 122.35 28.35 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 118.655 -1.218 . . . . 0.0 109.711 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.512 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 16.5 t70 -81.44 -15.85 53.82 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.406 0.622 . . . . 0.0 109.421 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -159.97 156.39 27.04 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.075 -175.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -93.68 151.57 40.1 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 14.8 Cg_exo -63.81 132.65 35.75 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.519 1.479 . . . . 0.0 110.689 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 58.3 t30 -148.43 149.41 31.66 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.133 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -91.83 111.73 23.37 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -152.22 129.49 11.26 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.68 -178.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.26 25.57 74.15 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.448 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.462 ' HD2' ' SD ' ' A' ' 50' ' ' MET . 42.4 mmt180 70.13 8.36 6.63 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 123.883 0.873 . . . . 0.0 112.041 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.464 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 55.1 m-85 -117.74 144.55 45.19 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.273 176.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.534 HG12 HD12 ' A' ' 60' ' ' LEU . 91.1 t -98.65 110.57 26.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 171.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.55 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 9.6 p30 -111.44 146.01 37.97 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -172.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 63.8 ttp -145.08 138.01 26.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.252 175.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 17.0 mt -110.61 135.35 51.37 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 120.785 0.326 . . . . 0.0 111.483 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.407 ' CG2' ' HB ' ' A' ' 39' ' ' VAL . 14.2 m -120.05 132.95 68.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 121.337 0.589 . . . . 0.0 110.979 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.512 ' OG1' ' HB2' ' A' ' 74' ' ' ASP . 28.2 m -121.25 143.16 36.7 Favored Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.527 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 91.8 Cg_endo -71.84 154.95 58.63 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.926 1.751 . . . . 0.0 109.929 177.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.9 mttp . . . . . 0 C--N 1.321 -0.65 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.559 -179.928 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.566 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 27.1 t70 . . . . . 0 CA--C 1.512 -0.506 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 90.4 mt -88.95 129.1 40.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 120.992 0.425 . . . . 0.0 110.638 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -91.23 140.6 29.64 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-O 121.789 0.804 . . . . 0.0 111.43 -176.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.548 ' OE2' ' HD2' ' A' ' 42' ' ' ARG . 45.2 mt-10 -118.61 109.76 16.53 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.037 177.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 88.4 mt -93.14 118.98 40.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.63 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 62.3 tttm -88.82 136.68 32.88 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.643 0.735 . . . . 0.0 112.164 -177.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 46.4 mt -130.39 169.9 14.88 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.875 -178.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.499 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 19.9 m -128.7 149.84 50.52 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.0 t -64.41 -43.83 97.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.433 0.635 . . . . 0.0 109.755 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.495 ' HE2' ' O ' ' A' ' 46' ' ' LYS . 40.6 mttm -95.19 67.75 3.04 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.499 ' HB ' ' O ' ' A' ' 14' ' ' SER . 18.8 tt -101.5 148.5 7.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.758 -174.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.83 144.85 54.16 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.175 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -63.89 -39.68 94.76 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.804 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -63.85 -38.96 93.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.741 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -62.7 -37.98 88.61 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.85 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.52 ' O ' HG23 ' A' ' 26' ' ' VAL . 79.9 mt -61.37 -48.84 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 120.954 0.406 . . . . 0.0 110.456 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -61.95 -44.63 96.35 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.603 -177.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -62.73 -50.05 72.64 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.982 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -67.86 -43.58 79.09 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 22' ' ' ILE . 60.0 t -64.54 -42.26 94.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.914 0.387 . . . . 0.0 110.074 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.48 -44.44 97.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.211 176.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -37.46 87.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.765 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.513 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -57.04 -32.82 66.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.078 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.612 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 95.2 mt -61.41 -41.51 97.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.75 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 60.6 mt-10 -65.98 -36.7 84.02 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.379 -178.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -66.79 -37.09 83.89 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.156 0.503 . . . . 0.0 110.19 177.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 94.8 mt -62.67 -40.73 97.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.798 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.612 ' HG2' ' O ' ' A' ' 30' ' ' LEU . 51.8 mm-40 -59.3 -26.11 64.71 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.143 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 31' ' ' GLU . 74.0 mm-40 -77.39 -8.55 57.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.614 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.19 19.13 57.94 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.739 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.566 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 62.8 mttp -107.48 -178.3 3.59 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.337 0.589 . . . . 0.0 111.339 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.477 ' NE2' HG23 ' A' ' 89' ' ' THR . 7.2 m80 -113.35 146.22 39.8 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.386 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.8 t -114.78 127.59 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.386 175.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.486 ' HD2' ' OE2' ' A' ' 10' ' ' GLU . 42.4 ttm180 -111.61 113.03 25.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 177.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.621 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 93.3 m-85 -84.89 113.11 21.15 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.548 ' HD2' ' OE2' ' A' ' 10' ' ' GLU . 28.9 mtp180 -115.29 130.97 57.06 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.45 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.4 p -123.64 130.18 74.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-O 121.17 0.509 . . . . 0.0 110.626 -178.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.426 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 77.6 t80 -94.82 118.22 31.41 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.954 178.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.514 HD12 ' HA ' ' A' ' 50' ' ' MET . 35.1 mt -72.39 145.74 47.5 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.495 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 41.3 ttmt -142.4 118.0 10.37 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.924 -176.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.51 53.52 0.72 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.298 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 48' ' ' ARG . 41.0 ttm180 69.39 -0.82 2.41 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.781 0.433 . . . . 0.0 111.579 178.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.403 ' O ' HD13 ' A' ' 45' ' ' LEU . 38.0 mt-10 -70.63 1.45 5.24 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.514 ' HA ' HD12 ' A' ' 45' ' ' LEU . 1.5 mpt? -61.87 -34.51 76.13 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.135 0.493 . . . . 0.0 110.426 177.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.63 -8.19 55.6 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.111 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.1 m -124.23 92.08 48.69 Favored Pre-proline 0 N--CA 1.446 -0.645 0 CA-C-O 121.199 0.523 . . . . 0.0 111.063 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.406 ' O ' HG23 ' A' ' 57' ' ' VAL . 35.7 Cg_exo -64.5 -24.57 63.47 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.322 2.681 . . . . 0.0 111.529 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -56.76 -30.76 63.91 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.003 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.65 -38.79 82.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.027 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.16 -37.5 9.89 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.973 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 53' ' ' PRO . 63.5 t -63.85 -46.03 95.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.317 0.103 . . . . 0.0 111.141 -178.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.48 -37.47 87.43 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.031 0.443 . . . . 0.0 110.866 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.7 tp -62.01 -45.97 91.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.442 0.639 . . . . 0.0 109.759 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.517 HD13 ' HB2' ' A' ' 86' ' ' MET . 91.9 mt -67.2 -38.39 85.27 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.99 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -58.09 -39.9 79.74 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 121.074 -0.251 . . . . 0.0 110.606 177.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -60.63 -45.08 95.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.309 0.576 . . . . 0.0 109.76 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.25 -43.56 97.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.638 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -59.49 -37.49 78.41 Favored 'General case' 0 C--O 1.206 -1.201 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.991 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.2 m -61.34 -24.33 66.37 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.524 0.678 . . . . 0.0 110.69 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 97.0 mmm -84.11 -42.72 15.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.087 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.5 pt -105.23 8.08 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -173.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.91 -10.2 27.03 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -89.0 -53.35 4.63 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -96.02 -5.26 41.52 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -175.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -125.98 154.14 43.32 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.567 0.222 . . . . 0.0 110.483 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.58 ' OD1' ' HB ' ' A' ' 89' ' ' THR . 10.0 p30 -115.71 134.8 54.66 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.24 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -69.59 110.53 4.86 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.867 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.464 ' CB ' HD12 ' A' ' 87' ' ' LEU . 26.5 t70 -71.68 -46.46 58.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.197 0.522 . . . . 0.0 109.848 177.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -149.78 154.86 39.15 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.606 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.6 155.81 87.13 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.257 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -54.66 137.5 73.96 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.88 2.386 . . . . 0.0 112.56 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 49.7 t30 -128.44 150.07 50.29 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.409 -177.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -108.9 121.01 44.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.796 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -126.07 108.61 11.52 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.08 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.3 -78.91 0.31 Allowed Glycine 0 C--O 1.223 -0.544 0 C-N-CA 121.399 -0.429 . . . . 0.0 113.059 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.427 ' HD2' ' N ' ' A' ' 82' ' ' ARG . 0.6 OUTLIER -147.38 10.18 0.97 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.95 0.405 . . . . 0.0 110.605 178.1 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.426 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 89.2 m-85 -117.63 140.39 49.71 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.528 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.45 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 69.1 t -112.81 130.26 66.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 175.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.621 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 9.4 p30 -133.21 143.27 49.05 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -175.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.517 ' HB2' HD13 ' A' ' 60' ' ' LEU . 64.8 ttp -127.68 136.35 51.46 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.578 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.464 HD12 ' CB ' ' A' ' 74' ' ' ASP . 2.7 tm? -110.52 127.02 54.99 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.001 0.429 . . . . 0.0 109.853 -178.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.445 ' O ' ' HD2' ' A' ' 38' ' ' HIS . 19.1 m -120.1 134.27 64.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.138 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.58 ' HB ' ' OD1' ' A' ' 72' ' ' ASN . 21.1 m -102.0 136.21 19.53 Favored Pre-proline 0 C--N 1.31 -1.133 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.731 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.502 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 80.4 Cg_endo -68.83 144.16 58.11 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.714 2.276 . . . . 0.0 110.689 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 77.2 mttt . . . . . 0 N--CA 1.441 -0.894 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.95 179.459 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.6 t70 . . . . . 0 C--O 1.24 0.56 0 CA-C-O 120.821 0.344 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 88.7 mt -97.37 133.85 37.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.028 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -90.5 147.1 23.6 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.67 -175.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -125.83 132.16 52.29 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.693 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -120.54 112.12 34.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.403 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 40.3 ttmt -85.4 141.91 29.65 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.608 -176.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.5 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 36.6 mt -128.51 175.15 8.76 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.646 -175.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.8 p -149.93 153.69 37.05 Favored 'General case' 0 C--O 1.214 -0.815 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 176.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -70.22 -20.6 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-O 121.621 0.724 . . . . 0.0 110.321 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -89.05 15.76 8.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.714 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.4 tt -73.13 148.42 8.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.112 0.482 . . . . 0.0 111.362 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.97 152.53 21.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.186 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -63.49 -40.22 96.51 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -177.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -65.14 -29.67 70.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.029 0.443 . . . . 0.0 110.182 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -71.77 -38.85 70.29 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.328 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.54 -44.46 99.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -61.46 -41.66 97.58 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.331 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -65.51 -44.4 87.1 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.139 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -64.65 -41.81 95.86 Favored 'General case' 0 N--CA 1.461 0.088 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.0 m -62.95 -33.2 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.174 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -59.84 -48.27 82.36 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.879 0.371 . . . . 0.0 110.582 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -69.3 -37.05 77.63 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.462 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.487 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -59.39 -42.16 91.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.578 HD22 ' HB2' ' A' ' 70' ' ' GLU . 93.3 mt -62.27 -41.39 98.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.497 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 46.9 mt-10 -65.53 -38.12 88.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.472 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -70.28 -38.05 74.96 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.041 175.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.49 ' HB3' ' HB3' ' A' ' 90' ' ' PRO . 85.4 mt -62.29 -45.26 94.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.905 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -64.01 -18.45 64.33 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.895 0.379 . . . . 0.0 111.641 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 80.3 mt-30 -80.25 1.01 30.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.613 177.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.3 32.62 25.06 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -119.57 157.33 28.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.934 0.397 . . . . 0.0 111.066 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.481 ' NE2' HG23 ' A' ' 89' ' ' THR . 13.0 m170 -101.61 148.03 25.71 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.398 177.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.6 t -118.65 130.04 74.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.054 0.454 . . . . 0.0 109.994 176.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -108.29 115.46 30.15 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.665 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 73.9 m-85 -90.39 121.93 32.81 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.448 ' HG2' ' HB3' ' A' ' 85' ' ' ASN . 85.1 mtp180 -125.82 121.11 32.35 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.628 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 4.2 p -112.94 131.58 64.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.24 0.543 . . . . 0.0 111.556 -176.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.409 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 84.3 t80 -93.75 121.25 35.0 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.748 177.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.5 mt -84.79 85.53 7.44 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.302 0.572 . . . . 0.0 109.969 -178.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -66.06 129.6 40.36 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.06 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.64 -148.32 16.64 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.108 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -95.0 8.2 43.67 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.985 0.422 . . . . 0.0 110.286 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -63.84 -18.5 64.2 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.682 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 67.1 mtt -65.02 -10.32 28.74 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.53 -27.32 68.37 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-O 121.118 0.485 . . . . 0.0 110.387 176.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.4 t -129.99 109.51 16.85 Favored Pre-proline 0 N--CA 1.44 -0.948 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.832 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -63.77 -19.77 67.62 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.225 2.616 . . . . 0.0 112.075 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -60.32 -29.75 69.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.588 -177.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.34 -44.82 92.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.11 0.481 . . . . 0.0 110.364 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.537 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -69.86 -39.16 75.87 Favored Glycine 0 CA--C 1.506 -0.519 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.835 178.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.499 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 59.5 t -63.39 -44.7 99.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.628 0.251 . . . . 0.0 110.722 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.63 -37.91 83.01 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.343 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.4 tp -62.04 -45.44 93.53 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.495 HD13 ' HB2' ' A' ' 86' ' ' MET . 93.4 mt -65.71 -39.19 90.96 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.161 179.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 57' ' ' VAL . 61.8 mm-40 -55.83 -44.84 78.33 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.571 177.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -65.8 -42.49 90.62 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.162 0.506 . . . . 0.0 110.944 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.6 mt -64.77 -42.39 94.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.289 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -55.04 -45.21 75.21 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.043 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.0 p -66.58 -19.93 65.89 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.736 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 96.8 mmm -75.41 -38.54 59.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.556 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.9 pt -104.47 -7.58 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -174.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -58.5 -16.75 16.65 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.063 0.458 . . . . 0.0 111.904 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -64.38 -41.16 96.83 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.678 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.578 ' HB2' HD22 ' A' ' 30' ' ' LEU . 40.9 mt-10 -124.3 14.44 8.97 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.245 0.545 . . . . 0.0 110.914 -178.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.65 142.27 37.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.646 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -114.98 145.4 42.29 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.995 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.0 ttt-85 -70.89 121.77 18.72 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.385 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.425 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 26.2 t70 -93.63 -42.45 9.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.361 0.601 . . . . 0.0 109.998 176.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -144.33 157.67 44.15 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.796 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -86.12 154.11 57.39 Favored Pre-proline 0 C--N 1.316 -0.848 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.38 132.07 48.83 Favored 'Trans proline' 0 C--O 1.24 0.593 0 C-N-CA 122.674 2.249 . . . . 0.0 112.388 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -129.42 131.37 46.75 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.742 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.432 ' HB2' HG22 ' A' ' 84' ' ' VAL . 83.8 t80 -98.61 109.16 21.96 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.983 177.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -152.53 139.11 18.7 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.268 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.35 31.49 68.64 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.948 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 69.47 10.25 7.61 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 122.997 0.519 . . . . 0.0 112.14 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 56.3 m-85 -126.12 144.02 50.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.746 178.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.628 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 91.7 t -102.28 122.89 55.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 173.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.665 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 7.0 p30 -129.75 146.69 51.5 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -173.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.495 ' HB2' HD13 ' A' ' 60' ' ' LEU . 64.0 ttp -139.85 143.78 36.93 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.848 178.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 16.1 mt -107.6 129.76 54.96 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.475 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.6 m -122.06 135.33 62.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.562 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.481 HG23 ' NE2' ' A' ' 38' ' ' HIS . 17.9 m -108.89 143.15 27.0 Favored Pre-proline 0 C--N 1.306 -1.292 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.202 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.49 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 46.7 Cg_endo -63.73 143.57 86.96 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.256 1.971 . . . . 0.0 111.179 178.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt . . . . . 0 C--N 1.324 -0.543 0 CA-C-O 121.354 0.597 . . . . 0.0 111.945 -179.736 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--O 1.237 0.398 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.6 p -87.65 -18.84 8.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.556 0.693 . . . . 0.0 110.394 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 90.7 mt -85.18 108.6 17.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.704 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -91.11 127.99 36.75 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.22 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.455 HG12 ' HB2' ' A' ' 38' ' ' HIS . 77.5 mt -119.44 132.16 70.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-O 120.845 0.355 . . . . 0.0 111.272 -175.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 74.2 mmtt -97.45 130.59 44.54 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.441 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 43.2 mt-10 -107.83 97.65 7.34 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.8 mt -88.74 125.09 41.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.639 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -96.98 145.87 25.52 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.197 -176.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.538 HD22 HD11 ' A' ' 63' ' ' ILE . 5.5 mp -135.69 176.89 8.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.279 173.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.468 ' HA ' HG23 ' A' ' 43' ' ' VAL . 16.2 p -139.1 156.22 47.32 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.85 -42.94 94.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.238 0.542 . . . . 0.0 109.995 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -95.33 76.46 3.4 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.516 HD11 ' OD2' ' A' ' 21' ' ' ASP . 19.3 tt -125.38 148.5 29.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.114 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.6 142.09 44.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.161 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -64.52 -33.73 76.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.955 0.407 . . . . 0.0 110.976 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.49 -40.71 92.35 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.526 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.516 ' OD2' HD11 ' A' ' 17' ' ' ILE . 23.2 t70 -66.6 -39.08 88.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.574 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.3 mt -62.92 -45.66 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.167 0.508 . . . . 0.0 110.271 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -61.1 -42.51 98.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.494 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -63.14 -44.32 95.89 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.954 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -64.93 -41.64 95.36 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 m -63.8 -28.83 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.508 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -60.06 -49.8 76.21 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 120.99 0.424 . . . . 0.0 110.49 176.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -68.3 -36.75 79.81 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.312 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.585 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -56.41 -45.62 80.56 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.025 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.639 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 88.9 mt -62.67 -42.83 99.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.073 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.01 -39.95 95.25 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.67 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -68.39 -34.43 76.02 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.931 0.396 . . . . 0.0 111.125 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 95.0 mt -63.6 -39.85 95.43 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.639 ' HG3' ' O ' ' A' ' 30' ' ' LEU . 63.3 mt-10 -61.02 -22.71 64.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.546 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -85.13 -6.35 59.3 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.59 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.05 19.61 55.29 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.706 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -105.81 172.41 6.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.173 0.511 . . . . 0.0 111.2 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.455 ' HB2' HG12 ' A' ' 8' ' ' ILE . 12.3 m80 -104.82 145.57 30.2 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.02 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.528 ' O ' HD12 ' A' ' 87' ' ' LEU . 41.5 t -118.33 125.71 74.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.441 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 71.2 ttt180 -102.74 115.19 30.1 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -90.2 116.64 28.35 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -122.45 132.99 54.61 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.592 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 4.9 p -128.26 131.29 69.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 121.061 0.458 . . . . 0.0 110.31 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.451 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 88.0 t80 -104.58 129.14 52.71 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.494 ' CD1' ' HA ' ' A' ' 50' ' ' MET . 30.0 mt -73.49 128.02 34.34 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -60.5 -46.2 90.99 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -171.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.63 -61.55 0.15 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.163 -1.018 . . . . 0.0 112.671 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.417 ' HD2' ' N ' ' A' ' 48' ' ' ARG . 6.6 mpt_? -67.05 -37.32 83.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.141 0.496 . . . . 0.0 111.512 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.501 ' CD ' ' H ' ' A' ' 49' ' ' GLU . 1.1 pm0 -80.45 -3.95 51.83 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.952 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.494 ' HA ' ' CD1' ' A' ' 45' ' ' LEU . 56.3 ttm -63.21 -19.68 64.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.871 0.367 . . . . 0.0 111.351 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.51 -11.1 59.82 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.251 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.0 m -131.19 100.06 17.25 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 121.153 0.501 . . . . 0.0 111.449 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.34 -25.71 71.42 Favored 'Trans proline' 0 N--CA 1.477 0.504 0 C-N-CA 123.505 2.803 . . . . 0.0 112.511 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -63.07 -25.5 68.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.523 -177.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.3 -44.96 94.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.881 0.372 . . . . 0.0 110.32 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.1 -38.38 92.29 Favored Glycine 0 CA--C 1.506 -0.474 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.614 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.504 HG13 ' HG2' ' A' ' 77' ' ' PRO . 99.1 t -62.74 -47.3 93.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.516 -0.342 . . . . 0.0 110.831 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.09 -37.79 88.62 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.042 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.4 ' O ' HG13 ' A' ' 63' ' ' ILE . 39.9 tp -62.57 -47.58 83.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.071 0.463 . . . . 0.0 110.239 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.562 HD12 HG12 ' A' ' 84' ' ' VAL . 62.1 mt -66.15 -39.6 89.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.666 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 57' ' ' VAL . 71.1 mt-10 -60.58 -36.66 79.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.684 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 66' ' ' MET . 86.0 tttt -63.84 -39.91 95.35 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.538 HD11 HD22 ' A' ' 13' ' ' LEU . 65.9 mt -61.7 -47.73 91.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.789 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.489 ' CZ2' ' HB2' ' A' ' 73' ' ' ARG . 40.3 t-105 -58.04 -40.64 81.4 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.414 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.45 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 19.0 m -61.28 -39.76 91.61 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.082 0.467 . . . . 0.0 110.728 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' A' ' 62' ' ' LYS . 97.3 mmm -66.78 -41.98 86.79 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.4 pt -105.06 -0.26 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -173.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 65' ' ' THR . 0.1 OUTLIER -56.31 -18.68 11.44 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -65.71 -36.55 83.93 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.523 ' HB2' HD22 ' A' ' 30' ' ' LEU . 47.8 mt-10 -122.75 6.09 9.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.801 0.334 . . . . 0.0 111.598 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -121.18 152.47 38.75 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.959 0.409 . . . . 0.0 111.752 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -112.23 148.37 34.25 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.489 ' HB2' ' CZ2' ' A' ' 64' ' ' TRP . 74.9 ttt180 -90.94 111.12 22.42 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 120.763 0.316 . . . . 0.0 111.102 -176.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -72.71 -38.73 67.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.8 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -163.28 -177.8 5.56 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.902 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.473 ' HG2' ' NH2' ' A' ' 73' ' ' ARG . 42.4 mt-10 -91.92 150.62 40.97 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.971 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.504 ' HG2' HG13 ' A' ' 57' ' ' VAL . 34.7 Cg_endo -68.99 132.26 24.17 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.106 1.871 . . . . 0.0 110.541 174.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.443 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 62.7 t30 -147.63 151.49 36.3 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.82 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.51 ' CE1' ' HA ' ' A' ' 82' ' ' ARG . 91.1 t80 -86.87 115.48 24.31 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.744 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.97 109.74 3.65 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.181 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.54 31.57 21.38 Favored Glycine 0 C--O 1.223 -0.559 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.327 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.51 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . 96.4 mtt180 69.25 3.49 4.14 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.749 0.82 . . . . 0.0 112.15 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 89.7 m-85 -121.12 137.58 54.59 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.427 174.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.592 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 74.2 t -99.86 124.09 53.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -130.84 142.76 50.4 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -175.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.467 ' SD ' HG13 ' A' ' 88' ' ' VAL . 16.4 tmm? -135.1 143.21 46.49 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.167 176.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.528 HD12 ' O ' ' A' ' 39' ' ' VAL . 47.9 tp -122.57 140.5 52.72 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.104 0.478 . . . . 0.0 111.438 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.467 HG13 ' SD ' ' A' ' 86' ' ' MET . 17.8 m -122.85 133.63 68.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.701 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.438 HG23 ' CE1' ' A' ' 38' ' ' HIS . 18.1 m -98.74 136.88 20.56 Favored Pre-proline 0 C--N 1.312 -1.022 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.75 144.8 84.97 Favored 'Trans proline' 0 C--N 1.326 -0.64 0 C-N-CA 122.336 2.024 . . . . 0.0 111.088 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -78.69 -3.3 43.41 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.483 0.659 . . . . 0.0 111.441 -176.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -91.2 13.92 15.76 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.83 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.38 168.92 19.19 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.686 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 66.27 24.12 10.71 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.03 -39.52 93.1 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 175.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 65.83 -48.33 0.4 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.726 1.21 . . . . 0.0 113.731 177.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -112.64 -4.29 14.14 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.049 0.452 . . . . 0.0 110.582 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -84.68 69.82 10.7 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.311 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -163.04 144.09 9.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.559 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 83.5 t60 64.09 110.3 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.525 0.73 . . . . 0.0 111.838 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.105 179.217 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.0 pttm . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.48 -42.95 91.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-O 121.83 0.824 . . . . 0.0 109.563 175.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.4 mm -96.64 124.21 49.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.631 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.471 ' HB2' ' HD2' ' A' ' 37' ' ' LYS . 16.2 m-20 -73.58 100.87 3.43 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-O 121.195 0.521 . . . . 0.0 110.833 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.458 HG12 ' HB2' ' A' ' 38' ' ' HIS . 79.8 mt -109.13 116.05 51.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.43 ' HE2' ' HB3' ' A' ' 7' ' ' ASP . 3.5 mptp? -83.87 134.73 34.68 Favored 'General case' 0 CA--C 1.488 -1.427 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.675 -175.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.415 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 59.9 mt-10 -102.57 112.02 24.59 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.594 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.7 mt -104.11 115.09 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.099 177.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 86.5 tttt -96.58 141.28 30.03 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.991 -175.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 5.5 mp -135.52 171.21 14.78 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.868 175.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.8 m -132.5 154.18 50.19 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.616 ' HB ' ' OE1' ' A' ' 49' ' ' GLU . 86.0 t -63.53 -33.53 62.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.338 0.59 . . . . 0.0 109.777 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.516 ' HG3' ' OE2' ' A' ' 49' ' ' GLU . 65.2 mttp -97.38 76.65 2.59 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.0 tt -134.55 154.0 36.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.751 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.74 143.74 49.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.186 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -64.46 -30.2 71.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.215 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -63.28 -39.05 93.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.644 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.9 -43.08 99.58 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.089 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.1 mt -62.16 -44.83 99.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.774 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -62.12 -43.67 98.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.239 0.542 . . . . 0.0 111.625 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -64.58 -43.27 94.4 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.496 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -65.24 -42.18 93.63 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.421 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 12.9 m -63.22 -33.17 59.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.004 178.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -62.52 -41.47 98.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.454 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -67.42 -42.49 83.12 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.599 177.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.531 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -60.01 -38.84 83.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.124 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 26' ' ' VAL . 97.4 mt -62.02 -41.77 98.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.026 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.617 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 67.0 mm-40 -65.3 -43.04 92.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.549 0.214 . . . . 0.0 110.714 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -64.02 -38.04 89.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.521 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 96.7 mt -62.18 -43.57 98.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.452 0.644 . . . . 0.0 109.435 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -61.64 -22.81 65.59 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.257 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.617 ' HG2' ' O ' ' A' ' 31' ' ' GLU . 76.5 mm-40 -85.13 -8.5 58.6 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.934 0.397 . . . . 0.0 110.528 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.42 13.72 56.74 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.024 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.471 ' HD2' ' HB2' ' A' ' 7' ' ' ASP . 75.7 mmtt -96.29 159.74 14.79 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.484 ' NE2' HG23 ' A' ' 89' ' ' THR . 23.6 m170 -107.85 147.29 31.13 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.476 ' O ' HD12 ' A' ' 87' ' ' LEU . 41.5 t -114.29 126.43 71.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.415 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 41.6 ttm180 -102.78 115.87 31.45 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -92.61 120.11 32.72 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 78.1 mtp180 -126.71 133.77 50.83 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.604 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.2 p -121.37 131.6 72.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 121.359 0.599 . . . . 0.0 111.217 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -101.26 124.37 46.84 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.849 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 49' ' ' GLU . 42.1 mt -76.24 133.61 40.06 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -112.31 116.81 30.98 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.082 0.467 . . . . 0.0 112.082 -174.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.48 -134.14 12.21 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.476 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 -74.84 -6.66 50.29 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.021 0.438 . . . . 0.0 110.817 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.616 ' OE1' ' HB ' ' A' ' 15' ' ' VAL . 99.5 mt-10 -60.35 -24.17 64.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.971 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 91.1 mtp -62.56 -29.27 70.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.528 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.49 -10.21 59.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.868 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.454 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 24.0 m -128.26 95.17 34.17 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-O 121.484 0.659 . . . . 0.0 111.456 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' A' ' 52' ' ' THR . 37.9 Cg_endo -68.0 -18.09 46.18 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.296 2.664 . . . . 0.0 111.944 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -62.7 -31.67 72.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.936 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.74 -41.07 97.16 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.219 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.47 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -64.88 -38.4 95.48 Favored Glycine 0 CA--C 1.504 -0.625 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.813 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.466 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 99.4 t -63.66 -45.93 96.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 120.839 0.352 . . . . 0.0 110.413 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.17 -41.45 96.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.38 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.544 ' O ' HG13 ' A' ' 63' ' ' ILE . 44.5 tp -63.89 -47.24 81.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.785 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.551 HD12 HG12 ' A' ' 84' ' ' VAL . 82.8 mt -64.41 -41.18 96.77 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.938 -177.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 57' ' ' VAL . 5.5 mm-40 -64.36 -35.74 81.88 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.52 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -63.81 -40.75 97.37 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 59' ' ' LEU . 65.9 mt -64.47 -44.98 97.02 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.865 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 57.2 t-105 -58.43 -38.15 76.87 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.599 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.9 m -57.44 -38.91 75.19 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.338 0.589 . . . . 0.0 110.225 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 98.1 mmm -67.32 -40.67 85.97 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.731 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.9 pt -102.02 -6.25 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -174.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -58.54 -21.13 51.52 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.074 0.464 . . . . 0.0 111.328 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -64.57 -33.25 75.48 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.306 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.518 ' HA ' ' HE3' ' A' ' 91' ' ' LYS . 73.3 mm-40 -131.94 6.5 4.29 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -122.0 157.56 31.07 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.957 0.408 . . . . 0.0 111.324 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -111.72 150.78 29.74 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -94.79 113.13 24.85 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 120.717 0.294 . . . . 0.0 111.172 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -77.96 -44.89 25.46 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.334 0.588 . . . . 0.0 110.422 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -145.68 149.99 35.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.332 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.46 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 9.9 pt-20 -80.38 163.15 58.39 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.402 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.629 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 29.9 Cg_endo -62.68 138.5 69.94 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 121.814 1.676 . . . . 0.0 111.981 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.585 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 23.3 p-10 -144.84 156.89 44.26 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.004 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -105.78 108.41 19.9 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.039 0.447 . . . . 0.0 110.487 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -123.33 120.08 31.99 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.511 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.72 -102.7 1.24 Allowed Glycine 0 N--CA 1.432 -1.619 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.683 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -127.17 7.13 6.5 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.738 0.304 . . . . 0.0 110.796 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -125.84 143.87 50.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.88 0.372 . . . . 0.0 111.844 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.604 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 92.3 t -99.54 124.9 53.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 172.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.629 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 10.8 m-80 -119.55 144.43 47.07 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -172.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 13.1 tmm? -145.03 132.31 20.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.476 HD12 ' O ' ' A' ' 39' ' ' VAL . 49.8 tp -114.91 142.74 46.18 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.062 0.458 . . . . 0.0 111.917 -175.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.0 m -124.92 158.71 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.27 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.484 HG23 ' NE2' ' A' ' 38' ' ' HIS . 25.3 m -131.86 143.51 49.37 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.429 ' HD2' ' CG2' ' A' ' 89' ' ' THR . 74.1 Cg_endo -68.17 153.86 73.7 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 122.15 1.9 . . . . 0.0 110.852 177.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' A' ' 70' ' ' GLU . 97.2 mttt -65.04 85.91 0.05 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -100.66 -25.67 14.07 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.393 0.616 . . . . 0.0 109.485 175.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.92 79.61 1.47 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.037 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -94.4 -56.16 2.91 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -86.36 65.99 3.73 Favored Glycine 0 N--CA 1.438 -1.185 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -77.34 -55.42 5.41 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.18 0.514 . . . . 0.0 110.142 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 40.7 p-80 -121.95 124.59 44.4 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.11 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 26.5 p-80 -156.34 -43.53 0.07 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.441 -177.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -120.08 115.2 23.23 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -148.13 162.27 39.75 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 71.9 m80 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.664 178.718 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.645 HG12 ' H ' ' A' ' 6' ' ' ILE . 1.6 t -129.67 -173.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -177.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.645 ' H ' HG12 ' A' ' 5' ' ' VAL . 84.4 mt -69.78 134.08 30.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.078 0.466 . . . . 0.0 110.907 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.526 ' OD2' ' HE2' ' A' ' 9' ' ' LYS . 7.7 t70 -70.45 119.83 15.2 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.184 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 87.1 mt -127.07 136.79 59.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.503 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.526 ' HE2' ' OD2' ' A' ' 7' ' ' ASP . 4.1 mptp? -101.55 157.82 16.54 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-O 121.793 0.806 . . . . 0.0 112.65 -177.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.444 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 46.0 mt-10 -124.74 123.23 39.54 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.848 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.9 mt -109.13 114.6 47.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 87.7 tttt -98.72 135.52 40.08 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.139 -174.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.639 HD22 HD11 ' A' ' 63' ' ' ILE . 5.5 mp -132.07 -177.09 4.29 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.61 177.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.403 ' HA ' HG23 ' A' ' 43' ' ' VAL . 22.4 p -143.73 156.51 44.55 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.512 ' HB ' ' OE2' ' A' ' 49' ' ' GLU . 79.8 t -63.67 -44.02 98.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.706 ' HG2' ' OE2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -85.48 71.29 10.8 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 173.395 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.444 HD11 ' OD2' ' A' ' 21' ' ' ASP . 16.7 tt -122.62 160.67 24.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.864 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.73 147.12 24.04 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.12 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -63.52 -33.53 75.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.014 0.435 . . . . 0.0 110.283 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -62.28 -40.54 96.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.389 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 21.1 t70 -66.9 -34.79 78.56 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.839 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.8 mt -61.77 -41.55 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.261 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -58.13 -43.6 87.37 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.752 0.787 . . . . 0.0 109.795 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.403 ' HB3' ' O ' ' A' ' 21' ' ' ASP . 57.9 t80 -61.88 -43.96 97.78 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.689 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 74.2 mmtt -61.96 -46.88 87.33 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.246 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.416 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 9.7 m -71.35 -32.96 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -60.76 -42.56 97.68 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.022 0.439 . . . . 0.0 109.94 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -73.38 -36.79 66.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.273 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.486 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -58.98 -38.49 79.24 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.193 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.427 ' HA ' HD12 ' A' ' 33' ' ' LEU . 96.7 mt -61.4 -39.54 91.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.527 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 61.8 mt-10 -65.54 -40.52 92.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.169 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -65.95 -37.65 86.58 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.117 0.484 . . . . 0.0 110.598 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 90' ' ' PRO . 97.2 mt -62.49 -42.2 99.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.068 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -57.62 -25.17 59.72 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.908 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 31' ' ' GLU . 64.1 mm-40 -84.05 -8.96 58.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.008 0.432 . . . . 0.0 110.67 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.79 9.97 63.6 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.267 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -101.84 174.0 6.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.01 0.433 . . . . 0.0 111.865 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -104.73 150.32 24.85 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.519 -176.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.2 t -116.06 125.05 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.018 173.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.444 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 40.0 ttm180 -100.68 111.97 24.3 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.506 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 63.5 m-85 -89.69 125.68 35.36 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 81.6 mtp180 -132.02 139.77 48.7 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.602 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.5 p -121.36 133.45 67.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 121.126 0.488 . . . . 0.0 110.891 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -101.72 125.9 48.47 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.633 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 50' ' ' MET . 33.0 mt -87.09 111.82 21.3 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.8 -44.99 84.02 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 49' ' ' GLU . . . 168.01 141.04 3.07 Favored Glycine 0 N--CA 1.434 -1.437 0 C-N-CA 120.118 -1.039 . . . . 0.0 111.709 -177.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 72.44 -10.24 0.95 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.54 0.686 . . . . 0.0 110.23 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.706 ' OE2' ' HG2' ' A' ' 16' ' ' LYS . 61.0 mt-10 -90.3 -17.85 26.65 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.458 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.416 ' HA ' HD13 ' A' ' 45' ' ' LEU . 96.3 mtp -70.26 -16.11 62.99 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.767 -177.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.36 -34.64 78.15 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.193 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.2 p -130.23 96.52 24.76 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.392 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -67.12 -14.37 43.1 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 123.509 2.806 . . . . 0.0 112.405 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.41 ' OE2' ' HB2' ' A' ' 58' ' ' ALA . 8.4 tm-20 -56.99 -35.01 68.71 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.649 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.43 -36.59 71.56 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.876 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.45 -42.22 97.67 Favored Glycine 0 CA--C 1.504 -0.602 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.96 -43.75 89.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.41 ' HB2' ' OE2' ' A' ' 54' ' ' GLU . . . -60.66 -40.05 90.62 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.136 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.6 tp -61.91 -45.91 91.66 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.448 HD12 HG12 ' A' ' 84' ' ' VAL . 88.1 mt -65.76 -39.02 90.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.292 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -59.49 -43.82 93.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.118 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -63.1 -40.8 98.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.639 HD11 HD22 ' A' ' 13' ' ' LEU . 96.2 mt -63.5 -43.9 98.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.041 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.7 t-105 -58.55 -42.95 89.03 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.776 -178.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.555 ' HA ' ' OE2' ' A' ' 68' ' ' GLU . 22.4 p -64.4 -16.33 62.15 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 68.1 mtt -89.9 -48.52 7.17 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.156 0.503 . . . . 0.0 111.232 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.2 pt -86.0 -14.87 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -174.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.555 ' OE2' ' HA ' ' A' ' 65' ' ' THR . 14.0 pt-20 -57.48 -14.8 5.48 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -63.48 -41.57 98.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.476 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -117.89 -4.4 11.11 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.163 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.454 ' HB2' HD13 ' A' ' 33' ' ' LEU . . . -119.68 146.99 45.1 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.47 -177.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -113.26 138.23 50.31 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -69.58 109.94 4.55 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-O 121.245 0.545 . . . . 0.0 111.359 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.4 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 10.2 t70 -77.94 -42.91 31.45 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.098 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -146.22 137.12 24.35 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.054 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -64.83 157.37 75.36 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.63 178.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 23.4 Cg_exo -61.82 142.35 93.28 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 122.06 1.84 . . . . 0.0 111.577 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -141.39 140.68 33.74 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.423 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -99.11 116.13 30.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.917 0.389 . . . . 0.0 110.418 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -134.49 128.89 34.29 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.74 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.85 -94.42 0.6 Allowed Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.803 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -140.97 6.89 2.01 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.66 0.743 . . . . 0.0 109.41 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -119.33 143.81 47.19 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.717 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.602 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 68.8 t -106.28 123.31 60.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 172.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.538 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 8.6 p30 -125.86 149.63 48.51 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -174.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 64.6 ttp -140.87 141.43 34.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.513 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.0 mt -109.75 131.65 54.87 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.024 0.44 . . . . 0.0 111.692 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.7 m -122.95 136.44 59.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.628 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.454 ' CG2' ' HD2' ' A' ' 90' ' ' PRO . 24.4 m -116.07 140.18 26.02 Favored Pre-proline 0 C--N 1.307 -1.276 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.357 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.521 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 72.1 Cg_endo -68.0 152.51 76.71 Favored 'Trans proline' 0 C--O 1.237 0.463 0 C-N-CA 122.815 2.343 . . . . 0.0 111.772 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -77.62 65.09 3.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.199 0.523 . . . . 0.0 110.841 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -66.07 -40.7 91.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.114 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.07 103.89 8.29 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.098 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -137.35 101.85 4.63 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -92.01 125.73 8.2 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.869 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -95.45 81.07 3.53 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -127.0 109.78 12.27 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.185 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 -121.01 159.84 24.8 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -67.05 120.45 13.69 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -71.89 101.57 2.69 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.983 -177.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.429 ' CD2' ' H ' ' A' ' 101' ' ' HIS . 7.4 p80 . . . . . 0 C--N 1.315 -0.913 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.063 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 121.125 0.488 . . . . 0.0 110.022 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.7 t -92.74 -22.47 5.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.677 0.751 . . . . 0.0 111.218 -177.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 84.2 mt -113.9 132.16 63.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.278 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -69.01 111.34 4.95 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.114 0.483 . . . . 0.0 109.915 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.477 HG12 ' HB2' ' A' ' 38' ' ' HIS . 71.1 mt -95.05 134.5 32.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.715 -178.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.41 ' HG3' ' CD1' ' A' ' 32' ' ' PHE . 66.4 mmtt -85.71 127.05 34.41 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.83 -176.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -102.55 115.51 30.71 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 120.868 0.366 . . . . 0.0 110.363 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.0 mt -108.81 116.21 51.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.604 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -98.25 137.43 37.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.135 -175.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.492 HD22 HD11 ' A' ' 63' ' ' ILE . 5.5 mp -128.93 179.12 5.91 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.019 176.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 p -135.91 151.66 50.21 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.579 HG11 ' HG2' ' A' ' 49' ' ' GLU . 49.0 t -66.98 -25.6 34.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.383 0.611 . . . . 0.0 110.158 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.565 ' HE2' ' O ' ' A' ' 46' ' ' LYS . 64.6 mttm -103.29 72.37 1.15 Allowed 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 174.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.5 tt -126.84 153.42 35.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.124 -178.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.407 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -92.57 159.97 15.24 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -62.78 -33.09 74.45 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 120.948 0.404 . . . . 0.0 110.315 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -59.25 -45.05 92.22 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.242 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.4 -39.59 74.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.174 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.62 ' O ' HG23 ' A' ' 26' ' ' VAL . 75.7 mt -60.79 -51.43 73.23 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -60.39 -42.36 95.73 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.982 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.412 ' CZ ' ' HE1' ' A' ' 28' ' ' HIS . 92.0 t80 -64.3 -47.25 80.17 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.99 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -66.78 -42.91 85.29 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 22' ' ' ILE . 60.1 t -63.89 -29.63 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.473 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.05 -41.92 97.49 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 177.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.412 ' HE1' ' CZ ' ' A' ' 24' ' ' TYR . 31.4 m80 -68.41 -34.29 75.74 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.682 178.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.583 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -55.6 -45.25 77.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.238 -178.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.0 mt -62.76 -38.93 92.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.988 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -59.71 -46.23 89.74 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.172 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.41 ' CD1' ' HG3' ' A' ' 9' ' ' LYS . 84.2 m-85 -68.0 -34.78 77.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.82 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 95.0 mt -61.97 -43.01 99.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.287 0.565 . . . . 0.0 110.015 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -59.84 -34.45 73.12 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.596 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -69.4 -18.86 63.8 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.182 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.52 27.02 10.17 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.967 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -112.05 162.85 14.95 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.988 0.423 . . . . 0.0 110.519 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.477 ' HB2' HG12 ' A' ' 8' ' ' ILE . 5.4 m80 -97.53 146.7 25.0 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.7 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.3 t -115.27 129.56 71.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.635 176.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -108.4 112.25 24.58 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 97.4 m-85 -85.78 127.33 34.52 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.724 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 71.4 mtp85 -127.19 131.24 50.71 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.263 -176.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.6 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 5.9 p -130.0 137.05 57.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.106 0.479 . . . . 0.0 110.764 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.446 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 93.3 t80 -104.53 131.21 52.18 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.467 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.4 mt -80.21 85.32 5.75 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.129 0.49 . . . . 0.0 110.411 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.565 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 63.9 tttp -88.77 126.03 35.15 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.132 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.03 -154.94 16.35 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -77.81 -7.21 56.31 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.056 0.455 . . . . 0.0 110.68 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.579 ' HG2' HG11 ' A' ' 15' ' ' VAL . 2.3 mp0 -60.08 -13.61 12.67 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.594 178.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 10.3 mmt -59.33 -20.65 56.31 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.79 0.329 . . . . 0.0 111.361 177.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.45 -5.5 59.29 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.478 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.4 m -138.49 102.59 7.93 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-O 121.175 0.512 . . . . 0.0 111.455 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.28 -20.2 49.31 Favored 'Trans proline' 0 C--N 1.331 -0.369 0 C-N-CA 123.26 2.64 . . . . 0.0 111.76 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -64.04 -22.64 67.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.206 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.19 -45.17 91.77 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.96 0.409 . . . . 0.0 110.382 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.62 -38.86 93.61 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.941 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.1 t -64.12 -43.92 97.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 61' ' ' GLU . . . -63.66 -39.45 94.36 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.223 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.407 ' O ' HG13 ' A' ' 63' ' ' ILE . 38.8 tp -64.51 -47.23 79.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.091 0.472 . . . . 0.0 110.437 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.612 HD12 HG12 ' A' ' 84' ' ' VAL . 47.7 mt -66.6 -40.92 89.1 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.586 -177.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -64.09 -31.73 73.02 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.286 179.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -65.01 -40.89 95.56 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.579 HG23 HG22 ' A' ' 26' ' ' VAL . 75.9 mt -65.53 -44.17 94.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.688 177.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 17.1 t-105 -55.76 -41.54 74.14 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.616 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.1 p -71.63 -12.74 61.5 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 98.0 mmm -87.21 -31.99 20.02 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.233 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.409 HG23 HG13 ' A' ' 26' ' ' VAL . 32.7 pt -108.15 -1.9 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -174.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -12.21 9.17 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -63.35 -46.89 84.47 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.407 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -119.43 0.89 11.17 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.87 0.367 . . . . 0.0 111.589 -174.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.57 ' HB2' HD13 ' A' ' 33' ' ' LEU . . . -125.26 149.81 47.67 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.178 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -114.17 131.73 56.34 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -72.53 106.67 4.69 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.24 -35.28 77.69 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.515 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -156.45 148.75 23.36 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.772 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' A' ' 76' ' ' GLU . 1.6 mp0 -62.27 162.28 19.91 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.499 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.401 ' HB3' HD12 ' A' ' 60' ' ' LEU . 31.9 Cg_exo -59.05 144.79 99.22 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.348 2.032 . . . . 0.0 112.375 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -130.0 132.46 46.28 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.934 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -93.08 107.42 19.21 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -127.77 132.04 49.56 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.758 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.13 -109.83 3.13 Favored Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.385 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -124.85 9.86 8.24 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.179 0.514 . . . . 0.0 109.998 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.446 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 73.0 m-85 -125.0 144.5 50.35 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.306 -177.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.612 HG12 HD12 ' A' ' 60' ' ' LEU . 87.5 t -100.89 122.07 52.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 173.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.724 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 39.7 m-80 -114.61 144.64 43.08 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.764 -173.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.557 ' HB2' HD13 ' A' ' 60' ' ' LEU . 63.7 ttp -139.62 130.04 25.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.312 175.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 17.4 mt -108.99 129.73 55.45 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.25 0.547 . . . . 0.0 111.623 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.73 135.66 62.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.928 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.418 HG23 ' CE1' ' A' ' 38' ' ' HIS . 16.1 m -102.28 134.11 20.2 Favored Pre-proline 0 C--N 1.307 -1.251 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.487 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 56.0 Cg_endo -66.39 135.76 40.79 Favored 'Trans proline' 0 C--N 1.327 -0.555 0 C-N-CA 121.884 1.723 . . . . 0.0 110.201 177.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -65.28 -39.77 92.99 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.24 0.543 . . . . 0.0 112.286 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -95.43 -74.39 0.55 Allowed 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.467 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.435 ' HB2' ' HG2' ' A' ' 90' ' ' PRO . . . 62.62 -90.98 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.74 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -137.23 135.11 36.94 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -100.13 -38.56 3.53 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.692 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -91.32 -179.82 5.5 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 51.5 t60 74.87 -16.4 0.56 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.394 0.677 . . . . 0.0 111.625 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -66.0 -35.29 80.17 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.344 0.592 . . . . 0.0 110.264 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -90.41 30.01 1.19 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.603 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.7 m80 74.11 -73.76 0.09 Allowed 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 123.963 0.905 . . . . 0.0 110.657 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.87 -179.964 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? . . . . . 0 N--CA 1.469 0.512 0 CA-C-O 121.217 0.532 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 t -107.71 -10.0 10.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.571 0.7 . . . . 0.0 110.856 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 92.6 mt -79.81 101.16 4.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.333 0.587 . . . . 0.0 110.103 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -78.35 115.18 17.88 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.467 HG12 ' HB2' ' A' ' 38' ' ' HIS . 69.3 mt -91.49 119.31 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.771 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.45 ' HG3' ' CD1' ' A' ' 32' ' ' PHE . 73.1 mmtt -89.22 126.69 35.6 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.936 -174.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.456 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 59.3 mt-10 -102.14 110.72 22.76 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.569 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.0 mt -94.23 107.94 20.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 47.6 tttm -98.32 122.87 42.04 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.593 -175.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.419 HD21 ' HG3' ' A' ' 25' ' ' LYS . 79.9 mt -122.65 179.36 4.63 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.517 -178.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.1 m -131.62 151.98 51.19 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.2 t -63.69 -40.98 91.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.331 0.586 . . . . 0.0 109.793 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -78.03 50.38 0.88 Allowed 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.323 176.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.2 tt -106.34 160.03 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.706 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.45 146.51 28.37 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 175.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.421 HE22 ' HD3' ' A' ' 62' ' ' LYS . 58.7 tp60 -63.75 -36.43 83.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.949 0.404 . . . . 0.0 111.512 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -63.91 -35.97 82.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.977 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.595 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 29.0 t70 -65.51 -35.23 80.25 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.884 0.373 . . . . 0.0 110.752 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.3 mt -61.32 -41.57 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.109 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -58.4 -41.92 86.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.887 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -63.86 -43.22 96.76 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.167 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.595 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 75.8 mmtt -61.53 -46.51 89.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.664 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.487 ' CG1' HG23 ' A' ' 63' ' ' ILE . 4.2 m -66.71 -40.82 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 111.791 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.56 -42.7 98.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.083 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -80.04 -25.5 40.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.696 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.419 ' O ' HD13 ' A' ' 33' ' ' LEU . . . -63.68 -37.1 86.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.034 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.536 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 65.7 mt -62.14 -33.53 74.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.689 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -57.76 -41.45 82.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.352 . . . . 0.0 110.116 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.45 ' CD1' ' HG3' ' A' ' 9' ' ' LYS . 94.9 m-85 -66.04 -35.7 81.24 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.105 0.478 . . . . 0.0 110.634 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.572 ' CB ' ' HB3' ' A' ' 90' ' ' PRO . 10.8 mp -62.36 -41.73 98.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.434 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 30' ' ' LEU . 32.6 mt-10 -62.43 -30.09 70.98 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.518 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -79.41 -8.66 59.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.904 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.46 19.77 50.98 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.189 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -95.98 164.97 12.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.935 0.397 . . . . 0.0 110.366 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.467 ' HB2' HG12 ' A' ' 8' ' ' ILE . 17.4 m170 -110.56 148.94 31.13 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.8 t -118.18 130.2 73.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 121.282 0.563 . . . . 0.0 110.682 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.456 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 39.5 ttm180 -111.55 113.18 25.42 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 175.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 92.8 m-85 -86.51 121.55 29.21 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.551 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 78.1 mtp180 -124.27 132.6 53.59 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.555 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.1 p -126.42 135.06 64.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 121.186 0.517 . . . . 0.0 110.799 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -101.37 127.19 48.11 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.799 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.5 mt -82.23 116.43 21.76 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -102.45 113.6 27.08 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.319 0.581 . . . . 0.0 111.956 -173.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.57 -137.21 13.29 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.394 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.4 ptt-85 -69.57 -11.87 61.19 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 122.577 0.351 . . . . 0.0 111.407 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -60.72 -21.12 62.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.566 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 91.2 mtp -62.66 -29.82 70.92 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.618 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.85 -13.81 62.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.349 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.6 p -125.28 94.36 43.44 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-O 121.171 0.51 . . . . 0.0 111.274 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -64.63 -20.33 65.34 Favored 'Trans proline' 0 N--CA 1.477 0.524 0 C-N-CA 123.461 2.774 . . . . 0.0 111.756 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -61.87 -30.07 70.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.183 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.62 -44.01 93.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.811 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.435 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -66.79 -38.44 93.05 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.623 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.8 t -63.87 -44.87 98.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.487 -0.356 . . . . 0.0 110.638 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.45 88.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.032 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.7 tp -62.63 -47.47 83.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.156 0.503 . . . . 0.0 110.036 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.427 HD12 HG12 ' A' ' 84' ' ' VAL . 56.3 mt -67.33 -39.73 85.87 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.975 -178.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -58.88 -39.47 81.51 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.704 0.288 . . . . 0.0 111.075 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.421 ' HD3' HE22 ' A' ' 19' ' ' GLN . 40.5 ttmt -62.76 -46.14 89.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.231 0.538 . . . . 0.0 109.97 177.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.487 HG23 ' CG1' ' A' ' 26' ' ' VAL . 96.0 mt -63.1 -45.14 99.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.897 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -60.66 -40.27 91.45 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.421 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.41 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 19.6 m -61.09 -37.34 82.37 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.096 0.474 . . . . 0.0 111.203 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 82.4 mtp -71.92 -35.94 69.81 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 63' ' ' ILE . 41.6 pt -103.28 -2.87 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -174.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -57.18 -25.97 59.85 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -177.252 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.417 ' H ' ' ND2' ' A' ' 69' ' ' ASN . 1.7 p30 -65.79 -39.23 90.75 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -107.96 -8.44 15.91 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.958 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -123.27 155.77 36.55 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.552 ' OD1' ' HB ' ' A' ' 89' ' ' THR . 5.3 p30 -117.86 128.37 54.77 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -77.75 108.02 10.67 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 121.305 0.574 . . . . 0.0 111.361 -176.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -66.63 -42.33 86.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.685 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.592 ' HD3' ' N ' ' A' ' 76' ' ' GLU . 7.1 tmtm? -146.19 138.5 25.26 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.592 ' N ' ' HD3' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -63.04 158.72 52.62 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.369 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.13 121.8 9.99 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 121.817 1.678 . . . . 0.0 110.799 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -130.23 138.93 50.79 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.491 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -92.98 117.25 29.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.883 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -138.22 139.98 39.5 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.29 -92.42 0.32 Allowed Glycine 0 N--CA 1.432 -1.567 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -177.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -153.08 17.23 0.56 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.398 0.618 . . . . 0.0 110.473 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -129.23 143.43 50.85 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.909 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.555 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 95.9 t -99.83 126.22 53.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 173.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.569 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 9.3 p30 -133.07 153.07 51.85 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.499 -175.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 64.8 ttp -144.04 134.53 24.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.747 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.5 mt -103.89 129.27 51.39 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.053 0.454 . . . . 0.0 111.494 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.48 135.29 63.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.165 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.552 ' HB ' ' OD1' ' A' ' 72' ' ' ASN . 13.8 m -114.43 143.29 29.57 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.572 ' HB3' ' CB ' ' A' ' 33' ' ' LEU . 60.2 Cg_endo -67.0 155.14 72.17 Favored 'Trans proline' 0 C--O 1.242 0.711 0 C-N-CA 122.81 2.34 . . . . 0.0 112.584 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -63.36 131.92 49.82 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -90.11 -71.23 0.63 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.951 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 57.88 -95.88 0.06 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.954 -176.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -140.14 7.46 2.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.7 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 65.82 -108.3 2.32 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.319 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -137.94 147.03 43.94 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.614 0.245 . . . . 0.0 110.636 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -98.88 -8.2 26.06 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.169 0.509 . . . . 0.0 110.228 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -113.88 146.31 40.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.176 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -66.15 -44.02 85.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.083 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -142.88 -32.02 0.49 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.425 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 72.4 t60 . . . . . 0 C--N 1.322 -0.623 0 CA-C-O 118.808 -0.615 . . . . 0.0 109.471 -178.331 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.3 tttt . . . . . 0 N--CA 1.438 -1.034 0 CA-C-O 121.029 0.442 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.3 t -84.15 133.2 29.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 94.8 mt -68.95 131.56 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-O 120.947 0.403 . . . . 0.0 110.004 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -80.07 107.88 13.22 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.6 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.432 HG23 ' HB3' ' A' ' 38' ' ' HIS . 88.7 mt -117.75 131.11 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.339 -178.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.418 ' HG2' ' CD1' ' A' ' 32' ' ' PHE . 3.6 mptp? -86.26 135.78 33.42 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 121.565 0.698 . . . . 0.0 110.335 -178.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -115.21 120.28 39.17 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.046 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.6 mt -108.75 114.31 46.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.984 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -84.13 139.71 32.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.707 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.487 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 49.8 mt -127.27 166.83 17.04 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.748 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.0 m -137.09 146.25 44.9 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.7 t -62.73 -45.0 99.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.911 0.386 . . . . 0.0 110.25 177.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -94.35 65.89 3.32 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.585 0.707 . . . . 0.0 109.975 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.433 HD11 ' OD1' ' A' ' 21' ' ' ASP . 19.7 tt -107.66 156.03 8.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.384 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 21' ' ' ASP . . . -64.77 141.71 58.68 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.8 tp60 -62.11 -39.4 92.37 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.958 0.408 . . . . 0.0 110.883 -176.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -76.32 -18.33 58.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.883 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.461 ' HB2' ' HB3' ' A' ' 18' ' ' ALA . 12.5 t70 -67.88 -35.79 79.13 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.276 0.56 . . . . 0.0 110.669 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.3 mt -61.49 -42.14 92.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.124 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -58.73 -43.12 90.08 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.716 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.534 ' CZ ' ' HE1' ' A' ' 28' ' ' HIS . 83.7 t80 -63.75 -45.86 87.92 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.469 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -65.52 -41.13 93.47 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.481 ' CG1' HG23 ' A' ' 63' ' ' ILE . 1.4 m -60.77 -29.86 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.549 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -61.83 -46.76 88.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.014 0.435 . . . . 0.0 110.37 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.534 ' HE1' ' CZ ' ' A' ' 24' ' ' TYR . 38.4 m80 -64.57 -37.83 88.9 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.111 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.612 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -56.56 -44.93 81.42 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.429 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 94.6 mt -62.5 -41.38 98.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.932 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -61.75 -44.82 96.17 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.967 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.418 ' CD1' ' HG2' ' A' ' 9' ' ' LYS . 81.4 m-85 -68.8 -32.91 72.97 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 96.7 mt -62.05 -42.02 98.74 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.404 0.621 . . . . 0.0 110.219 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 30' ' ' LEU . 44.6 mm-40 -56.24 -31.7 63.8 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.768 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -76.37 -8.51 57.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.726 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.63 17.95 62.86 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.07 -176.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -99.04 158.87 15.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.78 0.324 . . . . 0.0 110.523 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.432 ' HB3' HG23 ' A' ' 8' ' ' ILE . 1.9 t-80 -99.84 148.11 24.78 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.5 t -119.21 131.11 72.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.414 0.626 . . . . 0.0 111.829 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -112.38 126.0 54.8 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.053 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 96.8 m-85 -97.18 124.33 41.2 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.636 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 65.1 mtp180 -125.7 105.99 9.39 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.885 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.632 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 5.9 p -104.98 129.43 57.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.136 0.493 . . . . 0.0 111.31 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -99.01 134.79 41.34 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.915 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.2 mt -82.0 89.42 6.41 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 87.3 tttt -68.33 134.51 50.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.202 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.75 -132.38 11.16 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.349 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -110.6 18.37 19.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.683 0.278 . . . . 0.0 110.993 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 26.3 mm-40 -68.79 -2.47 9.51 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.196 -177.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 67.9 mtt -65.12 -13.33 57.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.037 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.49 -37.56 87.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.821 0.343 . . . . 0.0 110.697 178.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.3 p -124.72 96.91 39.83 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 121.082 0.468 . . . . 0.0 111.583 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.416 ' HB3' ' CG ' ' A' ' 79' ' ' PHE . 31.4 Cg_exo -62.99 -19.58 69.46 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.601 2.867 . . . . 0.0 112.471 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -59.48 -20.38 54.85 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.346 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.59 -38.93 86.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.036 0.446 . . . . 0.0 110.347 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.469 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -66.22 -39.17 94.37 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.766 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.0 t -64.12 -45.19 97.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.699 -0.25 . . . . 0.0 110.694 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.76 -40.75 89.22 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.066 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.5 tp -62.93 -45.82 90.66 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.028 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.528 HD13 ' HB2' ' A' ' 86' ' ' MET . 92.2 mt -65.22 -40.89 94.72 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.753 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -58.4 -43.05 88.41 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.95 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -64.34 -41.59 96.7 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.335 0.588 . . . . 0.0 109.89 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.481 HG23 ' CG1' ' A' ' 26' ' ' VAL . 91.6 mt -64.88 -43.84 96.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.384 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -58.26 -41.24 83.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.123 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.3 p -63.79 -16.82 62.19 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 68.7 mtt -85.97 -39.2 17.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.94 0.4 . . . . 0.0 111.824 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.6 pt -101.55 -7.15 9.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -57.1 -28.69 62.88 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -66.57 -22.23 66.15 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -130.15 8.41 5.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.665 0.269 . . . . 0.0 111.576 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.28 151.71 49.93 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.79 0.328 . . . . 0.0 111.116 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -113.44 152.45 30.07 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -94.71 128.35 41.33 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.064 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -90.48 -8.58 50.06 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.138 0.494 . . . . 0.0 110.28 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -176.06 164.58 2.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.458 -177.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -85.96 149.11 49.78 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 19.2 Cg_endo -58.71 136.63 75.17 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.344 2.029 . . . . 0.0 111.63 177.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -145.35 138.6 26.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.338 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.416 ' CG ' ' HB3' ' A' ' 53' ' ' PRO . 87.7 t80 -83.3 118.14 23.46 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.659 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -130.59 115.54 16.89 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.092 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.71 -95.75 0.91 Allowed Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.149 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -132.61 4.87 3.96 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.942 0.401 . . . . 0.0 110.368 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 82.1 m-85 -127.65 143.93 51.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.091 -176.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.632 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 93.1 t -99.31 120.98 49.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 172.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.636 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 41.9 m-80 -111.79 145.94 38.52 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -171.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.528 ' HB2' HD13 ' A' ' 60' ' ' LEU . 64.9 ttp -146.49 135.95 22.94 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.289 174.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 22.9 mt -108.68 132.42 53.94 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.749 0.309 . . . . 0.0 111.822 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.16 132.66 70.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.294 0.569 . . . . 0.0 110.692 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.8 m -110.29 141.28 23.58 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.491 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 89.4 Cg_endo -69.29 150.82 71.55 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.762 1.641 . . . . 0.0 109.437 177.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -66.99 107.72 2.35 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.565 0.698 . . . . 0.0 111.991 -175.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -76.02 102.49 5.67 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.9 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 64.71 175.26 0.2 Allowed 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.786 0.679 . . . . 0.0 111.103 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -107.69 121.08 43.98 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.621 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.8 132.34 4.5 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.68 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.533 ' ND1' ' HB3' ' A' ' 99' ' ' HIS . 61.2 t-80 -91.42 150.38 21.28 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -94.77 89.89 5.86 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.145 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 55.74 81.38 0.12 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.888 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.533 ' HB3' ' ND1' ' A' ' 96' ' ' HIS . 42.0 p-80 -100.38 -31.68 11.2 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.896 177.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 75.9 t60 57.93 -82.28 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 O-C-N 123.643 0.59 . . . . 0.0 110.771 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 . . . . . 0 C--O 1.245 0.832 0 C-N-CA 123.661 0.784 . . . . 0.0 111.295 179.403 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.0 t -122.49 132.54 70.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.2 mm -89.59 114.69 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.545 ' HB2' ' HD3' ' A' ' 37' ' ' LYS . 7.0 m-20 -73.23 109.58 6.87 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.851 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.423 HG12 ' HB2' ' A' ' 38' ' ' HIS . 97.7 mt -111.45 121.1 63.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 121.095 0.474 . . . . 0.0 110.176 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.439 ' HG3' ' CD1' ' A' ' 32' ' ' PHE . 75.1 mmtt -92.22 133.8 35.48 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.341 -173.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -102.75 102.89 13.08 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.589 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.1 mt -90.94 111.17 23.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.092 0.472 . . . . 0.0 109.85 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 88.3 tttt -85.26 137.67 32.83 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.988 -177.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.2 mt -126.8 175.98 7.61 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.648 -177.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.7 p -146.83 149.29 33.02 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.6 t -64.85 -42.95 96.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -80.8 63.04 5.05 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 174.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.7 tt -113.5 152.13 15.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.601 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.03 150.18 23.55 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -63.92 -36.47 84.04 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.764 0.316 . . . . 0.0 111.574 -177.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -62.88 -39.13 93.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.724 0.297 . . . . 0.0 111.154 178.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -64.99 -38.11 89.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.31 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.635 ' O ' HG23 ' A' ' 26' ' ' VAL . 95.5 mt -62.77 -46.86 95.31 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -60.59 -44.39 96.31 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.349 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -65.12 -49.24 70.73 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.123 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -65.54 -41.08 93.44 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 22' ' ' ILE . 59.6 t -63.19 -40.41 88.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.178 0.514 . . . . 0.0 109.984 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -59.75 -45.69 91.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.368 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.456 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 17.8 t-160 -65.43 -31.63 72.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.475 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.85 -31.78 67.0 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 178.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.34 -39.97 94.85 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.026 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.456 ' OE1' ' HA ' ' A' ' 28' ' ' HIS . 1.3 mp0 -54.29 -47.05 72.83 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.439 ' CD1' ' HG3' ' A' ' 9' ' ' LYS . 95.0 m-85 -68.28 -37.1 80.34 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.638 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.35 -42.21 98.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.378 0.608 . . . . 0.0 110.087 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' OE1' ' HG3' ' A' ' 92' ' ' LYS . 6.0 mm-40 -61.76 -29.89 70.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.12 178.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -73.91 -9.45 58.66 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.504 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.04 16.38 57.87 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.709 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.545 ' HD3' ' HB2' ' A' ' 7' ' ' ASP . 65.8 mttm -99.82 173.36 6.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.015 0.436 . . . . 0.0 111.37 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.514 ' NE2' HG23 ' A' ' 89' ' ' THR . 17.5 m170 -111.15 149.7 30.51 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.899 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.3 t -118.86 130.68 73.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -109.5 111.37 22.86 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.58 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 83.8 m-85 -85.01 119.5 25.47 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 29.2 mtm180 -125.08 132.79 53.1 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -177.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.454 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.8 p -125.15 132.18 71.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 120.956 0.408 . . . . 0.0 111.142 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.438 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 90.1 t80 -102.72 127.51 49.83 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.672 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.4 mt -90.16 111.01 22.01 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -83.88 88.45 7.12 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.9 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.07 153.39 0.62 Allowed Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.365 -0.834 . . . . 0.0 114.41 175.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 64.17 -64.58 0.14 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.351 1.06 . . . . 0.0 113.111 176.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -65.64 -11.75 47.42 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.649 0.78 . . . . 0.0 111.413 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 80.6 mtp -61.32 -28.96 69.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.449 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.67 -19.37 64.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.543 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.4 m -122.31 97.8 44.8 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-O 121.282 0.563 . . . . 0.0 111.156 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -63.33 -22.15 71.82 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 123.515 2.81 . . . . 0.0 112.521 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -60.81 -28.14 68.55 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.444 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.01 -43.24 95.37 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.887 0.375 . . . . 0.0 110.728 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.26 -39.04 92.1 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.754 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.6 t -62.83 -43.71 99.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 122.629 0.372 . . . . 0.0 110.715 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.68 -40.3 91.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.413 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 48.1 tp -63.42 -45.8 89.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.193 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.428 HD12 HG12 ' A' ' 84' ' ' VAL . 86.8 mt -66.05 -42.18 89.86 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.33 -33.08 74.75 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.269 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -60.5 -47.88 84.23 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.4 mt -66.08 -42.49 91.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.602 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 37.3 t-105 -54.84 -40.38 69.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.026 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.5 m -63.34 -23.16 67.29 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-O 121.106 0.479 . . . . 0.0 111.021 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 96.1 mtp -90.03 -35.59 15.41 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.451 ' CG2' HG13 ' A' ' 26' ' ' VAL . 40.2 pt -92.35 -6.34 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -175.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.93 -4.4 6.9 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -63.34 -46.06 88.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.125 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -121.26 -3.66 9.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.696 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -118.87 145.55 45.61 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.167 0.508 . . . . 0.0 111.718 -176.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -115.36 133.87 55.63 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.782 175.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -68.84 113.24 6.1 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 120.972 0.415 . . . . 0.0 111.993 -177.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -87.45 -40.83 14.0 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.813 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 58.2 tptt -134.19 136.43 43.72 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.775 -177.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -74.47 155.3 87.63 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.613 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 24.2 Cg_exo -61.05 139.6 85.29 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.599 1.533 . . . . 0.0 111.312 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -145.85 141.56 27.98 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.802 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -92.44 112.6 24.6 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -153.57 124.53 7.34 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.586 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.81 31.47 55.87 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 66.49 14.71 9.84 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.672 0.789 . . . . 0.0 112.536 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 37.3 m-85 -125.44 143.53 50.95 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.351 176.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.454 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 78.9 t -103.54 124.09 57.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 172.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.613 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 5.9 p30 -131.67 156.95 44.97 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.959 -0.697 . . . . 0.0 112.423 -173.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 54.5 ttp -142.67 135.62 28.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.528 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 12.4 mt -108.18 131.06 55.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.969 0.414 . . . . 0.0 111.198 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.2 m -124.69 138.67 53.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.777 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.514 HG23 ' NE2' ' A' ' 38' ' ' HIS . 11.2 m -109.43 135.32 20.31 Favored Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.471 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.98 143.8 37.05 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 C-N-CA 122.374 2.049 . . . . 0.0 110.963 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -83.07 9.22 10.81 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.354 0.597 . . . . 0.0 110.486 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.437 ' HG3' ' OE1' ' A' ' 34' ' ' GLU . 35.2 mmtp -101.73 36.34 2.09 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.869 -178.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.77 11.29 1.41 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.703 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -66.55 -43.91 83.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.833 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -157.37 133.15 3.44 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.315 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -87.03 -32.89 19.76 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 28.3 p80 41.84 42.95 2.39 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 114.849 -1.069 . . . . 0.0 113.09 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -75.45 141.94 43.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.208 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -62.12 95.05 0.06 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.041 0.448 . . . . 0.0 110.296 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -76.92 -47.29 21.45 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.262 -177.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 20.3 m80 . . . . . 0 C--N 1.313 -1.004 0 CA-C-O 117.963 -1.017 . . . . 0.0 109.757 178.358 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt . . . . . 0 N--CA 1.473 0.712 0 CA-C-O 121.255 0.55 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.4 p -76.51 150.85 6.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.315 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 88.0 mt -73.49 109.07 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.517 ' OD2' ' HE2' ' A' ' 9' ' ' LYS . 34.0 t70 -80.14 122.96 27.45 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.787 -177.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 88.4 mt -120.63 136.85 56.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.446 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.541 ' HE3' ' CE1' ' A' ' 32' ' ' PHE . 75.3 mmtt -98.24 136.47 38.39 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.904 -176.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.475 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 47.0 mt-10 -114.83 104.21 11.71 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.574 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.2 mt -90.21 103.6 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 121.753 0.787 . . . . 0.0 109.706 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.427 ' HE2' ' HB2' ' A' ' 44' ' ' PHE . 50.7 tttm -88.71 128.06 35.61 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.782 -177.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.502 HD21 ' HG3' ' A' ' 25' ' ' LYS . 74.4 mt -125.42 -178.55 4.27 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.713 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.424 ' HA ' HG23 ' A' ' 43' ' ' VAL . 58.4 p -141.68 161.58 37.58 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.78 0.324 . . . . 0.0 110.436 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.1 t -64.4 -25.93 39.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.192 0.52 . . . . 0.0 112.3 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -90.09 11.54 20.51 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.526 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.48 HD12 HD22 ' A' ' 13' ' ' LEU . 14.3 tt -68.24 152.73 9.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 CA-C-O 121.009 0.433 . . . . 0.0 111.163 -178.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.35 154.65 18.43 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.421 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -63.6 -34.21 77.31 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.765 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -64.16 -38.4 90.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.863 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -66.62 -36.87 83.63 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.895 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.6 mt -61.73 -43.74 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.555 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -60.42 -42.31 95.78 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.195 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -69.46 -39.54 77.69 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.452 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.502 ' HG3' HD21 ' A' ' 13' ' ' LEU . 48.6 mmtm -63.39 -42.16 98.78 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.595 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 4.4 m -63.66 -34.13 65.96 Favored 'Isoleucine or valine' 0 C--N 1.342 0.275 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.177 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -63.48 -39.7 95.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.723 0.297 . . . . 0.0 110.686 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -64.7 -40.66 95.75 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.157 0.503 . . . . 0.0 110.278 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.659 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -61.66 -39.13 90.28 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.768 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 26' ' ' VAL . 93.1 mt -61.43 -40.35 94.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.699 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 46.0 mt-10 -58.44 -47.06 85.21 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.799 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.541 ' CE1' ' HE3' ' A' ' 9' ' ' LYS . 94.2 m-85 -71.35 -32.37 68.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.951 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.659 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 90.2 mt -62.23 -43.27 99.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.45 0.643 . . . . 0.0 109.817 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -62.6 -30.72 71.55 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.979 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 80.4 mt-30 -73.54 -10.12 59.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.726 178.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.38 7.44 65.28 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.15 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.4 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 88.5 mttt -91.23 178.24 6.03 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.162 0.506 . . . . 0.0 110.323 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.496 ' NE2' HG23 ' A' ' 89' ' ' THR . 23.7 m170 -117.24 150.76 38.24 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.914 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.0 t -117.53 128.58 74.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.079 0.466 . . . . 0.0 110.046 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.475 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 51.8 ttt180 -109.26 115.9 30.87 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.528 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 76.2 m-85 -90.15 113.92 25.78 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -117.09 134.62 54.53 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.512 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.7 p -118.77 130.59 73.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-O 121.211 0.529 . . . . 0.0 111.462 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.427 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 91.2 t80 -94.63 125.22 39.15 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.394 177.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.474 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 51.6 mt -91.59 129.03 37.63 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -62.39 -48.23 80.63 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.27 -44.96 0.17 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 119.941 -1.123 . . . . 0.0 113.329 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -90.96 -19.27 23.44 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 117.168 0.484 . . . . 0.0 111.471 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.474 ' HG2' ' HB3' ' A' ' 45' ' ' LEU . 1.6 pm0 -79.54 2.66 21.35 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.597 0.713 . . . . 0.0 109.583 175.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 61.2 mtt -82.43 -133.93 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.337 175.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 61.06 -61.06 0.08 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.312 0.645 . . . . 0.0 111.249 -173.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 t -121.85 133.82 24.44 Favored Pre-proline 0 N--CA 1.437 -1.103 0 C-N-CA 123.566 0.746 . . . . 0.0 109.431 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.87 -8.89 23.88 Favored 'Trans proline' 0 C--N 1.331 -0.385 0 C-N-CA 123.425 2.75 . . . . 0.0 113.487 -176.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.88 -30.14 68.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.26 96.03 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.86 0.362 . . . . 0.0 110.465 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.29 -39.88 87.67 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.18 -42.47 94.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.531 -0.334 . . . . 0.0 110.436 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.81 -40.87 76.77 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.293 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.9 tp -62.4 -45.84 91.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.245 0.545 . . . . 0.0 109.993 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.414 ' CD1' HG12 ' A' ' 84' ' ' VAL . 89.3 mt -64.76 -41.09 96.16 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.891 -177.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -60.37 -39.41 87.12 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.309 0.575 . . . . 0.0 110.992 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -63.8 -41.18 97.96 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.105 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.2 mt -70.04 -46.23 73.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.065 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 41.7 t-105 -57.75 -41.4 81.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.322 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.8 p -62.8 -24.69 67.87 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 98.4 mtp -75.78 -34.43 60.22 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.9 pt -107.76 -6.89 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -56.32 -23.08 34.76 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -64.41 -39.19 93.36 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -121.13 6.51 10.27 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.45 146.29 50.54 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.945 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -114.31 147.72 38.66 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.0 ptt-85 -81.16 127.63 32.88 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.418 ' CB ' HD12 ' A' ' 87' ' ' LEU . 23.5 t70 -74.12 -35.54 64.13 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.384 0.611 . . . . 0.0 109.782 176.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -161.43 172.22 16.86 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.063 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -77.4 152.59 81.41 Favored Pre-proline 0 C--N 1.311 -1.073 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -61.58 140.64 87.99 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.686 1.591 . . . . 0.0 110.57 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -140.88 165.6 27.08 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.495 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -101.96 113.57 26.92 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.991 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -114.39 113.07 24.02 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.56 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.52 -93.08 0.16 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.497 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -133.94 11.37 3.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.142 0.496 . . . . 0.0 110.492 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -118.27 140.72 49.39 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.863 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.512 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 55.9 t -100.81 127.28 54.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 172.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.528 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 7.2 p30 -134.3 153.84 51.65 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 119.353 -0.939 . . . . 0.0 113.078 -174.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.402 ' HB2' HD13 ' A' ' 60' ' ' LEU . 53.0 ttp -140.55 138.15 34.29 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.817 177.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.418 HD12 ' CB ' ' A' ' 74' ' ' ASP . 2.9 tm? -109.89 126.93 54.38 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.1 m -112.83 134.1 56.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.385 0.612 . . . . 0.0 110.896 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.496 HG23 ' NE2' ' A' ' 38' ' ' HIS . 13.3 m -113.56 139.29 23.16 Favored Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.218 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.582 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 69.2 Cg_endo -66.82 142.35 62.78 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.35 2.033 . . . . 0.0 110.541 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -78.12 137.17 38.06 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.334 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -80.67 130.91 35.37 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.482 178.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.23 -46.53 83.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.937 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -167.05 -61.83 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.5 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 155.45 76.94 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.999 -0.619 . . . . 0.0 111.894 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -77.25 144.15 38.41 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -100.81 154.14 18.89 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.465 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -64.51 106.58 1.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.175 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -70.43 171.88 9.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.051 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -68.14 128.2 35.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.173 0.511 . . . . 0.0 111.493 -176.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 . . . . . 0 C--N 1.315 -0.93 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.777 178.553 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 65.6 pttt . . . . . 0 N--CA 1.446 -0.663 0 CA-C-O 120.831 0.348 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.3 t -103.21 133.86 45.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.5 mm -73.4 125.12 31.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.951 0.405 . . . . 0.0 110.288 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.539 ' HB2' ' HD3' ' A' ' 37' ' ' LYS . 22.2 m-20 -84.64 137.27 33.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.015 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 90.7 mt -129.16 129.55 67.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -101.46 135.77 42.42 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.789 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.466 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 58.3 mt-10 -104.38 112.28 25.26 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.896 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.4 mt -97.73 111.74 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 87.8 tttt -98.14 136.01 38.98 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.545 -175.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.554 HD22 HD11 ' A' ' 63' ' ' ILE . 5.2 mp -131.77 179.93 5.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.119 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.7 p -138.98 156.54 47.15 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.97 -25.01 37.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.437 0.637 . . . . 0.0 111.247 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -104.61 22.29 15.29 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.988 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.1 tt -74.37 147.72 8.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.949 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.46 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -75.25 155.22 36.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.74 -177.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 -62.7 -38.75 91.65 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.166 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -61.06 -41.14 96.07 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.563 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 21.1 m-20 -64.75 -38.84 92.35 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.394 177.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 18' ' ' ALA . 68.6 mt -61.95 -45.67 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-O 121.075 0.464 . . . . 0.0 110.703 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -60.08 -41.73 93.1 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.818 0.818 . . . . 0.0 110.323 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -61.97 -44.2 97.25 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.377 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 75.1 mmtt -64.06 -44.76 91.44 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.469 HG11 ' HB2' ' A' ' 66' ' ' MET . 4.7 m -67.9 -32.87 58.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.613 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -62.37 -45.47 93.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.096 0.474 . . . . 0.0 109.809 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -70.9 -32.53 69.51 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.191 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.595 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -55.85 -45.97 78.33 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.269 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.37 -40.41 96.36 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.79 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 52.2 mt-10 -57.14 -48.54 78.43 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 120.785 0.326 . . . . 0.0 111.159 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -68.76 -36.24 78.09 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 95.8 mt -63.04 -44.28 96.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.438 0.637 . . . . 0.0 110.428 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -57.88 -32.28 67.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.441 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 80.3 mt-30 -75.21 -7.36 53.66 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.281 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.68 15.75 56.1 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.021 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.539 ' HD3' ' HB2' ' A' ' 7' ' ' ASP . 31.1 mtmm -103.02 168.58 9.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.487 0.66 . . . . 0.0 112.306 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.407 ' NE2' HG23 ' A' ' 89' ' ' THR . 3.3 m80 -102.92 145.9 29.13 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.326 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.9 t -115.4 129.24 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.697 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.466 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 42.4 ttm180 -109.81 113.0 25.39 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 83.1 m-85 -89.89 124.29 34.57 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 73.0 mtp180 -128.22 135.53 49.82 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.513 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.7 p -118.88 131.95 70.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-O 121.18 0.514 . . . . 0.0 111.24 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -96.26 126.36 41.42 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.576 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 50' ' ' MET . 31.9 mt -92.31 114.0 26.43 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -95.16 119.84 34.37 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.866 0.365 . . . . 0.0 111.518 -174.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.2 -140.73 15.08 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -91.88 13.67 17.78 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.273 0.558 . . . . 0.0 110.43 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.422 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 71.8 mt-10 -62.35 -21.99 65.74 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.65 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.453 ' HA ' HD12 ' A' ' 45' ' ' LEU . 65.5 mtt -67.4 -11.3 57.42 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.969 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.94 -28.3 69.73 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.151 0.501 . . . . 0.0 110.515 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.4 m -130.87 99.63 18.11 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-O 121.23 0.538 . . . . 0.0 110.843 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -60.46 -22.81 73.1 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 123.529 2.82 . . . . 0.0 112.897 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -61.65 -22.38 65.23 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.749 0.309 . . . . 0.0 110.827 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.81 -40.6 95.84 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.048 0.451 . . . . 0.0 109.856 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.83 -38.55 93.07 Favored Glycine 0 CA--C 1.506 -0.488 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.382 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.411 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 88.1 t -63.33 -44.44 99.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.439 -0.381 . . . . 0.0 110.508 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.31 -41.2 88.47 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.38 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.0 tp -63.93 -45.63 88.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.355 0.598 . . . . 0.0 110.356 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.494 HD23 HD12 ' A' ' 63' ' ' ILE . 81.7 mt -64.53 -41.13 96.57 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.416 -177.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 57' ' ' VAL . 11.9 mm-40 -63.7 -34.26 77.46 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.539 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -62.04 -41.9 98.61 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.554 HD11 HD22 ' A' ' 13' ' ' LEU . 96.4 mt -63.75 -44.32 98.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.281 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -59.72 -36.91 77.52 Favored 'General case' 0 C--O 1.213 -0.83 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.779 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.4 m -57.82 -33.78 68.96 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.306 0.574 . . . . 0.0 110.325 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.469 ' HB2' HG11 ' A' ' 26' ' ' VAL . 97.8 mmm -76.85 -32.73 57.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.603 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.621 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 41.1 pt -117.96 15.84 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -174.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -62.61 -22.48 66.43 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.774 0.797 . . . . 0.0 110.291 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.443 HD22 ' HG3' ' A' ' 70' ' ' GLU . 4.5 p-10 -97.58 141.34 30.74 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 173.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.443 ' HG3' HD22 ' A' ' 69' ' ' ASN . 35.4 mt-10 74.9 -13.89 0.79 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.597 0.759 . . . . 0.0 111.842 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 67' ' ' ILE . . . -129.71 150.79 50.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.661 0.267 . . . . 0.0 110.4 177.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -116.47 149.25 39.82 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -87.57 106.31 17.92 Favored 'General case' 0 N--CA 1.412 -2.368 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.658 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -80.74 -41.14 24.03 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.002 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -137.32 136.8 38.3 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.14 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.42 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 0.3 OUTLIER -80.98 151.92 70.99 Favored Pre-proline 0 N--CA 1.442 -0.87 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 17.4 Cg_endo -56.29 131.1 43.75 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.463 2.109 . . . . 0.0 112.339 -177.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.427 ' ND2' ' HG3' ' A' ' 80' ' ' GLU . 3.1 p-10 -147.09 165.5 29.74 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.415 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.504 ' CZ ' ' HA ' ' A' ' 82' ' ' ARG . 84.6 t80 -93.83 123.32 37.1 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.844 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.427 ' HG3' ' ND2' ' A' ' 78' ' ' ASN . 38.4 mt-10 -146.77 120.07 8.96 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.48 178.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.447 ' O ' ' HD1' ' A' ' 83' ' ' TYR . . . 64.94 38.73 95.85 Favored Glycine 0 C--O 1.221 -0.696 0 CA-C-N 115.951 -0.568 . . . . 0.0 113.945 175.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.504 ' HA ' ' CZ ' ' A' ' 79' ' ' PHE . 75.2 mtt180 74.96 0.91 3.66 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.492 0.717 . . . . 0.0 111.228 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.447 ' HD1' ' O ' ' A' ' 81' ' ' GLY . 82.2 m-85 -117.38 149.17 40.97 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.891 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.513 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 70.3 t -105.2 128.09 59.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 173.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.529 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 9.2 p30 -133.11 161.44 34.4 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -173.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.445 ' CE ' ' HB3' ' A' ' 60' ' ' LEU . 13.8 ttm -143.71 146.01 32.85 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.217 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 16.2 mt -115.33 129.39 56.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.767 0.318 . . . . 0.0 111.238 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.7 132.46 70.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.85 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.41 ' CG2' ' HD2' ' A' ' 90' ' ' PRO . 15.2 m -104.95 141.2 22.04 Favored Pre-proline 0 C--N 1.309 -1.174 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.431 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 33.8 Cg_endo -61.38 147.21 96.1 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 121.949 1.766 . . . . 0.0 110.579 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -57.1 135.49 56.35 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.2 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -79.36 177.15 9.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.917 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.43 150.83 45.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.06 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -67.58 151.19 47.75 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.294 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.26 -32.92 85.36 Favored Glycine 0 CA--C 1.519 0.31 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.525 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 72.78 -67.17 0.28 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.529 0.732 . . . . 0.0 110.833 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -130.27 142.28 50.56 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -79.47 90.5 5.07 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -113.73 -8.24 13.24 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.236 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -108.21 117.87 35.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.187 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 C--O 1.246 0.909 0 CA-C-O 118.529 -0.748 . . . . 0.0 110.57 -178.246 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 N--CA 1.448 -0.545 0 CA-C-O 120.989 0.423 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -116.99 136.19 54.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.435 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 78.2 mt -70.99 102.47 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.099 0.476 . . . . 0.0 110.347 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.416 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 25.2 t70 -79.59 132.71 36.35 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.867 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.427 HG23 ' O ' ' A' ' 38' ' ' HIS . 92.7 mt -115.56 132.2 65.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.343 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -92.37 155.32 17.98 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.564 0.697 . . . . 0.0 111.126 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.585 ' CD ' HH21 ' A' ' 40' ' ' ARG . 43.4 mt-10 -125.74 114.35 18.52 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.972 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.5 mt -100.67 108.55 23.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -85.49 142.6 29.08 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.841 -176.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.0 mt -129.65 166.9 18.84 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.69 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.0 m -139.2 150.04 45.1 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 176.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.2 t -61.6 -43.89 97.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.309 0.576 . . . . 0.0 110.779 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -93.62 68.03 3.98 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.566 0.698 . . . . 0.0 110.797 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.431 HD11 ' HE2' ' A' ' 25' ' ' LYS . 18.3 tt -117.59 149.77 19.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.68 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.06 142.27 54.56 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.706 0.289 . . . . 0.0 110.874 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -62.96 -39.0 93.33 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.824 0.345 . . . . 0.0 111.32 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -61.8 -39.95 93.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.15 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.584 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 28.1 t70 -65.91 -38.23 88.15 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.024 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.87 -45.29 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.807 0.813 . . . . 0.0 109.47 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -65.39 -28.82 69.53 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.134 -1.393 . . . . 0.0 110.694 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -78.77 -40.77 32.32 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.161 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 21' ' ' ASP . 57.8 mttm -65.55 -38.94 91.06 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 m -59.59 -32.61 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.2 tttt -63.26 -42.24 99.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.852 0.358 . . . . 0.0 110.117 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -68.36 -38.53 81.52 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.52 176.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.415 ' O ' HD13 ' A' ' 33' ' ' LEU . . . -57.72 -44.17 85.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.28 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.446 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 88.2 mt -62.32 -34.66 77.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.82 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -56.22 -41.64 75.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.274 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -67.85 -37.14 81.49 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.935 0.398 . . . . 0.0 111.08 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.43 ' CB ' ' HB3' ' A' ' 90' ' ' PRO . 11.0 mp -63.09 -42.56 99.63 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.445 0.64 . . . . 0.0 110.423 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 30' ' ' LEU . 66.7 mm-40 -61.75 -22.8 65.71 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.993 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -87.74 -6.03 58.38 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.802 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.66 27.49 26.82 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.614 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.416 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 66.2 mttm -115.29 176.26 5.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.248 0.547 . . . . 0.0 111.311 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.427 ' O ' HG23 ' A' ' 8' ' ' ILE . 5.6 m80 -111.13 147.11 35.58 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.163 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.6 t -115.3 126.65 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.585 HH21 ' CD ' ' A' ' 10' ' ' GLU . 45.1 ttp180 -101.51 111.71 24.03 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -87.88 121.65 30.55 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.495 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 83.1 mtp180 -131.96 120.08 21.98 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.63 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 4.3 p -111.4 131.67 62.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.199 0.523 . . . . 0.0 111.53 -176.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.423 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 88.9 t80 -98.34 130.78 45.0 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.618 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' A' ' 50' ' ' MET . 40.7 mt -89.93 122.52 33.04 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -107.32 114.12 27.95 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.178 0.513 . . . . 0.0 111.674 -174.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.52 -143.86 15.97 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.485 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -83.18 4.86 24.88 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.154 0.502 . . . . 0.0 111.015 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -65.72 -25.75 67.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.153 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.523 ' HA ' HD12 ' A' ' 45' ' ' LEU . 49.2 ttm -59.46 -24.34 63.48 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.462 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.9 -25.61 67.96 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.321 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.9 p -126.69 101.55 26.78 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 121.303 0.573 . . . . 0.0 110.741 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.3 -15.36 38.75 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.446 2.764 . . . . 0.0 112.631 -177.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -61.69 -26.14 67.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.811 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.67 90.59 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.036 0.446 . . . . 0.0 110.119 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.437 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -67.03 -38.67 92.81 Favored Glycine 0 CA--C 1.505 -0.563 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.584 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.412 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 93.5 t -63.13 -45.85 97.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.571 -0.315 . . . . 0.0 110.947 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.37 -40.76 92.0 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.198 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.2 tp -63.2 -45.69 90.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.183 0.516 . . . . 0.0 110.289 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.442 HD13 ' HB2' ' A' ' 86' ' ' MET . 97.6 mt -65.17 -40.56 94.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.907 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 57' ' ' VAL . 46.6 mt-10 -62.55 -39.13 92.64 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.016 0.436 . . . . 0.0 110.471 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -62.64 -43.67 98.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.019 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.0 mt -67.35 -43.31 87.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.684 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.523 ' CZ2' ' HB2' ' A' ' 73' ' ' ARG . 41.9 t-105 -55.86 -41.16 73.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.281 -178.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 36.0 p -63.5 -29.13 70.45 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.256 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 66.0 mtt -67.66 -41.2 84.15 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.738 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.8 pt -106.52 -1.43 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -174.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -54.09 -32.0 53.54 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -176.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.554 ' ND2' ' HG2' ' A' ' 70' ' ' GLU . 4.9 p-10 -77.26 -14.74 59.7 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.554 ' HG2' ' ND2' ' A' ' 69' ' ' ASN . 58.6 mm-40 -117.71 -15.4 10.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.265 0.555 . . . . 0.0 111.203 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -124.16 155.57 38.25 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.788 -176.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -112.88 139.11 48.8 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 176.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.523 ' HB2' ' CZ2' ' A' ' 64' ' ' TRP . 71.0 ttp85 -87.28 112.3 21.91 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -177.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -70.97 -37.2 72.76 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.903 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -160.85 161.56 31.94 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.87 152.97 95.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.458 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 22.4 Cg_endo -61.16 139.41 83.66 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.165 1.91 . . . . 0.0 111.398 177.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -140.29 148.39 41.35 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.412 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -91.76 107.7 19.39 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.219 0.533 . . . . 0.0 110.156 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -114.84 116.05 27.96 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.513 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.4 -104.71 1.56 Allowed Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 120.363 -0.922 . . . . 0.0 110.92 -177.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -127.56 10.54 6.68 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.05 0.453 . . . . 0.0 110.324 178.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 81.2 m-85 -121.52 145.31 48.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.299 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.63 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 86.5 t -97.46 119.05 45.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 172.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.495 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 78.5 m-20 -111.25 144.08 40.99 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.081 -171.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.442 ' HB2' HD13 ' A' ' 60' ' ' LEU . 15.5 tmm? -147.05 137.75 23.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.746 175.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.2 mt -114.65 134.29 55.18 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.1 m -117.09 131.29 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.219 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.41 HG23 ' NE2' ' A' ' 38' ' ' HIS . 15.8 m -104.83 137.7 19.29 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.43 ' HB3' ' CB ' ' A' ' 33' ' ' LEU . 57.9 Cg_endo -64.47 148.34 90.66 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.429 2.086 . . . . 0.0 111.632 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 69' ' ' ASN . 36.7 mttp -70.26 98.87 1.44 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.925 0.393 . . . . 0.0 111.629 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -136.61 145.87 45.39 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.68 177.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -105.87 94.25 5.08 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 174.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -75.95 93.84 3.3 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.394 0.616 . . . . 0.0 112.298 -176.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -129.31 48.26 0.98 Allowed Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.8 m-70 -92.39 169.82 10.26 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -71.06 -100.99 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 51.71 23.01 1.81 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -60.76 -41.03 94.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.204 0.526 . . . . 0.0 110.19 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -94.89 91.18 6.3 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.313 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 . . . . . 0 C--N 1.307 -1.282 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.898 -178.191 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 66.2 tttm . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 p -71.19 141.22 17.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 87.2 mt -79.94 115.14 21.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -84.01 108.58 17.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.036 0.446 . . . . 0.0 110.57 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.9 mt -89.32 133.57 31.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.015 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -94.01 143.79 26.05 Favored 'General case' 0 CA--C 1.492 -1.288 0 CA-C-O 121.428 0.632 . . . . 0.0 111.167 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.615 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 91.1 mt-10 -120.49 126.28 49.98 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.945 178.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.9 mt -110.46 117.77 55.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 12.3 mptt -97.51 139.76 32.96 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.186 0.517 . . . . 0.0 112.161 -177.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mp -130.22 177.17 7.52 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.192 176.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.6 m -135.05 154.08 51.82 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.9 t -63.3 -33.09 59.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.257 0.551 . . . . 0.0 110.059 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -106.9 74.59 1.0 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.967 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.4 tt -130.39 160.84 41.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.969 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.418 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -73.85 142.62 46.08 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -38.39 90.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.055 0.455 . . . . 0.0 109.987 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -61.88 -41.22 97.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.596 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.71 ' OD2' ' HE2' ' A' ' 25' ' ' LYS . 6.1 t70 -65.58 -36.49 83.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.679 -178.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.647 ' O ' HG23 ' A' ' 26' ' ' VAL . 68.4 mt -60.98 -46.62 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -59.14 -43.19 92.01 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.517 0.675 . . . . 0.0 110.571 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -61.66 -46.11 91.13 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.022 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.71 ' HE2' ' OD2' ' A' ' 21' ' ' ASP . 68.8 mttm -65.38 -40.89 94.04 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.756 0.312 . . . . 0.0 111.769 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 22' ' ' ILE . 55.8 t -61.57 -39.71 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.611 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -56.08 -39.65 72.42 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.534 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 20.9 m80 -64.35 -38.24 90.35 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.989 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.614 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -60.86 -38.58 86.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.726 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.68 -39.1 90.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.99 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 6.1 mm-40 -59.58 -50.64 73.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.057 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -64.75 -34.84 79.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.518 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.649 HD13 ' HB2' ' A' ' 71' ' ' ALA . 96.1 mt -62.75 -43.72 98.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.292 0.568 . . . . 0.0 110.474 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -67.14 -26.73 66.81 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.915 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 78.9 mt-30 -77.67 -7.65 56.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.902 178.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.63 22.52 50.1 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.908 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -103.71 158.83 16.11 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.994 0.426 . . . . 0.0 110.298 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -98.35 138.66 35.27 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.512 176.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.3 t -112.15 128.18 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.615 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 67.2 ttt180 -108.51 112.76 25.31 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 176.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -86.9 117.97 25.98 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 81.8 mtp180 -125.65 138.78 53.92 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.572 -177.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.606 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.1 p -126.61 135.66 63.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.014 0.435 . . . . 0.0 111.076 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -101.14 132.35 46.65 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.707 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.56 ' HB2' ' SD ' ' A' ' 50' ' ' MET . 29.1 mt -90.33 111.99 23.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.024 0.44 . . . . 0.0 109.852 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -104.27 123.21 46.95 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.58 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.45 -147.42 16.33 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.209 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -89.07 15.28 8.97 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.224 0.535 . . . . 0.0 110.02 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -73.86 -11.75 60.46 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.193 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.56 ' SD ' ' HB2' ' A' ' 45' ' ' LEU . 95.6 mmm -61.23 -35.92 78.54 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.276 -176.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.74 -21.22 65.65 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.486 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.0 p -119.71 94.94 48.97 Favored Pre-proline 0 N--CA 1.446 -0.64 0 CA-C-O 121.143 0.497 . . . . 0.0 111.839 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -64.4 -23.62 64.99 Favored 'Trans proline' 0 N--CA 1.477 0.552 0 C-N-CA 123.349 2.7 . . . . 0.0 111.26 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.94 -22.13 66.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.74 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.87 97.04 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.927 0.394 . . . . 0.0 110.519 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.42 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -68.37 -39.32 87.58 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.905 177.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.427 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 97.3 t -63.41 -44.98 99.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.648 0.261 . . . . 0.0 111.018 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.99 -40.94 95.43 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.16 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.3 tp -63.15 -45.15 93.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.192 0.52 . . . . 0.0 110.001 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.488 HD12 HG12 ' A' ' 84' ' ' VAL . 63.1 mt -65.76 -37.75 87.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.767 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 57' ' ' VAL . 56.3 mt-10 -55.69 -42.23 74.89 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.621 0.248 . . . . 0.0 110.583 177.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -61.89 -43.53 98.65 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.06 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.473 ' O ' HG12 ' A' ' 67' ' ' ILE . 65.1 mt -62.39 -45.32 99.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.826 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.477 ' CZ2' ' HB2' ' A' ' 73' ' ' ARG . 45.6 t-105 -57.6 -40.96 80.26 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.072 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.405 ' HA ' ' OE2' ' A' ' 68' ' ' GLU . 25.2 m -63.22 -25.69 68.45 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 121.126 0.489 . . . . 0.0 110.581 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 95.6 mtp -89.47 -43.3 10.94 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.888 0.375 . . . . 0.0 111.799 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.474 HG12 ' HA ' ' A' ' 64' ' ' TRP . 40.5 pt -81.44 -18.35 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -174.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.405 ' OE2' ' HA ' ' A' ' 65' ' ' THR . 14.6 pt-20 -58.8 -15.42 12.22 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.102 0.477 . . . . 0.0 111.863 -177.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -63.17 -40.71 98.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.668 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -116.48 -9.71 11.39 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.532 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.649 ' HB2' HD13 ' A' ' 33' ' ' LEU . . . -121.9 160.3 25.06 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.642 ' OD1' ' HG2' ' A' ' 91' ' ' LYS . 11.3 m-20 -116.08 156.89 25.57 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.732 176.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.477 ' HB2' ' CZ2' ' A' ' 64' ' ' TRP . 69.3 ttt180 -85.4 106.5 16.82 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.006 -176.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -82.25 -36.77 26.8 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.027 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -160.18 160.03 32.35 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.851 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.449 ' HB3' HH21 ' A' ' 73' ' ' ARG . 9.7 pt-20 -84.78 155.75 61.57 Favored Pre-proline 0 C--N 1.316 -0.868 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 16.1 Cg_endo -57.1 132.7 53.03 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.474 2.116 . . . . 0.0 111.788 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -127.75 134.04 49.52 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.347 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -82.28 113.66 20.24 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -127.34 114.86 18.13 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.234 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.39 -105.81 1.68 Allowed Glycine 0 N--CA 1.428 -1.888 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.687 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -121.31 7.73 10.2 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.209 0.528 . . . . 0.0 110.445 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -123.47 149.58 44.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.996 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.606 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 69.7 t -108.93 126.29 65.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 173.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 6.5 m-80 -124.06 139.04 54.33 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.492 -0.483 . . . . 0.0 112.124 -172.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.423 ' HB2' HD13 ' A' ' 60' ' ' LEU . 63.2 ttp -130.01 128.99 43.12 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -108.27 127.22 53.66 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.969 0.414 . . . . 0.0 110.031 -178.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.431 HG11 ' CD1' ' A' ' 67' ' ' ILE . 20.6 m -123.18 145.43 30.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.042 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.1 m -115.42 135.43 22.59 Favored Pre-proline 0 C--N 1.303 -1.414 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.125 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.422 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 55.5 Cg_endo -64.17 152.52 80.83 Favored 'Trans proline' 0 C--N 1.329 -0.481 0 C-N-CA 122.319 2.013 . . . . 0.0 110.054 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.642 ' HG2' ' OD1' ' A' ' 72' ' ' ASN . 68.6 mttm -60.91 96.6 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -174.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -71.94 -34.61 69.16 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.987 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 73.87 149.66 0.1 Allowed 'General case' 0 N--CA 1.468 0.445 0 O-C-N 124.038 0.836 . . . . 0.0 111.544 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -78.31 -61.38 2.02 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.64 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 65.94 88.19 0.06 OUTLIER Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.034 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -72.84 143.48 47.82 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.855 0.36 . . . . 0.0 111.153 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -103.16 18.38 21.87 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.577 0.704 . . . . 0.0 109.154 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -87.53 167.78 13.65 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.263 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -70.48 155.62 40.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.441 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -61.4 123.67 18.45 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 . . . . . 0 C--N 1.316 -0.89 0 CA-C-O 118.53 -0.748 . . . . 0.0 110.267 -178.858 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.708 0.289 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.2 t -78.43 -4.15 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.649 0.738 . . . . 0.0 110.931 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.6 mm -67.96 144.8 14.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.182 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -64.62 118.71 9.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.875 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 88.7 mt -104.22 133.49 48.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.387 0.613 . . . . 0.0 111.38 -176.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -96.13 149.59 21.46 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.833 -175.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -119.88 137.48 53.99 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.185 0.517 . . . . 0.0 111.272 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.8 mm -110.21 114.85 48.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -90.21 141.74 28.41 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.309 0.576 . . . . 0.0 111.321 -176.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.47 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 49.4 mt -133.46 165.99 23.58 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.597 -176.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.5 p -140.82 152.3 45.05 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.7 t -62.79 -33.74 61.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.325 0.583 . . . . 0.0 109.551 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -93.55 73.2 4.39 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.575 176.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.8 tt -126.34 145.58 33.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.515 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.77 142.55 53.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.292 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.446 HE22 ' HD3' ' A' ' 62' ' ' LYS . 62.2 tp60 -62.98 -38.33 90.71 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.305 0.574 . . . . 0.0 110.505 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -62.5 -38.25 89.18 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.952 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -64.96 -36.1 83.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.602 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 94.2 mt -61.73 -42.74 95.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.424 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 6.4 m-20 -60.15 -41.11 92.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.515 178.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -68.63 -40.5 80.3 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.8 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -60.81 -42.4 97.58 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.57 HG12 HG23 ' A' ' 63' ' ' ILE . 13.2 m -64.04 -35.97 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.316 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 23' ' ' ASN . 99.1 mttt -62.54 -42.67 99.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.411 0.624 . . . . 0.0 109.49 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -65.94 -41.6 91.12 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.218 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.432 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -64.03 -38.94 92.91 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.299 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.0 mt -61.36 -38.48 87.12 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.263 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 57.9 mt-10 -57.69 -42.85 84.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.683 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.442 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 80.1 m-85 -74.63 -37.19 62.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.873 0.368 . . . . 0.0 111.798 177.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 92.4 mt -62.84 -43.43 98.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.599 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -63.4 -22.88 67.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.919 0.39 . . . . 0.0 111.183 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 32' ' ' PHE . 78.1 mt-30 -71.17 -34.95 71.4 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.364 175.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.27 -0.3 12.85 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.268 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -88.13 164.81 15.51 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.56 151.25 20.86 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.652 -176.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.5 t -119.18 130.01 74.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.223 0.535 . . . . 0.0 110.315 175.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -103.33 114.53 28.88 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 85.9 m-85 -92.3 120.0 32.42 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.584 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.739 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 78.5 mtp85 -122.37 118.81 29.32 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.623 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.5 p -115.68 128.89 72.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.321 0.581 . . . . 0.0 110.931 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -95.58 121.38 37.22 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.817 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.4 mt -79.55 143.71 34.57 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -130.92 137.72 49.44 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.961 -0.295 . . . . 0.0 110.344 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.87 -147.07 33.11 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.102 -0.57 . . . . 0.0 113.576 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.444 ' O ' ' HD2' ' A' ' 48' ' ' ARG . 2.6 tmm_? -59.64 -35.85 75.21 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.909 0.884 . . . . 0.0 110.415 -177.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -54.18 -16.5 2.11 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 84.5 mtp -63.23 -34.08 76.89 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.073 0.463 . . . . 0.0 110.848 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.13 -33.53 73.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.232 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.428 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 68.4 p -117.11 105.25 49.41 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-O 121.097 0.475 . . . . 0.0 111.911 -177.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.63 -15.29 45.3 Favored 'Trans proline' 0 N--CA 1.485 0.998 0 C-N-CA 124.014 3.142 . . . . 0.0 113.14 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.428 ' HG2' ' HB ' ' A' ' 52' ' ' THR . 14.5 pt-20 -54.82 -31.26 58.96 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.585 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.08 -42.22 99.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.913 0.387 . . . . 0.0 111.102 -178.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.485 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -67.69 -41.32 89.49 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.749 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.4 t -63.66 -45.95 96.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.583 -0.309 . . . . 0.0 111.177 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.38 -38.5 87.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.769 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.405 HD21 ' HB3' ' A' ' 13' ' ' LEU . 39.2 tp -63.55 -45.88 88.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.288 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.51 ' CD1' HG12 ' A' ' 84' ' ' VAL . 94.2 mt -65.58 -40.74 93.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.14 -178.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -62.22 -33.99 75.62 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.776 0.322 . . . . 0.0 111.269 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HD3' HE22 ' A' ' 19' ' ' GLN . 40.7 ttmt -62.11 -47.71 83.41 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-O 121.146 0.498 . . . . 0.0 109.688 176.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.57 HG23 HG12 ' A' ' 26' ' ' VAL . 70.8 mt -63.75 -43.06 97.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.047 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -56.66 -36.56 69.69 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.479 177.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.52 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 96.7 m -59.63 -44.38 93.5 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 120.988 0.423 . . . . 0.0 110.829 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -67.17 -39.55 86.46 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 63' ' ' ILE . 41.6 pt -98.37 -5.59 9.43 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.639 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -173.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 65' ' ' THR . 13.0 pt-20 -56.05 -34.86 66.3 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -176.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.413 ' ND2' ' HG3' ' A' ' 70' ' ' GLU . 3.3 p-10 -69.63 -18.77 63.62 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.413 ' HG3' ' ND2' ' A' ' 69' ' ' ASN . 43.3 mt-10 -123.44 -1.37 8.6 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.931 0.396 . . . . 0.0 111.76 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -131.87 153.75 49.89 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.965 -177.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -111.71 144.23 41.32 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -81.71 111.86 18.36 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -176.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -66.45 -41.76 88.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.194 0.521 . . . . 0.0 109.872 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -163.66 161.18 23.53 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.264 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -74.6 152.93 87.49 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.495 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.34 134.89 64.47 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.714 2.276 . . . . 0.0 111.884 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -135.5 137.77 42.45 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.689 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -90.69 106.78 18.74 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.166 0.507 . . . . 0.0 110.564 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -118.14 118.74 32.71 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.424 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.64 -108.93 2.67 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -123.33 8.77 9.1 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.974 0.416 . . . . 0.0 110.611 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -122.8 141.4 51.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.405 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.623 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 89.3 t -97.38 115.86 38.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 173.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.739 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 47.5 m-80 -108.52 144.16 36.56 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.195 -173.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.496 ' HB2' HD13 ' A' ' 60' ' ' LEU . 65.0 ttp -144.99 134.98 23.8 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.533 174.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 16.9 mt -109.72 135.34 50.81 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.032 0.444 . . . . 0.0 110.976 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.0 m -122.62 133.86 67.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.427 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.0 m -104.45 132.96 20.46 Favored Pre-proline 0 N--CA 1.432 -1.367 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -65.56 147.33 86.42 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.173 1.915 . . . . 0.0 111.656 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -70.64 84.62 0.63 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -138.99 172.78 12.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.835 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 74.98 -171.07 0.1 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.523 0.729 . . . . 0.0 111.189 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -85.36 130.74 34.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.496 -177.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -156.47 17.61 0.43 Allowed Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.159 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -70.05 139.98 52.73 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.809 0.337 . . . . 0.0 110.986 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -138.42 -83.22 0.3 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.734 177.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -156.96 152.05 26.19 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.591 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -134.58 158.46 43.94 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.315 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -93.61 -10.98 32.8 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.628 -177.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 27.3 p-80 . . . . . 0 C--O 1.241 0.608 0 CA-C-O 118.481 -0.771 . . . . 0.0 110.758 179.181 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.8 pttt . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.1 t -91.04 125.57 43.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 67.8 mt -105.65 93.84 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -86.82 124.32 32.93 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.039 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 80.9 mt -90.65 122.85 42.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.121 0.486 . . . . 0.0 110.396 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.472 ' HG2' ' CE1' ' A' ' 32' ' ' PHE . 4.2 mptp? -85.01 148.98 25.9 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.624 -175.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -110.85 118.05 35.08 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.955 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.3 mm -96.18 97.9 7.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 175.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 62.8 tttp -81.15 134.97 35.72 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.89 -177.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 67.3 mt -129.33 171.44 12.49 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.384 -175.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.9 p -144.2 149.98 37.26 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.58 -40.54 89.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -88.06 67.25 8.86 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.0 tt -117.6 152.69 19.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.35 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.403 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -84.94 154.69 22.03 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.231 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -63.49 -37.41 87.2 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.844 0.354 . . . . 0.0 111.098 -178.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -60.33 -42.64 96.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.272 0.558 . . . . 0.0 110.052 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.49 -40.52 97.3 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.004 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.619 ' O ' HG23 ' A' ' 26' ' ' VAL . 72.0 mt -61.41 -48.69 87.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -61.05 -47.6 85.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.377 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -62.44 -48.84 77.89 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.689 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -65.66 -42.47 91.32 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -177.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 22' ' ' ILE . 60.5 t -64.69 -43.74 96.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.138 0.494 . . . . 0.0 110.079 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.2 -42.21 99.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.112 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -66.69 -36.41 82.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.696 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.38 -34.49 73.98 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.801 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.452 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 96.7 mt -61.41 -38.2 86.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.523 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.463 ' HA ' ' OE1' ' A' ' 34' ' ' GLU . 41.5 mt-10 -61.75 -37.05 82.85 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.068 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.472 ' CE1' ' HG2' ' A' ' 9' ' ' LYS . 93.1 m-85 -69.26 -35.95 76.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.058 0.456 . . . . 0.0 110.579 177.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 90' ' ' PRO . 87.9 mt -62.86 -41.16 99.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.416 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.463 ' OE1' ' HA ' ' A' ' 31' ' ' GLU . 46.8 mt-10 -53.07 -32.89 49.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.404 177.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -78.16 -8.89 58.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.557 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.5 10.43 61.96 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.46 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -94.44 -176.47 3.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.958 0.409 . . . . 0.0 110.158 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -116.31 154.31 30.41 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.012 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.474 ' O ' HD12 ' A' ' 87' ' ' LEU . 25.6 t -118.51 125.33 74.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -103.24 112.32 25.14 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.261 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -84.07 128.29 34.46 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.341 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 9.1 mmm180 -131.33 107.69 9.13 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.225 -175.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.565 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 9.7 p -108.77 132.98 55.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 120.921 0.391 . . . . 0.0 110.568 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -106.99 134.0 50.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.243 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.404 ' CD1' ' HA ' ' A' ' 50' ' ' MET . 30.2 mt -94.58 115.02 27.07 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -106.86 -64.7 1.15 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -171.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.559 ' O ' ' HG3' ' A' ' 49' ' ' GLU . . . -82.74 88.2 1.47 Allowed Glycine 0 CA--C 1.49 -1.485 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -178.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 61.22 -111.4 0.45 Allowed 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -171.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.559 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 89.4 mt-10 63.21 -42.98 0.21 Allowed 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 173.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.404 ' HA ' ' CD1' ' A' ' 45' ' ' LEU . 42.9 ttm -63.28 -20.13 65.2 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.046 0.539 . . . . 0.0 111.866 -177.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.26 -30.43 71.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.168 0.509 . . . . 0.0 109.726 175.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 p -126.71 92.61 44.45 Favored Pre-proline 0 N--CA 1.452 -0.334 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.225 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -62.84 -20.51 71.46 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 123.6 2.867 . . . . 0.0 112.552 -176.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.05 -23.72 65.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.418 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.14 -41.05 91.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.017 0.437 . . . . 0.0 110.402 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.45 -39.61 91.34 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.7 t -64.73 -44.4 96.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.603 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.85 -39.77 86.29 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.252 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.4 tp -62.53 -46.49 88.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.165 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.434 HD13 ' HB2' ' A' ' 86' ' ' MET . 94.3 mt -65.53 -40.46 92.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.298 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -58.12 -39.96 80.01 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.356 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -61.96 -43.62 98.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.418 0.627 . . . . 0.0 110.345 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.2 mt -65.36 -43.57 94.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.913 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.2 t-105 -58.34 -39.47 79.55 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.807 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.439 ' HA ' ' OE2' ' A' ' 68' ' ' GLU . 19.5 m -57.75 -38.23 75.02 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.3 0.571 . . . . 0.0 110.583 178.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 78.3 mtm -77.1 -34.2 56.83 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.9 pt -98.41 -12.01 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 113.493 0.924 . . . . 0.0 113.493 -174.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.439 ' OE2' ' HA ' ' A' ' 65' ' ' THR . 14.1 pt-20 -59.83 -23.85 63.7 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -175.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -65.29 -30.98 71.89 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -127.09 3.27 6.47 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -128.68 153.79 46.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.144 0.497 . . . . 0.0 111.56 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.488 ' OD1' ' HG2' ' A' ' 91' ' ' LYS . 75.8 m-20 -111.85 149.33 31.96 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -89.01 106.56 18.51 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-O 121.025 0.44 . . . . 0.0 110.821 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -75.9 -41.05 53.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.421 0.629 . . . . 0.0 110.715 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -137.27 150.03 47.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.061 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -85.31 154.8 60.08 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 29.1 Cg_endo -63.4 115.29 2.93 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.76 1.64 . . . . 0.0 110.961 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -136.1 144.56 45.19 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.336 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -81.91 109.83 16.63 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.562 ' HB3' HD21 ' A' ' 85' ' ' ASN . 73.4 tt0 -148.71 123.43 9.87 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.808 -176.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 82' ' ' ARG . . . 75.52 28.53 61.31 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.315 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 81' ' ' GLY . 88.0 mtm180 72.28 3.18 4.6 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.357 0.663 . . . . 0.0 111.339 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -119.87 145.46 46.65 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.054 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.565 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 92.0 t -95.35 112.27 27.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 172.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.562 HD21 ' HB3' ' A' ' 80' ' ' GLU . 9.5 p30 -116.48 148.97 40.27 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -172.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.434 ' HB2' HD13 ' A' ' 60' ' ' LEU . 66.0 ttp -141.85 136.74 30.86 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.31 175.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.474 HD12 ' O ' ' A' ' 39' ' ' VAL . 44.7 tp -118.82 140.15 50.43 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.904 0.383 . . . . 0.0 110.59 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.8 m -130.26 161.72 39.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.229 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.2 m -137.28 138.94 26.45 Favored Pre-proline 0 C--N 1.309 -1.178 0 CA-C-N 115.46 -0.791 . . . . 0.0 108.985 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.519 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 92.8 Cg_endo -68.41 142.87 55.85 Favored 'Trans proline' 0 C--N 1.329 -0.48 0 C-N-CA 122.242 1.961 . . . . 0.0 110.15 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.488 ' HG2' ' OD1' ' A' ' 72' ' ' ASN . 69.0 mttm -64.86 124.01 20.89 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.605 -177.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt 61.11 80.54 0.21 Allowed 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.739 0.649 . . . . 0.0 111.452 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.92 -41.68 13.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.391 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -66.47 -44.82 81.64 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.006 0.431 . . . . 0.0 111.008 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.76 66.14 2.62 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.845 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -63.15 -36.05 82.33 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.19 0.519 . . . . 0.0 109.757 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -109.51 129.05 55.59 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -76.94 107.61 9.4 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.852 0.358 . . . . 0.0 110.346 -178.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -67.73 116.9 8.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.568 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -94.62 -16.05 23.51 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.285 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.3 t60 . . . . . 0 C--O 1.247 0.922 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.281 -177.821 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.7 mttt . . . . . 0 CA--C 1.511 -0.54 0 CA-C-O 121.899 0.857 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.3 t -86.45 97.53 6.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.901 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.4 mm -83.07 136.4 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.418 ' CG ' ' HZ1' ' A' ' 9' ' ' LYS . 13.6 t0 -77.18 114.57 16.13 Favored 'General case' 0 C--O 1.212 -0.919 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.693 -177.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 74.4 mt -121.3 133.63 67.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.05 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.48 ' N ' ' HE2' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -80.26 147.76 31.07 Favored 'General case' 0 CA--C 1.485 -1.541 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.304 -177.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -133.78 112.21 11.16 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.661 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.9 mt -107.72 114.15 45.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.389 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 86.7 tttt -86.52 131.13 34.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 122.157 0.98 . . . . 0.0 112.297 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.2 mt -129.55 179.58 5.73 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.404 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.425 ' HA ' HG23 ' A' ' 43' ' ' VAL . 42.4 p -149.6 156.91 42.7 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.0 t -69.85 -17.71 21.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 121.529 0.68 . . . . 0.0 110.301 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -96.66 26.27 4.61 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.401 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.8 tt -88.72 138.89 18.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.255 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.76 145.57 48.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.927 177.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -56.43 -40.59 75.01 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -176.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -62.89 -36.0 81.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.754 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.57 -32.81 68.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.181 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.626 ' O ' HG23 ' A' ' 26' ' ' VAL . 62.5 mt -58.91 -46.9 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 109.614 -0.514 . . . . 0.0 109.614 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -57.48 -41.99 81.75 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 124.281 0.988 . . . . 0.0 110.573 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -62.99 -48.01 80.66 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.839 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -64.78 -43.36 93.46 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 120.568 0.223 . . . . 0.0 110.761 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 22' ' ' ILE . 50.0 t -63.55 -42.49 96.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.133 -178.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -57.22 -45.77 83.56 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.429 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -65.91 -37.13 85.28 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.601 177.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.71 -39.48 80.92 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.943 0.401 . . . . 0.0 109.971 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.493 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 98.2 mt -62.28 -41.35 98.41 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.211 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -63.32 -39.65 95.14 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.509 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -66.56 -35.18 79.6 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.183 0.516 . . . . 0.0 110.741 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.616 HD13 ' HB2' ' A' ' 71' ' ' ALA . 88.9 mt -62.56 -42.32 99.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.251 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 30' ' ' LEU . 86.9 mt-10 -56.7 -34.69 67.68 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.501 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -66.98 -19.82 65.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.598 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.77 35.54 6.11 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.306 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.482 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -124.52 164.92 18.75 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.304 0.573 . . . . 0.0 110.058 179.442 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.421 ' CD2' ' HA ' ' A' ' 89' ' ' THR . 16.2 m170 -97.81 137.5 36.58 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.961 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 68.5 t -104.48 118.97 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.697 175.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -95.37 110.48 22.5 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.44 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 94.0 m-85 -83.94 108.74 17.1 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.502 ' HA ' ' OD1' ' A' ' 85' ' ' ASN . 53.2 mtp85 -106.18 108.5 20.05 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.782 -177.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 84' ' ' VAL . 4.9 p -109.11 127.64 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-O 121.641 0.734 . . . . 0.0 111.161 -177.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -98.67 123.92 43.17 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.545 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 50' ' ' MET . 89.4 mt -72.53 -56.28 5.62 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -176.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.8 tttp 69.08 124.81 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.118 0.485 . . . . 0.0 112.099 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.29 -155.57 25.25 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.798 176.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -72.41 -14.66 61.75 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.718 0.294 . . . . 0.0 111.384 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -61.88 -20.1 63.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.392 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.483 ' HA ' HD12 ' A' ' 45' ' ' LEU . 94.7 mtp -67.92 -15.3 63.55 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.737 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.56 -11.41 59.17 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 120.946 0.403 . . . . 0.0 110.684 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.436 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 41.5 p -128.33 106.58 19.44 Favored Pre-proline 0 N--CA 1.442 -0.856 0 CA-C-O 121.481 0.658 . . . . 0.0 111.204 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 52' ' ' THR . 35.3 Cg_endo -68.56 -16.65 42.95 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 122.902 2.401 . . . . 0.0 111.876 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -58.87 -33.82 70.91 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.974 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.49 -41.86 90.84 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.103 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.444 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -68.01 -41.58 87.13 Favored Glycine 0 C--O 1.219 -0.815 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 177.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.07 -44.49 99.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 O-C-N 123.727 0.31 . . . . 0.0 111.182 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.91 -41.82 96.88 Favored 'General case' 0 C--O 1.257 1.467 0 C-N-CA 122.448 0.299 . . . . 0.0 111.312 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.0 tp -62.85 -44.07 97.12 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.202 0.525 . . . . 0.0 109.805 177.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.56 HD13 ' HB2' ' A' ' 86' ' ' MET . 90.9 mt -65.76 -40.45 92.07 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.621 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -60.24 -37.67 81.11 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.333 0.396 . . . . 0.0 110.967 178.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -62.68 -44.32 96.55 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.603 0.716 . . . . 0.0 109.241 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.56 HG23 HG22 ' A' ' 26' ' ' VAL . 61.9 mt -67.26 -43.23 88.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.719 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.555 ' CZ2' ' HB2' ' A' ' 73' ' ' ARG . 37.6 t-105 -56.73 -39.23 73.56 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.827 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.7 m -63.23 -23.92 67.64 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 123.485 0.491 . . . . 0.0 111.212 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 96.5 mtp -91.1 -30.4 16.76 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.7 pt -98.73 -9.74 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -175.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -15.38 47.65 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -79.52 -21.9 44.64 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.668 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -119.9 -13.12 9.08 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.743 0.306 . . . . 0.0 111.246 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.616 ' HB2' HD13 ' A' ' 33' ' ' LEU . . . -126.67 154.68 43.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.102 0.477 . . . . 0.0 112.137 -175.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.464 ' OD1' ' HB ' ' A' ' 89' ' ' THR . 7.0 p30 -116.73 135.77 53.5 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.821 176.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.555 ' HB2' ' CZ2' ' A' ' 64' ' ' TRP . 36.1 ttp180 -74.87 112.14 10.78 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.247 -176.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -71.89 -37.84 70.07 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -159.32 158.94 33.32 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.115 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -72.79 150.52 90.78 Favored Pre-proline 0 C--N 1.306 -1.284 0 C-N-CA 122.536 0.334 . . . . 0.0 110.736 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.35 134.69 65.85 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 122.685 2.257 . . . . 0.0 112.511 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -133.62 149.12 51.6 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.99 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -91.82 116.25 28.74 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.38 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -128.3 137.76 52.1 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.64 -109.94 3.08 Favored Glycine 0 N--CA 1.426 -2.019 0 C-N-CA 119.966 -1.111 . . . . 0.0 111.769 -178.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -127.81 17.76 6.79 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.371 0.605 . . . . 0.0 110.273 177.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -129.24 150.94 50.41 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.908 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 43' ' ' VAL . 87.2 t -104.06 113.2 40.35 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.87 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 171.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' ' 42' ' ' ARG . 88.2 m-20 -113.88 137.5 51.58 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.343 -173.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.56 ' HB2' HD13 ' A' ' 60' ' ' LEU . 64.5 ttp -122.02 129.67 52.63 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.926 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -103.0 122.25 44.22 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 m -119.52 148.74 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.514 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.464 ' HB ' ' OD1' ' A' ' 72' ' ' ASN . 35.8 m -117.33 136.77 23.56 Favored Pre-proline 0 C--N 1.295 -1.785 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.474 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 91.4 Cg_endo -71.07 156.59 59.55 Favored 'Trans proline' 0 C--N 1.329 -0.494 0 C-N-CA 122.871 2.381 . . . . 0.0 111.508 177.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -74.34 142.12 45.16 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.299 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 86.8 tttt 62.33 102.65 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 124.415 1.086 . . . . 0.0 112.055 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -167.26 -28.42 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.965 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 67.11 12.55 9.03 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.856 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.51 90.38 1.39 Allowed Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -132.64 171.44 13.84 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.749 0.309 . . . . 0.0 110.206 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -122.69 93.23 3.91 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.69 177.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -105.54 -53.58 2.63 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.652 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -74.14 -66.6 0.7 Allowed 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.511 0.507 . . . . 0.0 111.958 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 43.4 t60 67.8 -67.66 0.18 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.152 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 65.7 t60 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.824 -0.608 . . . . 0.0 110.577 -179.995 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 N--CA 1.45 -0.462 0 CA-C-O 121.015 0.436 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.2 p -143.25 134.83 23.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.853 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.8 pt -81.21 129.36 37.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.186 0.517 . . . . 0.0 110.92 178.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.423 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 35.4 t70 -84.91 101.56 12.43 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.318 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.442 HG12 ' HB2' ' A' ' 38' ' ' HIS . 77.0 mt -87.86 130.3 37.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.481 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -86.52 135.9 33.28 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.452 ' HG2' ' HB3' ' A' ' 40' ' ' ARG . 46.0 mt-10 -110.25 114.38 27.81 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.197 178.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.4 mt -107.14 109.27 27.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -101.51 126.7 48.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.222 -175.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.46 HD23 ' CD1' ' A' ' 17' ' ' ILE . 5.1 mp -116.69 -178.89 3.53 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.036 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.0 p -139.28 157.98 44.96 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.2 t -64.08 -36.66 77.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 175.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -83.21 65.64 8.35 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.695 174.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.46 ' CD1' HD23 ' A' ' 13' ' ' LEU . 18.1 tt -123.44 149.36 27.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.1 152.14 26.69 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.731 176.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -64.02 -34.82 78.86 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.182 0.515 . . . . 0.0 109.924 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -62.32 -40.34 96.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.155 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.612 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 20.8 t70 -65.42 -36.92 85.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.055 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.7 mt -61.51 -42.85 95.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -60.31 -42.72 96.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.596 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -63.81 -44.15 94.13 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.3 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 75.6 mmtt -63.97 -43.9 94.37 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -176.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.555 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 11.1 m -67.92 -28.91 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.606 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.89 -44.69 94.09 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.227 0.537 . . . . 0.0 109.626 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -75.2 -36.92 61.35 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.234 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.511 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -59.63 -37.56 78.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.021 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.636 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 94.0 mt -61.9 -41.29 97.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.192 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -59.74 -45.09 93.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.086 0.469 . . . . 0.0 111.303 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -66.37 -36.2 82.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.876 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.653 HD13 ' HB2' ' A' ' 71' ' ' ALA . 96.8 mt -63.11 -40.0 96.36 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.067 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.636 ' HG3' ' O ' ' A' ' 30' ' ' LEU . 60.4 mt-10 -59.48 -33.3 71.15 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.987 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -79.84 -5.35 55.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.011 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.45 18.4 62.32 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.713 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.423 ' HD2' ' O ' ' A' ' 7' ' ' ASP . 41.4 mmtm -92.85 153.66 18.71 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.338 0.589 . . . . 0.0 111.401 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.442 ' HB2' HG12 ' A' ' 8' ' ' ILE . 7.7 m80 -98.21 140.18 32.9 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.69 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 49.6 t -115.15 128.42 72.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.452 ' HB3' ' HG2' ' A' ' 10' ' ' GLU . 64.5 ttt180 -102.43 111.01 23.13 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -90.94 120.44 31.95 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.422 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 82.1 mtp180 -131.2 138.45 49.4 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.662 -177.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.542 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.4 p -129.48 135.93 60.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 121.144 0.497 . . . . 0.0 110.751 177.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -98.55 130.59 45.12 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.001 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.7 mt -95.5 125.09 39.87 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -102.43 128.31 49.08 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -172.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.98 -120.18 8.5 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.214 -0.903 . . . . 0.0 113.65 177.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 48' ' ' ARG . 61.2 mtt85 -76.48 -9.01 58.33 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 122.927 0.491 . . . . 0.0 111.696 -175.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -66.51 -23.23 66.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.999 0.428 . . . . 0.0 110.944 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 65.9 mtt -64.12 -19.51 65.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.92 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.41 -14.71 61.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.501 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -140.64 105.98 6.42 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 122.192 0.996 . . . . 0.0 111.331 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.27 -20.61 36.92 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.337 2.691 . . . . 0.0 113.773 -176.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.432 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -66.49 -20.51 66.06 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -177.044 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.93 99.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.117 0.484 . . . . 0.0 109.783 176.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.444 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -69.44 -37.82 79.43 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.43 176.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.0 t -62.62 -44.72 99.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.265 -0.468 . . . . 0.0 111.055 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.27 -40.8 95.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.541 ' O ' HG13 ' A' ' 63' ' ' ILE . 39.1 tp -62.25 -46.72 87.59 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.287 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.492 HD12 HG12 ' A' ' 84' ' ' VAL . 88.6 mt -65.29 -41.13 94.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.054 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -64.78 -35.39 80.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.954 0.407 . . . . 0.0 110.5 179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -63.03 -41.56 99.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.538 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 59' ' ' LEU . 63.1 mt -64.32 -43.99 97.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.138 176.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 53.4 t-105 -56.48 -42.32 78.07 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.158 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.7 p -64.37 -21.8 66.75 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.58 -0.448 . . . . 0.0 112.133 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 66.9 mtt -83.05 -31.69 27.24 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.5 pt -108.16 -4.7 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -54.45 -30.5 53.01 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -175.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.607 ' ND2' ' HG2' ' A' ' 70' ' ' GLU . 3.7 p-10 -72.83 -23.11 60.72 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.607 ' HG2' ' ND2' ' A' ' 69' ' ' ASN . 61.1 mm-40 -112.25 -19.96 12.04 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.079 0.466 . . . . 0.0 110.845 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.653 ' HB2' HD13 ' A' ' 33' ' ' LEU . . . -117.76 150.64 38.77 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.551 -176.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -112.51 137.86 50.12 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 175.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -76.21 119.81 20.64 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.076 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -85.33 -38.81 18.38 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.014 0.435 . . . . 0.0 110.607 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -148.03 156.08 42.23 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.269 -177.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -77.4 155.0 81.86 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.935 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 23.2 Cg_endo -61.76 138.49 74.89 Favored 'Trans proline' 0 C--O 1.24 0.617 0 C-N-CA 122.095 1.863 . . . . 0.0 111.446 176.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 27.4 p-10 -145.21 167.24 23.27 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.244 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.583 ' CZ ' ' HA ' ' A' ' 82' ' ' ARG . 89.8 t80 -107.84 111.07 23.02 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.112 0.482 . . . . 0.0 110.486 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -138.58 126.06 21.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.399 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.67 34.42 88.87 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.841 177.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.583 ' HA ' ' CZ ' ' A' ' 79' ' ' PHE . 89.2 mtt180 70.74 11.3 7.18 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -120.58 145.54 47.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.401 175.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.542 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 92.7 t -99.27 114.16 36.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 173.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.547 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 80.8 m-20 -110.25 147.58 33.54 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.987 0.422 . . . . 0.0 112.093 -173.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.676 ' SD ' HG13 ' A' ' 88' ' ' VAL . 17.8 tmm? -145.48 130.55 18.38 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -112.32 130.95 55.78 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.128 0.489 . . . . 0.0 111.206 -175.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.676 HG13 ' SD ' ' A' ' 86' ' ' MET . 15.2 m -119.81 135.91 58.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.496 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.409 HG23 ' CE1' ' A' ' 38' ' ' HIS . 37.9 m -105.84 133.51 20.17 Favored Pre-proline 0 N--CA 1.431 -1.4 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 176.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.04 151.01 84.96 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.185 1.924 . . . . 0.0 110.189 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.27 92.01 0.4 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.123 0.487 . . . . 0.0 110.764 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -145.22 136.33 24.85 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.378 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.64 113.29 24.73 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.69 0.281 . . . . 0.0 110.487 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -164.94 153.71 12.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.05 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 119.79 136.51 5.26 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.668 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -91.22 65.58 5.47 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.562 0.696 . . . . 0.0 110.423 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -142.46 137.85 30.61 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.82 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -132.47 153.61 50.71 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 177.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -113.91 4.8 15.96 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.768 0.318 . . . . 0.0 111.588 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -154.86 -53.11 0.09 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.276 -178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.429 -0.796 . . . . 0.0 111.091 -178.572 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 120.657 0.265 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.5 t -67.05 -43.26 89.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.512 0.672 . . . . 0.0 111.46 -178.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 80.5 mt -102.91 126.58 57.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.806 -177.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.591 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 7.5 m-20 -78.16 113.29 15.98 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.755 178.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 88.3 mt -103.99 115.01 45.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.198 0.523 . . . . 0.0 109.599 176.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.422 ' HG2' ' CE1' ' A' ' 32' ' ' PHE . 4.0 mptp? -81.99 143.34 31.66 Favored 'General case' 0 CA--C 1.489 -1.367 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.202 -177.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -109.59 126.93 54.13 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.522 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.481 HG23 ' HD2' ' A' ' 25' ' ' LYS . 31.8 mm -100.54 107.22 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.197 178.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 2.1 mptt -80.47 139.94 36.17 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.651 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 60.7 mt -133.67 164.79 26.42 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.624 -177.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 63.5 m -141.46 151.46 43.4 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.6 t -61.03 -42.19 92.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -81.99 62.95 6.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.635 176.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.5 tt -115.68 151.07 17.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.856 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.11 150.82 21.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.339 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -62.76 -34.31 76.96 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.924 0.392 . . . . 0.0 110.899 -178.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -62.46 -41.26 98.64 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -66.63 -35.73 80.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.76 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.417 HG23 HG12 ' A' ' 63' ' ' ILE . 94.1 mt -61.49 -42.71 94.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.261 0.553 . . . . 0.0 109.563 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -60.46 -44.33 95.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.222 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -63.44 -44.31 94.89 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.069 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.481 ' HD2' HG23 ' A' ' 11' ' ' ILE . 49.7 mmtm -63.26 -45.39 91.72 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.531 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 17.3 m -67.09 -36.61 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.621 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -60.54 -47.09 87.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.203 0.525 . . . . 0.0 110.099 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -68.29 -39.25 82.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.579 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.96 -36.22 80.79 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.842 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.616 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 88.6 mt -60.71 -40.26 91.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.086 -178.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.584 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 62.7 mt-10 -61.21 -41.73 97.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.839 -177.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.422 ' CE1' ' HG2' ' A' ' 9' ' ' LYS . 93.4 m-85 -63.6 -37.76 88.55 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.192 0.52 . . . . 0.0 110.35 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 90' ' ' PRO . 97.2 mt -63.62 -42.22 98.22 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.567 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.616 ' HG3' ' O ' ' A' ' 30' ' ' LEU . 40.3 mt-10 -61.84 -21.37 64.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.309 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 31' ' ' GLU . 73.3 mm-40 -84.52 -6.6 59.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.799 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.3 15.16 59.21 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.627 -177.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.591 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 63.8 mttp -105.11 177.21 4.92 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 120.978 0.418 . . . . 0.0 110.512 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -112.84 158.78 19.74 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.843 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.6 t -113.42 130.24 67.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -98.8 102.41 14.13 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.696 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 69.3 m-85 -85.91 117.37 24.72 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 120.594 -0.442 . . . . 0.0 109.959 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 82.6 mtp180 -125.94 110.42 13.59 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.243 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.569 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.8 p -107.13 128.42 62.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-O 121.234 0.54 . . . . 0.0 110.955 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.411 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 83.8 t80 -95.55 132.4 40.71 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.033 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.0 mt -81.26 83.11 6.94 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.223 0.535 . . . . 0.0 110.355 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -76.54 131.18 38.81 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.143 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.66 -140.82 16.52 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.475 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -105.75 -2.49 23.17 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.393 0.616 . . . . 0.0 109.92 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -74.04 -2.46 24.37 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.298 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.498 ' SD ' ' HD2' ' A' ' 82' ' ' ARG . 56.6 ttm -61.6 -22.18 65.0 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 122.52 0.328 . . . . 0.0 111.801 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.34 -13.66 60.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.938 0.399 . . . . 0.0 111.124 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.3 p -123.14 103.56 36.04 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.256 0.551 . . . . 0.0 111.482 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.75 -18.25 47.6 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.2 2.6 . . . . 0.0 112.548 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -63.52 -29.19 70.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.041 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.93 -43.62 86.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.03 0.443 . . . . 0.0 110.606 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.406 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -66.16 -41.52 94.87 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.862 177.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.09 -44.64 97.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.739 0.304 . . . . 0.0 110.639 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.0 -41.08 97.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.887 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.44 HD23 HG21 ' A' ' 43' ' ' VAL . 42.6 tp -62.8 -45.28 93.38 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.212 0.529 . . . . 0.0 110.19 177.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.495 HD13 ' HB2' ' A' ' 86' ' ' MET . 98.0 mt -64.03 -40.16 95.7 Favored 'General case' 0 C--O 1.212 -0.876 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.812 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -58.19 -41.89 84.95 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.719 0.295 . . . . 0.0 111.156 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -63.96 -46.34 85.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.462 0.648 . . . . 0.0 109.738 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.466 ' CD1' HD13 ' A' ' 13' ' ' LEU . 96.3 mt -65.06 -42.67 95.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.171 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.526 ' CZ2' ' HB2' ' A' ' 73' ' ' ARG . 28.1 t-105 -56.45 -40.19 74.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.78 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 23.2 m -61.13 -34.2 74.61 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.269 0.557 . . . . 0.0 110.736 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 98.2 mmm -69.33 -39.25 78.31 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.261 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.9 pt -97.49 -10.06 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -174.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -58.06 -14.93 7.61 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -177.499 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -61.67 -41.95 98.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.902 0.382 . . . . 0.0 110.218 178.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -126.52 14.94 7.65 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.902 -175.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -134.73 144.68 47.87 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.329 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -113.41 142.12 46.27 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 175.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.526 ' HB2' ' CZ2' ' A' ' 64' ' ' TRP . 53.7 ttp180 -95.47 114.55 26.33 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.642 -177.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -65.51 -41.15 93.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.86 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -155.73 160.45 40.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.934 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.434 ' CD ' ' H ' ' A' ' 76' ' ' GLU . 22.9 mp0 -69.11 161.28 74.0 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 123.346 0.404 . . . . 0.0 110.054 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.413 ' HB3' HD12 ' A' ' 60' ' ' LEU . 38.0 Cg_exo -60.61 146.05 97.76 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.544 2.163 . . . . 0.0 112.306 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -138.41 137.83 37.63 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.592 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -89.59 125.35 35.19 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.703 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -142.32 125.42 16.31 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.29 -109.25 2.8 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.498 ' HD2' ' SD ' ' A' ' 50' ' ' MET . 29.0 mmt180 -125.42 12.81 8.16 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.12 0.486 . . . . 0.0 110.627 176.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.411 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 95.5 m-85 -119.85 151.32 39.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.339 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.569 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 76.5 t -108.94 122.25 63.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 171.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 87.5 m-20 -112.49 143.04 44.3 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -171.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.495 ' HB2' HD13 ' A' ' 60' ' ' LEU . 62.5 ttp -138.5 126.89 23.09 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.192 175.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -104.04 126.35 51.09 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.1 m -117.77 140.34 41.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.227 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.3 m -107.0 138.84 19.93 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.422 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 55.6 Cg_endo -64.23 140.3 70.34 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 122.115 1.876 . . . . 0.0 111.978 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -85.83 96.43 9.76 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 176.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -68.66 122.65 18.96 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.272 0.558 . . . . 0.0 111.524 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.29 -4.14 58.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.448 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -63.37 -41.39 98.82 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.602 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 146.76 154.69 6.27 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.323 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -101.47 14.96 30.39 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.388 0.613 . . . . 0.0 109.602 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -148.72 161.81 41.03 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.64 -177.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -152.85 143.64 22.86 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -165.1 155.13 13.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.251 -0.432 . . . . 0.0 109.89 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -125.81 -63.52 1.12 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.5 m80 . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.415 177.939 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 CA--C 1.52 -0.188 0 CA-C-O 121.536 0.684 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.1 p -102.24 12.93 6.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 122.319 1.057 . . . . 0.0 109.172 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.417 HG23 ' HG2' ' A' ' 37' ' ' LYS . 83.1 mt -90.93 114.73 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 CA-C-N 114.728 -1.123 . . . . 0.0 109.739 -177.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.5 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 34.6 t70 -76.69 115.23 16.27 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.887 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 82.9 mt -88.84 129.68 39.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.148 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.499 ' HG3' ' CD1' ' A' ' 32' ' ' PHE . 73.6 mmtt -85.43 135.82 33.7 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.657 -177.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -107.6 107.83 18.84 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.086 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.9 mm -92.43 106.62 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 65.2 tttp -84.02 133.64 34.66 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.888 -178.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.465 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 66.0 mt -125.17 169.49 12.16 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.733 -177.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.457 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 40.0 m -140.78 150.66 43.64 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -59.96 -43.73 93.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.273 0.558 . . . . 0.0 109.586 174.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -78.77 62.26 3.23 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 121.743 0.782 . . . . 0.0 110.311 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.539 HG21 HD11 ' A' ' 59' ' ' LEU . 18.8 tt -111.21 161.21 9.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.836 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.599 -178.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.35 150.22 22.82 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.239 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -66.69 -38.47 86.85 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.645 -177.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -67.7 -33.26 74.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.906 0.384 . . . . 0.0 110.231 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -64.2 -38.1 89.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.835 177.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.688 HG23 HG12 ' A' ' 63' ' ' ILE . 92.5 mt -62.88 -43.64 99.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.568 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -61.38 -42.62 99.01 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.784 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -62.36 -47.4 84.36 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.987 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -65.72 -40.67 92.43 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -178.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 22' ' ' ILE . 2.3 m -64.09 -35.54 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.535 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -61.76 -41.54 97.81 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.416 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 7.0 m80 -67.98 -41.74 81.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.095 176.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.54 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -59.58 -37.53 78.74 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.703 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.534 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 94.1 mt -61.8 -39.35 91.4 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.519 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.544 ' HA ' ' OE1' ' A' ' 34' ' ' GLU . 46.0 mt-10 -65.16 -44.57 88.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.375 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.499 ' CD1' ' HG3' ' A' ' 9' ' ' LYS . 90.0 m-85 -65.68 -34.49 78.33 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.917 0.389 . . . . 0.0 111.15 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 93.7 mt -62.93 -39.65 95.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.736 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.544 ' OE1' ' HA ' ' A' ' 31' ' ' GLU . 45.3 mt-10 -51.36 -40.79 59.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.77 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -70.69 -4.82 25.54 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.94 20.65 49.37 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.562 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.55 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 63.5 mttm -101.07 177.04 5.06 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 120.997 0.427 . . . . 0.0 110.599 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.423 ' NE2' HG23 ' A' ' 89' ' ' THR . 15.0 m170 -112.69 155.59 24.22 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.921 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.9 t -116.07 127.96 73.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 173.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -102.63 109.8 21.53 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -88.49 112.37 22.89 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.337 -0.545 . . . . 0.0 109.708 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.705 ' HG2' ' OD1' ' A' ' 85' ' ' ASN . 76.4 mtp85 -115.78 120.39 39.14 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.634 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.551 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.6 p -121.07 129.69 75.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.232 0.539 . . . . 0.0 111.349 -178.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -95.49 130.68 42.23 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.0 mt -78.67 84.57 4.76 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.87 0.367 . . . . 0.0 111.043 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.415 ' HD3' ' N ' ' A' ' 47' ' ' GLY . 4.8 tmtt? -83.65 120.6 26.17 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.415 ' N ' ' HD3' ' A' ' 46' ' ' LYS . . . 131.86 -133.56 7.22 Favored Glycine 0 N--CA 1.433 -1.555 0 C-N-CA 120.216 -0.993 . . . . 0.0 112.106 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -124.59 10.43 8.46 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.484 0.659 . . . . 0.0 110.543 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -80.91 6.06 14.36 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.23 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 96.5 mtp -65.62 -30.38 71.09 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.055 0.455 . . . . 0.0 110.562 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.96 -26.92 66.39 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.723 178.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.5 m -143.39 116.91 6.03 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.148 0.499 . . . . 0.0 111.044 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.06 2.96 4.93 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 123.487 2.791 . . . . 0.0 113.269 -176.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -59.5 -36.05 75.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.8 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.96 -43.8 94.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.146 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.415 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -68.98 -43.32 73.68 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.315 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.4 t -63.39 -47.25 92.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-O 120.578 0.228 . . . . 0.0 111.069 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.06 -37.14 86.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.421 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.539 HD11 HG21 ' A' ' 17' ' ' ILE . 42.2 tp -61.2 -49.55 76.7 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.962 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.531 HD12 HG12 ' A' ' 84' ' ' VAL . 88.5 mt -65.22 -42.15 93.74 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.826 -177.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.413 ' HA ' ' HB3' ' A' ' 64' ' ' TRP . 42.5 mt-10 -67.83 -35.33 78.4 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -63.77 -42.71 97.74 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.501 0.667 . . . . 0.0 109.297 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.688 HG12 HG23 ' A' ' 22' ' ' ILE . 86.7 mt -64.4 -43.55 97.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.876 -1.057 . . . . 0.0 109.889 177.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.413 ' HB3' ' HA ' ' A' ' 61' ' ' GLU . 13.0 t-105 -57.29 -40.05 77.01 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.789 176.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.49 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 91.5 m -60.88 -29.43 69.55 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 121.102 0.477 . . . . 0.0 111.225 -178.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 67.6 mtt -72.5 -35.07 68.07 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.558 HD11 HG11 ' A' ' 88' ' ' VAL . 37.1 pt -102.37 -7.36 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -174.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 65' ' ' THR . 15.2 pt-20 -58.91 -16.02 15.62 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -177.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -70.67 -14.07 62.32 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.479 ' HA ' ' HD2' ' A' ' 91' ' ' LYS . 11.6 pt-20 -150.19 29.89 0.71 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.57 0.7 . . . . 0.0 110.259 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -147.23 153.27 39.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.723 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.47 ' OD1' ' HB ' ' A' ' 89' ' ' THR . 7.2 p30 -123.89 135.8 53.95 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -70.68 110.75 5.67 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.086 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -69.31 -43.24 74.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.211 0.529 . . . . 0.0 109.779 178.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -153.85 143.78 21.95 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.71 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -62.77 157.62 57.91 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.859 176.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 31.4 Cg_exo -59.45 142.42 98.95 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.156 1.904 . . . . 0.0 111.968 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -137.51 133.41 34.53 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.447 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -87.69 118.67 27.35 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.989 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -130.85 110.89 11.63 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.944 -178.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.14 -97.58 0.6 Allowed Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.629 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.34 8.11 5.97 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.859 0.361 . . . . 0.0 110.626 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.432 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 65.3 m-85 -119.8 141.87 49.11 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.448 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.551 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 97.2 t -103.8 118.22 50.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 172.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.705 ' OD1' ' HG2' ' A' ' 42' ' ' ARG . 35.0 m-80 -109.14 143.97 37.82 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -173.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -149.84 137.03 19.69 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.1 mt -112.92 134.32 54.48 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.558 HG11 HD11 ' A' ' 67' ' ' ILE . 14.6 m -117.22 133.72 63.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.58 176.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.485 ' CG2' ' HD2' ' A' ' 90' ' ' PRO . 14.6 m -109.27 143.89 28.64 Favored Pre-proline 0 C--N 1.302 -1.485 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 60.7 Cg_endo -65.46 152.99 80.23 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.989 1.793 . . . . 0.0 109.352 177.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.479 ' HD2' ' HA ' ' A' ' 70' ' ' GLU . 37.0 tttm -53.94 119.83 5.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.235 0.54 . . . . 0.0 111.105 -174.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -65.9 138.3 57.76 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.94 -175.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.23 110.31 10.63 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.488 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 73.79 130.99 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 O-C-N 124.057 0.848 . . . . 0.0 110.824 -177.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 133.3 -110.38 0.9 Allowed Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -77.72 90.34 4.01 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 177.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -65.62 -52.25 53.38 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.912 -178.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -144.34 178.32 8.01 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.699 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 54.0 p-80 -130.9 132.38 45.09 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.652 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -66.17 -46.39 77.54 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.1 t60 . . . . . 0 C--O 1.243 0.762 0 CA-C-O 118.707 -0.664 . . . . 0.0 109.929 -179.705 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt . . . . . 0 CA--C 1.52 -0.174 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.6 t 72.74 94.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.992 -177.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.1 mm -106.05 124.1 61.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.416 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.407 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 21.9 t0 -80.05 117.43 20.87 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.007 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 90.4 mt -118.71 133.4 65.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.718 -176.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.461 ' HB2' HG22 ' A' ' 39' ' ' VAL . 68.1 mmtt -84.12 121.81 27.96 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.607 0.718 . . . . 0.0 111.21 -175.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.47 ' OE1' ' HD3' ' A' ' 42' ' ' ARG . 47.9 mm-40 -93.47 105.53 17.58 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.12 -178.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.6 mt -108.29 110.82 33.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.385 0.612 . . . . 0.0 110.297 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 87.6 tttt -101.16 130.23 47.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.197 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.587 HD21 ' HG3' ' A' ' 25' ' ' LYS . 82.1 mt -129.23 -177.29 4.18 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.431 -178.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 p -137.53 158.22 44.86 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.726 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.401 ' HB ' ' OE1' ' A' ' 49' ' ' GLU . 72.4 t -64.19 -41.91 93.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.645 0.736 . . . . 0.0 109.169 177.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -90.28 71.94 7.15 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.384 177.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.4 tt -124.19 146.42 29.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.901 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.9 143.04 52.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.315 177.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -64.89 -32.42 74.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.519 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -62.08 -39.18 91.55 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.224 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.492 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 9.5 t70 -65.41 -37.81 88.05 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.569 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.429 ' O ' HG22 ' A' ' 26' ' ' VAL . 93.4 mt -62.05 -42.58 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.081 0.467 . . . . 0.0 109.95 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -59.52 -41.59 90.32 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.533 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -63.29 -43.33 98.19 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.574 177.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.587 ' HG3' HD21 ' A' ' 13' ' ' LEU . 75.5 mmtt -65.23 -44.74 87.26 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 22' ' ' ILE . 2.5 m -64.51 -34.44 69.63 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.653 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -60.32 -44.37 95.53 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 176.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.417 ' O ' ' HD2' ' A' ' 32' ' ' PHE . 11.2 m170 -64.5 -42.44 95.84 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.837 177.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.557 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -55.13 -48.62 73.39 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.661 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.62 -41.88 99.26 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.795 0.331 . . . . 0.0 111.099 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.5 -31.05 72.1 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.72 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.417 ' HD2' ' O ' ' A' ' 28' ' ' HIS . 82.4 m-85 -85.95 -31.7 21.96 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 121.059 -0.257 . . . . 0.0 111.483 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 86.9 mt -62.52 -44.97 95.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.96 0.41 . . . . 0.0 111.245 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -18.51 61.34 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.669 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -77.03 -13.63 59.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.887 0.375 . . . . 0.0 110.338 177.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.37 12.97 50.03 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.309 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.407 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 96.9 mttt -103.48 -179.56 3.99 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.107 0.48 . . . . 0.0 111.202 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -116.65 155.8 28.18 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.927 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.461 HG22 ' HB2' ' A' ' 9' ' ' LYS . 41.7 t -121.25 131.08 73.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 175.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.413 ' HG2' ' HG2' ' A' ' 42' ' ' ARG . 40.4 ttp180 -109.84 116.72 32.17 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 176.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -89.47 120.62 30.95 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.47 ' HD3' ' OE1' ' A' ' 10' ' ' GLU . 12.8 mtm180 -120.9 115.7 23.73 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -178.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.503 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 4.1 p -112.96 124.4 69.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.425 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.464 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 77.7 t80 -101.09 124.01 46.14 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.56 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' A' ' 50' ' ' MET . 34.2 mt -77.24 107.34 9.57 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -67.37 -78.84 0.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -171.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 49' ' ' GLU . . . -126.13 119.74 3.53 Favored Glycine 0 CA--C 1.499 -0.908 0 C-N-CA 119.853 -1.165 . . . . 0.0 112.666 -175.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 72.18 -21.34 0.23 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.764 0.826 . . . . 0.0 111.308 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.508 ' H ' ' C ' ' A' ' 47' ' ' GLY . 14.9 mt-10 -61.94 -32.98 73.44 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.981 0.912 . . . . 0.0 110.623 178.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.522 ' HA ' HD12 ' A' ' 45' ' ' LEU . 44.3 ttm -63.61 -19.08 64.56 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.128 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.33 -13.62 61.14 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.913 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.424 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 32.3 m -140.78 101.27 6.52 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 121.334 0.588 . . . . 0.0 110.787 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 52' ' ' THR . 39.7 Cg_endo -68.7 -16.55 42.17 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.421 2.747 . . . . 0.0 112.321 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -58.48 -34.11 70.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.646 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.66 94.89 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.475 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.459 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -64.45 -40.98 98.19 Favored Glycine 0 CA--C 1.504 -0.654 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.859 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.8 t -66.26 -44.19 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 120.664 0.268 . . . . 0.0 110.734 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.2 -40.69 90.94 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.958 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.7 tp -61.89 -47.85 83.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.654 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.534 HD12 HG12 ' A' ' 84' ' ' VAL . 87.3 mt -65.26 -41.74 93.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.742 -178.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -64.49 -36.93 85.79 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.973 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -61.62 -43.53 98.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.464 0.65 . . . . 0.0 109.255 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.85 -44.12 96.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.462 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.419 ' CE3' HG13 ' A' ' 67' ' ' ILE . 50.8 t-105 -59.61 -35.84 75.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.377 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.6 m -60.3 -24.57 65.09 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.085 0.469 . . . . 0.0 110.85 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 92.6 mtp -91.55 -28.25 17.68 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.148 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.59 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 32.8 pt -111.27 16.07 8.11 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -176.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -21.21 66.52 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.426 0.631 . . . . 0.0 111.08 178.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.421 ' O ' ' HG2' ' A' ' 70' ' ' GLU . 3.2 p30 -73.93 134.97 43.24 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.093 178.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 69' ' ' ASN . 10.0 pt-20 54.57 5.9 0.1 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.811 1.244 . . . . 0.0 113.295 -176.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 67' ' ' ILE . . . -124.02 161.55 25.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.813 0.339 . . . . 0.0 110.691 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -140.14 150.46 44.28 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -83.36 122.35 28.35 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 118.655 -1.218 . . . . 0.0 109.711 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.512 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 16.5 t70 -81.44 -15.85 53.82 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.406 0.622 . . . . 0.0 109.421 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -159.97 156.39 27.04 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.075 -175.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -93.68 151.57 40.1 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 85' ' ' ASN . 14.8 Cg_exo -63.81 132.65 35.75 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.519 1.479 . . . . 0.0 110.689 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 58.3 t30 -148.43 149.41 31.66 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.133 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -91.83 111.73 23.37 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -152.22 129.49 11.26 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.68 -178.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.26 25.57 74.15 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.448 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.462 ' HD2' ' SD ' ' A' ' 50' ' ' MET . 42.4 mmt180 70.13 8.36 6.63 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 123.883 0.873 . . . . 0.0 112.041 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.464 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 55.1 m-85 -117.74 144.55 45.19 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.273 176.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.534 HG12 HD12 ' A' ' 60' ' ' LEU . 91.1 t -98.65 110.57 26.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 171.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.55 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 9.6 p30 -111.44 146.01 37.97 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -172.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 63.8 ttp -145.08 138.01 26.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.252 175.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 17.0 mt -110.61 135.35 51.37 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 120.785 0.326 . . . . 0.0 111.483 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.407 ' CG2' ' HB ' ' A' ' 39' ' ' VAL . 14.2 m -120.05 132.95 68.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 121.337 0.589 . . . . 0.0 110.979 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.512 ' OG1' ' HB2' ' A' ' 74' ' ' ASP . 28.2 m -121.25 143.16 36.7 Favored Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.527 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 91.8 Cg_endo -71.84 154.95 58.63 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.926 1.751 . . . . 0.0 109.929 177.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -63.98 134.96 56.02 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.559 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -70.03 98.78 1.35 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.404 -175.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.96 -37.83 87.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.368 0.604 . . . . 0.0 109.531 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -116.15 132.81 56.55 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.617 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 85.43 81.33 1.1 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.436 -178.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -102.96 166.99 10.13 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.146 0.498 . . . . 0.0 110.993 -177.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -69.77 163.2 26.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.829 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -60.75 -77.26 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.608 0.242 . . . . 0.0 111.186 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -168.36 9.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.342 0.592 . . . . 0.0 109.845 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -90.53 -4.9 56.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.388 -176.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 . . . . . 0 C--O 1.243 0.757 0 O-C-N 123.803 0.689 . . . . 0.0 109.964 -176.716 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 N--CA 1.446 -0.67 0 CA-C-O 121.266 0.555 . . . . 0.0 111.368 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.26 76.34 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-O 122.082 0.944 . . . . 0.0 109.906 177.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 77.7 mt -113.91 107.68 23.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.998 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.566 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 27.1 t70 -103.17 107.38 18.17 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.788 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 90.4 mt -88.95 129.1 40.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 120.992 0.425 . . . . 0.0 110.638 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -91.23 140.6 29.64 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-O 121.789 0.804 . . . . 0.0 111.43 -176.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.548 ' OE2' ' HD2' ' A' ' 42' ' ' ARG . 45.2 mt-10 -118.61 109.76 16.53 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.037 177.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 88.4 mt -93.14 118.98 40.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.63 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 62.3 tttm -88.82 136.68 32.88 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.643 0.735 . . . . 0.0 112.164 -177.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 46.4 mt -130.39 169.9 14.88 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.875 -178.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.499 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 19.9 m -128.7 149.84 50.52 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.0 t -64.41 -43.83 97.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.433 0.635 . . . . 0.0 109.755 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.495 ' HE2' ' O ' ' A' ' 46' ' ' LYS . 40.6 mttm -95.19 67.75 3.04 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.499 ' HB ' ' O ' ' A' ' 14' ' ' SER . 18.8 tt -101.5 148.5 7.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.758 -174.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.83 144.85 54.16 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.175 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -63.89 -39.68 94.76 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.804 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -63.85 -38.96 93.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.741 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -62.7 -37.98 88.61 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.85 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.52 ' O ' HG23 ' A' ' 26' ' ' VAL . 79.9 mt -61.37 -48.84 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 120.954 0.406 . . . . 0.0 110.456 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -61.95 -44.63 96.35 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.603 -177.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -62.73 -50.05 72.64 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.982 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -67.86 -43.58 79.09 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 22' ' ' ILE . 60.0 t -64.54 -42.26 94.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.914 0.387 . . . . 0.0 110.074 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.48 -44.44 97.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.211 176.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -37.46 87.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.765 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.513 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -57.04 -32.82 66.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.078 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.612 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 95.2 mt -61.41 -41.51 97.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.75 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 60.6 mt-10 -65.98 -36.7 84.02 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.379 -178.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -66.79 -37.09 83.89 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.156 0.503 . . . . 0.0 110.19 177.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 29' ' ' ALA . 94.8 mt -62.67 -40.73 97.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.798 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.612 ' HG2' ' O ' ' A' ' 30' ' ' LEU . 51.8 mm-40 -59.3 -26.11 64.71 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.143 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 31' ' ' GLU . 74.0 mm-40 -77.39 -8.55 57.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.614 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.19 19.13 57.94 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.739 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.566 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 62.8 mttp -107.48 -178.3 3.59 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.337 0.589 . . . . 0.0 111.339 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.477 ' NE2' HG23 ' A' ' 89' ' ' THR . 7.2 m80 -113.35 146.22 39.8 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.386 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.8 t -114.78 127.59 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.386 175.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.486 ' HD2' ' OE2' ' A' ' 10' ' ' GLU . 42.4 ttm180 -111.61 113.03 25.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 177.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.621 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 93.3 m-85 -84.89 113.11 21.15 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.548 ' HD2' ' OE2' ' A' ' 10' ' ' GLU . 28.9 mtp180 -115.29 130.97 57.06 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.45 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 3.4 p -123.64 130.18 74.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-O 121.17 0.509 . . . . 0.0 110.626 -178.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.426 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 77.6 t80 -94.82 118.22 31.41 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.954 178.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.514 HD12 ' HA ' ' A' ' 50' ' ' MET . 35.1 mt -72.39 145.74 47.5 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.495 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 41.3 ttmt -142.4 118.0 10.37 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.924 -176.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.51 53.52 0.72 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.298 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 48' ' ' ARG . 41.0 ttm180 69.39 -0.82 2.41 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.781 0.433 . . . . 0.0 111.579 178.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.403 ' O ' HD13 ' A' ' 45' ' ' LEU . 38.0 mt-10 -70.63 1.45 5.24 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.514 ' HA ' HD12 ' A' ' 45' ' ' LEU . 1.5 mpt? -61.87 -34.51 76.13 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.135 0.493 . . . . 0.0 110.426 177.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.63 -8.19 55.6 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.111 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.1 m -124.23 92.08 48.69 Favored Pre-proline 0 N--CA 1.446 -0.645 0 CA-C-O 121.199 0.523 . . . . 0.0 111.063 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.406 ' O ' HG23 ' A' ' 57' ' ' VAL . 35.7 Cg_exo -64.5 -24.57 63.47 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.322 2.681 . . . . 0.0 111.529 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -56.76 -30.76 63.91 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.003 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.65 -38.79 82.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.027 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.16 -37.5 9.89 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.973 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 53' ' ' PRO . 63.5 t -63.85 -46.03 95.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.317 0.103 . . . . 0.0 111.141 -178.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.48 -37.47 87.43 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.031 0.443 . . . . 0.0 110.866 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.7 tp -62.01 -45.97 91.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.442 0.639 . . . . 0.0 109.759 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.517 HD13 ' HB2' ' A' ' 86' ' ' MET . 91.9 mt -67.2 -38.39 85.27 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.99 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -58.09 -39.9 79.74 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 121.074 -0.251 . . . . 0.0 110.606 177.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -60.63 -45.08 95.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.309 0.576 . . . . 0.0 109.76 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.25 -43.56 97.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.638 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -59.49 -37.49 78.41 Favored 'General case' 0 C--O 1.206 -1.201 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.991 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.2 m -61.34 -24.33 66.37 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.524 0.678 . . . . 0.0 110.69 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 97.0 mmm -84.11 -42.72 15.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.087 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.5 pt -105.23 8.08 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -173.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.91 -10.2 27.03 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -89.0 -53.35 4.63 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -96.02 -5.26 41.52 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -175.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -125.98 154.14 43.32 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.567 0.222 . . . . 0.0 110.483 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.58 ' OD1' ' HB ' ' A' ' 89' ' ' THR . 10.0 p30 -115.71 134.8 54.66 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.24 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -69.59 110.53 4.86 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.867 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.464 ' CB ' HD12 ' A' ' 87' ' ' LEU . 26.5 t70 -71.68 -46.46 58.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.197 0.522 . . . . 0.0 109.848 177.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -149.78 154.86 39.15 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.606 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.6 155.81 87.13 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.257 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -54.66 137.5 73.96 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.88 2.386 . . . . 0.0 112.56 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 49.7 t30 -128.44 150.07 50.29 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.409 -177.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -108.9 121.01 44.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.796 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -126.07 108.61 11.52 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.08 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.3 -78.91 0.31 Allowed Glycine 0 C--O 1.223 -0.544 0 C-N-CA 121.399 -0.429 . . . . 0.0 113.059 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.427 ' HD2' ' N ' ' A' ' 82' ' ' ARG . 0.6 OUTLIER -147.38 10.18 0.97 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.95 0.405 . . . . 0.0 110.605 178.1 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.426 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 89.2 m-85 -117.63 140.39 49.71 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.528 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.45 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 69.1 t -112.81 130.26 66.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 175.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.621 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 9.4 p30 -133.21 143.27 49.05 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -175.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.517 ' HB2' HD13 ' A' ' 60' ' ' LEU . 64.8 ttp -127.68 136.35 51.46 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.578 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.464 HD12 ' CB ' ' A' ' 74' ' ' ASP . 2.7 tm? -110.52 127.02 54.99 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.001 0.429 . . . . 0.0 109.853 -178.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.445 ' O ' ' HD2' ' A' ' 38' ' ' HIS . 19.1 m -120.1 134.27 64.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.138 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.58 ' HB ' ' OD1' ' A' ' 72' ' ' ASN . 21.1 m -102.0 136.21 19.53 Favored Pre-proline 0 C--N 1.31 -1.133 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.731 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.502 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 80.4 Cg_endo -68.83 144.16 58.11 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.714 2.276 . . . . 0.0 110.689 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -85.78 88.9 7.62 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.95 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -82.21 -46.56 13.58 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.867 177.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -167.08 79.53 0.2 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.59 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -94.28 144.15 25.77 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.045 0.45 . . . . 0.0 111.215 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.67 1.65 69.04 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -72.21 133.4 45.08 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.451 -0.374 . . . . 0.0 110.194 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -80.33 134.49 36.06 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.998 178.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -65.58 -67.5 0.44 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.914 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -163.61 73.18 0.3 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -104.67 163.45 12.47 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.197 -176.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 65.3 m80 . . . . . 0 C--N 1.312 -1.05 0 CA-C-O 118.635 -0.698 . . . . 0.0 110.23 -179.5 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.0 mtpt . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.8 t 66.53 151.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 O-C-N 123.514 0.509 . . . . 0.0 111.03 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.1 mm -80.95 97.22 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -73.37 122.2 21.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.717 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 88.7 mt -97.37 133.85 37.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.028 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -90.5 147.1 23.6 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.67 -175.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -125.83 132.16 52.29 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.693 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -120.54 112.12 34.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.403 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 40.3 ttmt -85.4 141.91 29.65 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.608 -176.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.5 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 36.6 mt -128.51 175.15 8.76 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.646 -175.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.8 p -149.93 153.69 37.05 Favored 'General case' 0 C--O 1.214 -0.815 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 176.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -70.22 -20.6 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-O 121.621 0.724 . . . . 0.0 110.321 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -89.05 15.76 8.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.714 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.4 tt -73.13 148.42 8.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.112 0.482 . . . . 0.0 111.362 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.97 152.53 21.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.186 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -63.49 -40.22 96.51 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -177.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -65.14 -29.67 70.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.029 0.443 . . . . 0.0 110.182 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -71.77 -38.85 70.29 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.328 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.54 -44.46 99.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -61.46 -41.66 97.58 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.331 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -65.51 -44.4 87.1 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.139 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -64.65 -41.81 95.86 Favored 'General case' 0 N--CA 1.461 0.088 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.0 m -62.95 -33.2 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.174 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -59.84 -48.27 82.36 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.879 0.371 . . . . 0.0 110.582 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -69.3 -37.05 77.63 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.462 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.487 ' O ' ' HG ' ' A' ' 33' ' ' LEU . . . -59.39 -42.16 91.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.578 HD22 ' HB2' ' A' ' 70' ' ' GLU . 93.3 mt -62.27 -41.39 98.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.497 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 46.9 mt-10 -65.53 -38.12 88.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.472 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -70.28 -38.05 74.96 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.041 175.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.49 ' HB3' ' HB3' ' A' ' 90' ' ' PRO . 85.4 mt -62.29 -45.26 94.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.905 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -64.01 -18.45 64.33 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.895 0.379 . . . . 0.0 111.641 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 80.3 mt-30 -80.25 1.01 30.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.613 177.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.3 32.62 25.06 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -119.57 157.33 28.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.934 0.397 . . . . 0.0 111.066 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.481 ' NE2' HG23 ' A' ' 89' ' ' THR . 13.0 m170 -101.61 148.03 25.71 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.398 177.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.6 t -118.65 130.04 74.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.054 0.454 . . . . 0.0 109.994 176.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -108.29 115.46 30.15 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.665 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 73.9 m-85 -90.39 121.93 32.81 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.448 ' HG2' ' HB3' ' A' ' 85' ' ' ASN . 85.1 mtp180 -125.82 121.11 32.35 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.628 ' CG1' ' HB ' ' A' ' 84' ' ' VAL . 4.2 p -112.94 131.58 64.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.24 0.543 . . . . 0.0 111.556 -176.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.409 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 84.3 t80 -93.75 121.25 35.0 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.748 177.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.5 mt -84.79 85.53 7.44 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.302 0.572 . . . . 0.0 109.969 -178.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -66.06 129.6 40.36 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.06 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.64 -148.32 16.64 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.108 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -95.0 8.2 43.67 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.985 0.422 . . . . 0.0 110.286 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -63.84 -18.5 64.2 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.682 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 67.1 mtt -65.02 -10.32 28.74 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.53 -27.32 68.37 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-O 121.118 0.485 . . . . 0.0 110.387 176.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.4 t -129.99 109.51 16.85 Favored Pre-proline 0 N--CA 1.44 -0.948 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.832 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -63.77 -19.77 67.62 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.225 2.616 . . . . 0.0 112.075 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -60.32 -29.75 69.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.588 -177.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.34 -44.82 92.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.11 0.481 . . . . 0.0 110.364 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.537 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -69.86 -39.16 75.87 Favored Glycine 0 CA--C 1.506 -0.519 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.835 178.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.499 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 59.5 t -63.39 -44.7 99.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.628 0.251 . . . . 0.0 110.722 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.63 -37.91 83.01 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.343 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.4 tp -62.04 -45.44 93.53 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.495 HD13 ' HB2' ' A' ' 86' ' ' MET . 93.4 mt -65.71 -39.19 90.96 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.161 179.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 57' ' ' VAL . 61.8 mm-40 -55.83 -44.84 78.33 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.571 177.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -65.8 -42.49 90.62 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.162 0.506 . . . . 0.0 110.944 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.6 mt -64.77 -42.39 94.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.289 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -55.04 -45.21 75.21 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.043 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.0 p -66.58 -19.93 65.89 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.736 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 96.8 mmm -75.41 -38.54 59.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.556 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.9 pt -104.47 -7.58 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -174.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -58.5 -16.75 16.65 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.063 0.458 . . . . 0.0 111.904 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -64.38 -41.16 96.83 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.678 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.578 ' HB2' HD22 ' A' ' 30' ' ' LEU . 40.9 mt-10 -124.3 14.44 8.97 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.245 0.545 . . . . 0.0 110.914 -178.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.65 142.27 37.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.646 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -114.98 145.4 42.29 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.995 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.0 ttt-85 -70.89 121.77 18.72 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.385 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.425 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 26.2 t70 -93.63 -42.45 9.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.361 0.601 . . . . 0.0 109.998 176.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -144.33 157.67 44.15 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.796 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -86.12 154.11 57.39 Favored Pre-proline 0 C--N 1.316 -0.848 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.38 132.07 48.83 Favored 'Trans proline' 0 C--O 1.24 0.593 0 C-N-CA 122.674 2.249 . . . . 0.0 112.388 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -129.42 131.37 46.75 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.742 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.432 ' HB2' HG22 ' A' ' 84' ' ' VAL . 83.8 t80 -98.61 109.16 21.96 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.983 177.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -152.53 139.11 18.7 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.268 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.35 31.49 68.64 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.948 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 69.47 10.25 7.61 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 122.997 0.519 . . . . 0.0 112.14 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' A' ' 44' ' ' PHE . 56.3 m-85 -126.12 144.02 50.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.746 178.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.628 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 91.7 t -102.28 122.89 55.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 173.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.665 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 7.0 p30 -129.75 146.69 51.5 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -173.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.495 ' HB2' HD13 ' A' ' 60' ' ' LEU . 64.0 ttp -139.85 143.78 36.93 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.848 178.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 16.1 mt -107.6 129.76 54.96 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.475 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.6 m -122.06 135.33 62.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.562 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.481 HG23 ' NE2' ' A' ' 38' ' ' HIS . 17.9 m -108.89 143.15 27.0 Favored Pre-proline 0 C--N 1.306 -1.292 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.202 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.49 ' HB3' ' HB3' ' A' ' 33' ' ' LEU . 46.7 Cg_endo -63.73 143.57 86.96 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.256 1.971 . . . . 0.0 111.179 178.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -80.34 66.91 6.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.354 0.597 . . . . 0.0 111.945 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 55.31 -89.78 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.509 -1.223 . . . . 0.0 112.982 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -152.41 38.05 0.55 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.747 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -74.59 152.24 39.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.164 0.507 . . . . 0.0 112.057 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.84 103.35 2.87 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.945 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -76.01 -54.18 7.25 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 49.8 p-80 -136.06 121.05 18.76 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.121 177.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -86.29 90.65 8.23 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.264 0.554 . . . . 0.0 110.316 -176.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.43 ' CE1' ' HA ' ' A' ' 101' ' ' HIS . 36.1 t-80 -165.69 122.26 1.39 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.481 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -92.65 -6.24 49.75 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.497 -177.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.43 ' HA ' ' CE1' ' A' ' 99' ' ' HIS . 37.6 t60 . . . . . 0 C--O 1.245 0.853 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.274 -179.413 . . . . . . . . 1 1 . 1 stop_ save_